Citrus Sinensis ID: 048055

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-
Protein Sequence
MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI
Secondary Structure (PSIPRED)
ccccccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEEcccccccHccccccEccccccEEEEEEcccccccHHHHHHccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccHHHHccccHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mtgtrtsgggkplhwtSCLKIAEDLASGLlyihqnpglthgnlkssnvllgadfescltdyglgsfrnpdsveepsatslfykapecreiwkqptqqadVYSFGVLLLELltgktpfqdlvlehgsdiprwvrsvreeetesgddppssneaSEEKLQALLNIAIACVslapenrpvMREVSKMIRDSRAEaqmssnssdhspgrwsdtvqslpreehlsi
Flexible Loop (DISEMBL)
mtgtrtsgggkplHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQdlvlehgsdiprwvRSVREEEtesgddppssneASEEKLQALLNIAIACvslapenrpvMREVSKMIRDSRAEAqmssnssdhspgrwsdtvqslpreehlsi
Low Complexity Region (SEG)
MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI
Disordered region (IsUnstruct)
************LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR**********TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWV*************************QALLNIAIACVSLA**************************************************
Disordered Region (DISOPRED)
MT*******G***HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF********SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK**************************************
Disordered Region (DISEMBL)
***********PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRS*******************EEKLQALLNIAIACVSLAPENRPVMREVSKMIRD**********************************
Disordered Region (DISPRO)
********GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR***********************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	221	2.2.26 [Sep-21-2011]
Q84MA9	652	Inactive leucine-rich rep	no	no	0.972	0.329	0.731	5e-87
Q93Y06	669	Probable inactive recepto	no	no	0.809	0.267	0.47	5e-40
O48788	658	Probable inactive recepto	no	no	0.823	0.276	0.455	8e-34
Q9LVM0	654	Probable inactive recepto	no	no	0.837	0.282	0.396	1e-29
Q9FMD7	625	Probable inactive recepto	no	no	0.846	0.299	0.414	3e-29
Q9M9C5	670	Probable leucine-rich rep	no	no	0.846	0.279	0.412	1e-28
Q9M8T0	627	Probable inactive recepto	no	no	0.773	0.272	0.406	1e-28
Q9FHK7	640	Probable leucine-rich rep	no	no	0.819	0.282	0.402	2e-28
Q9C9Y8	640	Probable inactive recepto	no	no	0.809	0.279	0.427	1e-27
Q9LVI6	647	Probable inactive recepto	no	no	0.809	0.276	0.417	2e-27

>sp|Q84MA9|Y1063_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630 OS=Arabidopsis thaliana GN=At1g60630 PE=2 SV=1

 Score =  320 bits (819), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 161/220 (73%), Positives = 183/220 (83%), Gaps = 5/220 (2%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
           G++ SG GKPLHWTSCLKIAEDLA GL+YIHQNPGLTHGNLKSSNVLLG DFESCLTDYG
Sbjct: 437 GSKVSGSGKPLHWTSCLKIAEDLAMGLVYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYG 496

Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
           L    +P S+E+ SA SLFYKAPECR++ K  TQ ADVYSFGVLLLELLTG+T F+DLV 
Sbjct: 497 LSDLHDPYSIEDTSAASLFYKAPECRDLRKASTQPADVYSFGVLLLELLTGRTSFKDLVH 556

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
           ++GSDI  WVR+VREEETE          ASEEKLQALL IA ACV++ PENRP MREV 
Sbjct: 557 KYGSDISTWVRAVREEETEV----SEELNASEEKLQALLTIATACVAVKPENRPAMREVL 612

Query: 183 KMIRDSRAEAQM-SSNSSDHSPGRWSDTVQSLPREEHLSI 221
           KM++D+RAEA + S NSSDHSPGRWSDT+QSLPRE+H+SI
Sbjct: 613 KMVKDARAEAALFSFNSSDHSPGRWSDTIQSLPREDHMSI 652

Arabidopsis thaliana (taxid: 3702)

>sp|Q93Y06|Y5720_ARATH Probable inactive receptor kinase At5g67200 OS=Arabidopsis thaliana GN=At5g67200 PE=1 SV=1

 Score =  164 bits (414), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 94/200 (47%), Positives = 120/200 (60%), Gaps = 21/200 (10%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDY 61
           G+R+S   KPLHWTSCLKIAED+A GL YIHQ +  L HGNLKS+N+LLG DFE+CLTDY
Sbjct: 482 GSRSSRA-KPLHWTSCLKIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDY 540

Query: 62  GLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKT----PF 117
            L    +  S       S  YKAPE R+  ++PT + DVYSFGVL+ ELLTGK     PF
Sbjct: 541 CLSVLTDSSSASPDDPDSSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPF 600

Query: 118 QDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV 177
              +  H  D+  WVR++REEE  + D+          +L  +   A  C   +PE RP 
Sbjct: 601 ---MAPH--DMLDWVRAMREEEEGTEDN----------RLGMMTETACLCRVTSPEQRPT 645

Query: 178 MREVSKMIRDSRAEAQMSSN 197
           MR+V KMI++ +       N
Sbjct: 646 MRQVIKMIQEIKESVMAEEN 665

Arabidopsis thaliana (taxid: 3702)

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  143 bits (361), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 86/189 (45%), Positives = 116/189 (61%), Gaps = 7/189 (3%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           + G+R SG   PL W + ++IA   A GL ++H +  L HGN+K+SN+LL  + ++C++D
Sbjct: 435 LHGSRGSGR-TPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSD 493

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL    +  S   P      Y APE  E  ++ T ++DVYSFGVLLLELLTGK+P Q  
Sbjct: 494 YGLNQLFSNSS---PPNRLAGYHAPEVLET-RKVTFKSDVYSFGVLLLELLTGKSPNQAS 549

Query: 121 VLEHGSDIPRWVRSVREEE--TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVM 178
           + E G D+PRWV SV  EE   E  D         EE++  LL IA+ACVS  P+ RPVM
Sbjct: 550 LGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVM 609

Query: 179 REVSKMIRD 187
           +EV +MI D
Sbjct: 610 QEVLRMIED 618

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  129 bits (324), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/194 (39%), Positives = 116/194 (59%), Gaps = 9/194 (4%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQ--NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           PL W S +KI    A G+ ++H    P  +HGN+KSSNV++  + ++C++D+GL      
Sbjct: 453 PLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLM-- 510

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
            +V         Y+APE  E  K  T ++DVYSFGVL+LE+LTGK+P Q    +   D+P
Sbjct: 511 -AVPIAPMRGAGYRAPEVMETRKH-THKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLP 568

Query: 130 RWVRSVREEE--TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
           RWV+SV  EE  +E  D      +  EE++  +L IA+ACV+  PE RP M +V +MI +
Sbjct: 569 RWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEE 628

Query: 188 SR-AEAQMSSNSSD 200
            R ++++ +  SSD
Sbjct: 629 IRVSDSETTRPSSD 642

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1

 Score =  128 bits (322), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/205 (41%), Positives = 120/205 (58%), Gaps = 18/205 (8%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLT-HGNLKSSNVLLGADFESCLTDYGLGSFR 67
           G  PL+W +   IA   A  + Y+H     T HGN+KSSN+LL   FE+ ++DY L    
Sbjct: 434 GRSPLNWETRANIALGAARAISYLHSRDATTSHGNIKSSNILLSESFEAKVSDYCLAPMI 493

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +P S   P+     Y+APE  +  K  +Q+ADVYSFGVL+LELLTGK+P    + E G D
Sbjct: 494 SPTST--PNRID-GYRAPEVTDARKI-SQKADVYSFGVLILELLTGKSPTHQQLHEEGVD 549

Query: 128 IPRWVRSVREEETESGD-DPPSSNEASE--EKLQALLNIAIACVSLAPENRPVMREVSKM 184
           +PRWV S+ E+++ S   DP  +   S+  E +  LLNI I+C +  P++RP M EV+++
Sbjct: 550 LPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRL 609

Query: 185 IRD-SRAEAQMSSNSSDHSPGRWSD 208
           I + SR+ A         SPG  SD
Sbjct: 610 IEEVSRSPA---------SPGPLSD 625

Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1

 Score =  126 bits (317), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/199 (41%), Positives = 115/199 (57%), Gaps = 12/199 (6%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIH---QNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           G  PL WT+ LKIA   A GL +IH   +   LTHG++KS+NVLL     + ++D+GL  
Sbjct: 455 GRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSI 514

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
           F    +V + +     Y+APE  +  ++ TQ++DVYSFGVLLLE+LTGK P        G
Sbjct: 515 FAPSQTVAKSNG----YRAPELID-GRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSG 569

Query: 126 S--DIPRWVRSVREEE--TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              D+PRWV+SV  EE   E  D      +  EE++  LL IA+AC ++A ++RP M  V
Sbjct: 570 GAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHV 629

Query: 182 SKMIRDSRAEAQMSSNSSD 200
            K+I D R     +S  +D
Sbjct: 630 VKLIEDIRGGGSEASPCND 648

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1

 Score =  126 bits (317), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/187 (40%), Positives = 113/187 (60%), Gaps = 16/187 (8%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLT-HGNLKSSNVLLGADFESCLTDYGLG--- 64
           G  PL+W +   IA   A  + Y+H   G T HGN+KSSN+LL   +E+ ++DYGL    
Sbjct: 436 GRTPLNWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAPII 495

Query: 65  -SFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
            S   P+ ++        Y+APE  +  ++ +Q+ADVYSFGVL+LELLTGK+P    + E
Sbjct: 496 SSTSAPNRIDG-------YRAPEITDA-RKISQKADVYSFGVLILELLTGKSPTHQQLNE 547

Query: 124 HGSDIPRWVRSVREEETESGD-DPPSSNEASE--EKLQALLNIAIACVSLAPENRPVMRE 180
            G D+PRWV+SV E++T S   DP  +    E  E +  LL I ++C +  P++RP M E
Sbjct: 548 EGVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAE 607

Query: 181 VSKMIRD 187
           V+++I +
Sbjct: 608 VTRLIEE 614

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  125 bits (315), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/194 (40%), Positives = 114/194 (58%), Gaps = 13/194 (6%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           M G R   G + + W + +KIA   +  + Y+H +    HG++KSSN+LL  D E CL+D
Sbjct: 432 MHGNR---GDRGVDWETRMKIATGTSKAISYLH-SLKFVHGDIKSSNILLTEDLEPCLSD 487

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
             L +  N   +   +  ++ Y APE  E  ++ +Q++DVYSFGV++LE+LTGKTP    
Sbjct: 488 TSLVTLFN---LPTHTPRTIGYNAPEVIET-RRVSQRSDVYSFGVVILEMLTGKTPLTQP 543

Query: 121 VLEHGS---DIPRWVRSVREEE--TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENR 175
            LE      D+PRWVRSV  EE   E  D      +  EE++  +L +A+ACV+  PE+R
Sbjct: 544 GLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESR 603

Query: 176 PVMREVSKMIRDSR 189
           P M EV++MI D R
Sbjct: 604 PKMEEVARMIEDVR 617

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  123 bits (309), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/187 (42%), Positives = 110/187 (58%), Gaps = 8/187 (4%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLGADFESCLTDYGLGS 65
           GG   L W + L+I  + A G+ +IH   G  L HGN+KS NVLL  +   C++D+G+  
Sbjct: 432 GGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAP 491

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
             +  ++  PS  SL Y+APE  E  K  TQ++DVYSFGVLLLE+LTGK   +    E  
Sbjct: 492 LMSHHTLI-PS-RSLGYRAPEAIETRKH-TQKSDVYSFGVLLLEMLTGKAAGKTTGHEEV 548

Query: 126 SDIPRWVRS-VREEETESGDDPP--SSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
            D+P+WV+S VREE T    D          EE++  +L IA+ACVS  P++RP M EV 
Sbjct: 549 VDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVV 608

Query: 183 KMIRDSR 189
            M+ + R
Sbjct: 609 NMMEEIR 615

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1

 Score =  122 bits (307), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/189 (41%), Positives = 111/189 (58%), Gaps = 10/189 (5%)

Query: 8   GGGKP-LHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           G G+P L+W     IA   A GL Y+H Q+P  +HGN+KSSN+LL    ++ ++D+GL  
Sbjct: 454 GAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNSHDARVSDFGLAQ 513

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
             +  S     AT   Y+APE  +  ++ +Q+ADVYSFGV+LLELLTGK P   ++ E G
Sbjct: 514 LVSASSTTPNRATG--YRAPEVTD-PRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEG 570

Query: 126 SDIPRWVRSVREEE--TESGDDPPSSNE---ASEEKLQALLNIAIACVSLAPENRPVMRE 180
            D+ RWV SV  EE   E  D    S E   + EE++  +L + I C    P+ RPVM E
Sbjct: 571 MDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVE 630

Query: 181 VSKMIRDSR 189
           V + I++ R
Sbjct: 631 VVRRIQELR 639

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	221
449449066	660	PREDICTED: inactive leucine-rich repeat	1.0	0.334	0.868	1e-109
449481332	765	PREDICTED: inactive leucine-rich repeat	1.0	0.288	0.868	1e-109
147864361	695	hypothetical protein VITISV_005661 [Viti	1.0	0.317	0.855	1e-109
359473670	662	PREDICTED: inactive leucine-rich repeat	0.990	0.330	0.858	1e-108
224099677	657	predicted protein [Populus trichocarpa]	1.0	0.336	0.855	1e-108
255555553	663	receptor-kinase, putative [Ricinus commu	1.0	0.333	0.859	1e-107
224111340	661	predicted protein [Populus trichocarpa]	1.0	0.334	0.850	1e-107
356544420	667	PREDICTED: inactive leucine-rich repeat	0.990	0.328	0.844	1e-106
356541016	653	PREDICTED: inactive leucine-rich repeat	0.990	0.335	0.840	1e-105
62319472	663	receptor-kinase isolog [Arabidopsis thal	0.990	0.330	0.804	2e-93

>gi|449449066|ref|XP_004142286.1| PREDICTED: inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630-like [Cucumis sativus]

 Score =  400 bits (1028), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 192/221 (86%), Positives = 206/221 (93%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           + G+RTSGGGKPLHWTSCLKIAEDLA+GLLYIHQNPG THGNLKSSNVLLG+DFESCLTD
Sbjct: 440 IHGSRTSGGGKPLHWTSCLKIAEDLANGLLYIHQNPGSTHGNLKSSNVLLGSDFESCLTD 499

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL  FR+PDS++EPSATSLFY+APECR+I K  TQQADVYSFGVLLLELLTGKTPFQDL
Sbjct: 500 YGLNLFRDPDSLDEPSATSLFYRAPECRDIRKPTTQQADVYSFGVLLLELLTGKTPFQDL 559

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           V EHGSDIP+WV SVREEETESGDDP S NEASEEKLQALLNIA+ACVSL P+NRP MRE
Sbjct: 560 VQEHGSDIPKWVSSVREEETESGDDPTSGNEASEEKLQALLNIAMACVSLMPQNRPTMRE 619

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           V KMIRD+RAEAQ+SSNSSDHSPGRWSD VQSLPREEHLSI
Sbjct: 620 VLKMIRDTRAEAQISSNSSDHSPGRWSDIVQSLPREEHLSI 660

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449481332|ref|XP_004156151.1| PREDICTED: inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630-like [Cucumis sativus]

 Score =  399 bits (1025), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 192/221 (86%), Positives = 206/221 (93%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           + G+RTSGGGKPLHWTSCLKIAEDLA+GLLYIHQNPG THGNLKSSNVLLG+DFESCLTD
Sbjct: 545 IHGSRTSGGGKPLHWTSCLKIAEDLANGLLYIHQNPGSTHGNLKSSNVLLGSDFESCLTD 604

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL  FR+PDS++EPSATSLFY+APECR+I K  TQQADVYSFGVLLLELLTGKTPFQDL
Sbjct: 605 YGLNLFRDPDSLDEPSATSLFYRAPECRDIRKPTTQQADVYSFGVLLLELLTGKTPFQDL 664

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           V EHGSDIP+WV SVREEETESGDDP S NEASEEKLQALLNIA+ACVSL P+NRP MRE
Sbjct: 665 VQEHGSDIPKWVSSVREEETESGDDPTSGNEASEEKLQALLNIAMACVSLMPQNRPTMRE 724

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           V KMIRD+RAEAQ+SSNSSDHSPGRWSD VQSLPREEHLSI
Sbjct: 725 VLKMIRDTRAEAQISSNSSDHSPGRWSDIVQSLPREEHLSI 765

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864361|emb|CAN80935.1| hypothetical protein VITISV_005661 [Vitis vinifera]

 Score =  398 bits (1023), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 189/221 (85%), Positives = 208/221 (94%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           ++G+RTSGGGKPLHWTSCLKI EDLA+GLLYIHQNPGLTHGNLKSSNVLLG+DFESCLTD
Sbjct: 475 ISGSRTSGGGKPLHWTSCLKIGEDLATGLLYIHQNPGLTHGNLKSSNVLLGSDFESCLTD 534

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL +FR+PD+VEE SA+SLFY+APECR+    PTQQADVYSFGV+LLELLTGKTPFQDL
Sbjct: 535 YGLTTFRDPDTVEESSASSLFYRAPECRDTRNPPTQQADVYSFGVILLELLTGKTPFQDL 594

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           V EHGSDIPRWVRSVREEETESGDDP S NE SEEKL ALLNIA+ACVSL+PENRPVMRE
Sbjct: 595 VQEHGSDIPRWVRSVREEETESGDDPASGNETSEEKLGALLNIAMACVSLSPENRPVMRE 654

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           V +MI+++RAEAQ+SSNSSDHSPGRWSDTVQSLPREEHLSI
Sbjct: 655 VLRMIKETRAEAQVSSNSSDHSPGRWSDTVQSLPREEHLSI 695

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473670|ref|XP_003631342.1| PREDICTED: inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630-like [Vitis vinifera]

 Score =  395 bits (1016), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 188/219 (85%), Positives = 205/219 (93%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
           G+RTSGGGKPLHWTSCLKI EDLA+GLLYIHQNPGLTHGNLKSSNVLLG+DFESCLTDYG
Sbjct: 444 GSRTSGGGKPLHWTSCLKIGEDLATGLLYIHQNPGLTHGNLKSSNVLLGSDFESCLTDYG 503

Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
           L +FR+PD+VEE SA+SLFY+APECR+     TQQADVYSFGV+LLELLTGKTPFQDLV 
Sbjct: 504 LTTFRDPDTVEESSASSLFYRAPECRDTRNPSTQQADVYSFGVILLELLTGKTPFQDLVQ 563

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
           EHGSDIPRWVRSVREEETESGDDP S NE SEEKL ALLNIA+ACVSL+PENRPVMREV 
Sbjct: 564 EHGSDIPRWVRSVREEETESGDDPASGNETSEEKLGALLNIAMACVSLSPENRPVMREVL 623

Query: 183 KMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           +MI+++RAEAQ+SSNSSDHSPGRWSDTVQSLPREEHLSI
Sbjct: 624 RMIKETRAEAQVSSNSSDHSPGRWSDTVQSLPREEHLSI 662

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099677|ref|XP_002311575.1| predicted protein [Populus trichocarpa] gi|222851395|gb|EEE88942.1| predicted protein [Populus trichocarpa]

 Score =  395 bits (1016), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 189/221 (85%), Positives = 205/221 (92%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           + GTRTSGGGKPLHWTSCLKIAEDLA+GLLYIHQNPG THGNLKSSNVLLG +FESCLTD
Sbjct: 437 LHGTRTSGGGKPLHWTSCLKIAEDLATGLLYIHQNPGSTHGNLKSSNVLLGPEFESCLTD 496

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL +FRNPDS+EEPSATSLFY+APE R++ K PTQ ADVYSFGVLLLELLTGKTPFQDL
Sbjct: 497 YGLTTFRNPDSLEEPSATSLFYRAPEIRDVRKPPTQPADVYSFGVLLLELLTGKTPFQDL 556

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           V EHG DIPRWVRSVREEETESGDDP S NEA EEKLQAL++IA+ACVSL PENRP MR+
Sbjct: 557 VQEHGPDIPRWVRSVREEETESGDDPASGNEAGEEKLQALVSIAMACVSLTPENRPSMRD 616

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           V KMIRD+RAEAQ+SSNSSD+SPGRWSDTVQSLPREEHL+I
Sbjct: 617 VLKMIRDARAEAQLSSNSSDYSPGRWSDTVQSLPREEHLTI 657

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555553|ref|XP_002518813.1| receptor-kinase, putative [Ricinus communis] gi|223542194|gb|EEF43738.1| receptor-kinase, putative [Ricinus communis]

 Score =  393 bits (1010), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 190/221 (85%), Positives = 205/221 (92%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           + GTRTSGGGKPLHWTSCLKIAEDLA+GLLYIHQNPGLTHGNLKSSNVLLG +FESCLTD
Sbjct: 443 LHGTRTSGGGKPLHWTSCLKIAEDLATGLLYIHQNPGLTHGNLKSSNVLLGPEFESCLTD 502

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL  FR+PD VEEPSATSLFY+APE R++ K  TQQADVYSFGVLLLELLTGKTPFQDL
Sbjct: 503 YGLTVFRDPDLVEEPSATSLFYRAPESRDMRKPSTQQADVYSFGVLLLELLTGKTPFQDL 562

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           V EHGSDIPRWVRSVREEETESGDDP S NEA+EEKL AL+N+A+ACVSL PE+RP MRE
Sbjct: 563 VQEHGSDIPRWVRSVREEETESGDDPTSGNEAAEEKLLALVNVAMACVSLTPESRPSMRE 622

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           V KMIRD+RAEAQ+SSNSSDHSPGRWSDTVQSLPR+EHLSI
Sbjct: 623 VLKMIRDARAEAQVSSNSSDHSPGRWSDTVQSLPRDEHLSI 663

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111340|ref|XP_002315819.1| predicted protein [Populus trichocarpa] gi|222864859|gb|EEF01990.1| predicted protein [Populus trichocarpa]

 Score =  393 bits (1010), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 188/221 (85%), Positives = 205/221 (92%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           + GTRTSGGGKPLHWTSCLKIAEDLA+GLLYIHQNPGLTHGNLKSSNVLLG +FESCLTD
Sbjct: 441 LHGTRTSGGGKPLHWTSCLKIAEDLATGLLYIHQNPGLTHGNLKSSNVLLGPEFESCLTD 500

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           YGL  F+NPDS+EEPSATSLFY+APE R++ K  TQ ADVYSFGVLLLELLTGKTPFQDL
Sbjct: 501 YGLTMFQNPDSLEEPSATSLFYRAPEIRDVRKPSTQPADVYSFGVLLLELLTGKTPFQDL 560

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           V EHG DIPRWVRSVREEETESGDDP S NEA+EEKLQAL+NIA+ACVSL P+NRP MR+
Sbjct: 561 VQEHGPDIPRWVRSVREEETESGDDPASGNEAAEEKLQALVNIAMACVSLTPDNRPSMRD 620

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           V +MIRD+RAEA++SSNSSDHSPGRWSDTVQSLPREEHLSI
Sbjct: 621 VFRMIRDARAEARVSSNSSDHSPGRWSDTVQSLPREEHLSI 661

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356544420|ref|XP_003540649.1| PREDICTED: inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630-like [Glycine max]

 Score =  389 bits (1000), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 185/219 (84%), Positives = 199/219 (90%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
           G++TSGGGKPLHWTSCLKIAEDLA+G+LYIHQNPGLTHGNLKSSNVLLG+DFESCLTDYG
Sbjct: 449 GSKTSGGGKPLHWTSCLKIAEDLATGMLYIHQNPGLTHGNLKSSNVLLGSDFESCLTDYG 508

Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
           L  F NPD+++EPSATSLFY+APECR   +  TQ ADVYSFGVLLLELLTGKTPFQDLV 
Sbjct: 509 LTVFLNPDTMDEPSATSLFYRAPECRNFQRSQTQPADVYSFGVLLLELLTGKTPFQDLVQ 568

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
            +GSDIPRWVRSVREEETESGDDP S NEASEEKLQALLNIA+ACVSL PENRP MREV 
Sbjct: 569 TYGSDIPRWVRSVREEETESGDDPASGNEASEEKLQALLNIAMACVSLVPENRPTMREVL 628

Query: 183 KMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           KMIRD+R EA +SSNSSDHSPGRWSDTVQS PREEH SI
Sbjct: 629 KMIRDARGEAHVSSNSSDHSPGRWSDTVQSFPREEHQSI 667

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356541016|ref|XP_003538980.1| PREDICTED: inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630-like [Glycine max]

 Score =  386 bits (992), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 184/219 (84%), Positives = 197/219 (89%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
           G++TSGGGKPLHWTSCLKIAEDLA+G+LYIHQNPGLTHGNLKSSNVLLG+DFESCLTDYG
Sbjct: 435 GSKTSGGGKPLHWTSCLKIAEDLATGMLYIHQNPGLTHGNLKSSNVLLGSDFESCLTDYG 494

Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
           L  F NPDS++EPSATSLFY+APECR   +  TQ ADVYSFGVLLLELLTGKTPFQDLV 
Sbjct: 495 LTVFLNPDSMDEPSATSLFYRAPECRNFQRSQTQPADVYSFGVLLLELLTGKTPFQDLVQ 554

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
            +GSDIP WVRSVREEETESGDDP S NE SEEKLQALLNIA+ACVSL PENRP MREV 
Sbjct: 555 TYGSDIPTWVRSVREEETESGDDPASGNEVSEEKLQALLNIAMACVSLVPENRPTMREVL 614

Query: 183 KMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
           KMIRD+R EA +SSNSSDHSPGRWSDTVQS PREEH SI
Sbjct: 615 KMIRDARGEAHVSSNSSDHSPGRWSDTVQSFPREEHQSI 653

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62319472|dbj|BAD94850.1| receptor-kinase isolog [Arabidopsis thaliana]

 Score =  347 bits (890), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 177/220 (80%), Positives = 196/220 (89%), Gaps = 1/220 (0%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
           GTR+SG GKPLHWTSCLKIAEDLAS LLYIHQNPGLTHGNLKSSNVLLG DFESCLTDYG
Sbjct: 444 GTRSSGSGKPLHWTSCLKIAEDLASALLYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYG 503

Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
           L +  +PDSVEE SA SLFYKAPECR+  K  TQ ADVYSFGVLLLELLTG+TPFQDLV 
Sbjct: 504 LSTLHDPDSVEETSAVSLFYKAPECRDPRKASTQPADVYSFGVLLLELLTGRTPFQDLVQ 563

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSS-NEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           E+GSDI RWVR+VREEETESG++P SS NEASEEKLQALL+IA  CV++ P+NRPVMREV
Sbjct: 564 EYGSDISRWVRAVREEETESGEEPTSSGNEASEEKLQALLSIATVCVTIQPDNRPVMREV 623

Query: 182 SKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
            KM+RD+RAEA  SSNSS+HSPGRWSDTVQSLPR++ +SI
Sbjct: 624 LKMVRDARAEAPFSSNSSEHSPGRWSDTVQSLPRDDQVSI 663

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	221
TAIR|locus:2196464	663	AT1G10850 [Arabidopsis thalian	0.990	0.330	0.804	2.4e-92
TAIR|locus:2036499	652	AT1G60630 [Arabidopsis thalian	0.972	0.329	0.731	3.9e-83
TAIR|locus:2155508	669	AT5G67200 [Arabidopsis thalian	0.823	0.272	0.472	5.3e-38
TAIR|locus:2074830	660	AT3G50230 [Arabidopsis thalian	0.823	0.275	0.477	8.2e-38
TAIR|locus:2167781	669	AT5G43020 [Arabidopsis thalian	0.832	0.275	0.482	4.1e-36
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.914	0.306	0.446	1e-33
TAIR|locus:2174190	625	LRR1 [Arabidopsis thaliana (ta	0.819	0.289	0.418	1.2e-30
TAIR|locus:2075502	627	AT3G02880 [Arabidopsis thalian	0.796	0.280	0.416	7.3e-30
TAIR|locus:2044913	672	AT2G36570 [Arabidopsis thalian	0.610	0.200	0.415	2.8e-29
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.886	0.299	0.395	3.8e-29

TAIR|locus:2196464 AT1G10850 [Arabidopsis thaliana (taxid:3702)]

 Score = 920 (328.9 bits), Expect = 2.4e-92, P = 2.4e-92
 Identities = 177/220 (80%), Positives = 195/220 (88%)

Query:     3 GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
             GTR SG GKPLHWTSCLKIAEDLAS LLYIHQNPGLTHGNLKSSNVLLG DFESCLTDYG
Sbjct:   444 GTRASGSGKPLHWTSCLKIAEDLASALLYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYG 503

Query:    63 LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
             L +  +PDSVEE SA SLFYKAPECR+  K  TQ ADVYSFGVLLLELLTG+TPFQDLV 
Sbjct:   504 LSTLHDPDSVEETSAVSLFYKAPECRDPRKASTQPADVYSFGVLLLELLTGRTPFQDLVQ 563

Query:   123 EHGSDIPRWVRSVREEETESGDDPPSS-NEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             E+GSDI RWVR+VREEETESG++P SS NEASEEKLQALL+IA  CV++ P+NRPVMREV
Sbjct:   564 EYGSDISRWVRAVREEETESGEEPTSSGNEASEEKLQALLSIATVCVTIQPDNRPVMREV 623

Query:   182 SKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEHLSI 221
              KM+RD+RAEA  SSNSS+HSPGRWSDTVQSLPR++ +SI
Sbjct:   624 LKMVRDARAEAPFSSNSSEHSPGRWSDTVQSLPRDDQVSI 663

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2036499 AT1G60630 [Arabidopsis thaliana (taxid:3702)]

 Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
 Identities = 161/220 (73%), Positives = 185/220 (84%)

Query:     3 GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
             G++ SG GKPLHWTSCLKIAEDLA GL+YIHQNPGLTHGNLKSSNVLLG DFESCLTDYG
Sbjct:   437 GSKVSGSGKPLHWTSCLKIAEDLAMGLVYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYG 496

Query:    63 LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
             L    +P S+E+ SA SLFYKAPECR++ K  TQ ADVYSFGVLLLELLTG+T F+DLV 
Sbjct:   497 LSDLHDPYSIEDTSAASLFYKAPECRDLRKASTQPADVYSFGVLLLELLTGRTSFKDLVH 556

Query:   123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
             ++GSDI  WVR+VREEETE  ++      ASEEKLQALL IA ACV++ PENRP MREV 
Sbjct:   557 KYGSDISTWVRAVREEETEVSEEL----NASEEKLQALLTIATACVAVKPENRPAMREVL 612

Query:   183 KMIRDSRAEAQMSS-NSSDHSPGRWSDTVQSLPREEHLSI 221
             KM++D+RAEA + S NSSDHSPGRWSDT+QSLPRE+H+SI
Sbjct:   613 KMVKDARAEAALFSFNSSDHSPGRWSDTIQSLPREDHMSI 652

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2155508 AT5G67200 [Arabidopsis thaliana (taxid:3702)]

 Score = 412 (150.1 bits), Expect = 5.3e-38, P = 5.3e-38
 Identities = 93/197 (47%), Positives = 119/197 (60%)

Query:     3 GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDY 61
             G+R+S   KPLHWTSCLKIAED+A GL YIHQ +  L HGNLKS+N+LLG DFE+CLTDY
Sbjct:   482 GSRSSRA-KPLHWTSCLKIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDY 540

Query:    62 GLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD-L 120
              L    +  S       S  YKAPE R+  ++PT + DVYSFGVL+ ELLTGK   +   
Sbjct:   541 CLSVLTDSSSASPDDPDSSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPF 600

Query:   121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
             +  H  D+  WVR++REEE E  +D          +L  +   A  C   +PE RP MR+
Sbjct:   601 MAPH--DMLDWVRAMREEE-EGTED---------NRLGMMTETACLCRVTSPEQRPTMRQ 648

Query:   181 VSKMIRDSRAEAQMSSN 197
             V KMI++ +       N
Sbjct:   649 VIKMIQEIKESVMAEEN 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2074830 AT3G50230 [Arabidopsis thaliana (taxid:3702)]

 Score = 410 (149.4 bits), Expect = 8.2e-38, P = 8.2e-38
 Identities = 95/199 (47%), Positives = 125/199 (62%)

Query:     3 GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
             G+RTS   KPLHWTSCLKIAED+A  L YIHQ+    HGNLKS+N+LLG DFE+C+TDY 
Sbjct:   472 GSRTSKA-KPLHWTSCLKIAEDVAQALHYIHQSSAKFHGNLKSTNILLGHDFEACVTDYC 530

Query:    63 LGSFRNPDSV--EEPSATSLFYKAPECREIW-KQPTQQADVYSFGVLLLELLTGKTPFQD 119
             L S     SV   +P  +S  YKAPE R+    +PT + DVYSFGV LLELLTGKT  + 
Sbjct:   531 L-SVLTDSSVPPNDPDISS--YKAPEIRKSTDSRPTSKCDVYSFGVFLLELLTGKTASRQ 587

Query:   120 LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMR 179
              ++E  +D+  WVR++R+EE  S +         E  L+ +   A  C   +PE RP M+
Sbjct:   588 PIMEP-NDMLDWVRAMRQEEERSKE---------ENGLEMMTQTACLCRVTSPEQRPTMK 637

Query:   180 EVSKMIRDSRAEAQMSSNS 198
             EV KMI++ +    M+  +
Sbjct:   638 EVIKMIQEIKGSVVMTEEN 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2167781 AT5G43020 [Arabidopsis thaliana (taxid:3702)]

 Score = 395 (144.1 bits), Expect = 4.1e-36, P = 4.1e-36
 Identities = 96/199 (48%), Positives = 120/199 (60%)

Query:     3 GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
             GT++S    PLHWTSCLKIAED+A GL YIHQ   L HGNLKSSNVLLG DFE+C+ DY 
Sbjct:   464 GTKSSRA-TPLHWTSCLKIAEDVAQGLSYIHQAWQLVHGNLKSSNVLLGQDFEACIADYC 522

Query:    63 LGSFR-NP-----DSVEEPSATSLFYKAPECR-EIWKQPTQQADVYSFGVLLLELLTGKT 115
             L +   NP     D  E+  A +  YK PE R +     + +ADVYSFG+LLLELLTGK 
Sbjct:   523 LVALATNPPLTSNDGQEDADAAA--YKPPEARHKSLNYQSVKADVYSFGILLLELLTGKQ 580

Query:   116 PFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENR 175
             P +  VL     I  WVR VREE    G+    +     +K   L  +A+AC   +PE R
Sbjct:   581 PSKIPVLPLDEMI-EWVRKVREE----GEKKNGNWREDRDKFGMLTEVAVACSLASPEQR 635

Query:   176 PVMREVSKMIRDSRAEAQM 194
             P M +V KM+++ +  A M
Sbjct:   636 PTMWQVLKMLQEIKEAAVM 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 373 (136.4 bits), Expect = 1.0e-33, P = 1.0e-33
 Identities = 95/213 (44%), Positives = 128/213 (60%)

Query:     3 GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
             G+R SG   PL W + ++IA   A GL ++H +  L HGN+K+SN+LL  + ++C++DYG
Sbjct:   437 GSRGSGR-TPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYG 495

Query:    63 LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
             L    +  S   P      Y APE  E  ++ T ++DVYSFGVLLLELLTGK+P Q  + 
Sbjct:   496 LNQLFSNSS---PPNRLAGYHAPEVLET-RKVTFKSDVYSFGVLLLELLTGKSPNQASLG 551

Query:   123 EHGSDIPRWVRSV-REEET-ESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
             E G D+PRWV SV REE T E  D         EE++  LL IA+ACVS  P+ RPVM+E
Sbjct:   552 EEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQE 611

Query:   181 VSKMIRD-SRAEAQ---MSSNSSDHSPGRWSDT 209
             V +MI D +R+E     +  +S D S G    T
Sbjct:   612 VLRMIEDVNRSETTDDGLRQSSDDPSKGSEGQT 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)]

 Score = 344 (126.2 bits), Expect = 1.2e-30, P = 1.2e-30
 Identities = 80/191 (41%), Positives = 118/191 (61%)

Query:     8 GGGK-PLHWTSCLKIAEDLASGLLYIHQNPGLT-HGNLKSSNVLLGADFESCLTDYGLGS 65
             G G+ PL+W +   IA   A  + Y+H     T HGN+KSSN+LL   FE+ ++DY L  
Sbjct:   432 GSGRSPLNWETRANIALGAARAISYLHSRDATTSHGNIKSSNILLSESFEAKVSDYCLAP 491

Query:    66 FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
               +P S   P+     Y+APE  +  ++ +Q+ADVYSFGVL+LELLTGK+P    + E G
Sbjct:   492 MISPTST--PNRID-GYRAPEVTDA-RKISQKADVYSFGVLILELLTGKSPTHQQLHEEG 547

Query:   126 SDIPRWVRSVREEETESGD-DPPSSNEASE--EKLQALLNIAIACVSLAPENRPVMREVS 182
              D+PRWV S+ E+++ S   DP  +   S+  E +  LLNI I+C +  P++RP M EV+
Sbjct:   548 VDLPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVT 607

Query:   183 KMIRD-SRAEA 192
             ++I + SR+ A
Sbjct:   608 RLIEEVSRSPA 618

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009610 "response to symbiotic fungus" evidence=IEP

GO:0016020 "membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)]

 Score = 337 (123.7 bits), Expect = 7.3e-30, P = 7.3e-30
 Identities = 77/185 (41%), Positives = 114/185 (61%)

Query:     8 GGGK-PLHWTSCLKIAEDLASGLLYIHQNPGLT-HGNLKSSNVLLGADFESCLTDYGLGS 65
             G G+ PL+W +   IA   A  + Y+H   G T HGN+KSSN+LL   +E+ ++DYGL  
Sbjct:   434 GNGRTPLNWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAP 493

Query:    66 FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
               +  S   P+     Y+APE  +  ++ +Q+ADVYSFGVL+LELLTGK+P    + E G
Sbjct:   494 IIS--STSAPNRID-GYRAPEITDA-RKISQKADVYSFGVLILELLTGKSPTHQQLNEEG 549

Query:   126 SDIPRWVRSVREEETESGD-DPPSSNEASE--EKLQALLNIAIACVSLAPENRPVMREVS 182
              D+PRWV+SV E++T S   DP  +    E  E +  LL I ++C +  P++RP M EV+
Sbjct:   550 VDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVT 609

Query:   183 KMIRD 187
             ++I +
Sbjct:   610 RLIEE 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046658 "anchored to plasma membrane" evidence=IDA

GO:0005618 "cell wall" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)]

 Score = 219 (82.2 bits), Expect = 2.8e-29, Sum P(2) = 2.8e-29
 Identities = 66/159 (41%), Positives = 87/159 (54%)

Query:     8 GGGK-PLHWTSCLKIAEDLASGLLYIHQNPGLT---HGNLKSSNVLLGADFESCLTDYGL 63
             G G+ PL WT+ + +    A GL  IH    ++   HGN+KSSNVLL  +  + + D+GL
Sbjct:   448 GPGRIPLDWTTRISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRNGVALIADFGL 507

Query:    64 GSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP--FQD-- 119
                 NP       A    Y+APE  EI K+ +Q+ADVYSFGVLLLE+LTGK P  F    
Sbjct:   508 SLLLNP---VHAIARLGGYRAPEQSEI-KRLSQKADVYSFGVLLLEVLTGKAPSIFPSPS 563

Query:   120 -------LVLEHGS----DIPRWVRSV-REEETESGDDP 146
                    + +E       D+P+WVRSV +EE T    DP
Sbjct:   564 RPRSAASVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDP 602

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 331 (121.6 bits), Expect = 3.8e-29, P = 3.8e-29
 Identities = 81/205 (39%), Positives = 120/205 (58%)

Query:    12 PLHWTSCLKIAEDLASGLLYIHQ--NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
             PL W S +KI    A G+ ++H    P  +HGN+KSSNV++  + ++C++D+GL      
Sbjct:   453 PLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLM-- 510

Query:    70 DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
              +V         Y+APE  E  K  T ++DVYSFGVL+LE+LTGK+P Q    +   D+P
Sbjct:   511 -AVPIAPMRGAGYRAPEVMETRKH-THKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLP 568

Query:   130 RWVRSV-REEET-ESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             RWV+SV REE T E  D      +  EE++  +L IA+ACV+  PE RP M +V +MI +
Sbjct:   569 RWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEE 628

Query:   188 SR-AEAQMSSNSSDHSPGRWSDTVQ 211
              R ++++ +  SSD +       VQ
Sbjct:   629 IRVSDSETTRPSSDDNSKPKDSNVQ 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00021264001 SubName- Full=Chromosome chr1 scaffold_22, whole genome shotgun sequence; (653 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	221
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-21
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-20
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-14
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-12
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-12
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-12
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-07
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-07
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-06
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-06
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-06
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-05
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-04
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-04
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-04
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-04
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-04
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.001
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	0.001
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.001
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	0.001
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.001
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.001
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	0.002
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.002
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.002
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.002
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	0.002
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	0.002
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.002
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.003
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	0.003
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.003
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.003
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	0.003
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	0.003
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.004
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.004
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.004
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.004
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	0.004
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.004
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.004
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 86.9 bits (216), Expect = 3e-21
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 7/113 (6%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGS-FRN 68
             L     L+I   +  GL Y+H N G+ H +LK  N+LL +D     L D+GL     +
Sbjct: 87  GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145

Query: 69  PDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
             S+ +    +  Y APE        ++++D++S GV+L EL       +DL+
Sbjct: 146 DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----PELKDLI 194

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 85.8 bits (213), Expect = 3e-20
 Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 19/177 (10%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN- 68
           G PL      KIA  +  GL Y+H N G+ H +LK  N+LL  +    + D+GL      
Sbjct: 92  GGPLSEDEAKKIALQILRGLEYLHSN-GIIHRDLKPENILLDENGVVKIADFGLAKKLLK 150

Query: 69  PDSVEEPSATSLFYKAPE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
             S       + +Y APE              + DV+S GV+L ELLTGK PF     E+
Sbjct: 151 SSSSLTTFVGTPWYMAPEVLLGGNGY----GPKVDVWSLGVILYELLTGKPPFSG---EN 203

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             D  + +R +     E   D P  +  SEE  + L+     C++  P  RP   E+
Sbjct: 204 ILDQLQLIRRILGPPLEF--DEPKWSSGSEE-AKDLIK---KCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 82.2 bits (204), Expect = 5e-19
 Identities = 43/166 (25%), Positives = 67/166 (40%), Gaps = 16/166 (9%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
                + S L Y+H   G+ H +LK  N+LL  D    L D+GL    +P         +
Sbjct: 101 FYLRQILSALEYLHSK-GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGT 159

Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
             Y APE   +  +   +  D++S GV+L ELLTGK PF          +    + + + 
Sbjct: 160 PEYMAPEV--LLGKGYGKAVDIWSLGVILYELLTGKPPFPG-----DDQLLELFKKIGKP 212

Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
           +      PP   + S E  + L+      +   PE R    E  + 
Sbjct: 213 KPP---FPPPEWDISPE-AKDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 73.2 bits (178), Expect = 3e-15
 Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 14/168 (8%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSA 77
           L I   + S L Y+H   G+ H ++K  N+LL  D     L D+GL              
Sbjct: 104 LFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162

Query: 78  T-------SLFYKAPECREI--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   +  Y APE          +  +D++S G+ L ELLTG  PF+       S  
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SAT 220

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
            + ++ + E  T S    P S    E   +A  ++    ++  P+NR 
Sbjct: 221 SQTLKIILELPTPS-LASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 70.3 bits (173), Expect = 1e-14
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 29/176 (16%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  A  +A G+ Y+       H +L + N L+G D    ++D+GL   R+    +     
Sbjct: 108 LSFAIQIAKGMEYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKK 164

Query: 79  S-----LFYKAPEC--REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPR 130
           +     + + APE     I+   T ++DV+SFGVLL E+ T G TP+  L  E   ++  
Sbjct: 165 TGGKLPIRWMAPESLKDGIF---TSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE 218

Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           ++R         G   P      +E    L  + ++C  L PE+RP   E+ + + 
Sbjct: 219 YLR--------KGYRLPKPEYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 69.8 bits (172), Expect = 2e-14
 Identities = 38/167 (22%), Positives = 76/167 (45%), Gaps = 28/167 (16%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL---- 80
           L   L Y+H    L H ++K  N+ L ++    L D+G+    +        A ++    
Sbjct: 112 LCLALKYLHSRKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---DLAKTVVGTP 167

Query: 81  FYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +Y +PE   + + +P   ++D++S G +L EL T K PF+      G ++      + + 
Sbjct: 168 YYLSPE---LCQNKPYNYKSDIWSLGCVLYELCTLKHPFE------GENLLELALKILKG 218

Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
           +      PP  ++ S E L+ L++   + +   PE RP + ++ +  
Sbjct: 219 QY-----PPIPSQYSSE-LRNLVS---SLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 68.8 bits (169), Expect = 4e-14
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 4/101 (3%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           + ++L  GL Y+H N G+ H ++K++N+LL +D E  L D+GL +  +          + 
Sbjct: 103 VCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTP 161

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
           ++ APE   I  +P   +AD++S G+  +EL  GK P+ +L
Sbjct: 162 YWMAPEV--INGKPYDYKADIWSLGITAIELAEGKPPYSEL 200

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 7e-14
 Identities = 40/104 (38%), Positives = 52/104 (50%), Gaps = 12/104 (11%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +   L Y+H   G+ + +LK  N+LL AD    LTD+GL      +   E S T+ 
Sbjct: 99  AAE-IVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGL----AKELSSEGSRTNT 152

Query: 81  F-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           F     Y APE     K   +  D +S GVLL E+LTGK PF  
Sbjct: 153 FCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 16/192 (8%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQN--PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           L W    KIA  +A  L ++H    P +  GNL    +++    E  L      S     
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RLSLPGLL 832

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPR 130
             +     S  Y APE RE  K  T+++D+Y FG++L+ELLTGK+P       HGS I  
Sbjct: 833 CTDTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVE 890

Query: 131 WVR-SVREEETESGDDPPSSNEAS--EEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
           W R    +   +   DP    + S  + ++  ++N+A+ C +  P  RP   +V K +  
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL-- 948

Query: 188 SRAEAQMSSNSS 199
              E+   S+SS
Sbjct: 949 ---ESASRSSSS 957

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 64.5 bits (158), Expect = 2e-12
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 20/170 (11%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  A  +A G+ Y+       H +L + N L+G +    ++D+GL      D        
Sbjct: 105 LSFALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
            L  +  APE  +   + T ++DV+SFGVLL E+ T G+ P+  +  E   ++  ++   
Sbjct: 164 KLPIRWMAPESLKE-GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---EVLEYL--- 216

Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
                ++G   P       E    L ++ + C +  PE+RP   E+ +++
Sbjct: 217 -----KNGYRLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 20/180 (11%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
             K L  +  L  A  +A G+ Y+       H +L + N L+G +    ++D+GL     
Sbjct: 96  RPKELSLSDLLSFALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154

Query: 69  PDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHG 125
            D   +     L  +  APE  +   + T ++DV+SFGVLL E+ T G+ P+  +     
Sbjct: 155 DDDYYKVKGGKLPIRWMAPESLKE-GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA-- 211

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++  ++        + G   P       E    L  + + C +  PE+RP   E+ +++
Sbjct: 212 -EVLEYL--------KKGYRLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 25/173 (14%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEP 75
           L++A  +A G+ Y+       H +L + N L+  +    ++D+GL      D        
Sbjct: 105 LQMALQIAKGMEYLESK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163

Query: 76  SATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWV 132
               + + APE     K    T ++DV+SFGVLL E+ T G+ P+  +      ++   +
Sbjct: 164 GKLPIKWMAPES---LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM---SNEEVLELL 217

Query: 133 RSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
                   E G   P      +E    L  + + C +  PE+RP   E+ + +
Sbjct: 218 --------EDGYRLPRPENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 63.3 bits (155), Expect = 4e-12
 Identities = 29/101 (28%), Positives = 54/101 (53%), Gaps = 7/101 (6%)

Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SL 80
            +  GL Y+H N G+ H ++K +N+L+ +D    L D+G           E + +   + 
Sbjct: 109 QILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 81  FYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           ++ APE  R   ++  + AD++S G  ++E+ TGK P+ +L
Sbjct: 168 YWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 63.4 bits (155), Expect = 4e-12
 Identities = 32/121 (26%), Positives = 53/121 (43%), Gaps = 26/121 (21%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +   L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S  E +    
Sbjct: 108 AAE-ILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165

Query: 81  ---------------------FYKAPEC-REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                                 Y +PE   E  K   + +D+++ G ++ ++LTGK PF+
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFR 223

Query: 119 D 119
            
Sbjct: 224 G 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 8e-12
 Identities = 30/97 (30%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLFYK 83
            GL Y+H+  G+ H ++K++N+L   D    L D+G+ +    + V +  A+   + ++ 
Sbjct: 110 QGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWM 166

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           APE  E+    +  +D++S G  ++ELLTG  P+ DL
Sbjct: 167 APEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDL 202

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 60.6 bits (147), Expect = 4e-11
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 17/160 (10%)

Query: 29  LLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR 88
           L Y+H+   + H +L  +N++LG D +  +TD+GL   + P+S       ++ Y  PE  
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI- 184

Query: 89  EIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPP 147
            +  +P  ++ADV++FG +L ++ T + PF      + +++      + E   E     P
Sbjct: 185 -VKNEPYGEKADVWAFGCILYQMCTLQPPF------YSTNMLSLATKIVEAVYE-----P 232

Query: 148 SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
                  E +  ++    +C++   E RP + +VS MI D
Sbjct: 233 LPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.9 bits (145), Expect = 8e-11
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 22/177 (12%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEP 75
            ++A ++ASGLL++HQ     H +L   N  L AD    + DYGL   + P+     ++ 
Sbjct: 103 QRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161

Query: 76  SATSLFYKAPECREIWKQ------PTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDI 128
            A  L + APE  EI  Q       T++++++S GV + EL T    P+ DL     SD 
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-----SDE 216

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
               + VRE++ +     P  +    ++   ++        L PE RP   EV +++
Sbjct: 217 QVLKQVVREQDIKL--PKPQLDLKYSDRWYEVMQFCW----LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL YIH   G+ H +LK  N+ +  D E  + D+GL   R  DS       + +Y+APE 
Sbjct: 130 GLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLA--RQTDSEMTGYVVTRWYRAPEV 186

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              W   TQ  D++S G ++ E+LTGK  F+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 15/102 (14%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----L 80
           L  GL Y+H N G+ H ++K SN+L+  D    L D+GL   R          T+    L
Sbjct: 109 LLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLA--RPYTKRNSADYTNRVITL 165

Query: 81  FYKAPE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +Y+ PE          +   + D++S G +L EL  GK  FQ
Sbjct: 166 WYRPPELLLGA----TRYGPEVDMWSVGCILAELFLGKPIFQ 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 11/100 (11%)

Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           +LA  L ++H + G+ + +LK  N+LL  +    LTD+GL    + +S++       F  
Sbjct: 106 ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCG 160

Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              Y APE     +  TQ AD +SFGVL+ E+LTG  PFQ
Sbjct: 161 TVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL YIH   G+ H +LK  N+ +  D E  + D+GL   R+ D+       + +Y+APE 
Sbjct: 129 GLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVTRWYRAPEV 185

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              W    Q  D++S G ++ E+LTGKT F+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 5e-10
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)

Query: 18  CLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R+ 
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHT 170

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.4 bits (139), Expect = 5e-10
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 6/104 (5%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEE 74
           L  +  +  G+ Y+  +    H +L + N+L+ ++    ++D+GL      D     V+E
Sbjct: 112 LLFSSQICKGMDYLG-SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170

Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           P  + +F+ APEC    K  +  +DV+SFGV L EL T   P Q
Sbjct: 171 PGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-----Y 82
           GL Y+H N G  H ++K+ N+LLG D    + D+G+ +               F     +
Sbjct: 114 GLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
            APE  E       +AD++SFG+  +EL TG  P+   
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.0 bits (137), Expect = 6e-10
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 20/183 (10%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF- 66
           G GK L     + +A  +A G+ YI +     H +L+++N+L+G +    + D+GL    
Sbjct: 94  GDGKYLKLPQLVDMAAQIADGMAYI-ERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152

Query: 67  -RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
             N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL+T G+ P+       
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELVTKGRVPY------- 204

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
               P  V     E+ E G   P   +   E L  L+ +   C    P+ RP    +   
Sbjct: 205 ----PGMVNREVLEQVERGYRMPCP-QGCPESLHELMKL---CWKKDPDERPTFEYIQSF 256

Query: 185 IRD 187
           + D
Sbjct: 257 LED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.0 bits (137), Expect = 9e-10
 Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 3/93 (3%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           L  GL YIH + G+ H +LK SNV +  D E  + D+GL   R  D        + +Y+A
Sbjct: 127 LLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA--RQADDEMTGYVATRWYRA 183

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE    W    Q  D++S G ++ ELL GK  F
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.5 bits (137), Expect = 1e-09
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL YIH + G+ H +LK SN+ +  D E  + D+GL   R+ D        + +Y+APE 
Sbjct: 130 GLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAPEI 186

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
              W    Q  D++S G ++ ELLTGKT F
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 20/172 (11%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNPDSVEEPS 76
           +  +  +A G+ +I Q     H +L+++N+L+ A     + D+GL      N  +  E +
Sbjct: 105 IDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    +   T ++DV+SFG+LL+E++T G+ P+       G   P  +R++
Sbjct: 164 KFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYP------GMSNPEVIRAL 216

Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
                E G   P      EE    L NI + C    PE RP    +  ++ D
Sbjct: 217 -----ERGYRMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 35/112 (31%), Positives = 50/112 (44%), Gaps = 11/112 (9%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--F 66
           GG P  W +   IAE +  G+  +HQ  G+ H ++K  N+L+       LTD+GL     
Sbjct: 92  GGLPEDW-AKQYIAE-VVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148

Query: 67  RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            N   V  P      Y APE         + +D +S G ++ E L G  PF 
Sbjct: 149 ENKKFVGTPD-----YLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 96  GKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+         
Sbjct: 155 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY--------- 204

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
             P  V     ++ E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 205 --PGMVNREVLDQVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Query: 187 D 187
           D
Sbjct: 259 D 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 54.6 bits (131), Expect = 4e-09
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 28/187 (14%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF- 66
           G G+ L   + + +A  +A+G+ YI +     H +L+S+N+L+G      + D+GL    
Sbjct: 94  GEGRALKLPNLVDMAAQVAAGMAYI-ERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152

Query: 67  -RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL---- 120
             N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL+T G+ P+  +    
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
           VLE    + R  R          D P S +E           + + C    PE RP    
Sbjct: 212 VLEQ---VERGYRM-----PCPQDCPISLHE-----------LMLQCWKKDPEERPTFEY 252

Query: 181 VSKMIRD 187
           +   + D
Sbjct: 253 LQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.1 bits (133), Expect = 5e-09
 Identities = 37/124 (29%), Positives = 60/124 (48%), Gaps = 21/124 (16%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++  GL ++H+  G+ + +LK  NVLL ++    + D+G+      + +     TS F
Sbjct: 102 AAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTF 156

Query: 82  -----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGSD 127
                Y APE   +  QP     D ++ GVLL E+L G++PF+          +LE    
Sbjct: 157 CGTPDYIAPEI--LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR 214

Query: 128 IPRW 131
            PRW
Sbjct: 215 YPRW 218

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.8 bits (132), Expect = 5e-09
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 13/102 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++A GL ++H + G+ + +LK  NV+L A+    + D+G+      +++     T  F
Sbjct: 107 AAEIAIGLFFLH-SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTF 161

Query: 82  -----YKAPECREIWKQPTQQA-DVYSFGVLLLELLTGKTPF 117
                Y APE   I  QP  ++ D ++FGVLL E+L G+ PF
Sbjct: 162 CGTPDYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 54.2 bits (131), Expect = 7e-09
 Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 14/109 (12%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEEPS 76
           IAE +   L Y+H N G+ H +LK  N+L+ ++    LTD+GL       R  +  ++  
Sbjct: 99  IAE-IVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156

Query: 77  ATSLF-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                     Y APE   I  Q  ++  D +S G +L E L G  PF  
Sbjct: 157 EDKRIVGTPDYIAPEV--ILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 54.0 bits (130), Expect = 9e-09
 Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 27/165 (16%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL----FY 82
            GL Y+H + G+ H +LK+ N+L+ AD    ++D+G+ S ++ D  +     S+    F+
Sbjct: 119 EGLAYLH-SKGILHRDLKADNLLVDADGICKISDFGI-SKKSDDIYDNDQNMSMQGSVFW 176

Query: 83  KAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL-----VLEHGSDIPRWVRSVR 136
            APE    + Q  + + D++S G ++LE+  G+ P+ D      + + G+          
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA------ 230

Query: 137 EEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                    PP   + S       L+   AC ++ P+NRP  RE+
Sbjct: 231 ---------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 53.7 bits (130), Expect = 1e-08
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 17/160 (10%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT- 78
            IA  +  GL Y+H    + H ++K SN+L+ +  E  + D+G+         +  +   
Sbjct: 103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG 162

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           ++ Y +PE R   +  +  AD++S G+ LLE   GK PF           P +   ++  
Sbjct: 163 TVTYMSPE-RIQGESYSYAADIWSLGLTLLECALGKFPFLPP------GQPSFFELMQA- 214

Query: 139 ETESGDDPPS--SNEASEEKLQALLNIAIACVSLAPENRP 176
                  PPS  + E S E      +   AC+   P+ RP
Sbjct: 215 --ICDGPPPSLPAEEFSPE----FRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 53.3 bits (128), Expect = 1e-08
 Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 20/169 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+PL      +    +  GL ++H    + H ++KS N+ L A     + D G+    + 
Sbjct: 95  GRPLPEDQVWRFFIQILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153

Query: 70  DSV-EEPSATSLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           ++        + +Y +PE C +  K   +++DV++ GV+L E  TGK PF       G+ 
Sbjct: 154 NTNFANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFD--ANNQGAL 209

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           I + +R         G  PP S   S    Q L  +   C++     RP
Sbjct: 210 ILKIIR---------GVFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 38/142 (26%), Positives = 63/142 (44%), Gaps = 16/142 (11%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           I E +   L Y+H   G+ H ++K  N+LL       +TD+ + +   PD++   ++ + 
Sbjct: 106 ICE-IVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP 163

Query: 81  FYKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
            Y APE  CR+ +       D +S GV   E L GK P++     H   I   +R+ +E 
Sbjct: 164 GYMAPEVLCRQGYSVAV---DWWSLGVTAYECLRGKRPYRG----HSRTIRDQIRAKQET 216

Query: 139 ETESGDDPPSSNEASEEKLQAL 160
                 D       S E + A+
Sbjct: 217 A-----DVLYPATWSTEAIDAI 233

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 31/98 (31%), Positives = 57/98 (58%), Gaps = 2/98 (2%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KIA  +  GL Y+H+   + H ++K SN+L+ +  +  L D+G+ S +  +S+ +    +
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV-SGQLVNSLAKTFVGT 162

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y APE R      + ++D++S G+ L+EL TG+ P+
Sbjct: 163 SSYMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 29/174 (16%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL---- 80
           L S L ++H    + H ++K +NV + A     L D GLG F    S +  +A SL    
Sbjct: 115 LCSALEHMHSKR-IMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTP 170

Query: 81  FYKAPE-CREI---WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
           +Y +PE   E    +K     +D++S G LL E+   ++PF      +G  +  +     
Sbjct: 171 YYMSPERIHENGYNFK-----SDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC-- 217

Query: 137 EEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRA 190
            ++ E  D PP   +   E+L+ L++    C++  PE RP +  V ++ ++  A
Sbjct: 218 -KKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 4/109 (3%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           P+      KIA  +  GL Y++    + H ++K SN+L+ +  +  L D+G+ G   N  
Sbjct: 99  PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-- 156

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           S+ +    +  Y +PE R    + T ++DV+S G+ ++EL  GK PF  
Sbjct: 157 SIADTFVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS-----ATSLFY 82
           GL YIH +  + H +LK  N+L+ AD E  + D+GL    + +  E          + +Y
Sbjct: 117 GLKYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +APE    ++  T+  DV+S G +L ELL  K  F+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 20/166 (12%)

Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLF 81
             + S + YIH+  G+ H ++K+ N+ L       L D+G+      + S+ E    + +
Sbjct: 108 FQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 82  YKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET 140
           Y +PE C+    +   ++D+++ G +L ELLT K  F        ++    V  + +   
Sbjct: 167 YMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFD------ATNPLNLVVKIVQGNY 218

Query: 141 ESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
                  SS          L+++  + +   PE RP   EV     
Sbjct: 219 TPVVSVYSS---------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 7e-08
 Identities = 34/115 (29%), Positives = 58/115 (50%), Gaps = 7/115 (6%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           SG GK L     + +A  +A G+ Y+       H +L + N+L+G +    + D+GL   
Sbjct: 94  SGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARL 152

Query: 67  RNPDSVEEPSATSLF---YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
              D        + F   + APE    + + T ++DV+SFG+LL E++T G+ P+
Sbjct: 153 IE-DDEYTAREGAKFPIKWTAPEA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.5 bits (123), Expect = 7e-08
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 45/211 (21%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
           G    L+W  C++IA+    G+ Y+ +   L H +L + NVL+       +TD+GL    
Sbjct: 107 GSQYLLNW--CVQIAK----GMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159

Query: 68  NPDSVE---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL--- 120
             D  E   E     + + A E        T Q+DV+S+GV + EL+T G  P+  +   
Sbjct: 160 GADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPAS 218

Query: 121 ----VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
               +LE G  +P+               PP            +  I + C  +  ++RP
Sbjct: 219 EISSILEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRP 256

Query: 177 VMREV----SKMIRDSRAEAQMSSNSSDHSP 203
             RE+    SKM RD +    +  +   H P
Sbjct: 257 KFRELIIEFSKMARDPQRYLVIQGDERMHLP 287

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 51.4 bits (124), Expect = 8e-08
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL----FYK 83
           GL Y+H +  + H +LK SN+L+ ++ +  + D+GL    +PD  E+   T      +Y+
Sbjct: 115 GLKYLH-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE      + T+  D++S G +  ELLT K  F 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 50.9 bits (122), Expect = 9e-08
 Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 25/145 (17%)

Query: 7   SGGGKPLHWTSCLKIAEDLA--------SGLLYIHQNPGLTHGNLKSSNVLLGADFESCL 58
           +GG    H  S  +  E  A         GL ++H+  G+ + +LK  NVLL  D    +
Sbjct: 79  NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKI 137

Query: 59  TDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTG 113
            D+G+      +++      S F     Y APE  +  K   +  D +SFGVLL E+L G
Sbjct: 138 ADFGMCK----ENMNGEGKASTFCGTPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIG 192

Query: 114 KTPFQDLVLEHGSDIPRWVRSVREE 138
           ++PF      HG D      S+  +
Sbjct: 193 QSPF------HGEDEDELFDSILND 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 9e-08
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 37/186 (19%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ +   L H +L + NVL+       +TD+GL    + D  
Sbjct: 112 LNW--CVQIAK----GMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164

Query: 73  E---EPSATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHG 125
           E   E     + + A E    R      T ++DV+S+GV + EL+T G  P++ +     
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIY----THKSDVWSYGVTVWELMTFGAKPYEGI---PA 217

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMREV 181
            +IP  +     E+ E    PP            +  + + C  +  E+RP    ++ E 
Sbjct: 218 VEIPDLL-----EKGERLPQPPICT-------IDVYMVLVKCWMIDAESRPTFKELINEF 265

Query: 182 SKMIRD 187
           SKM RD
Sbjct: 266 SKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 25/143 (17%)

Query: 7   SGGGKPLHWTSCLKI--------AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL 58
           +GG    H  SC K         A ++  GL ++H   G+ + +LK  N+LL  D    +
Sbjct: 79  NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKI 137

Query: 59  TDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTG 113
            D+G+      +++   + T  F     Y APE   + ++     D +SFGVLL E+L G
Sbjct: 138 ADFGMCK----ENMLGDAKTCTFCGTPDYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIG 192

Query: 114 KTPFQDLVLEHGSDIPRWVRSVR 136
           ++PF      HG D     +S+R
Sbjct: 193 QSPF------HGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 26/166 (15%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +I   L  GL  +H+   + H +LKS+N+LL A+    + D G+      +  +    T 
Sbjct: 107 RIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165

Query: 80  LFYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE 137
             Y APE   +WK +P + ++D++S G LL E+ T   PF+              RS+++
Sbjct: 166 -HYMAPE---VWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQD 208

Query: 138 --EETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              + + G  PP     S++    L N   + + + P+ RP   ++
Sbjct: 209 LRYKVQRGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 6/111 (5%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+ L   S + +A  +A G+ Y+ +     H +L + N+L+G D    + D+GL      
Sbjct: 98  GQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIK- 155

Query: 70  DSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
           + V   S   + YK  APE        + ++DV+SFG+LL E+ T G+ P+
Sbjct: 156 EDVYLSSDKKIPYKWTAPEA-ASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 5/102 (4%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K+   +   L Y+ +  G+ H ++K SN+LL A     L D+G+         +  SA  
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177

Query: 80  LFYKAPECREIWKQPTQ----QADVYSFGVLLLELLTGKTPF 117
             Y APE  +    P      +ADV+S G+ L+EL TG+ P+
Sbjct: 178 AAYMAPERIDP-PDPNPKYDIRADVWSLGISLVELATGQFPY 218

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYKAPE 86
           GL Y+H N  L H +LK +N+L+ +D    L D+GL  SF +P+        + +Y+APE
Sbjct: 114 GLEYLHSNWIL-HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 87  ----CREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                R          D++S G +  ELL    PF
Sbjct: 173 LLFGAR----HYGVGVDMWSVGCIFAELLLRV-PF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 13/102 (12%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG------LGSFRNPDSVEEPSAT-SL 80
           GL Y+H N G+ H ++K +N+L+       ++D+G        S     +   PS   S+
Sbjct: 118 GLNYLH-NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 81  FYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDL 120
           F+ APE   + KQ   T++AD++S G L++E+LTGK PF D 
Sbjct: 177 FWMAPE---VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPDSVEEPSAT 78
           KIAE +  GL Y+H    + H ++K SN+LL    +  L D+G+ G   N  S+      
Sbjct: 109 KIAESVLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFTG 165

Query: 79  SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
           + FY APE   I  +P +  +DV+S G+ LLE+   + PF
Sbjct: 166 TSFYMAPE--RIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 50.3 bits (121), Expect = 1e-07
 Identities = 27/102 (26%), Positives = 52/102 (50%), Gaps = 11/102 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  ++  GL Y+H    + H ++KS N+LL  D    L D+G   F    + E+    S+
Sbjct: 121 VCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSV 176

Query: 81  ----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
               ++ APE   I ++    + D++S G++ +E+  G+ P+
Sbjct: 177 VGTPYWMAPEV--IKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 31/183 (16%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ +   L H +L + NVL+ +     +TD+GL    + D  
Sbjct: 112 LNW--CVQIAK----GMSYL-EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDI 128
           E   +     + + A E   + ++ T Q+DV+S+GV + EL+T G  P+  +      +I
Sbjct: 165 EYHADGGKVPIKWMALESI-LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI---PAREI 220

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKM 184
           P        +  E G+  P     + +    +  I + C  +  E RP  RE+    S+M
Sbjct: 221 P--------DLLEKGERLPQPPICTID----VYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Query: 185 IRD 187
            RD
Sbjct: 269 ARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 19/129 (14%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS- 71
           L+W  C++IA+    G+ Y+ ++  + H NL + N+LL +D    + D+G+     PD  
Sbjct: 112 LNW--CVQIAK----GMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164

Query: 72  --VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
                   T + + A E   ++ + T Q+DV+S+GV + E+++ G  P+  +       +
Sbjct: 165 KYFYSEHKTPIKWMALESI-LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223

Query: 122 LEHGSDIPR 130
           LE G  + +
Sbjct: 224 LEKGERLAQ 232

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 22/171 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS-- 79
           A  +A G+ Y+ ++    H +L + NVLL    ++ ++D+G+       S    + T+  
Sbjct: 101 AHQVAMGMAYL-ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159

Query: 80  --LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVR 136
             L + APEC    K  ++ +DV+S+GV L E  + G  P+ ++    G+++   +    
Sbjct: 160 WPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAML---- 211

Query: 137 EEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
               ESG+  P   E  +E    + +I ++C    PE+RP   E+    R 
Sbjct: 212 ----ESGERLPRPEECPQE----IYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 3/90 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL Y+H + G+ H +LK SN+L+  + +  + D+GL   ++P      S  + +Y+APE 
Sbjct: 120 GLKYVH-SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS--TRYYRAPEI 176

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
              W++   + D++S G +  E+L GK  F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 3e-07
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 2/91 (2%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYKAPE 86
           GL + H + G+ H +LK  N+L+  +    L D+GL  SF +P         + +Y+APE
Sbjct: 110 GLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPE 168

Query: 87  CREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                K  +   D++S G +  ELL+ +  F
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 40/127 (31%), Positives = 53/127 (41%), Gaps = 15/127 (11%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG--ADFESC----- 57
                   LHW   L +A+ LAS L Y+     L HGN+   N+L+      E       
Sbjct: 92  HREKNNVSLHWK--LDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIK 148

Query: 58  LTDYGLGSFRNPDSVEEPSATSLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKT 115
           L+D G+       S EE      +  APEC R      T  AD +SFG  LLE+ + G+ 
Sbjct: 149 LSDPGIP--ITVLSREERVERIPWI-APECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205

Query: 116 PFQDLVL 122
           P   L  
Sbjct: 206 PLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG--SFRNPDSVEEPSATSLFY 82
           L  GL YIH +  + H +LK SN+LL A+ +  + D+GL   +    D + E   T  +Y
Sbjct: 117 LLRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR-WY 174

Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +APE      + T   DV+S G +  ELL  K  F 
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 17/122 (13%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++  GL ++H   G+ + +LK  NV+L  D    + D+G+      ++V   +  S F
Sbjct: 102 AAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTF 156

Query: 82  -----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
                Y APE  +  K  T   D +SFGVLL E+L G++PF      HG D      S+R
Sbjct: 157 CGTPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPF------HGDDEDELFESIR 209

Query: 137 EE 138
            +
Sbjct: 210 VD 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 14/113 (12%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KIA  +   L Y+H    + H ++K SNVL+  + +  L D+G+  +      +   A  
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166

Query: 80  LFYKAPECREIWKQPTQQ-----ADVYSFGVLLLELLTG-------KTPFQDL 120
             Y APE   I  +  Q+     +DV+S G+ ++EL TG       KTPFQ L
Sbjct: 167 KPYMAPE--RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 44/185 (23%), Positives = 85/185 (45%), Gaps = 27/185 (14%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           R+  GG  L     LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL 
Sbjct: 96  RSVLGGDCL-----LKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLT 149

Query: 65  SFRNPDSVEEPSATSLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL 122
             +   S ++     + + APE  RE  K+ + ++DV+SFG+LL E+ + G+ P+  + L
Sbjct: 150 --KEASSTQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
           +    +PR  +  +    ++ D  P            + ++   C  L    RP   ++ 
Sbjct: 206 K--DVVPRVEKGYK---MDAPDGCP----------PVVYDVMKQCWHLDAATRPSFLQLR 250

Query: 183 KMIRD 187
           + +  
Sbjct: 251 EQLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 27/191 (14%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    E  L D+G+ G   +  
Sbjct: 97  PLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155

Query: 71  SVEEPSATSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDL-VLEHGSD 127
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  +L  ++    
Sbjct: 156 IKRNTFVGTPFWMAPE---VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---M 184
           IP+             ++PP+      + L+  +    AC++  P  RP  +E+ K   +
Sbjct: 213 IPK-------------NNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAKELLKHKFI 256

Query: 185 IRDSRAEAQMS 195
           +R ++  + ++
Sbjct: 257 VRFAKKTSYLT 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE-PSA 77
           L +A D   GL  +++     + NL S + L+  ++                S     + 
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY---KLKIICHGLEKILSSPPFKNV 181

Query: 78  TSLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
             + Y + +   +I+ + T + D+YS GV+L E+ TGK PF++L
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 6e-07
 Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 10/96 (10%)

Query: 29  LLYIHQ--NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN---PDSVEEPSATSLFYK 83
           LL +H   +  + H ++KS+N+LL ++    L D+G          D V      + +Y 
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 84  APECREIWKQP--TQQADVYSFGVLLLELLTGKTPF 117
           APE   IW++   +++AD++S GVLL ELLT K PF
Sbjct: 213 APE---IWRRKPYSKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 48.5 bits (115), Expect = 6e-07
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 22/175 (12%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    +  L D+G+ G   +  
Sbjct: 97  PLEETYIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQ--QADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  DL        
Sbjct: 156 IKRNTFVGTPFWMAPE---VIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-------- 204

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                 +R       + PP+      +  +  +    AC++  P  RP  +E+ K
Sbjct: 205 ----HPMRVLFLIPKNSPPTLEGQYSKPFKEFVE---ACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 6e-07
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 15/99 (15%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGA--DFESCLTDYGLGSFRNPDSVEEPS-------AT 78
           GL YIH +  + H +LK SN+LL    D + C  D+GL   R  D   + +       AT
Sbjct: 118 GLKYIH-SANVLHRDLKPSNLLLNTNCDLKIC--DFGLA--RIADPEHDHTGFLTEYVAT 172

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 173 R-WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 48.5 bits (116), Expect = 7e-07
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 2/95 (2%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-FRNPDSVEEPSATS 79
           +   L  GL Y+H+N  + H +LK SN+LL       + D+GL   +  P     P   +
Sbjct: 113 LMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVT 171

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGK 114
           L+Y+APE        T   D+++ G +L ELL  K
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.0 bits (114), Expect = 8e-07
 Identities = 41/168 (24%), Positives = 80/168 (47%), Gaps = 24/168 (14%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L+ + D+A G+ Y+ ++  L H +L + N+L+  D  + ++D+GL        V+  S  
Sbjct: 103 LQFSLDVAEGMEYL-ESKKLVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDN-SKL 159

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVRE 137
            + + APE  +  K+ + ++DV+S+GVLL E+ + G+ P+  + L+              
Sbjct: 160 PVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK----------- 207

Query: 138 EETESG--DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           E  E G   +PP      E     +  +  +C    P+ RP   ++ +
Sbjct: 208 ECVEKGYRMEPP------EGCPADVYVLMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 38/123 (30%), Positives = 60/123 (48%), Gaps = 21/123 (17%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++A GL ++H   G+ + +LK  NV+L ++    + D+G+      D V     T  F
Sbjct: 107 AAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV----TTKTF 161

Query: 82  -----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGSD 127
                Y APE   I  QP  +  D ++FGVLL E+L G+ PF+          ++EH   
Sbjct: 162 CGTPDYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219

Query: 128 IPR 130
            P+
Sbjct: 220 YPK 222

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.8 bits (113), Expect = 1e-06
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 19/129 (14%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G++Y+ +   L H +L + NVL+ +     +TD+GL      D  
Sbjct: 112 LNW--CVQIAK----GMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   +     + + A EC   +++ T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 165 EYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 223

Query: 122 LEHGSDIPR 130
           LE G  +P+
Sbjct: 224 LEKGERLPQ 232

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 20/181 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     + +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 96  GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIED 154

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+       G 
Sbjct: 155 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYP------GM 207

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
             P  ++++     E G   P  +   EE    L  +   C    PE RP    +  ++ 
Sbjct: 208 TNPEVIQNL-----ERGYRMPRPDNCPEE----LYELMRLCWKEKPEERPTFEYLRSVLE 258

Query: 187 D 187
           D
Sbjct: 259 D 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 15/163 (9%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT-SLFYK 83
           L S L ++H    + H ++K +NV + A     L D GLG F +  +    S   + +Y 
Sbjct: 115 LCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
           +PE R        ++D++S G LL E+   ++PF      +G  +  +      ++ E  
Sbjct: 174 SPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC---KKIEQC 223

Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D PP  ++   E+L+ L+N+   C++  PE RP +  V  + +
Sbjct: 224 DYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 32/176 (18%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+   + Y+  N G  H +L + N L+G D    ++D+GL  +   D       T
Sbjct: 103 LDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161

Query: 79  SLFYKAPECREIWKQP--------TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIP 129
               K       W  P        + ++DV+SFGVL+ E+ + GK P+            
Sbjct: 162 KFPVK-------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY-----------E 203

Query: 130 RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
           R+  S   E   +G        A  E    +  I  +C    PE+RP  +++   +
Sbjct: 204 RFSNSEVVESVSAGYRLYRPKLAPTE----VYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 5/97 (5%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP---SATSLF 81
           L  GL Y H      H ++K SN+LL    +  L D+GL    N +    P      +L+
Sbjct: 125 LLEGLNYCH-KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE-SRPYTNKVITLW 182

Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           Y+ PE     ++     DV+S G +L EL T K  FQ
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 12/101 (11%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT------ 78
           L   L YIH    + H +LK  N+L  AD +  + D+GL      D+   P+A       
Sbjct: 112 LLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT---PTAIFWTDYV 167

Query: 79  -SLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            + +Y+APE C   + + T   D++S G +  E+LTGK  F
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 11/103 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA--T 78
           IAE +   L ++HQ  G+ + ++K  N+LL ++    LTD+GL      +  E   +   
Sbjct: 111 IAE-IVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 79  SLFYKAPECREIWKQPT----QQADVYSFGVLLLELLTGKTPF 117
           ++ Y APE   + +  +    +  D +S GVL  ELLTG +PF
Sbjct: 169 TIEYMAPE---VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 21/123 (17%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A +++ GL ++H+  G+ + +LK  NV+L ++    + D+G+      + + +   T  F
Sbjct: 107 AAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTF 161

Query: 82  -----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGSD 127
                Y APE   I  QP  +  D +++GVLL E+L G+ PF           ++EH   
Sbjct: 162 CGTPDYIAPEI--IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219

Query: 128 IPR 130
            P+
Sbjct: 220 YPK 222

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 13/102 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++AS L Y+H +  + + +LK  N+LL +     LTD+GL      +++E    TS F
Sbjct: 102 AAEIASALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTF 156

Query: 82  -----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
                Y APE   + KQP  +  D +  G +L E+L G  PF
Sbjct: 157 CGTPEYLAPEV--LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 9/102 (8%)

Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-- 80
             +  GL Y+H      H ++K +N+L+  +    L D+G+        VE   A S   
Sbjct: 109 RQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKG 163

Query: 81  --FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
             ++ APE           AD++S G  +LE+ TGK P+  L
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 4e-06
 Identities = 29/119 (24%), Positives = 52/119 (43%), Gaps = 21/119 (17%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE---- 74
           L I   + + + Y+H   G+ H +LK  N+LLG   E  + D+G   F+  +  +     
Sbjct: 116 LSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 75  -PSATSLF--------------YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                  +              Y APE R +    ++  D+Y+ GV+L ++LT   P++
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPE-RLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Length = 932

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.8 bits (108), Expect = 4e-06
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 3/114 (2%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
             +     L     L  A D+A G+ Y+ Q     H +L + N+L+G ++ + + D+GL 
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLS 159

Query: 65  SFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
             +     +      + + A E    +   T  +DV+S+GVLL E+++ G TP+
Sbjct: 160 RGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 26/90 (28%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 29  LLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT-SLFYKAPEC 87
           L ++H N  + H ++KS N+LLG D    LTD+G  +   P+  +  +   + ++ APE 
Sbjct: 128 LEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
               K    + D++S G++ +E++ G+ P+
Sbjct: 187 -VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 45.8 bits (108), Expect = 5e-06
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 21/156 (13%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL---- 80
           L S + ++H    + H ++K +NV + A     L D GLG F    S +  +A SL    
Sbjct: 115 LCSAVEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTP 170

Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET 140
           +Y +PE R        ++D++S G LL E+   ++PF      +G  +  +      ++ 
Sbjct: 171 YYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLFSLC---QKI 220

Query: 141 ESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           E  D PP   E   EKL+ L+++   C+   P+ RP
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSM---CIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 45.5 bits (108), Expect = 6e-06
 Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 9/115 (7%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESC-LTDYGLGS 65
           G G+ L     + +A  +ASG+ Y+  QN    H +L + NVL+G +   C + D+GL  
Sbjct: 95  GAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLAR 151

Query: 66  FRNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
               D  E         K  APE   ++ + + ++DV+SFG+LL E++T G+ P+
Sbjct: 152 VIKEDIYEAREGAKFPIKWTAPEA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 45.6 bits (108), Expect = 6e-06
 Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 15/144 (10%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A  +  GL ++HQ   + + +LK  NVLL       ++D GL          +  A +  
Sbjct: 101 AAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159

Query: 82  YKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPR--WVRSVRE 137
           Y APE    E++       D ++ G  L E++ G++PF+         + +    R   E
Sbjct: 160 YMAPEVLQGEVYDFS---VDWFALGCTLYEMIAGRSPFRQ----RKEKVEKEELKRRTLE 212

Query: 138 EETESGDDPPSSNEASEEKLQALL 161
              E    P   +  +++  +ALL
Sbjct: 213 MAVEY---PDKFSPEAKDLCEALL 233

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 40  HGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSAT-SLFYKAPECREIW-KQPT 95
           H +L + N+LL  +    + D+GL    +++PD V + SA   L + APE   I+ K  T
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE--SIFDKVYT 254

Query: 96  QQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE 154
            Q+DV+SFGVLL E+ + G +P+  +              + EE  +   D  +   A E
Sbjct: 255 TQSDVWSFGVLLWEIFSLGASPYPGV-------------QINEEFCQRLKD-GTRMRAPE 300

Query: 155 EKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
                +  I +AC    P+ RP    + +++ D
Sbjct: 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 45.4 bits (107), Expect = 6e-06
 Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 22/169 (13%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           +K A D A+G+ Y+ ++    H +L + N L+G +    ++D+G+ S +  D +   S  
Sbjct: 96  VKFALDAAAGMAYL-ESKNCIHRDLAARNCLVGENNVLKISDFGM-SRQEDDGIYSSSGL 153

Query: 79  S---LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRS 134
               + + APE    + + + ++DV+S+G+LL E  + G  P+           P     
Sbjct: 154 KQIPIKWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPY-----------PGMTNQ 201

Query: 135 VREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
              E+ E G       +  ++    +  +   C    PENRP   E+ K
Sbjct: 202 QAREQVEKGYRMSCPQKCPDD----VYKVMQRCWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (108), Expect = 6e-06
 Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 18/128 (14%)

Query: 3   GTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG 62
           G R  G      W +   I  +   GL Y+H+N  + H ++K  N+LL  + E  L D+G
Sbjct: 102 GLRKKGKRLKEEWIA--YILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFG 158

Query: 63  LGSFRNPDSVEEPSATSL---FYKAPE---CREIWKQPT----QQADVYSFGVLLLELLT 112
           +      DS      T +   ++ APE   C E   QP      ++DV+S G+  +EL  
Sbjct: 159 VS--AQLDSTLGRRNTFIGTPYWMAPEVIACDE---QPDASYDARSDVWSLGITAIELAD 213

Query: 113 GKTPFQDL 120
           GK P  D+
Sbjct: 214 GKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 26/119 (21%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP----- 75
           I +D+ + L YIH   G  H ++K+S++LL  D +  L+       R   S+ +      
Sbjct: 106 ILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLS-----GLRYSVSMIKHGKRQR 159

Query: 76  --------SATSLFYKAPECREIWKQP----TQQADVYSFGVLLLELLTGKTPFQDLVL 122
                   S  +L + +PE   + +Q      +++D+YS G+   EL  G  PF+D+  
Sbjct: 160 VVHDFPKSSVKNLPWLSPE---VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.7 bits (108), Expect = 6e-06
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 13/102 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++AS + Y+H +  + + +LK  N+LL +     LTD+GL      + VE    TS F
Sbjct: 102 AAEVASAIGYLH-SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTF 156

Query: 82  -----YKAPECREIWKQPTQQA-DVYSFGVLLLELLTGKTPF 117
                Y APE   + K+P  +  D +  G +L E+L G  PF
Sbjct: 157 CGTPEYLAPEV--LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 7e-06
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 33/177 (18%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESC----LTDYGLGSFRNPDS 71
            K+A+ LAS L Y+ ++  L HGN+ + N+LL   G D E      L+D G+     P +
Sbjct: 108 FKVAKQLASALSYL-EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-----PIT 161

Query: 72  V--EEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLEL-LTGKTPFQDLVLEHGSDI 128
           V   +     + + APEC E  K  +  AD +SFG  L E+   G+ P +D  L   ++ 
Sbjct: 162 VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL---AEK 218

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            R+        T      PS  E        L ++   C++  P  RP  R + + I
Sbjct: 219 ERFYEGQCMLVT------PSCKE--------LADLMTHCMNYDPNQRPFFRAIMRDI 261

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 7e-06
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 11/102 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           IAE L   L ++H+   + + +LK  N+LL A     L D+GL      + + +   T+ 
Sbjct: 102 IAE-LVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLS---KAN-LTDNKTTNT 155

Query: 81  F-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           F     Y APE     K  T+  D +S GVL+ E+  G +PF
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.2 bits (107), Expect = 8e-06
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 16/109 (14%)

Query: 16  TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           T+C  ++E   + L ++HQ  G+ + +LK  N+LL A     LTD+GL      +S+ E 
Sbjct: 101 TACFYLSEISLA-LEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEG 154

Query: 76  SATSLF-----YKAPECREIWKQPTQQADV--YSFGVLLLELLTGKTPF 117
           + T  F     Y AP   EI  +      V  +S G L+ ++LTG  PF
Sbjct: 155 TVTHTFCGTIEYMAP---EILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (108), Expect = 8e-06
 Identities = 32/108 (29%), Positives = 55/108 (50%), Gaps = 17/108 (15%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG------SFRNPDSVEE 74
           I  ++  GL Y+H+  G  H ++K++N+LL  + +  L D+G+         +    V  
Sbjct: 103 ILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT 161

Query: 75  PSATSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDL 120
           P     F+ APE   + KQ    ++AD++S G+  +EL  G+ P  DL
Sbjct: 162 P-----FWMAPE---VIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 9e-06
 Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA 77
            + I E L + L YIH+  G+ H ++K++N+L+       L D+G+ +  N +S +  + 
Sbjct: 104 SVIIREVLVA-LKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161

Query: 78  T-SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
             + ++ APE     K    +AD++S G+ + E+ TG  P+ D+
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.2 bits (107), Expect = 9e-06
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 13/102 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++AS L Y+H +  + + +LK  N+LL +     LTD+GL      + +E    TS F
Sbjct: 102 AAEIASALGYLH-SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTF 156

Query: 82  -----YKAPECREIWKQPTQQA-DVYSFGVLLLELLTGKTPF 117
                Y APE   + KQP  +  D +  G +L E+L G  PF
Sbjct: 157 CGTPEYLAPEV--LRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 15/107 (14%)

Query: 16  TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           T CL +   L+    Y+H N G+ H ++KS ++LL +D    L+D+G   F    S E P
Sbjct: 122 TVCLSVLRALS----YLH-NQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVP 173

Query: 76  SATSL----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
              SL    ++ APE   I + P   + D++S G++++E++ G+ P+
Sbjct: 174 KRKSLVGTPYWMAPEV--ISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 31/118 (26%), Positives = 61/118 (51%), Gaps = 9/118 (7%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           G+ ++H + G+ H +LK SN+++ +D    + D+GL      + +  P   + +Y+APE 
Sbjct: 135 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETESGD 144
             +     +  D++S G ++ EL+ G   FQ      G+D I +W + + +  T S +
Sbjct: 194 I-LGMGYKENVDIWSVGCIMGELVKGSVIFQ------GTDHIDQWNKVIEQLGTPSAE 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 2/97 (2%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KI+  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 103 KISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 161

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP 116
             Y +PE R      T Q+D++S G+ L+E+  G+ P
Sbjct: 162 RSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 29/94 (30%), Positives = 53/94 (56%), Gaps = 11/94 (11%)

Query: 29  LLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL----FYKA 84
           L ++H   G+ H ++KS ++LL +D    L+D+G   F    S E P   SL    ++ A
Sbjct: 128 LSFLH-AQGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMA 183

Query: 85  PECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
           PE   I + P   + D++S G++++E++ G+ P+
Sbjct: 184 PEV--ISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 40/199 (20%)

Query: 2   TGTRTSGGGK-PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           +  R  G    PL  T  L IA+ +A+G+ Y+ +     H +L + N L+G +    + D
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIAD 173

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLE 109
           +GL   RN  S +       +YKA E   I   W  P        T ++DV+++GV+L E
Sbjct: 174 FGLS--RNIYSAD-------YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224

Query: 110 LLT-GKTPFQDLVLEHGSDIPRWVRSVREEETES-GDDPPSSNEASEEKLQALLNIAIAC 167
           + + G  P+  +  E        +  VR+    S  D+ P            L N+   C
Sbjct: 225 IFSYGMQPYYGMAHE------EVIYYVRDGNVLSCPDNCPLE----------LYNLMRLC 268

Query: 168 VSLAPENRPVMREVSKMIR 186
            S  P +RP    ++++++
Sbjct: 269 WSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 10/87 (11%)

Query: 38  LTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL----FYKAPECREIW-- 91
           + H +LKS+N+ L       L D+G  S +  DSV    A+S     +Y APE   +W  
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGF-SKQYSDSVSLDVASSFCGTPYYLAPE---LWER 245

Query: 92  KQPTQQADVYSFGVLLLELLTGKTPFQ 118
           K+ +++AD++S GV+L ELLT   PF+
Sbjct: 246 KRYSKKADMWSLGVILYELLTLHRPFK 272

Length = 478

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           S  G  +     +  +  +A G+ YI +     H +L+++NVL+       + D+GL   
Sbjct: 94  SDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARV 152

Query: 67  --RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL--- 120
              N  +  E +   + + APE    +   T ++DV+SFG+LL E++T GK P+  +   
Sbjct: 153 IEDNEYTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211

Query: 121 ----VLEHGSDIPR 130
                L+ G  +PR
Sbjct: 212 DVMSALQRGYRMPR 225

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 42/183 (22%), Positives = 83/183 (45%), Gaps = 33/183 (18%)

Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPDSVEEPSATSLF 81
           +++  GL Y+H    + H ++K++NVLL    +  L D+G+ G   +          + F
Sbjct: 108 KEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 82  YKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDL----VLEHGSDIPRWVRSV 135
           + APE   + +Q     +AD++S G+  +EL  G+ P  D+    VL     IP+     
Sbjct: 167 WMAPE---VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---IPKN---- 216

Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---MIRDSRAEA 192
               T +G+      E  +           AC++  P  RP  +E+ K   ++++++  +
Sbjct: 217 -NPPTLTGEFSKPFKEFID-----------ACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264

Query: 193 QMS 195
            ++
Sbjct: 265 YLT 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 21/153 (13%)

Query: 40  HGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSAT-SLFYKAPECREIW-KQPT 95
           H +L + N+LL  +    + D+GL    +++PD V +  A   L + APE   I+ K  T
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE--SIFDKVYT 253

Query: 96  QQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE 154
            Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E     G    +   A+ 
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRRLKE-----GTRMRAPEYATP 303

Query: 155 EKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
           E    +L     C    PE+RP   E+ +++ D
Sbjct: 304 EIYSIML----DCWHNNPEDRPTFSELVEILGD 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 24/112 (21%), Positives = 57/112 (50%), Gaps = 6/112 (5%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF-RNPDS 71
                 + +   +ASG+ Y+       H +L + N+L+ ++    ++D+GL     + ++
Sbjct: 103 FTVGQLVGMLRGIASGMKYL-SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161

Query: 72  VEEPSA--TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
                     + + APE    +++ T  +DV+SFG+++ E+++ G+ P+ D+
Sbjct: 162 TYTTKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 27/98 (27%), Positives = 51/98 (52%), Gaps = 3/98 (3%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATS 79
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P+ S       +
Sbjct: 121 VCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 180 PYWMAPEV-VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 26/98 (26%), Positives = 52/98 (53%), Gaps = 3/98 (3%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT-S 79
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P+  +  +   +
Sbjct: 120 VCRECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 179 PYWMAPEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 3/84 (3%)

Query: 37  GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT--SLFYKAPECREIWKQP 94
           G+ + ++K  N+LL ++    LTD+GL    + D VE   +   ++ Y AP+        
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 95  TQQA-DVYSFGVLLLELLTGKTPF 117
             +A D +S GVL+ ELLTG +PF
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 2/94 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  G+ + H+N  + H +LK  N+L+    E  L D+GL  +F  P +       +L+Y+
Sbjct: 109 LLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR 167

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     +  +   D++S G ++ E++TG+  F
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 3/114 (2%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           +  G    L     L+ A D+A+G+ Y+ +     H +L + NVL+G +  S + D+GL 
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-FIHRDLAARNVLVGENLASKIADFGLS 166

Query: 65  SFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
                   +      + + A E    +   T ++DV+SFGVLL E+++ G TP+
Sbjct: 167 RGEEVYVKKTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 20/104 (19%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLG--------ADFESCLTDYGLGSFRNPDSVEEPSATS 79
           GL Y+H N  + H ++K  NVL+         +DF +     G+    NP    E    +
Sbjct: 120 GLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI----NP--CTETFTGT 172

Query: 80  LFYKAPECREIWKQPT---QQADVYSFGVLLLELLTGKTPFQDL 120
           L Y APE   I K P      AD++S G  ++E+ TGK PF +L
Sbjct: 173 LQYMAPEV--IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 13/103 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++ S L+++H   G+ + +LK  NVLL  +    L D+G+      + +     TS F
Sbjct: 102 AAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTF 156

Query: 82  -----YKAPEC-REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                Y APE  +E+   P+   D ++ GVLL E+L G  PF+
Sbjct: 157 CGTPDYIAPEILQEMLYGPS--VDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 14/108 (12%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--------FRNPD 70
           L  A+ +  G+ Y+H    + H +L + NVLL  D    + D+GL          +R   
Sbjct: 110 LLFAQQICEGMAYLHSQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--- 165

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            V E   + +F+ A EC +  K  +  +DV+SFGV L ELLT     Q
Sbjct: 166 -VREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQ 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 24/134 (17%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-------FRNPDSV 72
           ++A ++A GLL++H+N    H +L   N LL AD    + DYGL         +  PD +
Sbjct: 104 RMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Query: 73  EEPSATSLFYKAPECRE------IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHG 125
             P    L + APE  +      +    T++++V+S GV + EL   G  P++     H 
Sbjct: 163 WVP----LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR-----HL 213

Query: 126 SDIPRWVRSVREEE 139
           SD      +VRE++
Sbjct: 214 SDEQVLTYTVREQQ 227

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 48/185 (25%), Positives = 73/185 (39%), Gaps = 40/185 (21%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           KPL       I      GL Y+H +    H ++K+ N+LL       L D+G  S  +P 
Sbjct: 110 KPLQEVEIAAICHGALQGLAYLH-SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168

Query: 71  S--VEEPSATSLFYKAPECREIWK----QPTQQADVYSFGVLLLELLTGKTPFQDL---- 120
           +  V  P     ++ APE   I      Q   + DV+S G+  +EL   K P  ++    
Sbjct: 169 NSFVGTP-----YWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPP--SSNEASEEKLQALLNIAIACVSLAPENRPVM 178
            L H +                 +D P  SSN+ S        N   +C+   P++RP  
Sbjct: 222 ALYHIAQ----------------NDSPTLSSNDWS----DYFRNFVDSCLQKIPQDRPSS 261

Query: 179 REVSK 183
            E+ K
Sbjct: 262 EELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 29/103 (28%), Positives = 56/103 (54%), Gaps = 13/103 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++   L+++H++ G+ + +LK  N+LL A+    L D+G+      + +     T+ F
Sbjct: 102 AAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTF 156

Query: 82  -----YKAPEC-REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                Y APE  +E+   P+   D ++ GVL+ E++ G+ PF+
Sbjct: 157 CGTPDYIAPEILQELEYGPS--VDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 3/93 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA--TSLFYKAP 85
           GL Y+H + G+ H ++K  N+L+ ++    + D+GL     PD  +  +    + +Y+AP
Sbjct: 115 GLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 86  ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           E     +  T   D++S G +  ELL  +  FQ
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 43.2 bits (102), Expect = 3e-05
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 25/186 (13%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           R       +     L+++ D A+G+ Y+       H +L + N L+G +    ++D+G+ 
Sbjct: 84  RKKKNRLTVK--KLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGM- 139

Query: 65  SFRNPDSVEEPSA----TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
           S      +   S       + + APE     +  T ++DV+S+G+LL E  + G TP+  
Sbjct: 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPY-- 196

Query: 120 LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMR 179
                    P        E  ESG   P+     EE    +  + + C +  PENRP   
Sbjct: 197 ---------PGMSNQQTRERIESGYRMPAPQLCPEE----IYRLMLQCWAYDPENRPSFS 243

Query: 180 EVSKMI 185
           E+   +
Sbjct: 244 EIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 11/102 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           + E +   L Y+H   G+ H ++KS ++LL  D    L+D+G   F    S + P   SL
Sbjct: 122 VCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSL 177

Query: 81  ----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
               ++ APE   I + P   + D++S G++++E++ G+ P+
Sbjct: 178 VGTPYWMAPEV--ISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 4/105 (3%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           L IA  +ASG++Y+  +    H +L + N L+GA+    + D+G+     + D       
Sbjct: 126 LHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 78  TSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
           T L  +  P    ++++ T ++DV+SFGV+L E+ T GK P+  L
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 10/87 (11%)

Query: 37  GLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLF-----YKAPECREI 90
           G+ + ++K  N+LL ++    LTD+GL   F +    EE   T  F     Y APE    
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS----EEKERTYSFCGTIEYMAPEIIRG 180

Query: 91  WKQPTQQADVYSFGVLLLELLTGKTPF 117
                +  D +S G+L+ ELLTG +PF
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 43.6 bits (102), Expect = 3e-05
 Identities = 27/98 (27%), Positives = 52/98 (53%), Gaps = 3/98 (3%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT-S 79
           +  +    L ++H N  + H ++KS NVLLG D    LTD+G  +   P+  +  +   +
Sbjct: 120 VCRECLQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 179 PYWMAPEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 43.2 bits (103), Expect = 4e-05
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 10/99 (10%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL Y H +  + H +LK  N+L+  D    L D+GL  +F  P         +L+Y+
Sbjct: 107 LLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR 165

Query: 84  APE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     +      +   D++S G +  E++TGK  F 
Sbjct: 166 APEILLGSKHY----STAVDIWSVGCIFAEMITGKPLFP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.1 bits (101), Expect = 4e-05
 Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 21/178 (11%)

Query: 9   GGKPLHWTS--CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS- 65
           G  P +  +   +K   D+ASG+ Y+  +    H +L + N +L  +   C+ D+GL   
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYL-SSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
             N D   +     +  K      +  +  T ++DV+SFGV + E+ T G+TP+  +   
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--- 218

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             S+I  ++R     +      PP         L  L ++  +C  L P++RP    +
Sbjct: 219 ENSEIYDYLR-----QGNRLKQPPDC-------LDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 3/110 (2%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +IA  +  GL Y+  +  + H ++K SN+L+    +  L D+G+ S +  +S+ +    +
Sbjct: 99  RIAVAVVKGLTYL-WSLKILHRDVKPSNMLVNTRGQVKLCDFGV-STQLVNSIAKTYVGT 156

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
             Y APE R   +Q    +DV+S G+  +EL  G+ P+  +    GS +P
Sbjct: 157 NAYMAPE-RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 11/101 (10%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++   L ++H+  G+ + +LK  NVLL AD    LTDYG+      + +     TS F
Sbjct: 102 AAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTF 156

Query: 82  -----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                Y APE     ++     D ++ GVL+ E++ G++PF
Sbjct: 157 CGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 29/103 (28%), Positives = 53/103 (51%), Gaps = 5/103 (4%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L + +D+  G+ Y+ +N    H +L + N L+ +     ++D+G+  +   D     S  
Sbjct: 103 LSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ 118
               K   PE    + + + ++DV+SFGVL+ E+ T GK PF+
Sbjct: 162 KFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 23/90 (25%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+APE 
Sbjct: 138 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +     +  D++S G ++ E++ G   F
Sbjct: 197 I-LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 42.6 bits (101), Expect = 5e-05
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 13/99 (13%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-----GSFRNPDSVEEPSATSLFY 82
           GL Y+H N    H ++K+ N+LL  + ++ L D+G+      +    ++V      + F+
Sbjct: 111 GLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV----IGTPFW 165

Query: 83  KAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            APE   I +     +AD++S G+  +E+  GK P+ D+
Sbjct: 166 MAPEV--IQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 5e-05
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 14/96 (14%)

Query: 35  NPGLTHGNLKSSNVLLGA-DFESC--LTDYGLGS----FRNPDSVEEPSATSLF----YK 83
           N G+ H +LK  N+++          + D+G+G+     R+ D       T +     Y 
Sbjct: 97  NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYC 156

Query: 84  APE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE  R   +  T  +D+Y++G++ LE LTG+   Q
Sbjct: 157 APEQLRG--EPVTPNSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.6 bits (100), Expect = 6e-05
 Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 4/102 (3%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           ++   D+ASG+ Y+  +    H +L + N +L  +   C+ D+GL     + D   +  A
Sbjct: 116 VRFMIDIASGMEYL-SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 78  TSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPF 117
           + L  K      +     T  +DV++FGV + E++T G+TP+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 5/109 (4%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 107 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
               K  APE     K   + +DV++FGVLL E+ T G +P+  + L  
Sbjct: 166 KFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 42.4 bits (100), Expect = 6e-05
 Identities = 31/102 (30%), Positives = 57/102 (55%), Gaps = 9/102 (8%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG--SFRNPDSVEEPS 76
           L  A D+  G+ Y+ +     H +L + NVL+  D  + ++D+GL   + +  DS + P 
Sbjct: 105 LGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP- 162

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
              + + APE     K+ + ++DV+SFG+LL E+ + G+ P+
Sbjct: 163 ---VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 42.7 bits (100), Expect = 6e-05
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 4/112 (3%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPD 70
            L     L IA  +ASG++Y+  +    H +L + N L+G      + D+G+     + D
Sbjct: 118 QLTLGQMLAIASQIASGMVYL-ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 71  SVEEPSATSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
                  T L  +  P    ++++ T ++D++SFGV+L E+ T GK P+  L
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 42.5 bits (101), Expect = 6e-05
 Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 14/94 (14%)

Query: 31  YIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF----YKAPE 86
           Y+H    + + +LK  N+LL +D    +TD+G   F       +    +L     Y APE
Sbjct: 116 YLHSL-DIVYRDLKPENLLLDSDGYIKITDFG---F---AKRVKGRTYTLCGTPEYLAPE 168

Query: 87  CREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
              I  +   +  D ++ G+L+ E+L G  PF D
Sbjct: 169 I--ILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 42.3 bits (99), Expect = 7e-05
 Identities = 38/165 (23%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----LFYK 83
           G+ Y+ +     H +L + NVLL     + ++D+GL      D     + T     + + 
Sbjct: 107 GMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY 165

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETES 142
           APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    G+++ + +        ES
Sbjct: 166 APECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGM---KGNEVTQMI--------ES 213

Query: 143 GDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
           G+          E    + ++   C +   + RP    V   +R+
Sbjct: 214 GERMECPQRCPPE----MYDLMKLCWTYGVDERPGFAVVELRLRN 254

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.4 bits (100), Expect = 7e-05
 Identities = 32/101 (31%), Positives = 45/101 (44%), Gaps = 23/101 (22%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLG-------ADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           GL Y+H+N  + + +LK  N+LL        ADF  C    G G             TS 
Sbjct: 113 GLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-----------RTST 160

Query: 81  FYKAPE--CREIW--KQPTQQADVYSFGVLLLELLTGKTPF 117
           F   PE    E+      T+  D +  GVL+ E+L G++PF
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 16/107 (14%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           + +++  L ++H+  G+ + +LK  NVLL A+    LTDYG+      + +     TS F
Sbjct: 102 SAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTF 156

Query: 82  -----YKAPECREIWKQPTQ--QADVYSFGVLLLELLTGKTPFQDLV 121
                Y AP   EI +        D ++ GVL+ E++ G++PF D+V
Sbjct: 157 CGTPNYIAP---EILRGEDYGFSVDWWALGVLMFEMMAGRSPF-DIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 42.3 bits (99), Expect = 8e-05
 Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 2/97 (2%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 165

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP 116
             Y +PE R      + Q+D++S G+ L+EL  G+ P
Sbjct: 166 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 42.3 bits (99), Expect = 8e-05
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 3/100 (3%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  A D+A G+ Y+ Q     H +L + N+L+G ++ + + D+GL   +     +     
Sbjct: 127 LHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + A E    +   T  +DV+S+GVLL E+++ G TP+
Sbjct: 186 PVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 21/147 (14%)

Query: 40  HGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSAT-SLFYKAPECREIW-KQPT 95
           H +L + N+LL  +    + D+GL    +++PD V +  A   L + APE   I+ +  T
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET--IFDRVYT 259

Query: 96  QQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE 154
            Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E     G    + +  + 
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-----GTRMRAPDYTTP 309

Query: 155 EKLQALLNIAIACVSLAPENRPVMREV 181
           E  Q +L+    C    P  RP   E+
Sbjct: 310 EMYQTMLD----CWHGEPSQRPTFSEL 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 13/102 (12%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++AS L Y+H +  + + +LK  N+LL +     LTD+GL      + + +   T+ F
Sbjct: 102 AAEIASALGYLH-SINIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTF 156

Query: 82  -----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
                Y APE   I KQP     D +  G +L E+L G  PF
Sbjct: 157 CGTPEYLAPEV--IRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 12/109 (11%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNPDSVEEPSATSL-- 80
           L  GL Y+H + G+ H ++K +N+ L  +    L D+G       N  ++ E   +    
Sbjct: 108 LLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Query: 81  -FYKAPECREIWKQPTQ----QADVYSFGVLLLELLTGKTPFQDLVLEH 124
             Y APE   I     +     AD++S G ++LE+ TGK P+ +L  E 
Sbjct: 167 PAYMAPEV--ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 24/166 (14%)

Query: 26  ASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPSATSLFY 82
           A G+ Y+       H +L + N +L   F   + D+GL      +   SV   +   L  
Sbjct: 108 AKGMEYLASKK-FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 83  KAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWV-RSVREEE 139
           K      +  Q  T ++DV+SFGVLL EL+T G  P+ D+      DI  ++ +  R  +
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLLQGRRLLQ 223

Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE-VSKM 184
            E   DP             L  + ++C    PE RP   E VS++
Sbjct: 224 PEYCPDP-------------LYEVMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 8/125 (6%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSAT 78
           A ++  GL ++H N  + + +LK +N+LL       ++D GL    S + P +    S  
Sbjct: 103 AAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 157

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +  Y APE  +        AD +S G +L +LL G +PF+    +   +I R   ++  E
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217

Query: 139 ETESG 143
             +S 
Sbjct: 218 LPDSF 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 3/121 (2%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++  GL  +HQ   + + +LK  N+LL       ++D GL          +    ++ 
Sbjct: 108 AAEICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166

Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE-HGSDIPRWVRSVREEET 140
           Y APE  +  ++ T   D ++ G LL E++ G++PFQ    +    ++ R V+ V+EE +
Sbjct: 167 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS 225

Query: 141 E 141
           E
Sbjct: 226 E 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 32/131 (24%)

Query: 4   TRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
           +R  G  + L   + LK   D+A G+ Y+  N    H +L + N +L  D   C+ D+GL
Sbjct: 101 SRLGGLPEKLPLQTLLKFMVDIALGMEYL-SNRNFIHRDLAARNCMLREDMTVCVADFGL 159

Query: 64  GSFRNPDSVEEPSATSLFYKAPECRE--IWKQP--------------TQQADVYSFGVLL 107
                         +   Y     R+  I K P              T ++DV++FGV +
Sbjct: 160 --------------SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 205

Query: 108 LELLT-GKTPF 117
            E+ T G+TP+
Sbjct: 206 WEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 27/102 (26%), Positives = 50/102 (49%), Gaps = 9/102 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC----LTDYGLGSFRNPDSV----EEPS 76
           + +G+ Y+H N  L H +LK +N+L+  +        + D GL    N         +P 
Sbjct: 117 ILNGVHYLHSNWVL-HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             +++Y+APE     +  T+  D+++ G +  ELLT +  F+
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 109 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 27/104 (25%), Positives = 61/104 (58%), Gaps = 11/104 (10%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +A+G+ Y+ +     H +L + N+L+ ++    ++D+GL  F   D+  +P+ TS     
Sbjct: 115 IAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-SDPTYTSSLGGK 172

Query: 80  --LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
             + + APE    +++ T  +DV+S+G+++ E+++ G+ P+ D+
Sbjct: 173 IPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 26/77 (33%), Positives = 41/77 (53%), Gaps = 5/77 (6%)

Query: 40  HGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPECREIWKQPT 95
           H +L + N+L+ ++    + D+GL      D     V EP  + +F+ APE     K  +
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF-S 189

Query: 96  QQADVYSFGVLLLELLT 112
             +DV+SFGV+L EL T
Sbjct: 190 VASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 8/116 (6%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           +PL       + +     L Y+H+N  + H +LK+ N+L   D +  L D+G+ S +N  
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENK-IIHRDLKAGNILFTLDGDIKLADFGV-SAKNTR 155

Query: 71  SVEEPSA--TSLFYKAPE---CREIWKQPTQ-QADVYSFGVLLLELLTGKTPFQDL 120
           +++   +   + ++ APE   C     +P   +ADV+S G+ L+E+   + P  +L
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 5/104 (4%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+  +  + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 103 LGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE     K  ++ +DV+SFGVL+ E+ + GKTP+++
Sbjct: 162 KFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSAT 78
           A ++  GL ++H N  + + +LK +N+LL       ++D GL    S + P +    S  
Sbjct: 103 ATEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 157

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +  Y APE  +        AD +S G +L +LL G +PF+    +   +I R   +V  E
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217

Query: 139 ETES 142
             +S
Sbjct: 218 LPDS 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 41.1 bits (97), Expect = 2e-04
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS--ATSLFY 82
           L  G+ Y+H N G+ H +LK +N+L+ AD    + D+GL    + +     S    + +Y
Sbjct: 108 LLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 83  KAPECREIWKQP--TQQADVYSFGVLLLELLTG 113
           +APE   ++         D+++ G +  ELL G
Sbjct: 167 RAPEL--LYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 11/101 (10%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           + +++  L Y+H+  G+ + +LK  NVLL ++    LTDYG+      + +     TS F
Sbjct: 102 SAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTF 156

Query: 82  -----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                Y APE     +      D ++ GVL+ E++ G++PF
Sbjct: 157 CGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 27/98 (27%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           +  G+L++H    + + ++K  NVLL       L+D GL    ++  ++ + + T+  Y 
Sbjct: 104 ITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN-GYM 161

Query: 84  APEC--REIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           APE    E +  P    D ++ G  + E++ G+TPF+D
Sbjct: 162 APEILKEEPYSYPV---DWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 33/185 (17%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
             + L     +  A  ++ G+ Y+ +   L H +L + NVL+    +  ++D+GL     
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMK-LVHRDLAARNVLVAEGRKMKISDFGLSR--- 175

Query: 69  PDSVEEPSATS-------LFYKAPEC--REIWKQPTQQADVYSFGVLLLELLT-GKTPFQ 118
            D  EE S          + + A E     I+   T Q+DV+SFGVLL E++T G  P+ 
Sbjct: 176 -DVYEEDSYVKRSKGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYP 231

Query: 119 DLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVM 178
            +  E   ++ +     R E  E+          SEE    + N+ + C    P+ RP  
Sbjct: 232 GIAPERLFNLLK--TGYRMERPEN---------CSEE----MYNLMLTCWKQEPDKRPTF 276

Query: 179 REVSK 183
            ++SK
Sbjct: 277 ADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 40.3 bits (94), Expect = 3e-04
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-FRNPDSVEEPSATSLFYKAPE 86
           G+ +IH+   L H ++KS N+ L  + +  L D+G      +P +       + +Y  PE
Sbjct: 112 GVQHIHEKRVL-HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170

Query: 87  CREIWKQ-P-TQQADVYSFGVLLLELLTGKTPFQ 118
              IW+  P   ++D++S G +L EL T K PFQ
Sbjct: 171 ---IWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 28/99 (28%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA--TSLFYKAP 85
            L ++H +  + H +LK+ N+LL  D +  L D+G+ S +N  ++++      + ++ AP
Sbjct: 115 ALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTFIGTPYWMAP 172

Query: 86  E---CREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
           E   C      P   +AD++S G+ L+EL   + P  +L
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 27/81 (33%), Positives = 33/81 (40%), Gaps = 3/81 (3%)

Query: 37  GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQ 96
           G  H +LK  N L+ A     LTD+GL       +       S  Y APE     K    
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLR-GKGYDF 177

Query: 97  QADVYSFGVLLLELLTGKTPF 117
             D +S G +L E L G  PF
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 13/116 (11%)

Query: 14  HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSV 72
              S    A  +A G+ ++     + H +L + NVL+  D    + D+GL     + D  
Sbjct: 133 DLVSF---AYQVARGMEFLASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 73  EEPSATSLFYK--APEC--REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
            + +   L  K  APE     ++   T Q+DV+SFGVLL E+ T G +P+  + +E
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 33/117 (28%), Positives = 60/117 (51%), Gaps = 6/117 (5%)

Query: 9   GGKPLHWTSC--LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-S 65
           G +P   T    L IA+ +A+G++Y+  +    H +L + N L+G +    + D+G+   
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 169

Query: 66  FRNPDSVEEPSATSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
             + D       T L  +  P    ++++ T ++DV+S GV+L E+ T GK P+  L
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 2/97 (2%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 165

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP 116
             Y +PE R      + Q+D++S G+ L+E+  G+ P
Sbjct: 166 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 40.3 bits (94), Expect = 4e-04
 Identities = 27/105 (25%), Positives = 57/105 (54%), Gaps = 15/105 (14%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT------ 78
           +A+G+ Y+  +    H +L + N+L+ ++ E  ++D+GL      D    P  T      
Sbjct: 116 IAAGMKYL-SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD----PEGTYTTSGG 170

Query: 79  --SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
              + + APE    +++ T  +DV+SFG+++ E+++ G+ P+ D+
Sbjct: 171 KIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 27/116 (23%), Positives = 53/116 (45%), Gaps = 18/116 (15%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG--------SFRNPDSVEEPS 76
           L  G+ Y+H+N  + H ++K++N+L+       + D+GL         + +         
Sbjct: 124 LLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 77  ATSL----FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
            T+L    +Y+ PE     ++ T   D++  G +  E+ T + P    +L+  SDI
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-P----ILQGKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 31  YIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRN-PDSVEEPSAT----SLFYKA 84
           YIH    + H +LK SN+LL +D    L D+GL  S     ++ E P  T    + +Y+A
Sbjct: 122 YIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE      + T+  D++S G +L E+L GK  F
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.2 bits (94), Expect = 4e-04
 Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 22/176 (12%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPS 76
           ++A ++A+G+ ++H++  L H +L   N  L +D    + DYG+G  R  +     E+  
Sbjct: 103 RMACEIAAGVTHMHKHNFL-HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161

Query: 77  ATSLFYKAPEC------REIWKQPTQQADVYSFGVLLLELL-TGKTPFQDLVLEHGSDIP 129
              L + APE         I  + T+ ++V++ GV L EL      P+  L     SD  
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-----SDRE 216

Query: 130 RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
                +++++ +     P       E+   +L        L+PE R    EV +++
Sbjct: 217 VLNHVIKDQQVKLFK--PQLELPYSERWYEVLQFCW----LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 40.2 bits (94), Expect = 4e-04
 Identities = 31/112 (27%), Positives = 46/112 (41%), Gaps = 12/112 (10%)

Query: 31  YIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI 90
           Y+H +  + + +LK  N+LL       +TD+G    + PD       T   Y APE  + 
Sbjct: 133 YLH-SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLCGTPE-YLAPEVIQS 189

Query: 91  WKQPTQQADVYSFGVLLLELLTGKTPFQD--------LVLEHGSDIPRWVRS 134
            K   +  D ++ GVLL E + G  PF D         +L      P W   
Sbjct: 190 -KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Length = 329

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 39.9 bits (93), Expect = 4e-04
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 8/104 (7%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVE--EPSATSLF 81
           ++ GL +IH    L H ++KS N+ L  +   + L D+G+    N DS+E       + +
Sbjct: 110 ISLGLKHIHDRKIL-HRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPY 167

Query: 82  YKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
           Y +PE C+   +    + D++S G +L EL T K PF+   L  
Sbjct: 168 YLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 40.0 bits (93), Expect = 4e-04
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 15/107 (14%)

Query: 16  TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
             CL + + L+     +    G+ H ++KS ++LL  D    L+D+G   F    S E P
Sbjct: 120 AVCLAVLKALS-----VLHAQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVP 171

Query: 76  SATSL----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
              SL    ++ APE   I + P   + D++S G++++E++ G+ P+
Sbjct: 172 RRKSLVGTPYWMAPEL--ISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 39.5 bits (93), Expect = 5e-04
 Identities = 32/99 (32%), Positives = 44/99 (44%), Gaps = 24/99 (24%)

Query: 31  YIHQNPGLTHGNLKSSNVLLGADFESCLTDYG----LGSFRNPDSVEEPSATSLF----- 81
           Y+H   G+ + +LK  N+LL ++    L D+G    L S +          T  F     
Sbjct: 108 YLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---------TWTFCGTPE 157

Query: 82  YKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQ 118
           Y APE   I          D +S G+LL ELLTG+ PF 
Sbjct: 158 YVAPE---IILNKGYDFSVDYWSLGILLYELLTGRPPFG 193

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 2/100 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYK 83
           L  GL Y H+   L H +LK  N+L+    E  L D+GL   ++ P         +L+Y+
Sbjct: 113 LLRGLNYCHRRKVL-HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYR 171

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
            P+        + Q D++  G +  E+ TG+  F    +E
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGAD---------FESCLTDYGLGSFRNPDSVEEPSAT 78
           GL Y+HQN G  H N+K+S++L+  D             L   G  + +      + S +
Sbjct: 113 GLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA-KVVYDFPQFSTS 170

Query: 79  SLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
            L + +PE  R+       ++D+YS G+   EL TG+ PFQD+
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 39.7 bits (92), Expect = 5e-04
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 24/179 (13%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           KPL       I      GL Y+H +  + H ++K+ N+LL    +  L D+G  S  +P 
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178

Query: 71  S--VEEPSATSLFYKAPECREIWK--QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
           +  V  P     ++ APE        Q   + DV+S G+  +EL   K P  ++      
Sbjct: 179 NSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------ 227

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
           +    +  + + E+ +      SNE S+       N   +C+   P++RP   E+ K +
Sbjct: 228 NAMSALYHIAQNESPT----LQSNEWSD----YFRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 39.7 bits (93), Expect = 6e-04
 Identities = 24/72 (33%), Positives = 41/72 (56%), Gaps = 6/72 (8%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSAT 78
           K+ + L +GL YIH+N  L H ++K++N+L+  D    L D+GL  +F    + +    T
Sbjct: 123 KVMKMLLNGLYYIHRNKIL-HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 79  ----SLFYKAPE 86
               +L+Y+ PE
Sbjct: 182 NRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 6e-04
 Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 43/191 (22%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG----ADFESC--- 57
           R   G  P+ W   + +A+ LAS L Y+ ++  L HGN+ + N+LL     A+  S    
Sbjct: 108 RKEKGRVPVAWK--ITVAQQLASALSYL-EDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 58  LTDYG--LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLEL-LTGK 114
           L+D G    +    + VE      + + APEC       +  AD +SFG  LLE+   G+
Sbjct: 165 LSDPGVSFTALSREERVER-----IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 115 TPFQDLVLEHGSDIPRWVRSVREEE----TESGDDPPSSNEASEEKLQALLNIAIACVSL 170
            P ++             R+  E+E     +     PS  E     L  L++    C++ 
Sbjct: 220 VPLKE-------------RTPSEKERFYEKKHRLPEPSCKE-----LATLIS---QCLTY 258

Query: 171 APENRPVMREV 181
            P  RP  R +
Sbjct: 259 EPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 39.6 bits (92), Expect = 6e-04
 Identities = 30/106 (28%), Positives = 55/106 (51%), Gaps = 8/106 (7%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA--T 78
           I   +   L Y+H    + H +LK+ NVLL  D +  L D+G+ S +N  +++   +   
Sbjct: 115 ICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGV-SAKNVKTLQRRDSFIG 172

Query: 79  SLFYKAPE---CREIWKQPTQ-QADVYSFGVLLLELLTGKTPFQDL 120
           + ++ APE   C  +   P   +AD++S G+ L+E+   + P  +L
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 6/99 (6%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +      GL ++H N  + H +LK  N+L+ +  +  L D+GL    +      P   +L
Sbjct: 113 LMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTL 171

Query: 81  FYKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE   +  +  P    D++S G +  E+   K  F
Sbjct: 172 WYRAPEVLLQSTYATPV---DMWSVGCIFAEMFRRKPLF 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 7e-04
 Identities = 15/46 (32%), Positives = 30/46 (65%), Gaps = 1/46 (2%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           I +D+ + L YIH++ G++HG++K  N+++  +    + DYG+ S 
Sbjct: 131 IMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYIIDYGIASH 175

Length = 294

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.3 bits (91), Expect = 9e-04
 Identities = 23/90 (25%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+APE 
Sbjct: 131 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +     +  D++S G ++ E++  K  F
Sbjct: 190 I-LGMGYKENVDIWSVGCIMGEMVRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 6/98 (6%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD----SVEE 74
           LK A  +  G+ Y+       H +L + NVL+ ++ +  + D+GL      D    +V++
Sbjct: 112 LKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170

Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC  I  +    +DV+SFGV L ELLT
Sbjct: 171 DLDSPVFWYAPECL-IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.001
 Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 16/93 (17%)

Query: 9   GGKPLH---WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
            G+ L      +   +  ++   +  +H+  G+ HG+L +SN++L         D+GLG 
Sbjct: 82  EGELLKDALEEARPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGG-RIYFIDFGLGE 139

Query: 66  FRNPDSVE---------EPSATSLFYKAPECRE 89
           F   D VE         E +  S   KA E   
Sbjct: 140 FS--DEVEDKAVDLHVLERALESTHEKAEELFA 170

Length = 204

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 22/119 (18%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             L  +  L+IA  +ASG++Y+  +    H +L + N L+G D    + D+G+   R+  
Sbjct: 117 GELTLSQLLQIAVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS--RDVY 173

Query: 71  SVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-GKTPF 117
           + +       +Y+      +   W  P        T ++DV+SFGV+L E+ T GK P+
Sbjct: 174 TTD-------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 2/94 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYK 83
           L  GL YIHQ   + H +LK  N+L+    E  L D+GL   ++ P         +L+Y+
Sbjct: 112 LLRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYR 170

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            P+      + +   D++  G + +E++ G   F
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 38.7 bits (91), Expect = 0.001
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 2/95 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L SG+ ++H N  L H +LK+SN+LL       + D+GL   + +P         +L+Y+
Sbjct: 115 LLSGVAHLHDNWIL-HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K+ +   D++S G +  ELLT K  F 
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 16/103 (15%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS------FRNPDSVEEPSATSLF 81
           GL ++H N  + H ++K +N+LL  +    L D+G+ +       R   SV  P     F
Sbjct: 140 GLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP-----F 193

Query: 82  YKAPE---CREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
           + APE   C + +      + DV+S G+  +EL  G  P  D+
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 36/124 (29%), Positives = 57/124 (45%), Gaps = 13/124 (10%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDSVEE----PSATS 79
           L  GL YIH +  + H +LK +NV +   D    + D+GL    +P    +        +
Sbjct: 123 LLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 80  LFYKAPECREIWKQP---TQQADVYSFGVLLLELLTGKTPFQ-DLVLEHGSDIPRWVRSV 135
            +Y++P    +   P   T+  D+++ G +  E+LTGK  F     LE    I   V  V
Sbjct: 182 KWYRSPR---LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 136 REEE 139
           REE+
Sbjct: 239 REED 242

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 37/143 (25%), Positives = 49/143 (34%), Gaps = 47/143 (32%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL----------------- 63
           IAE L   +  +H   G  H ++K  N+L+  D    LTD+GL                 
Sbjct: 107 IAE-LTCAIESVH-KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 64  ----GSFRNPDSVEEPS-------------------ATSLF----YKAPECREIWKQPTQ 96
                S    +   E                     A SL     Y APE        TQ
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQ 223

Query: 97  QADVYSFGVLLLELLTGKTPFQD 119
             D +S GV+L E+L G+ PF  
Sbjct: 224 LCDWWSVGVILYEMLVGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 2/97 (2%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPE 86
           GL Y H+   L H +LK  N+L+    E  L D+GL   ++ P         +L+Y+ P+
Sbjct: 116 GLAYCHRRKVL-HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174

Query: 87  CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
                 + + Q D++  G +  E+ +G+  F    +E
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 38.5 bits (90), Expect = 0.001
 Identities = 28/106 (26%), Positives = 54/106 (50%), Gaps = 11/106 (10%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+APE 
Sbjct: 130 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188

Query: 88  REIWKQPTQQ-ADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRW 131
             I     ++  D++S G ++ E++ G   F       G+D I +W
Sbjct: 189 --ILGMGYKENVDIWSVGCIMGEMIRGTVLFP------GTDHIDQW 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 2/94 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYK 83
           L  GL YIH    L H +LK  N+L+    E  L D+GL   ++ P         +L+Y+
Sbjct: 112 LLRGLAYIHGQHIL-HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            P+        +   D++  G + +E+L G+  F
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 17/97 (17%)

Query: 32  IHQNPGLTHGNLKSSNVLLG-------ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +HQ  G  H ++K  NVLL        ADF SCL     G+ ++  +V  P      Y +
Sbjct: 118 VHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD-----YIS 171

Query: 85  PECREIWKQPT----QQADVYSFGVLLLELLTGKTPF 117
           PE  +  +        + D +S GV + E+L G+TPF
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 40/183 (21%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
            PL     + +   +A G+ ++  N    H +L + N L+ +  E  ++   L   ++  
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVY 168

Query: 71  SVE----EPSATSLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
           + E      +   L + APE  +E     + ++DV+SFGVL+ E+ T G+ PF  L  E 
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE- 225

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
                  +  ++  + E     P    +   KL         C ++ P++RP   E+   
Sbjct: 226 -----EVLNRLQAGKLEL--PVPEGCPSRLYKLMT------RCWAVNPKDRPSFSELVSA 272

Query: 185 IRD 187
           + +
Sbjct: 273 LGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 41/190 (21%), Positives = 76/190 (40%), Gaps = 38/190 (20%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           +PL     L I + +  GL Y+H    + H ++K+ N+ +    + C+ D G   F    
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLGAAQF---- 206

Query: 71  SVEEPS----ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
            V  P+    A ++   APE     K  + +AD++S G++L E+L               
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNS-KADIWSAGIVLFEMLA-------------- 251

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPE---NRPVMREVSK 183
               +  ++ E+   + ++   S  +   K+       I+ + + PE     P  R V  
Sbjct: 252 ----YPSTIFEDPPSTPEEYVKSCHSHLLKI-------ISTLKVHPEEFPRDPGSRLVRG 300

Query: 184 MIRDSRAEAQ 193
            I  +  E Q
Sbjct: 301 FIEYASLERQ 310

Length = 357

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 37.9 bits (88), Expect = 0.002
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 29/172 (16%)

Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLG--------ADFESC--LTDYGLGSFRNPDSV 72
           E L  GL Y+H+N  + H ++K +N+L+         ADF +   L   G G+       
Sbjct: 110 EQLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA----GEF 164

Query: 73  EEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ-DLVLEHGSDIPRW 131
           +     ++ + APE     +Q  +  DV+S G +++E+ T K P+  +    H + I + 
Sbjct: 165 QGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK- 222

Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                     S    PS     E     L ++ + C+ L PE+RP  RE+ K
Sbjct: 223 --------IASATTAPS---IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 38.0 bits (89), Expect = 0.002
 Identities = 46/165 (27%), Positives = 61/165 (36%), Gaps = 43/165 (26%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL----------------- 63
           IAE L   L  +H+  G  H ++K  N+L+ AD    L D+GL                 
Sbjct: 107 IAE-LVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 64  --GSFRNPDSVEEPSATSLF-----------YKAPE--CREIWKQPTQQADVYSFGVLLL 108
               FR+   V                    Y APE            + D +S GV+L 
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILY 221

Query: 109 ELLTGKTPF-QDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
           E+L G  PF  D + E  + I  W  S+R        DPP S EA
Sbjct: 222 EMLYGFPPFYSDTLQETYNKIINWKESLRFP-----PDPPVSPEA 261

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 10/99 (10%)

Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    F  
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCG 158

Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
              Y APE  E      +  D +  GV++ E++ G+ PF
Sbjct: 159 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 38.1 bits (89), Expect = 0.002
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 8/90 (8%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE------EPSATSLF 81
           GL YIH +  + H +LK SN+L+  D E  + D+G+    +    E      E  AT  +
Sbjct: 119 GLKYIH-SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176

Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELL 111
           Y+APE      + T   D++S G +  E+L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 6/106 (5%)

Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSL 80
           A  +A G+ Y+     + H +L + NVL+  D    + D+GL     N D  ++ +   L
Sbjct: 140 AYQVARGMEYLASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 81  FYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
             K  APE     +  T Q+DV+SFGVLL E+ T G +P+  + +E
Sbjct: 199 PVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 2/94 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYK 83
           L  GL Y H+   L H +LK  N+L+    E  L D+GL   ++ P         +L+Y+
Sbjct: 112 LLRGLSYCHKRKIL-HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYR 170

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            P+      + +   D++  G +L E+ TG+  F
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 37.5 bits (87), Expect = 0.003
 Identities = 50/191 (26%), Positives = 72/191 (37%), Gaps = 59/191 (30%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESC-----LTDYGLGSFRNPD 70
           L++A+ LA  L ++    GLTHGN+ + NVLL               L+D G+     P 
Sbjct: 103 LEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP- 160

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPR 130
             +E     + +  PEC E  +  +  AD +SFG  L E+                    
Sbjct: 161 --KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF------------------- 199

Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQ--------------ALLNIAIACVSLAPENRP 176
                      SG D P S   S++KLQ               L N+   C+   P+ RP
Sbjct: 200 -----------SGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRP 248

Query: 177 VMREVSKMIRD 187
             R +   IRD
Sbjct: 249 SFRAI---IRD 256

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 22/122 (18%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
                L  +  L IA  +A+G+ Y+  +    H +L + N L+G      ++D+GL   R
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGL--SR 172

Query: 68  NPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-GKT 115
           +  S +       +Y+      +   W  P        T ++D++SFGV+L E+ + G  
Sbjct: 173 DIYSAD-------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225

Query: 116 PF 117
           P+
Sbjct: 226 PY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 21/183 (11%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
           G  P      +++A ++A G+ Y++      H +L + N ++  DF   + D+G+     
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170

Query: 69  PDSVEEPSATSLF---YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
                      L    + APE  +     T  +D++SFGV+L E+ +  + P+Q L  E 
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
              + ++V      +    D P    +   E++  L+ +   C    P+ RP   E+  +
Sbjct: 230 ---VLKFVM-----DGGYLDQP----DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNL 274

Query: 185 IRD 187
           ++D
Sbjct: 275 LKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 37.4 bits (87), Expect = 0.003
 Identities = 34/123 (27%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           S +  +  L++ L Y+  +    H ++ + NVL+ +     L D+GL  +   +S  + S
Sbjct: 108 SLILYSYQLSTALAYLE-SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS 166

Query: 77  ATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------VLEHGS 126
              L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ +        +E+G 
Sbjct: 167 KGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225

Query: 127 DIP 129
            +P
Sbjct: 226 RLP 228

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 37.4 bits (87), Expect = 0.003
 Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 2/93 (2%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYKAP 85
            G+L+ H    L H +LK  N+L+       L D+GL  +F  P  V      +L+Y+AP
Sbjct: 112 QGILFCHSRRVL-HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170

Query: 86  ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           E      + +   D++S G +  E+ T K  F 
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 37.3 bits (86), Expect = 0.003
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVL-LGADFESC---LTDYGLGSFRN----PDSVEEPSATS 79
           G+ Y+H N  + H +LK +N+L +G   E     + D G     N    P +  +P   +
Sbjct: 120 GIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            +Y+APE     +  T+  D+++ G +  ELLT +  F 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 37.3 bits (86), Expect = 0.003
 Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 10/111 (9%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           KPL       I      GL Y+H +  + H ++K+ N+LL    +  L D+G  S  +P 
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174

Query: 71  S--VEEPSATSLFYKAPECREIWK--QPTQQADVYSFGVLLLELLTGKTPF 117
           +  V  P     ++ APE        Q   + DV+S G+  +EL   K P 
Sbjct: 175 NSFVGTP-----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 37/196 (18%)

Query: 4   TRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
              +    P      +++A ++A G+ Y++ N    H +L + N ++  DF   + D+G+
Sbjct: 107 MENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGM 165

Query: 64  G-SFRNPDSVEEPSATSLFYKAPECREIWKQP--------TQQADVYSFGVLLLELLT-G 113
                  D   +     L  +       W  P        T  +DV+SFGV+L E+ T  
Sbjct: 166 TRDIYETDYYRKGGKGLLPVR-------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218

Query: 114 KTPFQDLVLEHGSDIPRWVRSVREEETESG--DDPPSSNEASEEKLQALLNIAIACVSLA 171
           + P+Q +  E    + R+V        E G  D P +  +        L  +   C    
Sbjct: 219 EQPYQGMSNEQ---VLRFV-------MEGGLLDKPDNCPD-------MLFELMRMCWQYN 261

Query: 172 PENRPVMREVSKMIRD 187
           P+ RP   E+   I++
Sbjct: 262 PKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 16/103 (15%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS------FRNPDSVEEPSATSLF 81
           GL ++H N  + H ++K +N+LL  +    L D+G+ +       R   SV  P     F
Sbjct: 136 GLQHLHVNKTI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP-----F 189

Query: 82  YKAPEC----REIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           + APE     +++      + DV+S G+  +EL  G  P  DL
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 32/117 (27%), Positives = 58/117 (49%), Gaps = 6/117 (5%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNP 69
           + + +   +     +A G+ Y+     + H +L + NVL+  +    + D+GL     N 
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNI 190

Query: 70  DSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
           D  ++ +   L  K  APE     +  T Q+DV+SFGVL+ E+ T G +P+  + +E
Sbjct: 191 DYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 37.0 bits (85), Expect = 0.004
 Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 16/110 (14%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS------FRNPDSVEE 74
           I  ++  GL ++HQ+  + H ++K  NVLL  + E  L D+G+ +       R    +  
Sbjct: 116 ICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174

Query: 75  PSATSLFYKAPECREIWKQPTQ----QADVYSFGVLLLELLTGKTPFQDL 120
           P     ++ APE     + P      ++D++S G+  +E+  G  P  D+
Sbjct: 175 P-----YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 36.8 bits (85), Expect = 0.004
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 18/154 (11%)

Query: 29  LLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           L ++H    + H +LK+ N+LL        + D+G+    +  S       +  Y +PE 
Sbjct: 114 LHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPP 147
            E  K   Q++D+++ G +L EL + K  F+       +++P  V  +      SG   P
Sbjct: 173 CE-GKPYNQKSDIWALGCVLYELASLKRAFE------AANLPALVLKIM-----SGTFAP 220

Query: 148 SSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
            S+  S +  Q +L++    ++L P  RP + ++
Sbjct: 221 ISDRYSPDLRQLILSM----LNLDPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 37.0 bits (85), Expect = 0.004
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVL-LGADFESC---LTDYGLGSFRN----PDSVEEPSATS 79
           G+ Y+H N  + H +LK +N+L +G   E     + D G     N    P +  +P   +
Sbjct: 120 GIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            +Y+APE     +  T+  D+++ G +  ELLT +  F 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 36.8 bits (85), Expect = 0.004
 Identities = 24/101 (23%), Positives = 58/101 (57%), Gaps = 7/101 (6%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNPDSVEEPSA--TSL 80
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      +P++          +
Sbjct: 115 IASGMKYL-SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173

Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
            + APE    +++ T  +DV+S+G+++ E+++ G+ P+ ++
Sbjct: 174 RWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 37.0 bits (85), Expect = 0.004
 Identities = 27/112 (24%), Positives = 54/112 (48%), Gaps = 4/112 (3%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           PL  +    ++ +   GL Y+H + G  H ++K +N+LL  +    L D+G+ +      
Sbjct: 102 PLSESQIAYVSRETLQGLYYLH-SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160

Query: 72  VEEPS-ATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDL 120
            +  S   + ++ APE   + ++    Q  D+++ G+  +EL   + P  DL
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	221
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.98
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.95
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
PHA03209	357	serine/threonine kinase US3; Provisional	99.94
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.94
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.94
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.94
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.93
PHA03211	461	serine/threonine kinase US3; Provisional	99.93
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
KOG0584	632	consensus Serine/threonine protein kinase [General	99.93
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.93
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.93
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.93
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.93
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.93
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.93
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.93
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.93
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.93
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.93
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.92
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.92
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.92
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.92
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.92
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.92
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.92
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.92
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.92
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.92
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.92
PHA03210	501	serine/threonine kinase US3; Provisional	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.92
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.92
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.92
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.92
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.92
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.92
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.92
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.92
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.92
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.92
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.92
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.92
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.92
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.92
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.92
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.92
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.92
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.92
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.92
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.92
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.92
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.92
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
KOG0605	550	consensus NDR and related serine/threonine kinases	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.91
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.91
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.91
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.91
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.91
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
PLN00009	294	cyclin-dependent kinase A; Provisional	99.91
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.9
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.9
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.9
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.9
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.9
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.9
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.89
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.89
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.89
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.89
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.89
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.89
KOG0610	459	consensus Putative serine/threonine protein kinase	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.89
KOG3653	534	consensus Transforming growth factor beta/activin	99.89
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.89
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.88
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.88
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.88
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.88
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
KOG0586	596	consensus Serine/threonine protein kinase [General	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.86
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.86
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.86
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.86
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.84
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.83
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.83
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.83
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.83
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.83
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.82
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.82
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.81
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.81
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.78
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.77
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.7
KOG1152	772	consensus Signal transduction serine/threonine kin	99.69
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.65
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.64
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.64
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.63
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.56
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.56
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.54
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.49
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.45
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.43
COG4248	637	Uncharacterized protein with protein kinase and he	99.22
PRK12274	218	serine/threonine protein kinase; Provisional	99.12
PRK09188	365	serine/threonine protein kinase; Provisional	99.06
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.05
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.03
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.01
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	98.98
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	98.97
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.85
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.77
smart00090	237	RIO RIO-like kinase.	98.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.56
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.43
PRK10345	210	hypothetical protein; Provisional	98.38
PRK14879	211	serine/threonine protein kinase; Provisional	98.38
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.33
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.17
KOG1243	690	consensus Protein kinase [General function predict	98.15
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.03
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.96
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.82
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.31
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.26
PRK09902	216	hypothetical protein; Provisional	97.15
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	96.69
KOG3087	229	consensus Serine/threonine protein kinase [General	96.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.31
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	96.06
COG0478	304	RIO-like serine/threonine protein kinase fused to	95.82
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	95.81
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	95.74
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	95.68
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.04
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	92.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.35
PRK05231	319	homoserine kinase; Provisional	91.72
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.42
PF01636	239	APH: Phosphotransferase enzyme family This family	90.91
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	90.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	90.53
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	90.37
PRK10271	188	thiK thiamine kinase; Provisional	90.36
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	90.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	90.31
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	90.3
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	90.14
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	89.74
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	89.51
COG0661	517	AarF Predicted unusual protein kinase [General fun	88.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	88.38
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	87.55
PLN02236	344	choline kinase	87.52
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	86.37
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	85.72
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	85.6
COG2334	331	Putative homoserine kinase type II (protein kinase	85.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	84.48
KOG1235	538	consensus Predicted unusual protein kinase [Genera	82.55
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	81.18
KOG1093	725	consensus Predicted protein kinase (contains TBC a	80.41

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=227.74  Aligned_cols=169  Identities=30%  Similarity=0.453  Sum_probs=136.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCC-ceeeCcCCCCeEEcCCC-ceEEeccCCccccCCC-CCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPG-LTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPD-SVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~-i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~p   85 (221)
                      ..+.+++..++.++.||+.||.|||+. + |+|||||+.|+|++.++ ++||+|||+++..... ...+...||..||||
T Consensus       135 ~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAP  213 (362)
T KOG0192|consen  135 RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAP  213 (362)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccCh
Confidence            468999999999999999999999998 8 99999999999999998 9999999999766544 233447889999999


Q ss_pred             ccchh-cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREI-WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~-~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+.. ...++.++||||||+++||+++|+.||.+...      ......+    .....++..+..    ++..+..+|
T Consensus       214 Ev~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v----~~~~~Rp~~p~~----~~~~l~~l~  279 (362)
T KOG0192|consen  214 EVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAV----VVGGLRPPIPKE----CPPHLSSLM  279 (362)
T ss_pred             hhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHH----HhcCCCCCCCcc----CCHHHHHHH
Confidence            99873 24789999999999999999999999975321      1222222    122233332333    334699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+||+.||.+||++.+|+..|+.+....
T Consensus       280 ~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  280 ERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             HHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999988754

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=230.61  Aligned_cols=166  Identities=26%  Similarity=0.503  Sum_probs=138.5

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCc
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAP   85 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~p   85 (221)
                      +.++.+...+.+.++.||++|++||+++ ++|||||.++|||++.+..+||+|||+++......  ......-+..|.||
T Consensus       295 ~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAP  373 (468)
T KOG0197|consen  295 REGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAP  373 (468)
T ss_pred             cCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCH
Confidence            5678899999999999999999999998 99999999999999999999999999998443322  22233346679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++||||||+++||++| |+.||.      ++.....++.+     ..+.+++.+..|++    .+.++|
T Consensus       374 Ea~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~------~msn~ev~~~l-----e~GyRlp~P~~CP~----~vY~lM  437 (468)
T KOG0197|consen  374 EALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYP------GMSNEEVLELL-----ERGYRLPRPEGCPD----EVYELM  437 (468)
T ss_pred             HHHh-hCCcccccceeehhhhHHHHhccCCCCCC------CCCHHHHHHHH-----hccCcCCCCCCCCH----HHHHHH
Confidence            9998 7888999999999999999999 999997      44444555554     34556666666655    599999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ..||..+|++||||..+...|+++..
T Consensus       438 ~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  438 KSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            99999999999999999999988764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=219.85  Aligned_cols=162  Identities=22%  Similarity=0.340  Sum_probs=131.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.+++....+++.+|+.||.|||..++|+||||||.|+|++.+|.+||+|||.++..... ...+..||..||+||.+. 
T Consensus       173 g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~-  250 (364)
T KOG0581|consen  173 GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERIS-  250 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhc-
Confidence            668999999999999999999996449999999999999999999999999999876655 557789999999999997 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..|+.++||||||+.++|++.|+.||...    ......+...+..-....++..|.. .++    .+++.|+..||++
T Consensus       251 g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~----~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS----~ef~~FV~~CL~K  321 (364)
T KOG0581|consen  251 GESYSVKSDIWSLGLSLLELAIGRFPYPPP----NPPYLDIFELLCAIVDEPPPRLPEG-EFS----PEFRSFVSCCLRK  321 (364)
T ss_pred             CCcCCcccceecccHHHHHHhhCCCCCCCc----CCCCCCHHHHHHHHhcCCCCCCCcc-cCC----HHHHHHHHHHhcC
Confidence            789999999999999999999999999753    1112233333333333233333322 233    4599999999999


Q ss_pred             CCCCCCCHHHHHH
Q 048055          171 APENRPVMREVSK  183 (221)
Q Consensus       171 dp~~Rps~~~l~~  183 (221)
                      ||.+||++.++++
T Consensus       322 dp~~R~s~~qLl~  334 (364)
T KOG0581|consen  322 DPSERPSAKQLLQ  334 (364)
T ss_pred             CcccCCCHHHHhc
Confidence            9999999999964

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.98  E-value=2.4e-32  Score=211.04  Aligned_cols=173  Identities=20%  Similarity=0.292  Sum_probs=140.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~   87 (221)
                      ....++...+.+++.|++.|+.|||++ +++||||||+|||+++++.+|++|||+|+... +....+....|.+|+|||.
T Consensus        94 ~p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPEL  172 (396)
T KOG0593|consen   94 YPNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPEL  172 (396)
T ss_pred             ccCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhh
Confidence            345678899999999999999999999 99999999999999999999999999998776 5556667788999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccc---------cccCCChHHHHHHhhhhhhccCCCCCCCChhh-----
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLV---------LEHGSDIPRWVRSVREEETESGDDPPSSNEAS-----  153 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  153 (221)
                      +.+...|+..+||||+||++.||++|++.|++..         ...+..++.....+.....+.+.+.|.+....     
T Consensus       173 LvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k  252 (396)
T KOG0593|consen  173 LVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERK  252 (396)
T ss_pred             hcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhh
Confidence            9877899999999999999999999999998643         22344455555555555555554444332211     


Q ss_pred             -HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048055          154 -EEKLQALLNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       154 -~~~~~~l~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                       +.....+.+|+..|++.||++|+++++++
T Consensus       253 ~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  253 YPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             cccchHHHHHHHHHHhcCCccccccHHHHh
Confidence             12234799999999999999999999996

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.4e-31  Score=221.45  Aligned_cols=157  Identities=23%  Similarity=0.392  Sum_probs=131.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .++|++..+..++.||+.||.|||+. +|+|||||-.|++++.+..+||+|||+|.... .+....+..||+.|.|||++
T Consensus       112 rk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl  190 (592)
T KOG0575|consen  112 RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVL  190 (592)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHh
Confidence            68899999999999999999999999 99999999999999999999999999997765 44667889999999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ....+..+||||+||++|.++.|++||+.      ..+...+.++....    +..|.      .......+||..+|
T Consensus       191 ~-k~gHsfEvDiWSlGcvmYtLL~G~PPFet------k~vkety~~Ik~~~----Y~~P~------~ls~~A~dLI~~lL  253 (592)
T KOG0575|consen  191 N-KSGHSFEVDIWSLGCVMYTLLVGRPPFET------KTVKETYNKIKLNE----YSMPS------HLSAEAKDLIRKLL  253 (592)
T ss_pred             c-cCCCCCchhhhhhhhHHHhhhhCCCCccc------chHHHHHHHHHhcC----ccccc------ccCHHHHHHHHHHh
Confidence            7 67778999999999999999999999973      33334444444333    33332      11235889999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.||.+|||+++|+..
T Consensus       254 ~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  254 RPNPSERPSLDEVLDH  269 (592)
T ss_pred             cCCcccCCCHHHHhcC
Confidence            9999999999999754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=214.09  Aligned_cols=156  Identities=21%  Similarity=0.346  Sum_probs=127.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--------------CCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--------------EEP   75 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--------------~~~   75 (221)
                      -+.|+...+..++.+|+.||.|||+. |||||||||+|||++.+++++|.|||-++.+.....              ...
T Consensus       168 ~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~S  246 (604)
T KOG0592|consen  168 YGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSS  246 (604)
T ss_pred             hCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccc
Confidence            36788889999999999999999998 999999999999999999999999999986543321              134


Q ss_pred             CCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHH
Q 048055           76 SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEE  155 (221)
Q Consensus        76 ~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (221)
                      .+||..|++||++. +...+..+|+|+|||++|.|+.|++||..      .+-.-..+++.......+..++        
T Consensus       247 FVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra------~NeyliFqkI~~l~y~fp~~fp--------  311 (604)
T KOG0592|consen  247 FVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRA------ANEYLIFQKIQALDYEFPEGFP--------  311 (604)
T ss_pred             eeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCcc------ccHHHHHHHHHHhcccCCCCCC--------
Confidence            68899999999987 77778999999999999999999999974      2223334444444443333333        


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          156 KLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       156 ~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        ..+.+|+.+.|..||.+|+++.+|.+
T Consensus       312 --~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  312 --EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --HHHHHHHHHHHccCccccccHHHHhh
Confidence              46899999999999999999988864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-30  Score=200.20  Aligned_cols=167  Identities=23%  Similarity=0.376  Sum_probs=133.0

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCC--C-CceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCcccc
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQN--P-GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYK   83 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~--~-~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~   83 (221)
                      ...+.++...+++++.|++.||..||+.  + -++||||||.||+++.+|.+|++|||++++..... ......||++||
T Consensus       116 ~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYM  195 (375)
T KOG0591|consen  116 KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYM  195 (375)
T ss_pred             hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCccc
Confidence            3578899999999999999999999993  1 38899999999999999999999999998776554 345679999999


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +||.+. +..|+.++||||+||++|||+.-+.||.+.      ++...-.++.+     .+.++.+.+   .....+..|
T Consensus       196 SPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~q-----gd~~~~p~~---~YS~~l~~l  260 (375)
T KOG0591|consen  196 SPERIH-ESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQ-----GDYPPLPDE---HYSTDLREL  260 (375)
T ss_pred             CHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHc-----CCCCCCcHH---HhhhHHHHH
Confidence            999987 889999999999999999999999999753      33333333322     233333323   233569999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.-|+..||+.||+.-.++..+.+..
T Consensus       261 i~~ci~vd~~~RP~t~~~v~di~~~l  286 (375)
T KOG0591|consen  261 INMCIAVDPEQRPDTVPYVQDIQSEL  286 (375)
T ss_pred             HHHHccCCcccCCCcchHHHHHHHHh
Confidence            99999999999998555555555543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-31  Score=212.94  Aligned_cols=162  Identities=23%  Similarity=0.333  Sum_probs=129.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC---CceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD---FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+.......++.|++.|+.|||+. ||+||||||+|||+..+   ..+||+|||+++..+......+..||+.|.|||
T Consensus       270 nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPE  348 (475)
T KOG0615|consen  270 NKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPE  348 (475)
T ss_pred             ccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChh
Confidence            56677778888999999999999999 99999999999999877   778999999999988887888899999999999


Q ss_pred             cchhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           87 CREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        87 ~~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ++...  ..+..++|+||+||++|-+++|.+||.+....     +...+++..+....      ......+......++|
T Consensus       349 Vl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-----~sl~eQI~~G~y~f------~p~~w~~Iseea~dlI  417 (475)
T KOG0615|consen  349 VLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-----PSLKEQILKGRYAF------GPLQWDRISEEALDLI  417 (475)
T ss_pred             heecCCeecccchheeeeccceEEEEeccCCCcccccCC-----ccHHHHHhcCcccc------cChhhhhhhHHHHHHH
Confidence            87632  22345789999999999999999999754321     22223332222211      1233445556799999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||..||++||++.|+++
T Consensus       418 ~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  418 NWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHhhEeCcccCcCHHHHhc
Confidence            9999999999999999974

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=210.18  Aligned_cols=168  Identities=17%  Similarity=0.237  Sum_probs=133.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ++.|+...+..|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+|+........+...-|.+|+|||++.
T Consensus       104 ~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLL  182 (538)
T KOG0661|consen  104 NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLL  182 (538)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhh
Confidence            78999999999999999999999999 99999999999999999999999999999887777777788899999999887


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh---------------ccCCCCCC-----C
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET---------------ESGDDPPS-----S  149 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~-----~  149 (221)
                      ....|+.+.|+|++||+++|+.+-++.|++...     +-.+ .++.....               ...-.+|.     .
T Consensus       183 rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-----~Dqi-~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l  256 (538)
T KOG0661|consen  183 RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-----IDQI-YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPL  256 (538)
T ss_pred             hccccCCchHHHHHHHHHHHHHHhcccCCCCcH-----HHHH-HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCCh
Confidence            788999999999999999999999999986321     1111 11111000               00011111     1


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ....+....+..++|.+|+..||.+|||+.++++.
T Consensus       257 ~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  257 KDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11222244578999999999999999999999764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-30  Score=213.68  Aligned_cols=159  Identities=21%  Similarity=0.372  Sum_probs=128.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      .-.+++.++..++.+++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++....... ...+..||++|||||..
T Consensus       363 ~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVv  441 (550)
T KOG0578|consen  363 KTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVV  441 (550)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhh
Confidence            44578999999999999999999999 99999999999999999999999999987665544 45678999999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...|+.++||||||++++||+.|++||...      +.......+.......       ....+.....+.+|+.+||
T Consensus       442 t-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa~ng~P~-------lk~~~klS~~~kdFL~~cL  507 (550)
T KOG0578|consen  442 T-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIATNGTPK-------LKNPEKLSPELKDFLDRCL  507 (550)
T ss_pred             h-hcccCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHhhcCCCC-------cCCccccCHHHHHHHHHHh
Confidence            7 678899999999999999999999999631      2222233332222211       1122233346999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.|+++|+++.+||+
T Consensus       508 ~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  508 VVDVEQRASAKELLE  522 (550)
T ss_pred             hcchhcCCCHHHHhc
Confidence            999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-31  Score=217.91  Aligned_cols=167  Identities=24%  Similarity=0.396  Sum_probs=138.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+++++....+.|..+||.|+.|||.+ +|+|||||.-|||+..+..+||+|||-++......+++.+.||..|||||++
T Consensus       205 a~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvI  283 (904)
T KOG4721|consen  205 AGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVI  283 (904)
T ss_pred             ccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHh
Confidence            467889999999999999999999999 9999999999999999999999999999887777788899999999999999


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      + ....+.++||||||+++|||++|+.||.+....      .    ++.+......-.+    ++..+++-+.=||..||
T Consensus       284 r-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------A----IIwGVGsNsL~Lp----vPstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  284 R-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------A----IIWGVGSNSLHLP----VPSTCPDGFKLLLKQCW  348 (904)
T ss_pred             h-cCCcccccceehhHHHHHHHHhcCCCccccchh------e----eEEeccCCccccc----CcccCchHHHHHHHHHH
Confidence            8 778899999999999999999999999753211      0    1111111111122    22334456888999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHH
Q 048055          169 SLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +..|.+||+|++|+..|+-...+
T Consensus       349 ~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             hcCCCCCccHHHHHHHHhhcCHH
Confidence            99999999999999999887655

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=207.71  Aligned_cols=161  Identities=23%  Similarity=0.387  Sum_probs=122.1

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCC----CCCCCCCCCCccccCcc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNP----DSVEEPSATSLFYKAPE   86 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~~~~pe   86 (221)
                      .|+...+..+++||+.||+|||++ |++|+||||.|||++. ++.+||+|||.++....    ........|++.|||||
T Consensus       113 ~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPE  191 (313)
T KOG0198|consen  113 KLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPE  191 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCch
Confidence            799999999999999999999998 9999999999999999 79999999999875542    12234578899999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      ....+......+||||+||++.||++|..||...     .......-.+....    ..|.    .+........+|+.+
T Consensus       192 vi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~----~~P~----ip~~ls~~a~~Fl~~  258 (313)
T KOG0198|consen  192 VIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED----SLPE----IPDSLSDEAKDFLRK  258 (313)
T ss_pred             hhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC----CCCC----CCcccCHHHHHHHHH
Confidence            8873222335899999999999999999999752     11111111111111    1111    111233468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~  186 (221)
                      |+..||++||||.++++.--
T Consensus       259 C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  259 CFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HhhcCcccCcCHHHHhhChh
Confidence            99999999999999987643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=207.76  Aligned_cols=178  Identities=33%  Similarity=0.571  Sum_probs=139.2

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCC--CceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCC-CCCccccCccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNP--GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPS-ATSLFYKAPEC   87 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~--~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~-~~~~~~~~pe~   87 (221)
                      +++|..+++++.++|.||+|||...  .|+|||||+.|||+|.++.+||+|||+++.... ....... .++..|++||+
T Consensus       170 ~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy  249 (361)
T KOG1187|consen  170 PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEY  249 (361)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhh
Confidence            8899999999999999999999973  599999999999999999999999999965544 3322222 78899999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-CCCCCC-ChhhH-HHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-DDPPSS-NEASE-EKLQALLNIA  164 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~-~~~~~l~~l~  164 (221)
                      .. ....+.++||||||+++.|+++|+.+...........+..|............ .++... ..... +....+..++
T Consensus       250 ~~-~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a  328 (361)
T KOG1187|consen  250 AS-TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELA  328 (361)
T ss_pred             hc-cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHH
Confidence            87 56778999999999999999999988775443334446676655444432221 122211 33332 5778899999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      .+|++.+|.+||+|.+|++.|+.+..
T Consensus       329 ~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  329 LRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999999999999965543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-30  Score=201.09  Aligned_cols=156  Identities=24%  Similarity=0.316  Sum_probs=126.9

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~   87 (221)
                      .++.|+...+.-++.+|+.||.|||++ +|+|||+||+|||++..|+++|+|||+++... ......+..||+.|+|||.
T Consensus       118 ~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEi  196 (357)
T KOG0598|consen  118 REGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEI  196 (357)
T ss_pred             hcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHH
Confidence            467899999999999999999999999 99999999999999999999999999998544 3345567899999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. ...++..+|.||+|+++|+|++|.+||.      +.+...+++.+.......   ++  .-.+    ....+++.+.
T Consensus       197 l~-~~gy~~~vDWWsLGillYeML~G~pPF~------~~~~~~~~~~I~~~k~~~---~p--~~ls----~~ardll~~L  260 (357)
T KOG0598|consen  197 LL-GKGYDKAVDWWSLGILLYEMLTGKPPFY------AEDVKKMYDKILKGKLPL---PP--GYLS----EEARDLLKKL  260 (357)
T ss_pred             Hh-cCCCCcccchHhHHHHHHHHhhCCCCCc------CccHHHHHHHHhcCcCCC---CC--ccCC----HHHHHHHHHH
Confidence            87 6788999999999999999999999997      344445555554444111   11  1111    2588999999


Q ss_pred             ccCCCCCCC----CHHHH
Q 048055          168 VSLAPENRP----VMREV  181 (221)
Q Consensus       168 l~~dp~~Rp----s~~~l  181 (221)
                      +..||++|.    ++.+|
T Consensus       261 L~rdp~~RLg~~~d~~~i  278 (357)
T KOG0598|consen  261 LKRDPRQRLGGPGDAEEI  278 (357)
T ss_pred             hccCHHHhcCCCCChHHh
Confidence            999999995    45554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=3.5e-29  Score=205.21  Aligned_cols=165  Identities=24%  Similarity=0.397  Sum_probs=126.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ..++++..+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++......   ......++..|+|||
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence            46799999999999999999999998 99999999999999999999999999986543221   112233456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....     .......+...     .....+...    +..+.+++.
T Consensus       247 ~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-----~~~~~~~~~~~-----~~~~~~~~~----~~~l~~li~  311 (338)
T cd05102         247 SIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-----NEEFCQRLKDG-----TRMRAPENA----TPEIYRIML  311 (338)
T ss_pred             Hhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHhcC-----CCCCCCCCC----CHHHHHHHH
Confidence            886 5677899999999999999997 9999975321     11111111111     111111122    246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||.+|||+.+|++.|+++..
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.2e-29  Score=211.48  Aligned_cols=158  Identities=27%  Similarity=0.389  Sum_probs=136.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .++|+...+.+++.||+.|+.|||.. +|+|||+||+|+|++.++.+||+|||.|....+.+...+.+|.+.|.+||.+.
T Consensus       106 kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~  184 (786)
T KOG0588|consen  106 KGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVS  184 (786)
T ss_pred             hCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhc
Confidence            57899999999999999999999998 99999999999999999999999999998888888888999999999999988


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +....+.++||||+|+++|.+++|..||.      +.++...+.++..+....+..-+          .+.++|+++|+.
T Consensus       185 G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlKV~~G~f~MPs~Is----------~eaQdLLr~ml~  248 (786)
T KOG0588|consen  185 GRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLKVQRGVFEMPSNIS----------SEAQDLLRRMLD  248 (786)
T ss_pred             CCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHHHHcCcccCCCcCC----------HHHHHHHHHHhc
Confidence            43444899999999999999999999996      45555656666555544432222          368999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .||++|.|++||++.
T Consensus       249 VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  249 VDPSTRITTEEILKH  263 (786)
T ss_pred             cCccccccHHHHhhC
Confidence            999999999999764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-29  Score=205.56  Aligned_cols=157  Identities=29%  Similarity=0.391  Sum_probs=128.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCcccc-CCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFR-NPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .+++....+..++.|+++|++|||+. ||+|||||++|+|++.+ +.+||+|||++... ..........|++.|+|||+
T Consensus       114 ~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEv  192 (370)
T KOG0583|consen  114 KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEV  192 (370)
T ss_pred             cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHH
Confidence            57889999999999999999999998 99999999999999999 99999999999877 46667778899999999999


Q ss_pred             chhcCCC-CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~-~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +.....| +.++|+||+|+++|.|++|..||.+      .+.......+.......+...    . +    ..+..++.+
T Consensus       193 l~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~ki~~~~~~~p~~~----~-S----~~~~~Li~~  257 (370)
T KOG0583|consen  193 LSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRKIRKGEFKIPSYL----L-S----PEARSLIEK  257 (370)
T ss_pred             hCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHHHhcCCccCCCCc----C-C----HHHHHHHHH
Confidence            8733315 6889999999999999999999975      333333344333222222111    0 2    358999999


Q ss_pred             cccCCCCCCCCHHHHH
Q 048055          167 CVSLAPENRPVMREVS  182 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~  182 (221)
                      |+..||.+|+++.+|+
T Consensus       258 mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  258 MLVPDPSTRITLLEIL  273 (370)
T ss_pred             HcCCCcccCCCHHHHh
Confidence            9999999999999997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-29  Score=201.01  Aligned_cols=166  Identities=20%  Similarity=0.307  Sum_probs=127.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----C-CCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----E-EPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~-~~~~~~~~~~~   84 (221)
                      ...|+...+..++++++.||.|||.. |.+|||+|+.|||++.+|.++|+|||....+...+.    . ....+++.|||
T Consensus       120 ~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA  198 (516)
T KOG0582|consen  120 PDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA  198 (516)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence            34588899999999999999999998 999999999999999999999999998766554431    1 45688999999


Q ss_pred             cccc-hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECR-EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~-~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+ .....|..|+||||||++..|+..|..||.....      ..+.-...++............+......+.+.++
T Consensus       199 PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~  272 (516)
T KOG0582|consen  199 PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREM  272 (516)
T ss_pred             hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHH
Confidence            9983 3346789999999999999999999999974322      12222222221111112222344444556789999


Q ss_pred             HHHcccCCCCCCCCHHHHH
Q 048055          164 AIACVSLAPENRPVMREVS  182 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~  182 (221)
                      +..||++||.+|||+++++
T Consensus       273 i~~CL~kDP~kRptAskLl  291 (516)
T KOG0582|consen  273 IALCLVKDPSKRPTASKLL  291 (516)
T ss_pred             HHHHhhcCcccCCCHHHHh
Confidence            9999999999999999995

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=1.6e-28  Score=196.81  Aligned_cols=164  Identities=21%  Similarity=0.295  Sum_probs=126.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.|++.||.|||+..+++|||+||.|++++.++.+|++|||+++......  ....++..|+|||.+.
T Consensus       116 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~  193 (283)
T PHA02988        116 EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLN  193 (283)
T ss_pred             CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhh
Confidence            45789999999999999999999984378899999999999999999999999986543221  2345677899999876


Q ss_pred             h-cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 I-WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~-~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...++.++|+||||+++|++++|..||...      ........+....    ..++.+..+    +..+.+++.+||
T Consensus       194 ~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~------~~~~~~~~i~~~~----~~~~~~~~~----~~~l~~li~~cl  259 (283)
T PHA02988        194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL------TTKEIYDLIINKN----NSLKLPLDC----PLEIKCIVEACT  259 (283)
T ss_pred             hccccccchhhhhHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhcC----CCCCCCCcC----cHHHHHHHHHHh
Confidence            2 256789999999999999999999999642      2222222221111    111211122    346999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhH
Q 048055          169 SLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.||++|||+.++++.|+.+.
T Consensus       260 ~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        260 SHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCCcccCcCHHHHHHHHHHHH
Confidence            999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=7.9e-29  Score=213.31  Aligned_cols=165  Identities=23%  Similarity=0.445  Sum_probs=134.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ..+|+..+.+.++.|||.|+.||-++ .+|||||..+|+|++.+..+||+|||+++-.....   ......-+.+||+||
T Consensus       597 ~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  597 PPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            56699999999999999999999998 89999999999999999999999999987433221   112233467899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++||||||+++||+++ |..||.+..      ..++++.+..+..     .+.+.    .++..+.+||.
T Consensus       676 sIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------n~EVIe~i~~g~l-----L~~Pe----~CP~~vY~LM~  739 (774)
T KOG1026|consen  676 SIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------NQEVIECIRAGQL-----LSCPE----NCPTEVYSLML  739 (774)
T ss_pred             Hhh-cCcccchhhhhhhhhhhhhhhccccCcccccc------hHHHHHHHHcCCc-----ccCCC----CCCHHHHHHHH
Confidence            997 8999999999999999999998 999997543      3355555544333     22223    34457999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .||+.+|.+||++.||-..|+.....
T Consensus       740 ~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  740 ECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            99999999999999999999987754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-29  Score=205.79  Aligned_cols=170  Identities=25%  Similarity=0.428  Sum_probs=132.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC---CCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN---PDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~~~~pe   86 (221)
                      ..+|.+.+...++.||+.|+.|||.+ +|+|+|||..||++..+++++|+|||++..-.   .........+...|+|||
T Consensus       482 etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPE  560 (678)
T KOG0193|consen  482 ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPE  560 (678)
T ss_pred             hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHH
Confidence            35678889999999999999999999 99999999999999999999999999975322   122334556777899999


Q ss_pred             cchh--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           87 CREI--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        87 ~~~~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      +++-  ...++..+||||||+++|||++|..||.....      ..++..+     ..++..+........+++++++|+
T Consensus       561 vIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~------dqIifmV-----GrG~l~pd~s~~~s~~pk~mk~Ll  629 (678)
T KOG0193|consen  561 VIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR------DQIIFMV-----GRGYLMPDLSKIRSNCPKAMKRLL  629 (678)
T ss_pred             HHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh------hheEEEe-----cccccCccchhhhccCHHHHHHHH
Confidence            8763  24678999999999999999999999962111      0111111     122333444444556678999999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ..||.+++++||.+.+|+..|+.+...
T Consensus       630 ~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  630 SDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             HHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            999999999999999999999988864

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=2.4e-28  Score=195.95  Aligned_cols=166  Identities=16%  Similarity=0.241  Sum_probs=122.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.............++..|+|||.+.
T Consensus       104 ~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (290)
T cd07862         104 EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL  182 (290)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHh
Confidence            34588999999999999999999998 99999999999999999999999999987654443334556788999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-C---------------CCCCC-CChh
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-G---------------DDPPS-SNEA  152 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~---------------~~~~~-~~~~  152 (221)
                       ...++.++|+|||||++|++++|..||.....      ......+....... .               ..... ....
T Consensus       183 -~~~~~~~~DiwslG~il~el~~g~~~f~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T cd07862         183 -QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF  255 (290)
T ss_pred             -CCCCCCccchHHHHHHHHHHHcCCCCcCCCCH------HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHH
Confidence             56778899999999999999999999974321      11111111110000 0               00000 0011


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          153 SEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       153 ~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+.....+.+++.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         256 VTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1122346889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-28  Score=214.57  Aligned_cols=179  Identities=23%  Similarity=0.299  Sum_probs=136.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCC-CCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEP-SATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~-~~~~~~~~~p   85 (221)
                      ....|+....+.++.|||.|+.||+++ ++|||||.++|+|++....+||+|||+++......  .... ..-+..||||
T Consensus       795 ~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  795 QPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             CCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCH
Confidence            477889999999999999999999999 99999999999999999999999999998332211  1111 1334689999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++||||||+++||+++ |..||....+      ..+......+    + +.+.+..|+    ..+.++|
T Consensus       874 Esl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~~v~~~~~~g----g-RL~~P~~CP----~~ly~lM  937 (1025)
T KOG1095|consen  874 ESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------FEVLLDVLEG----G-RLDPPSYCP----EKLYQLM  937 (1025)
T ss_pred             HHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCcch------HHHHHHHHhC----C-ccCCCCCCC----hHHHHHH
Confidence            9987 6888999999999999999999 9999975322      1222211111    1 333334443    4689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCC
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPG  204 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~  204 (221)
                      ..||+.+|++||++..|++.++++..........+.....
T Consensus       938 ~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~  977 (1025)
T KOG1095|consen  938 LQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADY  977 (1025)
T ss_pred             HHHccCChhhCccHHHHHhhhhhhhhhhccCccccccccc
Confidence            9999999999999999999999988765444433333333

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=193.21  Aligned_cols=176  Identities=24%  Similarity=0.343  Sum_probs=128.9

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC---CCCCCCCCCCccccC
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP---DSVEEPSATSLFYKA   84 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~~   84 (221)
                      +++..|+..++.-+..||+.||+|+|+. +++|||+||.|++++.+..+||+|||+++....   ....+....|.+|+|
T Consensus       117 k~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRA  195 (359)
T KOG0660|consen  117 KSQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRA  195 (359)
T ss_pred             HcCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecC
Confidence            4566799999999999999999999998 999999999999999999999999999987653   333455677889999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhh-----hccCCCCCCC-
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEE-----TESGDDPPSS-  149 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~-----~~~~~~~~~~-  149 (221)
                      ||.......|+...||||.||++.||++|++.|++...-+         +.........+....     ...+..++.+ 
T Consensus       196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f  275 (359)
T KOG0660|consen  196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPF  275 (359)
T ss_pred             HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCH
Confidence            9987778899999999999999999999999998532110         111111111111000     0011111111 


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ....+.......+|+.+||..||.+|+|++|.++.
T Consensus       276 ~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  276 SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            01111222458999999999999999999999753

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=1.6e-27  Score=192.08  Aligned_cols=171  Identities=22%  Similarity=0.361  Sum_probs=128.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++..............+..|++||.+.
T Consensus       113 ~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (297)
T cd05089         113 ASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN  191 (297)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhc
Confidence            45789999999999999999999998 99999999999999999999999999875322211111222345699999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       ...++.++|+||||+++|+|++ |..||....      ...........     .....+..+    ...+.+|+.+||
T Consensus       192 -~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~------~~~~~~~~~~~-----~~~~~~~~~----~~~~~~li~~~l  255 (297)
T cd05089         192 -YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT------CAELYEKLPQG-----YRMEKPRNC----DDEVYELMRQCW  255 (297)
T ss_pred             -cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcC-----CCCCCCCCC----CHHHHHHHHHHc
Confidence             5667889999999999999997 999996432      11222222111     111111112    246899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHHhhcCCC
Q 048055          169 SLAPENRPVMREVSKMIRDSRAEAQMSSN  197 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~~~~~~~  197 (221)
                      +.+|.+||++.++++.|+.+........+
T Consensus       256 ~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~  284 (297)
T cd05089         256 RDRPYERPPFAQISVQLSRMLEARKAYVN  284 (297)
T ss_pred             CCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence            99999999999999999998876544443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-28  Score=187.07  Aligned_cols=146  Identities=20%  Similarity=0.228  Sum_probs=122.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      -++|+...+.-++.||+.||.|||+. +|++||+||+|+|++++|.+||.|||+++.....  ..+.+||+.|+|||.+.
T Consensus       138 ~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~  214 (355)
T KOG0616|consen  138 SGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQ  214 (355)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhh
Confidence            45899999999999999999999998 9999999999999999999999999999866543  45678999999999887


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|.|+||+++|||+.|.+||...      +....++++.......+..+.          ..+.+|+...++
T Consensus       215 -sk~ynkavDWWalGVLIYEMlaG~pPF~~~------~~~~iY~KI~~~~v~fP~~fs----------~~~kdLl~~LL~  277 (355)
T KOG0616|consen  215 -SKGYNKAVDWWALGVLIYEMLAGYPPFYDD------NPIQIYEKILEGKVKFPSYFS----------SDAKDLLKKLLQ  277 (355)
T ss_pred             -cCCCCcchhHHHHHHHHHHHHcCCCCCcCC------ChHHHHHHHHhCcccCCcccC----------HHHHHHHHHHHh
Confidence             788899999999999999999999999742      234555555554443332222          258899999999


Q ss_pred             CCCCCC
Q 048055          170 LAPENR  175 (221)
Q Consensus       170 ~dp~~R  175 (221)
                      .|-.+|
T Consensus       278 vD~t~R  283 (355)
T KOG0616|consen  278 VDLTKR  283 (355)
T ss_pred             hhhHhh
Confidence            999999

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=1.7e-27  Score=198.01  Aligned_cols=163  Identities=25%  Similarity=0.425  Sum_probs=123.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ..++++..++.++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++.......   .....++..|+|||
T Consensus       206 ~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  284 (374)
T cd05106         206 SWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE  284 (374)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence            45789999999999999999999998 999999999999999999999999999865432221   11223456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++|+||||+++|++++ |..||......     ....... ...    ..+..+...    +..+.+++.
T Consensus       285 ~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-----~~~~~~~-~~~----~~~~~~~~~----~~~l~~li~  349 (374)
T cd05106         285 SIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-----SKFYKMV-KRG----YQMSRPDFA----PPEIYSIMK  349 (374)
T ss_pred             Hhc-CCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----HHHHHHH-Hcc----cCccCCCCC----CHHHHHHHH
Confidence            876 5677899999999999999997 99999753211     0111111 110    111111111    246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +||+.||.+||++.+|++.|+++
T Consensus       350 ~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         350 MCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=9.9e-28  Score=192.26  Aligned_cols=160  Identities=20%  Similarity=0.250  Sum_probs=121.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++.............++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~  174 (285)
T cd05631          96 NPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN  174 (285)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhc
Confidence            34689999999999999999999998 99999999999999999999999999987654333334456788999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|++++|..||......  .........+..    ...  .....    ....+.+|+.+||+
T Consensus       175 -~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~----~~~--~~~~~----~s~~~~~li~~~l~  241 (285)
T cd05631         175 -NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKE----DQE--EYSEK----FSEDAKSICRMLLT  241 (285)
T ss_pred             -CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhc----ccc--cCCcc----CCHHHHHHHHHHhh
Confidence             677889999999999999999999999753211  000111111111    000  01111    22468999999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 048055          170 LAPENRPV-----MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~  183 (221)
                      .||.+||+     ++++++
T Consensus       242 ~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         242 KNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCHHHhcCCCCCCHHHHhc
Confidence            99999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.95  E-value=1e-27  Score=189.17  Aligned_cols=170  Identities=21%  Similarity=0.280  Sum_probs=127.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++...+..++.||+.||+|||++ +|+||||||+|++++.+|.+||+|||+++... +.........|..|+|||.+.
T Consensus       115 ~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLl  193 (323)
T KOG0594|consen  115 QGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLL  193 (323)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhc
Confidence            4567789999999999999999999 99999999999999999999999999998665 445567788899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc---------CCC--C---CCCChhhHH
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES---------GDD--P---PSSNEASEE  155 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--~---~~~~~~~~~  155 (221)
                      ....|+...||||+||++.||++++..|++....  ..+..+.+. .......         ...  .   ..+......
T Consensus       194 Gs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~-lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~  270 (323)
T KOG0594|consen  194 GSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRL-LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSI  270 (323)
T ss_pred             CCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHH-cCCCCccCCCCccccccccccCcCCCCccchHHh
Confidence            5568899999999999999999999999864331  001111111 1100000         000  0   001111221


Q ss_pred             HH---HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          156 KL---QALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       156 ~~---~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+   ....+++.+|++++|.+|.|+...+..
T Consensus       271 ~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  271 LPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            22   268899999999999999999998765

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=1.3e-27  Score=191.37  Aligned_cols=165  Identities=19%  Similarity=0.265  Sum_probs=122.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+|+||.||+++.++.++|+|||++.............++..|+|||.+. 
T Consensus       103 ~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-  180 (288)
T cd07863         103 PGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL-  180 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhh-
Confidence            4589999999999999999999998 99999999999999999999999999987655443334456678899999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-----------------ccCCCCCCCChhh
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-----------------ESGDDPPSSNEAS  153 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~  153 (221)
                      +..++.++|+||+||++|++++|.+||.....      ......+.....                 .............
T Consensus       181 ~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (288)
T cd07863         181 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE------ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVV  254 (288)
T ss_pred             CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH------HHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhC
Confidence            56778999999999999999999999964211      111111111000                 0000000001111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.....+.+++.+||+.||++|||+.+++.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         255 PEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            223456899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=7.4e-28  Score=196.36  Aligned_cols=156  Identities=21%  Similarity=0.268  Sum_probs=120.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||+|||+. +++||||||.||+++.++.++|+|||+++.... ........+++.|+|||.+
T Consensus        89 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~  167 (323)
T cd05571          89 ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL  167 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhh
Confidence            46789999999999999999999998 999999999999999999999999999865322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||...      ........+....    ...+  ...    ...+.+++.+||
T Consensus       168 ~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~~~~~~----~~~p--~~~----~~~~~~li~~~L  230 (323)
T cd05571         168 E-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMEE----IRFP--RTL----SPEAKSLLAGLL  230 (323)
T ss_pred             c-CCCCCccccCcccchhhhhhhcCCCCCCCC------CHHHHHHHHHcCC----CCCC--CCC----CHHHHHHHHHHc
Confidence            6 677789999999999999999999999642      1112222221111    1111  112    245899999999


Q ss_pred             cCCCCCCC-----CHHHHHH
Q 048055          169 SLAPENRP-----VMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rp-----s~~~l~~  183 (221)
                      +.||++||     ++.++++
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHc
Confidence            99999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=6e-28  Score=204.47  Aligned_cols=168  Identities=19%  Similarity=0.186  Sum_probs=121.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      ....+++..+..++.||+.||.|||+. +++||||||+||+++.++ .++|+|||+++............+++.|+|||.
T Consensus       163 ~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~  241 (440)
T PTZ00036        163 NNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL  241 (440)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHH
Confidence            356789999999999999999999998 999999999999998665 699999999976544333344567889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-------------ccCCCCCCCC----
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-------------ESGDDPPSSN----  150 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~----  150 (221)
                      +.....++.++|+|||||++|+|++|.+||.+...      ......+.....             ......+...    
T Consensus       242 ~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~------~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l  315 (440)
T PTZ00036        242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS------VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDL  315 (440)
T ss_pred             hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhH
Confidence            76445678899999999999999999999975321      111111111000             0000001000    


Q ss_pred             --hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 --EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 --~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       316 ~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        316 KKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence              011112346899999999999999999999974

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2e-28  Score=197.16  Aligned_cols=155  Identities=24%  Similarity=0.356  Sum_probs=123.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+....+.-++++++.||.|||++ +.+|||||+.||++...|.++++|||++...... ....+..||++|||||++.
T Consensus       106 ~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~  184 (467)
T KOG0201|consen  106 NILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK  184 (467)
T ss_pred             CCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhc
Confidence            3446677777889999999999999 9999999999999999999999999998655433 2336789999999999998


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...|..++||||||++.+||++|.+|+......            +..-......+|....   ...+.+++||..||.
T Consensus       185 -~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------rvlflIpk~~PP~L~~---~~S~~~kEFV~~CL~  248 (467)
T KOG0201|consen  185 -QSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------RVLFLIPKSAPPRLDG---DFSPPFKEFVEACLD  248 (467)
T ss_pred             -cccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------eEEEeccCCCCCcccc---ccCHHHHHHHHHHhh
Confidence             788999999999999999999999999754321            1111111122222222   333569999999999


Q ss_pred             CCCCCCCCHHHHH
Q 048055          170 LAPENRPVMREVS  182 (221)
Q Consensus       170 ~dp~~Rps~~~l~  182 (221)
                      +||+.||++.+++
T Consensus       249 k~P~~RpsA~~LL  261 (467)
T KOG0201|consen  249 KNPEFRPSAKELL  261 (467)
T ss_pred             cCcccCcCHHHHh
Confidence            9999999999996

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=201.61  Aligned_cols=152  Identities=24%  Similarity=0.291  Sum_probs=126.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~   87 (221)
                      ..+.|+...+.-|+..|+.||.|||++ ||+|||||-+|||++..|.+||+|||+++... .....++..||+.|+|||.
T Consensus       461 ~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEi  539 (694)
T KOG0694|consen  461 HTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEV  539 (694)
T ss_pred             ecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhh
Confidence            357899999999999999999999999 99999999999999999999999999998654 5556788999999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..|+.++|.|+||+++|||+.|+.||++.      +-..+...+.......+      ...+    .+..+||+++
T Consensus       540 l~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd------dEee~FdsI~~d~~~yP------~~ls----~ea~~il~~l  602 (694)
T KOG0694|consen  540 LT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGD------DEEEVFDSIVNDEVRYP------RFLS----KEAIAIMRRL  602 (694)
T ss_pred             hc-cCcccchhhHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHhcCCCCCC------Cccc----HHHHHHHHHH
Confidence            97 899999999999999999999999999843      22233333333322222      2222    4588999999


Q ss_pred             ccCCCCCCCCH
Q 048055          168 VSLAPENRPVM  178 (221)
Q Consensus       168 l~~dp~~Rps~  178 (221)
                      |..+|++|.-+
T Consensus       603 l~k~p~kRLG~  613 (694)
T KOG0694|consen  603 LRKNPEKRLGS  613 (694)
T ss_pred             hccCcccccCC
Confidence            99999999743

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=1.1e-27  Score=192.97  Aligned_cols=160  Identities=19%  Similarity=0.342  Sum_probs=120.4

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--------CCCCCCCCcccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--------VEEPSATSLFYK   83 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~   83 (221)
                      .++...+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......        ......+++.|+
T Consensus       122 ~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~  200 (294)
T PHA02882        122 CKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYA  200 (294)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcccc
Confidence            356778889999999999999998 99999999999999999999999999986542211        112245788999


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChH----HHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP----RWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      |||... +..++.++|+|||||++|++++|..||...... .....    .....+.....    ..+   .    .++.
T Consensus       201 ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~---~----~~~~  267 (294)
T PHA02882        201 GLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN-GNLIHAAKCDFIKRLHEGKI----KIK---N----ANKF  267 (294)
T ss_pred             CHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc-hHHHHHhHHHHHHHhhhhhh----ccC---C----CCHH
Confidence            999876 677899999999999999999999999754211 00000    11111111111    011   1    1356


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHH
Q 048055          160 LLNIAIACVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~~L  185 (221)
                      +.+++..||..+|++||++.+|++.|
T Consensus       268 ~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        268 IYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            99999999999999999999998876

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=182.92  Aligned_cols=162  Identities=24%  Similarity=0.335  Sum_probs=128.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .++++...+-++...++.||.||-.+++++|||+||+|||++..|.+|++|||++..+......+...|.+.||+||.+.
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERid  264 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERID  264 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccC
Confidence            45688888899999999999999998899999999999999999999999999998877777777788889999999765


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ...|...+||||||+.++|+++|+.||.....    ++ .....+.+   ..+...+.....+    ..+++|+..|
T Consensus       265 p~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----dF-e~ltkvln---~ePP~L~~~~gFS----p~F~~fv~~C  332 (391)
T KOG0983|consen  265 PPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----DF-EVLTKVLN---EEPPLLPGHMGFS----PDFQSFVKDC  332 (391)
T ss_pred             CCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----cH-HHHHHHHh---cCCCCCCcccCcC----HHHHHHHHHH
Confidence            3  34567889999999999999999999975311    11 11222222   1222222222233    3699999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |.+|+.+||...++++
T Consensus       333 L~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  333 LTKDHRKRPKYNKLLE  348 (391)
T ss_pred             hhcCcccCcchHHHhc
Confidence            9999999999999964

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=2.1e-27  Score=189.80  Aligned_cols=160  Identities=23%  Similarity=0.458  Sum_probs=124.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|+||.||+++.++.++|+|||++.......   ......++..|+|||.
T Consensus       119 ~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05048         119 SSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA  197 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHH
Confidence            6789999999999999999999998 99999999999999999999999999986543221   1223344677999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. ...++.++|+|||||++|++++ |..||....      .......+....     ..+.+.    ..+..+.+|+.+
T Consensus       198 ~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~------~~~~~~~i~~~~-----~~~~~~----~~~~~~~~l~~~  261 (283)
T cd05048         198 IL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS------NQEVIEMIRSRQ-----LLPCPE----DCPARVYALMIE  261 (283)
T ss_pred             hc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCC-----cCCCcc----cCCHHHHHHHHH
Confidence            76 5667889999999999999998 999986422      222222222211     111112    233569999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.||.+||++.+|++.|++
T Consensus       262 c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         262 CWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HccCChhhCcCHHHHHHHHhc
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=1.8e-27  Score=196.41  Aligned_cols=171  Identities=19%  Similarity=0.309  Sum_probs=121.8

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   91 (221)
                      .++...+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++............++..|+|||.+. +
T Consensus       115 ~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~  192 (355)
T cd07874         115 ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-G  192 (355)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHc-C
Confidence            478888999999999999999998 99999999999999999999999999987654443344556788999999886 6


Q ss_pred             CCCCCcccchHHHHHHHHHHhCCCCCcccccccC---------CChHHHHHHhhhh--------hhccC---------CC
Q 048055           92 KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG---------SDIPRWVRSVREE--------ETESG---------DD  145 (221)
Q Consensus        92 ~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~---------~~~~~~~~~~~~~--------~~~~~---------~~  145 (221)
                      ..++.++|+|||||++|+|++|..||........         .........+...        .....         ..
T Consensus       193 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (355)
T cd07874         193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL  272 (355)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccc
Confidence            6778899999999999999999999964321000         0000000000000        00000         00


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          146 PPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       146 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+............+.+|+.+||+.||.+|||+.++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000011111123468999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=5.8e-27  Score=188.24  Aligned_cols=165  Identities=24%  Similarity=0.425  Sum_probs=126.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.||+.||+|||+. +++|+||||.||+++.++.++++|||++.......   ......++..|++||
T Consensus       117 ~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  195 (291)
T cd05094         117 KGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  195 (291)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence            35689999999999999999999998 99999999999999999999999999986543221   122234466799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....      ...........     .+....    ..+..+.+++.
T Consensus       196 ~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~~-----~~~~~~----~~~~~~~~li~  259 (291)
T cd05094         196 SIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECITQGR-----VLERPR----VCPKEVYDIML  259 (291)
T ss_pred             Hhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhCCC-----CCCCCc----cCCHHHHHHHH
Confidence            876 5677889999999999999998 9999864321      11222221111     111111    12346899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.+|.+||++.++++.|+++...
T Consensus       260 ~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         260 GCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHcccChhhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=6e-27  Score=186.04  Aligned_cols=163  Identities=23%  Similarity=0.384  Sum_probs=124.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~p   85 (221)
                      ....+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++|+|||+++.......   ......+..|++|
T Consensus       105 ~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         105 CPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCH
Confidence            345689999999999999999999998 999999999999999999999999999875433221   1222345679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |... ...++.++|+||||+++|++++ |..||....      .......+....     ..+....    .+..+.+++
T Consensus       184 e~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~~~~li  247 (272)
T cd05075         184 ESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE------NSEIYDYLRQGN-----RLKQPPD----CLDGLYSLM  247 (272)
T ss_pred             HHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCC-----CCCCCCC----CCHHHHHHH
Confidence            9876 5667889999999999999998 888986421      122222222111     1111111    224589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.+|++|||+.+|++.|+++
T Consensus       248 ~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         248 SSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.1e-27  Score=195.78  Aligned_cols=173  Identities=22%  Similarity=0.302  Sum_probs=128.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPE   86 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe   86 (221)
                      .+-.|+..++..++.|++.||+|||+. |++|||||..|||++.+|.+||+|||+++++....  ..+..+-|++|+|||
T Consensus       211 p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPE  289 (560)
T KOG0600|consen  211 PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPE  289 (560)
T ss_pred             CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChH
Confidence            356899999999999999999999998 99999999999999999999999999998765443  356667799999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHH----------HHhhhhhhccCCCCCCC-----Ch
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWV----------RSVREEETESGDDPPSS-----NE  151 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~-----~~  151 (221)
                      .+.....|+..+|+||.||++.||+.|++.|++...-..  +..+.          +............+...     .+
T Consensus       290 LLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E  367 (560)
T KOG0600|consen  290 LLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRE  367 (560)
T ss_pred             HhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHH
Confidence            988778999999999999999999999999985321100  00000          00111110000001100     01


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .....+....+|+..+|.+||.+|.|+.+.++.
T Consensus       368 ~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  368 TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            111123468899999999999999999988654

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=3.3e-27  Score=191.91  Aligned_cols=165  Identities=24%  Similarity=0.395  Sum_probs=125.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||+|||+. +++|+||||.||+++.++.++|+|||+++........   .....+..|++||
T Consensus       103 ~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE  181 (316)
T cd05108         103 KDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE  181 (316)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChH
Confidence            34578899999999999999999998 9999999999999999999999999998765433211   1122345799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++|+||||+++|++++ |..||.+..      ........ .    .....+.+..++    ..+.+++.
T Consensus       182 ~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~~~~~~~~-~----~~~~~~~~~~~~----~~~~~li~  245 (316)
T cd05108         182 SIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEISSIL-E----KGERLPQPPICT----IDVYMIMV  245 (316)
T ss_pred             Hhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHH-h----CCCCCCCCCCCC----HHHHHHHH
Confidence            886 5677889999999999999997 999986421      11111111 1    111112112222    35889999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.+|.+||++.+++..|.++..+
T Consensus       246 ~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         246 KCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHcC
Confidence            99999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=2.2e-27  Score=180.50  Aligned_cols=171  Identities=21%  Similarity=0.256  Sum_probs=128.3

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcc
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPE   86 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe   86 (221)
                      +....|+-.++..|+.+++.||+|||++ .|+|||+||.|+|++.+|.+|++|||+++..+... ......-|.+|+|||
T Consensus        93 d~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPE  171 (318)
T KOG0659|consen   93 DKNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPE  171 (318)
T ss_pred             ccccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChH
Confidence            3466788999999999999999999999 99999999999999999999999999998766443 333446788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC----------------CCCC-CC
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG----------------DDPP-SS  149 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-~~  149 (221)
                      .+.+...|+..+|+||.||++.|++-|.+-|++..     ++......++.......                ..+. +.
T Consensus       172 LLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-----DidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~  246 (318)
T KOG0659|consen  172 LLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-----DIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPL  246 (318)
T ss_pred             HhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-----hHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcc
Confidence            88777889999999999999999998888887532     11111111111111100                0111 11


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ....+.....+.+|+..+|.+||.+|+++.|.++.
T Consensus       247 ~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  247 NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11222334467999999999999999999999765

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=9.2e-28  Score=183.63  Aligned_cols=160  Identities=20%  Similarity=0.279  Sum_probs=129.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      -.++.....+++.|+..|+.|||.. +|+|||+||+|||++.+..++|+|||++....++.......||+.|+|||.+..
T Consensus       118 VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC  196 (411)
T KOG0599|consen  118 VTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKC  196 (411)
T ss_pred             eeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheee
Confidence            4577888999999999999999998 999999999999999999999999999988888777777899999999997552


Q ss_pred             -----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           91 -----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        91 -----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                           ...|+..+|+|++|+++|.++.|-+||.....          -.+..........+.+  +.........++|+.
T Consensus       197 ~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----------mlMLR~ImeGkyqF~s--peWadis~~~KdLIs  264 (411)
T KOG0599|consen  197 SMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----------MLMLRMIMEGKYQFRS--PEWADISATVKDLIS  264 (411)
T ss_pred             ecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----------HHHHHHHHhcccccCC--cchhhccccHHHHHH
Confidence                 35678899999999999999999999975311          1111222222233332  233344567999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|.|+.+++.
T Consensus       265 rlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  265 RLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHeeCchhcccHHHHhc
Confidence            999999999999999974

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=4.8e-27  Score=192.69  Aligned_cols=164  Identities=25%  Similarity=0.427  Sum_probs=124.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      .++++..+..++.||+.||.|||+. +++|+|+||.||+++.++.++|+|||++.......   ......++..|+|||.
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            4789999999999999999999998 99999999999999999999999999986543221   1122334567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+|||||++|++++ |..||......     ......+...     ..+..+..    ....+.+++.+
T Consensus       247 ~~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~-----~~~~~~~~----~~~~~~~l~~~  311 (337)
T cd05054         247 IF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----EEFCRRLKEG-----TRMRAPEY----ATPEIYSIMLD  311 (337)
T ss_pred             hc-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----HHHHHHHhcc-----CCCCCCcc----CCHHHHHHHHH
Confidence            86 6778899999999999999997 99999642111     1111111111     11111111    22458999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||+.+|++||++.+|++.|+.+..
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=5.3e-27  Score=185.14  Aligned_cols=162  Identities=20%  Similarity=0.404  Sum_probs=123.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++|+|||++........    .....++..|++|
T Consensus        89 ~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05116          89 NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP  167 (257)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCH
Confidence            35689999999999999999999998 999999999999999999999999999865443221    1112234679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++|+||||+++|++++ |..||....      .......+....     .++.+...+    ..+.+++
T Consensus       168 E~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~i~~~~-----~~~~~~~~~----~~l~~li  231 (257)
T cd05116         168 ECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK------GNEVTQMIESGE-----RMECPQRCP----PEMYDLM  231 (257)
T ss_pred             hHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHCCC-----CCCCCCCCC----HHHHHHH
Confidence            9875 5667789999999999999998 999996431      122223222211     111112222    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.||++||++.+|.+.|++.
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         232 KLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHhccCchhCcCHHHHHHHHhcc
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=5.1e-27  Score=195.19  Aligned_cols=163  Identities=22%  Similarity=0.388  Sum_probs=123.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........   ......+..|+|||
T Consensus       208 ~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  286 (375)
T cd05104         208 ELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE  286 (375)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence            45789999999999999999999998 999999999999999999999999999865433221   11223345799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||......     ......+....     .+..+...    +..+.+|+.
T Consensus       287 ~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~----~~~l~~li~  351 (375)
T cd05104         287 SIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-----SKFYKMIKEGY-----RMLSPECA----PSEMYDIMK  351 (375)
T ss_pred             Hhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----HHHHHHHHhCc-----cCCCCCCC----CHHHHHHHH
Confidence            886 6677899999999999999998 88898643211     11112121111     11111111    246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +||+.||++||++.+|++.|++.
T Consensus       352 ~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         352 SCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHccCChhHCcCHHHHHHHHHhh
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=2.1e-27  Score=192.92  Aligned_cols=109  Identities=24%  Similarity=0.371  Sum_probs=91.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE----cCCCceEEeccCCccccCCCC----CCCCCCCCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL----GADFESCLTDYGLGSFRNPDS----VEEPSATSLF   81 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~   81 (221)
                      ...++...+..++.||+.||.|||+. +++|+||||+||++    +..+.++|+|||++.......    ......+++.
T Consensus       102 ~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~  180 (317)
T cd07868         102 PVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  180 (317)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence            34689999999999999999999998 99999999999999    456789999999987543221    1234566888


Q ss_pred             ccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           82 YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        82 ~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      |+|||.+.....++.++|+||+||++|++++|..||..
T Consensus       181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            99999876345678899999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=2.7e-27  Score=196.02  Aligned_cols=165  Identities=19%  Similarity=0.271  Sum_probs=121.4

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   91 (221)
                      .++...+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||+++............++..|+|||.+. +
T Consensus       122 ~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~  199 (364)
T cd07875         122 ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-G  199 (364)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHh-C
Confidence            467888999999999999999998 99999999999999999999999999987654443334556788999999886 6


Q ss_pred             CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh-----------------------hccC-----
Q 048055           92 KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE-----------------------TESG-----  143 (221)
Q Consensus        92 ~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~-----  143 (221)
                      ..++.++|+|||||++|+|++|..||.....      ......+....                       ....     
T Consensus       200 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (364)
T cd07875         200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK  273 (364)
T ss_pred             CCCCchhhHHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHh
Confidence            7778899999999999999999999964211      11111110000                       0000     


Q ss_pred             ----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          144 ----DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       144 ----~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                          ...+............+.+++.+||+.||.+|||+.++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                00000001111122468899999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=1.9e-27  Score=192.25  Aligned_cols=167  Identities=21%  Similarity=0.348  Sum_probs=121.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++......   ......++..|+||
T Consensus       131 ~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         131 CLPAISYSSLLHVALQIASGMKYLSSL-NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHC-CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            345688999999999999999999998 99999999999999999999999999986543221   11223346679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh--CCCCCcccccccCCChHHHHHHhhhhhhc--cCCCCCCCChhhHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT--GKTPFQDLVLEHGSDIPRWVRSVREEETE--SGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~  161 (221)
                      |.+. ...++.++|+||||+++|++++  +..||.....      .............  ..........    ++..+.
T Consensus       210 E~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  278 (304)
T cd05096         210 ECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD------EQVIENAGEFFRDQGRQVYLFRPPP----CPQGLY  278 (304)
T ss_pred             HHHh-cCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH------HHHHHHHHHHhhhccccccccCCCC----CCHHHH
Confidence            9876 5667889999999999999986  5677764321      1111111110000  0000111111    224689


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHh
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      +|+.+||+.||.+|||+.+|.+.|++
T Consensus       279 ~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         279 ELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHHHHccCCchhCcCHHHHHHHHhC
Confidence            99999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.2e-27  Score=192.62  Aligned_cols=156  Identities=24%  Similarity=0.300  Sum_probs=119.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+++++..+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++..... .......++..|+|||.+
T Consensus        87 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  165 (312)
T cd05585          87 EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL  165 (312)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHH
Confidence            45689999999999999999999998 9999999999999999999999999998653222 222344678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|++++|..||...      .............    ...+  ..    ....+.+++.+||
T Consensus       166 ~-~~~~~~~~DvwslGvil~el~tg~~pf~~~------~~~~~~~~~~~~~----~~~~--~~----~~~~~~~li~~~L  228 (312)
T cd05585         166 L-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDE------NVNEMYRKILQEP----LRFP--DG----FDRDAKDLLIGLL  228 (312)
T ss_pred             c-CCCCCCccceechhHHHHHHHhCCCCcCCC------CHHHHHHHHHcCC----CCCC--Cc----CCHHHHHHHHHHc
Confidence            6 677789999999999999999999999642      2222222222111    1111  11    2245899999999


Q ss_pred             cCCCCCCCC---HHHHHH
Q 048055          169 SLAPENRPV---MREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps---~~~l~~  183 (221)
                      +.||.+||+   +.+++.
T Consensus       229 ~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         229 SRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCHHHcCCCCCHHHHHc
Confidence            999999985   566643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.1e-28  Score=195.19  Aligned_cols=165  Identities=23%  Similarity=0.270  Sum_probs=125.5

Q ss_pred             CCCCC-cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC------CCCCCCCCCc
Q 048055            8 GGGKP-LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD------SVEEPSATSL   80 (221)
Q Consensus         8 ~~~~~-l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~   80 (221)
                      ...++ |+..++.+++++++.||.|||.+ ||+||||||.|+|++.+|++||+|||.+......      .......||+
T Consensus       201 p~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP  279 (576)
T KOG0585|consen  201 PPDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTP  279 (576)
T ss_pred             CCCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCc
Confidence            34566 99999999999999999999999 9999999999999999999999999998543111      1223368899


Q ss_pred             cccCcccchhc---CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHH
Q 048055           81 FYKAPECREIW---KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKL  157 (221)
Q Consensus        81 ~~~~pe~~~~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (221)
                      .|+|||....+   ...+.+.||||+|+++|.++.|+.||.+.      .......++..    ....+|...    +..
T Consensus       280 AF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~------~~~~l~~KIvn----~pL~fP~~p----e~~  345 (576)
T KOG0585|consen  280 AFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD------FELELFDKIVN----DPLEFPENP----EIN  345 (576)
T ss_pred             cccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc------hHHHHHHHHhc----CcccCCCcc----ccc
Confidence            99999987632   23368889999999999999999999642      22222233322    222222222    223


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 048055          158 QALLNIAIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       158 ~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ..+.+|+.++|++||++|.+..+|.....-
T Consensus       346 e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  346 EDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHHHHHHHHHhhcChhheeehhhheeccee
Confidence            469999999999999999999999766544

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.2e-27  Score=196.00  Aligned_cols=158  Identities=23%  Similarity=0.365  Sum_probs=133.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      +..|+.+.++.|+.|++.|+.|||+. .|+|||+|+.||++..++.++++|||+++..++.. ...+..||+.|++||.+
T Consensus       100 ~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil  178 (426)
T KOG0589|consen  100 GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEIL  178 (426)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHh
Confidence            46789999999999999999999987 99999999999999999999999999999888775 66788999999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +.+|+.++|+|||||++|||++-+.+|.      +.++...+.++....     ..|.+..+    ...+..+|..|+
T Consensus       179 ~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~------a~~m~~Li~ki~~~~-----~~Plp~~y----s~el~~lv~~~l  242 (426)
T KOG0589|consen  179 S-DIPYNEKSDIWSLGCCLYEMCTLKPAFK------ASNMSELILKINRGL-----YSPLPSMY----SSELRSLVKSML  242 (426)
T ss_pred             C-CCCCCccCcchhhcchHHHHHhcccccC------ccchHHHHHHHhhcc-----CCCCCccc----cHHHHHHHHHHh
Confidence            7 8999999999999999999999999996      344444444443322     22222222    346999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      ..+|+.||++.+++..
T Consensus       243 ~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  243 RKNPEHRPSALELLRR  258 (426)
T ss_pred             hcCCccCCCHHHHhhC
Confidence            9999999999999865

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=5.3e-27  Score=193.94  Aligned_cols=172  Identities=20%  Similarity=0.312  Sum_probs=121.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.............++..|+|||.+. 
T Consensus       118 ~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-  195 (359)
T cd07876         118 MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL-  195 (359)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhcc-
Confidence            3478888999999999999999998 99999999999999999999999999986544333334456788899999986 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhh---h-ccCCC------------
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEE---T-ESGDD------------  145 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~---~-~~~~~------------  145 (221)
                      +..++.++|+||+||++|+|++|..||.......         +..............   . .....            
T Consensus       196 ~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (359)
T cd07876         196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDW  275 (359)
T ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccc
Confidence            6778889999999999999999999997431100         000000000000000   0 00000            


Q ss_pred             -CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          146 -PPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       146 -~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                       .+............+.+|+.+||+.||++|||+.|++..
T Consensus       276 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         276 IFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             ccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence             000000011112458999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=1.1e-26  Score=187.91  Aligned_cols=175  Identities=21%  Similarity=0.349  Sum_probs=129.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++|+|||++..............+..|++||.+.
T Consensus       118 ~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (303)
T cd05088         118 ASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  196 (303)
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence            45789999999999999999999998 99999999999999999999999999875322111111122345699999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       +..++.++|+||||+++|++++ |..||....      ..........     ......+...    ...+.+++.+||
T Consensus       197 -~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~~~~~li~~~l  260 (303)
T cd05088         197 -YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQ-----GYRLEKPLNC----DDEVYDLMRQCW  260 (303)
T ss_pred             -ccCCcccccchhhhhHHHHHHhcCCCCcccCC------hHHHHHHHhc-----CCcCCCCCCC----CHHHHHHHHHHc
Confidence             5667889999999999999998 999996421      1122222211     1111111112    235899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCC
Q 048055          169 SLAPENRPVMREVSKMIRDSRAEAQMSSNSSDH  201 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~  201 (221)
                      +.+|.+||++.++++.|+++........+....
T Consensus       261 ~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~~~  293 (303)
T cd05088         261 REKPYERPSFAQILVSLNRMLEERKTYVNTTLY  293 (303)
T ss_pred             CCChhhCcCHHHHHHHHHHHHHhhhhhhhhhhh
Confidence            999999999999999999988776655554433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=8.7e-27  Score=186.31  Aligned_cols=161  Identities=19%  Similarity=0.367  Sum_probs=123.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.|++.||.|||+. +++|+|+||.||+++.++.++|+|||+++.......   .....++..|+|||
T Consensus       118 ~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05091         118 KSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE  196 (283)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHH
Confidence            35689999999999999999999998 999999999999999999999999998765432221   12233456899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ....+...+.....     .+.+..    .+..+.+++.
T Consensus       197 ~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------~~~~~~~~i~~~~~-----~~~~~~----~~~~~~~li~  260 (283)
T cd05091         197 AIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------SNQDVIEMIRNRQV-----LPCPDD----CPAWVYTLML  260 (283)
T ss_pred             HHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHcCCc-----CCCCCC----CCHHHHHHHH
Confidence            876 5667889999999999999998 88888642      22222222222111     111122    2345899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHh
Q 048055          166 ACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      +||+.+|.+||++.+|+..|+.
T Consensus       261 ~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         261 ECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHhCCCcccCCCHHHHHHHhhC
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=1.2e-27  Score=189.06  Aligned_cols=172  Identities=19%  Similarity=0.231  Sum_probs=128.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .+..++.-.+.-+..||..||+|||+. +|+||||||+|+|++.+ |.+||+|||.|+.............+.+|+|||.
T Consensus       118 ~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPEL  196 (364)
T KOG0658|consen  118 ANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPEL  196 (364)
T ss_pred             cCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHH
Confidence            356778888888999999999999998 99999999999999987 8899999999998777666666677889999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHh--------hhhhhcc-CCCCCCCC------hh
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSV--------REEETES-GDDPPSSN------EA  152 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~------~~  152 (221)
                      +.....|+.+.||||.||++.||+.|++.|++....  ..+..+++.+        ....... ....+...      -.
T Consensus       197 ifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~  274 (364)
T KOG0658|consen  197 IFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVF  274 (364)
T ss_pred             HcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeec
Confidence            887789999999999999999999999999863211  1111111110        0000000 00001000      01


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          153 SEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       153 ~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .......+.+|+.+++.++|.+|.++.+++.
T Consensus       275 ~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  275 FKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1223346899999999999999999999863

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-27  Score=178.87  Aligned_cols=156  Identities=24%  Similarity=0.331  Sum_probs=123.8

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ++...+.++++||+.+|.|||.. +|+|||+||.|+++..   ..-+|++|||++...+.+.......|++.|++||..+
T Consensus       107 ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr  185 (355)
T KOG0033|consen  107 YSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK  185 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh
Confidence            46667888999999999999998 9999999999999854   4558999999998877666777889999999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++..+|||+.|+++|-++.|.+||.+.      ...+.++++....    ...+++.+  +......++|+++||.
T Consensus       186 -kdpy~kpvDiW~cGViLfiLL~G~~PF~~~------~~~rlye~I~~g~----yd~~~~~w--~~is~~Ak~LvrrML~  252 (355)
T KOG0033|consen  186 -KDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYEQIKAGA----YDYPSPEW--DTVTPEAKSLIRRMLT  252 (355)
T ss_pred             -cCCCCCcchhhhhhHHHHHHHhCCCCCCCc------cHHHHHHHHhccc----cCCCCccc--CcCCHHHHHHHHHHhc
Confidence             678899999999999999999999999853      2223344443332    22222111  1112358999999999


Q ss_pred             CCCCCCCCHHHHH
Q 048055          170 LAPENRPVMREVS  182 (221)
Q Consensus       170 ~dp~~Rps~~~l~  182 (221)
                      .||.+|.|+.|.+
T Consensus       253 ~dP~kRIta~EAL  265 (355)
T KOG0033|consen  253 VNPKKRITADEAL  265 (355)
T ss_pred             cChhhhccHHHHh
Confidence            9999999998874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=1.6e-26  Score=185.44  Aligned_cols=164  Identities=21%  Similarity=0.419  Sum_probs=125.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++++|||++.......   ......++..|+|||.
T Consensus       115 ~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  193 (288)
T cd05093         115 AELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  193 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHH
Confidence            4589999999999999999999998 99999999999999999999999999986443221   1122334567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|+|++ |..||....      .......+....     ........    +..+.+|+.+
T Consensus       194 ~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~------~~~~~~~i~~~~-----~~~~~~~~----~~~l~~li~~  257 (288)
T cd05093         194 IM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVIECITQGR-----VLQRPRTC----PKEVYDLMLG  257 (288)
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCC-----cCCCCCCC----CHHHHHHHHH
Confidence            76 5677889999999999999998 899986432      112222221111     11111111    2359999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ||+.+|.+|||+.+++..|+++...
T Consensus       258 ~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         258 CWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HccCChhhCCCHHHHHHHHHHHHHh
Confidence            9999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=1.5e-26  Score=184.85  Aligned_cols=164  Identities=21%  Similarity=0.383  Sum_probs=125.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+|+||.||+++.++.++++|||.++......   ......++..|++||
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE  181 (279)
T cd05111         103 RDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE  181 (279)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHH
Confidence            45689999999999999999999998 99999999999999999999999999986543221   122334556799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.+..      .......+..     ...++....+.    ..+.+++.
T Consensus       182 ~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~~~----~~~~~li~  245 (279)
T cd05111         182 SIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR------PHEVPDLLEK-----GERLAQPQICT----IDVYMVMV  245 (279)
T ss_pred             Hhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHC-----CCcCCCCCCCC----HHHHHHHH
Confidence            876 5667899999999999999998 999996431      1111111111     11111111222    35788999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||..+|++||++.++++.|..+..
T Consensus       246 ~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         246 KCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHcCCCcccCcCHHHHHHHHHHHHh
Confidence            9999999999999999999888664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.95  E-value=1.5e-27  Score=197.67  Aligned_cols=157  Identities=25%  Similarity=0.369  Sum_probs=128.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      +++.++.+.+..++.|++.||.|||+. +|.|||+||+|||++.++.+|++|||+++.+.... ......||+.|||||.
T Consensus        93 ~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPEl  171 (808)
T KOG0597|consen   93 QDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPEL  171 (808)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHH
Confidence            578899999999999999999999999 99999999999999999999999999998776543 4466789999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .. +..+...+|+||+||++||++.|++||...      .    +..+.......+..+|.      .....+.+|+...
T Consensus       172 v~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~------s----i~~Lv~~I~~d~v~~p~------~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  172 VE-EQPYDHTSDLWSLGCILYELYVGQPPFYAR------S----ITQLVKSILKDPVKPPS------TASSSFVNFLQGL  234 (808)
T ss_pred             Hc-CCCccchhhHHHHHHHHHHHhcCCCCchHH------H----HHHHHHHHhcCCCCCcc------cccHHHHHHHHHH
Confidence            87 889999999999999999999999999532      1    12222222222222221      2223588999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      +.+||.+|.++.+++.
T Consensus       235 L~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  235 LIKDPAQRLTWTDLLG  250 (808)
T ss_pred             hhcChhhcccHHHHhc
Confidence            9999999999999974

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=4.2e-27  Score=192.33  Aligned_cols=157  Identities=20%  Similarity=0.261  Sum_probs=120.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||+|||+. +++||||||.||+++.++.++|+|||+++.... ........+++.|+|||.+
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~  167 (328)
T cd05593          89 ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL  167 (328)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhh
Confidence            45789999999999999999999998 999999999999999999999999999865322 2222344678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|++++|..||...      ........+....    ...+  ...    ...+.+++.+||
T Consensus       168 ~-~~~~~~~~DiwslGvil~elltG~~Pf~~~------~~~~~~~~~~~~~----~~~p--~~~----~~~~~~li~~~L  230 (328)
T cd05593         168 E-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMED----IKFP--RTL----SADAKSLLSGLL  230 (328)
T ss_pred             c-CCCCCccCCccccchHHHHHhhCCCCCCCC------CHHHHHHHhccCC----ccCC--CCC----CHHHHHHHHHHc
Confidence            6 567789999999999999999999999642      1112222221111    1111  112    235889999999


Q ss_pred             cCCCCCCC-----CHHHHHHH
Q 048055          169 SLAPENRP-----VMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rp-----s~~~l~~~  184 (221)
                      +.||.+|+     ++.++++.
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcC
Confidence            99999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=7.7e-27  Score=194.94  Aligned_cols=172  Identities=18%  Similarity=0.266  Sum_probs=121.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC--CCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD--SVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..++.++.||+.||.|||+. +|+||||||.||+++.++.++|+|||++......  .......+++.|+|||.
T Consensus       176 ~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~  254 (391)
T PHA03212        176 KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPEL  254 (391)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhh
Confidence            45688999999999999999999998 9999999999999999999999999998643221  12234567889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCC-ChHHHHHHhhhhh----------------------hccCC
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS-DIPRWVRSVREEE----------------------TESGD  144 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~----------------------~~~~~  144 (221)
                      +. +..++.++|+|||||++|++++|..||.......+. ........+....                      .....
T Consensus       255 ~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (391)
T PHA03212        255 LA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS  333 (391)
T ss_pred             hc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC
Confidence            86 567789999999999999999999876432111000 0000001010000                      00000


Q ss_pred             CCCC---CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          145 DPPS---SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       145 ~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+.   ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       334 ~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        334 RKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000   00111123457899999999999999999999975

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=2.5e-27  Score=189.56  Aligned_cols=171  Identities=25%  Similarity=0.356  Sum_probs=123.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~pe   86 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||++........    .....++..|++||
T Consensus       102 ~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE  180 (283)
T cd05080         102 HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE  180 (283)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHh
Confidence            3589999999999999999999998 999999999999999999999999999865433211    11223455699999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHH------HHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRW------VRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      .+. ....+.++|+||||+++|++++|..||....... ......      ....... .......+.+.    ..+..+
T Consensus       181 ~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~  253 (283)
T cd05080         181 CLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL-LERGMRLPCPK----NCPQEV  253 (283)
T ss_pred             Hhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh-hhcCCCCCCCC----CCCHHH
Confidence            876 5667889999999999999999999985321100 000000      0000000 00011111111    223569


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      .+++.+||+.+|.+||++.++++.|+++.
T Consensus       254 ~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         254 YILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            99999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=4.9e-27  Score=191.57  Aligned_cols=156  Identities=21%  Similarity=0.278  Sum_probs=120.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus        89 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  167 (323)
T cd05595          89 ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL  167 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccc
Confidence            45789999999999999999999998 999999999999999999999999998864322 2222345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|++++|..||...      .............    ...+  ...    ...+.+++.+||
T Consensus       168 ~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~------~~~~~~~~~~~~~----~~~p--~~~----~~~~~~li~~~L  230 (323)
T cd05595         168 E-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEE----IRFP--RTL----SPEAKSLLAGLL  230 (323)
T ss_pred             c-CCCCCchhchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHhcCC----CCCC--CCC----CHHHHHHHHHHc
Confidence            6 567789999999999999999999999642      1112222221111    1111  112    245899999999


Q ss_pred             cCCCCCCC-----CHHHHHH
Q 048055          169 SLAPENRP-----VMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rp-----s~~~l~~  183 (221)
                      +.||.+||     ++.++++
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHc
Confidence            99999998     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=5.1e-27  Score=189.66  Aligned_cols=168  Identities=21%  Similarity=0.283  Sum_probs=119.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        97 ~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  175 (303)
T cd07869          97 PGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL  175 (303)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHH
Confidence            35688999999999999999999998 9999999999999999999999999998643222 222344567889999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-----------CCCCC------CCCh
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-----------GDDPP------SSNE  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~------~~~~  151 (221)
                      .....++.++|+||+||++|+|++|..||....     ........+.......           ....+      ....
T Consensus       176 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (303)
T cd07869         176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-----DIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKN  250 (303)
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-----cHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCcc
Confidence            534556788999999999999999999997421     1111111111100000           00000      0000


Q ss_pred             hhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASE-----EKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~-----~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...     .....+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         251 LRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000     01235789999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.2e-26  Score=185.24  Aligned_cols=164  Identities=24%  Similarity=0.375  Sum_probs=123.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++........   .....+..|++||
T Consensus       103 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (279)
T cd05109         103 KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE  181 (279)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHH
Confidence            35689999999999999999999998 9999999999999999999999999998765432211   1123356799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      ... +..++.++|+|||||++|++++ |..||.....      ......+..     ....+....    ....+.+++.
T Consensus       182 ~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~-----~~~~~~~~~----~~~~~~~li~  245 (279)
T cd05109         182 SIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA------REIPDLLEK-----GERLPQPPI----CTIDVYMIMV  245 (279)
T ss_pred             Hhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHC-----CCcCCCCcc----CCHHHHHHHH
Confidence            876 5667889999999999999998 8999864211      111111111     111111112    2346899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||++||++.+++..|+....
T Consensus       246 ~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         246 KCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHhhc
Confidence            9999999999999999998877653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=199.81  Aligned_cols=168  Identities=23%  Similarity=0.444  Sum_probs=135.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCC--CCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA--TSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~--~~~~~~~pe~   87 (221)
                      ...|+......++.||+.+|+|||+. .+|||||.++|||+.....+|++|||+++.+....-.....  -+..||+||.
T Consensus       485 k~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPES  563 (974)
T KOG4257|consen  485 KDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPES  563 (974)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccc
Confidence            45678888999999999999999999 99999999999999999999999999998776554333223  3567999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|||.||+++||++. |..||.+..+.      .++     .....+.++|.+..|+    .+|..||.+
T Consensus       564 IN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------DVI-----~~iEnGeRlP~P~nCP----p~LYslmsk  627 (974)
T KOG4257|consen  564 IN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------DVI-----GHIENGERLPCPPNCP----PALYSLMSK  627 (974)
T ss_pred             cc-hhcccchhhHHHHHHHHHHHHHhcCCcccccccc------ceE-----EEecCCCCCCCCCCCC----hHHHHHHHH
Confidence            87 7888999999999999999987 99999864322      111     1122344445444444    479999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHHhhc
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAEAQM  194 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~~~~  194 (221)
                      ||.+||.+||.+.+|+..|+++..+++.
T Consensus       628 cWayeP~kRPrftei~~~lsdv~qeek~  655 (974)
T KOG4257|consen  628 CWAYEPSKRPRFTEIKAILSDVLQEEKI  655 (974)
T ss_pred             HhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence            9999999999999999999998876543

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.6e-26  Score=183.46  Aligned_cols=163  Identities=22%  Similarity=0.398  Sum_probs=124.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~p   85 (221)
                      ....+++..+..++.|++.||.|||+. +++|+|+||+||+++.++.++|+|||+++........   .....+..|++|
T Consensus       106 ~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         106 LPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCH
Confidence            345789999999999999999999998 9999999999999999999999999998754332211   112335579999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++|+||||+++|++++ |..||....      .......+...     .....+..    ....+.+++
T Consensus       185 e~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li  248 (273)
T cd05035         185 ESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE------NHEIYDYLRHG-----NRLKQPED----CLDELYDLM  248 (273)
T ss_pred             hhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcC-----CCCCCCcC----CCHHHHHHH
Confidence            9875 5677889999999999999998 888886422      11222222111     11111112    234699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.||.+||++.++++.|+++
T Consensus       249 ~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         249 YSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHhh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=4.2e-27  Score=188.91  Aligned_cols=167  Identities=17%  Similarity=0.217  Sum_probs=119.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +..+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||+++..... .......++..|+|||.+
T Consensus        97 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~  175 (288)
T cd07871          97 GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL  175 (288)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHh
Confidence            34578899999999999999999998 9999999999999999999999999998654322 222344567889999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh---------------ccCCCCCC-----
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET---------------ESGDDPPS-----  148 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~-----  148 (221)
                      .....++.++|+||+||++|++++|..||.....      ......+.....               ......+.     
T Consensus       176 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (288)
T cd07871         176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV------KEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQP  249 (288)
T ss_pred             cCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCc
Confidence            6445678899999999999999999999964321      111111111000               00000000     


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...........+.+++.+||+.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         250 LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000111235789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=189.77  Aligned_cols=108  Identities=33%  Similarity=0.530  Sum_probs=99.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC------CceEEeccCCccccCCCCCCCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD------FESCLTDYGLGSFRNPDSVEEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~   83 (221)
                      .+.++..++..++.|++.||++||++ +|+||||||+|||++..      -.+||+|||+++...+.....+..|++.||
T Consensus       103 ~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYM  181 (429)
T KOG0595|consen  103 RGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYM  181 (429)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCcccc
Confidence            45889999999999999999999998 99999999999999875      468999999999988877777889999999


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      |||.+. ...|..|+|+||+|+++|++++|..||..
T Consensus       182 APEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  182 APEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            999987 78899999999999999999999999973

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=6.4e-27  Score=190.64  Aligned_cols=151  Identities=23%  Similarity=0.291  Sum_probs=117.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||+++.... ........+++.|+|||.+
T Consensus        90 ~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (320)
T cd05590          90 SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL  168 (320)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHH
Confidence            45789999999999999999999998 999999999999999999999999999865322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|++++|..||...      ........+.....    ..+  ...    ...+.+++.+||
T Consensus       169 ~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~------~~~~~~~~i~~~~~----~~~--~~~----~~~~~~li~~~L  231 (320)
T cd05590         169 Q-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAE------NEDDLFEAILNDEV----VYP--TWL----SQDAVDILKAFM  231 (320)
T ss_pred             c-CCCCCCccchhhhHHHHHHHhhCCCCCCCC------CHHHHHHHHhcCCC----CCC--CCC----CHHHHHHHHHHc
Confidence            6 667788999999999999999999999642      22222232222111    111  112    235899999999


Q ss_pred             cCCCCCCCCH
Q 048055          169 SLAPENRPVM  178 (221)
Q Consensus       169 ~~dp~~Rps~  178 (221)
                      +.||.+||++
T Consensus       232 ~~dP~~R~~~  241 (320)
T cd05590         232 TKNPTMRLGS  241 (320)
T ss_pred             ccCHHHCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=4.3e-27  Score=192.57  Aligned_cols=174  Identities=25%  Similarity=0.357  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+++......    ......++..|+||
T Consensus        97 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859          97 NDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCH
Confidence            34689999999999999999999998 99999999999999999999999999986432211    11334678889999


Q ss_pred             ccchh-cCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhh------hccCCCCCCC
Q 048055           86 ECREI-WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEE------TESGDDPPSS  149 (221)
Q Consensus        86 e~~~~-~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~------~~~~~~~~~~  149 (221)
                      |.+.. ...++.++|+|||||++|+|++|+.||.......         +.........+....      ......+...
T Consensus       176 E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  255 (338)
T cd07859         176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF  255 (338)
T ss_pred             HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch
Confidence            98652 1466889999999999999999999996432100         000000001100000      0000000000


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ....+.....+.+++.+||+.||++||++.++++.
T Consensus       256 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         256 SQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00001122457899999999999999999999753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=1.1e-26  Score=189.56  Aligned_cols=156  Identities=24%  Similarity=0.284  Sum_probs=120.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.... ........++..|+|||.+
T Consensus        95 ~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  173 (324)
T cd05589          95 TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL  173 (324)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHh
Confidence            45789999999999999999999998 999999999999999999999999998864322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ..    ....+.+++.+||
T Consensus       174 ~-~~~~~~~~DiwslG~il~el~~G~~pf~~~------~~~~~~~~i~~~~~----~~p--~~----~~~~~~~li~~~L  236 (324)
T cd05589         174 T-ETSYTRAVDWWGLGVLIYEMLVGESPFPGD------DEEEVFDSIVNDEV----RYP--RF----LSREAISIMRRLL  236 (324)
T ss_pred             c-CCCCCcccchhhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCC----CCC--CC----CCHHHHHHHHHHh
Confidence            6 667788999999999999999999999642      22222222222111    111  11    1245889999999


Q ss_pred             cCCCCCCC-----CHHHHHH
Q 048055          169 SLAPENRP-----VMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rp-----s~~~l~~  183 (221)
                      +.||.+||     ++.++++
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhh
Confidence            99999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=1.6e-26  Score=183.68  Aligned_cols=163  Identities=21%  Similarity=0.349  Sum_probs=122.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.|++.||+|||+. +++|+|+||.||+++.++.++++|||++..............+..|++||.+.
T Consensus       106 ~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~  184 (270)
T cd05047         106 ASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  184 (270)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHc
Confidence            44689999999999999999999998 99999999999999999999999999875322111111222345699999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       ...++.++|+||||+++|++++ |..||....      .......+...     ........    ....+.+++.+||
T Consensus       185 -~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~~l  248 (270)
T cd05047         185 -YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQG-----YRLEKPLN----CDDEVYDLMRQCW  248 (270)
T ss_pred             -cCCCCchhhHHHHHHHHHHHHcCCCCCccccC------HHHHHHHHhCC-----CCCCCCCc----CCHHHHHHHHHHc
Confidence             5667889999999999999997 999996421      11222222111     11111111    2235899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhH
Q 048055          169 SLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.+|.+||++.+++..|+++.
T Consensus       249 ~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         249 REKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ccChhhCCCHHHHHHHHHHhh
Confidence            999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.8e-26  Score=171.18  Aligned_cols=160  Identities=24%  Similarity=0.337  Sum_probs=119.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ++++++..++.++.||+.||.|||+. +      ||.||+++.++.+++  ||.+.......    ..++..|+|||.+.
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~   77 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQ   77 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc----CCCcccccChHHhc
Confidence            46799999999999999999999998 6      999999999999999  99886544322    25678999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH--HHHHHHHHc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ--ALLNIAIAC  167 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~l~~~c  167 (221)
                       +..++.++|||||||++|++++|..||....     ........+........   +...........  .+.+++.+|
T Consensus        78 -~~~~~~~~DiwSlG~il~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       78 -GQSYTEKADIYSLGITLYEALDYELPYNEER-----ELSAILEILLNGMPADD---PRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             -CCCCcchhhHHHHHHHHHHHHhCCCCccccc-----hhcHHHHHHHHHhccCC---ccccccHHHHHhhhhHHHHHHHH
Confidence             6778899999999999999999999996421     11111222221111111   110111112222  599999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      |+.+|.+||++.++++.+.....+
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HhcccccccCHHHHHHHHHHHHHH
Confidence            999999999999999998877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=3.2e-26  Score=181.24  Aligned_cols=162  Identities=21%  Similarity=0.411  Sum_probs=123.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++.........  .....+..|++||.
T Consensus        98 ~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~  176 (263)
T cd05052          98 RQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  176 (263)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHH
Confidence            34689999999999999999999998 9999999999999999999999999998654432211  11222456999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||...      ........+...     .....+..    .+..+.+++.+
T Consensus       177 ~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~  240 (263)
T cd05052         177 LA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEKG-----YRMERPEG----CPPKVYELMRA  240 (263)
T ss_pred             hc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHCC-----CCCCCCCC----CCHHHHHHHHH
Confidence            76 6677889999999999999998 89998643      222222222111     11111111    23469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|++||++.++++.|+.+
T Consensus       241 cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         241 CWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HccCCcccCCCHHHHHHHHHhh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=8.4e-27  Score=189.25  Aligned_cols=110  Identities=24%  Similarity=0.370  Sum_probs=91.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE----cCCCceEEeccCCccccCCCC----CCCCCCCCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL----GADFESCLTDYGLGSFRNPDS----VEEPSATSLF   81 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~   81 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||+||++    +.++.++|+|||+++......    ......++..
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~  180 (317)
T cd07867         102 PMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  180 (317)
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence            34688999999999999999999998 99999999999999    566789999999987544322    1123456788


Q ss_pred             ccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 048055           82 YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        82 ~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~  120 (221)
                      |+|||.+.....++.++|+||+||++|+|++|..||...
T Consensus       181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999998763455788999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=1.2e-26  Score=188.71  Aligned_cols=155  Identities=23%  Similarity=0.317  Sum_probs=119.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  168 (316)
T cd05592          90 SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL  168 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHH
Confidence            45689999999999999999999998 999999999999999999999999999865322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+...      .+..+...    ...+.+++.+||
T Consensus       169 ~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~------~~~~~~~~----~~~~~~ll~~~l  231 (316)
T cd05592         169 K-GQKYNESVDWWSFGVLLYEMLIGQSPFHGE------DEDELFDSILND------RPHFPRWI----SKEAKDCLSKLF  231 (316)
T ss_pred             c-CCCCCCcccchhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcC------CCCCCCCC----CHHHHHHHHHHc
Confidence            6 567788999999999999999999999642      222222222111      11111112    235889999999


Q ss_pred             cCCCCCCCCHH-HHH
Q 048055          169 SLAPENRPVMR-EVS  182 (221)
Q Consensus       169 ~~dp~~Rps~~-~l~  182 (221)
                      +.||.+||++. +++
T Consensus       232 ~~~P~~R~~~~~~l~  246 (316)
T cd05592         232 ERDPTKRLGVDGDIR  246 (316)
T ss_pred             cCCHHHcCCChHHHH
Confidence            99999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-26  Score=186.80  Aligned_cols=155  Identities=20%  Similarity=0.247  Sum_probs=120.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||+|||+. +++|+||||.||+++.++.++|+|||++......  .....+++.|+|||.+.
T Consensus        95 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~  171 (291)
T cd05612          95 SGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQ  171 (291)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHc
Confidence            45688999999999999999999998 9999999999999999999999999998654322  22345788899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|++++|..||...      ........+.....    ..+  ...    ...+.+++.+||+
T Consensus       172 -~~~~~~~~DiwSlG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~~----~~~--~~~----~~~~~~li~~~l~  234 (291)
T cd05612         172 -SKGHNKAVDWWALGILIYEMLVGYPPFFDD------NPFGIYEKILAGKL----EFP--RHL----DLYAKDLIKKLLV  234 (291)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCc----CCC--ccC----CHHHHHHHHHHcC
Confidence             566788999999999999999999999642      22222222222111    111  111    2358999999999


Q ss_pred             CCCCCCCC-----HHHHHHH
Q 048055          170 LAPENRPV-----MREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~~  184 (221)
                      .||.+||+     +.++++.
T Consensus       235 ~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         235 VDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCHHHccCCccCCHHHHhcC
Confidence            99999995     8887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=9.2e-27  Score=189.53  Aligned_cols=156  Identities=23%  Similarity=0.327  Sum_probs=120.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  168 (318)
T cd05570          90 SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL  168 (318)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHh
Confidence            35789999999999999999999998 9999999999999999999999999998643222 222334578889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|++++|..||...      ........+.....    ..+  ..    ....+.+|+.+||
T Consensus       169 ~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~------~~~~~~~~i~~~~~----~~~--~~----~~~~~~~li~~~l  231 (318)
T cd05570         169 S-YQPYGPAVDWWALGVLLYEMLAGQSPFEGD------DEDELFQSILEDEV----RYP--RW----LSKEAKSILKSFL  231 (318)
T ss_pred             c-CCCCCcchhhhhHHHHHHHHhhCCCCCCCC------CHHHHHHHHHcCCC----CCC--Cc----CCHHHHHHHHHHc
Confidence            6 677788999999999999999999999642      12222222221111    111  11    2246899999999


Q ss_pred             cCCCCCCCCH-----HHHHH
Q 048055          169 SLAPENRPVM-----REVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~-----~~l~~  183 (221)
                      +.||.+||++     .+++.
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhc
Confidence            9999999998     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=5.8e-27  Score=187.84  Aligned_cols=157  Identities=23%  Similarity=0.373  Sum_probs=133.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ..+.|+...+.++++||.+|+.|||++ +++|||+|.+|||+++++.+||+|||++..+...+...++.|++.|.+||..
T Consensus       146 er~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  146 ERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIV  224 (668)
T ss_pred             HhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCcccc
Confidence            367899999999999999999999999 9999999999999999999999999999888888888889999999999988


Q ss_pred             hhcCCC-CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~-~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..| +..+|.||||+++|.++.|.+||.+      .+....+.++..+..+.+..+.           ...-||++|
T Consensus       225 N-G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG------~Dhk~lvrQIs~GaYrEP~~PS-----------dA~gLIRwm  286 (668)
T KOG0611|consen  225 N-GTPYKGPEVDSWSLGVLLYTLVYGTMPFDG------RDHKRLVRQISRGAYREPETPS-----------DASGLIRWM  286 (668)
T ss_pred             C-CCCCCCCccchhhHHHHHHHHhhcccccCC------chHHHHHHHhhcccccCCCCCc-----------hHHHHHHHH
Confidence            7 4444 7789999999999999999999974      4444555555554444433332           467899999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |..+|++|.|+.||...
T Consensus       287 LmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  287 LMVNPERRATIEDIASH  303 (668)
T ss_pred             HhcCcccchhHHHHhhh
Confidence            99999999999999543

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=3.4e-26  Score=182.42  Aligned_cols=162  Identities=23%  Similarity=0.414  Sum_probs=123.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.......   .......+..|+||
T Consensus       115 ~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         115 PMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecCh
Confidence            346689999999999999999999998 99999999999999999999999999886432221   11222345679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|+|++ |..||....      ...........     ........    .+..+.+++
T Consensus       194 E~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li  257 (280)
T cd05049         194 ESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS------NEEVIECITQG-----RLLQRPRT----CPSEVYDIM  257 (280)
T ss_pred             hhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcC-----CcCCCCCC----CCHHHHHHH
Confidence            9886 6677889999999999999998 999986432      11222222111     11111111    224689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      .+||+.||++||++.|+++.|++
T Consensus       258 ~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         258 LGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHcCCCcccCCCHHHHHHHhhC
Confidence            99999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=199.20  Aligned_cols=158  Identities=24%  Similarity=0.344  Sum_probs=123.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      .+.++...+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.....   .......+++.|+|||
T Consensus       137 ~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE  215 (496)
T PTZ00283        137 NRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE  215 (496)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHH
Confidence            46789999999999999999999998 9999999999999999999999999998754322   1223456788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+|||||++|++++|..||...      .............     ..+.+..    .+..+.+++.+
T Consensus       216 ~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------~~~~~~~~~~~~~-----~~~~~~~----~~~~l~~li~~  279 (496)
T PTZ00283        216 IWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGE------NMEEVMHKTLAGR-----YDPLPPS----ISPEMQEIVTA  279 (496)
T ss_pred             HhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHhcCC-----CCCCCCC----CCHHHHHHHHH
Confidence            987 567889999999999999999999999642      2222222222111     1111111    22468999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+||++.+++..
T Consensus       280 ~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        280 LLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HcccChhhCcCHHHHHhC
Confidence            999999999999998753

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=2.7e-26  Score=180.94  Aligned_cols=159  Identities=22%  Similarity=0.396  Sum_probs=122.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++.......  .....+..|++||.+. 
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~-  172 (256)
T cd05082          97 SVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR-  172 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHc-
Confidence            3578999999999999999999998 99999999999999999999999999886433221  2223345799999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      ...++.++|+||||+++|++++ |..||...      ........+.....     .....    ..+..+.+++.+||+
T Consensus       173 ~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~~~~~~-----~~~~~----~~~~~~~~li~~~l~  237 (256)
T cd05082         173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRVEKGYK-----MDAPD----GCPPVVYDVMKQCWH  237 (256)
T ss_pred             cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHhcCCC-----CCCCC----CCCHHHHHHHHHHhc
Confidence            5667889999999999999997 99998632      22222222221111     11111    223468999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhh
Q 048055          170 LAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+|++|||+.++++.|+.+
T Consensus       238 ~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         238 LDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CChhhCcCHHHHHHHHhcC
Confidence            9999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=2.2e-26  Score=184.82  Aligned_cols=165  Identities=22%  Similarity=0.345  Sum_probs=125.6

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccC
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKA   84 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~   84 (221)
                      ...+.+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||+++.......   .....++..|++
T Consensus       124 ~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  202 (293)
T cd05053         124 PPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA  202 (293)
T ss_pred             ccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccC
Confidence            3466899999999999999999999998 999999999999999999999999999875443221   112233457999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||... +..++.++|+|||||++|++++ |..||...      ........+...     ..+..+..    ....+.+|
T Consensus       203 PE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~----~~~~~~~l  266 (293)
T cd05053         203 PEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------PVEELFKLLKEG-----YRMEKPQN----CTQELYHL  266 (293)
T ss_pred             HHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCC------CHHHHHHHHHcC-----CcCCCCCC----CCHHHHHH
Confidence            99875 5667889999999999999997 89998642      122222222111     11111111    22468999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.+||+.+|++|||+.++++.|+++.
T Consensus       267 i~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         267 MRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcccCcccCcCHHHHHHHHHHhh
Confidence            99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=1.4e-26  Score=185.49  Aligned_cols=172  Identities=17%  Similarity=0.174  Sum_probs=120.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.
T Consensus        94 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (287)
T cd07848          94 PNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL  172 (287)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHH
Confidence            35689999999999999999999998 99999999999999999999999999987643221  2223457788999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCC---------ChHHHHHHhhhhhhccCCCCCCC-------Ch
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS---------DIPRWVRSVREEETESGDDPPSS-------NE  151 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~-------~~  151 (221)
                      +. +..++.++|+||+||++|++++|+.||.........         ....................+..       ..
T Consensus       173 ~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T cd07848         173 LL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERR  251 (287)
T ss_pred             Hc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHh
Confidence            86 566788999999999999999999999743211000         00000000000000000000000       00


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ........+.+|+.+||+.||++|||+.++++
T Consensus       252 ~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         252 YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            01112356999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=2.7e-26  Score=181.77  Aligned_cols=167  Identities=22%  Similarity=0.358  Sum_probs=126.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      ....+++..++.++.||+.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|++||.
T Consensus        99 ~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~  177 (267)
T cd08229          99 QKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHH
Confidence            345789999999999999999999998 99999999999999999999999999876543322 1223456778999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +...+.++|+||||+++|++++|..||.....    ........+..     ...++...   ......+.+++.+|
T Consensus       178 ~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~li~~~  244 (267)
T cd08229         178 IH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQ-----CDYPPLPS---DHYSEELRQLVNMC  244 (267)
T ss_pred             hc-CCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhc-----CCCCCCCc---ccccHHHHHHHHHh
Confidence            76 56678899999999999999999999964211    11121111111     11111111   12334699999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhH
Q 048055          168 VSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      |..+|.+|||+.+|++.+++..
T Consensus       245 l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         245 INPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cCCCcccCCCHHHHHHHHhhhc
Confidence            9999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=9.8e-27  Score=189.58  Aligned_cols=156  Identities=20%  Similarity=0.271  Sum_probs=120.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (321)
T cd05591          90 SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL  168 (321)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHH
Confidence            45688999999999999999999998 999999999999999999999999999864322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||....      .......+.....    ..+  ...    ...+.+++.+||
T Consensus       169 ~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------~~~~~~~i~~~~~----~~p--~~~----~~~~~~ll~~~L  231 (321)
T cd05591         169 Q-ELEYGPSVDWWALGVLMYEMMAGQPPFEADN------EDDLFESILHDDV----LYP--VWL----SKEAVSILKAFM  231 (321)
T ss_pred             c-CCCCCCccceechhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC----CCC--CCC----CHHHHHHHHHHh
Confidence            6 6677889999999999999999999996432      2222222222111    111  111    235889999999


Q ss_pred             cCCCCCCC-------CHHHHHH
Q 048055          169 SLAPENRP-------VMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rp-------s~~~l~~  183 (221)
                      +.||.+||       ++.++++
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhc
Confidence            99999999       7777763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=3.6e-27  Score=186.60  Aligned_cols=159  Identities=34%  Similarity=0.555  Sum_probs=118.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|++|++.||+++.++.+||+|||++.......   ..........|+|||
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE  175 (259)
T PF07714_consen   97 KEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPE  175 (259)
T ss_dssp             TTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HH
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            56789999999999999999999998 99999999999999999999999999986652221   123334566899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++||||||+++||+++ |..||...      ........+.....     ++.+..+    +..+.+++.
T Consensus       176 ~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~~-----~~~~~~~----~~~~~~li~  239 (259)
T PF07714_consen  176 VLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQR-----LPIPDNC----PKDIYSLIQ  239 (259)
T ss_dssp             HHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTEE-----TTSBTTS----BHHHHHHHH
T ss_pred             ccc-ccccccccccccccccccccccccccccccc------cccccccccccccc-----ceeccch----hHHHHHHHH
Confidence            887 5667899999999999999999 78888642      22333344422222     1111112    246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L  185 (221)
                      .||+.+|.+||++.+|++.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=1.8e-26  Score=182.28  Aligned_cols=162  Identities=20%  Similarity=0.408  Sum_probs=122.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++++|||++........    .....++..|++|
T Consensus        89 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05115          89 KDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP  167 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCH
Confidence            45689999999999999999999998 999999999999999999999999999864432211    1111224579999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++|+||||+++|++++ |..||....      .......+....     .+..+..    .+..+.+++
T Consensus       168 E~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~l~~li  231 (257)
T cd05115         168 ECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK------GPEVMSFIEQGK-----RLDCPAE----CPPEMYALM  231 (257)
T ss_pred             HHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC------HHHHHHHHHCCC-----CCCCCCC----CCHHHHHHH
Confidence            9876 5667889999999999999996 999996431      122222221111     1111111    224689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.+|++||++.+|.+.|+.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHHHhhh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.94  E-value=6.6e-27  Score=180.75  Aligned_cols=166  Identities=21%  Similarity=0.322  Sum_probs=132.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc---CCCceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG---ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      .+..|+...+..++.||..|+.|||+. +|.|||+||+|+|+.   .+..+|++|||+++.-.......+...|++|.||
T Consensus       154 g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  154 GDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAP  232 (400)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCH
Confidence            466799999999999999999999998 999999999999996   4567899999999876655556677889999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. ...|...+|+||+|+++|-+++|.+||...   ++..+.   ..++.........+|.+.  .....+..+++|+
T Consensus       233 evlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~---hg~ais---pgMk~rI~~gqy~FP~pE--Ws~VSe~aKdlIR  303 (400)
T KOG0604|consen  233 EVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAIS---PGMKRRIRTGQYEFPEPE--WSCVSEAAKDLIR  303 (400)
T ss_pred             HHhC-chhcCCCCCccchhHHHHHhhcCCCccccc---CCccCC---hhHHhHhhccCccCCChh--HhHHHHHHHHHHH
Confidence            9986 567889999999999999999999999642   222211   222233333445555433  3445568999999


Q ss_pred             HcccCCCCCCCCHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~  184 (221)
                      ..|..+|.+|.|+.+++..
T Consensus       304 ~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  304 KLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHhcCCchhheeHHHhhcC
Confidence            9999999999999999643

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=1.3e-26  Score=188.49  Aligned_cols=155  Identities=23%  Similarity=0.282  Sum_probs=118.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.|++.||+|||+. +++||||||.||+++.++.++|+|||+++.... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (316)
T cd05620          90 KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL  168 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHH
Confidence            45789999999999999999999998 999999999999999999999999998764321 1222345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||....      .......+...    ....  +...+    ..+.+++.+||
T Consensus       169 ~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~------~~~~~~~~~~~----~~~~--~~~~~----~~~~~li~~~l  231 (316)
T cd05620         169 Q-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD------EDELFESIRVD----TPHY--PRWIT----KESKDILEKLF  231 (316)
T ss_pred             c-CCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC----CCCC--CCCCC----HHHHHHHHHHc
Confidence            6 6677889999999999999999999996431      12222222111    1111  11222    35889999999


Q ss_pred             cCCCCCCCCHH-HHH
Q 048055          169 SLAPENRPVMR-EVS  182 (221)
Q Consensus       169 ~~dp~~Rps~~-~l~  182 (221)
                      +.||.+||++. +++
T Consensus       232 ~~dP~~R~~~~~~~~  246 (316)
T cd05620         232 ERDPTRRLGVVGNIR  246 (316)
T ss_pred             cCCHHHcCCChHHHH
Confidence            99999999974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=1.1e-26  Score=190.16  Aligned_cols=161  Identities=21%  Similarity=0.253  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++......  ......++..|+|||.
T Consensus        99 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~  177 (332)
T cd05614          99 RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI  177 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHH
Confidence            45689999999999999999999998 99999999999999999999999999986543221  1223467889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.....++.++|+|||||++|+|++|..||......  .........+..    .  .++.+...    ...+.+++.+|
T Consensus       178 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~----~--~~~~~~~~----~~~~~~li~~~  245 (332)
T cd05614         178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER--NTQSEVSRRILK----C--DPPFPSFI----GPEAQDLLHKL  245 (332)
T ss_pred             hcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC--CCHHHHHHHHhc----C--CCCCCCCC----CHHHHHHHHHH
Confidence            763344678899999999999999999999642111  111111111111    1  11111112    24589999999


Q ss_pred             ccCCCCCCC-----CHHHHHH
Q 048055          168 VSLAPENRP-----VMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rp-----s~~~l~~  183 (221)
                      |+.||.+||     ++.++++
T Consensus       246 l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         246 LRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             cCCCHHHcCCCCCCCHHHHHc
Confidence            999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.6e-26  Score=188.49  Aligned_cols=156  Identities=22%  Similarity=0.275  Sum_probs=119.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++..... .......++..|+|||.+
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  172 (323)
T cd05584          94 EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL  172 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhc
Confidence            45678888899999999999999998 9999999999999999999999999998643222 222334678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|+|++|..||...      ........+.....   ..+   ...    ...+.+++.+||
T Consensus       173 ~-~~~~~~~~DiwslG~il~ell~G~~pf~~~------~~~~~~~~~~~~~~---~~~---~~~----~~~~~~li~~~l  235 (323)
T cd05584         173 M-RSGHGKAVDWWSLGALMYDMLTGAPPFTAE------NRKKTIDKILKGKL---NLP---PYL----TPEARDLLKKLL  235 (323)
T ss_pred             c-CCCCCCcceecccHHHHHHHhcCCCCCCCC------CHHHHHHHHHcCCC---CCC---CCC----CHHHHHHHHHHc
Confidence            6 566788999999999999999999999642      22222222222111   111   111    235899999999


Q ss_pred             cCCCCCCC-----CHHHHHH
Q 048055          169 SLAPENRP-----VMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rp-----s~~~l~~  183 (221)
                      +.+|++||     ++.+++.
T Consensus       236 ~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         236 KRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ccCHhHcCCCCCCCHHHHhc
Confidence            99999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=3.3e-26  Score=181.61  Aligned_cols=162  Identities=19%  Similarity=0.386  Sum_probs=122.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++++|||...........  ....++..|+|||.
T Consensus       101 ~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  179 (266)
T cd05064         101 EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA  179 (266)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHH
Confidence            35789999999999999999999998 9999999999999999999999999986543222111  12233467999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+|||||++|++++ |..||....      .......+...     ...+.+..    .+..+.+++.+
T Consensus       180 ~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~  243 (266)
T cd05064         180 IQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMS------GQDVIKAVEDG-----FRLPAPRN----CPNLLHQLMLD  243 (266)
T ss_pred             Hh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCC------HHHHHHHHHCC-----CCCCCCCC----CCHHHHHHHHH
Confidence            76 5777889999999999999875 999996432      12222222111     11122222    33469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|.+||++.+|++.|++.
T Consensus       244 c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         244 CWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HcCCCchhCCCHHHHHHHHHhh
Confidence            9999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=1.1e-26  Score=190.00  Aligned_cols=154  Identities=20%  Similarity=0.224  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ....+++.|+|||.+.
T Consensus       112 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~  188 (329)
T PTZ00263        112 AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQ  188 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHc
Confidence            45788999999999999999999998 99999999999999999999999999986543322  2346788899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ...+    ..+.+|+.+||+
T Consensus       189 -~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~~~~----~~p--~~~~----~~~~~li~~~L~  251 (329)
T PTZ00263        189 -SKGHGKAVDWWTMGVLLYEFIAGYPPFFDD------TPFRIYEKILAGRL----KFP--NWFD----GRARDLVKGLLQ  251 (329)
T ss_pred             -CCCCCCcceeechHHHHHHHHcCCCCCCCC------CHHHHHHHHhcCCc----CCC--CCCC----HHHHHHHHHHhh
Confidence             566788999999999999999999999642      11222222222111    111  1122    358899999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 048055          170 LAPENRPV-----MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~  183 (221)
                      .||.+||+     +.+++.
T Consensus       252 ~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        252 TDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             cCHHHcCCCCCCCHHHHhc
Confidence            99999996     677763

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=4.1e-26  Score=182.12  Aligned_cols=164  Identities=24%  Similarity=0.397  Sum_probs=126.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      +..+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||+++.......   .....++..|+|||
T Consensus       111 ~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE  189 (280)
T cd05043         111 PQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE  189 (280)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHH
Confidence            36789999999999999999999998 999999999999999999999999999875432211   11223456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||....      .......+...     ........    .+..+.+++.
T Consensus       190 ~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~  253 (280)
T cd05043         190 SLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEID------PFEMAAYLKDG-----YRLAQPIN----CPDELFAVMA  253 (280)
T ss_pred             HHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC------HHHHHHHHHcC-----CCCCCCCc----CCHHHHHHHH
Confidence            876 5667889999999999999998 999996421      11222222111     11111111    2246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.+|++||++.++++.|+++..
T Consensus       254 ~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         254 CCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHcCCChhhCCCHHHHHHHHHHHHh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.4e-26  Score=191.37  Aligned_cols=106  Identities=25%  Similarity=0.426  Sum_probs=90.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++++..+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||.++............++..|+|||.+.
T Consensus       151 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        151 SRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA  229 (357)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecC
Confidence            46789999999999999999999998 99999999999999999999999999986543333333456788999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCC
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPF  117 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf  117 (221)
                       +..++.++|+|||||++|+++++..++
T Consensus       230 -~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        230 -RDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             567789999999999999999854443

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.94  E-value=2.5e-26  Score=182.01  Aligned_cols=166  Identities=22%  Similarity=0.351  Sum_probs=126.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|++||.+
T Consensus       100 ~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~  178 (267)
T cd08228         100 KRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI  178 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhh
Confidence            34578899999999999999999998 99999999999999999999999999886543322 12234567789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +...+.++|+||+|+++|++++|..||...    ..........+..     ...++..   .......+.+++.+||
T Consensus       179 ~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~----~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~li~~cl  245 (267)
T cd08228         179 H-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQKIEQ-----CDYPPLP---TEHYSEKLRELVSMCI  245 (267)
T ss_pred             c-cCCCCchhhHHHHHHHHHHHhcCCCCCccc----cccHHHHHHHHhc-----CCCCCCC---hhhcCHHHHHHHHHHC
Confidence            6 566788999999999999999999998542    1112222222211     1111111   1123356999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhH
Q 048055          169 SLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.+|++||++.++++.|+++.
T Consensus       246 ~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         246 YPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCcccCcCHHHHHHHHHHhc
Confidence            999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=1.3e-26  Score=189.07  Aligned_cols=151  Identities=23%  Similarity=0.343  Sum_probs=117.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++.... ........+++.|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~  173 (323)
T cd05616          95 VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII  173 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHh
Confidence            35688999999999999999999998 999999999999999999999999999864332 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+....    ...+  ...    ...+.+++.+||
T Consensus       174 ~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~------~~~~~~~~i~~~~----~~~p--~~~----s~~~~~li~~~l  236 (323)
T cd05616         174 A-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHN----VAYP--KSM----SKEAVAICKGLM  236 (323)
T ss_pred             c-CCCCCCccchhchhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC----CCCC--CcC----CHHHHHHHHHHc
Confidence            7 677889999999999999999999999642      1222222222111    1111  112    235889999999


Q ss_pred             cCCCCCCCCH
Q 048055          169 SLAPENRPVM  178 (221)
Q Consensus       169 ~~dp~~Rps~  178 (221)
                      +.+|.+|+++
T Consensus       237 ~~~p~~R~~~  246 (323)
T cd05616         237 TKHPGKRLGC  246 (323)
T ss_pred             ccCHHhcCCC
Confidence            9999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.94  E-value=5.5e-28  Score=206.16  Aligned_cols=166  Identities=19%  Similarity=0.431  Sum_probs=136.9

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCC--CccccC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSAT--SLFYKA   84 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~--~~~~~~   84 (221)
                      +++.|++.+...+++.|+.|++||-+. +.|||||.++|||++.+-.||++|||+++......  ..++..|  +.+|.|
T Consensus       724 ~DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTA  802 (996)
T KOG0196|consen  724 NDGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTA  802 (996)
T ss_pred             cCCceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecC
Confidence            346699999999999999999999998 99999999999999999999999999998664332  2333333  468999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|+||+|+++||+++ |+.||.+..++      ++++.+     ..+.+.|++.+|+    .+|.+|
T Consensus       803 PEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------dVIkaI-----e~gyRLPpPmDCP----~aL~qL  866 (996)
T KOG0196|consen  803 PEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVIKAI-----EQGYRLPPPMDCP----AALYQL  866 (996)
T ss_pred             hhHhh-hcccCchhhccccceEEEEecccCCCcccccchH------HHHHHH-----HhccCCCCCCCCc----HHHHHH
Confidence            99987 7889999999999999999987 99999864322      232322     3455666666655    479999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      |..||++|-.+||.|.+|+..|.++-.+
T Consensus       867 MldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  867 MLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            9999999999999999999999997654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=5.4e-27  Score=191.41  Aligned_cols=157  Identities=20%  Similarity=0.267  Sum_probs=120.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..+..++.||+.||.|||+ . +++|+||||.||+++.++.++|+|||+++.... ........++..|+|||.
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  167 (325)
T cd05594          89 ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV  167 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHH
Confidence            4578999999999999999999997 6 999999999999999999999999999864322 222234467889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+|||||++|++++|..||...      ........+....    ...+  ...    ...+.+++.+|
T Consensus       168 ~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~------~~~~~~~~i~~~~----~~~p--~~~----~~~~~~li~~~  230 (325)
T cd05594         168 LE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMEE----IRFP--RTL----SPEAKSLLSGL  230 (325)
T ss_pred             Hc-cCCCCCccccccccceeeeeccCCCCCCCC------CHHHHHHHHhcCC----CCCC--CCC----CHHHHHHHHHH
Confidence            86 667789999999999999999999999642      1112222221111    1111  111    23588999999


Q ss_pred             ccCCCCCCC-----CHHHHHHH
Q 048055          168 VSLAPENRP-----VMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rp-----s~~~l~~~  184 (221)
                      |+.||.+|+     ++.++++.
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcC
Confidence            999999996     88888743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=1.4e-26  Score=184.83  Aligned_cols=166  Identities=21%  Similarity=0.255  Sum_probs=122.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............++..|+|||.+.
T Consensus        89 ~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  167 (277)
T cd05607          89 ERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK  167 (277)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHc
Confidence            34588999999999999999999998 99999999999999999999999999986554433333456778999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+||++|++++|..||......  ............    .. .......    ....+.+++.+||+
T Consensus       168 -~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~----~~-~~~~~~~----~~~~~~~li~~~L~  235 (277)
T cd05607         168 -EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE----DE-VKFEHQN----FTEESKDICRLFLA  235 (277)
T ss_pred             -cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc----cc-ccccccc----CCHHHHHHHHHHhc
Confidence             556889999999999999999999999642110  011111111111    00 0000111    22458999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhh
Q 048055          170 LAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~L~~~  188 (221)
                      .||++||++.++++.+..+
T Consensus       236 ~~P~~R~~~~~~~~~~~~h  254 (277)
T cd05607         236 KKPEDRLGSREKNDDPRKH  254 (277)
T ss_pred             cCHhhCCCCccchhhhhcC
Confidence            9999999998776544443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=2.8e-26  Score=187.64  Aligned_cols=108  Identities=24%  Similarity=0.359  Sum_probs=92.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.|++.||.|||+..+++|+||||.||+++.++.++|+|||++...... ......++..|+|||.+.
T Consensus        97 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~  175 (331)
T cd06649          97 AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ  175 (331)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhc
Confidence            3568899999999999999999998536999999999999999999999999998654332 223346788999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                       +..++.++|+|||||++|++++|..||..
T Consensus       176 -~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         176 -GTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             -CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence             66778899999999999999999999963

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=5e-26  Score=182.69  Aligned_cols=164  Identities=23%  Similarity=0.378  Sum_probs=125.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ..++++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||+++.......   .....++..|++||
T Consensus       121 ~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE  199 (290)
T cd05045         121 ERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE  199 (290)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence            45789999999999999999999998 999999999999999999999999999865432211   11223456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ............     ...+.+...    ...+.+++.
T Consensus       200 ~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~i~  263 (290)
T cd05045         200 SLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI------APERLFNLLKTG-----YRMERPENC----SEEMYNLML  263 (290)
T ss_pred             HHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHhCC-----CCCCCCCCC----CHHHHHHHH
Confidence            875 5667889999999999999998 99999642      222222222111     111111222    246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.+|++||++.++++.|+++-.
T Consensus       264 ~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         264 TCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHccCCcccCCCHHHHHHHHHHHHh
Confidence            9999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=3.5e-26  Score=182.76  Aligned_cols=159  Identities=22%  Similarity=0.420  Sum_probs=120.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++|+|||++........   .....++..|++||.
T Consensus       117 ~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (280)
T cd05092         117 GQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES  195 (280)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHH
Confidence            5689999999999999999999998 999999999999999999999999999864432211   122233567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+|||||++|++++ |..||.....      ...........     ....+..+    +..+.+++.+
T Consensus       196 ~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~li~~  259 (280)
T cd05092         196 IL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIECITQGR-----ELERPRTC----PPEVYAIMQG  259 (280)
T ss_pred             hc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------HHHHHHHHcCc-----cCCCCCCC----CHHHHHHHHH
Confidence            76 5667889999999999999998 8999854211      11111111111     11111112    2458999999


Q ss_pred             cccCCCCCCCCHHHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~  186 (221)
                      ||+.||++||++.+|++.|+
T Consensus       260 cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         260 CWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HccCChhhCCCHHHHHHHHh
Confidence            99999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=6.2e-26  Score=179.18  Aligned_cols=162  Identities=25%  Similarity=0.483  Sum_probs=124.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~pe~~   88 (221)
                      +..+++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++++|||.+........ .....++..|++||.+
T Consensus        98 ~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~  176 (261)
T cd05148          98 GQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA  176 (261)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHH
Confidence            46789999999999999999999998 999999999999999999999999999865543221 1223345679999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . ...++.++|+||||+++|++++ |..||....      .......+..     ....+.+..    .+..+.+++.+|
T Consensus       177 ~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~i~~~  240 (261)
T cd05148         177 S-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN------NHEVYDQITA-----GYRMPCPAK----CPQEIYKIMLEC  240 (261)
T ss_pred             c-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHHh-----CCcCCCCCC----CCHHHHHHHHHH
Confidence            6 5667889999999999999998 899996432      1122222221     111111122    224689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhh
Q 048055          168 VSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~  188 (221)
                      |+.+|.+|||+.++.+.|+.+
T Consensus       241 l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         241 WAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCchhCcCHHHHHHHHhcC
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.6e-26  Score=179.72  Aligned_cols=161  Identities=24%  Similarity=0.466  Sum_probs=122.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----CCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----EPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.|++.||.|||.. +++|+||+|.||+++.++.++++|||++.........    ....++..|++||
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  168 (257)
T cd05060          90 REIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE  168 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHH
Confidence            3689999999999999999999998 9999999999999999999999999998654332211    1112235799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++|+||||+++|++++ |..||...      ........+....     ..+.+..    .+..+.+++.
T Consensus       169 ~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~----~~~~l~~li~  232 (257)
T cd05060         169 CIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM------KGAEVIAMLESGE-----RLPRPEE----CPQEIYSIML  232 (257)
T ss_pred             Hhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccC------CHHHHHHHHHcCC-----cCCCCCC----CCHHHHHHHH
Confidence            876 5667889999999999999998 99999642      1122222221111     1111111    2246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +||+.+|.+||++.++++.|+.+
T Consensus       233 ~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         233 SCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HHhcCChhhCcCHHHHHHHHHhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=4.8e-26  Score=179.90  Aligned_cols=162  Identities=23%  Similarity=0.446  Sum_probs=123.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++........  .....++..|+|||.
T Consensus        97 ~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  175 (261)
T cd05072          97 GGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA  175 (261)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHH
Confidence            45688999999999999999999998 999999999999999999999999999865433221  122234567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .. ...++.++|+||||+++|++++ |..||....      .......+...     ...+....    .+..+.+++.+
T Consensus       176 ~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~  239 (261)
T cd05072         176 IN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS------NSDVMSALQRG-----YRMPRMEN----CPDELYDIMKT  239 (261)
T ss_pred             hc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCC------HHHHHHHHHcC-----CCCCCCCC----CCHHHHHHHHH
Confidence            76 5667888999999999999998 999996421      11222222111     11111112    22468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|++||++.++.+.|+++
T Consensus       240 ~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         240 CWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HccCCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=1.4e-26  Score=197.71  Aligned_cols=107  Identities=22%  Similarity=0.296  Sum_probs=90.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----------------ceEEeccCCccccCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----------------ESCLTDYGLGSFRNPDSVE   73 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----------------~~~l~dfg~~~~~~~~~~~   73 (221)
                      .+.+++..+..++.||+.||.|||++.+|+||||||+|||++.++                .+||+|||.+.....  ..
T Consensus       225 ~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~  302 (467)
T PTZ00284        225 HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SR  302 (467)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--cc
Confidence            357899999999999999999999733999999999999998765                489999998753222  22


Q ss_pred             CCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           74 EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        74 ~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      ....++..|+|||.+. +..++.++|||||||++|+|++|+.||..
T Consensus       303 ~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        303 TAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3456788999999986 67788999999999999999999999964

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.94  E-value=5.8e-26  Score=183.52  Aligned_cols=165  Identities=21%  Similarity=0.343  Sum_probs=126.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.......   .....++..|+|||
T Consensus       131 ~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE  209 (304)
T cd05101         131 DEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE  209 (304)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence            45688999999999999999999998 999999999999999999999999999875543221   12223456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ........+....     ....+..    .+..+.+++.
T Consensus       210 ~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~----~~~~~~~li~  273 (304)
T cd05101         210 ALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------PVEELFKLLKEGH-----RMDKPAN----CTNELYMMMR  273 (304)
T ss_pred             hhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccC------CHHHHHHHHHcCC-----cCCCCCC----CCHHHHHHHH
Confidence            876 5667889999999999999998 78888532      2223333322111     1111112    2346899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.+|.+||++.++++.|+++...
T Consensus       274 ~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         274 DCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHcccChhhCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999887753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=4e-26  Score=180.82  Aligned_cols=155  Identities=28%  Similarity=0.412  Sum_probs=115.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc-------eEEeccCCccccCCCCCCCCCCCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE-------SCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      ...+++..++.++.||+.||.|||+. +++|+|+||.||+++.++.       ++++|||++......   ....++..|
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y  174 (262)
T cd05077          99 SDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPW  174 (262)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccc
Confidence            35689999999999999999999998 9999999999999987654       799999987543322   233456789


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHH-hCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELL-TGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      +|||.+..+..++.++|+||||+++|+++ .|..||.....      .. .........      .....    ....+.
T Consensus       175 ~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~-~~~~~~~~~------~~~~~----~~~~~~  237 (262)
T cd05077         175 IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL------AE-KERFYEGQC------MLVTP----SCKELA  237 (262)
T ss_pred             cChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch------hH-HHHHHhcCc------cCCCC----ChHHHH
Confidence            99998753466788999999999999997 48888754211      11 111111110      00011    123589


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHH
Q 048055          162 NIAIACVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L  185 (221)
                      +|+.+||+.||++||++.+|++.|
T Consensus       238 ~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         238 DLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHhc
Confidence            999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=1.3e-26  Score=189.05  Aligned_cols=152  Identities=20%  Similarity=0.229  Sum_probs=117.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (323)
T cd05575          90 ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL  168 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhh
Confidence            45788999999999999999999998 999999999999999999999999999864322 2223344678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+......    .+  ...    ...+.+++.+||
T Consensus       169 ~-~~~~~~~~DvwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~----~~--~~~----~~~~~~li~~~l  231 (323)
T cd05575         169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DTAEMYDNILNKPLR----LK--PNI----SVSARHLLEGLL  231 (323)
T ss_pred             c-CCCCCccccccccchhhhhhhcCCCCCCCC------CHHHHHHHHHcCCCC----CC--CCC----CHHHHHHHHHHh
Confidence            6 667788999999999999999999999642      222222222221111    11  111    245899999999


Q ss_pred             cCCCCCCCCHH
Q 048055          169 SLAPENRPVMR  179 (221)
Q Consensus       169 ~~dp~~Rps~~  179 (221)
                      +.||.+||++.
T Consensus       232 ~~~p~~R~~~~  242 (323)
T cd05575         232 QKDRTKRLGAK  242 (323)
T ss_pred             hcCHHhCCCCC
Confidence            99999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=1.1e-26  Score=189.63  Aligned_cols=155  Identities=19%  Similarity=0.213  Sum_probs=118.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. |++||||||.||+++.++.++|+|||+++.... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~  168 (325)
T cd05602          90 ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL  168 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHH
Confidence            45678888899999999999999998 999999999999999999999999999864322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||...      ........+......   ..   ..    ....+.+++.+||
T Consensus       169 ~-~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~~---~~---~~----~~~~~~~li~~~l  231 (325)
T cd05602         169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNILNKPLQ---LK---PN----ITNSARHLLEGLL  231 (325)
T ss_pred             c-CCCCCCccccccccHHHHHHhcCCCCCCCC------CHHHHHHHHHhCCcC---CC---CC----CCHHHHHHHHHHc
Confidence            6 677788999999999999999999999642      222222222221111   11   11    2245899999999


Q ss_pred             cCCCCCCCCHHHHH
Q 048055          169 SLAPENRPVMREVS  182 (221)
Q Consensus       169 ~~dp~~Rps~~~l~  182 (221)
                      +.||.+||++.+.+
T Consensus       232 ~~~p~~R~~~~~~~  245 (325)
T cd05602         232 QKDRTKRLGAKDDF  245 (325)
T ss_pred             ccCHHHCCCCCCCH
Confidence            99999999876443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=2e-26  Score=187.94  Aligned_cols=151  Identities=23%  Similarity=0.339  Sum_probs=116.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.... .........++..|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  173 (324)
T cd05587          95 VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII  173 (324)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhh
Confidence            35688999999999999999999998 99999999999999999999999999986432 22222344678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||....      .......+....    ...+  ...    ...+.+++.+||
T Consensus       174 ~-~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~~~~----~~~~--~~~----~~~~~~li~~~l  236 (324)
T cd05587         174 A-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQSIMEHN----VSYP--KSL----SKEAVSICKGLL  236 (324)
T ss_pred             c-CCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCC----CCCC--CCC----CHHHHHHHHHHh
Confidence            6 6677889999999999999999999996421      122222222111    1111  112    235889999999


Q ss_pred             cCCCCCCCCH
Q 048055          169 SLAPENRPVM  178 (221)
Q Consensus       169 ~~dp~~Rps~  178 (221)
                      ..||.+|++.
T Consensus       237 ~~~P~~R~~~  246 (324)
T cd05587         237 TKHPAKRLGC  246 (324)
T ss_pred             hcCHHHcCCC
Confidence            9999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.94  E-value=9.6e-26  Score=184.66  Aligned_cols=166  Identities=23%  Similarity=0.364  Sum_probs=126.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||+++.......   .....++..|++||
T Consensus       128 ~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (334)
T cd05100         128 EEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE  206 (334)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence            45688999999999999999999998 999999999999999999999999999865433221   11222345799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ........+...     ..+......    ...+.+++.
T Consensus       207 ~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~----~~~l~~li~  270 (334)
T cd05100         207 ALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------PVEELFKLLKEG-----HRMDKPANC----THELYMIMR  270 (334)
T ss_pred             Hhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCCC----CHHHHHHHH
Confidence            876 5677889999999999999998 88888642      222222222111     111111112    236899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      +||+.+|++||++.++++.|+++....
T Consensus       271 ~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         271 ECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.94  E-value=3.1e-26  Score=184.12  Aligned_cols=167  Identities=22%  Similarity=0.396  Sum_probs=121.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      +...+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++++|||++.......   ......++..|++|
T Consensus       123 ~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         123 NSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            345789999999999999999999998 99999999999999999999999999986543221   11223445679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh--CCCCCcccccccCCChHHHHHHhhhhhhc--cCCCCCCCChhhHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT--GKTPFQDLVLEHGSDIPRWVRSVREEETE--SGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~  161 (221)
                      |.+. ...++.++|+||||+++|++++  +..||....      ..............  .....+.+.    ..+..+.
T Consensus       202 E~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~  270 (296)
T cd05051         202 ESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT------DQQVIENAGHFFRDDGRQIYLPRPP----NCPKDIY  270 (296)
T ss_pred             HHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC------hHHHHHHHHhccccccccccCCCcc----CCCHHHH
Confidence            9876 5567899999999999999987  677775321      11111111111000  000011111    1224699


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHh
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      +++.+||+.||.+||++.+|++.|++
T Consensus       271 ~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         271 ELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHHhccChhcCCCHHHHHHHhcC
Confidence            99999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.94  E-value=1.5e-26  Score=192.12  Aligned_cols=168  Identities=21%  Similarity=0.351  Sum_probs=120.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.
T Consensus        97 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~  175 (372)
T cd07853          97 PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI  175 (372)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHH
Confidence            46789999999999999999999998 99999999999999999999999999986543221  1223456778999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh-------------------hhhccCCCCCC
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE-------------------EETESGDDPPS  148 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~  148 (221)
                      +.....++.++|+||+||++|+|++|..||......      .....+..                   ........++.
T Consensus       176 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (372)
T cd07853         176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI------QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS  249 (372)
T ss_pred             HcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc
Confidence            763345688999999999999999999999643211      11111100                   00000111110


Q ss_pred             CC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          149 SN---EASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       149 ~~---~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ..   .........+.+|+.+||+.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         250 LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00   0011113468899999999999999999999753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=6.7e-26  Score=179.05  Aligned_cols=161  Identities=25%  Similarity=0.516  Sum_probs=122.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++........  .....++..|+|||.
T Consensus        96 ~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  174 (260)
T cd05070          96 GRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA  174 (260)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHH
Confidence            45689999999999999999999998 999999999999999999999999999865432211  112233457999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. ...++.++|+||||+++|++++ |..||...      ........+...     ...+.+.    ..+..+.+++.+
T Consensus       175 ~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~li~~  238 (260)
T cd05070         175 AL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGM------NNREVLEQVERG-----YRMPCPQ----DCPISLHELMLQ  238 (260)
T ss_pred             Hh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHcC-----CCCCCCC----cCCHHHHHHHHH
Confidence            75 5667889999999999999998 88999642      112222222111     1111111    223469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||..+|.+|||++++.+.|++
T Consensus       239 ~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         239 CWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=9.5e-26  Score=177.53  Aligned_cols=160  Identities=28%  Similarity=0.477  Sum_probs=124.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||.+.......   ......++..|++||
T Consensus        99 ~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  177 (262)
T cd00192          99 KSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE  177 (262)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHH
Confidence            57889999999999999999999998 99999999999999999999999999987654432   122344567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++|+||+|+++|++++ |..||...      ........+..     ......+...    +..+.+++.
T Consensus       178 ~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~-----~~~~~~~~~~----~~~~~~li~  241 (262)
T cd00192         178 SLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGL------SNEEVLEYLRK-----GYRLPKPEYC----PDELYELML  241 (262)
T ss_pred             Hhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHc-----CCCCCCCccC----ChHHHHHHH
Confidence            876 4567889999999999999998 69999643      12222222221     1111111122    346999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +||+.+|.+||++.+++..|+
T Consensus       242 ~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         242 SCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHccCCcccCcCHHHHHHhhC
Confidence            999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=5.7e-26  Score=180.86  Aligned_cols=161  Identities=23%  Similarity=0.396  Sum_probs=122.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||+++.......   .....++..|++||
T Consensus       113 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05032         113 LGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (277)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence            44678999999999999999999998 999999999999999999999999999865433221   12234466799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ....+.++|+||||+++|++++ |..||...      ...........     ...+..+...    +..+.+++.
T Consensus       192 ~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~------~~~~~~~~~~~-----~~~~~~~~~~----~~~~~~li~  255 (277)
T cd05032         192 SLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL------SNEEVLKFVID-----GGHLDLPENC----PDKLLELMR  255 (277)
T ss_pred             HHh-cCCCCcccchHHHHHHHHHhhccCCCCCccC------CHHHHHHHHhc-----CCCCCCCCCC----CHHHHHHHH
Confidence            876 5667889999999999999998 99998642      11222222211     1111111122    346999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHh
Q 048055          166 ACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      +||+.+|++|||+.+++..|++
T Consensus       256 ~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         256 MCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHcCCChhhCCCHHHHHHHhcC
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-27  Score=195.05  Aligned_cols=168  Identities=23%  Similarity=0.368  Sum_probs=131.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCC-CCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE-PSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~pe~~   88 (221)
                      ++.++..++..++.+++.||+|||++ +++||||-++|+|++.++.+||+|||+++......... ...-+..|+|||.+
T Consensus       256 ~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl  334 (474)
T KOG0194|consen  256 KKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETL  334 (474)
T ss_pred             CCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhh
Confidence            44799999999999999999999999 99999999999999999999999999986543222111 22456789999999


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . ...++.++||||||+++||+++ |..||++.      ........+    .....+.+.+.    ..+..+..++..|
T Consensus       335 ~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~------~~~~v~~kI----~~~~~r~~~~~----~~p~~~~~~~~~c  399 (474)
T KOG0194|consen  335 N-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGM------KNYEVKAKI----VKNGYRMPIPS----KTPKELAKVMKQC  399 (474)
T ss_pred             c-cCccccccchhheeeeEEeeeccCCCCCCCC------CHHHHHHHH----HhcCccCCCCC----CCHHHHHHHHHHh
Confidence            8 5688999999999999999998 88899753      222222222    12222333222    2335689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      |..+|+.||+|.++.+.|+.+.....
T Consensus       400 ~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  400 WKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ccCChhhccCHHHHHHHHHHHHhccc
Confidence            99999999999999999999887643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.94  E-value=2.7e-26  Score=179.65  Aligned_cols=167  Identities=22%  Similarity=0.254  Sum_probs=127.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+|....+.-++.|++.|++|||.. .|+|||+|++|+|+...|.+||+|||+|+.++.. +..+...-|.+|+|||.+.
T Consensus       172 q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLL  250 (419)
T KOG0663|consen  172 QPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLL  250 (419)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhc
Confidence            6888999999999999999999998 9999999999999999999999999999877655 4455667789999999988


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-CC------CC---------C-----
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-DD------PP---------S-----  148 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~---------~-----  148 (221)
                      ....|+.+.|+||+||++.|++.+.+.|++...     +.. +.++........ ..      ++         .     
T Consensus       251 G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-----~dQ-l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~l  324 (419)
T KOG0663|consen  251 GAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-----IDQ-LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNL  324 (419)
T ss_pred             CCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-----HHH-HHHHHHHhCCCccccCCCccccchhhccccCCCCchhh
Confidence            778889999999999999999999999986422     111 122111111100 00      00         0     


Q ss_pred             CChhhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          149 SNEASE-EKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       149 ~~~~~~-~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ...... .....-.+|++..+.+||.+|.|+.|.++.
T Consensus       325 r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  325 RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            000000 012467899999999999999999998754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=2.7e-26  Score=186.70  Aligned_cols=156  Identities=24%  Similarity=0.342  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||+++..... .......++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (316)
T cd05619          90 CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL  168 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHH
Confidence            35689999999999999999999998 9999999999999999999999999998643221 122334578889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|++++|..||...      ........+...    ....+  ...    ...+.+++.+||
T Consensus       169 ~-~~~~~~~~DvwslG~il~el~~G~~pf~~~------~~~~~~~~i~~~----~~~~~--~~~----~~~~~~li~~~l  231 (316)
T cd05619         169 L-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGH------DEEELFQSIRMD----NPCYP--RWL----TREAKDILVKLF  231 (316)
T ss_pred             c-CCCCCchhhhhhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhC----CCCCC--ccC----CHHHHHHHHHHh
Confidence            6 667789999999999999999999999642      222222222111    11111  112    235889999999


Q ss_pred             cCCCCCCCCHH-HHHH
Q 048055          169 SLAPENRPVMR-EVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~-~l~~  183 (221)
                      +.||.+||++. ++++
T Consensus       232 ~~~P~~R~~~~~~l~~  247 (316)
T cd05619         232 VREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCHhhcCCChHHHHc
Confidence            99999999996 6643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=1.4e-26  Score=189.29  Aligned_cols=157  Identities=20%  Similarity=0.287  Sum_probs=116.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.... ........++..|+|||.+
T Consensus        90 ~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (329)
T cd05618          90 QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL  168 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHH
Confidence            45789999999999999999999998 999999999999999999999999999864322 2223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC--CChHHHH-HHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG--SDIPRWV-RSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      . +..++.++|+|||||++|++++|..||........  ....... ......    ....+  ...    ...+.+++.
T Consensus       169 ~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----~~~~p--~~~----~~~~~~ll~  237 (329)
T cd05618         169 R-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QIRIP--RSL----SVKAASVLK  237 (329)
T ss_pred             c-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----CCCCC--CCC----CHHHHHHHH
Confidence            6 66778899999999999999999999953211111  1111111 111111    11111  111    235889999


Q ss_pred             HcccCCCCCCCCH
Q 048055          166 ACVSLAPENRPVM  178 (221)
Q Consensus       166 ~cl~~dp~~Rps~  178 (221)
                      +||+.||.+||++
T Consensus       238 ~~L~~dP~~R~~~  250 (329)
T cd05618         238 SFLNKDPKERLGC  250 (329)
T ss_pred             HHhcCCHHHcCCC
Confidence            9999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=6.8e-26  Score=178.63  Aligned_cols=158  Identities=23%  Similarity=0.403  Sum_probs=120.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+.........  ....++..|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~  173 (256)
T cd05114          95 GKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF  173 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhc
Confidence            3588999999999999999999998 9999999999999999999999999988654322211  122334579999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|+||||+++|++++ |+.||...      ........+....     ....+...    ...+.+++.+|
T Consensus       174 ~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~------~~~~~~~~i~~~~-----~~~~~~~~----~~~~~~li~~c  237 (256)
T cd05114         174 N-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK------SNYEVVEMISRGF-----RLYRPKLA----SMTVYEVMYSC  237 (256)
T ss_pred             c-cCccchhhhhHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHCCC-----CCCCCCCC----CHHHHHHHHHH
Confidence            6 5677889999999999999999 89999642      1222222222211     11111111    24689999999


Q ss_pred             ccCCCCCCCCHHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKMI  185 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L  185 (221)
                      |+.+|.+||++.++++.|
T Consensus       238 ~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         238 WHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ccCCcccCcCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=6.6e-26  Score=179.18  Aligned_cols=161  Identities=25%  Similarity=0.505  Sum_probs=122.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.......  ......++..|++||.
T Consensus        96 ~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~  174 (260)
T cd05069          96 GKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA  174 (260)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHH
Confidence            34578999999999999999999998 99999999999999999999999999986543221  1112234567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .. +...+.++|+||||+++|++++ |..||.+..      ...........     ...+...    ..+..+.+++.+
T Consensus       175 ~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~----~~~~~~~~li~~  238 (260)
T cd05069         175 AL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMV------NREVLEQVERG-----YRMPCPQ----GCPESLHELMKL  238 (260)
T ss_pred             hc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcC-----CCCCCCc----ccCHHHHHHHHH
Confidence            76 5667889999999999999998 899996432      11222222111     1111111    223569999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||..+|++||++.+|++.|++
T Consensus       239 ~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         239 CWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=3.5e-26  Score=195.65  Aligned_cols=157  Identities=24%  Similarity=0.292  Sum_probs=121.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ..+++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++......   ......+++.|+|||
T Consensus       163 ~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE  241 (478)
T PTZ00267        163 HLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE  241 (478)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHh
Confidence            45688999999999999999999998 99999999999999999999999999987543321   123445788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+|||||++|+|++|..||...      .............     ..+.+...    ...+.+++.+
T Consensus       242 ~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~------~~~~~~~~~~~~~-----~~~~~~~~----s~~~~~li~~  305 (478)
T PTZ00267        242 LWE-RKRYSKKADMWSLGVILYELLTLHRPFKGP------SQREIMQQVLYGK-----YDPFPCPV----SSGMKALLDP  305 (478)
T ss_pred             HhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC-----CCCCCccC----CHHHHHHHHH
Confidence            886 567788999999999999999999999632      2222222222111     11111112    2458999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||++||++.+++.
T Consensus       306 ~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        306 LLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhccChhhCcCHHHHHh
Confidence            99999999999999864

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-26  Score=172.74  Aligned_cols=167  Identities=23%  Similarity=0.354  Sum_probs=124.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----------CCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----------VEEPSAT   78 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----------~~~~~~~   78 (221)
                      +.-++..+++.++.+|+.||.+||.. +...|+|+||.||++...+.+++.|||.+....-.-          .......
T Consensus       121 g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~C  200 (302)
T KOG2345|consen  121 GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERC  200 (302)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhC
Confidence            44679999999999999999999998 238999999999999999999999999875322111          0122345


Q ss_pred             CccccCcccchhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           79 SLFYKAPECREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        79 ~~~~~~pe~~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      +..|+|||.+...  .-.+.++|||||||++|.|+.|..||...... +..+.-.       ........|....++   
T Consensus       201 t~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSlaLA-------v~n~q~s~P~~~~ys---  269 (302)
T KOG2345|consen  201 TIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLALA-------VQNAQISIPNSSRYS---  269 (302)
T ss_pred             CCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEEEe-------eeccccccCCCCCcc---
Confidence            7789999986532  23378999999999999999999999865442 2221110       011122233333333   


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                       ..+.+++..|++.||.+||++.+++..++.+
T Consensus       270 -e~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  270 -EALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -HHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence             4699999999999999999999999888765

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=2.2e-26  Score=189.02  Aligned_cols=155  Identities=19%  Similarity=0.156  Sum_probs=120.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.|++.||.|||+. +++||||||.||+++.++.++|+|||++......  .....+++.|+|||.+.
T Consensus       125 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~  201 (340)
T PTZ00426        125 NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILL  201 (340)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHh
Confidence            45789999999999999999999998 9999999999999999999999999998654322  23456788999999986


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+||++|+|++|..||...      ........+......    .+  ...    ...+.+++.+||+
T Consensus       202 -~~~~~~~~DiwSlGvil~ell~G~~Pf~~~------~~~~~~~~i~~~~~~----~p--~~~----~~~~~~li~~~l~  264 (340)
T PTZ00426        202 -NVGHGKAADWWTLGIFIYEILVGCPPFYAN------EPLLIYQKILEGIIY----FP--KFL----DNNCKHLMKKLLS  264 (340)
T ss_pred             -CCCCCccccccchhhHHHHHhcCCCCCCCC------CHHHHHHHHhcCCCC----CC--CCC----CHHHHHHHHHHcc
Confidence             566788999999999999999999999642      222222333222111    11  111    2357899999999


Q ss_pred             CCCCCCC-----CHHHHHHH
Q 048055          170 LAPENRP-----VMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~~  184 (221)
                      .||++|+     ++.++++.
T Consensus       265 ~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        265 HDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             cCHHHcCCCCCCCHHHHHcC
Confidence            9999995     78888653

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=8.6e-26  Score=178.52  Aligned_cols=162  Identities=26%  Similarity=0.491  Sum_probs=123.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~   87 (221)
                      +..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||+++........  .....+..|++||.
T Consensus        97 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  175 (261)
T cd05068          97 GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA  175 (261)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccc
Confidence            45789999999999999999999998 9999999999999999999999999998765432211  11122346999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |+.||...      ........+...     ...+...    ..+..+.+++.+
T Consensus       176 ~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~li~~  239 (261)
T cd05068         176 AL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGM------TNAEVLQQVDQG-----YRMPCPP----GCPKELYDIMLD  239 (261)
T ss_pred             cc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHcC-----CCCCCCC----cCCHHHHHHHHH
Confidence            76 5677889999999999999998 99999642      111222222111     1111111    123469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|.+||++.++++.|+++
T Consensus       240 ~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         240 CWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HhhcCcccCCCHHHHHHHHhcC
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=1.7e-26  Score=188.80  Aligned_cols=161  Identities=21%  Similarity=0.335  Sum_probs=119.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcccc-CCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR-NPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+++++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.. ..........++..|+|||.+
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (329)
T cd05588          90 QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL  168 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHH
Confidence            46789999999999999999999998 9999999999999999999999999998642 222233345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc--CCChHHHH-HHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH--GSDIPRWV-RSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      . +..++.++|+|||||++|++++|..||.......  ......+. ..+...    ....+  ...    ...+.+++.
T Consensus       169 ~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~p--~~~----~~~~~~li~  237 (329)
T cd05588         169 R-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----QIRIP--RSL----SVKASSVLK  237 (329)
T ss_pred             c-CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----CCCCC--CCC----CHHHHHHHH
Confidence            6 6677889999999999999999999996321111  11111111 111111    11111  112    235899999


Q ss_pred             HcccCCCCCCCC------HHHHH
Q 048055          166 ACVSLAPENRPV------MREVS  182 (221)
Q Consensus       166 ~cl~~dp~~Rps------~~~l~  182 (221)
                      +||+.||.+|++      +.+++
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHh
Confidence            999999999997      56775

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.1e-26  Score=188.19  Aligned_cols=165  Identities=24%  Similarity=0.321  Sum_probs=119.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++......  .....++..|+|||.+..
T Consensus       113 ~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         113 QKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcC
Confidence            4689999999999999999999998 9999999999999999999999999998654332  233467888999998764


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh--------------------ccCCCCCC-C
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET--------------------ESGDDPPS-S  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~-~  149 (221)
                      ...++.++|+|||||++|+|++|..||....      .............                    .....+.. .
T Consensus       190 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (343)
T cd07878         190 WMHYNQTVDIWSVGCIMAELLKGKALFPGND------YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDL  263 (343)
T ss_pred             CccCCchhhhHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhH
Confidence            4567889999999999999999999996421      1111111100000                    00000000 0


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ..........+.+|+.+||+.||.+|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         264 KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000112347899999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.94  E-value=6.2e-26  Score=180.89  Aligned_cols=160  Identities=23%  Similarity=0.396  Sum_probs=120.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||++........   .....++..|+|||.
T Consensus       114 ~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05062         114 APPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  192 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhH
Confidence            4568889999999999999999998 999999999999999999999999999864432211   112233567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||...      ..............     ......    .+..+.+++.+
T Consensus       193 ~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~------~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~li~~  256 (277)
T cd05062         193 LK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGM------SNEQVLRFVMEGGL-----LDKPDN----CPDMLFELMRM  256 (277)
T ss_pred             hh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHcCCc-----CCCCCC----CCHHHHHHHHH
Confidence            76 5667889999999999999998 78888642      11222222111110     111111    22468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.+|++||++.++++.|++
T Consensus       257 ~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         257 CWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HcCCChhhCcCHHHHHHHhhC
Confidence            999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=5.7e-26  Score=178.97  Aligned_cols=160  Identities=23%  Similarity=0.425  Sum_probs=122.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.......    ......++..|++||
T Consensus        92 ~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE  170 (257)
T cd05040          92 GHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE  170 (257)
T ss_pred             ccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHH
Confidence            5789999999999999999999998 99999999999999999999999999986553321    111234456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|+|++ |..||...      ...........    .....+...    ..+..+.+++.
T Consensus       171 ~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~li~  235 (257)
T cd05040         171 SLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGL------SGSQILKKIDK----EGERLERPE----ACPQDIYNVML  235 (257)
T ss_pred             Hhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHh----cCCcCCCCc----cCCHHHHHHHH
Confidence            876 5677889999999999999998 99999632      11222222211    111111111    22346999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +||+.+|++||++.++++.|.
T Consensus       236 ~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         236 QCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHCCCCcccCCCHHHHHHHhc
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=5.1e-26  Score=190.24  Aligned_cols=170  Identities=18%  Similarity=0.249  Sum_probs=122.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       179 ~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE  257 (392)
T PHA03207        179 SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE  257 (392)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHh
Confidence            46789999999999999999999998 99999999999999999999999999986543321   122346788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc---------------------cCCC
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE---------------------SGDD  145 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~  145 (221)
                      .+. +..++.++|+|||||++|+|++|..||.+.....   .......+......                     ....
T Consensus       258 ~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (392)
T PHA03207        258 LLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS---SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLR  333 (392)
T ss_pred             Hhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC---cHHHHHHHHHHhccCccccCCccchhHHHHHHhhccccc
Confidence            886 6677889999999999999999999996543211   00111111110000                     0000


Q ss_pred             CCCC---ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          146 PPSS---NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       146 ~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ++..   ..........+.+++.+||..||++||++.+++..
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        334 PPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000   00000112468899999999999999999999764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=2.6e-26  Score=187.55  Aligned_cols=158  Identities=23%  Similarity=0.280  Sum_probs=118.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||+|||+. +++|+||||.||+++.++.++|+|||+++... .........++..|+|||.+
T Consensus        90 ~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (327)
T cd05617          90 QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL  168 (327)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHH
Confidence            45789999999999999999999998 99999999999999999999999999986432 22233445678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|+|++|..||.....................   .....+  ...    ...+.+++.+||
T Consensus       169 ~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~p--~~~----~~~~~~li~~~L  238 (327)
T cd05617         169 R-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---KPIRIP--RFL----SVKASHVLKGFL  238 (327)
T ss_pred             C-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---CCCCCC--CCC----CHHHHHHHHHHh
Confidence            6 677788999999999999999999999643222222222221111111   111111  111    235789999999


Q ss_pred             cCCCCCCCCH
Q 048055          169 SLAPENRPVM  178 (221)
Q Consensus       169 ~~dp~~Rps~  178 (221)
                      +.||.+|+++
T Consensus       239 ~~dP~~R~~~  248 (327)
T cd05617         239 NKDPKERLGC  248 (327)
T ss_pred             ccCHHHcCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=6.8e-26  Score=178.82  Aligned_cols=159  Identities=22%  Similarity=0.385  Sum_probs=120.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.||+.||.|||+. +++|+|++|.||+++.++.++++|||.++........  ....++..|++||.+
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~  173 (256)
T cd05113          95 KRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL  173 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHH
Confidence            4689999999999999999999998 9999999999999999999999999988654332211  122334579999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|+||||+++|++++ |..||....      ............     ........    ...+.+++.+|
T Consensus       174 ~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~~~-----~~~~~~~~----~~~~~~li~~c  237 (256)
T cd05113         174 L-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN------NSETVEKVSQGL-----RLYRPHLA----SEKVYAIMYSC  237 (256)
T ss_pred             h-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCC------HHHHHHHHhcCC-----CCCCCCCC----CHHHHHHHHHH
Confidence            6 5667889999999999999998 999986321      112222222111     11111111    24689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~  186 (221)
                      |+.+|.+||++.+|+..|+
T Consensus       238 l~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         238 WHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             cCCCcccCCCHHHHHHhhC
Confidence            9999999999999988764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=5e-27  Score=191.04  Aligned_cols=153  Identities=27%  Similarity=0.283  Sum_probs=117.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|++||.+
T Consensus        92 ~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  170 (318)
T cd05582          92 EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV  170 (318)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHH
Confidence            35689999999999999999999998 9999999999999999999999999998654333 223345678889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ..    ....+.+++.+||
T Consensus       171 ~-~~~~~~~~DiwslG~il~el~tg~~p~~~~------~~~~~~~~i~~~~~----~~p--~~----~~~~~~~li~~~l  233 (318)
T cd05582         171 N-RRGHTQSADWWSFGVLMFEMLTGSLPFQGK------DRKETMTMILKAKL----GMP--QF----LSPEAQSLLRALF  233 (318)
T ss_pred             c-CCCCCCccceeccceEeeeeccCCCCCCCC------CHHHHHHHHHcCCC----CCC--CC----CCHHHHHHHHHHh
Confidence            6 566788999999999999999999999642      11222222211111    111  11    1245889999999


Q ss_pred             cCCCCCCCCHHH
Q 048055          169 SLAPENRPVMRE  180 (221)
Q Consensus       169 ~~dp~~Rps~~~  180 (221)
                      +.||.+||++.+
T Consensus       234 ~~~P~~R~~a~~  245 (318)
T cd05582         234 KRNPANRLGAGP  245 (318)
T ss_pred             hcCHhHcCCCCC
Confidence            999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2e-26  Score=193.42  Aligned_cols=159  Identities=19%  Similarity=0.311  Sum_probs=125.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      +++|+..++.-++.|++.||.|||+. +|+|||+|+.|||+..+|.++++|||.+..... ......+.||++|||||+.
T Consensus       124 ~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVv  202 (1187)
T KOG0579|consen  124 GRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVV  202 (1187)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchhe
Confidence            67899999999999999999999999 999999999999999999999999998743322 2234678999999999952


Q ss_pred             h----hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 E----IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~----~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .    ...+|..++||||||+++.+|..+.+|...      .+..+++-++..   ..+.    .-..+......+.+|+
T Consensus       203 mCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaK---SePP----TLlqPS~Ws~~F~DfL  269 (1187)
T KOG0579|consen  203 MCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAK---SEPP----TLLQPSHWSRSFSDFL  269 (1187)
T ss_pred             eeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhh---cCCC----cccCcchhhhHHHHHH
Confidence            2    257788999999999999999999999853      333333333322   1112    2223333445699999


Q ss_pred             HHcccCCCCCCCCHHHHH
Q 048055          165 IACVSLAPENRPVMREVS  182 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~  182 (221)
                      .+||.+||..||++++|+
T Consensus       270 k~cL~Knp~~Rp~aaqll  287 (1187)
T KOG0579|consen  270 KRCLVKNPRNRPPAAQLL  287 (1187)
T ss_pred             HHHHhcCCccCCCHHHHh
Confidence            999999999999999996

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=8.4e-26  Score=178.52  Aligned_cols=162  Identities=23%  Similarity=0.359  Sum_probs=119.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCccccCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYKAP   85 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~p   85 (221)
                      ..+++..++.++.||+.||+|||+. +++|+|++|.||+++.++.++++|||++.......     ......++..|+||
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP  171 (262)
T cd05058          93 HNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL  171 (262)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccCh
Confidence            3457788889999999999999998 99999999999999999999999999986432211     11122345679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |... ...++.++|+||||+++|++++ |.+||...      ........+..     ...++.....    +..+.+++
T Consensus       172 E~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~~~~-----~~~~~~~~~~----~~~~~~li  235 (262)
T cd05058         172 ESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLLQ-----GRRLLQPEYC----PDPLYEVM  235 (262)
T ss_pred             hHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHhc-----CCCCCCCCcC----CHHHHHHH
Confidence            9876 5667889999999999999999 56666532      11111111111     1111111111    24689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      .+||+.+|++||++.+|++.|+++.
T Consensus       236 ~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         236 LSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HHHcCCChhhCCCHHHHHHHHHHHh
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=3.1e-26  Score=186.61  Aligned_cols=152  Identities=22%  Similarity=0.296  Sum_probs=117.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++... .........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (321)
T cd05603          90 ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL  168 (321)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHh
Confidence            45688889999999999999999998 99999999999999999999999999986532 22223344678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      +.......+.....    ..+  ..    ....+.+++.+||
T Consensus       169 ~-~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~----~~~--~~----~~~~~~~li~~~l  231 (321)
T cd05603         169 R-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DVSQMYDNILHKPL----QLP--GG----KTVAACDLLVGLL  231 (321)
T ss_pred             c-CCCCCCcCcccccchhhhhhhcCCCCCCCC------CHHHHHHHHhcCCC----CCC--CC----CCHHHHHHHHHHc
Confidence            6 567788999999999999999999999642      22222233222111    111  11    2246899999999


Q ss_pred             cCCCCCCCCHH
Q 048055          169 SLAPENRPVMR  179 (221)
Q Consensus       169 ~~dp~~Rps~~  179 (221)
                      +.||.+||++.
T Consensus       232 ~~~p~~R~~~~  242 (321)
T cd05603         232 HKDQRRRLGAK  242 (321)
T ss_pred             cCCHhhcCCCC
Confidence            99999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=5.1e-26  Score=183.21  Aligned_cols=166  Identities=19%  Similarity=0.356  Sum_probs=121.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~p   85 (221)
                      ....+++..+..++.|++.||+|||+. +++|+|+||.||+++.++.++++|||++........   ......+..|++|
T Consensus       123 ~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         123 DVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            345688999999999999999999998 999999999999999999999999999865432221   1122335679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh--CCCCCcccccccCCChHHHHHHhh---hhhhccCCCCCCCChhhHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT--GKTPFQDLVLEHGSDIPRWVRSVR---EEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~--g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      |... ...++.++|+|||||++|++++  |..||.....      ........   ........ .+....    ++..+
T Consensus       202 e~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~  269 (296)
T cd05095         202 ESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD------EQVIENTGEFFRDQGRQVY-LPKPAL----CPDSL  269 (296)
T ss_pred             HHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccCh------HHHHHHHHHHHhhcccccc-CCCCCC----CCHHH
Confidence            9765 5667889999999999999998  7788864321      11111110   00000111 111111    22469


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHh
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      .+++.+||+.||.+||++.+|++.|++
T Consensus       270 ~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         270 YKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=6.2e-26  Score=189.88  Aligned_cols=164  Identities=23%  Similarity=0.397  Sum_probs=124.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.||+.||+|||+. +++|+||||.||+++.++.++|+|||+++.......   .....++..|+|||
T Consensus       231 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  309 (400)
T cd05105         231 SEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE  309 (400)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence            45789999999999999999999998 999999999999999999999999999865432221   12233456799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||......     ......+..     ...++...    ..+..+.+++.
T Consensus       310 ~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-----~~~~~~~~~-----~~~~~~~~----~~~~~l~~li~  374 (400)
T cd05105         310 SIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-----STFYNKIKS-----GYRMAKPD----HATQEVYDIMV  374 (400)
T ss_pred             hhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----HHHHHHHhc-----CCCCCCCc----cCCHHHHHHHH
Confidence            876 5667889999999999999997 99998643111     111111111     11111111    22346899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +||+.||++||++.+|.+.|+++.
T Consensus       375 ~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         375 KCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHCccCHhHCcCHHHHHHHHHHHc
Confidence            999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-25  Score=178.23  Aligned_cols=161  Identities=20%  Similarity=0.443  Sum_probs=123.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCC--CCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVE--EPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~--~~~~~~~~~~~pe~   87 (221)
                      +.+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++..... ....  .....+..|++||.
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~  179 (266)
T cd05033         101 GKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA  179 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhh
Confidence            4789999999999999999999998 999999999999999999999999999876542 1111  12233467999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||....      .......+..     ....+.+..+    +..+.+++.+
T Consensus       180 ~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~~l~~li~~  243 (266)
T cd05033         180 IA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDMS------NQDVIKAVED-----GYRLPPPMDC----PSALYQLMLD  243 (266)
T ss_pred             hc-cCCCccccchHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHc-----CCCCCCCCCC----CHHHHHHHHH
Confidence            76 5677889999999999999998 999986422      1122222211     1111222222    3468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|++||++.+|++.|+++
T Consensus       244 cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         244 CWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.8e-26  Score=187.75  Aligned_cols=163  Identities=18%  Similarity=0.178  Sum_probs=122.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.....  ......++..|+|||.+.
T Consensus        95 ~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~  171 (333)
T cd05600          95 LGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLR  171 (333)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhc
Confidence            45688999999999999999999998 999999999999999999999999999865433  223456788999999887


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||....      .......+....... ..+. ...........+.+++.+||.
T Consensus       172 -~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~-~~~~-~~~~~~~~s~~~~~li~~~l~  242 (333)
T cd05600         172 -GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST------PNETWENLKYWKETL-QRPV-YDDPRFNLSDEAWDLITKLIN  242 (333)
T ss_pred             -CCCCCCccceecchHHHhhhhhCCCCCCCCC------HHHHHHHHHhccccc-cCCC-CCccccccCHHHHHHHHHHhh
Confidence             5678899999999999999999999996422      112222221111100 0111 000001123468899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|.+||++.++++.
T Consensus       243 ~~~~rr~s~~~ll~h  257 (333)
T cd05600         243 DPSRRFGSLEDIKNH  257 (333)
T ss_pred             ChhhhcCCHHHHHhC
Confidence            999999999999854

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=5.3e-26  Score=187.60  Aligned_cols=161  Identities=19%  Similarity=0.305  Sum_probs=117.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+....+..++.||+.||.|||+. +++|+|||+.||+++.++.++|+|||++....... ......++..|++||.+.
T Consensus       163 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  241 (353)
T PLN00034        163 HIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN  241 (353)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccc
Confidence            3456778889999999999999998 99999999999999999999999999986543321 223456788999999764


Q ss_pred             h----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           90 I----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        90 ~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .    +...+.++|||||||++|++++|..||....   ...........   ..  ...+....    .....+.+|+.
T Consensus       242 ~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~---~~~~~~~~~~~---~~--~~~~~~~~----~~~~~l~~li~  309 (353)
T PLN00034        242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR---QGDWASLMCAI---CM--SQPPEAPA----TASREFRHFIS  309 (353)
T ss_pred             cccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CccHHHHHHHH---hc--cCCCCCCC----ccCHHHHHHHH
Confidence            2    1233468999999999999999999996221   11111111111   00  01111111    12246899999


Q ss_pred             HcccCCCCCCCCHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~  184 (221)
                      +||+.||++||++.|+++.
T Consensus       310 ~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        310 CCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHccCChhhCcCHHHHhcC
Confidence            9999999999999999864

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=1.3e-25  Score=181.68  Aligned_cols=165  Identities=23%  Similarity=0.353  Sum_probs=125.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++++|||.+........   ......+..|++||
T Consensus       134 ~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  212 (307)
T cd05098         134 EEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  212 (307)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence            35689999999999999999999998 999999999999999999999999999865432211   11122345799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|+|++ |..||...      ........+...     .....+.    .....+.+++.
T Consensus       213 ~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~li~  276 (307)
T cd05098         213 ALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEG-----HRMDKPS----NCTNELYMMMR  276 (307)
T ss_pred             Hhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC------CHHHHHHHHHcC-----CCCCCCC----cCCHHHHHHHH
Confidence            876 5667889999999999999998 88888532      222222222211     1111111    12346899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||..+|.+||++.++++.|+.+...
T Consensus       277 ~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         277 DCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHcccChhhCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=2e-25  Score=181.26  Aligned_cols=165  Identities=22%  Similarity=0.374  Sum_probs=125.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||+++.......   .....++..|++||
T Consensus       128 ~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (314)
T cd05099         128 EEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE  206 (314)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence            45689999999999999999999998 999999999999999999999999999865432211   11122345799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ........+...     .....+..    .+..+.+++.
T Consensus       207 ~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~----~~~~l~~li~  270 (314)
T cd05099         207 ALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGI------PVEELFKLLREG-----HRMDKPSN----CTHELYMLMR  270 (314)
T ss_pred             HHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCC----CCHHHHHHHH
Confidence            876 5667889999999999999998 88888632      222222222211     11111111    2236889999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.+|++||++.++++.|+++...
T Consensus       271 ~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         271 ECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=1.5e-26  Score=188.82  Aligned_cols=153  Identities=22%  Similarity=0.251  Sum_probs=117.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++...+..++.||+.||.|||+. |++|+||||.||+++.++.++|+|||+++.... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~  168 (325)
T cd05604          90 ERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI  168 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHH
Confidence            46789999999999999999999998 999999999999999999999999999864322 2223344678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+.....   ...+   ..    ...+.+++.+|+
T Consensus       169 ~-~~~~~~~~DvwslG~il~el~~G~~pf~~~------~~~~~~~~~~~~~~---~~~~---~~----~~~~~~ll~~ll  231 (325)
T cd05604         169 R-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCR------DVAEMYDNILHKPL---VLRP---GA----SLTAWSILEELL  231 (325)
T ss_pred             c-CCCCCCcCccccccceehhhhcCCCCCCCC------CHHHHHHHHHcCCc---cCCC---CC----CHHHHHHHHHHh
Confidence            6 667788999999999999999999999642      22222222222111   1111   11    235789999999


Q ss_pred             cCCCCCCCCHHH
Q 048055          169 SLAPENRPVMRE  180 (221)
Q Consensus       169 ~~dp~~Rps~~~  180 (221)
                      +.+|.+||++++
T Consensus       232 ~~~p~~R~~~~~  243 (325)
T cd05604         232 EKDRQRRLGAKE  243 (325)
T ss_pred             ccCHHhcCCCCC
Confidence            999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=1.2e-25  Score=178.01  Aligned_cols=167  Identities=22%  Similarity=0.357  Sum_probs=126.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      ....++...++.++.+++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.
T Consensus        99 ~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~  177 (267)
T cd08224          99 QKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             cCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHH
Confidence            345689999999999999999999998 99999999999999999999999999876543322 2223456778999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||||+++|++++|..||....    .............     ...+.+.   ......+.+++.+|
T Consensus       178 ~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~i~~c  244 (267)
T cd08224         178 IH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKC-----DYPPLPA---DHYSEELRDLVSRC  244 (267)
T ss_pred             hc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcC-----CCCCCCh---hhcCHHHHHHHHHH
Confidence            76 5667889999999999999999999985421    1222222222111     1111111   12234689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhH
Q 048055          168 VSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      |..+|.+||++.+|++.|+++.
T Consensus       245 l~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         245 INPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=1.4e-25  Score=177.67  Aligned_cols=162  Identities=27%  Similarity=0.515  Sum_probs=123.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      +..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++|+|||.+........  .....++..|++||.
T Consensus        96 ~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~  174 (262)
T cd05071          96 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA  174 (262)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhH
Confidence            34678999999999999999999998 999999999999999999999999999865433221  122334567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .. +..++.++|+||||+++|++++ |..||.....      .........     ....+.    ....+..+.+++.+
T Consensus       175 ~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------~~~~~~~~~-----~~~~~~----~~~~~~~l~~li~~  238 (262)
T cd05071         175 AL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVER-----GYRMPC----PPECPESLHDLMCQ  238 (262)
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHHHhc-----CCCCCC----ccccCHHHHHHHHH
Confidence            75 5667889999999999999999 8888864321      111121111     111111    11234568999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|++||++.++++.|+..
T Consensus       239 ~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         239 CWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HccCCcccCCCHHHHHHHHHHh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=6.1e-26  Score=181.47  Aligned_cols=161  Identities=19%  Similarity=0.202  Sum_probs=119.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      ....+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus        90 ~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  168 (280)
T cd05608          90 ENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL  168 (280)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHH
Confidence            456789999999999999999999998 99999999999999999999999999986543322 2223467788999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||||+++|++++|..||......  ..........    .....      ..+...+..+.+++.+|
T Consensus       169 ~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~----~~~~~------~~~~~~~~~~~~li~~~  235 (280)
T cd05608         169 LQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRI----LNDSV------TYPDKFSPASKSFCEAL  235 (280)
T ss_pred             hc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHhh----cccCC------CCcccCCHHHHHHHHHH
Confidence            87 667788999999999999999999999642111  0001111111    00000      11112234689999999


Q ss_pred             ccCCCCCCC-----CHHHHHH
Q 048055          168 VSLAPENRP-----VMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rp-----s~~~l~~  183 (221)
                      |+.||++||     ++.++++
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhc
Confidence            999999999     5666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.7e-26  Score=181.65  Aligned_cols=161  Identities=22%  Similarity=0.249  Sum_probs=121.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++.............++..|++||.+.
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (285)
T cd05605          96 NPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK  174 (285)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhc
Confidence            35689999999999999999999998 99999999999999999999999999987654333333446778999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+||+|+++|++++|..||......      .....+..........      .+......+.+|+.+||+
T Consensus       175 -~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~  241 (285)
T cd05605         175 -NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK------VKREEVERRVKEDQEE------YSEKFSEAARSICRQLLT  241 (285)
T ss_pred             -CCCCCccccchhHHHHHHHHHHCCCCCCCCchh------hHHHHHHHHhhhcccc------cCcccCHHHHHHHHHHcc
Confidence             566788999999999999999999999743211      1111111111111111      111223468999999999


Q ss_pred             CCCCCCC-----CHHHHHHH
Q 048055          170 LAPENRP-----VMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~~  184 (221)
                      .||.+||     ++.++++.
T Consensus       242 ~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         242 KDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CCHHHhcCCCCCCHHHHhcC
Confidence            9999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=1.4e-25  Score=177.15  Aligned_cols=161  Identities=24%  Similarity=0.497  Sum_probs=123.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      +..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++.......  ......++..|++||.
T Consensus        96 ~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~  174 (260)
T cd05067          96 GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA  174 (260)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHH
Confidence            45789999999999999999999998 99999999999999999999999999986543221  1112234567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. ...++.++|+||||+++|++++ |..||...      ........+...     ...+....    .+..+.+++.+
T Consensus       175 ~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~  238 (260)
T cd05067         175 IN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGM------TNPEVIQNLERG-----YRMPRPDN----CPEELYELMRL  238 (260)
T ss_pred             hc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCC------ChHHHHHHHHcC-----CCCCCCCC----CCHHHHHHHHH
Confidence            76 5667889999999999999998 99999642      122222222111     11111111    22469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.+|++||++.++...|+.
T Consensus       239 ~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         239 CWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=1.5e-25  Score=179.21  Aligned_cols=160  Identities=23%  Similarity=0.459  Sum_probs=121.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||+++......   ......++..|++||.
T Consensus       119 ~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05090         119 SSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA  197 (283)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHH
Confidence            4578999999999999999999998 99999999999999999999999999986543221   1122334567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||...      .............     ..+....+    +..+.+++.+
T Consensus       198 ~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~----~~~~~~li~~  261 (283)
T cd05090         198 IM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF------SNQEVIEMVRKRQ-----LLPCSEDC----PPRMYSLMTE  261 (283)
T ss_pred             hc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHcCC-----cCCCCCCC----CHHHHHHHHH
Confidence            76 5667889999999999999998 88898642      1122222222211     11111222    2468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.+|++||++.+|++.|..
T Consensus       262 cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         262 CWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcccCcccCcCHHHHHHHhhc
Confidence            999999999999999988864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=4.3e-26  Score=182.71  Aligned_cols=165  Identities=22%  Similarity=0.268  Sum_probs=120.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.|++.||+|||+..+++|+||+|.||+++.++.++|+|||++.............++..|++||.+.
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID  180 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhc
Confidence            46789999999999999999999974489999999999999999999999999986544333333345677899999876


Q ss_pred             hc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 IW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      ..  ..++.++|+||+|+++|++++|..||....     ..   ...+...........+  ..........+.+|+.+|
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~---~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~  250 (288)
T cd06616         181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SV---FDQLTQVVKGDPPILS--NSEEREFSPSFVNFINLC  250 (288)
T ss_pred             cccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hH---HHHHhhhcCCCCCcCC--CcCCCccCHHHHHHHHHH
Confidence            33  256889999999999999999999996421     11   1111111000000111  111112334699999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |+.+|.+||++.+|+..
T Consensus       251 l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         251 LIKDESKRPKYKELLEH  267 (288)
T ss_pred             ccCChhhCcCHHHHhcC
Confidence            99999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=4.7e-26  Score=184.53  Aligned_cols=171  Identities=18%  Similarity=0.278  Sum_probs=119.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +..+++..+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        98 ~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  176 (309)
T cd07872          98 GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL  176 (309)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHH
Confidence            34578999999999999999999998 9999999999999999999999999998654322 222334567789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHH-----------hhhhhhccCCCCCC-----CChh
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRS-----------VREEETESGDDPPS-----SNEA  152 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-----~~~~  152 (221)
                      .....++.++|+||+|+++|++++|..||........  .......           ............+.     ....
T Consensus       177 ~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (309)
T cd07872         177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH  254 (309)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhh
Confidence            6445678899999999999999999999964321100  0000000           00000000000000     0000


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          153 SEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       153 ~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .......+.+++.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         255 APRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             ccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0112345789999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.4e-26  Score=189.41  Aligned_cols=158  Identities=22%  Similarity=0.239  Sum_probs=119.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||+|||+. +++||||||.||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus        90 ~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  168 (330)
T cd05586          90 EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL  168 (330)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHH
Confidence            45689999999999999999999998 999999999999999999999999999865322 2223345678899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      .....++.++|+||+||++|+|++|..||...      ........+....    ...+. ...    ...+.+++.+||
T Consensus       169 ~~~~~~~~~~DvwslGvil~elltG~~Pf~~~------~~~~~~~~i~~~~----~~~~~-~~~----~~~~~~li~~~L  233 (330)
T cd05586         169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE------DTQQMYRNIAFGK----VRFPK-NVL----SDEGRQFVKGLL  233 (330)
T ss_pred             cCCCCCCCccceeccccEEEEeccCCCCCCCC------CHHHHHHHHHcCC----CCCCC-ccC----CHHHHHHHHHHc
Confidence            63445788999999999999999999999642      2222222222111    11111 111    235889999999


Q ss_pred             cCCCCCCC----CHHHHHH
Q 048055          169 SLAPENRP----VMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rp----s~~~l~~  183 (221)
                      +.||.+||    ++.++++
T Consensus       234 ~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhc
Confidence            99999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=1.3e-25  Score=181.53  Aligned_cols=164  Identities=22%  Similarity=0.429  Sum_probs=124.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||+++.......   ......+..|++||.
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (303)
T cd05110         104 DNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC  182 (303)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHH
Confidence            4678999999999999999999998 999999999999999999999999999875432211   112233567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||.+..      .......+..     ...++....+    ...+.+++..
T Consensus       183 ~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~~~~~li~~  246 (303)
T cd05110         183 IH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------TREIPDLLEK-----GERLPQPPIC----TIDVYMVMVK  246 (303)
T ss_pred             hc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHC-----CCCCCCCCCC----CHHHHHHHHH
Confidence            76 6777889999999999999997 889986421      1111111111     1111211122    2358999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ||..+|++||++.++++.|+.+...
T Consensus       247 c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         247 CWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HcCCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=8.1e-26  Score=197.69  Aligned_cols=164  Identities=24%  Similarity=0.385  Sum_probs=130.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCC--CCC--CCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE--PSA--TSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~~~~pe   86 (221)
                      ..|+....+.++.||+.|+.||++. .++|||+.++|||+..+..+||+|||+++...+.....  ...  -+..|||||
T Consensus       413 ~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApE  491 (609)
T KOG0200|consen  413 DALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPE  491 (609)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHH
Confidence            3599999999999999999999998 89999999999999999999999999998554433221  111  355699999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++||||||+++||+++ |..||++...     .....+     ....+.++..+.-+.    .++.++|.
T Consensus       492 sl~-~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-----~~~l~~-----~l~~G~r~~~P~~c~----~eiY~iM~  556 (609)
T KOG0200|consen  492 SLF-DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-----TEELLE-----FLKEGNRMEQPEHCS----DEIYDLMK  556 (609)
T ss_pred             Hhc-cCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----HHHHHH-----HHhcCCCCCCCCCCC----HHHHHHHH
Confidence            987 6888999999999999999998 9999975210     112122     223344444444443    45899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      .||+.+|++||++.++.+.++.+..
T Consensus       557 ~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  557 SCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHhCCCcccCCCHHHHHHHHHHHHH
Confidence            9999999999999999999999654

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=2.1e-25  Score=177.16  Aligned_cols=164  Identities=23%  Similarity=0.404  Sum_probs=124.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||+++........  .....+..|++||.+
T Consensus       102 ~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (270)
T cd05056         102 YSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI  180 (270)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhh
Confidence            4689999999999999999999998 9999999999999999999999999998654333211  112234579999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . ...++.++|+||||+++|++++ |..||.....      ......+...     ...+.....    +..+.+++.+|
T Consensus       181 ~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~-----~~~~~~~~~----~~~~~~li~~~  244 (270)
T cd05056         181 N-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN------NDVIGRIENG-----ERLPMPPNC----PPTLYSLMTKC  244 (270)
T ss_pred             c-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcC-----CcCCCCCCC----CHHHHHHHHHH
Confidence            6 5667889999999999999986 9999964321      1111222111     111111222    24699999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      |..+|.+|||+.++++.|+++..+
T Consensus       245 l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         245 WAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             cCCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.3e-26  Score=187.69  Aligned_cols=159  Identities=21%  Similarity=0.265  Sum_probs=121.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-------------------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-------------------   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------------------   71 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......                   
T Consensus        96 ~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (350)
T cd05573          96 DVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL  174 (350)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccc
Confidence            5789999999999999999999998 99999999999999999999999999986544322                   


Q ss_pred             -----------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh
Q 048055           72 -----------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET  140 (221)
Q Consensus        72 -----------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  140 (221)
                                 ......++..|+|||.+. +..++.++|+|||||++|+|++|..||....      .......+.... 
T Consensus       175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~-  246 (350)
T cd05573         175 VRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDT------LQETYNKIINWK-  246 (350)
T ss_pred             ccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCC------HHHHHHHHhccC-
Confidence                       123346788899999887 5677899999999999999999999996432      122222221100 


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 048055          141 ESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV-MREVSKM  184 (221)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-~~~l~~~  184 (221)
                       .....+....    .+..+.+++.+|+. ||.+||+ +.++++.
T Consensus       247 -~~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         247 -ESLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             -CcccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence             1111111111    22458999999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=4.1e-26  Score=179.42  Aligned_cols=160  Identities=21%  Similarity=0.403  Sum_probs=119.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.........   .....+..|++||
T Consensus        88 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  166 (252)
T cd05084          88 GPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE  166 (252)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCch
Confidence            34688999999999999999999998 9999999999999999999999999998643322111   1112234699999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....      ......+..     ....+...    ..+..+.+++.
T Consensus       167 ~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------~~~~~~~~~-----~~~~~~~~----~~~~~~~~li~  230 (252)
T cd05084         167 ALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------QQTREAIEQ-----GVRLPCPE----LCPDAVYRLME  230 (252)
T ss_pred             hhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------HHHHHHHHc-----CCCCCCcc----cCCHHHHHHHH
Confidence            876 5667889999999999999997 8888854211      111111111     01111111    22346899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +||+.+|++||++.++.+.|.
T Consensus       231 ~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         231 RCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHcCCChhhCcCHHHHHHHHh
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.4e-25  Score=177.95  Aligned_cols=162  Identities=23%  Similarity=0.430  Sum_probs=124.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...++...++.++.|++.||.|||+..+++|+|++|.||+++.++.++++|||.+.............++..|++||.+.
T Consensus       107 ~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~  186 (269)
T cd08528         107 KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK  186 (269)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhc
Confidence            45688999999999999999999974389999999999999999999999999986654433334456677899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+||||+++|++++|..||...      .............    ..+......    ...+.+++.+||+
T Consensus       187 -~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~------~~~~~~~~~~~~~----~~~~~~~~~----~~~l~~li~~cl~  251 (269)
T cd08528         187 -NEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLATKIVEAV----YEPLPEGMY----SEDVTDVITSCLT  251 (269)
T ss_pred             -CCCCchHHHHHHHHHHHHHHHhCCCccccc------CHHHHHHHHhhcc----CCcCCcccC----CHHHHHHHHHHCC
Confidence             566788999999999999999999998532      2222222221111    111111111    2458999999999


Q ss_pred             CCCCCCCCHHHHHHHHH
Q 048055          170 LAPENRPVMREVSKMIR  186 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~L~  186 (221)
                      .||++||++.++...|+
T Consensus       252 ~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         252 PDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCCccCCCHHHHHHHhc
Confidence            99999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.93  E-value=2.3e-25  Score=177.05  Aligned_cols=162  Identities=21%  Similarity=0.362  Sum_probs=121.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||+|||+. +++|+|+||.||+++.++.++++|||+++......   ......++..|++||
T Consensus       107 ~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05074         107 PFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE  185 (273)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence            34578899999999999999999998 99999999999999999999999999986543221   112223456789999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ....+.++|+||||+++|++++ |..||....      ...........     .......    ..+..+.+++.
T Consensus       186 ~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~----~~~~~~~~l~~  249 (273)
T cd05074         186 SLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE------NSEIYNYLIKG-----NRLKQPP----DCLEDVYELMC  249 (273)
T ss_pred             HHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCCC------HHHHHHHHHcC-----CcCCCCC----CCCHHHHHHHH
Confidence            876 5566789999999999999998 888886321      11111111111     1111111    12346999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +||+.+|.+||++.++++.|+++
T Consensus       250 ~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         250 QCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.9e-25  Score=189.48  Aligned_cols=173  Identities=20%  Similarity=0.306  Sum_probs=119.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.||+.||.|||+. +|+||||||.||+++.++.++|+|||+++......   ......++..|++||
T Consensus       254 ~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE  332 (461)
T PHA03211        254 LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE  332 (461)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHH
Confidence            34789999999999999999999998 99999999999999999999999999986543221   122345788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC-CCh-HHHHHHhhhhhhccCCC-------------------
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG-SDI-PRWVRSVREEETESGDD-------------------  145 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~-------------------  145 (221)
                      .+. +..++.++|+|||||++|++++|..++........ ... ......+..........                   
T Consensus       333 ~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  411 (461)
T PHA03211        333 VLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN  411 (461)
T ss_pred             HHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcc
Confidence            886 66778899999999999999987655432211100 111 11111111111100000                   


Q ss_pred             --CCCCChhhH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          146 --PPSSNEASE---EKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       146 --~~~~~~~~~---~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                        +........   .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       412 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        412 RRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence              000000000   112358899999999999999999999864

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.5e-25  Score=175.36  Aligned_cols=159  Identities=22%  Similarity=0.416  Sum_probs=122.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.++.......  ....+..|++||.+. 
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~-  172 (256)
T cd05039          97 AVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALR-  172 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhc-
Confidence            3689999999999999999999998 999999999999999999999999999876533222  223345799999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      ...++.++|+||||+++|++++ |..||....      .......+....     ......    ..+..+.+++.+||.
T Consensus       173 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~-----~~~~~~----~~~~~~~~li~~~l~  237 (256)
T cd05039         173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPHVEKGY-----RMEAPE----GCPPEVYKVMKDCWE  237 (256)
T ss_pred             CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHhcCC-----CCCCcc----CCCHHHHHHHHHHhc
Confidence            5667789999999999999997 999986321      112222221110     111111    123468999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhh
Q 048055          170 LAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+|.+||++.++++.|+++
T Consensus       238 ~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         238 LDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             cChhhCcCHHHHHHHHhcC
Confidence            9999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=1.8e-25  Score=180.71  Aligned_cols=162  Identities=23%  Similarity=0.385  Sum_probs=122.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++........   .....++..|++||.
T Consensus       136 ~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (302)
T cd05055         136 SFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES  214 (302)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhh
Confidence            3489999999999999999999998 999999999999999999999999999865433221   112234567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||+|+++|++++ |..||.....     ..........     ..........    ...+.+++.+
T Consensus       215 ~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~~~~~----~~~~~~li~~  279 (302)
T cd05055         215 IF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-----DSKFYKLIKE-----GYRMAQPEHA----PAEIYDIMKT  279 (302)
T ss_pred             hc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-----hHHHHHHHHc-----CCcCCCCCCC----CHHHHHHHHH
Confidence            76 5667889999999999999998 9999864321     1111111111     1111111111    2369999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||+.+|++||++.++++.|++.
T Consensus       280 cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         280 CWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCCchhCcCHHHHHHHHHhh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=1.2e-25  Score=179.28  Aligned_cols=171  Identities=18%  Similarity=0.233  Sum_probs=120.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++. +.++|+|||++.............++..|++||....
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  172 (282)
T cd07831          95 RPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT  172 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhc
Confidence            5689999999999999999999998 9999999999999999 9999999999876544333334456778999997643


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhhhccCCCCCCC----ChhhHHHH
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEETESGDDPPSS----NEASEEKL  157 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  157 (221)
                      ....+.++|+||+||++|++++|..||.......         +.....+..............+...    .......+
T Consensus       173 ~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07831         173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS  252 (282)
T ss_pred             CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccccc
Confidence            4556789999999999999999999996421100         0000011000000000000000000    00111234


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          158 QALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       158 ~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       253 ~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         253 AEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHHHHHHHhccCcccccCHHHHhh
Confidence            67999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.7e-25  Score=180.00  Aligned_cols=165  Identities=19%  Similarity=0.321  Sum_probs=119.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|+||.||+++.++.++++|||++.......   ......++..|+|||.
T Consensus       124 ~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  202 (295)
T cd05097         124 PSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES  202 (295)
T ss_pred             CcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence            3578999999999999999999998 99999999999999999999999999986543221   1122234567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh--CCCCCcccccccCCChHHHHHHhhhhhhc--cCCCCCCCChhhHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT--GKTPFQDLVLEHGSDIPRWVRSVREEETE--SGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +. ...++.++|+||||+++|++++  +..||.....      .............  ..........    .+..+.+|
T Consensus       203 ~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~l  271 (295)
T cd05097         203 IL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD------EQVIENTGEFFRNQGRQIYLSQTPL----CPSPVFKL  271 (295)
T ss_pred             hc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh------HHHHHHHHHhhhhccccccCCCCCC----CCHHHHHH
Confidence            76 5667899999999999999987  6677754211      1111111110000  0000000111    22469999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHh
Q 048055          164 AIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      +.+||+.+|++||++.+|++.|++
T Consensus       272 i~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         272 MMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHcCCCchhCcCHHHHHHHHhC
Confidence            999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.2e-25  Score=175.80  Aligned_cols=158  Identities=24%  Similarity=0.437  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC--CCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||.++........  .....+..|++||.+
T Consensus        95 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~  173 (256)
T cd05059          95 GKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF  173 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHh
Confidence            3689999999999999999999998 9999999999999999999999999988654332211  111223469999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|+||||+++|++++ |..||....      ...........     .....+..    .+..+.+++.+|
T Consensus       174 ~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~c  237 (256)
T cd05059         174 D-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS------NSEVVESVSAG-----YRLYRPKL----APTEVYTIMYSC  237 (256)
T ss_pred             c-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCC------HHHHHHHHHcC-----CcCCCCCC----CCHHHHHHHHHH
Confidence            6 5667889999999999999998 889986421      11222222111     11111111    234699999999


Q ss_pred             ccCCCCCCCCHHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKMI  185 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L  185 (221)
                      |..+|++||++.++++.|
T Consensus       238 l~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         238 WHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             hcCChhhCcCHHHHHHHh
Confidence            999999999999998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=2.5e-25  Score=178.37  Aligned_cols=162  Identities=24%  Similarity=0.451  Sum_probs=122.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~p   85 (221)
                      +...+++..++.++.|++.||.|||.. +++|+|++|.||+++.++.++++|||++........   ......+..|++|
T Consensus       123 ~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         123 NPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            345689999999999999999999998 999999999999999999999999998764332211   1122335569999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++ |..||....      .......+....     ..+....    .+..+.+++
T Consensus       202 E~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~l~~li  265 (288)
T cd05050         202 ESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA------HEEVIYYVRDGN-----VLSCPDN----CPLELYNLM  265 (288)
T ss_pred             HHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCC-----CCCCCCC----CCHHHHHHH
Confidence            9876 5677889999999999999997 888885321      122222222111     1111111    224699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      .+||+.+|.+||++.|+++.|++
T Consensus       266 ~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         266 RLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHcccCcccCCCHHHHHHHhhC
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=2e-25  Score=178.36  Aligned_cols=161  Identities=19%  Similarity=0.285  Sum_probs=118.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ..++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++...... .......++..|++||.+
T Consensus        97 ~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  175 (282)
T cd06643          97 ERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV  175 (282)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhc
Confidence            45789999999999999999999998 9999999999999999999999999998644322 122334567789999976


Q ss_pred             h----hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 E----IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~----~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .    ....++.++|+||+|+++|++++|..||.....      ..........   .......+.    ..+..+.+++
T Consensus       176 ~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~---~~~~~~~~~----~~~~~~~~li  242 (282)
T cd06643         176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS---EPPTLAQPS----RWSSEFKDFL  242 (282)
T ss_pred             cccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhc---CCCCCCCcc----ccCHHHHHHH
Confidence            3    134456789999999999999999999964211      1111111111   011111111    1234689999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+||+.+|.+||++.++++.
T Consensus       243 ~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         243 KKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            99999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=1.5e-25  Score=176.95  Aligned_cols=154  Identities=29%  Similarity=0.446  Sum_probs=114.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc--------eEEeccCCccccCCCCCCCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE--------SCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      ..+++..++.++.||+.||+|||+. +++|+|+||.||+++.++.        ++++|||++......   ....++..|
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y  170 (258)
T cd05078          95 NLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPW  170 (258)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCc
Confidence            4689999999999999999999998 9999999999999987765        589999987543322   223456789


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCC-CCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGK-TPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      ++||.+.....++.++|+||||+++|++++|. .||.....      .... .....    ....+.  .    ....+.
T Consensus       171 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~-~~~~~----~~~~~~--~----~~~~~~  233 (258)
T cd05078         171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKL-QFYED----RHQLPA--P----KWTELA  233 (258)
T ss_pred             cCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHH-HHHHc----cccCCC--C----CcHHHH
Confidence            99998863345688999999999999999984 55543211      1111 11111    111111  1    113589


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHH
Q 048055          162 NIAIACVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L  185 (221)
                      +++.+||+.+|.+|||+++|++.|
T Consensus       234 ~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         234 NLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHhccChhhCCCHHHHHHhc
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.93  E-value=2.4e-25  Score=177.54  Aligned_cols=159  Identities=23%  Similarity=0.318  Sum_probs=118.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccccCCCCC---CCCCCCCccccC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSFRNPDSV---EEPSATSLFYKA   84 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~   84 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||+|+||+++.++   .++++|||+++.......   ......+..|++
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  189 (277)
T cd05036         111 SSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP  189 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCC
Confidence            4689999999999999999999998 999999999999998754   589999999875432211   111222457999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|+|||||++|++++ |..||....      .......+....     ....+..    .+..+.++
T Consensus       190 PE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~  253 (277)
T cd05036         190 PEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------NQEVMEFVTGGG-----RLDPPKG----CPGPVYRI  253 (277)
T ss_pred             HHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCC-----cCCCCCC----CCHHHHHH
Confidence            99886 5678899999999999999997 999996432      112222211110     1111111    23468999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +.+||+.+|++||++.+|++.|.
T Consensus       254 i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         254 MTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcCCCcccCcCHHHHHHHhh
Confidence            99999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=2.6e-25  Score=182.84  Aligned_cols=164  Identities=23%  Similarity=0.376  Sum_probs=123.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.||+.||+|||+. +++|+||||.||+++.++.++++|||++.......   ......++..|++||.
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  252 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  252 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHH
Confidence            4689999999999999999999998 99999999999999999999999999986542221   1112233456999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||......     ......+...     .....+...+    ..+.+++.+
T Consensus       253 ~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~  317 (343)
T cd05103         253 IF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEG-----TRMRAPDYTT----PEMYQTMLD  317 (343)
T ss_pred             hc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----HHHHHHHhcc-----CCCCCCCCCC----HHHHHHHHH
Confidence            76 5677889999999999999997 99998643111     1111111111     1111111122    358999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||+.+|.+||++.+|++.|+.+..
T Consensus       318 cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         318 CWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=3.5e-25  Score=175.61  Aligned_cols=162  Identities=19%  Similarity=0.419  Sum_probs=122.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----CCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----EPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.........    .....+..|++|
T Consensus       101 ~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         101 DGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCH
Confidence            35689999999999999999999998 9999999999999999999999999998654322111    111223469999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++|+||||+++|++++ |..||....      .......+...     ...+....    .+..+.+++
T Consensus       180 E~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~------~~~~~~~i~~~-----~~~~~~~~----~~~~~~~li  243 (268)
T cd05063         180 EAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS------NHEVMKAINDG-----FRLPAPMD----CPSAVYQLM  243 (268)
T ss_pred             HHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC------HHHHHHHHhcC-----CCCCCCCC----CCHHHHHHH
Confidence            9876 5667889999999999999997 999996421      12222222111     11111122    234689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.+|++||++.+|++.|+++
T Consensus       244 ~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         244 LQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=3.1e-25  Score=185.67  Aligned_cols=164  Identities=24%  Similarity=0.368  Sum_probs=124.0

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.||+.||.|||+. +++|+|+||.||+++.++.++++|||+++......   ......++..|++|
T Consensus       232 ~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         232 ESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            456789999999999999999999998 99999999999999999999999999986543221   11223446679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++|+||||+++|++++ |..||.....     .......+..     ...+..+...    ...+.+|+
T Consensus       311 E~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-----~~~~~~~~~~-----~~~~~~p~~~----~~~l~~li  375 (401)
T cd05107         311 ESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-----NEQFYNAIKR-----GYRMAKPAHA----SDEIYEIM  375 (401)
T ss_pred             HHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-----hHHHHHHHHc-----CCCCCCCCCC----CHHHHHHH
Confidence            9876 5667889999999999999998 8889864211     0111111111     1111111122    24699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||..+|.+||++++|++.|+++
T Consensus       376 ~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         376 QKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=1.7e-25  Score=182.48  Aligned_cols=150  Identities=22%  Similarity=0.359  Sum_probs=116.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++..... .......++..|+|||.+.
T Consensus        96 ~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  174 (323)
T cd05615          96 GKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA  174 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHc
Confidence            5689999999999999999999998 9999999999999999999999999998643322 2223445788999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+|+++|++++|..||....      .......+.....    ..+  ...    ...+.+++.+||+
T Consensus       175 -~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~~~~~----~~p--~~~----~~~~~~li~~~l~  237 (323)
T cd05615         175 -YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED------EDELFQSIMEHNV----SYP--KSL----SKEAVSICKGLMT  237 (323)
T ss_pred             -CCCCCCccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC----CCC--ccC----CHHHHHHHHHHcc
Confidence             5677889999999999999999999996431      1222222222111    111  111    2358899999999


Q ss_pred             CCCCCCCCH
Q 048055          170 LAPENRPVM  178 (221)
Q Consensus       170 ~dp~~Rps~  178 (221)
                      .+|.+|++.
T Consensus       238 ~~p~~R~~~  246 (323)
T cd05615         238 KHPSKRLGC  246 (323)
T ss_pred             cCHhhCCCC
Confidence            999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.93  E-value=1.2e-25  Score=179.65  Aligned_cols=168  Identities=20%  Similarity=0.212  Sum_probs=118.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +..++...+..++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  173 (285)
T cd07861          95 GQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL  173 (285)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHh
Confidence            46789999999999999999999998 9999999999999999999999999998644322 122233456789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhh--------------hhcc----CCCCCCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE--------------ETES----GDDPPSSN  150 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~----~~~~~~~~  150 (221)
                      .....++.++|+||||+++|++++|..||......     ..........              ....    ........
T Consensus       174 ~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (285)
T cd07861         174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-----DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR  248 (285)
T ss_pred             cCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH
Confidence            53445678899999999999999999999642110     0000000000              0000    00000000


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .........+.+++.+||+.||.+|||+.+|+.
T Consensus       249 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000112346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=1.5e-25  Score=178.96  Aligned_cols=163  Identities=21%  Similarity=0.366  Sum_probs=120.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++...... ......++..|++||.+. 
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~-  166 (279)
T cd06619          90 RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERIS-  166 (279)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeec-
Confidence            4568888999999999999999998 9999999999999999999999999998654322 223346677899999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChH-HHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP-RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +..++.++|+||||+++|++++|..||............ ........   ......+ ...    ....+.+++.+||+
T Consensus       167 ~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~----~~~~~~~li~~~l~  238 (279)
T cd06619         167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD---EDPPVLP-VGQ----FSEKFVHFITQCMR  238 (279)
T ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc---cCCCCCC-CCc----CCHHHHHHHHHHhh
Confidence            567788999999999999999999999653322111111 11111100   0111111 011    12358999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|++||++.++++.
T Consensus       239 ~~P~~Rp~~~eil~~  253 (279)
T cd06619         239 KQPKERPAPENLMDH  253 (279)
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=3.3e-25  Score=175.73  Aligned_cols=161  Identities=25%  Similarity=0.389  Sum_probs=121.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-----ceEEeccCCccccCCCC---CCCCCCCCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-----ESCLTDYGLGSFRNPDS---VEEPSATSLF   81 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-----~~~l~dfg~~~~~~~~~---~~~~~~~~~~   81 (221)
                      ...+++..++.++.|++.||.|||+. +++|+|++|.||+++.++     .++++|||++.......   .......+..
T Consensus       100 ~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  178 (269)
T cd05044         100 PPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR  178 (269)
T ss_pred             CccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCcc
Confidence            44578999999999999999999998 999999999999999887     89999999986543221   1122234567


Q ss_pred             ccCcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           82 YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        82 ~~~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      |++||.+. ....+.++|+||||+++|++++ |..||....      .......+..     ........    ..+..+
T Consensus       179 y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~----~~~~~~  242 (269)
T cd05044         179 WMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALN------NQEVLQHVTA-----GGRLQKPE----NCPDKI  242 (269)
T ss_pred             ccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccC------HHHHHHHHhc-----CCccCCcc----cchHHH
Confidence            99999876 5667899999999999999998 999996321      1111111111     11111111    223468


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHh
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      .+++.+||+.+|.+||++.++++.|++
T Consensus       243 ~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         243 YQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=2.9e-25  Score=177.99  Aligned_cols=160  Identities=21%  Similarity=0.236  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.............++..|++||.+.
T Consensus        96 ~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~  174 (285)
T cd05632          96 NPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN  174 (285)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhc
Confidence            34689999999999999999999998 99999999999999999999999999886543333333456788999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+|+++|++++|..||.....      ......+.........  ....    .....+.+|+..||+
T Consensus       175 -~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~------~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~li~~~l~  241 (285)
T cd05632         175 -NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE------KVKREEVDRRVLETEE--VYSA----KFSEEAKSICKMLLT  241 (285)
T ss_pred             -CCCCCcccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhhhcccc--ccCc----cCCHHHHHHHHHHcc
Confidence             56778899999999999999999999964211      1111111111111000  0011    122358899999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 048055          170 LAPENRPV-----MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~  183 (221)
                      .||++||+     +.+++.
T Consensus       242 ~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         242 KDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHhHcCCCcccChHHHHc
Confidence            99999999     667764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2.5e-25  Score=177.98  Aligned_cols=172  Identities=24%  Similarity=0.361  Sum_probs=120.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++|+|||++........    ......+..|++|
T Consensus       102 ~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  180 (284)
T cd05081         102 RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP  180 (284)
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCH
Confidence            34689999999999999999999998 999999999999999999999999999875433221    1112233469999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc----CCCh--HHHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH----GSDI--PRWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~----~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      |.+. +..++.++|+||||+++|++++|..++.......    +...  ......+.. ........+.....    +..
T Consensus       181 E~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~  254 (284)
T cd05081         181 ESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-LLKNNGRLPAPPGC----PAE  254 (284)
T ss_pred             HHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-HHhcCCcCCCCCCC----CHH
Confidence            9876 5667889999999999999999766543211000    0000  000000100 00111111111222    246


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          160 LLNIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       255 ~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         255 IYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=5.1e-26  Score=190.31  Aligned_cols=157  Identities=20%  Similarity=0.372  Sum_probs=127.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..+..|++||+.||.|||++ +.|+|||||-.||+++.+ |.+||+|+|+|.........+ ..||+.|||||+
T Consensus       137 ~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks-vIGTPEFMAPEm  215 (632)
T KOG0584|consen  137 HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS-VIGTPEFMAPEM  215 (632)
T ss_pred             hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce-eccCccccChHH
Confidence            46778999999999999999999998 689999999999999765 889999999998776555444 789999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.  ..|...+||||||+++.||+|+..||...     .+...+++++..+.....-     ....   ...+++||.+|
T Consensus       216 YE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~sl-----~kV~---dPevr~fIekC  280 (632)
T KOG0584|consen  216 YE--ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPAAL-----SKVK---DPEVREFIEKC  280 (632)
T ss_pred             Hh--hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHHHh-----hccC---CHHHHHHHHHH
Confidence            85  78899999999999999999999999642     3345666665544433211     1111   12599999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      +.. ...|||+.|++.
T Consensus       281 l~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  281 LAT-KSERLSAKELLK  295 (632)
T ss_pred             hcC-chhccCHHHHhh
Confidence            999 899999999974

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.93  E-value=1.6e-25  Score=176.14  Aligned_cols=159  Identities=24%  Similarity=0.392  Sum_probs=120.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ..++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+
T Consensus        93 ~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~  171 (256)
T cd06612          93 NKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI  171 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHH
Confidence            46789999999999999999999998 99999999999999999999999999986544332 22233456789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +...+.++|+||||+++|++++|..||......      ......   ..    ...............+.+++.+||
T Consensus       172 ~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~------~~~~~~---~~----~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         172 Q-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM------RAIFMI---PN----KPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             h-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh------hhhhhh---cc----CCCCCCCchhhcCHHHHHHHHHHH
Confidence            6 567788999999999999999999999642111      000000   00    001111112223346899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.+|.+||++.++++
T Consensus       238 ~~~P~~Rps~~~il~  252 (256)
T cd06612         238 VKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcChhhCcCHHHHhc
Confidence            999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.93  E-value=2.3e-25  Score=178.04  Aligned_cols=171  Identities=18%  Similarity=0.217  Sum_probs=120.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|++||.+
T Consensus        94 ~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  172 (286)
T cd07847          94 PRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL  172 (286)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHH
Confidence            44689999999999999999999998 99999999999999999999999999986554332 22334556789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhh---h--------hhhccCCCCCCC------Ch
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR---E--------EETESGDDPPSS------NE  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~------~~  151 (221)
                      .....++.++|+||||+++|++++|..||.......  ..........   .        .........+..      ..
T Consensus       173 ~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd07847         173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLES  250 (286)
T ss_pred             hCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHH
Confidence            633556789999999999999999999997432110  0000000000   0        000000000000      00


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ........+.+|+.+||+.+|++||++.+++.
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         251 KFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            11122356899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=7.5e-26  Score=187.00  Aligned_cols=152  Identities=24%  Similarity=0.414  Sum_probs=113.6

Q ss_pred             HHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcccchhc--
Q 048055           17 SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPECREIW--   91 (221)
Q Consensus        17 ~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~--   91 (221)
                      .+..+..|++.+++++|.+ ||||.||||.|+|+- .|.+||+|||++..+....   ......||+.||+||.+...  
T Consensus       461 ~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s  538 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSS  538 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccc
Confidence            7778899999999999999 999999999999885 4789999999998776554   34667899999999975421  


Q ss_pred             --------CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-CCCCCCChhhHHHHHHHHH
Q 048055           92 --------KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-DDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        92 --------~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  162 (221)
                              ...++++||||+||++|+|+.|++||....        -.+.++........ ..++.....     .++.+
T Consensus       539 ~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------n~~aKl~aI~~P~~~Iefp~~~~~-----~~li~  605 (677)
T KOG0596|consen  539 SRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------NQIAKLHAITDPNHEIEFPDIPEN-----DELID  605 (677)
T ss_pred             cccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------HHHHHHHhhcCCCccccccCCCCc-----hHHHH
Confidence                    123689999999999999999999996431        11122211111101 012211111     23999


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 048055          163 IAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +|..||..||.+||++.++++
T Consensus       606 ~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  606 VMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHHhcCcccCCCcHHHhc
Confidence            999999999999999999973

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-26  Score=185.01  Aligned_cols=156  Identities=21%  Similarity=0.246  Sum_probs=125.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +..|+...+..++.+|+.||.+||.. +||+||+||+|||+|..|+++|+|+|++.............||.+|||||++.
T Consensus       281 ~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~  359 (591)
T KOG0986|consen  281 NPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQ  359 (591)
T ss_pred             CCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHc
Confidence            46899999999999999999999998 99999999999999999999999999998777776666779999999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...|+...|.|++||++|+|+.|+.||...-....  ...+..+....          +.++++....+..+|....|.
T Consensus       360 -ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--~eEvdrr~~~~----------~~ey~~kFS~eakslc~~LL~  426 (591)
T KOG0986|consen  360 -NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--REEVDRRTLED----------PEEYSDKFSEEAKSLCEGLLT  426 (591)
T ss_pred             -CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--HHHHHHHHhcc----------hhhcccccCHHHHHHHHHHHc
Confidence             56699999999999999999999999975321100  00111112111          123333444578899999999


Q ss_pred             CCCCCCCCHH
Q 048055          170 LAPENRPVMR  179 (221)
Q Consensus       170 ~dp~~Rps~~  179 (221)
                      +||.+|.-++
T Consensus       427 Kdp~~RLGcr  436 (591)
T KOG0986|consen  427 KDPEKRLGCR  436 (591)
T ss_pred             cCHHHhccCC
Confidence            9999997543

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.93  E-value=7.4e-26  Score=181.45  Aligned_cols=159  Identities=22%  Similarity=0.273  Sum_probs=119.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...++.++.|++.||.|||+. +++|+||||.||+++.++.++++|||++.............++..|+|||.+. 
T Consensus        97 ~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~-  174 (285)
T cd05630          97 AGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-  174 (285)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHc-
Confidence            4588999999999999999999998 99999999999999999999999999986543333333446788999999986 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||+|+++|++++|..||......   ..............   ...  ...    ....+.+|+.+||+.
T Consensus       175 ~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~~~~~~~~~---~~~--~~~----~~~~~~~li~~~l~~  242 (285)
T cd05630         175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---IKREEVERLVKEVQ---EEY--SEK----FSPDARSLCKMLLCK  242 (285)
T ss_pred             CCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc---chHHHHHhhhhhhh---hhc--Ccc----CCHHHHHHHHHHhhc
Confidence            567788999999999999999999999753211   00011111111110   000  111    223589999999999


Q ss_pred             CCCCCCC-----HHHHHH
Q 048055          171 APENRPV-----MREVSK  183 (221)
Q Consensus       171 dp~~Rps-----~~~l~~  183 (221)
                      ||++||+     +.++++
T Consensus       243 ~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         243 DPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CHHHccCCCCCchHHHHc
Confidence            9999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.93  E-value=1e-25  Score=180.17  Aligned_cols=168  Identities=17%  Similarity=0.189  Sum_probs=118.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +..+++..++.++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        93 ~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  171 (284)
T cd07839          93 NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL  171 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHH
Confidence            45689999999999999999999998 9999999999999999999999999998654322 222334557789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh------------h--ccCCCCCCC-----
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE------------T--ESGDDPPSS-----  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~--~~~~~~~~~-----  149 (221)
                      .....++.++|+||||+++|+|++|..||....     ........+....            .  .....+...     
T Consensus       172 ~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (284)
T cd07839         172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSL  246 (284)
T ss_pred             hCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC-----CHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchh
Confidence            644456889999999999999999888864311     1111111110000            0  000000000     


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..........+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         247 VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0011112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=4.9e-25  Score=176.16  Aligned_cols=165  Identities=19%  Similarity=0.272  Sum_probs=121.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+.............++..|++||.+. 
T Consensus       102 ~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~-  179 (287)
T cd07838         102 PGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL-  179 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhc-
Confidence            3689999999999999999999998 99999999999999999999999999986654433333344677899999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc-----------------cCCCCCCCChhh
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE-----------------SGDDPPSSNEAS  153 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~  153 (221)
                      +...+.++|+||||+++|++++|..||.....      .....+.......                 ............
T Consensus       180 ~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T cd07838         180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSE------ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFV  253 (287)
T ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCcccCCCh------HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhh
Confidence            56678899999999999999999999864221      1111111110000                 000001111122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ......+.+++.+||+.||.+||++.+++.
T Consensus       254 ~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         254 PEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            233467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=6.6e-26  Score=195.86  Aligned_cols=162  Identities=23%  Similarity=0.319  Sum_probs=123.7

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CC---------CCCCCCc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VE---------EPSATSL   80 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~---------~~~~~~~   80 (221)
                      .|+..++++|+.|+++|+++||.. +.|+|||||.+|||+..++..||||||.+.-..... ..         -....|+
T Consensus       140 ~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp  219 (738)
T KOG1989|consen  140 RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTP  219 (738)
T ss_pred             cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCc
Confidence            399999999999999999999997 349999999999999999999999999875322221 10         1123477


Q ss_pred             cccCcccchhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           81 FYKAPECREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        81 ~~~~pe~~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      .|++||++..+  ...+.|+|||+|||++|.++....||+..-     .     ..+.    ...+..|...    .+..
T Consensus       220 ~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-----~-----laIl----ng~Y~~P~~p----~ys~  281 (738)
T KOG1989|consen  220 QYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-----K-----LAIL----NGNYSFPPFP----NYSD  281 (738)
T ss_pred             cccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----c-----eeEE----eccccCCCCc----cHHH
Confidence            89999986543  455899999999999999999999997420     0     0011    1122223222    3446


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+.+||..||+.||.+||++-+++..+..+...
T Consensus       282 ~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  282 RLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            799999999999999999999998887776643

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=2.9e-25  Score=181.82  Aligned_cols=108  Identities=22%  Similarity=0.344  Sum_probs=91.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.|++.||.|||+..+++|+||||.||+++.++.++|+|||++...... ......++..|+|||.+.
T Consensus        97 ~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~  175 (333)
T cd06650          97 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ  175 (333)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhc
Confidence            3567889999999999999999997537999999999999999999999999998644322 223345778899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                       +..++.++|+|||||++|++++|..||..
T Consensus       176 -~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         176 -GTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             -CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             56778899999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=8.8e-26  Score=178.41  Aligned_cols=159  Identities=19%  Similarity=0.282  Sum_probs=119.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----CCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----EPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~p   85 (221)
                      .+.++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.........    ....++..|+||
T Consensus        98 ~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625          98 YGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCc
Confidence            34678889999999999999999998 9999999999999999999999999998654322111    223456789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +...+.++|+||+|+++|++++|+.||...     ...... .....    .......+.    .....+.+++.
T Consensus       177 E~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~-~~~~~----~~~~~~~~~----~~~~~~~~li~  241 (263)
T cd06625         177 EVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEF-----EAMAAI-FKIAT----QPTNPQLPS----HVSPDARNFLR  241 (263)
T ss_pred             ceec-cCCCCchhhhHHHHHHHHHHHhCCCCcccc-----chHHHH-HHHhc----cCCCCCCCc----cCCHHHHHHHH
Confidence            9987 566788999999999999999999999642     111111 11111    111111111    22346899999


Q ss_pred             HcccCCCCCCCCHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~  184 (221)
                      +||..+|.+||++.++++.
T Consensus       242 ~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         242 RTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHhhcCcccCCCHHHHhhC
Confidence            9999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=3.2e-25  Score=176.82  Aligned_cols=156  Identities=25%  Similarity=0.375  Sum_probs=115.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-------ceEEeccCCccccCCCCCCCCCCCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-------ESCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      .+.+++..++.++.||+.||+|||+. +++|+||||.||+++..+       .++++|||.+......   ....++..|
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~  186 (274)
T cd05076         111 KGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPW  186 (274)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcc
Confidence            45789999999999999999999998 999999999999997643       3799999987433221   123456679


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHH-hCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELL-TGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      ++||.+.....++.++|+||||+++|+++ +|..||......      .. ......    ....+  ...    ...+.
T Consensus       187 ~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~----~~~~~--~~~----~~~~~  249 (274)
T cd05076         187 IAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS------EK-ERFYEK----KHRLP--EPS----CKELA  249 (274)
T ss_pred             cCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH------HH-HHHHHh----ccCCC--CCC----ChHHH
Confidence            99998764456788999999999999985 689998643211      11 111111    11111  111    13589


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHH
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +++.+||+.+|++||++.+|++.|+
T Consensus       250 ~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         250 TLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHHcccChhhCcCHHHHHHhhC
Confidence            9999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.93  E-value=1.2e-25  Score=181.16  Aligned_cols=158  Identities=20%  Similarity=0.362  Sum_probs=118.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++....... ......++..|++||.+.
T Consensus       111 ~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (296)
T cd06654         111 TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  189 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHc
Confidence            4578899999999999999999998 99999999999999999999999999876543222 122345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ....+.++|+||||+++|++++|..||.....     ...... ...   .......    .+......+.+++.+||.
T Consensus       190 -~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-----~~~~~~-~~~---~~~~~~~----~~~~~~~~l~~li~~~l~  255 (296)
T cd06654         190 -RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYL-IAT---NGTPELQ----NPEKLSAIFRDFLNRCLD  255 (296)
T ss_pred             -CCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-----HHhHHH-Hhc---CCCCCCC----CccccCHHHHHHHHHHCc
Confidence             56667899999999999999999999964211     011111 100   0000101    111233468999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|++||++.++++
T Consensus       256 ~~p~~Rpt~~eil~  269 (296)
T cd06654         256 MDVEKRGSAKELLQ  269 (296)
T ss_pred             CCcccCcCHHHHhh
Confidence            99999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=6.1e-25  Score=174.48  Aligned_cols=164  Identities=26%  Similarity=0.377  Sum_probs=115.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|+||.||+++.++.++++|||.++.......   .....++..|+|||.
T Consensus        95 ~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05087          95 MTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL  173 (269)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhH
Confidence            3556778889999999999999998 999999999999999999999999999864432221   122345667999997


Q ss_pred             chhc------CCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           88 REIW------KQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        88 ~~~~------~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      +...      ..++.++|+||||+++|++++ |..||.....      .................+.....    ....+
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  243 (269)
T cd05087         174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD------EQVLTYTVREQQLKLPKPRLKLP----LSDRW  243 (269)
T ss_pred             hccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHhhcccCCCCCCccCCC----CChHH
Confidence            6421      134678999999999999996 9999964321      11111111111111111111111    12358


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHH
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      .+++..|| .+|++|||+.+|++.|+
T Consensus       244 ~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         244 YEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            88999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.93  E-value=3.9e-25  Score=175.53  Aligned_cols=162  Identities=30%  Similarity=0.462  Sum_probs=114.2

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPECR   88 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~~   88 (221)
                      .+++...+.++.||+.||+|||+. +++|+|+||.||+++.++.++++|||++.......   ......++..|+|||..
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (269)
T cd05042          96 MAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV  174 (269)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHH
Confidence            346788899999999999999998 99999999999999999999999999975432221   11223345679999975


Q ss_pred             hh------cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           89 EI------WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        89 ~~------~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      ..      ....+.++|+|||||++|++++ |..||.....      ............   ...+. ..........+.
T Consensus       175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~  244 (269)
T cd05042         175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVLKQVVREQD---IKLPK-PQLDLKYSDRWY  244 (269)
T ss_pred             hhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhhccC---ccCCC-CcccccCCHHHH
Confidence            42      2345778999999999999998 7888864211      111111111111   11111 111112334678


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHH
Q 048055          162 NIAIACVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L  185 (221)
                      +++..|| .||++||++.+|++.|
T Consensus       245 ~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         245 EVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             HHHHHHh-cCcccccCHHHHHHHh
Confidence            8999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.93  E-value=5.1e-25  Score=173.28  Aligned_cols=158  Identities=25%  Similarity=0.362  Sum_probs=121.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||++
T Consensus        95 ~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~  173 (256)
T cd08529          95 GRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC  173 (256)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHh
Confidence            45788999999999999999999998 99999999999999999999999999886544332 22234567789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...++.++|+||||+++|++++|..||....      ..........     ...++...    .....+.+++.+||
T Consensus       174 ~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~----~~~~~~~~~i~~~l  237 (256)
T cd08529         174 E-DKPYNEKSDVWALGVVLYECCTGKHPFDANN------QGALILKIIR-----GVFPPVSQ----MYSQQLAQLIDQCL  237 (256)
T ss_pred             c-CCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHc-----CCCCCCcc----ccCHHHHHHHHHHc
Confidence            6 5667889999999999999999999996432      1111111111     11111111    22346999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.+|++||++.++++.
T Consensus       238 ~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         238 TKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cCCcccCcCHHHHhhC
Confidence            9999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=4.4e-25  Score=173.78  Aligned_cols=159  Identities=22%  Similarity=0.426  Sum_probs=121.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.......  .....+..|++||.+.
T Consensus        94 ~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~  170 (254)
T cd05083          94 RALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALK  170 (254)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccC--CCCCCCceecCHHHhc
Confidence            34689999999999999999999998 99999999999999999999999999886533221  1223345799999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       +..++.++|+||||+++|++++ |..||....      ..........     ...+.....    .+..+.+++.+||
T Consensus       171 -~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~----~~~~~~~li~~~l  234 (254)
T cd05083         171 -HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEVKECVEK-----GYRMEPPEG----CPADVYVLMTSCW  234 (254)
T ss_pred             -cCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHHHHHHhC-----CCCCCCCCc----CCHHHHHHHHHHc
Confidence             5667889999999999999997 999996432      2222222211     111111111    2346899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHh
Q 048055          169 SLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~  187 (221)
                      +.+|++||++.++++.|+.
T Consensus       235 ~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         235 ETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCChhhCcCHHHHHHHHcc
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=2.8e-25  Score=175.07  Aligned_cols=154  Identities=27%  Similarity=0.372  Sum_probs=116.0

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-------ceEEeccCCccccCCCCCCCCCCCCccccC
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-------ESCLTDYGLGSFRNPDSVEEPSATSLFYKA   84 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~   84 (221)
                      .+++..++.++.||+.||.|||+. +++|+||||.||+++.++       .++++|||++......   ....+...|++
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~a  172 (259)
T cd05037          97 NVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIA  172 (259)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc---cccccCCCccC
Confidence            689999999999999999999998 999999999999999887       7999999998654331   22344567999


Q ss_pred             cccchhc-CCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           85 PECREIW-KQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        85 pe~~~~~-~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      ||.+... ..++.++|+||||+++|++++ |..||.....      ....... .    .....+....      ..+.+
T Consensus       173 PE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~------~~~~~~~-~----~~~~~~~~~~------~~~~~  235 (259)
T cd05037         173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS------SEKERFY-Q----DQHRLPMPDC------AELAN  235 (259)
T ss_pred             hhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc------hhHHHHH-h----cCCCCCCCCc------hHHHH
Confidence            9987632 267889999999999999998 5777754311      1111111 1    0111111110      46899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHH
Q 048055          163 IAIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      ++.+||..+|.+||++.++++.|+
T Consensus       236 li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         236 LINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHHhccChhhCCCHHHHHHhcC
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=2.7e-25  Score=176.55  Aligned_cols=159  Identities=21%  Similarity=0.308  Sum_probs=118.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++|+|||++...... .......++..|++||.+
T Consensus       105 ~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  183 (272)
T cd06637         105 GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  183 (272)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHh
Confidence            34688999999999999999999998 9999999999999999999999999998654322 222345667789999986


Q ss_pred             hh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ..    ...++.++|+||+|+++|++++|..||.....      ....... .   ..........    ..+..+.+|+
T Consensus       184 ~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~-~---~~~~~~~~~~----~~~~~~~~li  249 (272)
T cd06637         184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLI-P---RNPAPRLKSK----KWSKKFQSFI  249 (272)
T ss_pred             ccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHH-h---cCCCCCCCCC----CcCHHHHHHH
Confidence            42    23457789999999999999999999964211      1111111 0   0111111111    1224689999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||..+|.+||++.++++
T Consensus       250 ~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         250 ESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHcCCChhhCCCHHHHhh
Confidence            9999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=7e-25  Score=175.02  Aligned_cols=164  Identities=22%  Similarity=0.373  Sum_probs=124.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||+|||+. +++|+|++|.||+++.++.++|+|||++.........   .....+..|++||
T Consensus       103 ~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (279)
T cd05057         103 KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE  181 (279)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHH
Confidence            34589999999999999999999998 9999999999999999999999999998755432211   1122245799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...++.++|+||||+++|++++ |..||...      ....+...+...     ...+.+..++    ..+.+++.
T Consensus       182 ~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~  245 (279)
T cd05057         182 SIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI------PAVEIPDLLEKG-----ERLPQPPICT----IDVYMVLV  245 (279)
T ss_pred             Hhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCC------CHHHHHHHHhCC-----CCCCCCCCCC----HHHHHHHH
Confidence            875 5667889999999999999998 99999643      222222222211     1111111122    35889999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||..+|.+||++.++++.|+++..
T Consensus       246 ~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         246 KCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHcCCChhhCCCHHHHHHHHHHHHh
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.93  E-value=1.4e-25  Score=176.61  Aligned_cols=158  Identities=22%  Similarity=0.299  Sum_probs=120.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      +..++...++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|+|||.+
T Consensus        94 ~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  172 (255)
T cd08219          94 GKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW  172 (255)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHH
Confidence            34678999999999999999999998 99999999999999999999999999986543322 22334567789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +...+.++|+||||+++|++++|..||...      .............     ..+.+..    ....+.+++.+||
T Consensus       173 ~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~----~~~~~~~li~~~l  236 (255)
T cd08219         173 E-NMPYNNKSDIWSLGCILYELCTLKHPFQAN------SWKNLILKVCQGS-----YKPLPSH----YSYELRSLIKQMF  236 (255)
T ss_pred             c-cCCcCchhhhhhhchhheehhhccCCCCCC------CHHHHHHHHhcCC-----CCCCCcc----cCHHHHHHHHHHH
Confidence            6 566788999999999999999999999632      1122222221111     1111111    2235889999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.||++||++.+|+..
T Consensus       237 ~~~P~~Rp~~~~il~~  252 (255)
T cd08219         237 KRNPRSRPSATTILSR  252 (255)
T ss_pred             hCCcccCCCHHHHhhc
Confidence            9999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=7.4e-25  Score=173.90  Aligned_cols=162  Identities=19%  Similarity=0.442  Sum_probs=121.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCC---CCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSA---TSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~---~~~~~~   83 (221)
                      .+.+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.........   ....   .+..|+
T Consensus       100 ~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~  178 (269)
T cd05065         100 DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT  178 (269)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeec
Confidence            35689999999999999999999998 9999999999999999999999999988654332211   1111   134699


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      +||.+. +..++.++|+||||+++|++++ |..||....      .......+..     ....+....+    +..+.+
T Consensus       179 ~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~------~~~~~~~i~~-----~~~~~~~~~~----~~~~~~  242 (269)
T cd05065         179 APEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------NQDVINAIEQ-----DYRLPPPMDC----PTALHQ  242 (269)
T ss_pred             CHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCCC------HHHHHHHHHc-----CCcCCCcccC----CHHHHH
Confidence            999876 5677889999999999999886 999996432      1122222211     1111212222    245899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ++.+||+.+|.+||++.+|+..|+++
T Consensus       243 li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         243 LMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.93  E-value=3.4e-25  Score=182.73  Aligned_cols=170  Identities=19%  Similarity=0.326  Sum_probs=120.3

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcC
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK   92 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   92 (221)
                      ++...+..++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++.............++..|++||.+. +.
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~  192 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM  192 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHh-CC
Confidence            78888999999999999999998 99999999999999999999999999987654433333445677899999886 67


Q ss_pred             CCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhhh--------ccCC----------C
Q 048055           93 QPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEET--------ESGD----------D  145 (221)
Q Consensus        93 ~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~--------~~~~----------~  145 (221)
                      .++.++|+|||||++|++++|..||.......         +.....+...+.....        ....          .
T Consensus       193 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (353)
T cd07850         193 GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLF  272 (353)
T ss_pred             CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccccc
Confidence            77899999999999999999999996421100         0000000000000000        0000          0


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          146 PPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       146 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      +.............+.+++.+||+.||.+||++.++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000011234568999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.93  E-value=7.1e-25  Score=172.65  Aligned_cols=158  Identities=23%  Similarity=0.348  Sum_probs=121.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ..++++.++..++.|++.||++||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|+|||.+
T Consensus        96 ~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (257)
T cd08223          96 GKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF  174 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHh
Confidence            45689999999999999999999998 99999999999999999999999999986553322 22334567789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...++.++|+||+|++++++++|+.||...      +............     .+...    ......+.+++.+||
T Consensus       175 ~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~------~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~li~~~l  238 (257)
T cd08223         175 S-NKPYNYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRIIEGK-----LPPMP----KDYSPELGELIATML  238 (257)
T ss_pred             c-CCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcC-----CCCCc----cccCHHHHHHHHHHh
Confidence            6 566788999999999999999999998632      2222222221111     11111    123346999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.+|++||++.++++.
T Consensus       239 ~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         239 SKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccCcccCCCHHHHhcC
Confidence            9999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=4.9e-25  Score=176.42  Aligned_cols=167  Identities=24%  Similarity=0.384  Sum_probs=121.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.|++.||+|||+. +++|+|+||.||+++.++.++++|||++........    .....++..|+|||
T Consensus       104 ~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE  182 (284)
T cd05079         104 NKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE  182 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHH
Confidence            4689999999999999999999998 999999999999999999999999999865433221    12334556799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccc--------c-CCChHHHHHHhhhhhhccCCCCCCCChhhHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE--------H-GSDIPRWVRSVREEETESGDDPPSSNEASEEKL  157 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (221)
                      .+. +..++.++|+||||+++|+++++..|+......        . ..........+..     ....+....    ..
T Consensus       183 ~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~----~~  252 (284)
T cd05079         183 CLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE-----GKRLPRPPN----CP  252 (284)
T ss_pred             Hhc-cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc-----CccCCCCCC----CC
Confidence            876 566788999999999999999976554221000        0 0011111111110     111111111    23


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          158 QALLNIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       158 ~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus       253 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         253 EEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            4699999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=5.7e-25  Score=173.80  Aligned_cols=161  Identities=25%  Similarity=0.521  Sum_probs=121.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      +..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+.......  ......++..|++||.
T Consensus        96 ~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  174 (260)
T cd05073          96 GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA  174 (260)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhH
Confidence            45678899999999999999999998 99999999999999999999999999886443221  1112233456999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. ...++.++|+||||+++|++++ |..||....      .......+...     ...+...    ..+..+.+++.+
T Consensus       175 ~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~i~~  238 (260)
T cd05073         175 IN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRALERG-----YRMPRPE----NCPEELYNIMMR  238 (260)
T ss_pred             hc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHhCC-----CCCCCcc----cCCHHHHHHHHH
Confidence            76 5667889999999999999998 899996421      11111211111     1111111    223469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.+|++||++.++.+.|+.
T Consensus       239 ~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         239 CWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=2e-25  Score=176.88  Aligned_cols=164  Identities=18%  Similarity=0.284  Sum_probs=118.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      .++++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+
T Consensus       100 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~  178 (267)
T cd06646         100 TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHc
Confidence            35688999999999999999999998 99999999999999999999999999986543221 12334567789999976


Q ss_pred             hh--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           89 EI--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        89 ~~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      ..  ...++.++|+||+|+++|++++|..||.......     . ....... .........    .......+.+++.+
T Consensus       179 ~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----~-~~~~~~~-~~~~~~~~~----~~~~~~~~~~li~~  247 (267)
T cd06646         179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----A-LFLMSKS-NFQPPKLKD----KTKWSSTFHNFVKI  247 (267)
T ss_pred             ccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----h-heeeecC-CCCCCCCcc----ccccCHHHHHHHHH
Confidence            31  2345678999999999999999999985321110     0 0000000 000011111    11123468999999


Q ss_pred             cccCCCCCCCCHHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L  185 (221)
                      ||+.+|++||++++|++.|
T Consensus       248 ~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         248 SLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HhhCChhhCcCHHHHhcCC
Confidence            9999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.8e-26  Score=192.71  Aligned_cols=156  Identities=26%  Similarity=0.418  Sum_probs=121.8

Q ss_pred             CHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-CCCceEEeccCCccccCC-CCCCCCCCCCccccCcccchhc
Q 048055           14 HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        14 ~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~   91 (221)
                      +..+...+..||++||.|||.. .|||||||..|+|+. -.|.+||+|||-++.... .....+..||+.|||||.+..+
T Consensus       673 NEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG  751 (1226)
T KOG4279|consen  673 NESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQG  751 (1226)
T ss_pred             chhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccC
Confidence            6778888999999999999998 999999999999996 579999999999876543 3455678999999999998755


Q ss_pred             -CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           92 -KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        92 -~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                       ..|+.++|||||||++.||.+|++||...    +..-.   ..+..+  +...-|+    .+++.....++++.+|+..
T Consensus       752 ~RGYG~aADIWS~GCT~vEMATGrPPF~El----gspqA---AMFkVG--myKvHP~----iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  752 PRGYGKAADIWSFGCTMVEMATGRPPFVEL----GSPQA---AMFKVG--MYKVHPP----IPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             CcCCCchhhhhhccceeEeeccCCCCeeec----CChhH---hhhhhc--ceecCCC----CcHHHHHHHHHHHHHHcCC
Confidence             35689999999999999999999999743    21111   111111  1111122    2234445689999999999


Q ss_pred             CCCCCCCHHHHHH
Q 048055          171 APENRPVMREVSK  183 (221)
Q Consensus       171 dp~~Rps~~~l~~  183 (221)
                      ||.+||++.++++
T Consensus       819 d~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcccCccHHHhcc
Confidence            9999999999974

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.93  E-value=1.8e-25  Score=188.05  Aligned_cols=105  Identities=30%  Similarity=0.464  Sum_probs=92.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC--ceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF--ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+|++..+..++.||+.||.+||+. +|||+||||+|||+..-+  .+||+|||.+.+..... + ....+.+|+|||++
T Consensus       284 ~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-y-tYiQSRfYRAPEVI  360 (586)
T KOG0667|consen  284 RGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-Y-TYIQSRFYRAPEVI  360 (586)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCCcc-e-eeeeccccccchhh
Confidence            4589999999999999999999998 999999999999997543  58999999986654332 2 56677899999999


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      . +..|+.+.|||||||++.||++|.+.|++
T Consensus       361 L-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  361 L-GLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             c-cCCCCCccceeehhhhHHhHhcCccccCC
Confidence            8 89999999999999999999999998864

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.7e-25  Score=174.61  Aligned_cols=160  Identities=21%  Similarity=0.368  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|++||.+.
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  174 (262)
T cd06613          96 GPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA  174 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhc
Confidence            5789999999999999999999998 99999999999999999999999999886543321 223345667899999875


Q ss_pred             hcC---CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           90 IWK---QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        90 ~~~---~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                       ..   .++.++|+||||+++|+|++|..||.....      ..........    ....+ ........+..+.+++.+
T Consensus       175 -~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~li~~  242 (262)
T cd06613         175 -VERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------MRALFLISKS----NFPPP-KLKDKEKWSPVFHDFIKK  242 (262)
T ss_pred             -ccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhc----cCCCc-cccchhhhhHHHHHHHHH
Confidence             33   567889999999999999999999964321      1111111111    00111 111122334569999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.+|..||++.+|+.
T Consensus       243 ~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         243 CLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HcCCChhhCCCHHHHhc
Confidence            99999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=7.9e-25  Score=172.85  Aligned_cols=161  Identities=25%  Similarity=0.529  Sum_probs=122.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      +..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+........  ......+..|++||.
T Consensus        97 ~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~  175 (261)
T cd05034          97 GKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA  175 (261)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHH
Confidence            35789999999999999999999998 999999999999999999999999999865432211  111223457999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +...+.++|+||+|+++|++++ |..||...      ............     ...+.....    +..+.+++.+
T Consensus       176 ~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~i~~  239 (261)
T cd05034         176 AN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGM------TNREVLEQVERG-----YRMPRPPNC----PEELYDLMLQ  239 (261)
T ss_pred             hc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCCC----CHHHHHHHHH
Confidence            76 5667889999999999999998 99999642      112222222111     111111112    3468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.+|.+||++.++++.|+.
T Consensus       240 ~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         240 CWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=1.7e-24  Score=171.99  Aligned_cols=164  Identities=23%  Similarity=0.375  Sum_probs=114.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe~   87 (221)
                      ..++...+..++.||+.||.|||+. +++|+|+||.||+++.++.++++|||++......   .......++..|++||.
T Consensus        94 ~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (268)
T cd05086          94 RNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL  172 (268)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchh
Confidence            4456777889999999999999998 9999999999999999999999999987532211   11123345678999997


Q ss_pred             chh------cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           88 REI------WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        88 ~~~------~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      ...      ....+.++|+||||+++|++++ +..||...      ...................+......    ...+
T Consensus       173 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  242 (268)
T cd05086         173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL------SDREVLNHVIKDQQVKLFKPQLELPY----SERW  242 (268)
T ss_pred             cccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhhcccccCCCccCCCC----cHHH
Confidence            631      1234678999999999999997 56777532      11222222222221111111111122    2358


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHH
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      .+++..|| .+|.+||++.+|++.|.
T Consensus       243 ~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         243 YEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            88999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.93  E-value=6.6e-25  Score=176.71  Aligned_cols=163  Identities=25%  Similarity=0.335  Sum_probs=119.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++++..+..++.||+.||+|||+..+++|+|++|.||+++.++.++|+|||++.............++..|++||.+.
T Consensus       108 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  187 (296)
T cd06618         108 QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID  187 (296)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcC
Confidence            34789999999999999999999973389999999999999999999999999986544333333344567899999875


Q ss_pred             hc---CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           90 IW---KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        90 ~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      ..   ...+.++|+||||+++|++++|..||.....     ............   ....+....    ....+.+++.+
T Consensus       188 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~----~~~~l~~li~~  255 (296)
T cd06618         188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEE---PPSLPPNEG----FSPDFCSFVDL  255 (296)
T ss_pred             CCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCC---CCCCCCCCC----CCHHHHHHHHH
Confidence            22   2357889999999999999999999964211     111111111111   111111111    22468999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+||++.++++.
T Consensus       256 ~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         256 CLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HccCChhhCCCHHHHhcC
Confidence            999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.93  E-value=5.6e-25  Score=177.30  Aligned_cols=158  Identities=20%  Similarity=0.360  Sum_probs=118.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++|+|||++........ .....++..|++||.+.
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (296)
T cd06655         110 TCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  188 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhc
Confidence            4689999999999999999999998 999999999999999999999999998765433221 22345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+||||+++|++++|..||.....      ..........   .........    .....+.+++.+||.
T Consensus       189 -~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~~~~~---~~~~~~~~~----~~~~~~~~li~~~l~  254 (296)
T cd06655         189 -RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATN---GTPELQNPE----KLSPIFRDFLNRCLE  254 (296)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhc---CCcccCCcc----cCCHHHHHHHHHHhh
Confidence             56678899999999999999999999964211      1111111110   000111111    122458899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+||++.++++
T Consensus       255 ~dp~~Rpt~~~il~  268 (296)
T cd06655         255 MDVEKRGSAKELLQ  268 (296)
T ss_pred             cChhhCCCHHHHhh
Confidence            99999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-25  Score=185.96  Aligned_cols=159  Identities=22%  Similarity=0.434  Sum_probs=126.7

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCC---CCCccccCcccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS---ATSLFYKAPECR   88 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~---~~~~~~~~pe~~   88 (221)
                      -++--..+.++.||.+|+.||..+ +++||||.++|+|+..+..+|++|||+++++... ++...   .-++.|.|||.+
T Consensus       361 ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsL  438 (1157)
T KOG4278|consen  361 EVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL  438 (1157)
T ss_pred             hcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCcccc
Confidence            345556778899999999999998 9999999999999999999999999999876543 22222   335679999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|||+||+++||+.+ |-.||++.      +...++..+.+     +.++..+..|++    .+.+||+.|
T Consensus       439 A-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSqVY~LLEk-----gyRM~~PeGCPp----kVYeLMraC  502 (1157)
T KOG4278|consen  439 A-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYGLLEK-----GYRMDGPEGCPP----KVYELMRAC  502 (1157)
T ss_pred             c-ccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHHHHHHHhc-----cccccCCCCCCH----HHHHHHHHH
Confidence            6 7888999999999999999998 88899854      33344444433     333444444444    599999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhh
Q 048055          168 VSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~  188 (221)
                      |+..|.+||+++|+.+.+|.+
T Consensus       503 W~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  503 WNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             hcCCcccCccHHHHHHHHHHH
Confidence            999999999999999998863

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.3e-25  Score=175.91  Aligned_cols=160  Identities=26%  Similarity=0.417  Sum_probs=118.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +..++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+...... .......++..|+|||.+
T Consensus       107 ~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  185 (275)
T cd06608         107 GKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI  185 (275)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHh
Confidence            46789999999999999999999998 9999999999999999999999999987644322 222334567789999976


Q ss_pred             hh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ..    ...++.++|+||||+++|++++|..||....     .. .........       ..............+.+++
T Consensus       186 ~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~-~~~~~~~~~-------~~~~~~~~~~~~~~~~~li  252 (275)
T cd06608         186 ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-----PM-RALFKIPRN-------PPPTLKSPENWSKKFNDFI  252 (275)
T ss_pred             cccccccCCccccccHHHhHHHHHHHHhCCCCccccc-----hH-HHHHHhhcc-------CCCCCCchhhcCHHHHHHH
Confidence            42    2335678999999999999999999996321     11 111111110       0111111222345789999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||..||.+|||+.++++
T Consensus       253 ~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         253 SECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHhhcChhhCcCHHHHhc
Confidence            9999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=1.2e-24  Score=170.76  Aligned_cols=159  Identities=22%  Similarity=0.401  Sum_probs=119.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.|++.||.|+|+. +++|+|++|.||+++.++.++++|||++........  ......+..|++||.+
T Consensus        88 ~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~  166 (250)
T cd05085          88 DELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL  166 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHh
Confidence            4578999999999999999999998 999999999999999999999999998854332211  1112334569999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . ...++.++|+||||+++|++++ |..||...      ............     ........    .+..+.+++.+|
T Consensus       167 ~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~----~~~~~~~li~~~  230 (250)
T cd05085         167 N-YGRYSSESDVWSYGILLWETFSLGVCPYPGM------TNQQAREQVEKG-----YRMSCPQK----CPDDVYKVMQRC  230 (250)
T ss_pred             c-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCC----CCHHHHHHHHHH
Confidence            6 5667889999999999999998 99999642      111221222111     11111111    234699999999


Q ss_pred             ccCCCCCCCCHHHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~  186 (221)
                      |+.+|++||++.++++.|.
T Consensus       231 l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         231 WDYKPENRPKFSELQKELA  249 (250)
T ss_pred             cccCcccCCCHHHHHHHhc
Confidence            9999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=4.4e-25  Score=197.74  Aligned_cols=159  Identities=21%  Similarity=0.348  Sum_probs=118.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCC------CCceeeCcCCCCeEEcC-----------------CCceEEeccCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQN------PGLTHGNLKSSNVLLGA-----------------DFESCLTDYGLGSF   66 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~------~~i~h~dlk~~nil~~~-----------------~~~~~l~dfg~~~~   66 (221)
                      ...|++..++.++.||+.||.|||+.      .+|+|+||||.|||++.                 .+.++|+|||++..
T Consensus       112 ~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~  191 (1021)
T PTZ00266        112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN  191 (1021)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccc
Confidence            35789999999999999999999984      14999999999999964                 23489999999876


Q ss_pred             cCCCCCCCCCCCCccccCcccchh-cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCC
Q 048055           67 RNPDSVEEPSATSLFYKAPECREI-WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDD  145 (221)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (221)
                      ...........+++.|+|||.+.. ...++.++|||||||++|+|++|..||...     .........+...    . .
T Consensus       192 l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~-----~~~~qli~~lk~~----p-~  261 (1021)
T PTZ00266        192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-----NNFSQLISELKRG----P-D  261 (1021)
T ss_pred             ccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-----CcHHHHHHHHhcC----C-C
Confidence            544333344567889999998752 234678999999999999999999999642     2222222222111    1 1


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          146 PPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       146 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+. ..    ....+.+||..||+.+|.+||++.+++.
T Consensus       262 lpi-~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        262 LPI-KG----KSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCc-CC----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            111 11    1246899999999999999999999984

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.93  E-value=4.1e-25  Score=177.77  Aligned_cols=159  Identities=18%  Similarity=0.327  Sum_probs=119.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|+|||.+.
T Consensus       113 ~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (292)
T cd06658         113 TRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS  191 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHc
Confidence            4688999999999999999999998 99999999999999999999999999886443221 122345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+||||+++|++++|..||....      ...........   .........    .....+.+++.+||.
T Consensus       192 -~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~li~~~l~  257 (292)
T cd06658         192 -RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP------PLQAMRRIRDN---LPPRVKDSH----KVSSVLRGFLDLMLV  257 (292)
T ss_pred             -cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhc---CCCcccccc----ccCHHHHHHHHHHcc
Confidence             5667889999999999999999999996421      11111111111   111111111    122358899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .||.+|||+.++++.
T Consensus       258 ~~P~~Rpt~~~il~~  272 (292)
T cd06658         258 REPSQRATAQELLQH  272 (292)
T ss_pred             CChhHCcCHHHHhhC
Confidence            999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.92  E-value=8.9e-25  Score=172.09  Aligned_cols=158  Identities=22%  Similarity=0.406  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||.+........  ......+..|++||.+
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~  173 (256)
T cd05112          95 GKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF  173 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHh
Confidence            4688999999999999999999998 999999999999999999999999998765432211  1122234579999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|+||||+++|++++ |..||....      .......+.....     ...+..    .+..+.+|+.+|
T Consensus       174 ~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~-----~~~~~~----~~~~~~~l~~~~  237 (256)
T cd05112         174 S-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------NSEVVETINAGFR-----LYKPRL----ASQSVYELMQHC  237 (256)
T ss_pred             c-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHhCCCC-----CCCCCC----CCHHHHHHHHHH
Confidence            6 5667889999999999999998 899986321      1222222221111     111111    124699999999


Q ss_pred             ccCCCCCCCCHHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKMI  185 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L  185 (221)
                      |+.+|++||++.++++.|
T Consensus       238 l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         238 WKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             cccChhhCCCHHHHHHhh
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.92  E-value=1.3e-25  Score=176.94  Aligned_cols=164  Identities=31%  Similarity=0.462  Sum_probs=121.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcccc-CCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR-NPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..++.++.|++.||.+||+. +++|+||+|.||+++.++.++|+|||.+... ..........++..|+|||..
T Consensus        92 ~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  170 (260)
T PF00069_consen   92 NKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVL  170 (260)
T ss_dssp             HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHH
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            46789999999999999999999998 9999999999999999999999999998653 222333455677889999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      ..+.....++|+||+|+++|+|++|..||......   .....................      ......+.+++.+||
T Consensus       171 ~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l  241 (260)
T PF00069_consen  171 QQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRPLPSSSQQS------REKSEELRDLIKKML  241 (260)
T ss_dssp             TTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTHHHHHTTSH------TTSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccccccccccccch---hhhhhhhhccccccccccccc------chhHHHHHHHHHHHc
Confidence            53567789999999999999999999999753100   011111111111110000000      000146999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||++||++.++++
T Consensus       242 ~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  242 SKDPEQRPSAEELLK  256 (260)
T ss_dssp             SSSGGGSTTHHHHHT
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-25  Score=187.40  Aligned_cols=148  Identities=28%  Similarity=0.363  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE-cCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcCCC
Q 048055           16 TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL-GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQP   94 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~   94 (221)
                      ..+..|+.+|+.++.|||.+ |++|||+||.|||+ +..+.++|+|||.++.....  +.+..-|..|.|||... ...+
T Consensus       415 ~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~y  490 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEY  490 (612)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCC
Confidence            67778999999999999998 99999999999999 68899999999998765554  34445677899999987 7888


Q ss_pred             CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCC
Q 048055           95 TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPEN  174 (221)
Q Consensus        95 ~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~  174 (221)
                      +.++|+||||+++|+|++|..||......     .....++..        +.    .+.......++|+.+||+.||.+
T Consensus       491 t~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~--------~~----~s~~vS~~AKdLl~~LL~~dP~~  553 (612)
T KOG0603|consen  491 TEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQM--------PK----FSECVSDEAKDLLQQLLQVDPAL  553 (612)
T ss_pred             CcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcC--------Cc----cccccCHHHHHHHHHhccCChhh
Confidence            99999999999999999999999754322     111111111        00    01222346899999999999999


Q ss_pred             CCCHHHHHHH
Q 048055          175 RPVMREVSKM  184 (221)
Q Consensus       175 Rps~~~l~~~  184 (221)
                      |+++.++...
T Consensus       554 Rl~~~~i~~h  563 (612)
T KOG0603|consen  554 RLGADEIGAH  563 (612)
T ss_pred             CcChhhhccC
Confidence            9999998643

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=4e-25  Score=177.42  Aligned_cols=161  Identities=21%  Similarity=0.282  Sum_probs=118.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      .+..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|++||.
T Consensus       121 ~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  199 (291)
T cd06639         121 CGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  199 (291)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhh
Confidence            346789999999999999999999998 99999999999999999999999999986543222 1223456778999998


Q ss_pred             chhcC----CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           88 REIWK----QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        88 ~~~~~----~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +....    .++.++|+||||+++|++++|..||.....      .........   .......    ..+.....+.++
T Consensus       200 ~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~~~~~~~~~---~~~~~~~----~~~~~~~~l~~l  266 (291)
T cd06639         200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------VKTLFKIPR---NPPPTLL----HPEKWCRSFNHF  266 (291)
T ss_pred             hcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------HHHHHHHhc---CCCCCCC----cccccCHHHHHH
Confidence            65222    257899999999999999999999964211      111111111   0011111    111223469999


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.+||+.+|++||++.++++
T Consensus       267 i~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         267 ISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHhhcChhhCcCHHHHhc
Confidence            99999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=7.6e-25  Score=173.51  Aligned_cols=157  Identities=24%  Similarity=0.419  Sum_probs=118.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-------CCCCCCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-------EEPSATSLFY   82 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~   82 (221)
                      .+.++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||.++.......       .....++..|
T Consensus       100 ~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y  178 (267)
T cd06628         100 YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW  178 (267)
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCc
Confidence            35688999999999999999999998 999999999999999999999999998865432111       1122456789


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      ++||.+. ...++.++|+||+|+++|++++|..||....     . .........     ...+..+..    .+..+.+
T Consensus       179 ~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~-~~~~~~~~~-----~~~~~~~~~----~~~~~~~  242 (267)
T cd06628         179 MAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-----Q-LQAIFKIGE-----NASPEIPSN----ISSEAID  242 (267)
T ss_pred             cChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-----H-HHHHHHHhc-----cCCCcCCcc----cCHHHHH
Confidence            9999876 5566788999999999999999999996421     1 111111111     111111111    2346899


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 048055          163 IAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ++.+||+.||.+||++.++++
T Consensus       243 li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         243 FLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhh
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.92  E-value=9.8e-25  Score=175.34  Aligned_cols=160  Identities=20%  Similarity=0.284  Sum_probs=117.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|++||.+
T Consensus       104 ~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  182 (292)
T cd06644         104 DRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV  182 (292)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceee
Confidence            45689999999999999999999998 99999999999999999999999999875432221 12234566789999986


Q ss_pred             hh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ..    ...++.++|+||||+++|++++|..||....      ...........   .........    .....+.+++
T Consensus       183 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~li  249 (292)
T cd06644         183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKS---EPPTLSQPS----KWSMEFRDFL  249 (292)
T ss_pred             ccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc------HHHHHHHHhcC---CCccCCCCc----ccCHHHHHHH
Confidence            41    2345678999999999999999999986421      11111111111   011111111    2224589999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.+|++||++.++++
T Consensus       250 ~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         250 KTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHhcCCcccCcCHHHHhc
Confidence            9999999999999999965

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.92  E-value=7.2e-25  Score=172.14  Aligned_cols=159  Identities=22%  Similarity=0.421  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---CCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.+++.||.|||+. +++|+|++|.||+++.++.++++|||.+.........   .....+..|++||.
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~  166 (251)
T cd05041          88 NRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA  166 (251)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHh
Confidence            4678999999999999999999998 9999999999999999999999999998644321111   11122456999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||.....      ......+...     ...+.+.    ..+..+.+++.+
T Consensus       167 ~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~~~~~~~~~-----~~~~~~~----~~~~~~~~li~~  230 (251)
T cd05041         167 LN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQTRERIESG-----YRMPAPQ----LCPEEIYRLMLQ  230 (251)
T ss_pred             hc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HHHHHHHhcC-----CCCCCCc----cCCHHHHHHHHH
Confidence            76 5677889999999999999998 8888864321      1111111111     1111111    223469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~  186 (221)
                      ||+.+|.+||++.++++.|+
T Consensus       231 ~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         231 CWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HhccChhhCcCHHHHHHHhh
Confidence            99999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=7.2e-25  Score=175.04  Aligned_cols=161  Identities=24%  Similarity=0.369  Sum_probs=118.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +..+++..++.++.||+.||.|||++.+++|+|++|.||+++.++.++|+|||.+.............++..|++||.+.
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  176 (283)
T cd06617          97 GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN  176 (283)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcC
Confidence            35789999999999999999999985489999999999999999999999999986544332223345677899999775


Q ss_pred             hc---CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           90 IW---KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        90 ~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      ..   ..++.++|+||||+++|++++|..||....    ..... ......   ......+ ..    ..+..+.+++.+
T Consensus       177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~-~~~~~~---~~~~~~~-~~----~~~~~l~~li~~  243 (283)
T cd06617         177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK----TPFQQ-LKQVVE---EPSPQLP-AE----KFSPEFQDFVNK  243 (283)
T ss_pred             CcccccccCccccchhhHHHHHHHHhCCCCCCccc----cCHHH-HHHHHh---cCCCCCC-cc----ccCHHHHHHHHH
Confidence            21   335778999999999999999999996321    11111 111111   1111111 01    123468999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||..+|.+||++.++++
T Consensus       244 ~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         244 CLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=3.5e-25  Score=178.75  Aligned_cols=167  Identities=19%  Similarity=0.260  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++...... .......++..|++||.+
T Consensus        98 ~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~  176 (301)
T cd07873          98 GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL  176 (301)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHH
Confidence            45688999999999999999999998 9999999999999999999999999998654322 222334557789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh---------------hhhccCCCCCC-CC--
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE---------------EETESGDDPPS-SN--  150 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~-~~--  150 (221)
                      .....++.++|+||||+++|+|++|..||.....      .........               .........+. ..  
T Consensus       177 ~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (301)
T cd07873         177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV------EEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADC  250 (301)
T ss_pred             hCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCChhhchhhhccccccccccCcccccc
Confidence            6445567889999999999999999999964321      111111000               00000000000 00  


Q ss_pred             --hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 --EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 --~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        .........+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         251 LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              000112345889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.92  E-value=5.9e-25  Score=182.47  Aligned_cols=161  Identities=19%  Similarity=0.204  Sum_probs=120.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..++...+..++.||+.||+|||+. +++||||||.||+++.++.++|+|||++.......  ......+++.|+|||.+
T Consensus       137 ~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (370)
T cd05596         137 YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHh
Confidence            4578888999999999999999998 99999999999999999999999999986544322  12345678899999986


Q ss_pred             hhc---CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIW---KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      ...   ..++.++|+|||||++|+|++|..||....      .......+.....  ....+.....    ...+.+++.
T Consensus       216 ~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~~--~~~~~~~~~~----s~~~~~li~  283 (370)
T cd05596         216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMDHKN--SLTFPDDIEI----SKQAKDLIC  283 (370)
T ss_pred             ccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCC--cCCCCCcCCC----CHHHHHHHH
Confidence            522   236789999999999999999999997432      2222222221111  1111111112    246889999


Q ss_pred             HcccCCCCC--CCCHHHHHHH
Q 048055          166 ACVSLAPEN--RPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~--Rps~~~l~~~  184 (221)
                      +||+.+|.+  |+++.++++.
T Consensus       284 ~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         284 AFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHccChhhccCCCCHHHHhcC
Confidence            999999988  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=1.5e-24  Score=172.04  Aligned_cols=162  Identities=19%  Similarity=0.440  Sum_probs=122.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----CCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----EPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~p   85 (221)
                      .+.+++..++.++.|++.||.|||+. +++|+|++|.|++++.++.++++|||++.........    .....+..|++|
T Consensus       100 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         100 DGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCH
Confidence            35689999999999999999999998 9999999999999999999999999998755432211    111224569999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++ |..||.....      ......+...     ...+.....    +..+.+++
T Consensus       179 e~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------~~~~~~~~~~-----~~~~~~~~~----~~~~~~li  242 (267)
T cd05066         179 EAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------QDVIKAIEEG-----YRLPAPMDC----PAALHQLM  242 (267)
T ss_pred             hHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCCH------HHHHHHHhCC-----CcCCCCCCC----CHHHHHHH
Confidence            9886 5667889999999999999886 9999964321      1112222111     111211222    24689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.+|.+||++.++++.|+++
T Consensus       243 ~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         243 LDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHcccCchhCCCHHHHHHHHHhh
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-25  Score=183.03  Aligned_cols=158  Identities=22%  Similarity=0.268  Sum_probs=127.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE-cCCCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL-GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      ..+.++...+.+++.||+.|+.|||+- .+||||+||+|+.+ .+-|.+|+.|||++....+++...+..|.+.|-|||.
T Consensus       111 He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEI  189 (864)
T KOG4717|consen  111 HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEI  189 (864)
T ss_pred             hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchh
Confidence            467789999999999999999999998 89999999999755 6679999999999987778877888999999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +........++||||||+++|.+++|+.||+.........      .+-+    ..+.      .+....+...+||..|
T Consensus       190 LLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT------mImD----CKYt------vPshvS~eCrdLI~sM  253 (864)
T KOG4717|consen  190 LLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT------MIMD----CKYT------VPSHVSKECRDLIQSM  253 (864)
T ss_pred             hhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh------hhhc----cccc------CchhhhHHHHHHHHHH
Confidence            8844445778999999999999999999998643322111      1111    1111      2223445689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |..||.+|.+.++|..
T Consensus       254 LvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  254 LVRDPKKRASLEEIVS  269 (864)
T ss_pred             HhcCchhhccHHHHhc
Confidence            9999999999998854

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.92  E-value=4.8e-25  Score=176.39  Aligned_cols=161  Identities=20%  Similarity=0.289  Sum_probs=119.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|+|||.+
T Consensus       118 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         118 GERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             CccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhh
Confidence            45678899999999999999999998 99999999999999999999999999986543322 22334577889999976


Q ss_pred             hh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ..    ...++.++|+||+|+++|++++|..||.....     .... .....   ........+.    .....+.+++
T Consensus       197 ~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~~-~~~~~---~~~~~~~~~~----~~~~~~~~li  263 (286)
T cd06638         197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRAL-FKIPR---NPPPTLHQPE----LWSNEFNDFI  263 (286)
T ss_pred             chhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHHH-hhccc---cCCCcccCCC----CcCHHHHHHH
Confidence            42    23457899999999999999999999864311     1111 11100   0000001111    1123589999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+||+.+|++||++.++++.
T Consensus       264 ~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         264 RKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHccCCcccCCCHHHHhhc
Confidence            99999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.92  E-value=1.7e-24  Score=173.74  Aligned_cols=162  Identities=20%  Similarity=0.393  Sum_probs=121.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||+++.......   .....++..|++||.
T Consensus       114 ~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~  192 (288)
T cd05061         114 PPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHH
Confidence            4457788899999999999999998 999999999999999999999999999864432211   112233567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. ...++.++|+|||||++|++++ |..||....      ...........     .........    +..+.+++.+
T Consensus       193 ~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~~----~~~~~~li~~  256 (288)
T cd05061         193 LK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS------NEQVLKFVMDG-----GYLDQPDNC----PERVTDLMRM  256 (288)
T ss_pred             hc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcC-----CCCCCCCCC----CHHHHHHHHH
Confidence            76 5667889999999999999998 788886421      12222211111     111111111    2469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      ||+.+|.+||++.++++.|++..
T Consensus       257 ~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         257 CWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HcCCChhHCcCHHHHHHHHHhhc
Confidence            99999999999999998888753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=5.7e-25  Score=175.52  Aligned_cols=170  Identities=23%  Similarity=0.383  Sum_probs=122.3

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAPEC   87 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~pe~   87 (221)
                      .+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||.+........    ......+..|++||.
T Consensus       105 ~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  183 (284)
T cd05038         105 QINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC  183 (284)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHH
Confidence            589999999999999999999998 999999999999999999999999999865542211    112233456899998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCC-----ChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS-----DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      .. ...++.++|+||||+++|++++|..||.........     ........+..... .....+...    ..+..+.+
T Consensus       184 ~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~  257 (284)
T cd05038         184 LR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPP----SCPDEVYD  257 (284)
T ss_pred             Hc-cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH-cCCcCCCCc----cCCHHHHH
Confidence            76 566788999999999999999999887542211100     00000111111111 111111111    12246999


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ++.+||+.+|.+||++.+|++.|+.+
T Consensus       258 li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         258 LMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHhccChhhCCCHHHHHHHHhhc
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.92  E-value=1.2e-24  Score=171.08  Aligned_cols=156  Identities=24%  Similarity=0.462  Sum_probs=119.6

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCC--CCCCCccccCcccchh
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE--PSATSLFYKAPECREI   90 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~pe~~~~   90 (221)
                      +++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++..........  ...++..|++||.+. 
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-  177 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-  177 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhc-
Confidence            89999999999999999999998 99999999999999999999999999986554432111  123557899999875 


Q ss_pred             cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +..++.++|+||+|++++++++ |..||...      .............     ....+..    .+..+.+++.+||.
T Consensus       178 ~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~i~~~l~  242 (258)
T smart00219      178 DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------SNEEVLEYLKKGY-----RLPKPEN----CPPEIYKLMLQCWA  242 (258)
T ss_pred             cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHhcCC-----CCCCCCc----CCHHHHHHHHHHCc
Confidence            6677899999999999999998 78888632      2222222221111     1111111    23469999999999


Q ss_pred             CCCCCCCCHHHHHHHH
Q 048055          170 LAPENRPVMREVSKMI  185 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~L  185 (221)
                      .+|.+|||+.++++.|
T Consensus       243 ~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      243 EDPEDRPTFSELVEIL  258 (258)
T ss_pred             CChhhCcCHHHHHhhC
Confidence            9999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=8e-25  Score=174.58  Aligned_cols=166  Identities=18%  Similarity=0.193  Sum_probs=121.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|++||.+.
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  171 (283)
T cd05118          93 RGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL  171 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHh
Confidence            5789999999999999999999998 99999999999999999999999999886554332 223345667899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc--------------------cCCCCCCC
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE--------------------SGDDPPSS  149 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~  149 (221)
                      .....+.++|+||+|+++|++++|+.||.....      .............                    ........
T Consensus       172 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (283)
T cd05118         172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE------IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL  245 (283)
T ss_pred             cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH
Confidence            333678899999999999999999999964221      1111111100000                    00000011


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ....+.....+.+++.+||+.||.+||++.+++.
T Consensus       246 ~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         246 PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1122334567999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=7.2e-25  Score=176.14  Aligned_cols=167  Identities=19%  Similarity=0.242  Sum_probs=118.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCC-CCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~   87 (221)
                      +..+++..++.++.||+.||.|||+. +++|+|++|.||+++. ++.++++|||++...... .......+++.|+|||.
T Consensus       104 ~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~  182 (295)
T cd07837         104 GRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV  182 (295)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHH
Confidence            46789999999999999999999998 9999999999999998 889999999988644322 11222345677999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC------------------CCCCCC
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG------------------DDPPSS  149 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~  149 (221)
                      +.....++.++|+||||+++|++++|..||....     .. .....+........                  ..+...
T Consensus       183 ~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T cd07837         183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS-----EL-QQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDL  256 (295)
T ss_pred             hhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-----HH-HHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhH
Confidence            7534556889999999999999999999996421     11 11111111000000                  000000


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ....+.....+.+++.+||+.+|.+||++.+++.
T Consensus       257 ~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         257 SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0111123356899999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.92  E-value=6e-25  Score=177.22  Aligned_cols=160  Identities=19%  Similarity=0.349  Sum_probs=120.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|++||.+
T Consensus       111 ~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (297)
T cd06659         111 QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI  189 (297)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHH
Confidence            35688999999999999999999998 99999999999999999999999999876433221 12234567789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||....      .......+......   ......    .....+.+++.+||
T Consensus       190 ~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~---~~~~~~----~~~~~l~~~i~~~l  255 (297)
T cd06659         190 S-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKRLRDSPPP---KLKNAH----KISPVLRDFLERML  255 (297)
T ss_pred             c-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhccCCC---CccccC----CCCHHHHHHHHHHh
Confidence            6 5667889999999999999999999996321      11111222111100   001011    12245899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.+|++||++.++++.
T Consensus       256 ~~~P~~Rps~~~ll~~  271 (297)
T cd06659         256 TREPQERATAQELLDH  271 (297)
T ss_pred             cCCcccCcCHHHHhhC
Confidence            9999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.92  E-value=1.9e-25  Score=182.56  Aligned_cols=159  Identities=17%  Similarity=0.227  Sum_probs=118.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~~   88 (221)
                      ..++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........  .....++..|+|||.+
T Consensus        97 ~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~  175 (330)
T cd05601          97 DQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL  175 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHh
Confidence            5789999999999999999999998 999999999999999999999999999865543321  1234578889999986


Q ss_pred             hh-----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           89 EI-----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        89 ~~-----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ..     ...++.++|+|||||++|+|++|..||....      .......+......  ...+.....    ...+.++
T Consensus       176 ~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~~~~~--~~~~~~~~~----~~~~~~l  243 (330)
T cd05601         176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT------SAKTYNNIMNFQRF--LKFPEDPKV----SSDFLDL  243 (330)
T ss_pred             ccccccccCCCCCcceeecccceeeeeccCCCCCCCCC------HHHHHHHHHcCCCc--cCCCCCCCC----CHHHHHH
Confidence            52     2345788999999999999999999996421      12222222211110  111111112    2358899


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +..|++ +|.+||++.+++.
T Consensus       244 i~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         244 IQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHcc-ChhhCCCHHHHhC
Confidence            999998 9999999999974

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=1.3e-24  Score=172.90  Aligned_cols=160  Identities=22%  Similarity=0.341  Sum_probs=120.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||++.......  ......++..|++||.+
T Consensus       112 ~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         112 PPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhh
Confidence            3689999999999999999999998 99999999999999999999999999875432211  11223445679999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +.....++|+||||+++|++++ |..||....      ..............    .+....    .+..+.+++.+|
T Consensus       191 ~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~------~~~~~~~~~~~~~~----~~~~~~----~~~~l~~~i~~~  255 (275)
T cd05046         191 Q-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS------DEEVLNRLQAGKLE----LPVPEG----CPSRLYKLMTRC  255 (275)
T ss_pred             c-cCCCCchhhHHHHHHHHHHHHhCCCCCccccc------hHHHHHHHHcCCcC----CCCCCC----CCHHHHHHHHHH
Confidence            6 5566788999999999999998 888885421      11222222111110    111111    224699999999


Q ss_pred             ccCCCCCCCCHHHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~  186 (221)
                      |+.+|.+||++.+++..|.
T Consensus       256 l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         256 WAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCCcccCCCHHHHHHHhc
Confidence            9999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.92  E-value=6.5e-25  Score=177.77  Aligned_cols=167  Identities=22%  Similarity=0.237  Sum_probs=119.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++...... ........+..|+|||.+.
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         103 TPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL  181 (309)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhc
Confidence            5689999999999999999999998 9999999999999999999999999998655432 1222233466799999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc---------------C-CCCCCC----
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES---------------G-DDPPSS----  149 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------~-~~~~~~----  149 (221)
                      ....++.++|+||+|+++|++++|..||....      .......+.......               . ......    
T Consensus       182 ~~~~~~~~~DvwslG~il~el~~g~~~f~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (309)
T cd07845         182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKS------EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNL  255 (309)
T ss_pred             CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCch
Confidence            34556889999999999999999999996421      111111111100000               0 000000    


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ..........+.+++.+||+.||++|||+.+++..
T Consensus       256 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         256 KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             HHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00001123467899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.92  E-value=3.4e-25  Score=177.00  Aligned_cols=158  Identities=19%  Similarity=0.292  Sum_probs=116.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++...++.++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++...... .......++..|+|||.+.
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         116 NALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcC
Confidence            3577888999999999999999998 9999999999999999999999999987643221 1223345677899999764


Q ss_pred             h----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           90 I----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        90 ~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .    ...++.++|+||||+++|++++|..||.....     .... ...   ... ........    ..+..+.+++.
T Consensus       195 ~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-----~~~~-~~~---~~~-~~~~~~~~----~~~~~~~~li~  260 (282)
T cd06636         195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-----MRAL-FLI---PRN-PPPKLKSK----KWSKKFIDFIE  260 (282)
T ss_pred             cccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-----Hhhh-hhH---hhC-CCCCCccc----ccCHHHHHHHH
Confidence            2    23456789999999999999999999964211     0010 000   000 00000111    12346999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+||++.+|++
T Consensus       261 ~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         261 GCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHhCCChhhCcCHHHHhc
Confidence            999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.92  E-value=5.2e-25  Score=180.46  Aligned_cols=174  Identities=21%  Similarity=0.268  Sum_probs=122.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+||
T Consensus       100 ~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         100 TQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccCh
Confidence            35789999999999999999999998 99999999999999999999999999986543221    11223567789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-------------------ccCCCC
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-------------------ESGDDP  146 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~  146 (221)
                      |.+.....++.++|+||+|+++|++++|..||.....      ......+.....                   ......
T Consensus       179 E~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (336)
T cd07849         179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY------LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK  252 (336)
T ss_pred             HHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcC
Confidence            9765345668899999999999999999999964211      111110000000                   000000


Q ss_pred             CCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHH
Q 048055          147 PSSNE--ASEEKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSRA  190 (221)
Q Consensus       147 ~~~~~--~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~--L~~~~~  190 (221)
                      +....  ..+.....+.+++.+||+.+|++||++.++++.  +++..+
T Consensus       253 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         253 PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            00000  001123468999999999999999999999876  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=8.8e-25  Score=173.92  Aligned_cols=156  Identities=24%  Similarity=0.400  Sum_probs=119.9

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccchh
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++...... .......++..|++||.+. 
T Consensus        94 ~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~-  171 (274)
T cd06609          94 KLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK-  171 (274)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhc-
Confidence            789999999999999999999998 9999999999999999999999999998765443 2223345667899999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||||+++|++++|..||....      .......+...   .....+  ..   ..+..+.+++.+||..
T Consensus       172 ~~~~~~~sDv~slG~il~~l~tg~~p~~~~~------~~~~~~~~~~~---~~~~~~--~~---~~~~~~~~~l~~~l~~  237 (274)
T cd06609         172 QSGYDEKADIWSLGITAIELAKGEPPLSDLH------PMRVLFLIPKN---NPPSLE--GN---KFSKPFKDFVSLCLNK  237 (274)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcccCc------hHHHHHHhhhc---CCCCCc--cc---ccCHHHHHHHHHHhhC
Confidence            5668899999999999999999999996321      11111111111   011111  11   0234689999999999


Q ss_pred             CCCCCCCHHHHHH
Q 048055          171 APENRPVMREVSK  183 (221)
Q Consensus       171 dp~~Rps~~~l~~  183 (221)
                      +|++||+++++++
T Consensus       238 ~p~~Rpt~~~il~  250 (274)
T cd06609         238 DPKERPSAKELLK  250 (274)
T ss_pred             ChhhCcCHHHHhh
Confidence            9999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.2e-24  Score=187.08  Aligned_cols=165  Identities=16%  Similarity=0.190  Sum_probs=114.0

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccchh
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECREI   90 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~~~   90 (221)
                      .....+..++.||+.||.|||+. +|+||||||.|||++.++.++|+|||+++......  ......++..|++||.+. 
T Consensus       264 ~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-  341 (501)
T PHA03210        264 PLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA-  341 (501)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc-
Confidence            34667788999999999999998 99999999999999999999999999987554322  122346788999999986 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCC-CcccccccCCChHHHHHHhhhhhhccCCCCCCC-----------------Chh
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTP-FQDLVLEHGSDIPRWVRSVREEETESGDDPPSS-----------------NEA  152 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~  152 (221)
                      +..++.++|||||||++|+|++|..+ |....    .....................+..                 ...
T Consensus       342 ~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~  417 (501)
T PHA03210        342 GDGYCEITDIWSCGLILLDMLSHDFCPIGDGG----GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSV  417 (501)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC----CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccch
Confidence            66788999999999999999997654 43211    111111111111000000000000                 000


Q ss_pred             -----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          153 -----SEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       153 -----~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                           ....+..+.+++.+||+.||.+||++.|++.
T Consensus       418 ~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        418 PPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             hhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 0001235778899999999999999999975

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=1e-24  Score=171.78  Aligned_cols=158  Identities=23%  Similarity=0.363  Sum_probs=121.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      +..++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|.+||..
T Consensus        95 ~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~  173 (256)
T cd08221          95 GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC  173 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhc
Confidence            35689999999999999999999998 99999999999999999999999999986554332 22334567889999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +...+.++|+||||+++|++++|..||...      ...........     ....+..    ......+.+++.+||
T Consensus       174 ~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~~i~~~l  237 (256)
T cd08221         174 Q-GVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQ-----GNYTPVV----SVYSSELISLVHSLL  237 (256)
T ss_pred             C-CCCCCCcchhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHc-----CCCCCCc----cccCHHHHHHHHHHc
Confidence            6 556778899999999999999999999632      22222222211     1111111    122346899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.+|.+||++.++++.
T Consensus       238 ~~~p~~R~s~~~ll~~  253 (256)
T cd08221         238 QQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ccCcccCCCHHHHhhC
Confidence            9999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=185.67  Aligned_cols=155  Identities=25%  Similarity=0.357  Sum_probs=123.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++....+..++.+.+.||+|||++ +.+|||||+.|||++..|.+|++|||.+-...+.   ..+.||++|||||++.
T Consensus       120 kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVIL  195 (948)
T KOG0577|consen  120 KKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVIL  195 (948)
T ss_pred             hccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCch---hcccCCccccchhHhe
Confidence            57888889999999999999999999 9999999999999999999999999998665544   4578999999999765


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  .+.|.-++||||||++..|+..+++|+..      ++-......+..   ...+...     ..+....+.+|+..|
T Consensus       196 AMDEGqYdgkvDvWSLGITCIELAERkPPlFn------MNAMSALYHIAQ---NesPtLq-----s~eWS~~F~~Fvd~C  261 (948)
T KOG0577|consen  196 AMDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQ---NESPTLQ-----SNEWSDYFRNFVDSC  261 (948)
T ss_pred             eccccccCCccceeeccchhhhhhhcCCCccC------chHHHHHHHHHh---cCCCCCC-----CchhHHHHHHHHHHH
Confidence            2  46778899999999999999999999753      222222222222   1122222     234445799999999


Q ss_pred             ccCCCCCCCCHHHHH
Q 048055          168 VSLAPENRPVMREVS  182 (221)
Q Consensus       168 l~~dp~~Rps~~~l~  182 (221)
                      |++-|.+|||.++++
T Consensus       262 LqKipqeRptse~ll  276 (948)
T KOG0577|consen  262 LQKIPQERPTSEELL  276 (948)
T ss_pred             HhhCcccCCcHHHHh
Confidence            999999999998884

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.92  E-value=9.8e-25  Score=174.92  Aligned_cols=158  Identities=16%  Similarity=0.304  Sum_probs=119.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      +++++..+..++.|++.||+|||+. +++|+||+|.||+++.++.++++|||.+....... ......++..|++||.+.
T Consensus       110 ~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (285)
T cd06648         110 TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS  188 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhc
Confidence            4688899999999999999999998 99999999999999999999999999875433221 122345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+|+++|++++|..||...      +............   ........    .....+.+++.+||+
T Consensus       189 -~~~~~~~~Dv~slGv~l~ell~g~~p~~~~------~~~~~~~~~~~~~---~~~~~~~~----~~~~~l~~li~~~l~  254 (285)
T cd06648         189 -RLPYGTEVDIWSLGIMVIEMVDGEPPYFNE------PPLQAMKRIRDNL---PPKLKNLH----KVSPRLRSFLDRMLV  254 (285)
T ss_pred             -CCCCCCcccHHHHHHHHHHHHhCCCCCcCC------CHHHHHHHHHhcC---CCCCcccc----cCCHHHHHHHHHHcc
Confidence             556788999999999999999999998632      1112222222211   11111011    122469999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|.+||++.++++
T Consensus       255 ~~p~~Rpt~~~il~  268 (285)
T cd06648         255 RDPAQRATAAELLN  268 (285)
T ss_pred             cChhhCcCHHHHcc
Confidence            99999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=1.4e-24  Score=179.74  Aligned_cols=161  Identities=20%  Similarity=0.196  Sum_probs=114.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      .+.++...+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......                  
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  173 (363)
T cd05628          95 KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF  173 (363)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccc
Confidence            46789999999999999999999998 99999999999999999999999999986432110                  


Q ss_pred             ------------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHH
Q 048055           72 ------------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVR  133 (221)
Q Consensus        72 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~  133 (221)
                                        ......|++.|+|||.+. +..++.++|+|||||++|+|++|..||....      ......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~------~~~~~~  246 (363)
T cd05628         174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSET------PQETYK  246 (363)
T ss_pred             cccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCCCCC------HHHHHH
Confidence                              012346788999999886 6677889999999999999999999996421      122222


Q ss_pred             HhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 048055          134 SVREEETESGDDPPSSNEASEEKLQALLNIAIACVS--LAPENRPVMREVSKM  184 (221)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dp~~Rps~~~l~~~  184 (221)
                      .+.....  ....+.....+    ..+.+++.+++.  .++..||++.+|++.
T Consensus       247 ~i~~~~~--~~~~p~~~~~s----~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         247 KVMNWKE--TLIFPPEVPIS----EKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHcCcC--cccCCCcCCCC----HHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            2221110  11111111122    246667766443  344456899999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.92  E-value=1.5e-24  Score=171.13  Aligned_cols=158  Identities=22%  Similarity=0.324  Sum_probs=122.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhc-----CCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIH-----QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH-----~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~   83 (221)
                      ..++++..++.++.||+.||.|||     +. +++|+|++|.||+++.++.++++|||++........ .....++..|+
T Consensus        99 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~  177 (265)
T cd08217          99 RKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM  177 (265)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCcc
Confidence            467899999999999999999999     87 999999999999999999999999999876544332 33445678899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +||.+. ....+.++|+||||+++|++++|..||....      .......+....     ...    .+......+.++
T Consensus       178 ~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-----~~~----~~~~~~~~~~~l  241 (265)
T cd08217         178 SPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQLASKIKEGK-----FRR----IPYRYSSELNEV  241 (265)
T ss_pred             Chhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHHHHHHhcCC-----CCC----CccccCHHHHHH
Confidence            999876 5567788999999999999999999996421      122222221111     111    111233568999


Q ss_pred             HHHcccCCCCCCCCHHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      +.+||+.+|.+||++.+|++.
T Consensus       242 ~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         242 IKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHccCCcccCCCHHHHhhC
Confidence            999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.92  E-value=1.4e-24  Score=171.63  Aligned_cols=162  Identities=22%  Similarity=0.359  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----CCCCCCCccccCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----EEPSATSLFYKAP   85 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~p   85 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++........     .....++..|++|
T Consensus        97 ~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~P  175 (267)
T cd06610          97 GGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP  175 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcCh
Confidence            5689999999999999999999998 999999999999999999999999998765443221     1223466789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+......+.++|+||||+++|++++|+.||.....      ..........   ......... .....+..+.+++.
T Consensus       176 e~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~li~  245 (267)
T cd06610         176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP------MKVLMLTLQN---DPPSLETGA-DYKKYSKSFRKMIS  245 (267)
T ss_pred             HHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh------hhhHHHHhcC---CCCCcCCcc-ccccccHHHHHHHH
Confidence            9876433678899999999999999999999964211      1111111111   111111000 01123356899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||..||++||++.+|++
T Consensus       246 ~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         246 LCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHcCCChhhCcCHHHHhh
Confidence            999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=1.9e-24  Score=172.62  Aligned_cols=172  Identities=19%  Similarity=0.272  Sum_probs=121.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..++.++.|++.+|.|||+. +++|+|++|.||+++.++.++|+|||++.............++..|++||.+..
T Consensus        94 ~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  172 (283)
T cd07830          94 KPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR  172 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeec
Confidence            5789999999999999999999998 999999999999999999999999999876544433344556778999998754


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccC---------CCh-HHHHHHhhhhhhccCCCC----CCCChhhHHH
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG---------SDI-PRWVRSVREEETESGDDP----PSSNEASEEK  156 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  156 (221)
                      ....+.++|+||||+++|++++|..||........         ... ..+..............+    .......+..
T Consensus       173 ~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd07830         173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA  252 (283)
T ss_pred             CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccC
Confidence            55668899999999999999999999964311000         000 000000000000000000    0000111111


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...+.+++.+||+.+|++||++.|++.
T Consensus       253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         253 SPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            356999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=1.2e-24  Score=175.14  Aligned_cols=167  Identities=20%  Similarity=0.190  Sum_probs=119.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++....... .......+..|++||.+.
T Consensus        97 ~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (298)
T cd07841          97 IVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF  175 (298)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHh
Confidence            3789999999999999999999998 99999999999999999999999999986544322 222334566799999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh---------------hcc---CCCCCCCCh
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE---------------TES---GDDPPSSNE  151 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------~~~---~~~~~~~~~  151 (221)
                      ....++.++|+|||||++|++++|.++|.....     . ..........               ...   .........
T Consensus       176 ~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (298)
T cd07841         176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-----I-DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ  249 (298)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-----H-HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhh
Confidence            345567899999999999999999777754211     1 1111111000               000   000000011


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       250 ~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         250 IFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            112234568999999999999999999999773

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.92  E-value=2.2e-24  Score=169.68  Aligned_cols=157  Identities=22%  Similarity=0.354  Sum_probs=118.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.+++.||+|||+. +++|+|++|.||+++.+ +.++++|||.+.............++..|++||.+
T Consensus        95 ~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~  173 (256)
T cd08220          95 NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC  173 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhc
Confidence            45689999999999999999999998 99999999999999855 46799999998765443333334567789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ....+.++|+||+|+++|++++|..||...      +............     ..+....    ....+.+++.+||
T Consensus       174 ~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~----~~~~l~~li~~~l  237 (256)
T cd08220         174 E-GKPYNQKSDIWALGCVLYELASLKRAFEAA------NLPALVLKIMSGT-----FAPISDR----YSPDLRQLILSML  237 (256)
T ss_pred             c-CCCCCcccchHHHHHHHHHHHhCCCCcccC------chHHHHHHHHhcC-----CCCCCCC----cCHHHHHHHHHHc
Confidence            6 556688999999999999999999999642      1122222211110     1111111    2235899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.+|.+|||+.++++
T Consensus       238 ~~~p~~Rpt~~~ll~  252 (256)
T cd08220         238 NLDPSKRPQLSQIMA  252 (256)
T ss_pred             cCChhhCCCHHHHhh
Confidence            999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=4.9e-25  Score=186.55  Aligned_cols=158  Identities=20%  Similarity=0.368  Sum_probs=126.9

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----CCCCCCccccC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----EPSATSLFYKA   84 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~   84 (221)
                      -...|.......|+.||+.|+.||.++ ++||||+.++|+++.....+||+|||+.+..+.....    ....-...|.|
T Consensus       205 ~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCa  283 (1039)
T KOG0199|consen  205 KKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCA  283 (1039)
T ss_pred             cccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccC
Confidence            456778888999999999999999999 9999999999999999999999999998765543322    12233557999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.++ ...++.++|+|++|+++|||++ |+.||.+.      .-..++.++.     ...+.+.++.|+    ..+.++
T Consensus       284 PEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~------~g~qIL~~iD-----~~erLpRPk~cs----edIY~i  347 (1039)
T KOG0199|consen  284 PESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGC------RGIQILKNID-----AGERLPRPKYCS----EDIYQI  347 (1039)
T ss_pred             HhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCC------CHHHHHHhcc-----ccccCCCCCCCh----HHHHHH
Confidence            99998 6888999999999999999998 99999743      3334444443     333445455554    469999


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      |.+||..+|++||+|.+|.+
T Consensus       348 mk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             HHHhccCCccccccHHHHHH
Confidence            99999999999999999963

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=2.2e-24  Score=174.88  Aligned_cols=168  Identities=21%  Similarity=0.317  Sum_probs=117.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--------CCCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--------VEEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~   82 (221)
                      ..++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++||+.+.......        ......++..|
T Consensus        96 ~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (314)
T cd08216          96 EGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW  174 (314)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccc
Confidence            4578899999999999999999998 99999999999999999999999999875432111        11223445679


Q ss_pred             cCcccchhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc--------------------
Q 048055           83 KAPECREIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE--------------------  141 (221)
Q Consensus        83 ~~pe~~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------  141 (221)
                      ++||.+... ..++.++|+||+|+++|++++|..||.....     ..............                    
T Consensus       175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
T cd08216         175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS  249 (314)
T ss_pred             cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence            999987532 3467889999999999999999999964311     11111111000000                    


Q ss_pred             ---cCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          142 ---SGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       142 ---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                         ..................+.+++.+||+.||++|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               0000000111122233568899999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=1.1e-24  Score=177.85  Aligned_cols=167  Identities=19%  Similarity=0.262  Sum_probs=115.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--------CCCCCCCCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--------VEEPSATSLF   81 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~   81 (221)
                      .+.+++..++.++.|++.||.|||+. +++|+||||.||+++.++.+++.||+.........        ......++..
T Consensus        95 ~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (327)
T cd08227          95 MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP  173 (327)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceec
Confidence            34589999999999999999999998 99999999999999999999999997643221111        0112234566


Q ss_pred             ccCcccchhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc-------------------
Q 048055           82 YKAPECREIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE-------------------  141 (221)
Q Consensus        82 ~~~pe~~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------  141 (221)
                      |+|||.+... ..++.++|+|||||++|++++|..||......      ............                   
T Consensus       174 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T cd08227         174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT------QMLLEKLNGTVPCLLDTTTIPAEELTMKPSR  247 (327)
T ss_pred             ccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh------HHHHHHhcCCccccccccchhhhhcccCCcc
Confidence            9999987632 35678999999999999999999999642211      000000000000                   


Q ss_pred             -----------------cCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          142 -----------------SGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       142 -----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                                       ..................+.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         248 SGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                             000000001111123346899999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.92  E-value=4e-25  Score=176.71  Aligned_cols=160  Identities=20%  Similarity=0.217  Sum_probs=119.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||++....... .....++..|++||.+.
T Consensus        91 ~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  168 (279)
T cd05633          91 HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  168 (279)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhc
Confidence            45689999999999999999999998 99999999999999999999999999885433222 22345788899999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .+..++.++|+||+|+++|++++|..||......   . .......   .......      .+......+.+++.+||+
T Consensus       169 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~-~~~~~~~---~~~~~~~------~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---D-KHEIDRM---TLTVNVE------LPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc---C-HHHHHHH---hhcCCcC------CccccCHHHHHHHHHHhc
Confidence            3455678999999999999999999999643211   1 1111111   1111111      111223468999999999


Q ss_pred             CCCCCCC-----CHHHHHHH
Q 048055          170 LAPENRP-----VMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~~  184 (221)
                      .||.+||     ++.++++.
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhC
Confidence            9999999     58887663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.92  E-value=1.8e-24  Score=172.93  Aligned_cols=168  Identities=17%  Similarity=0.183  Sum_probs=117.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+
T Consensus        94 ~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  172 (284)
T cd07860          94 LSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL  172 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEE
Confidence            45789999999999999999999998 99999999999999999999999999986543221 22233456789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh-----------------hccCCCCC-CCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE-----------------TESGDDPP-SSN  150 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~-~~~  150 (221)
                      ......+.++|+||||+++|++++|..||......     ...........                 ........ ...
T Consensus       173 ~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (284)
T cd07860         173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-----DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFS  247 (284)
T ss_pred             ecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHH
Confidence            63344578899999999999999999999642110     01000000000                 00000000 000


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .........+.+++.+||+.||.+||++.++++
T Consensus       248 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         248 KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000112245789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=9.3e-25  Score=174.56  Aligned_cols=167  Identities=23%  Similarity=0.314  Sum_probs=120.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      +++++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++++|||.+.......  ......++..|++||.+
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  172 (286)
T cd07832          94 RPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL  172 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceee
Confidence            6789999999999999999999998 99999999999999999999999999886554332  23344667789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc---------------cCCCCCCC----
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE---------------SGDDPPSS----  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~----  149 (221)
                      .....++.++|+||+|+++|++++|.++|.....     . ............               .....+..    
T Consensus       173 ~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (286)
T cd07832         173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-----I-EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIP  246 (286)
T ss_pred             eccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-----H-HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcch
Confidence            5344567899999999999999999888753211     1 111111000000               00000000    


Q ss_pred             -ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 -NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 -~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                       ....+.....+.+++.+||+.+|++||++++++..
T Consensus       247 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         247 LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             01111223679999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.4e-25  Score=181.76  Aligned_cols=159  Identities=20%  Similarity=0.204  Sum_probs=117.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......                  
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (364)
T cd05599          95 KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD  173 (364)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccc
Confidence            45689999999999999999999998 99999999999999999999999999876432110                  


Q ss_pred             ---------------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHH
Q 048055           72 ---------------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPR  130 (221)
Q Consensus        72 ---------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~  130 (221)
                                           ......+++.|+|||.+. ...++.++|+|||||++|+|++|..||....      ...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~------~~~  246 (364)
T cd05599         174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPPFCSDN------PQE  246 (364)
T ss_pred             cccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCCCCCCCCC------HHH
Confidence                                 001235788999999876 5677899999999999999999999996432      112


Q ss_pred             HHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048055          131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV---MREVSK  183 (221)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~~l~~  183 (221)
                      ....+.....  ....+.....+    ..+.+++.+|+. +|.+|++   +.++++
T Consensus       247 ~~~~i~~~~~--~~~~~~~~~~s----~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         247 TYRKIINWKE--TLQFPDEVPLS----PEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHHHcCCC--ccCCCCCCCCC----HHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            2222211110  01111111122    357889999996 9999997   888865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1e-24  Score=163.78  Aligned_cols=157  Identities=23%  Similarity=0.314  Sum_probs=127.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      -.++++...+..++.|++.||.|+|.. +++|||+||+|+|++..+.+|++|||.+.... .....+..||..|++||+.
T Consensus       117 ~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv  194 (281)
T KOG0580|consen  117 RMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMV  194 (281)
T ss_pred             ccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhc
Confidence            356788899999999999999999998 99999999999999999999999999985443 4445677899999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +......+|+|++|++.||++.|.+||....      ...-+.++.......+.          .......+++.+|+
T Consensus       195 ~-~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~------~~etYkrI~k~~~~~p~----------~is~~a~dlI~~ll  257 (281)
T KOG0580|consen  195 E-GRGHDKFVDLWSLGVLCYEFLVGLPPFESQS------HSETYKRIRKVDLKFPS----------TISGGAADLISRLL  257 (281)
T ss_pred             C-CCCccchhhHHHHHHHHHHHHhcCCchhhhh------hHHHHHHHHHccccCCc----------ccChhHHHHHHHHh
Confidence            7 6777899999999999999999999997532      22333444443333221          11235899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      .++|.+|.+..|++..
T Consensus       258 ~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  258 VKNPIERLALTEVMDH  273 (281)
T ss_pred             ccCccccccHHHHhhh
Confidence            9999999999998754

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.92  E-value=7.9e-25  Score=175.88  Aligned_cols=166  Identities=22%  Similarity=0.232  Sum_probs=118.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++...... .......++..|++||.+.
T Consensus       101 ~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         101 QPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL  179 (293)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhc
Confidence            3689999999999999999999998 9999999999999999999999999988655433 2223345567899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-----------ccC-------CCCC--C-
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-----------ESG-------DDPP--S-  148 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-------~~~~--~-  148 (221)
                      .....+.++|+||+|+++|++++|..||......      ....++.....           ...       ....  . 
T Consensus       180 ~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (293)
T cd07843         180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI------DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL  253 (293)
T ss_pred             CCccccchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhh
Confidence            3344578899999999999999999999643211      11111100000           000       0000  0 


Q ss_pred             CChhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEE-KLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~-~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ....... ....+.+++.+||+.+|++|||+.|++.
T Consensus       254 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         254 RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000000 2346889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=7.2e-25  Score=176.74  Aligned_cols=158  Identities=21%  Similarity=0.374  Sum_probs=118.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++....... ......++..|++||.+.
T Consensus       110 ~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (297)
T cd06656         110 TCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  188 (297)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHc
Confidence            4578889999999999999999998 99999999999999999999999999886543322 122345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|++++|..||......      ......   ...  ..+.  ...+......+.+++.+||+
T Consensus       189 -~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~------~~~~~~---~~~--~~~~--~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         189 -RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLI---ATN--GTPE--LQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             -CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc------hheeee---ccC--CCCC--CCCccccCHHHHHHHHHHcc
Confidence             566788999999999999999999999642111      000000   000  0000  11112233468899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|++||++.++++
T Consensus       255 ~~p~~Rps~~~il~  268 (297)
T cd06656         255 MDVDRRGSAKELLQ  268 (297)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=6.1e-25  Score=180.16  Aligned_cols=180  Identities=23%  Similarity=0.288  Sum_probs=124.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++...... .......++..|++||.+
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (337)
T cd07858         102 SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL  180 (337)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHH
Confidence            46789999999999999999999998 9999999999999999999999999998655432 222334567789999976


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHH-----HhhhhhhccCCCC-CCCChhh
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVR-----SVREEETESGDDP-PSSNEAS  153 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~  153 (221)
                      .....++.++|+||||+++|++++|..||.......         +........     ............. +......
T Consensus       181 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (337)
T cd07858         181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF  260 (337)
T ss_pred             hcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHc
Confidence            533457889999999999999999999996421000         000000000     0000000000000 0001111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSRA  190 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~--L~~~~~  190 (221)
                      +.....+.+++.+||+.+|++||++.++++.  ++...+
T Consensus       261 ~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         261 PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             ccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            1234568999999999999999999999876  655443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.92  E-value=1.4e-24  Score=177.74  Aligned_cols=174  Identities=21%  Similarity=0.320  Sum_probs=121.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----CCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----EEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~   84 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+|+||.||+++.++.++|+|||++........     .....++..|++
T Consensus       101 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~  179 (334)
T cd07855         101 DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA  179 (334)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccC
Confidence            45689999999999999999999998 999999999999999999999999999865432211     123356778999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhh-----hccCCCCCCC-
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEE-----TESGDDPPSS-  149 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~-----~~~~~~~~~~-  149 (221)
                      ||.+.....++.++|+||||+++|++++|..||.......         +..............     .......... 
T Consensus       180 PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (334)
T cd07855         180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW  259 (334)
T ss_pred             hHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH
Confidence            9987533557889999999999999999999996431100         000000000000000     0000000000 


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .......+..+.+++.+||+.+|.+||++.+++..
T Consensus       260 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         260 SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11112234579999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=1.9e-24  Score=171.33  Aligned_cols=162  Identities=18%  Similarity=0.284  Sum_probs=117.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|+|||.+
T Consensus       100 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  178 (267)
T cd06645         100 TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhh
Confidence            45689999999999999999999998 99999999999999999999999999976443221 12334567889999976


Q ss_pred             h--hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           89 E--IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        89 ~--~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .  ....++.++|+||+||++|++++|..||.....     ... ........ ...........    .+..+.+++.+
T Consensus       179 ~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-----~~~-~~~~~~~~-~~~~~~~~~~~----~~~~~~~li~~  247 (267)
T cd06645         179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-----MRA-LFLMTKSN-FQPPKLKDKMK----WSNSFHHFVKM  247 (267)
T ss_pred             ccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-----hhh-HHhhhccC-CCCCcccccCC----CCHHHHHHHHH
Confidence            3  123467899999999999999999999854211     001 11110100 00000010111    12358899999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.+|++||++.+|++
T Consensus       248 ~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         248 ALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HccCCchhCcCHHHHhc
Confidence            99999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-24  Score=173.97  Aligned_cols=167  Identities=19%  Similarity=0.208  Sum_probs=118.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+...... .......++..|++||.+.
T Consensus        94 ~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  172 (283)
T cd07835          94 TGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL  172 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceee
Confidence            4689999999999999999999998 9999999999999999999999999998654322 2223334567899999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhh--------------h----hccCCCCCCCCh
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE--------------E----TESGDDPPSSNE  151 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~----~~~~~~~~~~~~  151 (221)
                      ....++.++|+||||+++|++++|..||......     ..........              .    ............
T Consensus       173 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (283)
T cd07835         173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-----DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSK  247 (283)
T ss_pred             cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhh
Confidence            3345678899999999999999999999642110     0100000000              0    000000000111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ........+.+++.+||+.+|.+||++.++++
T Consensus       248 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         248 VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            11122246889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.92  E-value=8.5e-25  Score=174.94  Aligned_cols=167  Identities=19%  Similarity=0.247  Sum_probs=120.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...++...+..++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++.......  ......++..|++||.
T Consensus        94 ~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~  172 (288)
T cd07833          94 PGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL  172 (288)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCch
Confidence            35589999999999999999999998 99999999999999999999999999986554332  2233456678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh---------------hhhccCCCCCCCC--
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE---------------EETESGDDPPSSN--  150 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~--  150 (221)
                      +.....++.++|+||||+++|++++|..||.....      .........               .........+...  
T Consensus       173 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (288)
T cd07833         173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD------IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQP  246 (288)
T ss_pred             hcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCc
Confidence            87333778899999999999999999999964211      111111000               0000000000000  


Q ss_pred             -----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 -----EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 -----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                           ......+..+.+++.+||+.+|++||++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         247 ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                 011112457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.92  E-value=1e-24  Score=172.90  Aligned_cols=157  Identities=19%  Similarity=0.327  Sum_probs=115.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .+.++...++.++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.......    ......++..|+||
T Consensus       100 ~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         100 YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCH
Confidence            34688999999999999999999998 99999999999999999999999999986443211    11223466789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++|+||+|+++|++++|+.||....     .... .....    .....+.    .+......+.+++ 
T Consensus       179 E~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-----~~~~-~~~~~----~~~~~~~----~~~~~~~~~~~li-  242 (266)
T cd06651         179 EVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-----AMAA-IFKIA----TQPTNPQ----LPSHISEHARDFL-  242 (266)
T ss_pred             HHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccc-----hHHH-HHHHh----cCCCCCC----CchhcCHHHHHHH-
Confidence            9886 5667889999999999999999999996421     1111 11111    0111111    1112224567777 


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      .||..+|++||++.+|++
T Consensus       243 ~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         243 GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHhcCChhhCcCHHHHhc
Confidence            688899999999999965

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=5.3e-24  Score=170.46  Aligned_cols=162  Identities=18%  Similarity=0.274  Sum_probs=118.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.|++.||.|||+..+++|+||+|.||+++.++.++++|||.+....... .....++..|++||.+.
T Consensus        96 ~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  174 (286)
T cd06622          96 TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIK  174 (286)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhc
Confidence            34789999999999999999999964489999999999999999999999999886543221 22345667899999864


Q ss_pred             hc-----CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           90 IW-----KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        90 ~~-----~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ..     ..++.++|+|||||++|++++|..||....      .......+.........  .    ........+.+++
T Consensus       175 ~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~li  242 (286)
T cd06622         175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET------YANIFAQLSAIVDGDPP--T----LPSGYSDDAQDFV  242 (286)
T ss_pred             CCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc------hhhHHHHHHHHhhcCCC--C----CCcccCHHHHHHH
Confidence            22     124678999999999999999999996421      11111111111111111  1    1112335689999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+||+.+|.+||++.+++..
T Consensus       243 ~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         243 AKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHHcccCcccCCCHHHHhcC
Confidence            99999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.92  E-value=1e-24  Score=174.13  Aligned_cols=168  Identities=21%  Similarity=0.356  Sum_probs=133.0

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      +.+.++-.+...++.|++.|++|||++ +++|.||.++|++++..-.+|++|=.+++...+..   .......+..||++
T Consensus       389 ~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  389 YAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             cccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCH
Confidence            456677788889999999999999998 99999999999999999999999988877554432   11233446789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++..+|+||||+++||+++ |+.||.+..+.      ++..-+.     .+++...+..|+    +++..+|
T Consensus       468 Eal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------Em~~ylk-----dGyRlaQP~NCP----DeLf~vM  531 (563)
T KOG1024|consen  468 EALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------EMEHYLK-----DGYRLAQPFNCP----DELFTVM  531 (563)
T ss_pred             HHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------HHHHHHh-----ccceecCCCCCc----HHHHHHH
Confidence            9987 7888999999999999999998 99999754322      1111121     233444444444    4699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      ..||...|++||++.+++.-|+++....+
T Consensus       532 acCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  532 ACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             HHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999886543

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.5e-24  Score=172.79  Aligned_cols=158  Identities=25%  Similarity=0.409  Sum_probs=119.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+.
T Consensus        96 ~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (277)
T cd06917          96 GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT  174 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhc
Confidence            4789999999999999999999998 99999999999999999999999999986554332 223345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .+..++.++|+||||+++|++++|..||....      ..........      ..++....  ......+.+++.+||+
T Consensus       175 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~------~~~~~~~~~~------~~~~~~~~--~~~~~~~~~~i~~~l~  240 (277)
T cd06917         175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVD------AFRAMMLIPK------SKPPRLED--NGYSKLLREFVAACLD  240 (277)
T ss_pred             cCCccccchhHHHHHHHHHHHHhCCCCCCCCC------hhhhhhcccc------CCCCCCCc--ccCCHHHHHHHHHHcC
Confidence            44556789999999999999999999996421      1111111100      01111000  0123469999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+||++.+++.
T Consensus       241 ~~p~~R~~~~~il~  254 (277)
T cd06917         241 EEPKERLSAEELLK  254 (277)
T ss_pred             CCcccCcCHHHHhh
Confidence            99999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.92  E-value=1.2e-24  Score=173.41  Aligned_cols=157  Identities=26%  Similarity=0.414  Sum_probs=119.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++++|||++....... ......++..|++||.+.
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (277)
T cd06642          96 GPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK  174 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhC
Confidence            5688999999999999999999998 99999999999999999999999999986544322 112234667899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|++++|..||......      ........      ...+.   ........+.+++.+||+
T Consensus       175 -~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~~~------~~~~~---~~~~~~~~~~~li~~~l~  238 (277)
T cd06642         175 -QSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFLIPK------NSPPT---LEGQYSKPFKEFVEACLN  238 (277)
T ss_pred             -cCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhhhhc------CCCCC---CCcccCHHHHHHHHHHcc
Confidence             566788999999999999999999998642111      11111100      00111   111223468999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|++||++.++++.
T Consensus       239 ~~p~~Rp~~~~il~~  253 (277)
T cd06642         239 KDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCcCHHHHHHh
Confidence            999999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.8e-24  Score=172.71  Aligned_cols=161  Identities=20%  Similarity=0.320  Sum_probs=118.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ++.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|++||.+
T Consensus        97 ~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~  175 (280)
T cd06611          97 ERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV  175 (280)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHH
Confidence            45789999999999999999999998 99999999999999999999999999875433221 12233567789999976


Q ss_pred             hh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ..    ...++.++|+||||+++|++++|..||....      .......+...   .......+.    .....+.+++
T Consensus       176 ~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~li  242 (280)
T cd06611         176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN------PMRVLLKILKS---EPPTLDQPS----KWSSSFNDFL  242 (280)
T ss_pred             hhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC------HHHHHHHHhcC---CCCCcCCcc----cCCHHHHHHH
Confidence            41    2345678999999999999999999996421      11212222111   111111111    1224588999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+||+.+|.+||++.++++.
T Consensus       243 ~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         243 KSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHhccChhhCcCHHHHhcC
Confidence            99999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.92  E-value=1.3e-24  Score=171.97  Aligned_cols=161  Identities=22%  Similarity=0.324  Sum_probs=119.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++...+..++.|++.||+|||+ . +++|+|++|.||+++.++.++|+|||.+......... ...++..|++||.+.
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~  172 (265)
T cd06605          95 GRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQ  172 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHc
Confidence            678899999999999999999999 7 9999999999999999999999999987544322211 255667899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|++++|..||...... ..............     ..+.....   .....+.+++.+||.
T Consensus       173 -~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~li~~~l~  242 (265)
T cd06605         173 -GNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNE-----PPPRLPSG---KFSPDFQDFVNLCLI  242 (265)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcC-----CCCCCChh---hcCHHHHHHHHHHcC
Confidence             567788999999999999999999999643211 01111111111111     11111111   133468999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|.+||++.+++.
T Consensus       243 ~~p~~Rpt~~~ll~  256 (265)
T cd06605         243 KDPRERPSYKELLE  256 (265)
T ss_pred             CCchhCcCHHHHhh
Confidence            99999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.92  E-value=3e-25  Score=176.26  Aligned_cols=172  Identities=22%  Similarity=0.284  Sum_probs=123.9

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc--------------------CCCceEEeccCCcccc
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG--------------------ADFESCLTDYGLGSFR   67 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~--------------------~~~~~~l~dfg~~~~~   67 (221)
                      .+..++++.++..++.|++.+++|||+. +++|-|+||+|||+.                    .+..++++|||.+...
T Consensus       184 N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~  262 (415)
T KOG0671|consen  184 NNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD  262 (415)
T ss_pred             CCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee
Confidence            3567899999999999999999999998 999999999999984                    1345789999998765


Q ss_pred             CCCCCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC---------CChHHHHHHhhhh
Q 048055           68 NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG---------SDIPRWVRSVREE  138 (221)
Q Consensus        68 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~---------~~~~~~~~~~~~~  138 (221)
                      ....  +....|..|+|||.+. +..++.++||||+||+++|+.+|...|+...+...         .....++.+....
T Consensus       263 ~e~h--s~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~  339 (415)
T KOG0671|consen  263 HEHH--STIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKE  339 (415)
T ss_pred             ccCc--ceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhH
Confidence            5443  4556678899999997 89999999999999999999999999974321100         0001111111000


Q ss_pred             hhccCCC------------------CCCC---ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          139 ETESGDD------------------PPSS---NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       139 ~~~~~~~------------------~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .......                  +.+.   ..+.+.+...|.+|+.+||..||.+|+|++|++.
T Consensus       340 Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  340 KYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            0000000                  0000   1122344557999999999999999999999864

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=2.4e-24  Score=170.59  Aligned_cols=158  Identities=20%  Similarity=0.332  Sum_probs=118.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-------CCCCCCCCCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-------SVEEPSATSLFYK   83 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~~   83 (221)
                      .+++...+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++......       .......++..|+
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (265)
T cd06631          97 GPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM  175 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCcccc
Confidence            5688999999999999999999998 9999999999999999999999999987643211       1112345677899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +||.+. +..++.++|+||||+++|++++|..||....     .... ......   .....+.....    ....+.++
T Consensus       176 ~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~-~~~~~~---~~~~~~~~~~~----~~~~~~~~  241 (265)
T cd06631         176 APEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMD-----RLAA-MFYIGA---HRGLMPRLPDS----FSAAAIDF  241 (265)
T ss_pred             Chhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCC-----hHHH-HHHhhh---ccCCCCCCCCC----CCHHHHHH
Confidence            999886 5667889999999999999999999996421     1111 111111   10111111112    23468999


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.+||+.+|.+||++.++++
T Consensus       242 i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         242 VTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-24  Score=178.82  Aligned_cols=157  Identities=22%  Similarity=0.317  Sum_probs=126.9

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC----CceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD----FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ++...+..++.||+.++.|||+. |++|||+||+|+|+...    +.++++|||++.............|++.|+|||.+
T Consensus       132 ~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl  210 (382)
T KOG0032|consen  132 YSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVL  210 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhh
Confidence            89999999999999999999998 99999999999999654    47999999999887776566778999999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...++..+|+||+|+++|.|++|.+||.+....     .... .+....    ....  .+..+.....+.+++..++
T Consensus       211 ~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----~~~~-~i~~~~----~~f~--~~~w~~is~~akd~i~~ll  277 (382)
T KOG0032|consen  211 G-GRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----EIFL-AILRGD----FDFT--SEPWDDISESAKDFIRKLL  277 (382)
T ss_pred             c-CCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----HHHH-HHHcCC----CCCC--CCCccccCHHHHHHHHHhc
Confidence            6 688899999999999999999999999864321     1111 111111    1111  2223334467999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      ..||.+|+++.++++
T Consensus       278 ~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  278 EFDPRKRLTAAQALQ  292 (382)
T ss_pred             ccCcccCCCHHHHhc
Confidence            999999999999988

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.92  E-value=2e-24  Score=174.66  Aligned_cols=167  Identities=17%  Similarity=0.199  Sum_probs=117.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC------------CCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE------------EPSA   77 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~   77 (221)
                      ...+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.........            ....
T Consensus       109 ~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (311)
T cd07866         109 SVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV  187 (311)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccce
Confidence            45789999999999999999999998 9999999999999999999999999988643322111            1123


Q ss_pred             CCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-----------------
Q 048055           78 TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-----------------  140 (221)
Q Consensus        78 ~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------  140 (221)
                      ++..|+|||.+.....++.++|+||||+++|++++|..||.....      ......+.....                 
T Consensus       188 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (311)
T cd07866         188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD------IDQLHLIFKLCGTPTEETWPGWRSLPGCE  261 (311)
T ss_pred             eccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChhhchhhhhccccc
Confidence            456799999875444568889999999999999999999964221      111111110000                 


Q ss_pred             --c-cCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          141 --E-SGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       141 --~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        . ....++............+.+++.+||+.||.+|||+.+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         262 GVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence              0 000000000001112246889999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=4.3e-24  Score=171.23  Aligned_cols=167  Identities=23%  Similarity=0.301  Sum_probs=120.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...++...+..++.|++.||+|||+. +++|+|+++.||+++.++.++++|||++....... .....++..|++||.+.
T Consensus        99 ~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~  176 (287)
T cd06621          99 GGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQ  176 (287)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhc
Confidence            45578889999999999999999998 99999999999999999999999999975443222 12334567899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|++|+++|++++|..||....... .....................+   .........+.+++.+||+
T Consensus       177 -~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~  251 (287)
T cd06621         177 -GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMPNPELKDEP---GNGIKWSEEFKDFIKQCLE  251 (287)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCCchhhccCC---CCCCchHHHHHHHHHHHcC
Confidence             5677889999999999999999999997542211 1111111111110100000001   0001123468999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|.+|||+.|+++
T Consensus       252 ~~p~~Rpt~~eil~  265 (287)
T cd06621         252 KDPTRRPTPWDMLE  265 (287)
T ss_pred             CCcccCCCHHHHHh
Confidence            99999999999976

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2e-24  Score=176.34  Aligned_cols=174  Identities=20%  Similarity=0.268  Sum_probs=125.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      ..++++..++.++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|++|
T Consensus        97 ~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834          97 PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCc
Confidence            34789999999999999999999998 99999999999999999999999999987654432    12334567789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc---------------------cCC
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE---------------------SGD  144 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~  144 (221)
                      |.+......+.++|+||+|+++|++++|..||.....      ......+......                     ...
T Consensus       176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (330)
T cd07834         176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY------IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKK  249 (330)
T ss_pred             eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH------HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccC
Confidence            9887333678899999999999999999999964321      1111111100000                     000


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHH
Q 048055          145 DPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSRA  190 (221)
Q Consensus       145 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~--L~~~~~  190 (221)
                      .........+..+..+.+++.+||+.+|.+||++.++++.  +++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         250 PKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             CcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            0000000111123568999999999999999999999874  555554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.92  E-value=8.6e-26  Score=175.11  Aligned_cols=159  Identities=24%  Similarity=0.374  Sum_probs=132.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +++|+.+.+..++..-+.||.|||.. .-+|||||+.|||+..+|..|++|||.+...... ....+..||++|+|||++
T Consensus       123 ~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI  201 (502)
T KOG0574|consen  123 RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI  201 (502)
T ss_pred             cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHH
Confidence            68999999999999999999999998 7789999999999999999999999998544322 233567899999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . .-.|..++||||||++..||..|++||.+..+.             ......+..+|+...-+++....+-++++.||
T Consensus       202 ~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------------RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  202 E-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------------RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             H-HhccchhhhHhhhcchhhhhhcCCCCccccccc-------------ceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            7 788899999999999999999999999865332             11223344555555566677778999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      .+.|++|-|+.++++
T Consensus       268 iK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  268 IKKPEERKTALRLCE  282 (502)
T ss_pred             cCCHHHHHHHHHHhh
Confidence            999999999998853

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.92  E-value=1.7e-24  Score=175.49  Aligned_cols=172  Identities=18%  Similarity=0.211  Sum_probs=119.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC----CCceEEeccCCccccCCCCC----CCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA----DFESCLTDYGLGSFRNPDSV----EEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~----~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~   82 (221)
                      ..++...+..++.||+.||.|||+. +++|+||+|.||+++.    ++.++++|||++........    .....++..|
T Consensus       103 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y  181 (316)
T cd07842         103 VSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY  181 (316)
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence            4788999999999999999999998 9999999999999999    99999999999865433221    1223456779


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc---------------------
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE---------------------  141 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------  141 (221)
                      +|||.+.....++.++|+||||+++|++++|..||.................+......                     
T Consensus       182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (316)
T cd07842         182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL  261 (316)
T ss_pred             cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence            99998763455688999999999999999999999754332211111000000000000                     


Q ss_pred             --cCCCCCCC-ChhhH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          142 --SGDDPPSS-NEASE------EKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       142 --~~~~~~~~-~~~~~------~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        ........ .....      .....+.+++.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              00000000 00000      12246899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.92  E-value=2.2e-24  Score=172.08  Aligned_cols=157  Identities=24%  Similarity=0.393  Sum_probs=120.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~pe~~~   89 (221)
                      .+++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++........ .....++..|++||.+.
T Consensus        96 ~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~  174 (277)
T cd06640          96 GPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ  174 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhc
Confidence            4678899999999999999999998 999999999999999999999999999865433221 22334567899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +...+.++|+||||+++|++++|..||.....      .......     .... +   .......+..+.+++.+||+
T Consensus       175 -~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~------~~~~~~~-----~~~~-~---~~~~~~~~~~~~~li~~~l~  238 (277)
T cd06640         175 -QSAYDSKADIWSLGITAIELAKGEPPNSDMHP------MRVLFLI-----PKNN-P---PTLTGEFSKPFKEFIDACLN  238 (277)
T ss_pred             -cCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh------HhHhhhh-----hcCC-C---CCCchhhhHHHHHHHHHHcc
Confidence             56678899999999999999999999964211      1111111     0000 1   11222345679999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|++||++.++++.
T Consensus       239 ~~p~~Rp~~~~il~~  253 (277)
T cd06640         239 KDPSFRPTAKELLKH  253 (277)
T ss_pred             cCcccCcCHHHHHhC
Confidence            999999999999755

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.92  E-value=1.6e-24  Score=173.22  Aligned_cols=166  Identities=20%  Similarity=0.308  Sum_probs=118.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..++.++.||+.||+|||+. +++|+|++|.||+++.++.++++|||++...... .......++..|++||.+.
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07846          95 NGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV  173 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhc
Confidence            4589999999999999999999998 9999999999999999999999999998654322 2223345677899999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh---------------hhhccCCCCCCC-----
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE---------------EETESGDDPPSS-----  149 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~-----  149 (221)
                      .....+.++|+||||+++|++++|..||.....     . ........               .........+..     
T Consensus       174 ~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (286)
T cd07846         174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----I-DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEP  247 (286)
T ss_pred             cccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----H-HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcch
Confidence            345567889999999999999999999863211     0 00000000               000000000000     


Q ss_pred             -ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 -NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 -~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       ....+..+..+.+++.+||+.+|++||++.++++
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         248 LEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0001122356999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.92  E-value=3.6e-24  Score=171.08  Aligned_cols=159  Identities=21%  Similarity=0.214  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++...... ......++..|++||.+.
T Consensus        91 ~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~  168 (278)
T cd05606          91 HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQ  168 (278)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhc
Confidence            45689999999999999999999998 9999999999999999999999999998644322 223346778899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .+..++.++|+||+|+++|++++|..||......   ......... .   ......+  ..    ....+.+++.+||.
T Consensus       169 ~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~---~~~~~~~~~-~---~~~~~~~--~~----~s~~~~~li~~~l~  235 (278)
T cd05606         169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMT-L---TMAVELP--DS----FSPELRSLLEGLLQ  235 (278)
T ss_pred             CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc---chHHHHHHh-h---ccCCCCC--Cc----CCHHHHHHHHHHhh
Confidence            4445788899999999999999999999653211   111111111 0   0011111  11    12469999999999


Q ss_pred             CCCCCCC-----CHHHHHH
Q 048055          170 LAPENRP-----VMREVSK  183 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~  183 (221)
                      .+|.+||     ++.++++
T Consensus       236 ~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         236 RDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCHHhccCCCCCCHHHHHh
Confidence            9999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.92  E-value=5.9e-24  Score=172.07  Aligned_cols=157  Identities=25%  Similarity=0.394  Sum_probs=118.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++......   ....++..|++||.+.
T Consensus       109 ~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~  184 (307)
T cd06607         109 KKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVIL  184 (307)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeee
Confidence            34689999999999999999999998 9999999999999999999999999988654322   2335667899999763


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ...++.++|+||||+++|++++|..||....      ..........      ...+.  .........+.+++.+|
T Consensus       185 ~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~~~~------~~~~~--~~~~~~~~~~~~li~~~  250 (307)
T cd06607         185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQ------NDSPT--LSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHhc------CCCCC--CCchhhCHHHHHHHHHH
Confidence            1  2446789999999999999999999986421      1111111110      01111  01112345699999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |+.+|.+||++.+|+..
T Consensus       251 l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         251 LQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hcCChhhCcCHHHHhcC
Confidence            99999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.92  E-value=1.7e-24  Score=192.19  Aligned_cols=154  Identities=22%  Similarity=0.373  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-------------------CCCCCCC
Q 048055           15 WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-------------------PDSVEEP   75 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-------------------~~~~~~~   75 (221)
                      ....++++++|++||+|+|+. |++|||+||.||+++.+..+||+|||++....                   .....+.
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~-giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts  774 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQ-GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS  774 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhC-ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence            678899999999999999998 99999999999999999999999999987511                   0112345


Q ss_pred             CCCCccccCcccchhcC--CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhh
Q 048055           76 SATSLFYKAPECREIWK--QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS  153 (221)
Q Consensus        76 ~~~~~~~~~pe~~~~~~--~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (221)
                      ..||..|+|||.+....  .|+.|.|+||||++++||+.   ||..     .+.-...+..++.......      ....
T Consensus       775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~LR~g~iP~~------~~f~  840 (1351)
T KOG1035|consen  775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTNLRKGSIPEP------ADFF  840 (1351)
T ss_pred             ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHhcccCCCCCC------cccc
Confidence            67888899999887444  58999999999999999973   3542     3333444444543332222      1111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ......-..+|+++++.||.+|||+.|++.
T Consensus       841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  841 DPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            112233578999999999999999999963

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=3.1e-24  Score=173.87  Aligned_cols=167  Identities=21%  Similarity=0.310  Sum_probs=118.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+..++.|++.||.|||+..+++|+|++|.||+++.++.++++|||++...... ......++..|++||.+. 
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~-  171 (308)
T cd06615          94 GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ-  171 (308)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhc-
Confidence            568899999999999999999997338999999999999999999999999987644322 123345677899999875 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh---------------------------ccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET---------------------------ESG  143 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~  143 (221)
                      +..++.++|+||||+++|++++|..||......   ..............                           ...
T Consensus       172 ~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (308)
T cd06615         172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN  248 (308)
T ss_pred             CCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhc
Confidence            566788999999999999999999998532110   00000000000000                           000


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       144 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ...+..  ........+.+++.+||+.+|++||++.++++.
T Consensus       249 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         249 EPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000  000123458999999999999999999999765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.92  E-value=4.7e-24  Score=172.36  Aligned_cols=169  Identities=20%  Similarity=0.235  Sum_probs=116.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----CCCCCCCccccCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----EEPSATSLFYKAP   85 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~p   85 (221)
                      ..+++..++.++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++........     .....++..|+||
T Consensus       114 ~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         114 VKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCc
Confidence            3689999999999999999999998 999999999999999999999999999865432211     1223456679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh----cc--------CCCCCCC-C-h
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET----ES--------GDDPPSS-N-E  151 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~--------~~~~~~~-~-~  151 (221)
                      |.+......+.++|+||||+++|++++|..||......   ........+.....    ..        ....+.. . .
T Consensus       193 E~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (310)
T cd07865         193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRK  269 (310)
T ss_pred             HHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchh
Confidence            98753344678899999999999999999998643211   00000111100000    00        0000000 0 0


Q ss_pred             hh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 AS-----EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..     ......+.+++.+||+.||++||+++++++
T Consensus       270 ~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         270 VKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00     001235789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.92  E-value=2.7e-24  Score=171.74  Aligned_cols=166  Identities=23%  Similarity=0.285  Sum_probs=119.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.||+.||+|||.. +++|+|++|.||+++.++.++++|||++.......  ......++..|++||.+
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~  173 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL  173 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceee
Confidence            5789999999999999999999998 99999999999999999999999999986554332  12233456779999976


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-----------------CCCCCC--
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-----------------DDPPSS--  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~--  149 (221)
                      .....++.++|+||||+++|++++|..||.....      ......+........                 ......  
T Consensus       174 ~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (287)
T cd07840         174 LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE------LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRR  247 (287)
T ss_pred             EccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhH
Confidence            5334567899999999999999999999964321      111111111000000                 000000  


Q ss_pred             -ChhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 -NEASEE-KLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 -~~~~~~-~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       ...... ....+.+++.+||+.+|.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         248 LREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             000001 1457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.92  E-value=2.6e-24  Score=176.08  Aligned_cols=174  Identities=23%  Similarity=0.318  Sum_probs=119.4

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----CCCCCCCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----EEPSATSLFYK   83 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~   83 (221)
                      ..+++++..+..++.||+.||.|||.. +++|+|+||.||+++.++.++|+|||++........     .....++..|+
T Consensus        98 ~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~  176 (332)
T cd07857          98 SGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR  176 (332)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCcccc
Confidence            356789999999999999999999998 999999999999999999999999999865432211     12235677899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhhh-----ccCCCC-CC
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEET-----ESGDDP-PS  148 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~-----~~~~~~-~~  148 (221)
                      +||.......++.++|+||+|+++|++++|..||.......         +.........+.....     .....+ ..
T Consensus       177 aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (332)
T cd07857         177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKP  256 (332)
T ss_pred             CcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcc
Confidence            99976534566889999999999999999999986421100         0000000000000000     000000 00


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .....+.....+.+++.+||+.||.+|||+.+++.
T Consensus       257 ~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         257 FESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00011112346899999999999999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.92  E-value=2.6e-24  Score=178.58  Aligned_cols=161  Identities=20%  Similarity=0.213  Sum_probs=117.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++.......  ......+++.|+|||.+
T Consensus       137 ~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         137 YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHH
Confidence            3578889999999999999999998 99999999999999999999999999987553322  12345688999999987


Q ss_pred             hhc---CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIW---KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      ...   ..++.++|+||+||++|+|++|..||....      .......+......  ...+....    ....+.+++.
T Consensus       216 ~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~------~~~~~~~i~~~~~~--~~~p~~~~----~s~~~~~li~  283 (370)
T cd05621         216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS------LVGTYSKIMDHKNS--LNFPEDVE----ISKHAKNLIC  283 (370)
T ss_pred             hccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCcc--cCCCCccc----CCHHHHHHHH
Confidence            522   236789999999999999999999996431      22222222211110  11111111    1235788999


Q ss_pred             HcccCCCCC--CCCHHHHHHH
Q 048055          166 ACVSLAPEN--RPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~--Rps~~~l~~~  184 (221)
                      .|+..++.+  |+++.++++.
T Consensus       284 ~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         284 AFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHccCchhccCCCCHHHHhcC
Confidence            999755543  8899999765

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=2.5e-24  Score=175.98  Aligned_cols=199  Identities=21%  Similarity=0.372  Sum_probs=133.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++...+..++.|++.||.|||+. +++|+|++|.|++++.++.++++|||.+......  .....++..|++||.+.
T Consensus       102 ~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~  178 (328)
T cd07856         102 SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIML  178 (328)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeee
Confidence            34678888899999999999999998 9999999999999999999999999988643322  12334567899999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhh-----hccCC-CCCCCChhhH
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEE-----TESGD-DPPSSNEASE  154 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~  154 (221)
                      ....++.++|+||||+++|++++|..||.......         +.....+........     ..... ..........
T Consensus       179 ~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (328)
T cd07856         179 TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK  258 (328)
T ss_pred             ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcC
Confidence            33567889999999999999999999996422100         000001111000000     00000 0000000001


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHHHhhcCCCCCCCCCCCccccCCCCC
Q 048055          155 EKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSRAEAQMSSNSSDHSPGRWSDTVQSLP  214 (221)
Q Consensus       155 ~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~--L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (221)
                      .....+.+++.+||+.+|++||++.+++..  ++...+.   ...+-..+-++|++|+.-++
T Consensus       259 ~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  317 (328)
T cd07856         259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP---TDEPVAEEKFDWSFNDADLP  317 (328)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC---ccccCchhhcCCchhcccCC
Confidence            123569999999999999999999999765  3332222   22233445888999987664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=2.6e-24  Score=174.03  Aligned_cols=163  Identities=20%  Similarity=0.226  Sum_probs=119.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----------------CC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----------------VE   73 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----------------~~   73 (221)
                      .+++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||+++......                ..
T Consensus        95 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (305)
T cd05609          95 IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD  173 (305)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccc
Confidence            35689999999999999999999998 99999999999999999999999999876321100                00


Q ss_pred             CCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhh
Q 048055           74 EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS  153 (221)
Q Consensus        74 ~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (221)
                      ....++..|++||.+. ...++.++|+||||+++|++++|..||.+.      ...............   .+....   
T Consensus       174 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~------~~~~~~~~~~~~~~~---~~~~~~---  240 (305)
T cd05609         174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGD------TPEELFGQVISDDIE---WPEGDE---  240 (305)
T ss_pred             cCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcccC---CCCccc---
Confidence            1224566799999876 566788999999999999999999999632      222222222111111   111111   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~  187 (221)
                       ..+..+.+++.+||+.+|++||++..+.+.|+.
T Consensus       241 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         241 -ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             122458999999999999999997666655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.91  E-value=1.7e-24  Score=178.34  Aligned_cols=158  Identities=22%  Similarity=0.242  Sum_probs=118.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC------------------C-
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP------------------D-   70 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~------------------~-   70 (221)
                      .+.|+...+..++.+++.||..+|+. |++||||||+|+|++..|++||+|||++.....                  . 
T Consensus       235 ~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~  313 (550)
T KOG0605|consen  235 KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEA  313 (550)
T ss_pred             cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccC
Confidence            46789999999999999999999999 999999999999999999999999999752110                  0 


Q ss_pred             ----CC-----C--------------------CCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 048055           71 ----SV-----E--------------------EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLV  121 (221)
Q Consensus        71 ----~~-----~--------------------~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~  121 (221)
                          ..     .                    ....||+.|+|||++. +..|+..+|.|||||++|||+.|.+||... 
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~-  391 (550)
T KOG0605|consen  314 KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWWSLGCIMYEMLVGYPPFCSE-  391 (550)
T ss_pred             CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHHHHHHHHHHHHhCCCCCCCC-
Confidence                00     0                    1235788899999998 778999999999999999999999999642 


Q ss_pred             cccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 048055          122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV---MREVS  182 (221)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~~l~  182 (221)
                           +......++..-..  ....|.....+    ....+||.+|+. ||++|.-   +.||.
T Consensus       392 -----tp~~T~rkI~nwr~--~l~fP~~~~~s----~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  392 -----TPQETYRKIVNWRE--TLKFPEEVDLS----DEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             -----CHHHHHHHHHHHhh--hccCCCcCccc----HHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence                 22222222221111  11122222222    458999999999 9999974   66664

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=5.1e-24  Score=171.02  Aligned_cols=168  Identities=18%  Similarity=0.256  Sum_probs=117.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|++||.+
T Consensus        97 ~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  175 (291)
T cd07870          97 PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL  175 (291)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCcee
Confidence            34578888999999999999999998 9999999999999999999999999988643222 122333457789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhh---------------hhccCC----CCCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE---------------ETESGD----DPPSS  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~----~~~~~  149 (221)
                      .....++.++|+||||+++|++++|..||.....     ...........               ......    ..+..
T Consensus       176 ~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T cd07870         176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD-----VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQ  250 (291)
T ss_pred             ecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-----HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcc
Confidence            6334567889999999999999999999964321     11111111000               000000    00000


Q ss_pred             -Chhh--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 -NEAS--EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 -~~~~--~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       ....  ......+.+++.+|+..||.+|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         251 LRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             0000  001246889999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.91  E-value=5.1e-24  Score=166.57  Aligned_cols=158  Identities=25%  Similarity=0.426  Sum_probs=120.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +++++..+..++.|++.||.+||.. +++|+|++|.||+++.++.++|+|||.+.............++..|++||... 
T Consensus        93 ~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-  170 (253)
T cd05122          93 QTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN-  170 (253)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHc-
Confidence            5789999999999999999999998 99999999999999999999999999886654433233445677899999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ....+.++|+||||+++|++++|..||....      ..........   ......+....    ....+.+++.+||+.
T Consensus       171 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~i~~~l~~  237 (253)
T cd05122         171 GKPYDYKADIWSLGITAIELAEGKPPYSELP------PMKALFKIAT---NGPPGLRNPEK----WSDEFKDFLKKCLQK  237 (253)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHh---cCCCCcCcccc----cCHHHHHHHHHHccC
Confidence            4557889999999999999999999996421      1111111111   11111111111    134699999999999


Q ss_pred             CCCCCCCHHHHHH
Q 048055          171 APENRPVMREVSK  183 (221)
Q Consensus       171 dp~~Rps~~~l~~  183 (221)
                      ||.+|||+.++++
T Consensus       238 ~p~~R~t~~~~l~  250 (253)
T cd05122         238 NPEKRPTAEQLLK  250 (253)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.91  E-value=1.8e-24  Score=192.98  Aligned_cols=166  Identities=22%  Similarity=0.323  Sum_probs=122.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-------------------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-------------------   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------------------   71 (221)
                      ..+++..++.++.||+.||.|||+. +++||||||.||+++.++.++++|||+++......                   
T Consensus       108 ~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t  186 (932)
T PRK13184        108 EKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT  186 (932)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccc
Confidence            4567788899999999999999998 99999999999999999999999999986541100                   


Q ss_pred             CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCCh
Q 048055           72 VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNE  151 (221)
Q Consensus        72 ~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (221)
                      ......+++.|+|||.+. +..++.++|+||+||++|+|++|..||.....   ....   .   .............  
T Consensus       187 ~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~---~ki~---~---~~~i~~P~~~~p~--  254 (932)
T PRK13184        187 IPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKG---RKIS---Y---RDVILSPIEVAPY--  254 (932)
T ss_pred             cCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch---hhhh---h---hhhccChhhcccc--
Confidence            011235788999999876 66778999999999999999999999964211   1000   0   0000000000101  


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRP-VMREVSKMIRDSRAE  191 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~~l~~~L~~~~~~  191 (221)
                        ...+..+.+++.+||+.||.+|| ++.++++.|+.....
T Consensus       255 --~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        255 --REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             --ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence              12234688999999999999997 577888888887653

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=3.6e-24  Score=177.82  Aligned_cols=161  Identities=20%  Similarity=0.226  Sum_probs=116.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||++.......  ......+++.|+|||.+
T Consensus       137 ~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l  215 (371)
T cd05622         137 YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL  215 (371)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHH
Confidence            4578888999999999999999998 99999999999999999999999999987554322  12345678899999987


Q ss_pred             hhc---CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIW---KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      ...   ..++.++|+|||||++|+|++|..||...      ........+......  ...+.....    ...+.+++.
T Consensus       216 ~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~--~~~~~~~~~----s~~~~~li~  283 (371)
T cd05622         216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMNHKNS--LTFPDDNDI----SKEAKNLIC  283 (371)
T ss_pred             hccCCCccCCCccceeehhHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCc--ccCCCcCCC----CHHHHHHHH
Confidence            522   23678999999999999999999999642      222222222221111  111111122    235889999


Q ss_pred             HcccCCCCC--CCCHHHHHHH
Q 048055          166 ACVSLAPEN--RPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~--Rps~~~l~~~  184 (221)
                      +|+..++.+  |+++.++++.
T Consensus       284 ~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         284 AFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHcCChhhhcCCCCHHHHhcC
Confidence            999844433  6789998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=3.8e-24  Score=178.27  Aligned_cols=161  Identities=22%  Similarity=0.237  Sum_probs=114.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++......                  
T Consensus        95 ~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (381)
T cd05626          95 MEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP  173 (381)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCc
Confidence            35688899999999999999999998 99999999999999999999999999864321000                  


Q ss_pred             ------------------------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 048055           72 ------------------------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLV  121 (221)
Q Consensus        72 ------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~  121 (221)
                                                    ......++..|+|||.+. +..++.++|+|||||++|+|++|..||....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  252 (381)
T cd05626         174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             ccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhHHHHHHhCCCCCcCCC
Confidence                                          001235788999999886 5677889999999999999999999996432


Q ss_pred             cccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 048055          122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA--CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~Rps~~~l~~~  184 (221)
                      .      ......+.....  ....+.....+    ..+.+++.+  |+..++..|+++.+++..
T Consensus       253 ~------~~~~~~i~~~~~--~~~~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         253 P------TETQLKVINWEN--TLHIPPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             H------HHHHHHHHcccc--ccCCCCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1      111111111000  01111111122    347778877  455666679999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.91  E-value=7.8e-24  Score=167.24  Aligned_cols=160  Identities=24%  Similarity=0.355  Sum_probs=117.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC-----CCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE-----EPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~   84 (221)
                      +..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.........     ....++..|++
T Consensus        93 ~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T cd06626          93 GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA  171 (264)
T ss_pred             cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccC
Confidence            34578999999999999999999998 9999999999999999999999999998654332211     12345678999


Q ss_pred             cccchhcCC---CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           85 PECREIWKQ---PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        85 pe~~~~~~~---~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      ||.+. ...   ...++|+|+||+++|++++|..||....     ..........  . ......+...    .....+.
T Consensus       172 PE~~~-~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-----~~~~~~~~~~--~-~~~~~~~~~~----~~~~~~~  238 (264)
T cd06626         172 PEVIT-GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-----NEFQIMFHVG--A-GHKPPIPDSL----QLSPEGK  238 (264)
T ss_pred             hhhcc-CCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-----chHHHHHHHh--c-CCCCCCCccc----ccCHHHH
Confidence            99876 333   6789999999999999999999996421     1111111111  1 1111111111    1134578


Q ss_pred             HHHHHcccCCCCCCCCHHHHHH
Q 048055          162 NIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +++.+||+.+|.+||++.+++.
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhc
Confidence            9999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=2.9e-24  Score=176.54  Aligned_cols=170  Identities=23%  Similarity=0.353  Sum_probs=120.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||+++.....  .....++..|+|||.+..
T Consensus       112 ~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         112 HPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcC
Confidence            3689999999999999999999998 9999999999999999999999999998654221  223345677999998763


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh-------------------hccCCCCCCC--
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE-------------------TESGDDPPSS--  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~--  149 (221)
                      ...++.++|+||||+++|++++|+.||....      .......+....                   .......+..  
T Consensus       189 ~~~~~~~~Dv~slGvil~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (342)
T cd07879         189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDF  262 (342)
T ss_pred             ccccCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchH
Confidence            4557889999999999999999999996421      111111110000                   0000000000  


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSR  189 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~--L~~~~  189 (221)
                      ....+.....+.+++.+||+.||++||++.+++..  ++...
T Consensus       263 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         263 STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            00001122458899999999999999999999843  65554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.7e-24  Score=195.34  Aligned_cols=155  Identities=19%  Similarity=0.271  Sum_probs=109.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-------------------CCceEEeccCCccccCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-------------------DFESCLTDYGLGSFRNPD   70 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-------------------~~~~~l~dfg~~~~~~~~   70 (221)
                      .+.++...++.++.||+.||+|||+. +|+||||||.|||++.                   ++.++++|||+++.....
T Consensus        74 ~~~~~~~~~~~i~~qi~~al~~lH~~-gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~  152 (793)
T PLN00181         74 DRSVDAFECFHVFRQIVEIVNAAHSQ-GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEIL  152 (793)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhC-CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccc
Confidence            45689999999999999999999998 9999999999999954                   344566666665432100


Q ss_pred             C-----------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHH
Q 048055           71 S-----------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVR  133 (221)
Q Consensus        71 ~-----------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~  133 (221)
                      .                 ......+++.|+|||.+. +..++.++|||||||++|||++|..|+....        ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~  223 (793)
T PLN00181        153 SERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN-GSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMS  223 (793)
T ss_pred             cccchhhhhccccCCCcccccccCCCcceEChhhhc-cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHH
Confidence            0                 001124677899999886 6778999999999999999999888875311        0111


Q ss_pred             HhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          134 SVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+....     .++....    ......+++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~~-----~~~~~~~----~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        224 SLRHRV-----LPPQILL----NWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhh-----cChhhhh----cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            111110     1110000    1123568889999999999999999964

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.91  E-value=3.6e-24  Score=170.11  Aligned_cols=156  Identities=24%  Similarity=0.279  Sum_probs=117.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +++++..+..++.||+.||.|||+. +++|+|++|.||+++.++ .++++|||++......   ....++..|+|||.+.
T Consensus       104 ~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~  179 (267)
T PHA03390        104 GKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIK  179 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhc
Confidence            4889999999999999999999998 999999999999999998 9999999988654332   2235677899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+|+++|++++|..||...... ......+    .... ..  ..+...    .....+.+++.+||+
T Consensus       180 -~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~----~~~~-~~--~~~~~~----~~~~~~~~li~~~l~  246 (267)
T PHA03390        180 -GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESL----LKRQ-QK--KLPFIK----NVSKNANDFVQSMLK  246 (267)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHH----HHhh-cc--cCCccc----ccCHHHHHHHHHHhc
Confidence             566788999999999999999999999743211 1111111    1111 11  111111    223468999999999


Q ss_pred             CCCCCCCC-HHHHHH
Q 048055          170 LAPENRPV-MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-~~~l~~  183 (221)
                      .+|.+||+ +.++++
T Consensus       247 ~~p~~R~~~~~~~l~  261 (267)
T PHA03390        247 YNINYRLTNYNEIIK  261 (267)
T ss_pred             cChhhCCchHHHHhc
Confidence            99999996 688864

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=5.9e-24  Score=170.57  Aligned_cols=167  Identities=19%  Similarity=0.254  Sum_probs=116.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++...... .......++..|+|||.+.
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  176 (291)
T cd07844          98 GGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL  176 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhh
Confidence            4688999999999999999999998 9999999999999999999999999987543221 1112223467799999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh---------------ccCCC-----CCCC
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET---------------ESGDD-----PPSS  149 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~-----~~~~  149 (221)
                      ....++.++|+||+|+++|+|++|..||.....     .............               .....     ....
T Consensus       177 ~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T cd07844         177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-----VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPL  251 (291)
T ss_pred             cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhH
Confidence            345567889999999999999999999964320     1111111100000               00000     0000


Q ss_pred             ChhhHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEK--LQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~--~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .......  ...+.+++.+||+.+|.+||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         252 INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000000  145789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.91  E-value=1e-23  Score=171.44  Aligned_cols=160  Identities=26%  Similarity=0.392  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++......   ....++..|++||.+.
T Consensus       119 ~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~  194 (317)
T cd06635         119 KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVIL  194 (317)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCc---ccccCCccccChhhhh
Confidence            45689999999999999999999998 9999999999999999999999999987543322   2345677899999863


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ....+.++|+||||+++|++++|..||...      ..............    ......    .....+.+++.+|
T Consensus       195 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~~----~~~~~l~~li~~~  260 (317)
T cd06635         195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES----PTLQSN----EWSDYFRNFVDSC  260 (317)
T ss_pred             cCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHhccC----CCCCCc----cccHHHHHHHHHH
Confidence            1  345678899999999999999999998642      11111111111110    111111    2234689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHh
Q 048055          168 VSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~  187 (221)
                      |+.+|.+||++.++++.+..
T Consensus       261 l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ccCCcccCcCHHHHHhChhh
Confidence            99999999999999876443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=3.3e-24  Score=171.59  Aligned_cols=168  Identities=24%  Similarity=0.341  Sum_probs=120.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.+++.||.|||+..+++|+|++|.||+++.++.++++|||++....... .....++..|++||.+.
T Consensus        97 ~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~  175 (284)
T cd06620          97 GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQ  175 (284)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHc
Confidence            35689999999999999999999974389999999999999999999999999875432221 22345678899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC--CChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG--SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                       +...+.++|+|||||++|++++|..||........  .....+...... .... ..+...   ....+..+.+++.+|
T Consensus       176 -~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~---~~~~~~~~~~li~~~  249 (284)
T cd06620         176 -GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-IVQE-PPPRLP---SSDFPEDLRDFVDAC  249 (284)
T ss_pred             -cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-Hhhc-cCCCCC---chhcCHHHHHHHHHH
Confidence             56778899999999999999999999974322100  001111111111 1110 011100   111334689999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |+.||++||++.++++.
T Consensus       250 l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         250 LLKDPTERPTPQQLCAM  266 (284)
T ss_pred             hcCCcccCcCHHHHhcC
Confidence            99999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.91  E-value=4.3e-24  Score=175.06  Aligned_cols=172  Identities=23%  Similarity=0.267  Sum_probs=118.7

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------CCCCCCCCccccCc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------VEEPSATSLFYKAP   85 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~p   85 (221)
                      .+++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++|+|||++.......      ......++..|++|
T Consensus       103 ~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         103 ILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence            678899999999999999999998 99999999999999999999999999886543221      11223467789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC---------CChHHHHHHhh----hhh--hccCCCCCCCC
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG---------SDIPRWVRSVR----EEE--TESGDDPPSSN  150 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~---------~~~~~~~~~~~----~~~--~~~~~~~~~~~  150 (221)
                      |.+......+.++|+||||+++|++++|..||........         .........+.    ...  ...........
T Consensus       182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (337)
T cd07852         182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD  261 (337)
T ss_pred             eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh
Confidence            9775345567889999999999999999999964221100         00000000000    000  00000000001


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       262 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            1111134568999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.91  E-value=7.3e-24  Score=167.52  Aligned_cols=160  Identities=22%  Similarity=0.230  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||+|||+. +++|+|++|.||+++.++.++++|||++.............++..|++||.+.
T Consensus        87 ~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~  165 (262)
T cd05572          87 RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL  165 (262)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhc
Confidence            34588999999999999999999998 99999999999999999999999999987654432223345677899999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+|++|+++|++++|..||.....    +..........    .......+..    ....+.+++.+||+
T Consensus       166 -~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~----~~~~~~~~~~----~~~~~~~~i~~~l~  232 (262)
T cd05572         166 -NKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILK----GNGKLEFPNY----IDKAAKDLIKQLLR  232 (262)
T ss_pred             -CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhc----cCCCCCCCcc----cCHHHHHHHHHHcc
Confidence             56678899999999999999999999964321    11122222111    0111111111    13469999999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 048055          170 LAPENRPV-----MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~  183 (221)
                      .+|.+||+     +.|+++
T Consensus       233 ~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CChhhCcCCcccCHHHHhc
Confidence            99999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=6.1e-24  Score=167.23  Aligned_cols=158  Identities=23%  Similarity=0.327  Sum_probs=118.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++|+|||++.............++..|++||.+..
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~  175 (258)
T cd06632          97 GSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ  175 (258)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcC
Confidence            4588999999999999999999998 999999999999999999999999998865443333344556778999998752


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ...++.++|+||||+++|++++|..||....      ........... ...   +....    .....+.+++.+||+.
T Consensus       176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~-~~~---~~~~~----~~~~~~~~li~~~l~~  241 (258)
T cd06632         176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRS-KEL---PPIPD----HLSDEAKDFILKCLQR  241 (258)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhc-ccC---CCcCC----CcCHHHHHHHHHHhhc
Confidence            2236889999999999999999999996421      11111111110 011   11111    1224689999999999


Q ss_pred             CCCCCCCHHHHHH
Q 048055          171 APENRPVMREVSK  183 (221)
Q Consensus       171 dp~~Rps~~~l~~  183 (221)
                      +|.+||++.++++
T Consensus       242 ~p~~Rp~~~~~l~  254 (258)
T cd06632         242 DPSLRPTAAELLE  254 (258)
T ss_pred             CcccCcCHHHHhc
Confidence            9999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.6e-24  Score=169.06  Aligned_cols=158  Identities=20%  Similarity=0.232  Sum_probs=117.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ++++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.....   .....++..|++||.+. 
T Consensus        92 ~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~-  166 (260)
T cd05611          92 GGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETIL-  166 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcCccChhhhc-
Confidence            5689999999999999999999998 999999999999999999999999998764332   12234567799999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||+|+++|++++|..||....      ..............   .+.   ......+..+.+++.+||+.
T Consensus       167 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAET------PDAVFDNILSRRIN---WPE---EVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             CCCCcchhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcccC---CCC---cccccCCHHHHHHHHHHccC
Confidence            4557889999999999999999999996421      12222222111111   111   01112234699999999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 048055          171 APENRPVMREVSKMI  185 (221)
Q Consensus       171 dp~~Rps~~~l~~~L  185 (221)
                      +|++||++.++.+.|
T Consensus       235 ~p~~R~~~~~~~~~l  249 (260)
T cd05611         235 DPAKRLGANGYQEIK  249 (260)
T ss_pred             CHHHccCCCcHHHHH
Confidence            999999876554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=5.2e-24  Score=167.70  Aligned_cols=157  Identities=21%  Similarity=0.321  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..++.++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+.
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  174 (256)
T cd08218          96 VLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE  174 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhC
Confidence            3578899999999999999999998 99999999999999999999999999886543321 112234567799999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +...+.++|+||||++++++++|..||...      ............     ..++...    .....+.+++.+||+
T Consensus       175 -~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~li~~~l~  238 (256)
T cd08218         175 -NRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVLKIIRG-----SYPPVSS----HYSYDLRNLVSQLFK  238 (256)
T ss_pred             -CCCCCCccchhHHHHHHHHHHcCCCCccCC------CHHHHHHHHhcC-----CCCCCcc----cCCHHHHHHHHHHhh
Confidence             566778999999999999999999998632      222222222111     1111111    223469999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|.+||++.++++.
T Consensus       239 ~~p~~Rp~~~~vl~~  253 (256)
T cd08218         239 RNPRDRPSVNSILEK  253 (256)
T ss_pred             CChhhCcCHHHHhhC
Confidence            999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.5e-24  Score=172.82  Aligned_cols=158  Identities=22%  Similarity=0.265  Sum_probs=116.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----------------   72 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------   72 (221)
                      +..++...+..++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++........                 
T Consensus        97 ~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (316)
T cd05574          97 GKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS  175 (316)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccc
Confidence            46789999999999999999999998 999999999999999999999999998754322110                 


Q ss_pred             -------------CCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh
Q 048055           73 -------------EEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE  139 (221)
Q Consensus        73 -------------~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  139 (221)
                                   .....++..|++||.+. +..++.++|+||||+++|++++|..||.....      .......... 
T Consensus       176 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~~~~~-  247 (316)
T cd05574         176 IPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR------DETFSNILKK-  247 (316)
T ss_pred             cchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCch------HHHHHHHhcC-
Confidence                         01124566799999876 56678899999999999999999999964321      1111111111 


Q ss_pred             hccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 048055          140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV----MREVSK  183 (221)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps----~~~l~~  183 (221)
                         ....+...    .....+.+++.+||+.+|++||+    +.+++.
T Consensus       248 ---~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         248 ---EVTFPGSP----PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ---CccCCCcc----ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence               11111111    13356999999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=3.2e-24  Score=172.66  Aligned_cols=159  Identities=21%  Similarity=0.361  Sum_probs=118.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|++||.+.
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  188 (293)
T cd06647         110 TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  188 (293)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhc
Confidence            4578889999999999999999998 99999999999999999999999999875443322 222345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+||||+++|++++|..||......      ......   .......    ..........+.+++.+||.
T Consensus       189 -~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~------~~~~~~---~~~~~~~----~~~~~~~~~~l~~li~~~l~  254 (293)
T cd06647         189 -RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLI---ATNGTPE----LQNPEKLSAIFRDFLNRCLE  254 (293)
T ss_pred             -cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh------hheeeh---hcCCCCC----CCCccccCHHHHHHHHHHcc
Confidence             556788999999999999999999999642111      000000   0000000    11111223468999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|++||++.+++..
T Consensus       255 ~~p~~Rp~~~~il~h  269 (293)
T cd06647         255 MDVEKRGSAKELLQH  269 (293)
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.91  E-value=4.1e-24  Score=172.28  Aligned_cols=166  Identities=23%  Similarity=0.250  Sum_probs=118.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.||+.||+|||+. +++|+|++|.||+++.++.++|+|||++.......  .......+..|++||.+
T Consensus       111 ~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~  189 (302)
T cd07864         111 VHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL  189 (302)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHh
Confidence            4689999999999999999999998 99999999999999999999999999986543322  11223346679999977


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCC-C-C------------------CC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGD-D-P------------------PS  148 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~------------------~~  148 (221)
                      ......+.++|+||||+++|++++|..||....      .......+......... . +                  ..
T Consensus       190 ~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd07864         190 LGEERYGPAIDVWSCGCILGELFTKKPIFQANQ------ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRR  263 (302)
T ss_pred             cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhhcccccccccccccccccccccc
Confidence            534456788999999999999999999996321      11111111111000000 0 0                  00


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ........+..+.+++.+||+.+|.+||++.+++.
T Consensus       264 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         264 LREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00001112457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=3.2e-24  Score=178.74  Aligned_cols=158  Identities=23%  Similarity=0.251  Sum_probs=112.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC--------------------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD--------------------   70 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~--------------------   70 (221)
                      +.++...+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++......                    
T Consensus        96 ~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (382)
T cd05625          96 GIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS  174 (382)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccc
Confidence            5678899999999999999999998 9999999999999999999999999986421100                    


Q ss_pred             ----------------------------CCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCccccc
Q 048055           71 ----------------------------SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL  122 (221)
Q Consensus        71 ----------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~  122 (221)
                                                  .......+++.|+|||.+. +..++.++|+||+||++|+|++|..||.... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-  252 (382)
T cd05625         175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQT-  252 (382)
T ss_pred             ccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHHHHHHHhCCCCCCCCC-
Confidence                                        0011235788899999886 6678899999999999999999999996421 


Q ss_pred             ccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048055          123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV---MREVSK  183 (221)
Q Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~~l~~  183 (221)
                           .......+....  .....+.....+    ..+.+++.+++ .+|.+|++   +.++++
T Consensus       253 -----~~~~~~~i~~~~--~~~~~p~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         253 -----PLETQMKVINWQ--TSLHIPPQAKLS----PEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             -----HHHHHHHHHccC--CCcCCCCcccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence                 111111111100  111111111222    24677777765 59999987   887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.91  E-value=9.1e-24  Score=169.60  Aligned_cols=153  Identities=20%  Similarity=0.202  Sum_probs=117.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++......  .....++..|++||.+.
T Consensus        95 ~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~  171 (290)
T cd05580          95 SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIIL  171 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhc
Confidence            36789999999999999999999998 9999999999999999999999999998655433  23345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +...+.++|+||||+++|++++|..||....      .............   .. +  ...    ...+.+++.+||.
T Consensus       172 -~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~---~~-~--~~~----~~~l~~li~~~l~  234 (290)
T cd05580         172 -SKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PIQIYEKILEGKV---RF-P--SFF----SPDAKDLIRNLLQ  234 (290)
T ss_pred             -CCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCc---cC-C--ccC----CHHHHHHHHHHcc
Confidence             5566788999999999999999999996421      1111122211111   11 1  111    2468999999999


Q ss_pred             CCCCCCC-----CHHHHH
Q 048055          170 LAPENRP-----VMREVS  182 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~  182 (221)
                      .+|.+|+     ++++++
T Consensus       235 ~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCHHHccCcccCCHHHHH
Confidence            9999999     677775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=1.2e-23  Score=167.82  Aligned_cols=166  Identities=22%  Similarity=0.243  Sum_probs=119.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||.+....... .......+..|+|||.+.
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~  171 (282)
T cd07829          93 GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL  171 (282)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhc
Confidence            4689999999999999999999998 99999999999999999999999999986544322 222334466799999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh------------c--cCCCCCC-----CC
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET------------E--SGDDPPS-----SN  150 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------~--~~~~~~~-----~~  150 (221)
                      ....++.++|+||||+++|++++|..||.....      ............            .  .....+.     ..
T Consensus       172 ~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd07829         172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE------IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLE  245 (282)
T ss_pred             CCcCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchH
Confidence            333678899999999999999999999964221      111111100000            0  0000000     00


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...+.....+.+++.+||+.+|++||++.+++.
T Consensus       246 ~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         246 KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            111112356999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.91  E-value=2.1e-24  Score=167.86  Aligned_cols=173  Identities=23%  Similarity=0.278  Sum_probs=125.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC----CceEEeccCCccccCCCC----CCCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD----FESCLTDYGLGSFRNPDS----VEEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~----~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~   82 (221)
                      +.++-..+..++-||++|++|||+. .++|||+||.||++..+    |.+||+|||+++.....-    ......-|.+|
T Consensus       127 ~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWY  205 (438)
T KOG0666|consen  127 KQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWY  205 (438)
T ss_pred             ccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEe
Confidence            6888999999999999999999998 99999999999999887    999999999998765432    12344568899


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh----ccCCCCCCCChhhHH---
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET----ESGDDPPSSNEASEE---  155 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~---  155 (221)
                      +|||.+.....|+.+.|+|+.||++.|+++-++.|.+...+.....+.....+...-.    ......|.....++-   
T Consensus       206 RAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~  285 (438)
T KOG0666|consen  206 RAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTL  285 (438)
T ss_pred             cChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHH
Confidence            9999988677889999999999999999999888876543333332222222211111    111111111111110   


Q ss_pred             -----------------------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          156 -----------------------KLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       156 -----------------------~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                                             ......+|+.++|.+||.+|.|+.+.++.
T Consensus       286 ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  286 LSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence                                   01237889999999999999999988654

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=4.6e-24  Score=175.40  Aligned_cols=164  Identities=24%  Similarity=0.355  Sum_probs=118.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      .++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++......  .....++..|++||....
T Consensus       113 ~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         113 QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhC
Confidence            4689999999999999999999998 9999999999999999999999999998654332  223355677999998753


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-----------------CCCCCC-CC--
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-----------------GDDPPS-SN--  150 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~-~~--  150 (221)
                      ....+.++|+||+|+++|++++|..||.....      ......+.......                 ...+.. ..  
T Consensus       190 ~~~~~~~~DvwslGv~l~elltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (343)
T cd07851         190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH------IDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF  263 (343)
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCH
Confidence            34567899999999999999999999964211      11111111100000                 000000 00  


Q ss_pred             -hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 -EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 -~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       .........+.+++.+||+.+|++|||+.+|++
T Consensus       264 ~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         264 KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence             000112356899999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.91  E-value=1.5e-23  Score=164.81  Aligned_cols=156  Identities=25%  Similarity=0.347  Sum_probs=121.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..++.++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++...... ......++..|++||...
T Consensus        97 ~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~  174 (256)
T cd08530          97 RKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWK  174 (256)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHC
Confidence            46789999999999999999999998 9999999999999999999999999998665443 233345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||+|+++|++++|..||....      .........     ....++.    +......+.+++.+||+
T Consensus       175 -~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~-----~~~~~~~----~~~~~~~~~~li~~~l~  238 (256)
T cd08530         175 -GRPYSYKSDIWSLGCLLYEMATFAPPFEARS------MQDLRYKVQ-----RGKYPPI----PPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHh-----cCCCCCC----chhhCHHHHHHHHHHcC
Confidence             5667789999999999999999999996421      111111111     1111111    11334569999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|++||++.++++
T Consensus       239 ~~p~~Rp~~~~~l~  252 (256)
T cd08530         239 VKPKLRPNCDKILA  252 (256)
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=7.7e-24  Score=168.91  Aligned_cols=158  Identities=21%  Similarity=0.247  Sum_probs=116.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||.+.............++..|++||.+. 
T Consensus        90 ~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~-  167 (277)
T cd05577          90 PGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-  167 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhc-
Confidence            4689999999999999999999998 99999999999999999999999999886544333333445667899999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||+|+++|++++|..||......  .....    +.......  ...    .+......+.+++.+||+.
T Consensus       168 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~~~~~--~~~----~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK--VEKEE----LKRRTLEM--AVE----YPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc--ccHHH----HHhccccc--ccc----CCccCCHHHHHHHHHHccC
Confidence            455788999999999999999999999643211  01111    11111100  001    1111234689999999999


Q ss_pred             CCCCCC-----CHHHHH
Q 048055          171 APENRP-----VMREVS  182 (221)
Q Consensus       171 dp~~Rp-----s~~~l~  182 (221)
                      +|.+||     ++.+++
T Consensus       236 ~p~~R~~~~~~~~~~ll  252 (277)
T cd05577         236 DPEKRLGCRGGSADEVR  252 (277)
T ss_pred             ChhHccCCCcccHHHHH
Confidence            999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.6e-24  Score=177.53  Aligned_cols=160  Identities=18%  Similarity=0.173  Sum_probs=115.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      .+.++...+..++.|++.||.|||+. +++||||||.||+++.++.++++|||+++......                  
T Consensus        95 ~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~  173 (377)
T cd05629          95 YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI  173 (377)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccc
Confidence            45788999999999999999999998 99999999999999999999999999885221100                  


Q ss_pred             ------------------------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccc
Q 048055           72 ------------------------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLV  121 (221)
Q Consensus        72 ------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~  121 (221)
                                                    ......+++.|+|||.+. +..++.++|+|||||++|+|++|..||....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  252 (377)
T cd05629         174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             ccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchhhhhhhcCCCCCCCCC
Confidence                                          000235788899999886 6677899999999999999999999996422


Q ss_pred             cccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 048055          122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENR---PVMREVSKM  184 (221)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---ps~~~l~~~  184 (221)
                            .......+....  .....+.....    ...+.+++.+|+. +|.+|   +++.+++..
T Consensus       253 ------~~~~~~~i~~~~--~~~~~p~~~~~----s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         253 ------SHETYRKIINWR--ETLYFPDDIHL----SVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             ------HHHHHHHHHccC--CccCCCCCCCC----CHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence                  111112211100  00111111111    2358899999997 67665   599998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.91  E-value=5.5e-24  Score=168.56  Aligned_cols=156  Identities=18%  Similarity=0.278  Sum_probs=116.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      +.++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.......    ......++..|++||
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (265)
T cd06652         101 GALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE  179 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChh
Confidence            4578888999999999999999998 99999999999999999999999999886433211    112234677899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +...+.++|+||||+++|++++|..||....     .... ....    ......+.    .+......+.+++.+
T Consensus       180 ~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~-~~~~----~~~~~~~~----~~~~~~~~~~~~i~~  244 (265)
T cd06652         180 VIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----AMAA-IFKI----ATQPTNPV----LPPHVSDHCRDFLKR  244 (265)
T ss_pred             hhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----hHHH-HHHH----hcCCCCCC----CchhhCHHHHHHHHH
Confidence            876 5667889999999999999999999996321     1111 1111    11111111    122333568899999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||. +|++||++++|++
T Consensus       245 ~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         245 IFV-EAKLRPSADELLR  260 (265)
T ss_pred             Hhc-ChhhCCCHHHHhc
Confidence            995 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=6.1e-24  Score=168.57  Aligned_cols=156  Identities=22%  Similarity=0.330  Sum_probs=113.0

Q ss_pred             CHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCCC-CCCCCCCCccccCcccchhc
Q 048055           14 HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        14 ~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~   91 (221)
                      +...+..++.||+.||+|||+. +++|+|++|.||+++. ++.++|+|||.+....... ......++..|++||.+...
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  184 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG  184 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccc
Confidence            7788888999999999999998 9999999999999976 6789999999886543221 22234567789999986522


Q ss_pred             -CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           92 -KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        92 -~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                       ..++.++|+||+|+++|++++|..||......     .......  .  .....+..+.    .....+.+++.+||+.
T Consensus       185 ~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~--~--~~~~~~~~~~----~~~~~~~~li~~~l~~  251 (268)
T cd06624         185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKV--G--MFKIHPEIPE----SLSAEAKNFILRCFEP  251 (268)
T ss_pred             cccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhh--h--hhccCCCCCc----ccCHHHHHHHHHHcCC
Confidence             23578899999999999999999999642110     0000000  0  0001111111    1234589999999999


Q ss_pred             CCCCCCCHHHHHH
Q 048055          171 APENRPVMREVSK  183 (221)
Q Consensus       171 dp~~Rps~~~l~~  183 (221)
                      +|.+||++.++++
T Consensus       252 ~p~~Rpt~~~ll~  264 (268)
T cd06624         252 DPDKRASAHDLLQ  264 (268)
T ss_pred             CchhCCCHHHHHh
Confidence            9999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.91  E-value=1.3e-23  Score=170.20  Aligned_cols=157  Identities=24%  Similarity=0.366  Sum_probs=117.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++......   ....++..|++||.+.
T Consensus       109 ~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~  184 (308)
T cd06634         109 KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVIL  184 (308)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHh
Confidence            45688999999999999999999998 9999999999999999999999999987654332   2335667899999763


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ....+.++|+||||+++|++++|..||.....      .........     ...+...   .......+.+++.+|
T Consensus       185 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-----~~~~~~~---~~~~~~~~~~li~~c  250 (308)
T cd06634         185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-----NESPALQ---SGHWSEYFRNFVDSC  250 (308)
T ss_pred             hcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhh-----cCCCCcC---cccccHHHHHHHHHH
Confidence            1  23457789999999999999999999864210      111111111     0111101   112234689999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |+.+|++||++.+++..
T Consensus       251 l~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         251 LQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             hhCCcccCCCHHHHhhC
Confidence            99999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=7.4e-24  Score=167.11  Aligned_cols=157  Identities=20%  Similarity=0.280  Sum_probs=119.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      .+++...+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.............++..|++||.+. 
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-  172 (258)
T cd05578          95 VKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC-  172 (258)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHc-
Confidence            5789999999999999999999998 99999999999999999999999999986554443334455677899999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ....+.++|+||+|+++|++++|..||......    ........   ........+      ...+..+.+++.+||+.
T Consensus       173 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~---~~~~~~~~~------~~~~~~~~~~i~~~l~~  239 (258)
T cd05578         173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAK---QETADVLYP------ATWSTEAIDAINKLLER  239 (258)
T ss_pred             ccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHH---hccccccCc------ccCcHHHHHHHHHHccC
Confidence            556788999999999999999999999753221    11111111   110111111      11235689999999999


Q ss_pred             CCCCCCCH--HHHH
Q 048055          171 APENRPVM--REVS  182 (221)
Q Consensus       171 dp~~Rps~--~~l~  182 (221)
                      ||.+||++  .|++
T Consensus       240 ~p~~R~~~~~~~l~  253 (258)
T cd05578         240 DPQKRLGDNLKDLK  253 (258)
T ss_pred             ChhHcCCccHHHHh
Confidence            99999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.91  E-value=8.7e-24  Score=166.75  Aligned_cols=160  Identities=21%  Similarity=0.310  Sum_probs=118.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---------CCCCCCCCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---------VEEPSATSLF   81 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~   81 (221)
                      +.++...++.++.||+.||.|||+. +++|+||+|.||+++.++.++++|||++.......         ......++..
T Consensus        88 ~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (265)
T cd05579          88 GSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD  166 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCcc
Confidence            4789999999999999999999998 99999999999999999999999999876433221         1122345667


Q ss_pred             ccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           82 YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        82 ~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      |++||... ....+.++|+||||+++|++++|..||....      .......+....    ...+....    ....+.
T Consensus       167 ~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~----~~~~~~~~----~~~~~~  231 (265)
T cd05579         167 YIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGET------PEEIFQNILNGK----IEWPEDVE----VSDEAI  231 (265)
T ss_pred             ccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCC----cCCCcccc----CCHHHH
Confidence            99999876 4557889999999999999999999996422      122222222111    11111111    134689


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHH
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +++.+||+.+|.+||++..+.+.|+
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         232 DLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHHHHhcCCHhhcCCCccHHHHhc
Confidence            9999999999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=2.2e-23  Score=165.59  Aligned_cols=163  Identities=25%  Similarity=0.465  Sum_probs=118.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      .+++...+..++.||+.||.|||+. +++|+|++|.||+++.++.++++|||++.......   ......++..|++||.
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  181 (272)
T cd06629         103 GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV  181 (272)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHH
Confidence            5789999999999999999999998 99999999999999999999999999986543211   1223346678999998


Q ss_pred             chhcC-CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWK-QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~-~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +.... .++.++|+||||+++|++++|..||...     ........ ...    ...............+..+.+++.+
T Consensus       182 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-----~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~li~~  251 (272)
T cd06629         182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-----EAIAAMFK-LGN----KRSAPPIPPDVSMNLSPVALDFLNA  251 (272)
T ss_pred             hccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-----chHHHHHH-hhc----cccCCcCCccccccCCHHHHHHHHH
Confidence            75332 3678899999999999999999999532     11111111 111    0011111111111234579999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||..+|.+||++.++++.
T Consensus       252 ~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         252 CFTINPDNRPTARELLQH  269 (272)
T ss_pred             HhcCChhhCCCHHHHhhC
Confidence            999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.91  E-value=7.8e-24  Score=166.24  Aligned_cols=157  Identities=24%  Similarity=0.403  Sum_probs=121.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.+++.||.|||+. +++|+|++|.||+++.++.++++|||.+....... ......++..|++||..
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~  175 (258)
T cd08215          97 GKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC  175 (258)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHh
Confidence            47789999999999999999999998 99999999999999999999999999886544332 22334567789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ....+.++|+|++|++++++++|..||...      .............     ..+.+.    .....+.+++.+||
T Consensus       176 ~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~i~~~l  239 (258)
T cd08215         176 Q-NKPYNYKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKGQ-----YPPIPS----QYSSELRNLVSSLL  239 (258)
T ss_pred             c-cCCCCccccHHHHHHHHHHHHcCCCCCCCC------cHHHHHHHHhcCC-----CCCCCC----CCCHHHHHHHHHHc
Confidence            6 566788999999999999999999999642      1222222221111     111111    12246899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      ..+|.+||++.++++
T Consensus       240 ~~~p~~Rp~~~~ll~  254 (258)
T cd08215         240 QKDPEERPSIAQILQ  254 (258)
T ss_pred             CCChhhCcCHHHHhc
Confidence            999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.4e-23  Score=171.78  Aligned_cols=163  Identities=18%  Similarity=0.218  Sum_probs=115.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...++...+..++.||+.||+|||+. +++|+||||.||+++.++.++|+|||++........  .....+++.|+|||.
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  174 (331)
T cd05597          96 EDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI  174 (331)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHH
Confidence            45688999999999999999999998 999999999999999999999999999865433221  122357889999998


Q ss_pred             chh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           88 REI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        88 ~~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +..    ...++.++|+||+||++|+|++|..||...      ........+..... ....++....    ....+.++
T Consensus       175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~------~~~~~~~~i~~~~~-~~~~~~~~~~----~~~~~~~l  243 (331)
T cd05597         175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKE-HFQFPPDVTD----VSEEAKDL  243 (331)
T ss_pred             HhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC------CHHHHHHHHHcCCC-cccCCCccCC----CCHHHHHH
Confidence            752    134577899999999999999999999642      11222222211111 1111111111    22357888


Q ss_pred             HHHcccCCCC--CCCCHHHHHHH
Q 048055          164 AIACVSLAPE--NRPVMREVSKM  184 (221)
Q Consensus       164 ~~~cl~~dp~--~Rps~~~l~~~  184 (221)
                      +.+|+..++.  .|+++.++++.
T Consensus       244 i~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         244 IRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHccCcccccCCCCHHHHhcC
Confidence            8887765443  37899988755

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.91  E-value=8.8e-24  Score=173.01  Aligned_cols=163  Identities=15%  Similarity=0.178  Sum_probs=117.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||++........  .....+++.|+|||.
T Consensus        96 ~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~  174 (332)
T cd05623          96 EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI  174 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHH
Confidence            35688999999999999999999998 999999999999999999999999999865432221  123467889999998


Q ss_pred             chh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           88 REI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        88 ~~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +..    ...++.++|+|||||++|++++|..||...      ........+...... ...+......    ...+.++
T Consensus       175 ~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~~~~~~-~~~p~~~~~~----s~~~~~l  243 (332)
T cd05623         175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKER-FQFPAQVTDV----SEDAKDL  243 (332)
T ss_pred             HhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------CHHHHHHHHhCCCcc-ccCCCccccC----CHHHHHH
Confidence            642    234678999999999999999999999642      222222222221111 1111111122    2458889


Q ss_pred             HHHcccCCCCC--CCCHHHHHHH
Q 048055          164 AIACVSLAPEN--RPVMREVSKM  184 (221)
Q Consensus       164 ~~~cl~~dp~~--Rps~~~l~~~  184 (221)
                      +.+|+..++.+  |+++.++++.
T Consensus       244 i~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         244 IRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHccChhhhcCCCCHHHHhCC
Confidence            99988665544  6789988755

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=3.5e-24  Score=178.13  Aligned_cols=160  Identities=24%  Similarity=0.235  Sum_probs=115.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-------------------   70 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-------------------   70 (221)
                      .+.++...+..++.||+.||+|||+. +++||||||.||+++.++.++|+|||++......                   
T Consensus        95 ~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~  173 (376)
T cd05598          95 LGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP  173 (376)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccc
Confidence            35678899999999999999999998 9999999999999999999999999987421100                   


Q ss_pred             -------------------------CCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC
Q 048055           71 -------------------------SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG  125 (221)
Q Consensus        71 -------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~  125 (221)
                                               .......+++.|+|||.+. +..++.++|+|||||++|+|++|..||.....   
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---  249 (376)
T cd05598         174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLADTP---  249 (376)
T ss_pred             cccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeeccceeeehhhCCCCCCCCCH---
Confidence                                     0001235788999999886 66778899999999999999999999974321   


Q ss_pred             CChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 048055          126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP---VMREVSKM  184 (221)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp---s~~~l~~~  184 (221)
                         ......+.....  ....+.....+    ..+.+++.+|+ .+|.+|+   ++.+++..
T Consensus       250 ---~~~~~~i~~~~~--~~~~~~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         250 ---AETQLKVINWET--TLHIPSQAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ---HHHHHHHhccCc--cccCCCCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence               111111111110  11111111222    34777888866 5999999   88999744

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.91  E-value=1.2e-23  Score=166.04  Aligned_cols=161  Identities=23%  Similarity=0.349  Sum_probs=121.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC-CCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE-EPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~pe~~   88 (221)
                      .+++...++.++.|++.||.|||+ . +++|+|++|.||+++.++.++++|||.+......... ....++..|++||.+
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~  172 (264)
T cd06623          94 GKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI  172 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhh
Confidence            678999999999999999999999 8 9999999999999999999999999988655433222 234556789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...++.++|+|+||+++|++++|..||.....   .........+..   .  ..+.....   ..+..+.+++.+||
T Consensus       173 ~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~---~--~~~~~~~~---~~~~~l~~li~~~l  240 (264)
T cd06623         173 Q-GESYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFELMQAICD---G--PPPSLPAE---EFSPEFRDFISACL  240 (264)
T ss_pred             C-CCCCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHHHHHHHhc---C--CCCCCCcc---cCCHHHHHHHHHHc
Confidence            6 56778899999999999999999999965321   111122222211   1  11111111   02346999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.+|.+||++.++++.
T Consensus       241 ~~~p~~R~~~~~ll~~  256 (264)
T cd06623         241 QKDPKKRPSAAELLQH  256 (264)
T ss_pred             cCChhhCCCHHHHHhC
Confidence            9999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=6.5e-24  Score=174.46  Aligned_cols=166  Identities=21%  Similarity=0.303  Sum_probs=115.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .++++..+..++.||+.||.|||+. +++|+||||.||+++. ++.++++|||.+.......    ......++..|+||
T Consensus       109 ~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         109 GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCH
Confidence            4689999999999999999999998 9999999999999974 5578999999986543221    11223456789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh------------------hccCCCCC
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE------------------TESGDDPP  147 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~  147 (221)
                      |.+.....++.++|+|||||++|++++|..||.....      ...........                  .......+
T Consensus       188 E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (342)
T cd07854         188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE------LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEP  261 (342)
T ss_pred             HHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccccc
Confidence            9765345667899999999999999999999963211      00000000000                  00000000


Q ss_pred             C--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          148 S--SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       148 ~--~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .  ...........+.+++.+||+.||++||++.+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         262 RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0  00011122346889999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.91  E-value=1.2e-23  Score=169.08  Aligned_cols=167  Identities=19%  Similarity=0.217  Sum_probs=115.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ..++...+..++.||+.||+|||+. +++|+|++|.||+++. ++.++++|||++...... .......++..|++||.+
T Consensus        97 ~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~  175 (294)
T PLN00009         97 FAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL  175 (294)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHH
Confidence            3457888889999999999999998 9999999999999985 567899999998654322 122334556789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc-----------------cCC-CCCCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE-----------------SGD-DPPSSN  150 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~-~~~~~~  150 (221)
                      .....++.++|+||+|+++|++++|..||.....     ..............                 ... ......
T Consensus       176 ~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (294)
T PLN00009        176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-----IDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA  250 (294)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH
Confidence            6334567899999999999999999999964211     11111110000000                 000 000000


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...+.....+.+++.+||+.+|++||++.++++
T Consensus       251 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        251 TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            001112245889999999999999999999975

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.91  E-value=1.7e-23  Score=167.61  Aligned_cols=158  Identities=20%  Similarity=0.349  Sum_probs=118.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++|+|||++....... ......++..|++||.+.
T Consensus       111 ~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  189 (286)
T cd06614         111 VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK  189 (286)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhc
Confidence            3789999999999999999999998 99999999999999999999999999875433221 112334567899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|++++|..||.....      .........  ...... .    .....+..+.+++.+||+
T Consensus       190 -~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~~~~--~~~~~~-~----~~~~~~~~l~~li~~~l~  255 (286)
T cd06614         190 -RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFLITT--KGIPPL-K----NPEKWSPEFKDFLNKCLV  255 (286)
T ss_pred             -CCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh--cCCCCC-c----chhhCCHHHHHHHHHHhc
Confidence             56678899999999999999999999863211      111111111  001000 0    111123569999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|.+||++.++++
T Consensus       256 ~~p~~Rpt~~~il~  269 (286)
T cd06614         256 KDPEKRPSAEELLQ  269 (286)
T ss_pred             cChhhCcCHHHHhh
Confidence            99999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=8.9e-24  Score=168.82  Aligned_cols=167  Identities=20%  Similarity=0.254  Sum_probs=119.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ..++++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++++|||++...... .......++..|++||.+
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~  172 (284)
T cd07836          94 RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL  172 (284)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHh
Confidence            35689999999999999999999998 9999999999999999999999999998644322 122234456789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhh--------------hhccCCCCCCC-----
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE--------------ETESGDDPPSS-----  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-----  149 (221)
                      .....++.++|+|+||+++|++++|..||......      .........              ........+..     
T Consensus       173 ~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (284)
T cd07836         173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE------DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL  246 (284)
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH
Confidence            53455678999999999999999999999643211      111111000              00000000100     


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ....+.....+.+++.+||+.||.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0111122456899999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=4.3e-24  Score=176.70  Aligned_cols=159  Identities=23%  Similarity=0.233  Sum_probs=115.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      .+.++...+..++.|++.||.|||+. +++||||||.||+++.++.++|+|||++.......                  
T Consensus        95 ~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (360)
T cd05627          95 KDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF  173 (360)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccc
Confidence            46789999999999999999999998 99999999999999999999999999875432110                  


Q ss_pred             ------------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHH
Q 048055           72 ------------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVR  133 (221)
Q Consensus        72 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~  133 (221)
                                        ......+++.|+|||.+. +..++.++|+|||||++|+|++|..||....      ......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~------~~~~~~  246 (360)
T cd05627         174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSET------PQETYR  246 (360)
T ss_pred             cccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCCCCCC------HHHHHH
Confidence                              011345788999999886 6778899999999999999999999996432      122222


Q ss_pred             HhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048055          134 SVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV---MREVSK  183 (221)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~~l~~  183 (221)
                      .+.....  ....+.....+    ..+.+++.+++ .||.+|++   +.++++
T Consensus       247 ~i~~~~~--~~~~p~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         247 KVMNWKE--TLVFPPEVPIS----EKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             HHHcCCC--ceecCCCCCCC----HHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            2221110  01111111122    34778888866 49999985   566653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.90  E-value=1.6e-23  Score=168.55  Aligned_cols=158  Identities=17%  Similarity=0.286  Sum_probs=118.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.||+|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+.
T Consensus       111 ~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~  189 (292)
T cd06657         111 TRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS  189 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhc
Confidence            4678999999999999999999998 99999999999999999999999999875443221 122345677899999875


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ...++.++|+||+|+++|++++|..||....      ............   .........    ....+.+++.+||+
T Consensus       190 -~~~~~~~~Dv~slGvil~el~tg~~p~~~~~------~~~~~~~~~~~~---~~~~~~~~~----~~~~l~~li~~~l~  255 (292)
T cd06657         190 -RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNL---PPKLKNLHK----VSPSLKGFLDRLLV  255 (292)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhhC---CcccCCccc----CCHHHHHHHHHHHh
Confidence             5666889999999999999999999986421      111111111111   111111111    22358899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|.+||++.++++
T Consensus       256 ~~P~~R~~~~~ll~  269 (292)
T cd06657         256 RDPAQRATAAELLK  269 (292)
T ss_pred             CCcccCcCHHHHhc
Confidence            99999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.90  E-value=1e-23  Score=172.71  Aligned_cols=167  Identities=20%  Similarity=0.219  Sum_probs=117.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---------------CCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---------------SVEE   74 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---------------~~~~   74 (221)
                      ...++...+..++.|++.||.|||+. +++|+||++.||+++.++.++++|||.+......               ....
T Consensus       113 ~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (335)
T PTZ00024        113 KIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT  191 (335)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccc
Confidence            45689999999999999999999998 9999999999999999999999999988654311               0111


Q ss_pred             CCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-----------
Q 048055           75 PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-----------  143 (221)
Q Consensus        75 ~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  143 (221)
                      ...++..|++||.+.....++.++|+||+|+++|++++|..||......      .....+........           
T Consensus       192 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~  265 (335)
T PTZ00024        192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI------DQLGRIFELLGTPNEDNWPQAKKLP  265 (335)
T ss_pred             ccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCchhhCcchhhcc
Confidence            2234667999998763345688999999999999999999999643211      11111100000000           


Q ss_pred             ------CC-CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          144 ------DD-PPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       144 ------~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                            .. +.............+.+++.+||+.+|.+||++.+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        266 LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             cccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence                  00 00000001112346889999999999999999999975

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.90  E-value=2.7e-23  Score=168.74  Aligned_cols=156  Identities=24%  Similarity=0.387  Sum_probs=116.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++++|||++.....   .....++..|++||.+.
T Consensus       115 ~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~  190 (313)
T cd06633         115 KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVIL  190 (313)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhcc
Confidence            45689999999999999999999998 999999999999999999999999998754322   22345677899999863


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ...++.++|+||||+++|++++|..||....      ...........   ..  +...   .......+.+++.+|
T Consensus       191 ~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~---~~--~~~~---~~~~~~~l~~li~~~  256 (313)
T cd06633         191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQN---DS--PTLQ---SNEWTDSFRGFVDYC  256 (313)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhc---CC--CCCC---ccccCHHHHHHHHHH
Confidence            1  2456778999999999999999999986421      11111111111   00  1100   111224589999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.+|.+||++.+++.
T Consensus       257 l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         257 LQKIPQERPASAELLR  272 (313)
T ss_pred             ccCChhhCcCHHHHhc
Confidence            9999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.90  E-value=2.3e-23  Score=191.88  Aligned_cols=172  Identities=27%  Similarity=0.451  Sum_probs=123.7

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhc---CCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIH---QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH---~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .++|..+..++.||+.||+|||   +. +++|||+||.||+++.++..++. ++.......   .....++..|+|||.+
T Consensus       776 ~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~  850 (968)
T PLN00113        776 NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETR  850 (968)
T ss_pred             cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccc
Confidence            4789999999999999999999   44 89999999999999988887765 554332211   1223567789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc---cCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE---SGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      . +..++.++|||||||++||+++|+.||...... ......+..........   ..................+.+++.
T Consensus       851 ~-~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  928 (968)
T PLN00113        851 E-TKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL  928 (968)
T ss_pred             c-CCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence            6 677889999999999999999999999543221 22333333222111100   001111111223345567899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||++||++.++++.|++...
T Consensus       929 ~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        929 HCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhCcCCchhCcCHHHHHHHHHHhhc
Confidence            9999999999999999999998764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.90  E-value=1.2e-23  Score=165.12  Aligned_cols=157  Identities=24%  Similarity=0.408  Sum_probs=120.9

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPECR   88 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~~   88 (221)
                      .+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||.+........   .....++..|++||.+
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606          97 KLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhh
Confidence            789999999999999999999998 999999999999999999999999999865544332   3345667789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ......++|+|+||++++++++|..||....     ...........    ......    .+......+.+++.+||
T Consensus       176 ~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~----~~~~~~----~~~~~~~~l~~~i~~~l  241 (260)
T cd06606         176 R-GEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS----SGEPPE----IPEHLSEEAKDFLRKCL  241 (260)
T ss_pred             c-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc----cCCCcC----CCcccCHHHHHHHHHhC
Confidence            6 4557889999999999999999999996532     11111111111    001111    11122457999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.+|.+||++.++++
T Consensus       242 ~~~p~~Rp~~~~ll~  256 (260)
T cd06606         242 RRDPKKRPTADELLQ  256 (260)
T ss_pred             cCChhhCCCHHHHhh
Confidence            999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=2.2e-23  Score=170.31  Aligned_cols=168  Identities=23%  Similarity=0.285  Sum_probs=114.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--------CCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--------EEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~   82 (221)
                      ..++...+..++.|++.||+|||+. +++|+|+||.||+++.++.+++.||+.+........        .....++..|
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (328)
T cd08226          96 EGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW  174 (328)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCc
Confidence            4578899999999999999999998 999999999999999999999999975422211100        0111234569


Q ss_pred             cCcccchhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-------------------
Q 048055           83 KAPECREIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-------------------  142 (221)
Q Consensus        83 ~~pe~~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  142 (221)
                      ++||.+... ..++.++|+||+||++|++++|..||......     ..............                   
T Consensus       175 ~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (328)
T cd08226         175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-----QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSG  249 (328)
T ss_pred             cChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-----HHHHHHhcCCCCCCccccccchhhhhhccchhh
Confidence            999987532 34578999999999999999999999643210     01001100000000                   


Q ss_pred             ----------------C-CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          143 ----------------G-DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       143 ----------------~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                                      . ................+.+|+.+||+.||++|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         250 VDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                            0 00000011122345679999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=1.3e-23  Score=166.51  Aligned_cols=161  Identities=23%  Similarity=0.387  Sum_probs=118.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCCC-----CCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSV-----EEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~   83 (221)
                      .+++++..+..++.|++.||.|||+. +++|+||+|.||+++.++ .++|+|||.+........     .....++..|+
T Consensus        97 ~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (268)
T cd06630          97 YGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM  175 (268)
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccccee
Confidence            35788999999999999999999998 999999999999998775 589999999865443211     12234567899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +||.+. +..++.++|+|++|+++|++++|..||.....   ............    ....    ...+......+.++
T Consensus       176 ~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~  243 (268)
T cd06630         176 APEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH---SNHLALIFKIAS----ATTA----PSIPEHLSPGLRDV  243 (268)
T ss_pred             CHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---cchHHHHHHHhc----cCCC----CCCchhhCHHHHHH
Confidence            999876 56678899999999999999999999963211   111111111100    0001    11112233568999


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.+||..+|.+||++.++++
T Consensus       244 i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         244 TLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHcCCCcccCcCHHHHhc
Confidence            99999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.90  E-value=7.5e-25  Score=166.99  Aligned_cols=165  Identities=19%  Similarity=0.217  Sum_probs=123.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...++..-.-+++...+.||.||-..-.|+|||+||+|||++..|.+|++|||.+......-..+--.|...|+|||.+.
T Consensus       161 ~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~  240 (361)
T KOG1006|consen  161 KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERID  240 (361)
T ss_pred             hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccC
Confidence            34566677777777788999999987689999999999999999999999999986555544445556777899999876


Q ss_pred             hcCC-CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQ-PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~-~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      .... +..++|+||||+++||+.+|..||..+..        ..+++.......+.......++ -+....+..++..|+
T Consensus       241 p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--------vfeql~~Vv~gdpp~l~~~~~~-~~~s~~~~~fintCl  311 (361)
T KOG1006|consen  241 PSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--------VFEQLCQVVIGDPPILLFDKEC-VHYSFSMVRFINTCL  311 (361)
T ss_pred             CccCCcchhhhhhhhcceEeeeecCCCCcchHHH--------HHHHHHHHHcCCCCeecCcccc-cccCHHHHHHHHHHh
Confidence            5443 78899999999999999999999975432        2233322222222222222221 123356999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      .+|-.+||...++++
T Consensus       312 ~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  312 IKDRSDRPKYDDLKK  326 (361)
T ss_pred             hcccccCcchhhhhc
Confidence            999999999999864

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.8e-23  Score=162.23  Aligned_cols=156  Identities=26%  Similarity=0.480  Sum_probs=118.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~pe~~~   89 (221)
                      .++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||.+........ .....++..|++||...
T Consensus        94 ~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  172 (254)
T cd06627          94 GPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE  172 (254)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhc
Confidence            5789999999999999999999998 999999999999999999999999999865543322 22345677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       ......++|+|++|+++|++++|..||....     ....... ..   ..  ..+..+..    ....+.+++.+||.
T Consensus       173 -~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~~~~~~~-~~---~~--~~~~~~~~----~~~~~~~~i~~~l~  236 (254)
T cd06627         173 -MSGASTASDIWSLGCTVIELLTGNPPYYDLN-----PMAALFR-IV---QD--DHPPLPEG----ISPELKDFLMQCFQ  236 (254)
T ss_pred             -CCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHH-Hh---cc--CCCCCCCC----CCHHHHHHHHHHHh
Confidence             4557889999999999999999999996421     1111111 11   11  11111111    12468999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .+|++||++.+++.
T Consensus       237 ~~p~~R~~~~~~l~  250 (254)
T cd06627         237 KDPNLRPTAKQLLK  250 (254)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.3e-23  Score=171.44  Aligned_cols=165  Identities=21%  Similarity=0.287  Sum_probs=117.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++......  .....++..|+|||.+..
T Consensus       115 ~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         115 QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhC
Confidence            4689999999999999999999998 9999999999999999999999999998653322  223456778999998653


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh--------------------ccCCCCCC-C
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET--------------------ESGDDPPS-S  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~-~  149 (221)
                      ...++.++|+||+|+++|++++|..||.....      ............                    .....+.. .
T Consensus       192 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (345)
T cd07877         192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF  265 (345)
T ss_pred             ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch
Confidence            35567889999999999999999999963211      010010000000                    00000000 0


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ..........+.+++.+|++.||.+||++.+++..
T Consensus       266 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         266 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00000112458899999999999999999998755

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-23  Score=164.58  Aligned_cols=155  Identities=20%  Similarity=0.253  Sum_probs=121.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.|+...+..+...|++||.|||+. +|++||+|.+|.+++.+|++||+|||+++.... .....+..||+.|+|||++
T Consensus       262 er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  262 ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhh
Confidence            56788888889999999999999998 999999999999999999999999999976543 3455788999999999999


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...|+.++|.|.+|+++|||++|..||.....      ......+.-    ....+|..  .+    .....|+...|
T Consensus       341 e-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------~kLFeLIl~----ed~kFPr~--ls----~eAktLLsGLL  403 (516)
T KOG0690|consen  341 E-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------EKLFELILM----EDLKFPRT--LS----PEAKTLLSGLL  403 (516)
T ss_pred             c-cccccceeehhhhhHHHHHHHhccCcccccch------hHHHHHHHh----hhccCCcc--CC----HHHHHHHHHHh
Confidence            7 78899999999999999999999999964321      111222222    22222211  11    24678888999


Q ss_pred             cCCCCCCC-----CHHHHH
Q 048055          169 SLAPENRP-----VMREVS  182 (221)
Q Consensus       169 ~~dp~~Rp-----s~~~l~  182 (221)
                      .+||.+|.     ++.+|.
T Consensus       404 ~kdP~kRLGgGpdDakEi~  422 (516)
T KOG0690|consen  404 KKDPKKRLGGGPDDAKEIM  422 (516)
T ss_pred             hcChHhhcCCCchhHHHHH
Confidence            99999995     356654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=3.6e-23  Score=162.81  Aligned_cols=157  Identities=22%  Similarity=0.332  Sum_probs=117.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|++|.||+++.++ .++++|||.+....... ......++..|++||.+
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~  174 (257)
T cd08225          96 VLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC  174 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHH
Confidence            3578999999999999999999998 999999999999998885 46999999886544322 12233567789999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ...++.++|+||||+++|++++|..||...      .............     ..+...    .....+.+++.+||
T Consensus       175 ~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~i~~~l  238 (257)
T cd08225         175 Q-NRPYNNKTDIWSLGCVLYELCTLKHPFEGN------NLHQLVLKICQGY-----FAPISP----NFSRDLRSLISQLF  238 (257)
T ss_pred             c-CCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHhccc-----CCCCCC----CCCHHHHHHHHHHh
Confidence            6 456778999999999999999999999632      1222222221111     111111    12246999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      ..+|++||++.++++.
T Consensus       239 ~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         239 KVSPRDRPSITSILKR  254 (257)
T ss_pred             ccChhhCcCHHHHhhC
Confidence            9999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.3e-24  Score=173.34  Aligned_cols=159  Identities=19%  Similarity=0.234  Sum_probs=128.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ..+.|...++..++..+++|+.|||++ +|++||+||+|++++.+|.+||.|||+++........-+..||+.|.|||.+
T Consensus       513 dRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEII  591 (732)
T KOG0614|consen  513 DRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEII  591 (732)
T ss_pred             hcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhh
Confidence            567888889999999999999999999 9999999999999999999999999999988887777788999999999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . ......++|.||||+++||+++|.+||..-      +....++.+..+.-..        +.+....+...++|.+..
T Consensus       592 L-nKGHD~avDyWaLGIli~ELL~G~pPFs~~------dpmktYn~ILkGid~i--------~~Pr~I~k~a~~Lik~LC  656 (732)
T KOG0614|consen  592 L-NKGHDRAVDYWALGILIYELLTGSPPFSGV------DPMKTYNLILKGIDKI--------EFPRRITKTATDLIKKLC  656 (732)
T ss_pred             h-ccCcchhhHHHHHHHHHHHHHcCCCCCCCC------chHHHHHHHHhhhhhh--------hcccccchhHHHHHHHHH
Confidence            6 566678999999999999999999999742      2223333333322111        111223356788999999


Q ss_pred             cCCCCCCCC-----HHHHHH
Q 048055          169 SLAPENRPV-----MREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps-----~~~l~~  183 (221)
                      ..+|.+|.-     +.||.+
T Consensus       657 r~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  657 RDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             hcCcHhhhccccCChHHHHh
Confidence            999999974     667753

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.90  E-value=9.5e-23  Score=159.78  Aligned_cols=152  Identities=26%  Similarity=0.255  Sum_probs=116.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||.+...... .......++..|++||...
T Consensus        88 ~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  166 (250)
T cd05123          88 GRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL  166 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhC
Confidence            4689999999999999999999998 9999999999999999999999999988654332 2233445677899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +...+.++|+|+||+++|++++|..||....      ..........    .....+  ..    .+..+.+++.+||.
T Consensus       167 -~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~----~~~~~~--~~----~~~~l~~~i~~~l~  229 (250)
T cd05123         167 -GKGYGKAVDWWSLGVLLYEMLTGKPPFYAED------RKEIYEKILK----DPLRFP--EF----LSPEARDLISGLLQ  229 (250)
T ss_pred             -CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc----CCCCCC--CC----CCHHHHHHHHHHhc
Confidence             4556788999999999999999999996421      1222222221    111111  11    13468999999999


Q ss_pred             CCCCCCCCHHH
Q 048055          170 LAPENRPVMRE  180 (221)
Q Consensus       170 ~dp~~Rps~~~  180 (221)
                      .||++||++.+
T Consensus       230 ~~p~~R~~~~~  240 (250)
T cd05123         230 KDPTKRLGSGG  240 (250)
T ss_pred             CCHhhCCCccc
Confidence            99999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=2.7e-23  Score=170.08  Aligned_cols=163  Identities=19%  Similarity=0.210  Sum_probs=115.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...++...+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++........  .....+++.|+|||.
T Consensus        96 ~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~  174 (331)
T cd05624          96 EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI  174 (331)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHH
Confidence            35788999999999999999999998 999999999999999999999999999865443322  123457889999998


Q ss_pred             chhc----CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           88 REIW----KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        88 ~~~~----~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +...    ..++.++|+||+|+++|+|++|..||...      ........+...... ...+.....    ....+.++
T Consensus       175 ~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~~~~~~-~~~p~~~~~----~~~~~~~l  243 (331)
T cd05624         175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHEER-FQFPSHITD----VSEEAKDL  243 (331)
T ss_pred             HhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC------CHHHHHHHHHcCCCc-ccCCCcccc----CCHHHHHH
Confidence            6521    34578899999999999999999999632      111222222111100 011111111    22468899


Q ss_pred             HHHcccCCCCC--CCCHHHHHHH
Q 048055          164 AIACVSLAPEN--RPVMREVSKM  184 (221)
Q Consensus       164 ~~~cl~~dp~~--Rps~~~l~~~  184 (221)
                      +.+|+..++.+  |+++.++++.
T Consensus       244 i~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         244 IQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHccCchhhcCCCCHHHHhcC
Confidence            99999866544  4578888643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=8e-23  Score=163.02  Aligned_cols=157  Identities=25%  Similarity=0.404  Sum_probs=119.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..+++..+..++.|++.|+.|||+. +++|+|++|.||+++.++.++++|||++....... ......++..|++||.+.
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~  174 (277)
T cd06641          96 GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK  174 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhc
Confidence            4688999999999999999999998 99999999999999999999999999886543322 122335567899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +...+.++|+||||+++|++++|..||....      .......+..     ...+....    ..+..+.+++.+||+
T Consensus       175 -~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~----~~~~~~~~~i~~~l~  238 (277)
T cd06641         175 -QSAYDSKADIWSLGITAIELAKGEPPHSELH------PMKVLFLIPK-----NNPPTLEG----NYSKPLKEFVEACLN  238 (277)
T ss_pred             -cCCCCchhhHHHHHHHHHHHHcCCCCCCccc------hHHHHHHHhc-----CCCCCCCc----ccCHHHHHHHHHHcc
Confidence             5566788999999999999999999996321      1111111111     11111111    223468999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .+|.+||++.++++.
T Consensus       239 ~~p~~Rp~~~~~l~~  253 (277)
T cd06641         239 KEPSFRPTAKELLKH  253 (277)
T ss_pred             CChhhCcCHHHHHhC
Confidence            999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=7.2e-23  Score=164.13  Aligned_cols=165  Identities=21%  Similarity=0.243  Sum_probs=118.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++........  .....++..|++||.
T Consensus        99 ~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  177 (288)
T cd05583          99 REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV  177 (288)
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHH
Confidence            35688999999999999999999998 999999999999999999999999998765432211  122346778999998


Q ss_pred             chhcC-CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWK-QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~-~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      ..... ..+.++|+||||+++|++++|..||.....  .............    .  ..+.+..    ....+.+++.+
T Consensus       178 ~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~----~--~~~~~~~----~~~~l~~li~~  245 (288)
T cd05583         178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE--QNSQSEISRRILK----S--KPPFPKT----MSAEARDFIQK  245 (288)
T ss_pred             hcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc--cchHHHHHHHHHc----c--CCCCCcc----cCHHHHHHHHH
Confidence            65221 257789999999999999999999953211  1111111111111    1  1111111    22358899999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.+|++|||+.++.+.|+.
T Consensus       246 ~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         246 LLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HhcCCHhhccCcchHHHHhcC
Confidence            999999999998888766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.89  E-value=3.2e-23  Score=179.92  Aligned_cols=165  Identities=15%  Similarity=0.172  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCCC--CCCCCCCCccccCcccchhc
Q 048055           15 WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~   91 (221)
                      ...+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......  ......+++.|+|||.+...
T Consensus       254 ~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~  332 (566)
T PLN03225        254 NKIIQTIMRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS  332 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhcc
Confidence            345667899999999999998 9999999999999986 5789999999987543221  22345667889999954311


Q ss_pred             C---------------------CCCCcccchHHHHHHHHHHhCCCCCccccc-------ccCCChHHHHHHhhhhhhccC
Q 048055           92 K---------------------QPTQQADVYSFGVLLLELLTGKTPFQDLVL-------EHGSDIPRWVRSVREEETESG  143 (221)
Q Consensus        92 ~---------------------~~~~~~di~slG~~l~~~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~  143 (221)
                      .                     .+..++||||+||++|+|+++..++.....       ..+.....|.......   ..
T Consensus       333 ~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~~  409 (566)
T PLN03225        333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR---AS  409 (566)
T ss_pred             CCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc---cc
Confidence            1                     123456999999999999987666532110       0011111111110000   00


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       144 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..................+|+.+||+.||.+|||+.++++
T Consensus       410 ~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             hhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence            0000000000011124568999999999999999999975

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.89  E-value=9.4e-23  Score=160.97  Aligned_cols=157  Identities=22%  Similarity=0.346  Sum_probs=118.4

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~   87 (221)
                      ....+++..++.++.|++.||.|||+. +++|+|++|.|++++. +.++++|||++...... .......++..|++||.
T Consensus        99 ~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~  176 (260)
T cd08222          99 TGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA  176 (260)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHH
Confidence            346789999999999999999999998 9999999999999975 56999999988654322 22233456778999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||+|+++|++++|..||...      ...........     ...+..    +...+..+.+++.+|
T Consensus       177 ~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~li~~~  240 (260)
T cd08222         177 LK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIVE-----GPTPSL----PETYSRQLNSIMQSM  240 (260)
T ss_pred             Hc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHc-----CCCCCC----cchhcHHHHHHHHHH
Confidence            75 566678899999999999999999998532      11222122111     111111    123345689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.+|++||++.++++
T Consensus       241 l~~~p~~Rp~~~~il~  256 (260)
T cd08222         241 LNKDPSLRPSAAEILR  256 (260)
T ss_pred             hcCChhhCcCHHHHhh
Confidence            9999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.7e-23  Score=166.19  Aligned_cols=176  Identities=25%  Similarity=0.401  Sum_probs=134.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCC-------CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQN-------PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSA   77 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~-------~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~   77 (221)
                      ...++....++++..+++||++||.+       +.|.|||||..|||+..++.+-|+|+|++.......     ......
T Consensus       302 r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rV  381 (513)
T KOG2052|consen  302 RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRV  381 (513)
T ss_pred             hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCcc
Confidence            45788999999999999999999984       568999999999999999999999999985433321     235678


Q ss_pred             CCccccCcccchhcCCC-----CCcccchHHHHHHHHHHhC----------CCCCcccccccCCChHHHHHHhhhhhhcc
Q 048055           78 TSLFYKAPECREIWKQP-----TQQADVYSFGVLLLELLTG----------KTPFQDLVLEHGSDIPRWVRSVREEETES  142 (221)
Q Consensus        78 ~~~~~~~pe~~~~~~~~-----~~~~di~slG~~l~~~~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  142 (221)
                      ||.+|||||.+....+.     =..+||||||.++||++.+          +.||.+..+.+.+ +    +.+++.....
T Consensus       382 GTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~----eeMrkVVCv~  456 (513)
T KOG2052|consen  382 GTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-F----EEMRKVVCVQ  456 (513)
T ss_pred             ceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-H----HHHhcceeec
Confidence            89999999987633222     2568999999999998752          5688765443222 2    2233333333


Q ss_pred             CCCCC-CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          143 GDDPP-SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       143 ~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ..+|. +..+.+.+....+.++|..||..+|..|-|+-.|.+.|.++..
T Consensus       457 ~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  457 KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            33333 2345677788899999999999999999999999999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2.1e-23  Score=158.18  Aligned_cols=168  Identities=20%  Similarity=0.255  Sum_probs=121.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCccccCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYKAP   85 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~p   85 (221)
                      .+|+..++.+++.++.+||.|+|.. .|+|||+|+.|+|++.++.++|+|||+++......     .......|+.|++|
T Consensus       119 vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  119 VRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence            5789999999999999999999998 99999999999999999999999999986443222     12334457899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC------------C-CCCCCChh
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG------------D-DPPSSNEA  152 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------~-~~~~~~~~  152 (221)
                      |.+..+..++.+.|+|..||++.+|++|.+.+++......   ...+..+........            . ..|.+...
T Consensus       198 EllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq---l~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~  274 (376)
T KOG0669|consen  198 ELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ---LHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQ  274 (376)
T ss_pred             HHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH---HHHHHHHhccCCcccCCCcccchHHHhccCCCCCcch
Confidence            9988888999999999999999999999998875322111   111111111110000            0 01111111


Q ss_pred             hH---HH------HHHHHHHHHHcccCCCCCCCCHHHHH
Q 048055          153 SE---EK------LQALLNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       153 ~~---~~------~~~l~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      ..   ..      ....++|+..++.+||.+|+++.+++
T Consensus       275 ~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al  313 (376)
T KOG0669|consen  275 KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL  313 (376)
T ss_pred             hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence            00   11      12578999999999999999998875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=5.1e-23  Score=169.24  Aligned_cols=169  Identities=24%  Similarity=0.355  Sum_probs=117.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.||+.||.|||+. +++|+|++|.||+++.++.++++|||++......  .....++..|++||.+..
T Consensus       113 ~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         113 EKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhC
Confidence            5789999999999999999999998 9999999999999999999999999998654322  123345678999998763


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhh--hccCCCCCC----CChhhHH
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEE--TESGDDPPS----SNEASEE  155 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~--~~~~~~~~~----~~~~~~~  155 (221)
                      ...++.++|+||+|+++|++++|..||.......         ......+...+....  ......+..    .......
T Consensus       190 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (343)
T cd07880         190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN  269 (343)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccC
Confidence            3456788999999999999999999996421100         000000000000000  000000000    0000111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048055          156 KLQALLNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       156 ~~~~l~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      ....+.+++.+|++.||.+||++.+++
T Consensus       270 ~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         270 ANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            223588999999999999999999997

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=7.4e-24  Score=189.12  Aligned_cols=156  Identities=22%  Similarity=0.312  Sum_probs=116.3

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCccccCccc
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYKAPEC   87 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~pe~   87 (221)
                      .+......+..|++.|++|||++ ||||||+||.||+++.+|.+|++|||.+.......     ......||+.|||||.
T Consensus      1331 ~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEv 1409 (1509)
T KOG4645|consen 1331 EDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEV 1409 (1509)
T ss_pred             hhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchh
Confidence            34555566789999999999999 99999999999999999999999999986554332     1134578999999998


Q ss_pred             chhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           88 REIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        88 ~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      +.+.  ..-..++||||+||++.||++|+.||.....    + ..+.-++     ..++.|..+...    ..+-.+|+.
T Consensus      1410 it~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e-~aIMy~V-----~~gh~Pq~P~~l----s~~g~dFle 1475 (1509)
T KOG4645|consen 1410 ITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----E-WAIMYHV-----AAGHKPQIPERL----SSEGRDFLE 1475 (1509)
T ss_pred             hcccccCCCCcchhhhcccceEEEeecCCCchhhccc----h-hHHHhHH-----hccCCCCCchhh----hHhHHHHHH
Confidence            8732  2335789999999999999999999975321    1 1111122     233444433333    345789999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +|++.||..|=++.||++
T Consensus      1476 ~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHHhcCchhhhHHHHHHH
Confidence            999999999977776643

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.89  E-value=2.6e-23  Score=162.38  Aligned_cols=144  Identities=22%  Similarity=0.237  Sum_probs=109.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      .++++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++++|||.+......  ......+..|++||... 
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~-  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG-  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccC-
Confidence            3588999999999999999999998 9999999999999999999999999987544332  12233456799999875 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ...++.++|+||+|+++|++++|..||......           . .. ... ...+  .    .....+.+++.+||+.
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~-~~-~~~-~~~~--~----~~~~~~~~li~~~l~~  215 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------I-NT-HTT-LNIP--E----WVSEEARSLLQQLLQF  215 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------c-cc-ccc-cCCc--c----cCCHHHHHHHHHHccC
Confidence            556678999999999999999999887532110           0 00 000 0001  1    1224589999999999


Q ss_pred             CCCCCCCH
Q 048055          171 APENRPVM  178 (221)
Q Consensus       171 dp~~Rps~  178 (221)
                      ||.+||++
T Consensus       216 dp~~R~~~  223 (237)
T cd05576         216 NPTERLGA  223 (237)
T ss_pred             CHHHhcCC
Confidence            99999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=174.88  Aligned_cols=161  Identities=20%  Similarity=0.350  Sum_probs=120.4

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcccchhc
Q 048055           15 WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~   91 (221)
                      -....+++.||++|++||.+- ++||||+.+.|+|++.++.+||+|||.++......   ......-+.+|+|+|.+. -
T Consensus       636 t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil-l  713 (807)
T KOG1094|consen  636 TAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL-L  713 (807)
T ss_pred             cchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHH-h
Confidence            345566999999999999998 99999999999999999999999999987433222   223344568899999887 6


Q ss_pred             CCCCCcccchHHHHHHHHHHh--CCCCCcccccccCCChHHHHHHh---hhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           92 KQPTQQADVYSFGVLLLELLT--GKTPFQDLVLEHGSDIPRWVRSV---REEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        92 ~~~~~~~di~slG~~l~~~~~--g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+++.++|+|+||+++||+++  .+.||.....+      ..++..   ...... ...++.+.    -++..+.++|.+
T Consensus       714 gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e------~vven~~~~~~~~~~-~~~l~~P~----~cp~~lyelml~  782 (807)
T KOG1094|consen  714 GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE------QVVENAGEFFRDQGR-QVVLSRPP----ACPQGLYELMLR  782 (807)
T ss_pred             ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH------HHHHhhhhhcCCCCc-ceeccCCC----cCcHHHHHHHHH
Confidence            788999999999999999865  89999754322      111111   111100 01112222    234568999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ||..|..+||+++++...|.+.
T Consensus       783 Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  783 CWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HhchhhhcCCCHHHHHHHHHHh
Confidence            9999999999999999988764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.89  E-value=1.1e-22  Score=161.92  Aligned_cols=155  Identities=23%  Similarity=0.335  Sum_probs=117.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-------------------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-------------------   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------------------   71 (221)
                      +.+++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++.......                   
T Consensus        97 ~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (280)
T cd05581          97 GSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN  175 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccc
Confidence            3789999999999999999999998 99999999999999999999999999876543221                   


Q ss_pred             --CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCC
Q 048055           72 --VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSS  149 (221)
Q Consensus        72 --~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (221)
                        ......++..|++||... ....+.++|+||+|++++++++|..||....      ..........    .....+  
T Consensus       176 ~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~----~~~~~~--  242 (280)
T cd05581         176 RRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSN------EYLTFQKILK----LEYSFP--  242 (280)
T ss_pred             ccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHh----cCCCCC--
Confidence              112234567799999875 4567889999999999999999999996431      1111122211    111111  


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVM----REVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~----~~l~~  183 (221)
                      .    ..+..+.+++.+||+.+|.+||++    .++++
T Consensus       243 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         243 P----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             C----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1    113468999999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=1.2e-22  Score=162.95  Aligned_cols=163  Identities=23%  Similarity=0.285  Sum_probs=121.9

Q ss_pred             CCCCCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC---------------
Q 048055            5 RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP---------------   69 (221)
Q Consensus         5 ~~~~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~---------------   69 (221)
                      |..-.++.|+...+.-++.+|+.||+|||-. |||+|||||+|||+..+|++-|+||.++.....               
T Consensus       168 rqkQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~  246 (459)
T KOG0610|consen  168 RQKQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS  246 (459)
T ss_pred             HhhCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC
Confidence            3344688999999999999999999999998 999999999999999999999999987532100               


Q ss_pred             ------------------C-CC-----------------------CCCCCCCccccCcccchhcCCCCCcccchHHHHHH
Q 048055           70 ------------------D-SV-----------------------EEPSATSLFYKAPECREIWKQPTQQADVYSFGVLL  107 (221)
Q Consensus        70 ------------------~-~~-----------------------~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l  107 (221)
                                        . +.                       ....+||-.|+|||.++ +..-+.++|.|+||+++
T Consensus       247 ~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~-G~GHgsAVDWWtfGIfl  325 (459)
T KOG0610|consen  247 QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR-GEGHGSAVDWWTFGIFL  325 (459)
T ss_pred             CcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-cCCCCchhhHHHHHHHH
Confidence                              0 00                       01234566799999998 77778999999999999


Q ss_pred             HHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 048055          108 LELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV----MREVSK  183 (221)
Q Consensus       108 ~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps----~~~l~~  183 (221)
                      |||+.|..||.+....     .. ..++..    ....++...    ....++.+||++.|.+||.+|.-    +.||.+
T Consensus       326 YEmLyG~TPFKG~~~~-----~T-l~NIv~----~~l~Fp~~~----~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  326 YEMLYGTTPFKGSNNK-----ET-LRNIVG----QPLKFPEEP----EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHHHhCCCCcCCCCch-----hh-HHHHhc----CCCcCCCCC----cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            9999999999863221     11 122211    112222211    22346999999999999999987    777753

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=4.6e-23  Score=163.26  Aligned_cols=157  Identities=17%  Similarity=0.242  Sum_probs=116.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .+++++..+..++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||+++......    ......++..|++|
T Consensus       100 ~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         100 YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCH
Confidence            35688899999999999999999998 99999999999999999999999999986542211    11223467789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +...+.++|+||||+++|++++|..||....     ..... ...   . .....+.    .+......+.+++.
T Consensus       179 E~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~-~~~---~-~~~~~~~----~p~~~~~~~~~~i~  243 (264)
T cd06653         179 EVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYE-----AMAAI-FKI---A-TQPTKPM----LPDGVSDACRDFLK  243 (264)
T ss_pred             hhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccC-----HHHHH-HHH---H-cCCCCCC----CCcccCHHHHHHHH
Confidence            9886 5667889999999999999999999996421     11111 111   1 1111111    11123346999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||. +|.+||++.+++.
T Consensus       244 ~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         244 QIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHhc-CcccCccHHHHhc
Confidence            9999 5799999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1e-22  Score=163.94  Aligned_cols=149  Identities=21%  Similarity=0.321  Sum_probs=118.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      -+.|-...++.++.+|+.||-|||++ ||++||+|..||+++..|++||+|||.++.... ..+..+..||+.|+|||.+
T Consensus       444 ~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi  522 (683)
T KOG0696|consen  444 VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEII  522 (683)
T ss_pred             hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceE
Confidence            35677888999999999999999998 999999999999999999999999999976543 3456778999999999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..|+..+|.||+|+++|||+.|++||.+...      ......+-......+.          ...++..+++...+
T Consensus       523 ~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------~elF~aI~ehnvsyPK----------slSkEAv~ickg~l  585 (683)
T KOG0696|consen  523 A-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQAIMEHNVSYPK----------SLSKEAVAICKGLL  585 (683)
T ss_pred             E-ecccccchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHccCcCcc----------cccHHHHHHHHHHh
Confidence            7 89999999999999999999999999986422      1222222221111111          12245777888888


Q ss_pred             cCCCCCCC
Q 048055          169 SLAPENRP  176 (221)
Q Consensus       169 ~~dp~~Rp  176 (221)
                      .+.|.+|.
T Consensus       586 tK~P~kRL  593 (683)
T KOG0696|consen  586 TKHPGKRL  593 (683)
T ss_pred             hcCCcccc
Confidence            99999995

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-22  Score=164.92  Aligned_cols=175  Identities=26%  Similarity=0.424  Sum_probs=123.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCC--------CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQN--------PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATS   79 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~--------~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~   79 (221)
                      -.++|....+++..++.||+|||+.        +.|.|||+|.+|||+..++.+.|+|||++.......   ......||
T Consensus       302 ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  302 NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhh
Confidence            4578999999999999999999994        469999999999999999999999999997655433   22347889


Q ss_pred             ccccCcccchhcCCCC-----CcccchHHHHHHHHHHhCC------------CCCcccccccCCChHHHHHHhhhhhhcc
Q 048055           80 LFYKAPECREIWKQPT-----QQADVYSFGVLLLELLTGK------------TPFQDLVLEHGSDIPRWVRSVREEETES  142 (221)
Q Consensus        80 ~~~~~pe~~~~~~~~~-----~~~di~slG~~l~~~~~g~------------~pf~~~~~~~~~~~~~~~~~~~~~~~~~  142 (221)
                      .+|||||++.+..+..     .+.||||+|.++|||+++-            .||+...   +.. +. .+.+.......
T Consensus       382 ~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev---G~h-Pt-~e~mq~~VV~k  456 (534)
T KOG3653|consen  382 RRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV---GNH-PT-LEEMQELVVRK  456 (534)
T ss_pred             hhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh---cCC-CC-HHHHHHHHHhh
Confidence            9999999987433333     4579999999999999742            2333111   111 00 11122222221


Q ss_pred             CCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          143 GDDPPSS-NEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       143 ~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ..+|..+ .+......+.+++.+..||..||+.|.|+.=+-+++.++..
T Consensus       457 K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  457 KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            1222111 22222445679999999999999999999888788777663

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.89  E-value=2.6e-22  Score=161.05  Aligned_cols=161  Identities=24%  Similarity=0.288  Sum_probs=115.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      .++++...+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++.......  ......++..|++||.
T Consensus        99 ~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  177 (290)
T cd05613          99 RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI  177 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhh
Confidence            35688899999999999999999998 99999999999999999999999999886543321  1123456778999998


Q ss_pred             chhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +... ...+.++|+||||+++|++++|..||.....  .............    .  .++.+..    ....+.+++.+
T Consensus       178 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~----~--~~~~~~~----~~~~~~~ll~~  245 (290)
T cd05613         178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILK----S--EPPYPQE----MSALAKDIIQR  245 (290)
T ss_pred             ccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhc----c--CCCCCcc----CCHHHHHHHHH
Confidence            6522 2346789999999999999999999853211  1111111111111    1  1111111    22468999999


Q ss_pred             cccCCCCCCC-----CHHHHHH
Q 048055          167 CVSLAPENRP-----VMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rp-----s~~~l~~  183 (221)
                      ||+.||.+||     ++.+++.
T Consensus       246 ~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         246 LLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HhcCCHHHhcCCCCCCHHHHHc
Confidence            9999999997     5555543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-22  Score=158.36  Aligned_cols=170  Identities=21%  Similarity=0.325  Sum_probs=123.7

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcC
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK   92 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   92 (221)
                      +.-.+...+..|++.|+.|||+. +|+||||||+||++..+..+||.|||++......-..+....+.+|.|||.+. +.
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil-~~  192 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVIL-GM  192 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchhee-cc
Confidence            34556778899999999999998 99999999999999999999999999997655544455667788999999987 66


Q ss_pred             CCCCcccchHHHHHHHHHHhCCCCCcccc---------cccCCChHHHHHHhhhhh----------h-------ccCCCC
Q 048055           93 QPTQQADVYSFGVLLLELLTGKTPFQDLV---------LEHGSDIPRWVRSVREEE----------T-------ESGDDP  146 (221)
Q Consensus        93 ~~~~~~di~slG~~l~~~~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~----------~-------~~~~~~  146 (221)
                      .+...+||||.||++.||+.|...|.+..         ...+..-.....++..-.          .       .....+
T Consensus       193 ~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f  272 (369)
T KOG0665|consen  193 GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLF  272 (369)
T ss_pred             CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccc
Confidence            68999999999999999999998886321         111111111111111100          0       001112


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          147 PSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       147 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      +...+.+......+.+++.+||-.+|++|.++.++++.
T Consensus       273 ~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  273 PVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            22233333344578999999999999999999999764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.88  E-value=4.9e-22  Score=154.24  Aligned_cols=157  Identities=28%  Similarity=0.376  Sum_probs=120.1

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcC
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK   92 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   92 (221)
                      ++...+..++.+++.++.+||+. +++|+|++|.||+++.++.++++|||.+.............++..|++||... ..
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~-~~  161 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL-GK  161 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc-cC
Confidence            78999999999999999999998 99999999999999999999999999987655443334455677899999876 55


Q ss_pred             CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCC
Q 048055           93 QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAP  172 (221)
Q Consensus        93 ~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp  172 (221)
                      ..+.++|+|++|++++++++|..||...     .........+......    ......   ..+..+.+++.+||..+|
T Consensus       162 ~~~~~~Di~slG~~l~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~i~~~l~~~p  229 (244)
T smart00220      162 GYGKAVDVWSLGVILYELLTGKPPFPGD-----DQLLELFKKIGKPKPP----FPPPEW---KISPEAKDLIRKLLVKDP  229 (244)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHhccCCC----Cccccc---cCCHHHHHHHHHHccCCc
Confidence            6678999999999999999999998531     1222222222211111    110000   022469999999999999


Q ss_pred             CCCCCHHHHHH
Q 048055          173 ENRPVMREVSK  183 (221)
Q Consensus       173 ~~Rps~~~l~~  183 (221)
                      .+||++.++++
T Consensus       230 ~~Rp~~~~~~~  240 (244)
T smart00220      230 EKRLTAEEALQ  240 (244)
T ss_pred             hhccCHHHHhh
Confidence            99999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.2e-22  Score=157.51  Aligned_cols=159  Identities=21%  Similarity=0.282  Sum_probs=123.9

Q ss_pred             CCCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcccc-CCCCCCCCCCCCccccCc
Q 048055            7 SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR-NPDSVEEPSATSLFYKAP   85 (221)
Q Consensus         7 ~~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~~p   85 (221)
                      +-.+++|+.+++..+..+|..||+|||+. ||++||+|..|+|++..|++|+.|+|.++.. .+....++..||+.|.||
T Consensus       342 mqrqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiap  420 (593)
T KOG0695|consen  342 MQRQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP  420 (593)
T ss_pred             hhhhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccch
Confidence            34578999999999999999999999998 9999999999999999999999999999754 455677889999999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCccc-ccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL-VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.++ +..|+..+|.|++|++++||+.|..||.-- +.....+.....-++..+.+....+..+         .....++
T Consensus       421 eilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls---------vkas~vl  490 (593)
T KOG0695|consen  421 EILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS---------VKASHVL  490 (593)
T ss_pred             hhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee---------hhhHHHH
Confidence            9998 899999999999999999999999999621 1112233333333333333322221111         1345566


Q ss_pred             HHcccCCCCCCC
Q 048055          165 IACVSLAPENRP  176 (221)
Q Consensus       165 ~~cl~~dp~~Rp  176 (221)
                      ..-+++||.+|.
T Consensus       491 kgflnkdp~erl  502 (593)
T KOG0695|consen  491 KGFLNKDPKERL  502 (593)
T ss_pred             HHhhcCCcHHhc
Confidence            777889999995

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.88  E-value=4.1e-23  Score=177.60  Aligned_cols=150  Identities=23%  Similarity=0.354  Sum_probs=111.1

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---C--CceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           16 TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---D--FESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~--~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      -....+..|++.||++||+- +|+|||+||+|||++.   +  .+++|+|||+++.....+    ...+..|+-+|+|||
T Consensus       606 i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE  684 (903)
T KOG1027|consen  606 IDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE  684 (903)
T ss_pred             ccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence            34566788999999999998 9999999999999987   3  457899999998765443    234567888999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. ...-..++||||+||++|++++ |..||.+..       .+..+-+.......... + ..    ++  ...+||.
T Consensus       685 ~L~-~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-------~R~~NIl~~~~~L~~L~-~-~~----d~--eA~dLI~  748 (903)
T KOG1027|consen  685 QLR-EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-------ERQANILTGNYTLVHLE-P-LP----DC--EAKDLIS  748 (903)
T ss_pred             HHh-ccccCcccchhhcCceEEEEecCCccCCCchH-------HhhhhhhcCccceeeec-c-Cc----hH--HHHHHHH
Confidence            987 5555779999999999999988 699996432       22111111111111111 1 01    11  5889999


Q ss_pred             HcccCCCCCCCCHHHHH
Q 048055          166 ACVSLAPENRPVMREVS  182 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~  182 (221)
                      +|++.+|..||++.+|+
T Consensus       749 ~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  749 RMLNPDPQLRPSATDVL  765 (903)
T ss_pred             HhcCCCcccCCCHHHHh
Confidence            99999999999999994

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=3.5e-22  Score=171.85  Aligned_cols=166  Identities=22%  Similarity=0.399  Sum_probs=130.6

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCC-C--CCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP-S--ATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~--~~~~~~~~p   85 (221)
                      ...++-.+..+.|+.||+.||.|||.+ .++||||-++|||+.....+|+.|||+++.......... .  ...+.|+|-
T Consensus       791 hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmal  869 (1177)
T KOG1025|consen  791 HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMAL  869 (1177)
T ss_pred             hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHH
Confidence            356777889999999999999999998 999999999999999999999999999988766543322 2  234679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. ...++.++||||||+++||++| |..||.+...      ..+.+.++     .+.+.+.+.-++    ..+..+|
T Consensus       870 e~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------~eI~dlle-----~geRLsqPpiCt----iDVy~~m  933 (1177)
T KOG1025|consen  870 ESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------EEIPDLLE-----KGERLSQPPICT----IDVYMVM  933 (1177)
T ss_pred             HHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------HHhhHHHh-----ccccCCCCCCcc----HHHHHHH
Confidence            9887 7889999999999999999998 9999975432      22222222     223333333333    4689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||..|++.||+|+++...+.+...+
T Consensus       934 vkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             HHHhccCcccCccHHHHHHHHHHHhcC
Confidence            999999999999999998777765543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.87  E-value=9.4e-23  Score=170.53  Aligned_cols=156  Identities=21%  Similarity=0.279  Sum_probs=124.0

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   91 (221)
                      ......+..++.|++++++|||++ +|+|||||++|++++.+..+||+|||++..........+..+++.|.|||.+...
T Consensus       151 r~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~  229 (596)
T KOG0586|consen  151 RMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGK  229 (596)
T ss_pred             cchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCc
Confidence            344478888999999999999999 9999999999999999999999999999887766667788899999999998844


Q ss_pred             CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCC
Q 048055           92 KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLA  171 (221)
Q Consensus        92 ~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  171 (221)
                      ...+..+|+|++|+++|.+++|..||++.      ++.....+........+....          ....+++++++.++
T Consensus       230 ~y~gpe~D~Wslgvvly~LV~GsLPFDG~------~lk~Lr~rvl~gk~rIp~~ms----------~dce~lLrk~lvl~  293 (596)
T KOG0586|consen  230 KYDGPEVDIWSLGVVLYALVEGSLPFDGQ------NLKELRPRVLRGKYRIPFYMS----------CDCEDLLRKFLVLN  293 (596)
T ss_pred             ccCCcceehhhhhhhheeeeecccccCCc------ccccccchheeeeecccceee----------chhHHHHHHhhccC
Confidence            44578899999999999999999999743      332222233222222221111          23668999999999


Q ss_pred             CCCCCCHHHHHHH
Q 048055          172 PENRPVMREVSKM  184 (221)
Q Consensus       172 p~~Rps~~~l~~~  184 (221)
                      |.+|+++.++.+.
T Consensus       294 Pskr~~~dqim~~  306 (596)
T KOG0586|consen  294 PSKRGPCDQIMKD  306 (596)
T ss_pred             ccccCCHHHhhhh
Confidence            9999999999654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.86  E-value=4e-22  Score=147.16  Aligned_cols=112  Identities=23%  Similarity=0.350  Sum_probs=96.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      -++.++....-+++..|+.||.|||++-+++|||+||.|||++.+|.+|++|||.+-.....-..+-..|...|+|||.+
T Consensus       141 ~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri  220 (282)
T KOG0984|consen  141 KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERI  220 (282)
T ss_pred             cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhc
Confidence            46778899999999999999999999878999999999999999999999999998766655544445666789999976


Q ss_pred             hhc---CCCCCcccchHHHHHHHHHHhCCCCCccc
Q 048055           89 EIW---KQPTQQADVYSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        89 ~~~---~~~~~~~di~slG~~l~~~~~g~~pf~~~  120 (221)
                      ..+   ..|+.++|+||||+.+.||.++..||+.+
T Consensus       221 ~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  221 NPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             CcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            532   35688999999999999999999999754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-21  Score=158.43  Aligned_cols=126  Identities=23%  Similarity=0.222  Sum_probs=81.3

Q ss_pred             eEEeccCCccccCCCCCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHh
Q 048055           56 SCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSV  135 (221)
Q Consensus        56 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~  135 (221)
                      |||+|||-+.+...+.  ..-..|..|++||++. +..|+..+||||++|+++|++||...|....-.....-..++..+
T Consensus       393 vKIaDlGNACW~~khF--T~DIQTRQYRapEVll-GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  393 VKIADLGNACWVHKHF--TEDIQTRQYRAPEVLL-GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEEeeccchhhhhhhh--chhhhhhhccCcceee-cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            3445555444332221  2223456799999998 899999999999999999999999999754433333322333222


Q ss_pred             hhhhhccC-----------CCC---------------C------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          136 REEETESG-----------DDP---------------P------SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       136 ~~~~~~~~-----------~~~---------------~------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .......+           ..+               +      ..-..+.+....+.+|+.-||+.+|++|||+.++++
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            22211111           000               0      012344566778999999999999999999999975


Q ss_pred             H
Q 048055          184 M  184 (221)
Q Consensus       184 ~  184 (221)
                      .
T Consensus       550 h  550 (590)
T KOG1290|consen  550 H  550 (590)
T ss_pred             C
Confidence            3

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.86  E-value=3.4e-21  Score=139.66  Aligned_cols=169  Identities=18%  Similarity=0.213  Sum_probs=124.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~   87 (221)
                      -++.+..+.+..++.|++.||.|+|++ ++.|||+||+|.++..+|.+|++|||+++..+ +.+..+....|.+|++|..
T Consensus        94 lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdv  172 (292)
T KOG0662|consen   94 LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV  172 (292)
T ss_pred             cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcce
Confidence            356778889999999999999999999 99999999999999999999999999997654 3345566777899999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccC------------C-----CCCCC
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESG------------D-----DPPSS  149 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------~-----~~~~~  149 (221)
                      +....-|+...|+||.||++.|+.. |.+.|++.      +......++........            +     .++..
T Consensus       173 lfgakly~tsidmwsagcifaelanagrplfpg~------dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypatt  246 (292)
T KOG0662|consen  173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN------DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATT  246 (292)
T ss_pred             eeeeehhccchHhhhcchHHHHHhhcCCCCCCCC------cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccc
Confidence            8755677889999999999999986 88888753      22233333222221111            0     01111


Q ss_pred             Ch--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NE--ASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~--~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+  ..+.....-.+++++.+.-+|..|.+++..++.
T Consensus       247 swsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  247 SWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             hHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            11  111222345778888888999999999877653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=8.1e-22  Score=151.33  Aligned_cols=170  Identities=19%  Similarity=0.294  Sum_probs=120.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPE   86 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe   86 (221)
                      +...|+-+++.-++.||+.||+|||+. +|.||||||.|.|++.|-.+||+|||+++......  ......-|-+|++||
T Consensus       149 SPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPE  227 (449)
T KOG0664|consen  149 SPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPE  227 (449)
T ss_pred             cCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHH
Confidence            567889999999999999999999998 99999999999999999999999999997543322  122334466899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh-------------------hccCCCCC
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE-------------------TESGDDPP  147 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  147 (221)
                      .+.....|+.+.||||.||++.|++.++..|+...      .....+.+.+..                   .......|
T Consensus       228 iLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~------PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~P  301 (449)
T KOG0664|consen  228 LLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG------PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAP  301 (449)
T ss_pred             HhhcchhhcCccceehhhHHHHHHHhhhhhhhccC------hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCC
Confidence            98877788999999999999999998888886321      111111111100                   01111222


Q ss_pred             CCCh-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 048055          148 SSNE-----ASEEKLQALLNIAIACVSLAPENRPVMREVSKMI  185 (221)
Q Consensus       148 ~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L  185 (221)
                      ....     .....-.....+..+++..||.+|.+..+.+..+
T Consensus       302 s~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  302 DTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             CccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1100     0011123456777888999999999988887554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=7.6e-21  Score=164.51  Aligned_cols=159  Identities=22%  Similarity=0.326  Sum_probs=128.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      +..+.+..+.-+++.++.|+.+||.. .++|||+|..|||++.++.+|+.|||++..... .....+..|++.|||||++
T Consensus       117 g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEVi  195 (953)
T KOG0587|consen  117 GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVI  195 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceee
Confidence            67889999999999999999999998 999999999999999999999999999865432 2344677899999999986


Q ss_pred             hhc----CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EIW----KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~~----~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ...    .-+...+|+||||++..||..|.+|+-+....      .       -.......||+....+....+.+-++|
T Consensus       196 ac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------r-------aLF~IpRNPPPkLkrp~kWs~~FndFI  262 (953)
T KOG0587|consen  196 ACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------R-------ALFLIPRNPPPKLKRPKKWSKKFNDFI  262 (953)
T ss_pred             ecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------h-------hhccCCCCCCccccchhhHHHHHHHHH
Confidence            533    34467899999999999999999998643211      1       111233445555556677778899999


Q ss_pred             HHcccCCCCCCCCHHHHH
Q 048055          165 IACVSLAPENRPVMREVS  182 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~  182 (221)
                      ..||.+|-++||++.+++
T Consensus       263 s~cL~Kd~e~RP~~~~ll  280 (953)
T KOG0587|consen  263 STCLVKDYEQRPSTEELL  280 (953)
T ss_pred             HHHHhhccccCcchhhhc
Confidence            999999999999998886

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.83  E-value=2.6e-20  Score=158.28  Aligned_cols=180  Identities=24%  Similarity=0.255  Sum_probs=126.6

Q ss_pred             CCCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCccccCCCCCCCCCCCCccc
Q 048055            7 SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus         7 ~~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      -++...|+....+.++.++..||.|||.+ ||+||||||.||++-...    ..||+|||.|+............||..|
T Consensus       111 PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~Y  189 (732)
T KOG4250|consen  111 PENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEY  189 (732)
T ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhh
Confidence            34677899999999999999999999998 999999999999875432    4689999999988777777888999999


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhh---------------hhccCCCCC
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE---------------ETESGDDPP  147 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~  147 (221)
                      ++||.......++..+|.|||||++|+++||..||........  ...+.......               ...-...+|
T Consensus       190 LhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP  267 (732)
T KOG4250|consen  190 LHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLP  267 (732)
T ss_pred             cChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhhhccCCCceeEeeecccCCceeeeccCC
Confidence            9999886447788999999999999999999999975321110  00111111111               111112333


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHhhH
Q 048055          148 SSNEASEEKLQALLNIAIACVSLAPENRP--VMREVSKMIRDSR  189 (221)
Q Consensus       148 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp--s~~~l~~~L~~~~  189 (221)
                      .+.-.+......+-+++..+|.-+|.+|-  .+.+....+..+.
T Consensus       268 ~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  268 QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            33333344445566667777777888886  4444443333333

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.6e-20  Score=164.88  Aligned_cols=157  Identities=22%  Similarity=0.254  Sum_probs=116.9

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccch
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~~   89 (221)
                      +++.+-+..|+..|+.||.-+|+. |+|||||||.|||++..|++|++|||.+-.+...+  .....+|||.|.+||.+.
T Consensus       171 ~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLq  249 (1317)
T KOG0612|consen  171 RLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQ  249 (1317)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHH
Confidence            789999999999999999999998 99999999999999999999999999986555443  235568999999999765


Q ss_pred             h---c-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           90 I---W-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        90 ~---~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .   + ..|+..+|.||+|+++|||+.|..||....      +..-+.++-. ... .-.+|.....++    ...+||.
T Consensus       250 s~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~-hk~-~l~FP~~~~VSe----eakdLI~  317 (1317)
T KOG0612|consen  250 SQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMN-HKE-SLSFPDETDVSE----EAKDLIE  317 (1317)
T ss_pred             hhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhc-hhh-hcCCCcccccCH----HHHHHHH
Confidence            2   3 567899999999999999999999996321      1111111111 011 112233333444    4677777


Q ss_pred             HcccCCCCCCCC---HHHHH
Q 048055          166 ACVSLAPENRPV---MREVS  182 (221)
Q Consensus       166 ~cl~~dp~~Rps---~~~l~  182 (221)
                      +.+. +|+.|..   +.|+.
T Consensus       318 ~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  318 ALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             HHhc-ChhhhcccccHHHHH
Confidence            6554 7888876   77774

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.4e-20  Score=151.62  Aligned_cols=161  Identities=25%  Similarity=0.385  Sum_probs=119.9

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCC--------CCCCC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDS--------VEEPS   76 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~--------~~~~~   76 (221)
                      ..+.++...+..++.||++||.||... +.|+|.|+||.|||+..   .|.+||.|||+++.+....        ..+..
T Consensus       561 QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQg  640 (775)
T KOG1151|consen  561 QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQG  640 (775)
T ss_pred             hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeeccc
Confidence            356788999999999999999999986 57999999999999965   4678999999998764332        23456


Q ss_pred             CCCccccCcccchhcC---CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc---CCCCCCCC
Q 048055           77 ATSLFYKAPECREIWK---QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES---GDDPPSSN  150 (221)
Q Consensus        77 ~~~~~~~~pe~~~~~~---~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  150 (221)
                      .||.+|++||++..+.   ..+.++||||.|+++|.++.|..||......         ..+.......   ...+|+..
T Consensus       641 AGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---------QdILqeNTIlkAtEVqFP~KP  711 (775)
T KOG1151|consen  641 AGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---------QDILQENTILKATEVQFPPKP  711 (775)
T ss_pred             CceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---------HHHHhhhchhcceeccCCCCC
Confidence            7889999999987553   3478999999999999999999999642111         1111111111   12233333


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      .++.    +..+||++||.+.-++|.+.-++.
T Consensus       712 vVss----eAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  712 VVSS----EAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ccCH----HHHHHHHHHHHhhhhhhhhHHHHc
Confidence            3333    478999999999999999887764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.83  E-value=9.3e-20  Score=142.60  Aligned_cols=172  Identities=21%  Similarity=0.285  Sum_probs=123.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccccCCCC--------CCCCCC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSFRNPDS--------VEEPSA   77 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~--------~~~~~~   77 (221)
                      .++.|+...+.++..+|+.||.|||.+ ||.|||+||+|||......   +||+||.+.-......        ...+..
T Consensus       169 ~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPv  247 (463)
T KOG0607|consen  169 KRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPV  247 (463)
T ss_pred             HhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcc
Confidence            367789999999999999999999998 9999999999999977655   6999998753322111        123345


Q ss_pred             CCccccCcccchh----cCCCCCcccchHHHHHHHHHHhCCCCCccccccc-C---CChHHH-HHHhhhhhhccCCCCCC
Q 048055           78 TSLFYKAPECREI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH-G---SDIPRW-VRSVREEETESGDDPPS  148 (221)
Q Consensus        78 ~~~~~~~pe~~~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~-~---~~~~~~-~~~~~~~~~~~~~~~~~  148 (221)
                      |+..|||||+...    ...|..++|.||||+++|-|++|.+||.+.+..+ +   ...... .+.+....+...+.+|.
T Consensus       248 GSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd  327 (463)
T KOG0607|consen  248 GSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD  327 (463)
T ss_pred             cchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh
Confidence            6677999996332    2356789999999999999999999997543211 1   111111 23344444444555563


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+  ........+++...+..|+..|.++.+++.
T Consensus       328 kdW--ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  328 KDW--AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             hhh--HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            333  334456888999999999999999988865

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.83  E-value=1.5e-21  Score=161.26  Aligned_cols=158  Identities=22%  Similarity=0.297  Sum_probs=124.9

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC---CceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD---FESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      ..++|+...-..++.||+.||.|||-+ +|+|+|+||+|||+...   -.+||+|||+++..+.........||+.|+||
T Consensus       657 EkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaP  735 (888)
T KOG4236|consen  657 EKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAP  735 (888)
T ss_pred             hcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCH
Confidence            456788888888999999999999999 99999999999999754   35899999999999988888889999999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |++. ...|+..-|+||.|+++|.-++|..||...     .++.   +++.....+   .++.   ...+......+||+
T Consensus       736 EVLr-nkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIn---dQIQNAaFM---yPp~---PW~eis~~AidlIn  800 (888)
T KOG4236|consen  736 EVLR-NKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDIN---DQIQNAAFM---YPPN---PWSEISPEAIDLIN  800 (888)
T ss_pred             HHHh-hccccccccceeeeEEEEEEecccccCCCc-----cchh---HHhhccccc---cCCC---chhhcCHHHHHHHH
Confidence            9998 788899999999999999999999999642     1121   222111111   1221   12233345789999


Q ss_pred             HcccCCCCCCCCHHHHH
Q 048055          166 ACVSLAPENRPVMREVS  182 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~  182 (221)
                      ..|+..-.+|-+..+.+
T Consensus       801 ~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             HHHHHHHHHhcchHhhc
Confidence            99999999998877653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.82  E-value=6.8e-20  Score=162.49  Aligned_cols=54  Identities=30%  Similarity=0.484  Sum_probs=50.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      +.++...++.++.||+.||.|||.. +|+|+||||.|||++.++.++|+|||+++
T Consensus        99 ~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          99 GYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            4678899999999999999999998 99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.82  E-value=5.4e-20  Score=137.99  Aligned_cols=169  Identities=18%  Similarity=0.249  Sum_probs=119.3

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      .|+.-.+..++.+++.||.|||+. ||+|||+||.|++++.. -.++++|+|++.+..+.....-...+.+|.-||.+..
T Consensus       128 tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd  206 (338)
T KOG0668|consen  128 TLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD  206 (338)
T ss_pred             hhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee
Confidence            456667888899999999999998 99999999999999865 4589999999988887766656667778899998876


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh---------hccC---------------CCC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE---------TESG---------------DDP  146 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~---------------~~~  146 (221)
                      ...+...-|+|||||.+..|+..+.||...... ...+..+...+-...         ....               ..+
T Consensus       207 y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~F  285 (338)
T KOG0668|consen  207 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRF  285 (338)
T ss_pred             chhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHh
Confidence            778888999999999999999988888532110 111111111110000         0000               000


Q ss_pred             CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          147 PSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       147 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ....... -......+|+.+.|..|-.+|+|+.|.+.
T Consensus       286 i~~~n~h-l~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  286 INSENQH-LVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CCccccc-cCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0000000 00135889999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.81  E-value=2.9e-20  Score=153.33  Aligned_cols=109  Identities=29%  Similarity=0.382  Sum_probs=91.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      -.-.|.+..+..|+.|+..||..|-.. |++|.||||.|||+... ..+||||||.|-..+... -.+...+.+|.|||.
T Consensus       529 ~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEI  606 (752)
T KOG0670|consen  529 RNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEI  606 (752)
T ss_pred             cccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcce
Confidence            345677888999999999999999997 99999999999999865 568999999885544332 233344567999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~  120 (221)
                      +. +..|....|+||.||++||+.+|+..|++.
T Consensus       607 iL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  607 IL-GLPYDYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             ee-cCcccCCccceeeceeeEEeeccceecCCC
Confidence            87 899999999999999999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.1e-19  Score=152.20  Aligned_cols=163  Identities=18%  Similarity=0.226  Sum_probs=109.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCC--CCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE--PSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.|++.||.|||+. +++|+|+||.||+++.++.++|+|||++..........  ....++.|++||.+
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            3467888999999999999999998 99999999999999999999999999986543322111  12336789999975


Q ss_pred             hhcCC-------------------C--CCcccchHHHHHHHHHHhCCC-CCcccccc------cCCChHHHHHHhhhhhh
Q 048055           89 EIWKQ-------------------P--TQQADVYSFGVLLLELLTGKT-PFQDLVLE------HGSDIPRWVRSVREEET  140 (221)
Q Consensus        89 ~~~~~-------------------~--~~~~di~slG~~l~~~~~g~~-pf~~~~~~------~~~~~~~~~~~~~~~~~  140 (221)
                      .....                   +  ..+.|+||+||++++|+++.. ||......      .......|    +. ..
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~----r~-~~  457 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW----RM-YK  457 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH----Hh-hc
Confidence            42110                   1  134699999999999999764 66432100      00111111    00 01


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 048055          141 ESGDDPPSSNEASEEKLQALLNIAIACVSLAP---ENRPVMREVSK  183 (221)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~Rps~~~l~~  183 (221)
                      ......+.    .........+|+.+++..+|   .+|+|+.|+++
T Consensus       458 ~~~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQKYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccCCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111111    11123468899999998766   68999999975

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.78  E-value=1.9e-18  Score=130.87  Aligned_cols=126  Identities=29%  Similarity=0.460  Sum_probs=105.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.+++.++.+||+. +++|+|+++.||+++. .+.++++|||.+....... ..........|++||..
T Consensus        87 ~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  165 (215)
T cd00180          87 GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL  165 (215)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHh
Confidence            4688999999999999999999998 9999999999999999 8999999999886543321 12223456679999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      ......+.+.|+|++|++++++                                               ..+.+++..|+
T Consensus       166 ~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~~~~~~l~~~l  198 (215)
T cd00180         166 LGKGYYSEKSDIWSLGVILYEL-----------------------------------------------PELKDLIRKML  198 (215)
T ss_pred             cccCCCCchhhhHHHHHHHHHH-----------------------------------------------HHHHHHHHHHh
Confidence            6322667889999999999998                                               25889999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.+|.+||++.++++.
T Consensus       199 ~~~p~~R~~~~~l~~~  214 (215)
T cd00180         199 QKDPEKRPSAKEILEH  214 (215)
T ss_pred             hCCcccCcCHHHHhhC
Confidence            9999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.77  E-value=4.2e-18  Score=130.70  Aligned_cols=169  Identities=21%  Similarity=0.278  Sum_probs=108.4

Q ss_pred             CCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC--CCceEEeccCCccccCCCCCCCCCCCC
Q 048055            2 TGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA--DFESCLTDYGLGSFRNPDSVEEPSATS   79 (221)
Q Consensus         2 ~~~~~~~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~   79 (221)
                      +|.++.-....+......+++.|+++||.|+|++ ++||||||.+|||+-.  ..++|++|||.....+..-..  ....
T Consensus       107 gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~--~~~~  183 (378)
T KOG1345|consen  107 GDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY--LEYV  183 (378)
T ss_pred             chhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehh--hhhh
Confidence            3445555567778888899999999999999999 9999999999999843  357999999987543322111  1122


Q ss_pred             ccccCcccchhc--C--CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHH
Q 048055           80 LFYKAPECREIW--K--QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEE  155 (221)
Q Consensus        80 ~~~~~pe~~~~~--~--~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (221)
                      ..|-+||....-  .  ......|+|.||++++.+++|..||+..... ......|..-. +....  ..|..-...++ 
T Consensus       184 ~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~-~rk~~--~~P~~F~~fs~-  258 (378)
T KOG1345|consen  184 NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWL-KRKNP--ALPKKFNPFSE-  258 (378)
T ss_pred             cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHh-cccCc--cCchhhcccCH-
Confidence            346677753311  1  2256789999999999999999999843322 22222222111 11111  11111122222 


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHH
Q 048055          156 KLQALLNIAIACVSLAPENRPVMREV  181 (221)
Q Consensus       156 ~~~~l~~l~~~cl~~dp~~Rps~~~l  181 (221)
                         .+..+..+-+..++++|=...+.
T Consensus       259 ---~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  259 ---KALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ---HHHHHHHHhcCCcccccchhHHH
Confidence               46677788899999988433333

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=5.3e-18  Score=143.09  Aligned_cols=108  Identities=27%  Similarity=0.339  Sum_probs=90.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcccc---------CCC---CC------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR---------NPD---SV------   72 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~---------~~~---~~------   72 (221)
                      +-|+...+..++.++..|+.+.|+. |++||||||.|||++.+|++||.|||++...         ...   ..      
T Consensus       724 gIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~  802 (1034)
T KOG0608|consen  724 GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPS  802 (1034)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCc
Confidence            3567888999999999999999998 9999999999999999999999999997521         100   00      


Q ss_pred             -------------------------CCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 048055           73 -------------------------EEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        73 -------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~  120 (221)
                                               .....||..|+|||++. ...++..+|.||.|+++|||+.|++||...
T Consensus       803 ~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  803 PEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD  874 (1034)
T ss_pred             hhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHhhCCCCccCC
Confidence                                     02235677899999987 577889999999999999999999999754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=8.7e-18  Score=146.21  Aligned_cols=165  Identities=19%  Similarity=0.198  Sum_probs=121.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-----CCCCCCCCCccccCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-----SVEEPSATSLFYKAP   85 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~~p   85 (221)
                      ..++...+--++.|++.|+.|+|+. |+.|||+|++|+++..++.+||+|||.+......     .......++..|+||
T Consensus       415 ~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  415 GKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAP  493 (601)
T ss_pred             cccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCc
Confidence            4678888888999999999999998 9999999999999999999999999987533211     123456777889999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+..........||||.|+++..|.+|+.||.....+....       ......................+...+.+|.
T Consensus       494 E~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~  566 (601)
T KOG0590|consen  494 EVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRNIFEGPNRLLSLLPRETRIIIY  566 (601)
T ss_pred             ccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccccccChHHHHHhchhhHHHHHH
Confidence            998733333677899999999999999999997543322111       0000000011111222333445567899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      ++|+.||.+|.|+.+|++
T Consensus       567 ~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  567 RMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHccCChhheecHHHHhh
Confidence            999999999999999975

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.71  E-value=1.6e-17  Score=133.85  Aligned_cols=107  Identities=29%  Similarity=0.426  Sum_probs=86.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCcccc-----------------CC-CC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFR-----------------NP-DS   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~-----------------~~-~~   71 (221)
                      ..++...+..++..++.||.++|+. ||+|||+||.|+|.+.. ++-.|.|||++...                 .. .+
T Consensus       127 ~~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g  205 (418)
T KOG1167|consen  127 RSLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMG  205 (418)
T ss_pred             hcCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCcccc
Confidence            4567889999999999999999999 99999999999999865 55689999997610                 00 00


Q ss_pred             ---------------------------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCc
Q 048055           72 ---------------------------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ  118 (221)
Q Consensus        72 ---------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~  118 (221)
                                                 ..-...||++|+|||++.....-+.+.||||.|+++..++++..||.
T Consensus       206 ~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  206 KDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             CcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence                                       00113467889999988767777899999999999999999999985

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.70  E-value=3.5e-17  Score=138.61  Aligned_cols=161  Identities=20%  Similarity=0.320  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++..++..+++..+.||+|||+. |-+|||+|..||+++..|.++++|||.+...... .......||++|||||+.
T Consensus       106 TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEva  184 (829)
T KOG0576|consen  106 TGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA  184 (829)
T ss_pred             cccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHH
Confidence            57888899999999999999999999 8899999999999999999999999997554433 234567899999999963


Q ss_pred             h--hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           89 E--IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        89 ~--~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .  ....|...+|+|++|+...|+..-++|-.+...      .+....+-...    ..++..+ -.......+.+|+..
T Consensus       185 averkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTkS~----~qpp~lk-Dk~kws~~fh~fvK~  253 (829)
T KOG0576|consen  185 AVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTKSG----FQPPTLK-DKTKWSEFFHNFVKG  253 (829)
T ss_pred             HHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhccC----CCCCccc-CCccchHHHHHHHHH
Confidence            3  245678999999999999999877777543221      11111111111    1122111 111223469999999


Q ss_pred             cccCCCCCCCCHHHHH
Q 048055          167 CVSLAPENRPVMREVS  182 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~  182 (221)
                      |+-++|.+||++..++
T Consensus       254 altknpKkRptaeklL  269 (829)
T KOG0576|consen  254 ALTKNPKKRPTAEKLL  269 (829)
T ss_pred             HhcCCCccCCChhhhe
Confidence            9999999999998875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.69  E-value=1.1e-17  Score=139.68  Aligned_cols=107  Identities=20%  Similarity=0.350  Sum_probs=92.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...++...+..++.||+.|+++||+. +|+|||||-+|+.++.+|-+|++|||.+.....+ ......||..|.|||.+.
T Consensus       664 kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~  741 (772)
T KOG1152|consen  664 KPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLG  741 (772)
T ss_pred             cCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhC
Confidence            45678889999999999999999999 9999999999999999999999999988554433 345678999999999997


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQ  118 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~  118 (221)
                      .....+...|||++|+++|.++..+.||.
T Consensus       742 g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  742 GEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            33344778899999999999999999985

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.69  E-value=7.3e-16  Score=125.76  Aligned_cols=185  Identities=20%  Similarity=0.272  Sum_probs=132.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-----CceEEeccCCcc--ccC-CCC-------C-C
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-----FESCLTDYGLGS--FRN-PDS-------V-E   73 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-----~~~~l~dfg~~~--~~~-~~~-------~-~   73 (221)
                      .+.|+..+++.++.|++.+|.++|+. |++||||||.|++++..     ..+.+.|||+++  ... ...       . .
T Consensus       116 ~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~  194 (322)
T KOG1164|consen  116 PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQK  194 (322)
T ss_pred             CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCc
Confidence            68999999999999999999999998 99999999999999876     358999999997  211 111       1 2


Q ss_pred             CCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhh
Q 048055           74 EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS  153 (221)
Q Consensus        74 ~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (221)
                      ....||..|.++.... +...+.+.|+||++.++.++..|..||.......  ..    ..+...........  .....
T Consensus       195 ~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~--~~----~~~~~~~~~~~~~~--~~~~~  265 (322)
T KOG1164|consen  195 GLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD--LK----SKFEKDPRKLLTDR--FGDLK  265 (322)
T ss_pred             cCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccc--hH----HHHHHHhhhhcccc--ccCCC
Confidence            2345889999999876 6777899999999999999999999996532211  11    11111111111000  11111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCccccCC
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQ  211 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (221)
                         +..+.+++..+-..+...+|....+...|++.....    ......+.+|.....
T Consensus       266 ---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~----~~~~~~~~dw~~~~~  316 (322)
T KOG1164|consen  266 ---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE----GSKEDSPFDWEVKLR  316 (322)
T ss_pred             ---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc----CCCCCCCCccccccc
Confidence               234666777777799999999999999988877654    344447888887643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.68  E-value=2.6e-16  Score=132.00  Aligned_cols=177  Identities=28%  Similarity=0.425  Sum_probs=124.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      .-.+++.....+..+|+.||.|+|..+...|+.++..|++++..+.+|+.|||+.......   ...........|.+||
T Consensus        42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPe  121 (484)
T KOG1023|consen   42 DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPE  121 (484)
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHH
Confidence            4566788889999999999999999844489999999999999999999999987554320   1111222345699999


Q ss_pred             cchhc--CC----CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           87 CREIW--KQ----PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        87 ~~~~~--~~----~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      .++..  ..    .+.+.|+||||++++|++..+.||.........  ...+.++.... ....+|.  .....+....+
T Consensus       122 llr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~--~eii~~~~~~~-~~~~rP~--i~~~~e~~~~l  196 (484)
T KOG1023|consen  122 LLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP--DEIILRVKKGG-SNPFRPS--IELLNELPPEL  196 (484)
T ss_pred             HhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh--HHHHHHHHhcC-CCCcCcc--hhhhhhcchHH
Confidence            87632  11    356789999999999999999999764332111  23333333301 1111111  11111334479


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ..++..||..+|..||++.++-..++.....
T Consensus       197 ~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  197 LLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9999999999999999999998888877653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.65  E-value=5e-17  Score=128.56  Aligned_cols=142  Identities=21%  Similarity=0.294  Sum_probs=94.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+....++.+..|++..+++||+. |++|+||+++|++++.+|.+.|+||+.....+....  ....+..|.+||....
T Consensus       140 ~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~  216 (288)
T PF14531_consen  140 SPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESC  216 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHH
T ss_pred             chhHHHHHHHHHHHHHHHHHHHhhc-ceEecccceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhh
Confidence            3445556677789999999999999 999999999999999999999999987544333221  1334466889996542


Q ss_pred             c-------CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           91 W-------KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        91 ~-------~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      .       ..++.+.|.|++|+++|.++++..||...........                   .-..|. ..+..+..|
T Consensus       217 ~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~L  276 (288)
T PF14531_consen  217 AGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFL  276 (288)
T ss_dssp             HTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHH
T ss_pred             hcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHH
Confidence            2       2457788999999999999999999964322111100                   111222 455679999


Q ss_pred             HHHcccCCCCCC
Q 048055          164 AIACVSLAPENR  175 (221)
Q Consensus       164 ~~~cl~~dp~~R  175 (221)
                      |..+|+.+|++|
T Consensus       277 I~~lL~~~~~~R  288 (288)
T PF14531_consen  277 IRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHT-SSGGGS
T ss_pred             HHHHccCCcccC
Confidence            999999999988

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.64  E-value=3.8e-15  Score=117.54  Aligned_cols=186  Identities=15%  Similarity=0.216  Sum_probs=137.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-----CceEEeccCCccccCCCCCC--------CC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-----FESCLTDYGLGSFRNPDSVE--------EP   75 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-----~~~~l~dfg~~~~~~~~~~~--------~~   75 (221)
                      +++.|+..+++.++.|++.-+.|+|++ .+|+|||||+|+|+...     ..+.++|||+++.+....+.        ..
T Consensus       117 CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KS  195 (449)
T KOG1165|consen  117 CGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKS  195 (449)
T ss_pred             hcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccc
Confidence            578999999999999999999999999 99999999999999754     45789999999876554432        34


Q ss_pred             CCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHH
Q 048055           76 SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEE  155 (221)
Q Consensus        76 ~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (221)
                      ..||.+||+..... +.+-+...|+-|+|-++.+.+.|..||+++-.   .+...-++++-     ......+..+....
T Consensus       196 LsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA---~tnK~kYeKIG-----e~Kr~T~i~~Lc~g  266 (449)
T KOG1165|consen  196 LSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKA---DTNKEKYEKIG-----ETKRSTPIEVLCEG  266 (449)
T ss_pred             cccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccC---cchHHHHHHhc-----cccccCCHHHHHhc
Confidence            57888999998776 67778899999999999999999999997632   22222222221     12222222333334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCccc
Q 048055          156 KLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSD  208 (221)
Q Consensus       156 ~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~  208 (221)
                      .+.++..-+...-.++=.+-|+.+.+...+.+..+.    ...+..-.+||..
T Consensus       267 ~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr----~g~t~Dg~yDW~~  315 (449)
T KOG1165|consen  267 FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR----LGETDDGEYDWMG  315 (449)
T ss_pred             CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh----cCCcccccccccc
Confidence            455677777777788999999998888777777664    3344555566654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.64  E-value=5.8e-16  Score=119.03  Aligned_cols=106  Identities=34%  Similarity=0.483  Sum_probs=89.8

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccchh
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECREI   90 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~~~   90 (221)
                      +++..+..++.+++.++.+||+. +++|+|+++.|++++.++.++++|||.+.......  ......+...|++||....
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  173 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLG  173 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcC
Confidence            78899999999999999999998 99999999999999999999999999886654432  2233455667999998732


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      ....+.++|+|+||++++++++|..||..
T Consensus       174 ~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      174 GKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            45566799999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.63  E-value=9.1e-16  Score=118.22  Aligned_cols=160  Identities=23%  Similarity=0.338  Sum_probs=112.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcCCCceEEe--ccCCccccCCCCCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGADFESCLT--DYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      .+-.+.-.++++++.+|+.|++|||+- +-|....+....++++.+...+|.  |--++   .   ........+.|++|
T Consensus       282 t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---f---qe~gr~y~pawmsp  355 (448)
T KOG0195|consen  282 TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---F---QEVGRAYSPAWMSP  355 (448)
T ss_pred             ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---e---eccccccCcccCCH
Confidence            344556778999999999999999996 345556788899999998877764  32222   1   12233446789999


Q ss_pred             ccchhcCCC--CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           86 ECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        86 e~~~~~~~~--~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      |.+......  ..++|+|||++++||+.+++.||.+..+. +..+      ...........+|..       ..-+.++
T Consensus       356 ealqrkped~n~raadmwsfaillwel~trevpfadlspm-ecgm------kialeglrv~ippgi-------s~hm~kl  421 (448)
T KOG0195|consen  356 EALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-ECGM------KIALEGLRVHIPPGI-------SRHMNKL  421 (448)
T ss_pred             HHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-hhhh------hhhhccccccCCCCc-------cHHHHHH
Confidence            987643322  46789999999999999999999865432 1111      111112222333322       2358899


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      |.-|+..||.+||.+..|+-.||+.
T Consensus       422 m~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  422 MNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHhcCCCCcCCCcceehhhHHHh
Confidence            9999999999999999999888874

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.56  E-value=6.3e-15  Score=131.19  Aligned_cols=154  Identities=23%  Similarity=0.255  Sum_probs=106.4

Q ss_pred             CCCc-CHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCC-------CCCCCCCCc
Q 048055           10 GKPL-HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDS-------VEEPSATSL   80 (221)
Q Consensus        10 ~~~l-~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~-------~~~~~~~~~   80 (221)
                      .+|| ..-+..=+++|++.||..+|.. ||+|+|||.+|||++.=+++.|+||...+.-. +..       ...+.....
T Consensus       113 TRPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRt  191 (1431)
T KOG1240|consen  113 TRPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRT  191 (1431)
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCcee
Confidence            3444 4555666789999999999999 99999999999999999999999998654311 111       112233334


Q ss_pred             cccCcccchhcC----------CCCCcccchHHHHHHHHHHh-CCCCCcccc----ccc-CCChHHHHHHhhhhhhccCC
Q 048055           81 FYKAPECREIWK----------QPTQQADVYSFGVLLLELLT-GKTPFQDLV----LEH-GSDIPRWVRSVREEETESGD  144 (221)
Q Consensus        81 ~~~~pe~~~~~~----------~~~~~~di~slG~~l~~~~~-g~~pf~~~~----~~~-~~~~~~~~~~~~~~~~~~~~  144 (221)
                      -|.|||.+....          ....+=||||+||++.|+++ |.++|.-..    ... ........+.+        .
T Consensus       192 CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I--------e  263 (1431)
T KOG1240|consen  192 CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI--------E  263 (1431)
T ss_pred             eecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC--------c
Confidence            599999765321          13456699999999999987 899996210    000 00001111111        0


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          145 DPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       145 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                                  ...+++++..|++.||.+|.++++.++.
T Consensus       264 ------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  264 ------------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence                        0148999999999999999999999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.56  E-value=3.7e-15  Score=123.71  Aligned_cols=147  Identities=27%  Similarity=0.437  Sum_probs=109.1

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-------CCCCCCCCc
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-------VEEPSATSL   80 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~   80 (221)
                      ......++...+.++.|++.|+.|   + +.+|+|+||.||++..+..++|+|||+........       ..+...++.
T Consensus       351 ~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~  426 (516)
T KOG1033|consen  351 RTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTL  426 (516)
T ss_pred             CcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhccccc
Confidence            345556788899999999999999   5 89999999999999999999999999976544333       335567899


Q ss_pred             cccCcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCC-CCChhhHHHHH
Q 048055           81 FYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPP-SSNEASEEKLQ  158 (221)
Q Consensus        81 ~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  158 (221)
                      .|++||.+. +..++.++|||+||++++|++. -...|...-         ....++.+.     .++ ...+++     
T Consensus       427 ~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------t~~d~r~g~-----ip~~~~~d~p-----  486 (516)
T KOG1033|consen  427 LYMSPEQIR-GQQYSEKVDIYALGLILAELLIQFSTQFERIA---------TLTDIRDGI-----IPPEFLQDYP-----  486 (516)
T ss_pred             ccCCHHHHh-hhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------hhhhhhcCC-----CChHHhhcCc-----
Confidence            999999997 7899999999999999999987 455554210         011111111     111 112222     


Q ss_pred             HHHHHHHHcccCCCCCCCCH
Q 048055          159 ALLNIAIACVSLAPENRPVM  178 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~  178 (221)
                      .-..|+.+++...|.+||++
T Consensus       487 ~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  487 EEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             HHHHHHHHhcCCCcccCchH
Confidence            23578999999999999944

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.54  E-value=1.4e-13  Score=110.55  Aligned_cols=169  Identities=25%  Similarity=0.313  Sum_probs=120.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCC-------CCCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDS-------VEEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~   82 (221)
                      ..++......+..|++.++.|+|+. +++|||+||.|++++..+ .+++.|||.+.......       ......++..|
T Consensus        96 ~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~  174 (384)
T COG0515          96 GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY  174 (384)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccccc
Confidence            3688899999999999999999998 999999999999999988 79999999986443322       23556778899


Q ss_pred             cCcccchhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc-cCCCCCCCChhhHHHHHH
Q 048055           83 KAPECREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE-SGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        83 ~~pe~~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  159 (221)
                      ++||.....  .......|+|++|+++++++.|..||......  .........+...... ......  ..........
T Consensus       175 ~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  250 (384)
T COG0515         175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTPSLASPLS--PSNPELISKA  250 (384)
T ss_pred             CCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCcccccccC--ccccchhhHH
Confidence            999987632  46688899999999999999999997543210  0112222222222211 000000  0000122246


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          160 LLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      +.+++..++..+|..|.+..+....
T Consensus       251 ~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         251 ASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHHHhcCchhcCCHHHHhhc
Confidence            8899999999999999988776554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=8.6e-14  Score=112.44  Aligned_cols=153  Identities=19%  Similarity=0.245  Sum_probs=102.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC--C--ceEEeccCCccccCCCCC-------CCCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD--F--ESCLTDYGLGSFRNPDSV-------EEPSATS   79 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~--~--~~~l~dfg~~~~~~~~~~-------~~~~~~~   79 (221)
                      ...+......++.|+++|+.|||++ |+.|||+|.+|||+.-+  +  .+.++|||.+-.-...+.       .....|.
T Consensus       336 ~~~s~r~~~~~laQlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN  414 (598)
T KOG4158|consen  336 RHRSYRTGRVILAQLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN  414 (598)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence            3456667778899999999999999 99999999999998543  2  367899998643222211       1223455


Q ss_pred             ccccCcccchh--cCCC---CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhH
Q 048055           80 LFYKAPECREI--WKQP---TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE  154 (221)
Q Consensus        80 ~~~~~pe~~~~--~~~~---~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (221)
                      ...+|||....  +...   =.++|.|+.|.+.||++....||...-.. ...         .........++.+..++ 
T Consensus       415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~---------~r~Yqe~qLPalp~~vp-  483 (598)
T KOG4158|consen  415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLD---------TRTYQESQLPALPSRVP-  483 (598)
T ss_pred             ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eec---------hhhhhhhhCCCCcccCC-
Confidence            56899997542  1111   25899999999999999999999752111 000         00111122223233333 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH
Q 048055          155 EKLQALLNIAIACVSLAPENRPVM  178 (221)
Q Consensus       155 ~~~~~l~~l~~~cl~~dp~~Rps~  178 (221)
                         ..+.+++...++.||.+|++.
T Consensus       484 ---p~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  484 ---PVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             ---hHHHHHHHHHhcCCccccCCc
Confidence               358889999999999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.49  E-value=4.1e-14  Score=125.66  Aligned_cols=136  Identities=21%  Similarity=0.275  Sum_probs=101.4

Q ss_pred             HHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----------------CCCCCCCCccccCcccch
Q 048055           26 ASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----------------VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        26 ~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++|+|+. +|+|||+||.|.++..-|++|+.|||+.+......                ......+++.|.|||++.
T Consensus       153 vla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  153 VLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            6789999998 99999999999999999999999999986422111                113347789999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       -..|+..+|.|++|+++|+.+-|..||.+.      ........+......-...   ..    ..+.++++++.+.|+
T Consensus       232 -rqgygkpvdwwamGiIlyeFLVgcvpffGd------tpeelfg~visd~i~wpE~---de----a~p~Ea~dli~~LL~  297 (1205)
T KOG0606|consen  232 -RQGYGKPVDWWAMGIILYEFLVGCVPFFGD------TPEELFGQVISDDIEWPEE---DE----ALPPEAQDLIEQLLR  297 (1205)
T ss_pred             -hhccCCCccHHHHHHHHHHHheeeeeccCC------CHHHHHhhhhhhhcccccc---Cc----CCCHHHHHHHHHHHH
Confidence             577899999999999999999999999753      2223233333322222111   11    122358899999999


Q ss_pred             CCCCCCC
Q 048055          170 LAPENRP  176 (221)
Q Consensus       170 ~dp~~Rp  176 (221)
                      .+|..|-
T Consensus       298 qnp~~Rl  304 (1205)
T KOG0606|consen  298 QNPLCRL  304 (1205)
T ss_pred             hChHhhc
Confidence            9999995

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.45  E-value=8.2e-14  Score=117.89  Aligned_cols=144  Identities=27%  Similarity=0.291  Sum_probs=111.2

Q ss_pred             CCCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055            7 SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus         7 ~~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ......++......+...++.++.++|+. +++|+|+|++||+++.+|++++.|||+++........   .++..||+||
T Consensus        88 l~~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApE  163 (612)
T KOG0603|consen   88 LSKEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPE  163 (612)
T ss_pred             cccCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhH
Confidence            34566677888888899999999999998 9999999999999999999999999998765544332   6788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+.   .....+|.||||++.+++++|..||..          ....++.....      .    .+.+....+.+++..
T Consensus       164 I~~---gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~~------~----~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  164 IIN---GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAEL------E----MPRELSAEARSLFRQ  220 (612)
T ss_pred             hhh---ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhcc------C----CchhhhHHHHHHHHH
Confidence            875   346788999999999999999999974          11222222111      1    112223457788888


Q ss_pred             cccCCCCCCCC
Q 048055          167 CVSLAPENRPV  177 (221)
Q Consensus       167 cl~~dp~~Rps  177 (221)
                      +...+|.+|.-
T Consensus       221 l~~r~p~nrLg  231 (612)
T KOG0603|consen  221 LFKRNPENRLG  231 (612)
T ss_pred             HHhhCHHHHhc
Confidence            99999999964

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.43  E-value=3e-13  Score=102.72  Aligned_cols=173  Identities=17%  Similarity=0.230  Sum_probs=121.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC---CceEEeccCCccccCCCCC--------CCCCC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD---FESCLTDYGLGSFRNPDSV--------EEPSA   77 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~---~~~~l~dfg~~~~~~~~~~--------~~~~~   77 (221)
                      ..+.|++.+++.++.|++.-++|+|.+ +.+||||||+|+|...+   ..+.++|||+++.......        .....
T Consensus       104 C~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~lt  182 (341)
T KOG1163|consen  104 CSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLT  182 (341)
T ss_pred             HhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccc
Confidence            467899999999999999999999998 99999999999999765   4578999999975433221        23345


Q ss_pred             CCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHH
Q 048055           78 TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKL  157 (221)
Q Consensus        78 ~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (221)
                      ||.+|.+..... +..-+...|+-|+|.++.+.-.|..||++.....   -..-.+++......     .+........+
T Consensus       183 GTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t---k~QKyEkI~EkK~s-----~~ie~LC~G~P  253 (341)
T KOG1163|consen  183 GTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT---KKQKYEKISEKKMS-----TPIEVLCKGFP  253 (341)
T ss_pred             eeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhh---HHHHHHHHHHhhcC-----CCHHHHhCCCc
Confidence            677887766554 4555788999999999988888999998764221   11222222221111     11111111233


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          158 QALLNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       158 ~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .++.-.+..|-.+-=++-|+...+.+.++.+-..
T Consensus       254 ~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  254 AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            5678888889888889999988877776665543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.22  E-value=5.3e-10  Score=91.72  Aligned_cols=189  Identities=17%  Similarity=0.269  Sum_probs=135.4

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh-
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI-   90 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~-   90 (221)
                      -+.|+..++.++.++.+.+-||.+ |.+-+|+.+.|+|+++.+.+.+.|-.......+.....+..+...|++||.... 
T Consensus       113 ~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~  191 (637)
T COG4248         113 HCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLP  191 (637)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccc
Confidence            457999999999999999999998 988899999999999999999988655444455556677788889999996431 


Q ss_pred             ---cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHH--HHH---hhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           91 ---WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW--VRS---VREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        91 ---~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                         +.......|.|.||+++++++. |..||.+...-.....+..  +..   ........+..+++......-.+..+.
T Consensus       192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vq  271 (637)
T COG4248         192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQ  271 (637)
T ss_pred             cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHH
Confidence               2334567899999999999977 5899976532211111100  000   111123334445544444445556788


Q ss_pred             HHHHHcccC--CCCCCCCHHHHHHHHHhhHHHhhcCCCCCCC
Q 048055          162 NIAIACVSL--APENRPVMREVSKMIRDSRAEAQMSSNSSDH  201 (221)
Q Consensus       162 ~l~~~cl~~--dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~  201 (221)
                      .+..+|+..  .+.-||++.-.+..|..+.++.+....+.-+
T Consensus       272 AlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H  313 (637)
T COG4248         272 ALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH  313 (637)
T ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence            899999943  4678999999999999998888776555444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.12  E-value=5.4e-11  Score=90.18  Aligned_cols=100  Identities=19%  Similarity=0.215  Sum_probs=70.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeCc-CCCCeEEcCCCceEEeccCCccccCCCCCC--------------CCCCCCcccc
Q 048055           19 LKIAEDLASGLLYIHQNPGLTHGNL-KSSNVLLGADFESCLTDYGLGSFRNPDSVE--------------EPSATSLFYK   83 (221)
Q Consensus        19 ~~~~~~i~~gl~~lH~~~~i~h~dl-k~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~   83 (221)
                      ..++.|++.+|.++|.. |++|+|| ||.||+++.++.++|+|||++.........              .-...++.++
T Consensus        94 ~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l  172 (218)
T PRK12274         94 LAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAAL  172 (218)
T ss_pred             HHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            45778999999999998 9999999 799999999999999999999744332210              0011234456


Q ss_pred             CcccchhcCCCC-CcccchHHHHHHHHHHhCCCCCcc
Q 048055           84 APECREIWKQPT-QQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        84 ~pe~~~~~~~~~-~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      .|+....-...+ ...+.++.|+-+|.++|+..++..
T Consensus       173 ~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        173 TPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            665322111222 334556789999999998887653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.06  E-value=2.1e-10  Score=94.50  Aligned_cols=70  Identities=24%  Similarity=0.274  Sum_probs=55.8

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeCc-CCCCeEEcCCCceEEeccCCccccCCCCCC---------CCCCCCccccCcccc
Q 048055           19 LKIAEDLASGLLYIHQNPGLTHGNL-KSSNVLLGADFESCLTDYGLGSFRNPDSVE---------EPSATSLFYKAPECR   88 (221)
Q Consensus        19 ~~~~~~i~~gl~~lH~~~~i~h~dl-k~~nil~~~~~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~~pe~~   88 (221)
                      ..++.|++.+|.|||+. |++|||| ||.||+++.++.++|+|||+++........         ....++..|.+||.+
T Consensus       114 ~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        114 PAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             HHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            46788999999999998 9999999 999999999999999999998755433211         122345568899976


Q ss_pred             h
Q 048055           89 E   89 (221)
Q Consensus        89 ~   89 (221)
                      .
T Consensus       193 ~  193 (365)
T PRK09188        193 T  193 (365)
T ss_pred             C
Confidence            5

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.05  E-value=2.8e-10  Score=85.93  Aligned_cols=55  Identities=16%  Similarity=0.164  Sum_probs=49.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHh-cCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYI-HQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~l-H~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      .++++...+..++.|++.+|.++ |+. +++|+|+||.||+++ ++.++++|||++..
T Consensus       111 ~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         111 DAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence            45788999999999999999999 687 999999999999998 47899999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=4.5e-11  Score=104.55  Aligned_cols=159  Identities=25%  Similarity=0.320  Sum_probs=114.4

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhc-CCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCC-CC---CCCCCCC-CccccC
Q 048055           12 PLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNP-DS---VEEPSAT-SLFYKA   84 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH-~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~-~~---~~~~~~~-~~~~~~   84 (221)
                      ..+...+..++.|+..++.|+| .. ++.|+|++|+|.+++..+ .++++|||++..... .+   ......+ ++.|.+
T Consensus       119 ~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a  197 (601)
T KOG0590|consen  119 GTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGA  197 (601)
T ss_pred             CCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCC
Confidence            4456678889999999999999 66 999999999999999999 999999999875544 22   2334456 888999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ||............|+||.|+++..+++|..|+.......... ..+...-    .....      ...........++.
T Consensus       198 ~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~----~~~~~------~~~~~~~~~~~~~l  266 (601)
T KOG0590|consen  198 PEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK----GRFTQ------LPWNSISDQAHDLL  266 (601)
T ss_pred             cccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc----ccccc------CccccCChhhhhcc
Confidence            9987632455778899999999999999999997654332111 1110000    00000      11111223578888


Q ss_pred             HHcccCCCCCCCCHHHHH
Q 048055          165 IACVSLAPENRPVMREVS  182 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~  182 (221)
                      .+++..+|..|.+.+++.
T Consensus       267 ~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  267 HKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccCCchhcccccccc
Confidence            999999999999988774

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=4e-10  Score=89.50  Aligned_cols=157  Identities=18%  Similarity=0.214  Sum_probs=101.4

Q ss_pred             CCCCCCcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcCCCceEEeccCCccc--cCC-C--CCCCCCCCCc
Q 048055            7 SGGGKPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP-D--SVEEPSATSL   80 (221)
Q Consensus         7 ~~~~~~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~--~~~-~--~~~~~~~~~~   80 (221)
                      ..+++.+......+|+.||++||.|||+. +-++|+++.-..+++..++.+|+........  ... .  ....-..+-+
T Consensus       167 ~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~  246 (458)
T KOG1266|consen  167 KKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLP  246 (458)
T ss_pred             HHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCC
Confidence            34577788888999999999999999997 5789999999999999999888865332111  000 0  0111223345


Q ss_pred             cccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           81 FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        81 ~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      +|.+|+.-. ..+.+.++|||+||+...+|..++..-......  ..    .+.-...........            .=
T Consensus       247 g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~--~~----~ee~ia~~i~~len~------------lq  307 (458)
T KOG1266|consen  247 GFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESK--VE----VEENIANVIIGLENG------------LQ  307 (458)
T ss_pred             ccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcce--ee----hhhhhhhheeeccCc------------cc
Confidence            678888643 345577899999999999988776542211000  00    000000000000000            12


Q ss_pred             HHHHHHcccCCCCCCCCHHHHH
Q 048055          161 LNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      ..++.+|++-.|..||++++++
T Consensus       308 r~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  308 RGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             cCcCcccccCCCCCCcchhhhh
Confidence            4578899999999999999985

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=2.2e-09  Score=96.98  Aligned_cols=160  Identities=17%  Similarity=0.112  Sum_probs=111.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-------CCceEEeccCCccccCCC---CCCCCCCC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-------DFESCLTDYGLGSFRNPD---SVEEPSAT   78 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-------~~~~~l~dfg~~~~~~~~---~~~~~~~~   78 (221)
                      +.+.+++..++.++.|++.-+..||.. +|||+||||+|+++..       ...++|+|||.+--+...   ........
T Consensus       787 ~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~  865 (974)
T KOG1166|consen  787 TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWH  865 (974)
T ss_pred             cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeec
Confidence            467788999999999999999999998 9999999999999853       456899999998644322   23345566


Q ss_pred             CccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           79 SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      +-.+-++|+.. +..++...|.|.++.+++.|+.|+.-=                 ..++......  .....+.  ...
T Consensus       866 td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~~~g~~~~~~--~~~~Ry~--~~~  923 (974)
T KOG1166|consen  866 TDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKYME-----------------VKNGSSWMVK--TNFPRYW--KRD  923 (974)
T ss_pred             cccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHHHH-----------------hcCCcceecc--ccchhhh--hHH
Confidence            77889999987 899999999999999999999875311                 0000000000  0000000  112


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+-+|...+|..|-..=|...+|...|++...+
T Consensus       924 ~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  924 MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            466777777775555556777777777776554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=98.97  E-value=8.8e-10  Score=83.27  Aligned_cols=55  Identities=24%  Similarity=0.298  Sum_probs=49.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR   67 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~   67 (221)
                      ..++...+..++.|++.++.++|. . |++|+|+||.||+++ ++.++++|||++...
T Consensus       112 ~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         112 VPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            456778899999999999999999 7 999999999999998 789999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.85  E-value=1.3e-09  Score=84.18  Aligned_cols=76  Identities=12%  Similarity=0.224  Sum_probs=55.9

Q ss_pred             HHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcCCCCCcccc
Q 048055           21 IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADV  100 (221)
Q Consensus        21 ~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di  100 (221)
                      ...+++.+|..+|.. |++|+|++|.|++++.++ ++++|||..........            -+.+.....+..++|+
T Consensus       140 ~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a------------~d~~vler~y~~~~di  205 (232)
T PRK10359        140 VKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEI  205 (232)
T ss_pred             HHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEECCCcccccchhh------------HHHHHHHhHhcccccc
Confidence            456999999999998 999999999999999888 99999997643321111            0111112334578999


Q ss_pred             hHHHHHHHHH
Q 048055          101 YSFGVLLLEL  110 (221)
Q Consensus       101 ~slG~~l~~~  110 (221)
                      |+||+++...
T Consensus       206 ~~lg~~~~~~  215 (232)
T PRK10359        206 KDLGYYLLIY  215 (232)
T ss_pred             cceeEeehHH
Confidence            9999986544

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.77  E-value=3.1e-09  Score=91.70  Aligned_cols=147  Identities=19%  Similarity=0.227  Sum_probs=97.2

Q ss_pred             HHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----------CCCCCCccccCcccchhc
Q 048055           22 AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----------EPSATSLFYKAPECREIW   91 (221)
Q Consensus        22 ~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~pe~~~~~   91 (221)
                      +.+++.|+.|+|...++||+++.|++|.++.++..|++.|+++.........          ........|.+||++. +
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~-~  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL-G  183 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-c
Confidence            4566789999999989999999999999999999999999987543321111          1112234599999886 4


Q ss_pred             CCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           92 KQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        92 ~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ...+.++|+||+|+++|.+.. |+.-+...    +............+....        .++...+.++.+=+.+.+..
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~----~~~~~~~~~~~~~~~~~~--------~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN----GGLLSYSFSRNLLNAGAF--------GYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhcc----CCcchhhhhhcccccccc--------cccccCcHHHHHHHHHHhcC
Confidence            666889999999999998874 55544321    111111111111111111        11122234578888889999


Q ss_pred             CCCCCCCHHHH
Q 048055          171 APENRPVMREV  181 (221)
Q Consensus       171 dp~~Rps~~~l  181 (221)
                      ++..||++..+
T Consensus       252 ~~~~rp~~~~l  262 (700)
T KOG2137|consen  252 DSAVRPTLDLL  262 (700)
T ss_pred             CcccCcchhhh
Confidence            99999977665

>smart00090 RIO RIO-like kinase

Probab=98.73  E-value=1.8e-08  Score=78.78  Aligned_cols=54  Identities=19%  Similarity=0.257  Sum_probs=47.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCC-ceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPG-LTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~-i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      ..+....+..++.||+.++.+||+. + ++|+|+||.||+++ ++.++++|||.+..
T Consensus       143 ~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      143 VEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            3455566788999999999999998 8 99999999999999 88899999998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.56  E-value=8.2e-08  Score=75.12  Aligned_cols=45  Identities=24%  Similarity=0.411  Sum_probs=41.0

Q ss_pred             HHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           21 IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        21 ~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      .+.+|+.+|.+||.. |++|+|+||.|||++.++.++++|||.+..
T Consensus       147 ~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        147 QWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            357899999999998 999999999999999989999999998743

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.55  E-value=1.2e-07  Score=71.95  Aligned_cols=49  Identities=16%  Similarity=0.320  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           16 TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .....++.+++.++.++|.. +++|+|++|.||+++.++.++|+|||.+.
T Consensus       125 ~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~~~~liDfg~~~  173 (198)
T cd05144         125 EDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDEKIYIIDWPQMV  173 (198)
T ss_pred             ccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCCcEEEEECCccc
Confidence            44567889999999999998 99999999999999999999999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.43  E-value=3.3e-07  Score=68.74  Aligned_cols=49  Identities=18%  Similarity=0.244  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           16 TSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      ..+..++.+++.++.++|. . +++|+|++|.||+++ ++.++++|||.+..
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119         114 EDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence            5678889999999999999 7 999999999999999 88999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.38  E-value=4.5e-07  Score=69.46  Aligned_cols=44  Identities=20%  Similarity=0.160  Sum_probs=36.7

Q ss_pred             HHHHHHHHHHH-HHhcCCCCceeeCcCCCCeEEcCC----CceEEeccCC
Q 048055           19 LKIAEDLASGL-LYIHQNPGLTHGNLKSSNVLLGAD----FESCLTDYGL   63 (221)
Q Consensus        19 ~~~~~~i~~gl-~~lH~~~~i~h~dlk~~nil~~~~----~~~~l~dfg~   63 (221)
                      ..++.+++.++ .|||++ +|+|||+||.||+++..    +.++|+|++.
T Consensus       107 ~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345        107 VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            35678888888 899999 99999999999999743    4799999543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.38  E-value=5.8e-07  Score=68.73  Aligned_cols=48  Identities=29%  Similarity=0.566  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           17 SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        17 ~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      .+..++.+++.+|.++|.. +++|+|++|.||+++ ++.++++|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            4568889999999999998 999999999999999 78899999998743

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.33  E-value=7.9e-07  Score=67.38  Aligned_cols=45  Identities=29%  Similarity=0.643  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           20 KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        20 ~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      .++.+++.+|.++|+. +++|+|++|.|++++ ++.+++.|||.+..
T Consensus        94 ~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            6789999999999998 999999999999999 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.32  E-value=5.7e-07  Score=78.53  Aligned_cols=47  Identities=28%  Similarity=0.574  Sum_probs=42.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           18 CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        18 ~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      ...++.+++.+|.+||+. +++|+|+||.||++ .++.++++|||+++.
T Consensus       430 ~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            567889999999999998 99999999999999 677899999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.31  E-value=7.1e-07  Score=75.99  Aligned_cols=151  Identities=23%  Similarity=0.266  Sum_probs=103.2

Q ss_pred             cCHHHHHHHHHHHHH----HHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCC-C-----CCCCCcc
Q 048055           13 LHWTSCLKIAEDLAS----GLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVE-E-----PSATSLF   81 (221)
Q Consensus        13 l~~~~~~~~~~~i~~----gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~-~-----~~~~~~~   81 (221)
                      ++....+....+...    ||.++|+. +++|-|++|.|++...+ ..+++.|||+.......... .     ...+...
T Consensus       215 ~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~  293 (524)
T KOG0601|consen  215 LPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCI  293 (524)
T ss_pred             CCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCce
Confidence            567778888888888    99999998 99999999999999999 88899999987655443311 1     1144567


Q ss_pred             ccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           82 YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        82 ~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      |++||...  .-++...|+|++|.++.+...+..++......      .| ..++...     .+.   +.......++.
T Consensus       294 Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W-~~~r~~~-----ip~---e~~~~~s~~l~  356 (524)
T KOG0601|consen  294 YAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW-SQLRQGY-----IPL---EFCEGGSSSLR  356 (524)
T ss_pred             EeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc-ccccccc-----Cch---hhhcCcchhhh
Confidence            99999864  56688999999999999988766554321110      00 1111111     100   00001112355


Q ss_pred             HHHHHcccCCCCCCCCHHHH
Q 048055          162 NIAIACVSLAPENRPVMREV  181 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l  181 (221)
                      ..+..+++.+|..|+++..+
T Consensus       357 ~~~~~~~d~~~~~~~~~q~~  376 (524)
T KOG0601|consen  357 SVTSQMLDEDPRLRLTAQIL  376 (524)
T ss_pred             hHHHHhcCcchhhhhHHHHH
Confidence            58888999999999998655

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.17  E-value=4.4e-06  Score=75.69  Aligned_cols=149  Identities=23%  Similarity=0.248  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC----------CC---------------
Q 048055           16 TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN----------PD---------------   70 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~----------~~---------------   70 (221)
                      .-+..+...+..++++||+. .+.|+|++|.+.+...++..++.+|+.....+          ..               
T Consensus       904 epaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~  982 (1205)
T KOG0606|consen  904 EPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRP  982 (1205)
T ss_pred             ccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccc
Confidence            34444566778889999997 78999999999999999999999987321100          00               


Q ss_pred             -------CCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC
Q 048055           71 -------SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG  143 (221)
Q Consensus        71 -------~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (221)
                             .......+++.|.+||... +......+|.|++|+++++.++|.+||.....+      ...+.+....    
T Consensus       983 ~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq------~~f~ni~~~~---- 1051 (1205)
T KOG0606|consen  983 QLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ------QIFENILNRD---- 1051 (1205)
T ss_pred             ccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCCCcchh------hhhhccccCC----
Confidence                   0012335577899999876 677788999999999999999999999643221      2222221111    


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 048055          144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMR  179 (221)
Q Consensus       144 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~  179 (221)
                       .+.  ...+.+......+++.+.+..+|.+|..+.
T Consensus      1052 -~~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1052 -IPW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             -CCC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence             111  111222234588889999999999997655

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.15  E-value=3.1e-05  Score=67.29  Aligned_cols=90  Identities=20%  Similarity=0.227  Sum_probs=62.4

Q ss_pred             HHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCccccCcccchhcCCCCCccc
Q 048055           21 IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYKAPECREIWKQPTQQAD   99 (221)
Q Consensus        21 ~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d   99 (221)
                      -+.||+.||.|||..++++|++++-..|+++..|..+|++|.++........ ......--.|..|+-+.   ...-..|
T Consensus       109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~---~s~~s~D  185 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID---PSEWSID  185 (690)
T ss_pred             HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC---ccccchh
Confidence            3689999999998766999999999999999999999999987632111100 00000111244444322   1113569


Q ss_pred             chHHHHHHHHHHhC
Q 048055          100 VYSFGVLLLELLTG  113 (221)
Q Consensus       100 i~slG~~l~~~~~g  113 (221)
                      .|.|||++|+++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999988

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.07  E-value=9.9e-06  Score=57.79  Aligned_cols=52  Identities=29%  Similarity=0.287  Sum_probs=45.7

Q ss_pred             CHHHHHHHHHHHHHHHHHhcCC--CCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           14 HWTSCLKIAEDLASGLLYIHQN--PGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        14 ~~~~~~~~~~~i~~gl~~lH~~--~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      +......++.+++.+++++|..  .+++|+|+++.|++++..+.+++.||+.+.
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            4567778889999999999985  269999999999999998999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.03  E-value=4.5e-06  Score=71.21  Aligned_cols=155  Identities=23%  Similarity=0.180  Sum_probs=100.2

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCcccc-Ccccchh
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYK-APECREI   90 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~-~pe~~~~   90 (221)
                      +...-++++..|++.++.++|+. .++|+|++|.||++..+ +..++.||+.+..+....  .......++. ..|.+..
T Consensus       363 ~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e  439 (524)
T KOG0601|consen  363 LDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLE  439 (524)
T ss_pred             cCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceec--ccccccccccccchhhcc
Confidence            44556778889999999999998 99999999999999987 778899999875422111  1112222333 2333333


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ......+.|+++||..+.+..++...-+..     ..         .........+. .....    ..+..+...+...
T Consensus       440 ~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----~~---------~~~i~~~~~p~-~~~~~----~~~q~~~kv~~~~  500 (524)
T KOG0601|consen  440 DYPHLSKADIFSLGLSVDEAITGSPLSESG-----VQ---------SLTIRSGDTPN-LPGLK----LQLQVLLKVMINP  500 (524)
T ss_pred             ccccccccccccccccccccccCcccCccc-----cc---------ceeeecccccC-CCchH----HhhhhhhhhhcCC
Confidence            566688999999999999888776543221     00         00011111111 11111    3467777888899


Q ss_pred             CCCCCCCHHHHHHHHHhhH
Q 048055          171 APENRPVMREVSKMIRDSR  189 (221)
Q Consensus       171 dp~~Rps~~~l~~~L~~~~  189 (221)
                      ++..||.+.++....+-..
T Consensus       501 ~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  501 DRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ccccchhhhhhcccchhhh
Confidence            9999999888766554443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.96  E-value=1.4e-05  Score=60.42  Aligned_cols=52  Identities=17%  Similarity=0.102  Sum_probs=43.2

Q ss_pred             cCHHHHHHHHHHHHHHHHHh-cCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           13 LHWTSCLKIAEDLASGLLYI-HQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~l-H~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      ++......+..+++.+|..+ |.. +++|+|+++.||++. ++.+.++|||.+..
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDLs~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYKEC-NLVHADLSEYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence            34455667788999999988 887 999999999999997 46799999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.82  E-value=3.8e-05  Score=56.42  Aligned_cols=44  Identities=27%  Similarity=0.304  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHHhcCCCC-----ceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           20 KIAEDLASGLLYIHQNPG-----LTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        20 ~~~~~i~~gl~~lH~~~~-----i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      ....+++.+|+.||.. +     ++|+|+++.||+++ ++.++++||+.+.
T Consensus        87 ~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          87 ENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            4567899999999997 6     49999999999999 6789999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.67  E-value=8.6e-05  Score=59.06  Aligned_cols=52  Identities=15%  Similarity=0.141  Sum_probs=44.5

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-------CCceEEeccCCcc
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-------DFESCLTDYGLGS   65 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-------~~~~~l~dfg~~~   65 (221)
                      .+...+..++.+++..+.-||.. |++|+|+++.||+++.       +..+.++||+.+.
T Consensus       135 ~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        135 PDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            34556678889999999999998 9999999999999975       4678999999764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.62  E-value=9.7e-05  Score=56.48  Aligned_cols=53  Identities=28%  Similarity=0.377  Sum_probs=45.8

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccc
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSF   66 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~   66 (221)
                      ++......++.+++..++-||.. |++|+|+++.|||+..++   .+.++||+.++.
T Consensus       115 ~~~~~~~~ll~~l~~~i~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  115 LDPSQRRELLRALARLIAKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cchhhHHHHHHHHHHHHHHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            34556778889999999999998 999999999999999887   788999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.50  E-value=0.00019  Score=61.24  Aligned_cols=48  Identities=25%  Similarity=0.323  Sum_probs=39.5

Q ss_pred             HHHHHHHHH-HHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcccc
Q 048055           19 LKIAEDLAS-GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR   67 (221)
Q Consensus        19 ~~~~~~i~~-gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~   67 (221)
                      ..++..++. .+..+|.. |++|+|++|.||++..++.+++.|||.+...
T Consensus       259 ~~ia~~~~~~~l~ql~~~-g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       259 KALAENLARSFLNQVLRD-GFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHHHHHHHHHHHHHHHhC-CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            345555555 36788988 9999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.31  E-value=0.00047  Score=51.33  Aligned_cols=44  Identities=27%  Similarity=0.591  Sum_probs=36.6

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           20 KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        20 ~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++..+=.-+.-||.. ||+|+|+.+.|+.+.... +.++|||++.
T Consensus        96 ~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          96 DLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             HHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCccc
Confidence            3455555567889998 999999999999998765 8999999974

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.26  E-value=0.00072  Score=50.89  Aligned_cols=48  Identities=21%  Similarity=0.484  Sum_probs=36.1

Q ss_pred             HHHHHHHHHHHHHHH-hcCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           17 SCLKIAEDLASGLLY-IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        17 ~~~~~~~~i~~gl~~-lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      ....++.+++..+.. +|.. |++|+|+++.||+++.+ .+.++|||.+..
T Consensus       107 ~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  107 EPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             THHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             hHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEecCccee
Confidence            455677778775555 5787 99999999999999887 899999997643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=97.15  E-value=0.00085  Score=51.23  Aligned_cols=53  Identities=11%  Similarity=0.105  Sum_probs=45.6

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc--eEEeccCCcc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE--SCLTDYGLGS   65 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~--~~l~dfg~~~   65 (221)
                      +.+...+..+..+|+..++-||.. |+.|+|+-+.||+++..+.  +.++||.-++
T Consensus       124 ~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        124 PYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            345666778999999999999998 9999999999999986667  8899998654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=96.69  E-value=0.0027  Score=48.79  Aligned_cols=42  Identities=21%  Similarity=0.396  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           21 IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        21 ~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      +...+.+++..+|+. |+.|+|..|.|++++.+ .+++.|++..
T Consensus       140 ~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             HHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC-cEEEEECccc
Confidence            445677889999999 99999999999999865 4899999754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=96.53  E-value=0.005  Score=46.00  Aligned_cols=47  Identities=34%  Similarity=0.570  Sum_probs=38.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccc
Q 048055           19 LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSF   66 (221)
Q Consensus        19 ~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~   66 (221)
                      ..++..|=..+.-||.. +++|+|+..+||++..++.   +.++|||++..
T Consensus       116 ~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            46677777778999998 9999999999999866543   47899998743

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.31  E-value=0.0024  Score=55.64  Aligned_cols=37  Identities=16%  Similarity=0.353  Sum_probs=31.1

Q ss_pred             HHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCcccc
Q 048055           30 LYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFR   67 (221)
Q Consensus        30 ~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~   67 (221)
                      ..+... |++|+|++|.||+++.++    .+++.|||.....
T Consensus       274 ~Qif~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        274 TQVFRD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHHHhC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            344556 999999999999999888    8999999987543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=96.06  E-value=0.024  Score=48.76  Aligned_cols=88  Identities=25%  Similarity=0.327  Sum_probs=66.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ++...+....|.++.|+..||.++|+. |+.-+-+.+.+|++..+.+++|+.-|.........           .  +.+
T Consensus       386 ~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~--~~l  451 (655)
T KOG3741|consen  386 QNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------T--EPL  451 (655)
T ss_pred             CCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCCC-----------C--cch
Confidence            466788999999999999999999998 88889999999999999888888766543322221           0  111


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGK  114 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~  114 (221)
                      .    ...+-|.-.||.++.-+.+|.
T Consensus       452 e----~~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  452 E----SQQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             h----HHhhhhHHHHHHHHHHHhhcc
Confidence            1    124557778888888888873

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=95.82  E-value=0.021  Score=45.25  Aligned_cols=49  Identities=18%  Similarity=0.278  Sum_probs=37.3

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           15 WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      ...+-.++..|+.-+.-.-.. |++|+|++.-||+++.+|.+.++||-.+
T Consensus       201 ~en~~~il~~il~~~~~~~~~-GiVHGDlSefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         201 VENPDEILDKILEEVRKAYRR-GIVHGDLSEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             ccCHHHHHHHHHHHHHHHHHc-CccccCCchheEEEecCCCEEEEeCccc
Confidence            344445555566555544455 9999999999999999999999999654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=95.81  E-value=0.031  Score=42.55  Aligned_cols=29  Identities=31%  Similarity=0.537  Sum_probs=25.1

Q ss_pred             CceeeCcCCCCeEEcC--CCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGA--DFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~--~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.||+++.  ++.+.++||+.+.
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            5789999999999998  5668899998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=95.74  E-value=0.023  Score=42.80  Aligned_cols=53  Identities=19%  Similarity=0.058  Sum_probs=46.5

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCC--CCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQN--PGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~--~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .-+|..+.+++.+++..+.+++..  ..+.-.|++++|+.++.++.+++.|+...
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence            458999999999999999999884  24666999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=95.68  E-value=0.025  Score=44.31  Aligned_cols=50  Identities=24%  Similarity=0.343  Sum_probs=42.1

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           15 WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      ...+..+..+++.++.-|-...++||+||+.-|||+. ++.+.++||+.+.
T Consensus       165 ~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV  214 (268)
T COG1718         165 LEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAV  214 (268)
T ss_pred             chhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcccc
Confidence            3356777788889988887744999999999999999 8899999999764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.65  E-value=0.049  Score=51.15  Aligned_cols=148  Identities=18%  Similarity=0.172  Sum_probs=89.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCC---CeEEcCCCceEEe--ccCCccccCCCCCCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSS---NVLLGADFESCLT--DYGLGSFRNPDSVEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~   84 (221)
                      -..++..+...+..++..||.++|+. ...|.-+...   +...+..+...+.  +|+..+.............+..+.+
T Consensus       280 v~~i~~~~~r~~~~~~~~GL~~~h~~-~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~  358 (1351)
T KOG1035|consen  280 VGSIPLETLRILHQKLLEGLAYLHSL-SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNA  358 (1351)
T ss_pred             ccccCHHHHHHHHHHHhhhHHHHHHh-ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccc
Confidence            35667888889999999999999998 6666555544   3333444445544  7766544333222222233344666


Q ss_pred             cccchhcCCC--CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           85 PECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        85 pe~~~~~~~~--~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      ++... ....  ....|+|.+|.+...+..|..+-...     ..+    ..      .......          ..+.+
T Consensus       359 ~e~~~-~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~-----~~~----~~------~l~~~~~----------~~~~d  412 (1351)
T KOG1035|consen  359 DEDLK-ENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS-----AVP----VS------LLDVLST----------SELLD  412 (1351)
T ss_pred             ccccc-cccchhhhhhHHHHHHHHHhhhhhcCcccccc-----cch----hh------hhccccc----------hhhhh
Confidence            66543 2222  34469999999988887765443210     000    00      0000000          13677


Q ss_pred             HHHHcccCCCCCCCCHHHHHHH
Q 048055          163 IAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ...+|+.-++++|+++.+++..
T Consensus       413 ~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  413 ALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhhcchhhhhccchhhhhhc
Confidence            8889999999999999998655

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.04  E-value=0.23  Score=38.39  Aligned_cols=28  Identities=21%  Similarity=0.344  Sum_probs=25.3

Q ss_pred             CceeeCcCCCCeEEcC-CCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGA-DFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~-~~~~~l~dfg~~   64 (221)
                      +++|+|+.+.||+++. ++.+.++||.++
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            6899999999999998 578999999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=92.50  E-value=0.12  Score=40.20  Aligned_cols=28  Identities=29%  Similarity=0.377  Sum_probs=24.7

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      +++|+|+.+.|++++.+....|.||+.+
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            6899999999999987766679999976

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.35  E-value=0.39  Score=38.72  Aligned_cols=28  Identities=25%  Similarity=0.372  Sum_probs=25.3

Q ss_pred             CceeeCcCCCCeEEcCC----CceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGAD----FESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~----~~~~l~dfg~~   64 (221)
                      +++|+|+.+.||+++.+    +.+.++||+++
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            68999999999999875    78999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=91.72  E-value=0.14  Score=41.71  Aligned_cols=28  Identities=32%  Similarity=0.465  Sum_probs=25.0

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      +++|+|+.+.|++++.+....|+||+.+
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccc
Confidence            8999999999999997766689999876

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.42  E-value=0.4  Score=38.89  Aligned_cols=29  Identities=28%  Similarity=0.445  Sum_probs=26.1

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .+++|+|+.+.|++++.++.+.|.||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            38999999999999998887789999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=90.91  E-value=0.26  Score=37.56  Aligned_cols=28  Identities=29%  Similarity=0.453  Sum_probs=20.0

Q ss_pred             CceeeCcCCCCeEEc-CCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLG-ADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~-~~~~~~l~dfg~~   64 (221)
                      .++|+|+.+.||+++ .++.+.|.||+.+
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             EEEEeccccccceeeeccceeEEEecccc
Confidence            789999999999999 6666689999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=90.85  E-value=0.57  Score=37.37  Aligned_cols=45  Identities=20%  Similarity=0.227  Sum_probs=34.1

Q ss_pred             HHHHHHHHHHHhcCC-CCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           21 IAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        21 ~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .+..+-.++.-.+.. .-++|+|+.+.|++.+..+.++++||..+.
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            344444455555553 357899999999999999999999998874

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=90.53  E-value=0.65  Score=38.82  Aligned_cols=54  Identities=20%  Similarity=0.180  Sum_probs=44.1

Q ss_pred             CHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC
Q 048055           14 HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN   68 (221)
Q Consensus        14 ~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~   68 (221)
                      .+.++..++.+.+.-++-+.++...-||++.-.||+++ +|.+.|+||.+++...
T Consensus       319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            57788888877777666666655678999999999999 9999999999987543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=90.37  E-value=0.22  Score=38.82  Aligned_cols=28  Identities=25%  Similarity=0.254  Sum_probs=25.3

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .++|+|+.+.|++++.+....|+||+.+
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            6899999999999999877889999865

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK10271 thiK thiamine kinase; Provisional

Probab=90.36  E-value=0.26  Score=37.06  Aligned_cols=28  Identities=18%  Similarity=0.205  Sum_probs=24.3

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      ..+|+|+.|.|+++..++ ++++||+++.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            458999999999998777 8899999874

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=90.34  E-value=0.27  Score=38.15  Aligned_cols=28  Identities=18%  Similarity=0.222  Sum_probs=24.9

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.|++++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            578999999999999887 9999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=90.31  E-value=0.73  Score=37.20  Aligned_cols=28  Identities=25%  Similarity=0.400  Sum_probs=24.4

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .+++|+|+.+.|++++. +.+.+.||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            37899999999999987 56789999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=90.30  E-value=0.22  Score=40.01  Aligned_cols=28  Identities=32%  Similarity=0.465  Sum_probs=25.5

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      +++|+|+.+.|++++.++.+.|.||+.+
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhh
Confidence            7999999999999998877889999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=90.14  E-value=0.26  Score=38.78  Aligned_cols=28  Identities=18%  Similarity=0.198  Sum_probs=24.7

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.|++++.++ +.++||+.+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            579999999999999876 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=89.74  E-value=0.35  Score=37.60  Aligned_cols=37  Identities=19%  Similarity=0.131  Sum_probs=31.3

Q ss_pred             HHHHHhcCC-CCceeeCcCCCCeEEcCCCceEEeccCC
Q 048055           27 SGLLYIHQN-PGLTHGNLKSSNVLLGADFESCLTDYGL   63 (221)
Q Consensus        27 ~gl~~lH~~-~~i~h~dlk~~nil~~~~~~~~l~dfg~   63 (221)
                      ..|.-.|+. .+.+|+|..|+||+.+..|-+|+.|-+.
T Consensus       152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  152 KDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            456777854 5889999999999999999999999653

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=89.51  E-value=0.41  Score=36.48  Aligned_cols=28  Identities=29%  Similarity=0.457  Sum_probs=20.2

Q ss_pred             CceeeCcCCCCeEE-cCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLL-GADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~-~~~~~~~l~dfg~~   64 (221)
                      .+.|.|+.+.||++ ..++.++++||.++
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya  172 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYA  172 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHH
Confidence            57899999999999 88899999999876

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=88.93  E-value=0.84  Score=39.95  Aligned_cols=35  Identities=23%  Similarity=0.418  Sum_probs=29.8

Q ss_pred             HhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           31 YIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        31 ~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      .+-.. |+.|.|..|.|+++..++.+.+.|||....
T Consensus       280 q~~~d-gffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         280 QLLRD-GFFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             HHHhc-CccccCCCccceEEecCCcEEEEcCcceec
Confidence            33334 899999999999999999999999998643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=88.38  E-value=0.28  Score=43.60  Aligned_cols=89  Identities=18%  Similarity=0.106  Sum_probs=63.3

Q ss_pred             HHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcCCCCCcccch
Q 048055           22 AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVY  101 (221)
Q Consensus        22 ~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~  101 (221)
                      .+.-..+++++|+. .-+|+|    ||+... +..+..+|+...............++..|++||... ...+..+.|.|
T Consensus       342 ~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~-~~~~~~~p~~~  414 (829)
T KOG0576|consen  342 LRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQ-ENTIDGCPDSG  414 (829)
T ss_pred             hhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhc-ccccccCCCcc
Confidence            44556678999997 557887    555544 677889998876555544455667788899999765 55667788999


Q ss_pred             HHHHHHHHHHhCCCCC
Q 048055          102 SFGVLLLELLTGKTPF  117 (221)
Q Consensus       102 slG~~l~~~~~g~~pf  117 (221)
                      ++|.--.++..|.+|-
T Consensus       415 ~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  415 SLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCcchhhcCCCCCCC
Confidence            9987655665565543

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=87.55  E-value=1  Score=36.58  Aligned_cols=30  Identities=23%  Similarity=0.315  Sum_probs=26.9

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .+++|+|+.+.|++++.++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            379999999999999999899999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=87.52  E-value=1.1  Score=37.15  Aligned_cols=29  Identities=24%  Similarity=0.511  Sum_probs=25.0

Q ss_pred             CceeeCcCCCCeEEcC-CCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGA-DFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~-~~~~~l~dfg~~~   65 (221)
                      .++|+|+++.||+++. ++.+.++||.++.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            6799999999999986 4679999998763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=86.37  E-value=0.61  Score=37.35  Aligned_cols=29  Identities=28%  Similarity=0.499  Sum_probs=24.3

Q ss_pred             CceeeCcCCCCeEEcCCCc-eEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFE-SCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~-~~l~dfg~~~   65 (221)
                      .++|+|+++.|++++.++. ..|.||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            6899999999999997454 5699999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=85.72  E-value=0.22  Score=48.84  Aligned_cols=91  Identities=16%  Similarity=0.089  Sum_probs=67.8

Q ss_pred             HHHHHHhcCCC----CceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccchhcCCCCCcccc
Q 048055           26 ASGLLYIHQNP----GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECREIWKQPTQQADV  100 (221)
Q Consensus        26 ~~gl~~lH~~~----~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~di  100 (221)
                      +.+..-+|+..    -.+|+++++.|.++..+..++++++|+.+...+.. ..+...+++.|+.++... ...++.++|+
T Consensus      1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDI 1423 (2724)
T ss_pred             HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHH
Confidence            55555555541    24799999999999999999999999998444432 334456677788888655 4566667999


Q ss_pred             hHHHHHHHHHHhCCCCC
Q 048055          101 YSFGVLLLELLTGKTPF  117 (221)
Q Consensus       101 ~slG~~l~~~~~g~~pf  117 (221)
                      |..|+.+|....|..+|
T Consensus      1424 lr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHHhcccHHH
Confidence            99999999887777766

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=85.60  E-value=0.83  Score=34.48  Aligned_cols=29  Identities=31%  Similarity=0.526  Sum_probs=24.1

Q ss_pred             CceeeCcCCCCeEEcCCC-----ceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADF-----ESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~-----~~~l~dfg~~~   65 (221)
                      .++|+|+.+.|+++..++     .+.+.||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            689999999999997543     57899998763

subfamily of choline kinases

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=85.00  E-value=2.1  Score=35.32  Aligned_cols=27  Identities=33%  Similarity=0.602  Sum_probs=24.5

Q ss_pred             ceeeCcCCCCeEEcCCCc-eEEeccCCc
Q 048055           38 LTHGNLKSSNVLLGADFE-SCLTDYGLG   64 (221)
Q Consensus        38 i~h~dlk~~nil~~~~~~-~~l~dfg~~   64 (221)
                      ++|+|+.+.||+++.+.. +.+.||+.+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            899999999999998874 889999876

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=84.48  E-value=1.1  Score=36.61  Aligned_cols=32  Identities=22%  Similarity=0.517  Sum_probs=28.2

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCcccc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLGSFR   67 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~   67 (221)
                      ..++|+|+.+.|++++...-+-|.||+.+...
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            37899999999999999998999999987543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=82.55  E-value=4.1  Score=35.84  Aligned_cols=30  Identities=33%  Similarity=0.465  Sum_probs=26.0

Q ss_pred             CceeeCcCCCCeEEcC----CCceEEeccCCccc
Q 048055           37 GLTHGNLKSSNVLLGA----DFESCLTDYGLGSF   66 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~----~~~~~l~dfg~~~~   66 (221)
                      |++|+|-.|.||++..    ++.+.+.|||+...
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            8999999999999984    67788999998654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=81.18  E-value=3.1  Score=34.18  Aligned_cols=28  Identities=25%  Similarity=0.457  Sum_probs=24.3

Q ss_pred             CceeeCcCCCCeEEcC-CCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGA-DFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~-~~~~~l~dfg~~   64 (221)
                      ...|.|+.+.||+++. ++.++++||+++
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEccccc
Confidence            4689999999999974 578999999986

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=80.41  E-value=0.48  Score=41.30  Aligned_cols=78  Identities=23%  Similarity=0.235  Sum_probs=44.0

Q ss_pred             CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCC-----ChhhHHHHHHHHHHHHHccc
Q 048055           95 TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSS-----NEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        95 ~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +.++|||++|.++.++.-|...+.....         .+.+..............     ....-++.+.++++...|+-
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~---------s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~  179 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTE---------SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLW  179 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHH---------HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCc
Confidence            3699999999999998877766643211         111111111111110000     01112334578889999999


Q ss_pred             CCCCCCCCHHHH
Q 048055          170 LAPENRPVMREV  181 (221)
Q Consensus       170 ~dp~~Rps~~~l  181 (221)
                      ..|..||...++
T Consensus       180 ~~~~ir~l~~~~  191 (725)
T KOG1093|consen  180 LEPIIRPLPMEL  191 (725)
T ss_pred             cccccccchhHH
Confidence            999988754443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	221
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-19
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-05
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-04
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-04
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-04
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-04
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 98/181 (54%), Gaps = 8/181 (4%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQ--NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           PL W    +IA   A GL Y+H   +P + H ++K++N+LL  +FE+ + D+GL    + 
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
                  A   ++ + APE     K  +++ DV+ +GV+LLEL+TG+  F    L +  D
Sbjct: 195 KDXHVXXAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 253
Query: 128 IP--RWVRS-VREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
           +    WV+  ++E++ E+  D        +E+++ L+ +A+ C   +P  RP M EV +M
Sbjct: 254 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 313
Query: 185 I 185
           +
Sbjct: 314 L 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 97/181 (53%), Gaps = 8/181 (4%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQ--NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           PL W    +IA   A GL Y+H   +P + H ++K++N+LL  +FE+ + D+GL    + 
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
                  A    + + APE     K  +++ DV+ +GV+LLEL+TG+  F    L +  D
Sbjct: 187 KDXHVXXAVRGXIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 128 IP--RWVRS-VREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
           +    WV+  ++E++ E+  D        +E+++ L+ +A+ C   +P  RP M EV +M
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 185 I 185
           +
Sbjct: 306 L 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 6/173 (3%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL---GSFRNP 69
           + W   L+I    A GL Y+H    + H ++KS N+LL  +F   +TD+G+   G+  + 
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
             +      +L Y  PE   I  + T+++DVYSFGV+L E+L  ++     +     ++ 
Sbjct: 195 THLXXVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 130 RW-VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
            W V S    + E   DP  +++   E L+   + A+ C++L+ E+RP M +V
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 6/173 (3%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL---GSFRNP 69
           + W   L+I    A GL Y+H    + H ++KS N+LL  +F   +TD+G+   G+    
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQ 194
Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
             +      +L Y  PE   I  + T+++DVYSFGV+L E+L  ++     +     ++ 
Sbjct: 195 THLXXVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 130 RW-VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
            W V S    + E   DP  +++   E L+   + A+ C++L+ E+RP M +V
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 96/187 (51%), Gaps = 11/187 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
           G  PL W    KIA+  A+G+ ++H+N  + H ++KS+N+LL   F + ++D+GL   R 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLA--RA 182
Query: 69  PDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
            +   +    S       Y APE   +  + T ++D+YSFGV+LLE++TG  P  D   E
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHRE 239
Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
               +        EE+T         N+A    ++A+ ++A  C+      RP +++V +
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 184 MIRDSRA 190
           ++++  A
Sbjct: 300 LLQEMTA 306

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 11/187 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
           G  PL W    KIA+  A+G+ ++H+N  + H ++KS+N+LL   F + ++D+GL   R 
Sbjct: 117 GTPPLSWHXRCKIAQGAANGINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLA--RA 173
Query: 69  PDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
            +   +    S       Y APE   +  + T ++D+YSFGV+LLE++TG  P  D   E
Sbjct: 174 SEKFAQXVXXSRIVGTTAYXAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHRE 230
Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
               +        EE+T         N+A    ++A  ++A  C+      RP +++V +
Sbjct: 231 PQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQ 290
Query: 184 MIRDSRA 190
           ++++  A
Sbjct: 291 LLQEXTA 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 95/186 (51%), Gaps = 9/186 (4%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---- 64
           G  PL W    KIA+  A+G+ ++H+N  + H ++KS+N+LL   F + ++D+GL     
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 65  SFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
            F           T+  Y APE   +  + T ++D+YSFGV+LLE++TG  P  D   E 
Sbjct: 185 KFAQTVMXXRIVGTTA-YMAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHREP 240
Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
              +        EE+T         N+A    ++A+ ++A  C+      RP +++V ++
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 185 IRDSRA 190
           +++  A
Sbjct: 301 LQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 95/186 (51%), Gaps = 9/186 (4%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---- 64
           G  PL W    KIA+  A+G+ ++H+N  + H ++KS+N+LL   F + ++D+GL     
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 65  SFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
            F           T+  Y APE   +  + T ++D+YSFGV+LLE++TG  P  D   E 
Sbjct: 179 KFAQXVMXXRIVGTTA-YMAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHREP 234
Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
              +        EE+T         N+A    ++A+ ++A  C+      RP +++V ++
Sbjct: 235 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 294
Query: 185 IRDSRA 190
           +++  A
Sbjct: 295 LQEMTA 300

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  GL YIH   G+ H +LK  N+ +  D E  + D+GL   R  DS       + +Y+A
Sbjct: 137 MLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLA--RQADSEMXGXVVTRWYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           PE    W + TQ  D++S G ++ E++TGKT F+
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 98  GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 156
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 157 NEXTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 215
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 216 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 260
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 261 DY-----FTSTEPQYQPG 273

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GLG     
Sbjct: 275 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLGRLIED 333
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 334 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 392
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 393 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 437
Query: 187 D 187
           D
Sbjct: 438 D 438

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 101 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 159
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 160 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 218
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 219 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 263
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 264 DY-----FTSTEPQYQPG 276

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEXTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 97  GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 155
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 156 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 214
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 215 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 259
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 260 DY-----FTSTEPQYQPG 272

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 99  GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 157
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 158 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 216
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 217 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 261
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 262 DY-----FTSTEPQYQPG 274

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 66/117 (56%), Gaps = 5/117 (4%)
Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           SG  + L     L +A D+A G+ Y+H +NP + H NLKS N+L+   +   + D+GL  
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 66  FRNPDSVEEPSATSL-FYKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPFQDL 120
            +    +   SA     + APE   +  +P+ +++DVYSFGV+L EL T + P+ +L
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEV--LRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 333 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 392 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 436
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 437 D-----YFTSTEPQYQPG 449

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + DYGL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDYGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +   +  GL YIH + G+ H +LK  N+ +  D E  + D+GL   R+ D+       + 
Sbjct: 149 LVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVTR 205
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +Y+APE    W    Q  D++S G ++ E+LTGKT F+
Sbjct: 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 134 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 135 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +   +  GL YIH + G+ H +LK  N+ +  D E  + D+GL   R+ D+       + 
Sbjct: 131 LVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVTR 187
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +Y+APE    W    Q  D++S G ++ E+LTGKT F+
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 109 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 167
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 168 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +   L  GL YIH + G+ H +LK SNV +  D E  + D+GL   R  D        + 
Sbjct: 128 LVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA--RQADEEMTGYVATR 184
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE    W    Q  D++S G ++ ELL GK  F
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 112 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + ++  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 105 GKYLRLPQLVDMSAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 163
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 164 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 222
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 223 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 267
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 268 DY-----FTSTEPQYQPG 280

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 112 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 415
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 416 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 475 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 519
Query: 187 D 187
           D
Sbjct: 520 D 520

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +   L  GL YIH + G+ H +LK SNV +  D E  + D+GL   R  D        + 
Sbjct: 136 LVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRILDFGLA--RQADEEMTGYVATR 192
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE    W    Q  D++S G ++ ELL GK  F
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +   L  GL YIH + G+ H +LK SNV +  D E  + D+GL   R  D        + 
Sbjct: 136 LVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRILDFGLA--RQADEEMTGYVATR 192
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE    W    Q  D++S G ++ ELL GK  F
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 107 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L ++N+L+G +    + D+GL      
Sbjct: 108 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLAAANILVGENLVCKVADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 167 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 226 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQAFLE 270
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 271 DY-----FTSTEPQYQPG 283

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 107 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 333 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 392 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 436
Query: 187 D 187
           D
Sbjct: 437 D 437

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 333 NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 392 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 436
Query: 187 D 187
           D
Sbjct: 437 D 437

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           GK L     + ++  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL      
Sbjct: 105 GKYLRLPQLVDMSAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED 163
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
           N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL T G+ P+  +V     
Sbjct: 164 NEWTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 222
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           D           + E G   P   E  E    +L ++   C    PE RP    +   + 
Sbjct: 223 D-----------QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 267
Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 268 DY-----FTSTEPQYQPG 280

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF- 66
           G  +PL     +  +  +A G+ +I Q     H +L+++N+L+ A     + D+GL    
Sbjct: 278 GSKQPL--PKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 67  -RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
             N  +  E +   + + APE    +   T ++DV+SFG+LL+E++T G+ P+       
Sbjct: 335 EDNEYTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYP------ 387
Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
           G   P  +R++     E G   P      EE    L NI + C    PE RP    +  +
Sbjct: 388 GMSNPEVIRAL-----ERGYRMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSV 438
Query: 185 IRD 187
           + D
Sbjct: 439 LDD 441

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDXELKILDFGLA--R 178
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 179 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 128 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDXELKILDFGLA--R 184
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 185 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF- 66
           G  +PL     +  +  +A G+ +I Q     H +L+++N+L+ A     + D+GL    
Sbjct: 105 GSKQPL--PKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVI 161
Query: 67  -RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
             N  +  E +   + + APE    +   T ++DV+SFG+LL+E++T G+ P+       
Sbjct: 162 EDNEYTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYP------ 214
Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
           G   P  +R++     E G   P      EE    L NI + C    PE RP    +  +
Sbjct: 215 GMSNPEVIRAL-----ERGYRMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSV 265
Query: 185 IRD 187
           + D
Sbjct: 266 LDD 268

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDXELKILDFGLA--R 178
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 179 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 137 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 193
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 194 HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 179
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 180 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 113 VKCAKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 169
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 179
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 180 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 135 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 180
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 181 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 196
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 197 HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 175
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 176 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 185
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 186 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 175
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 176 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 185
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 186 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 178
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 179 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 179
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 180 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 116 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 172
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 173 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 127 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 183
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 184 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 128 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 184
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 185 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 129 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 185
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 186 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 196
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 197 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 137 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 193
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 194 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 127 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 137 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 193
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 194 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 122 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 178
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 179 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 175
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 176 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 136 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 192
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 193 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 136 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 192
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 193 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 119 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDSELKILDFGLA--R 175
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 176 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 123 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDSELKILDFGLA--R 179
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 180 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 114 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 170
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 171 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 169
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 169
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 115 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 171
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 172 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 114 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 170
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 171 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 169
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 170 HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 62/107 (57%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 107 IDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 165
Query: 76  SATSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +  K P + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R+ D        + +Y+A
Sbjct: 134 ILRGLKYIH-SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN----PDSVEE 74
           + IA   A G+ Y+H    + H ++KS+N+ L       + D+GL + ++       VE+
Sbjct: 135 IDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ 193
Query: 75  PSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWV 132
           P+  S+ + APE   +      + Q+DVYS+G++L EL+TG+ P+      H ++  + +
Sbjct: 194 PTG-SVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY-----SHINNRDQII 247
Query: 133 RSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             V       G   P  ++  +   +A+  +   CV    E RP+  ++
Sbjct: 248 FMVGR-----GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 35/189 (18%)
Query: 12  PLHWTSCLKIAEDLASGLLYI-HQNPGLTHGNLKSSNVLLGADFESC-----LTDYGLGS 65
           P+ W+  L++  D+A G+ Y+ +QNP + H +L+S N+ L +  E+      + D+GL  
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 66  FRNPDSVEEPSAT--SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVL 122
                SV   S    +  + APE     ++  T++AD YSF ++L  +LTG+ PF     
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---- 229
Query: 123 EHGSDIPRWVRSVREE---ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP--- 176
           E+     +++  +REE    T   D PP            L N+   C S  P+ RP   
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPR-----------LRNVIELCWSGDPKKRPHFS 278
Query: 177 -VMREVSKM 184
            +++E+S++
Sbjct: 279 YIVKELSEL 287

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R+ D        + +Y+A
Sbjct: 134 ILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 68/117 (58%), Gaps = 5/117 (4%)
Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           SG  + L     L +A D+A G+ Y+H +NP + H +LKS N+L+   +   + D+GL  
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 66  FRNPDSV-EEPSATSLFYKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPFQDL 120
            +    +  + +A +  + APE   +  +P+ +++DVYSFGV+L EL T + P+ +L
Sbjct: 188 LKASXFLXSKXAAGTPEWMAPEV--LRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 29/202 (14%)
Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF- 66
           G G+ L   + + +A  +A+G+ YI +     H +L+S+N+L+G      + D+GL    
Sbjct: 97  GEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGNGLICKIADFGLARLI 155
Query: 67  -RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
             N  +  + +   + + APE   ++ + T ++DV+SFG+LL EL+T G+ P+  +    
Sbjct: 156 EDNEXTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---- 210
Query: 125 GSDIPRWVRSVRE--EETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
                    + RE  E+ E G   P   +       +L  + I C    PE RP    + 
Sbjct: 211 ---------NNREVLEQVERGYRMPCPQDCP----ISLHELMIHCWKKDPEERPTFEYLQ 257
Query: 183 KMIRDSRAEAQMSSNSSDHSPG 204
             + D       ++    + PG
Sbjct: 258 SFLEDY-----FTATEPQYQPG 274

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 111 IDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ 169
Query: 76  SATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +      + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 170 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 25/173 (14%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR------NPDSVEE 74
           I  ++  GL Y+H+N G  H ++K+ N+LLG D    + D+G+ +F         + V +
Sbjct: 121 ILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD------LVLEHGSDI 128
               +  + APE  E  +    +AD++SFG+  +EL TG  P+        L+L   +D 
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 239
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           P     V+++E             S  K+ +L      C+   PE RP   E+
Sbjct: 240 PSLETGVQDKEM------LKKYGKSFRKMISL------CLQKDPEKRPTAAEL 280

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 25/173 (14%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR------NPDSVEE 74
           I  ++  GL Y+H+N G  H ++K+ N+LLG D    + D+G+ +F         + V +
Sbjct: 126 ILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD------LVLEHGSDI 128
               +  + APE  E  +    +AD++SFG+  +EL TG  P+        L+L   +D 
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           P     V+++E             S  K+ +L      C+   PE RP   E+
Sbjct: 245 PSLETGVQDKEM------LKKYGKSFRKMISL------CLQKDPEKRPTAAEL 285

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDRGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL    
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLAR-H 181
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             D +    AT  +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 182 TADEMTGYVATR-WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL    
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLAR-H 181
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             D +    AT  +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 182 TADEMTGYVATR-WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDAGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL    
Sbjct: 124 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLAR-H 181
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             D +    AT  +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 182 TADEMTGYVATR-WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R+ D        + +Y+A
Sbjct: 134 ILRGLKYIH-SADIIHRDLKPSNLAVNEDSELKILDFGLC--RHTDDEMTGYVATRWYRA 190
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 146 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 202
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W       D++S G ++ ELLTG+T F
Sbjct: 203 HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLF 252

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 35/189 (18%)
Query: 12  PLHWTSCLKIAEDLASGLLYI-HQNPGLTHGNLKSSNVLLGADFESC-----LTDYGLGS 65
           P+ W+  L++  D+A G+ Y+ +QNP + H +L+S N+ L +  E+      + D+G   
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177
Query: 66  FRNPDSVEEPSAT--SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVL 122
                SV   S    +  + APE     ++  T++AD YSF ++L  +LTG+ PF     
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---- 229
Query: 123 EHGSDIPRWVRSVREE---ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP--- 176
           E+     +++  +REE    T   D PP            L N+   C S  P+ RP   
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPR-----------LRNVIELCWSGDPKKRPHFS 278
Query: 177 -VMREVSKM 184
            +++E+S++
Sbjct: 279 YIVKELSEL 287

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDGGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 123 IDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 76  SATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +      + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EP 75
           + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++  S     E 
Sbjct: 123 IDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 76  SATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQDL 120
            + S+ + APE   +      + Q+DVY+FG++L EL+TG+ P+ ++
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+ L   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFYLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  +  +GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILGFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE    W    Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 27/185 (14%)
Query: 12  PLHWTSCLKIAEDLASGLLYI-HQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR-NP 69
           P+ W+  L++  D+A G+ Y+ +QNP + H +L+S N+ L +  E+      +  F  + 
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
            SV   S    +  + APE     ++  T++AD YSF ++L  +LTG+ PF     E+  
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSY 233
Query: 127 DIPRWVRSVREE---ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMR 179
              +++  +REE    T   D PP            L N+   C S  P+ RP    +++
Sbjct: 234 GKIKFINMIREEGLRPTIPEDCPPR-----------LRNVIELCWSGDPKKRPHFSYIVK 282
Query: 180 EVSKM 184
           E+S++
Sbjct: 283 ELSEL 287

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 28/181 (15%)
Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
           G  +PL     +  +  +A G+ +I Q     H +L+++N+L+ A     + D+GL    
Sbjct: 272 GSKQPL--PKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVG 328
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
               ++        + APE    +   T ++DV+SFG+LL+E++T G+ P+       G 
Sbjct: 329 AKFPIK--------WTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYP------GM 373
Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
             P  +R++     E G   P      EE    L NI + C    PE RP    +  ++ 
Sbjct: 374 SNPEVIRAL-----ERGYRMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLD 424
Query: 187 D 187
           D
Sbjct: 425 D 425

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 16  TSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
             C K+ +D        +  GL YIH +  + H +LK SN+ +  D E  + D+GL   R
Sbjct: 117 VKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA--R 173
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + D        + +Y+APE         Q  D++S G ++ ELLTG+T F
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K+   +   L Y+ +  G+ H ++K SN+LL    +  L D+G+      D  ++ SA  
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 80  LFYKAPECREIWKQPTQ-----QADVYSFGVLLLELLTGKTPFQD 119
             Y APE R     PT+     +ADV+S G+ L+EL TG+ P+++
Sbjct: 188 AAYMAPE-RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           +LA  L ++H + G+ + +LK  N+LL  +    LTD+GL    + +S++       F  
Sbjct: 135 ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCG 189
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              Y APE     +  TQ AD +SFGVL+ E+LTG  PFQ
Sbjct: 190 TVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           +LA  L ++H + G+ + +LK  N+LL  +    LTD+GL    + +S++       F  
Sbjct: 134 ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCG 188
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              Y APE     +  TQ AD +SFGVL+ E+LTG  PFQ
Sbjct: 189 TVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 8/101 (7%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS-FRNPDSVEEPS 76
           I + + SG+ Y+H++  + H +LK  N+LL +  +  L    D+GL + F N   ++E  
Sbjct: 141 IIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            T+ +Y APE   + K+  ++ DV+S GV+L  LL G  PF
Sbjct: 200 GTA-YYIAPEV--LRKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 7   SGGGKPLHWTSCLKI--------AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL 58
           +GG    H  SC K         A ++  GL ++H + G+ + +LK  N+LL  D    +
Sbjct: 101 NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKI 159
Query: 59  TDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTG 113
            D+G+      +++   + T+ F     Y APE   + ++     D +SFGVLL E+L G
Sbjct: 160 ADFGMCK----ENMLGDAKTNXFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIG 214
Query: 114 KTPFQDLVLEHGSDIPRWVRSVR 136
           ++PF      HG D      S+R
Sbjct: 215 QSPF------HGQDEEELFHSIR 231

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           +LA  L ++H + G+ + +LK  N+LL  +    LTD+GL    + +S++       F  
Sbjct: 134 ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCG 188
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              Y APE     +  TQ AD +SFGVL+ E+LTG  PFQ
Sbjct: 189 TVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 16/112 (14%)
Query: 15  WTSCLKIAEDLASGLLYIHQN---------PGLTHGNLKSSNVLLGADFESCLTDYGLG- 64
           W     IAE +A GL Y+H++         P ++H ++KS NVLL  +  +C+ D+GL  
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 65  SFRNPDSVEEPSAT--SLFYKAPECRE----IWKQPTQQADVYSFGVLLLEL 110
            F    S  +      +  Y APE  E      +    + D+Y+ G++L EL
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 65/144 (45%), Gaps = 27/144 (18%)
Query: 7   SGGGKPLHWTSCLKI--------AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL 58
           +GG    H  SC K         A ++  GL ++H + G+ + +LK  N+LL  D    +
Sbjct: 102 NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKI 160
Query: 59  TDYG------LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
            D+G      LG  +  +    P      Y APE   + ++     D +SFGVLL E+L 
Sbjct: 161 ADFGMCKENMLGDAKTNEFCGTPD-----YIAPEIL-LGQKYNHSVDWWSFGVLLYEMLI 214
Query: 113 GKTPFQDLVLEHGSDIPRWVRSVR 136
           G++PF      HG D      S+R
Sbjct: 215 GQSPF------HGQDEEELFHSIR 232

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP 69
           P+     +++  D    L + HQN G+ H ++K +N+L+ A     + D+G+      + 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANILISATNAVKVVDFGIARAIADSG 170
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +SV + +A   +  Y +PE +        ++DVYS G +L E+LTG+ PF        S 
Sbjct: 171 NSVXQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSP 224
Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLN-IAIACVSLAPENR 175
           +    + VRE+       PPS   A  E L A L+ + +  ++  PENR
Sbjct: 225 VSVAYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H NL+++N+L+       + D+GL      
Sbjct: 99  GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRNLRAANILVSDTLSCKIADFGLARLIED 157
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 158 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 216
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 217 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 260
Query: 186 RD 187
            D
Sbjct: 261 ED 262

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 35/137 (25%)
Query: 16  TSCLKIAEDLASGLLYIH-------QNPGLTHGNLKSSNVLLGADFESCLTDYGLG---- 64
            SCL+I   +ASGL ++H         P + H +LKS N+L+  + + C+ D GL     
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 65  -SFRNPDSVEEPSATSLFYKAPE---------CREIWKQPTQQADVYSFGVLLLELLTG- 113
            S    D    P   +  Y APE         C + +K    + D+++FG++L E+    
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK----RVDIWAFGLVLWEVARRM 220
Query: 114 ---------KTPFQDLV 121
                    K PF D+V
Sbjct: 221 VSNGIVEDYKPPFYDVV 237

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 27/133 (20%)
Query: 16  TSCLKIAEDLASGLLYIH-------QNPGLTHGNLKSSNVLLGADFESCLTDYGLG---- 64
            SCL+I   +ASGL ++H         P + H +LKS N+L+  + + C+ D GL     
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 65  -SFRNPDSVEEPSATSLFYKAPECREIWKQ-----PTQQADVYSFGVLLLELLTG----- 113
            S    D    P   +  Y APE  +   Q       ++ D+++FG++L E+        
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
Query: 114 -----KTPFQDLV 121
                K PF D+V
Sbjct: 225 IVEDYKPPFYDVV 237

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 27/133 (20%)
Query: 16  TSCLKIAEDLASGLLYIH-------QNPGLTHGNLKSSNVLLGADFESCLTDYGLG---- 64
            SCL+I   +ASGL ++H         P + H +LKS N+L+  + + C+ D GL     
Sbjct: 134 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 193
Query: 65  -SFRNPDSVEEPSATSLFYKAPECREIWKQ-----PTQQADVYSFGVLLLELLTG----- 113
            S    D    P   +  Y APE  +   Q       ++ D+++FG++L E+        
Sbjct: 194 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 253
Query: 114 -----KTPFQDLV 121
                K PF D+V
Sbjct: 254 IVEDYKPPFYDVV 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 1/100 (1%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           ++ + + SG+ Y H++  + H +LK  NVLL A   + + D+GL +  +       S  S
Sbjct: 120 RLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGS 178
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE          + D++S GV+L  LL G  PF D
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KI       L ++ +N  + H ++K SN+LL       L D+G+         +   A  
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 80  LFYKAPECREIWKQPTQQ-----ADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRS 134
             Y APE   I    ++Q     +DV+S G+ L EL TG+ P+           P+W  S
Sbjct: 189 RPYMAPE--RIDPSASRQGYDVRSDVWSLGITLYELATGRFPY-----------PKW-NS 234
Query: 135 VREEETE--SGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           V ++ T+   GD P  SN    E   + +N    C++     RP  +E+ K
Sbjct: 235 VFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 17/134 (12%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSVEEPSA 77
           I + + SG+ Y+H++  + H ++K  N+LL    +     + D+GL SF + D       
Sbjct: 151 IMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209
Query: 78  TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF-----QDLV--LEHGS---D 127
            + +Y APE   + K+  ++ DV+S GV++  LL G  PF     QD++  +E G    D
Sbjct: 210 GTAYYIAPEV--LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 128 IPRWVRSVREEETE 141
              W +++ +E  E
Sbjct: 268 FNDW-KNISDEAKE 280

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 46/82 (56%), Gaps = 3/82 (3%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT--SLFYKAPECREIWKQPTQ 96
           TH ++K  N+L+ AD  + L D+G+ S    + + +   T  +L+Y APE R      T 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATY 214
Query: 97  QADVYSFGVLLLELLTGKTPFQ 118
           +AD+Y+   +L E LTG  P+Q
Sbjct: 215 RADIYALTCVLYECLTGSPPYQ 236

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP 69
           P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+      + 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +SV + +A   +  Y +PE +        ++DVYS G +L E+LTG+ PF         D
Sbjct: 171 NSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------GD 222
Query: 128 IPRWV--RSVREEETESGDDPPSSNEASEEKLQALLN-IAIACVSLAPENR 175
            P  V  + VRE+       PPS   A  E L A L+ + +  ++  PENR
Sbjct: 223 SPDSVAYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP 69
           P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+      + 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +SV + +A   +  Y +PE +        ++DVYS G +L E+LTG+ PF        S 
Sbjct: 171 NSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSP 224
Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLN-IAIACVSLAPENR 175
           +    + VRE+       PPS   A  E L A L+ + +  ++  PENR
Sbjct: 225 VSVAYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP 69
           P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+      + 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +SV + +A   +  Y +PE +        ++DVYS G +L E+LTG+ PF        S 
Sbjct: 171 NSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSP 224
Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLN-IAIACVSLAPENR 175
           +    + VRE+       PPS   A  E L A L+ + +  ++  PENR
Sbjct: 225 VSVAYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 111 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 169
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 170 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 228
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 229 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 272
Query: 186 RD 187
            D
Sbjct: 273 ED 274

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 21/122 (17%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQN----------PGLTHGNLKSSNVLLGADFESCLT 59
           G  + W     +AE ++ GL Y+H++          P + H + KS NVLL +D  + L 
Sbjct: 106 GNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLA 165
Query: 60  DYGLGSFRNPDSVEEPSAT-----SLFYKAPECRE----IWKQPTQQADVYSFGVLLLEL 110
           D+GL     P   + P  T     +  Y APE  E      +    + D+Y+ G++L EL
Sbjct: 166 DFGLAVRFEPG--KPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223
Query: 111 LT 112
           ++
Sbjct: 224 VS 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP 69
           P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+      + 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +SV + +A   +  Y +PE +        ++DVYS G +L E+LTG+ PF        S 
Sbjct: 171 NSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSP 224
Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLN-IAIACVSLAPENR 175
           +    + VRE+       PPS   A  E L A L+ + +  ++  PENR
Sbjct: 225 VSVAYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNP 69
           P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+      + 
Sbjct: 129 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 70  DSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +SV + +A   +  Y +PE +        ++DVYS G +L E+LTG+ PF        S 
Sbjct: 188 NSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSP 241
Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLN-IAIACVSLAPENR 175
           +    + VRE+       PPS   A  E L A L+ + +  ++  PENR
Sbjct: 242 VSVAYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENR 282

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 109 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 167
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 168 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 226
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 227 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 270
Query: 186 RD 187
            D
Sbjct: 271 ED 272

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 104 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 162
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 163 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 221
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 222 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 265
Query: 186 RD 187
            D
Sbjct: 266 ED 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 105 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 163
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 164 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 222
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 223 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 266
Query: 186 RD 187
            D
Sbjct: 267 ED 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 162 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 221 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 264
Query: 186 RD 187
            D
Sbjct: 265 ED 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 16/125 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + + SG+ Y+H++  + H +LK  N+LL +  + C   + D+GL +    ++  +  
Sbjct: 125 RIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF-----QDLVL-----EHGS 126
             + +Y APE   +     ++ DV+S GV+L  LL+G  PF      D++      ++  
Sbjct: 184 IGTAYYIAPEV--LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 127 DIPRW 131
           D+P+W
Sbjct: 242 DLPQW 246

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 112 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 170
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 171 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 229
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 230 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 273
Query: 186 RD 187
            D
Sbjct: 274 ED 275

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 162 NEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 221 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 264
Query: 186 RD 187
            D
Sbjct: 265 ED 266

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 16/125 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + + SG+ Y+H++  + H +LK  N+LL +  + C   + D+GL +    ++  +  
Sbjct: 125 RIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF-----QDLVL-----EHGS 126
             + +Y APE   +     ++ DV+S GV+L  LL+G  PF      D++      ++  
Sbjct: 184 IGTAYYIAPEV--LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 127 DIPRW 131
           D+P+W
Sbjct: 242 DLPQW 246

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 98  GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 156
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 157 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 215
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 216 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 259
Query: 186 RD 187
            D
Sbjct: 260 ED 261

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 16/125 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + + SG+ Y+H++  + H +LK  N+LL +  + C   + D+GL +    ++  +  
Sbjct: 125 RIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF-----QDLVL-----EHGS 126
             + +Y APE   +     ++ DV+S GV+L  LL+G  PF      D++      ++  
Sbjct: 184 IGTAYYIAPEV--LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 127 DIPRW 131
           D+P+W
Sbjct: 242 DLPQW 246

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 113 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 171
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 172 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 230
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 231 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 274
Query: 186 RD 187
            D
Sbjct: 275 ED 276

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 108 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 166
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 167 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 225
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 226 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 269
Query: 186 RD 187
            D
Sbjct: 270 ED 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 109 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 167
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 168 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 226
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 227 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 270
Query: 186 RD 187
            D
Sbjct: 271 ED 272

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           ++ + + S + Y H++  + H +LK  NVLL A   + + D+GL +  +       S  S
Sbjct: 115 RLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 173
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
             Y APE          + D++S GV+L  LL G  PF D   EH   +P   + +R
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD---EH---VPTLFKKIR 224

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--R 67
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL-EHG 125
           N  +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 162 NEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 221 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 264
Query: 186 RD 187
            D
Sbjct: 265 ED 266

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEE 74
           L  A+ +  G+ Y+H      H NL + NVLL  D    + D+GL            V E
Sbjct: 120 LLFAQQICEGMAYLHSQ-HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC + +K     +DV+SFGV L ELLT
Sbjct: 179 DGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEE 74
           L  A+ +  G+ Y+H      H NL + NVLL  D    + D+GL            V E
Sbjct: 120 LLFAQQICEGMAYLHAQ-HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC + +K     +DV+SFGV L ELLT
Sbjct: 179 DGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           ++ + + S + Y H++  + H +LK  NVLL A   + + D+GL +  +       S  S
Sbjct: 115 RLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGS 173
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
             Y APE          + D++S GV+L  LL G  PF D   EH   +P   + +R
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD---EH---VPTLFKKIR 224

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL    + + +  P   + +Y+A
Sbjct: 133 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRA 191
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETESG 143
           PE   +     +  D++S G ++ EL+ G   FQ      G+D I +W + + +  T S 
Sbjct: 192 PEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQ------GTDHIDQWNKVIEQLGTPSA 244
Query: 144 D 144
           +
Sbjct: 245 E 245

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 25/190 (13%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    E  L D+G+ G   +  
Sbjct: 100 PLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 158
Query: 71  SVEEPSATSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  +L   H   +
Sbjct: 159 IKRNTFVGTPFWMAPE---VIKQSAYDSKADIWSLGITAIELARGEPPHSEL---HPMKV 212
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---MI 185
              +           ++PP+      + L+  +    AC++  P  RP  +E+ K   ++
Sbjct: 213 LFLI---------PKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAKELLKHKFIL 260
Query: 186 RDSRAEAQMS 195
           R+++  + ++
Sbjct: 261 RNAKKTSYLT 270

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLF 81
           +A G+ Y+ ++ G+ H NL + NVLL +  +  + D+G+     PD    +   + T + 
Sbjct: 142 IAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 200
Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDI 128
           + A E     K  T Q+DV+S+GV + EL+T G  P+  L L    D+
Sbjct: 201 WMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 247

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 25/190 (13%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    E  L D+G+ G   +  
Sbjct: 100 PLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 158
Query: 71  SVEEPSATSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  +L   H   +
Sbjct: 159 IKRNXFVGTPFWMAPE---VIKQSAYDSKADIWSLGITAIELARGEPPHSEL---HPMKV 212
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---MI 185
              +           ++PP+      + L+  +    AC++  P  RP  +E+ K   ++
Sbjct: 213 LFLI---------PKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAKELLKHKFIL 260
Query: 186 RDSRAEAQMS 195
           R+++  + ++
Sbjct: 261 RNAKKTSYLT 270

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 25/190 (13%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    E  L D+G+ G   +  
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 71  SVEEPSATSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  +L   H   +
Sbjct: 174 IKRNXFVGTPFWMAPE---VIKQSAYDSKADIWSLGITAIELARGEPPHSEL---HPMKV 227
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---MI 185
              +           ++PP+      + L+  +    AC++  P  RP  +E+ K   ++
Sbjct: 228 LFLI---------PKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAKELLKHKFIL 275
Query: 186 RDSRAEAQMS 195
           R+++  + ++
Sbjct: 276 RNAKKTSYLT 285

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 13/101 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           +LA GL ++H + G+ + +LK  N+LL  +    LTD+GL    + ++++       F  
Sbjct: 138 ELALGLDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGL----SKEAIDHEKKAYSFCG 192
Query: 82  ---YKAPECREIWKQ-PTQQADVYSFGVLLLELLTGKTPFQ 118
              Y APE   + +Q  +  AD +S+GVL+ E+LTG  PFQ
Sbjct: 193 TVEYMAPEV--VNRQGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 19/129 (14%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G++Y+ +   L H +L + NVL+ +     +TD+GL      D  
Sbjct: 143 LNW--CVQIAK----GMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   +     + + A EC   +++ T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 196 EYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 254
Query: 122 LEHGSDIPR 130
           LE G  +P+
Sbjct: 255 LEKGERLPQ 263

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 25/190 (13%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    E  L D+G+ G   +  
Sbjct: 120 PLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 178
Query: 71  SVEEPSATSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  +L   H   +
Sbjct: 179 IKRNTFVGTPFWMAPE---VIKQSAYDSKADIWSLGITAIELARGEPPHSEL---HPMKV 232
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---MI 185
              +           ++PP+      + L+  +    AC++  P  RP  +E+ K   ++
Sbjct: 233 LFLIPK---------NNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAKELLKHKFIL 280
Query: 186 RDSRAEAQMS 195
           R+++  + ++
Sbjct: 281 RNAKKTSYLT 290

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 30/177 (16%)
Query: 15  WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---------- 64
           W+  +  A+D+ASG+ Y+H +  + H +L S N L+  +    + D+GL           
Sbjct: 107 WSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 65  ----SFRNPDSVEEPSAT-SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
               S + PD  +  +   + ++ APE     +   ++ DV+SFG++L E++ G+     
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEII-GRVNADP 223
Query: 120 LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
             L    D    VR   +      + PPS              I + C  L PE RP
Sbjct: 224 DYLPRTMDFGLNVRGFLDRYCPP-NCPPS-----------FFPITVRCCDLDPEKRP 268

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 14/110 (12%)
Query: 22  AEDLASGLLYIHQNP--GLTHGNLKSSNVLLGADFESC--------LTDYGLGSFRNPDS 71
           A  +A G+ Y+H      + H +LKSSN+L+    E+         +TD+GL   R    
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA--REWHR 168
Query: 72  VEEPSATSLF-YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
             + SA   + + APE        ++ +DV+S+GVLL ELLTG+ PF+ +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLF 81
           +A G+ Y+ ++ G+ H NL + NVLL +  +  + D+G+     PD    +   + T + 
Sbjct: 124 IAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDI 128
           + A E     K  T Q+DV+S+GV + EL+T G  P+  L L    D+
Sbjct: 183 WMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-FRNP 69
           KPL         +DL  G+ Y+H    + H ++K SN+L+G D    + D+G+ + F+  
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQK-IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 70  DSVEEPSATSLFYKAP----ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           D++   +  +  + AP    E R+I+    +  DV++ GV L   + G+ PF D
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFS--GKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 19/129 (14%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G++Y+ +   L H +L + NVL+ +     +TD+GL      D  
Sbjct: 120 LNW--CVQIAK----GMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   +     + + A EC   +++ T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 231
Query: 122 LEHGSDIPR 130
           LE G  +P+
Sbjct: 232 LEKGERLPQ 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  G+ + HQ+  + H +LK  N+L+ +D    L D+GL  +F  P         +L+Y+
Sbjct: 128 LLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     K+ +   D++S G +  E++TGK  F
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 133 ILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 192 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  G+ + HQ+  + H +LK  N+L+ +D    L D+GL  +F  P         +L+Y+
Sbjct: 128 LLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     K+ +   D++S G +  E++TGK  F
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  +    L ++H N  + H N+KS N+LLG D    LTD+G  +   P+  +  +    
Sbjct: 122 VCRECLQALEFLHSNQ-VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 180
Query: 81  -FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 181 PYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S  +    +L Y 
Sbjct: 117 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRDTLCGTLDYL 174
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 175 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 225
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 226 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 255

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 133 ILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 192 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 133 ILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 192 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 137 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 196 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 138 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 197 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 137 ILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 196 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 137 ILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 196 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S  +    +L Y 
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRDDLCGTLDYL 176
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 177 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 227
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 228 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 257

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEE 74
           L  A+ +  G+ Y+H      H +L + NVLL  D    + D+GL            V E
Sbjct: 137 LLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRE 195
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC + +K     +DV+SFGV L ELLT
Sbjct: 196 DGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 232

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-FRNPDSVEEPSATSLFYK 83
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  + F   + ++E   +   Y 
Sbjct: 122 IVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPP-YA 179
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 153 ILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 212 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 141 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 200 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 133 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 192 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 135 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 194 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 13/111 (11%)
Query: 16  TSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVE 73
           +  +K A D+A G+ ++H   P +    L S +V++  D  + ++   +  SF++P  + 
Sbjct: 111 SQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY 170
Query: 74  EPSATSLFYKAPECREIWKQP----TQQADVYSFGVLLLELLTGKTPFQDL 120
            P+     + APE  +  K+P     + AD++SF VLL EL+T + PF DL
Sbjct: 171 APA-----WVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 133 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 192 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 131 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 190 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 137 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 196 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 153 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 212 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 137 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 196 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 63/123 (51%), Gaps = 21/123 (17%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++A GL ++ Q+ G+ + +LK  NV+L ++    + D+G+      +++ +   T  F
Sbjct: 448 AAEIAIGLFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXF 502
Query: 82  -----YKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGSD 127
                Y APE   I  QP  +  D ++FGVLL E+L G+ PF+          ++EH   
Sbjct: 503 CGTPDYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 560
Query: 128 IPR 130
            P+
Sbjct: 561 YPK 563

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 131 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 190 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 138 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 197 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 139 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 198 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 130 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 189 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 137 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 196 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 135 ILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 194 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 119 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRAALCGTLDYL 176
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 177 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 227
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 228 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 257

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S  +    +L Y 
Sbjct: 142 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRDDLCGTLDYL 199
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            PE  E  +   ++ D++S GVL  E L GK PF+
Sbjct: 200 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCHSKK-VIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRAALCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQDTYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +        +    S  Y A
Sbjct: 120 IVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAA 178
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN- 68
           G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL      
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 69  -PDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEHG 125
              +  E +   + + APE    +   T ++DV+SFG+LL E++T G+ P+  +   E  
Sbjct: 162 AEXTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            ++ R  R VR       D+ P       E+L  L+ +   C    PE+RP    +  ++
Sbjct: 221 QNLERGYRMVRP------DNCP-------EELYQLMRL---CWKERPEDRPTFDYLRSVL 264
Query: 186 RD 187
            D
Sbjct: 265 ED 266

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 63/123 (51%), Gaps = 21/123 (17%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++A GL ++ Q+ G+ + +LK  NV+L ++    + D+G+      +++ +   T  F
Sbjct: 127 AAEIAIGLFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXF 181
Query: 82  -----YKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGSD 127
                Y APE   I  QP  +  D ++FGVLL E+L G+ PF+          ++EH   
Sbjct: 182 CGTPDYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 239
Query: 128 IPR 130
            P+
Sbjct: 240 YPK 242

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+LL    +  + D+GL    +PD      + E  AT 
Sbjct: 135 ILRGLKYIH-SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 194 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 121 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 178
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 179 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 229
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 230 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 259

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           L S L ++H    + H ++K +NV + A     L D GLG F +  +    S     +Y 
Sbjct: 145 LCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
           +PE R        ++D++S G LL E+   ++PF      +G  +  +      ++ E  
Sbjct: 204 SPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC---KKIEQC 253
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           D PP  ++   E+L+ L+N+   C++  PE RP
Sbjct: 254 DYPPLPSDHYSEELRQLVNM---CINPDPEKRP 283

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 118 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXLCGTLDYL 175
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 176 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 226
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 227 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 120 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 177
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 178 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 228
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 229 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 258

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 121 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 178
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 179 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 229
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 230 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 121 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDLCGTLDYL 178
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 179 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 229
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 230 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 119 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 176
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 177 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 227
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 228 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXLCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRAALCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 119 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXLCGTLDYL 176
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 177 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 227
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 228 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 257

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 121 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRXXLXGTLDYL 178
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 179 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 229
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 230 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 119 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 176
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 177 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 227
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 228 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 115 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 172
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 173 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 223
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 224 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 253

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDLCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 113 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 171 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 221
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 222 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 251

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTELCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 117 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDLCGTLDYL 174
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 175 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 225
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 226 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 255

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTXLCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +     +  +    S  Y A
Sbjct: 122 IVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +     +  +    S  Y A
Sbjct: 122 IVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +     +  +    S  Y A
Sbjct: 122 IVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 142 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 199
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            PE  E  +   ++ D++S GVL  E L GK PF+
Sbjct: 200 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 116 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTDLCGTLDYL 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 174 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 224
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 225 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 254

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL      + +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETESG 143
           PE   +        D++S G ++ EL+ G   FQ      G+D I +W + + +  T S 
Sbjct: 194 PEVI-LGMGYAANVDIWSVGCIMGELVKGCVIFQ------GTDHIDQWNKVIEQLGTPSA 246
Query: 144 D 144
           +
Sbjct: 247 E 247

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S     + +L Y 
Sbjct: 117 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SCHAPSSRRTTLSGTLDYL 174
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 175 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 225
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 226 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 133 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 190
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 191 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 241
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 242 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 271

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +     +  +    S  Y A
Sbjct: 115 IVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IAE    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 117 LNW--CVQIAE----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 169
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 170 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 228
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 229 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 266
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 267 IIEFSKMARDPQRYLVIQGDERMHLP 292

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 15/107 (14%)
Query: 16  TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           T CL +   L+    Y+H N G+ H ++KS ++LL +D    L+D+G   F    S E P
Sbjct: 145 TVCLSVLRALS----YLH-NQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVP 196
Query: 76  SATSL----FYKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPF 117
               L    ++ APE   I + P   + D++S G++++E++ G+ P+
Sbjct: 197 KRKXLVGTPYWMAPEV--ISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +        +    +  Y A
Sbjct: 123 IVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS-FRNPDSVEEPS 76
           I + + SG  Y+H++  + H +LK  N+LL +     L    D+GL + F     ++E  
Sbjct: 126 IMKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 184
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
            T+ +Y APE   + K+  ++ DV+S GV+L  LL G  PF       G    + +   R
Sbjct: 185 GTA-YYIAPEV--LRKKYDEKCDVWSCGVILYILLCGYPPF-------GGQTDQEILK-R 233
Query: 137 EEETESGDDPPSSNEASEEKLQ 158
            E+ +   DPP   + S+E  Q
Sbjct: 234 VEKGKFSFDPPDWTQVSDEAKQ 255

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H+N  L H +LK  N+L+    +  L D+GL  +F  P +       +L+Y+
Sbjct: 117 LLQGLAFCHENKIL-HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     +  +   D++S G +L E++TGK  F
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           ++  GGK L     +  +  +A G+ YI +     H +L+++NVL+       + D+GL 
Sbjct: 100 KSDEGGKVLL-PKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLA 157
Query: 65  SF--RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF---- 117
                N  +  E +   + + APE    +   T ++DV+SFG+LL E++T GK P+    
Sbjct: 158 RVIEDNEYTAREGAKFPIKWTAPEAIN-FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRT 216
Query: 118 -QDLV--LEHGSDIPR 130
             D++  L  G  +PR
Sbjct: 217 NADVMTALSQGYRMPR 232

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 107 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 166 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 31  YIHQNPGLTHGNLKSSNVL---LGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           Y+H + G+ H +LK  N+L   L  D +  ++D+GL    +P SV   +  +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 88  REIWKQPTQQA-DVYSFGVLLLELLTGKTPFQD----------LVLEHGSDIPRW 131
             + ++P  +A D +S GV+   LL G  PF D          L  E+  D P W
Sbjct: 190 --LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 109 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 168 XGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL  D    + D+G  +     +  +    S  Y A
Sbjct: 123 IVSAVQYCHQKY-IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+ L     L++ E +  G+ YIH    L H +LK SN+ L    +  + D+GL +    
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSKK-LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 70  DSVEEPSATSLFYKAPECREIWKQPT-QQADVYSFGVLLLELL 111
           D     S  +L Y +PE  +I  Q   ++ D+Y+ G++L ELL
Sbjct: 189 DGKRTRSKGTLRYMSPE--QISSQDYGKEVDLYALGLILAELL 229

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 13/102 (12%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++AS L Y+H +  + + +LK  N+LL +     LTD+GL      +++E  S TS F
Sbjct: 145 AAEIASALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTF 199
Query: 82  -----YKAPECREIWKQPTQQ-ADVYSFGVLLLELLTGKTPF 117
                Y APE   + KQP  +  D +  G +L E+L G  PF
Sbjct: 200 CGTPEYLAPEV--LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 22/175 (12%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPD 70
           PL  T    I  ++  GL Y+H    + H ++K++NVLL    +  L D+G+ G   +  
Sbjct: 112 PLEETYIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 170
Query: 71  SVEEPSATSLFYKAPECREIWKQPTQ--QADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                   + F+ APE   + KQ     +AD++S G+  +EL  G+ P  DL        
Sbjct: 171 IKRNXFVGTPFWMAPE---VIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-------- 219
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                 +R       + PP+      +  +  +    AC++  P  RP  +E+ K
Sbjct: 220 ----HPMRVLFLIPKNSPPTLEGQHSKPFKEFVE---ACLNKDPRFRPTAKELLK 267

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 31  YIHQNPGLTHGNLKSSNVL---LGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           Y+H + G+ H +LK  N+L   L  D +  ++D+GL    +P SV   +  +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 88  REIWKQPTQQA-DVYSFGVLLLELLTGKTPFQD----------LVLEHGSDIPRW 131
             + ++P  +A D +S GV+   LL G  PF D          L  E+  D P W
Sbjct: 190 --LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 8/103 (7%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDS--VEEP 75
           I   L S + ++H + G+ H +LK  N+L      + E  + D+G    + PD+  ++ P
Sbjct: 111 IMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             T L Y APE         +  D++S GV+L  +L+G+ PFQ
Sbjct: 170 CFT-LHYAAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           L IA  +ASG++Y+  +    H +L + N L+GA+    + D+G+     + D       
Sbjct: 136 LHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 78  TSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
           T L  +  P    ++++ T ++DV+SFGV+L E+ T GK P+  L
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 31  YIHQNPGLTHGNLKSSNVL---LGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           Y+H + G+ H +LK  N+L   L  D +  ++D+GL    +P SV   +  +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 88  REIWKQPTQQA-DVYSFGVLLLELLTGKTPFQD----------LVLEHGSDIPRW 131
             + ++P  +A D +S GV+   LL G  PF D          L  E+  D P W
Sbjct: 190 --LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P+  +  +    
Sbjct: 121 VCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 81  -FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 180 PYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS---FRNPDSVEEPS 76
           +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +   + N + +    
Sbjct: 108 RFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 77  ATSLFYKAPEC---REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +L Y APE    RE   +P    DV+S G++L  +L G+ P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELPW 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG++ E  + D+G  S   P S  +    +L Y 
Sbjct: 120 ELANALSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGW-SVHAPSSRRDTLCGTLDYL 177
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            PE  E  +   ++ D++S GVL  E L G  PF+
Sbjct: 178 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 31  YIHQNPGLTHGNLKSSNVL---LGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           Y+H + G+ H +LK  N+L   L  D +  ++D+GL    +P SV   +  +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 189
Query: 88  REIWKQPTQQA-DVYSFGVLLLELLTGKTPFQD----------LVLEHGSDIPRW 131
             + ++P  +A D +S GV+   LL G  PF D          L  E+  D P W
Sbjct: 190 --LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +     +  +    +  Y A
Sbjct: 122 IVSAVQYCHQK-FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS-FRNPDSVEEPS 76
           I + + SG  Y+H++  + H +LK  N+LL +     L    D+GL + F     ++E  
Sbjct: 109 IMKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 167
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
            T+ +Y APE   + K+  ++ DV+S GV+L  LL G  PF       G    + +   R
Sbjct: 168 GTA-YYIAPEV--LRKKYDEKCDVWSCGVILYILLCGYPPF-------GGQTDQEILK-R 216
Query: 137 EEETESGDDPPSSNEASEEKLQ 158
            E+ +   DPP   + S+E  Q
Sbjct: 217 VEKGKFSFDPPDWTQVSDEAKQ 238

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + D+G  S   P S       +L Y 
Sbjct: 121 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRTTLCGTLDYL 178
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            PE  E  +   ++ D++S GVL  E L GK PF+
Sbjct: 179 PPEXIE-GRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATS 79
           +  GL YIH +  + H +LK SN+L+    +  + D+GL    +P+      + E  AT 
Sbjct: 153 ILRGLKYIH-SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            +Y+APE     K  T+  D++S G +L E+L+ +  F
Sbjct: 212 -WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGS-FRNPDSVEEP 75
           +I   + SG+ Y+H+N  + H +LK  N+LL     D    + D+GL + F     +++ 
Sbjct: 130 RIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             T+ +Y APE   +     ++ DV+S GV+L  LL+G  PF
Sbjct: 189 IGTA-YYIAPEV--LHGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGS-FRNPDSVEEP 75
           +I   + SG+ Y+H+N  + H +LK  N+LL     D    + D+GL + F     +++ 
Sbjct: 153 RIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             T+ +Y APE   +     ++ DV+S GV+L  LL+G  PF
Sbjct: 212 IGTA-YYIAPEV--LHGTYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 1/100 (1%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +  + +   + Y H++  + H +LK  N+LL  +    + D+GL +     +  + S  S
Sbjct: 112 RFFQQIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE          + DV+S G++L  +L G+ PF D
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGS-FRNPDSVEEP 75
           +I   + SG+ Y+H+N  + H +LK  N+LL     D    + D+GL + F     +++ 
Sbjct: 154 RIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             T+ +Y APE   +     ++ DV+S GV+L  LL+G  PF
Sbjct: 213 IGTA-YYIAPEV--LHGTYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A S    
Sbjct: 140 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGT 197
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K  ++ +D+++ G ++ +L+ G  PF+
Sbjct: 198 AQYVSPELL-TEKSASKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 16  TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           T+C  +AE ++  L ++HQ  G+ + +LK  N++L       LTD+GL      +S+ + 
Sbjct: 122 TACFYLAE-ISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDG 175
Query: 76  SATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + T  F     Y APE   +     +  D +S G L+ ++LTG  PF
Sbjct: 176 TVTHXFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 113 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 171
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 172 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P+  +       
Sbjct: 121 VCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGT 179
Query: 81  -FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 180 PYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGS-FRNPDSVEEP 75
           +I   + SG+ Y+H+N  + H +LK  N+LL     D    + D+GL + F     +++ 
Sbjct: 136 RIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             T+ +Y APE   +     ++ DV+S GV+L  LL+G  PF
Sbjct: 195 IGTA-YYIAPEV--LHGTYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 16  TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           T+C  +AE ++  L ++HQ  G+ + +LK  N++L       LTD+GL      +S+ + 
Sbjct: 122 TACFYLAE-ISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDG 175
Query: 76  SATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + T  F     Y APE   +     +  D +S G L+ ++LTG  PF
Sbjct: 176 TVTHTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P+  +       
Sbjct: 121 VCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGT 179
Query: 81  -FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 180 PYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 106 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 164
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 165 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P+  +       
Sbjct: 122 VCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGT 180
Query: 81  -FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE     K    + D++S G++ +E++ G+ P+
Sbjct: 181 PYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 49/93 (52%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLVGIKHLH-SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S GV++ E++ G   F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG+  E  + ++G  S   P S       +L Y 
Sbjct: 118 ELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIANFGW-SVHAPSSRRTTLCGTLDYL 175
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 176 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 226
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 227 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 256

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 62/104 (59%), Gaps = 11/104 (10%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +A+G+ Y+  +    H +L + N+L+ ++    ++D+GL  F   D+  +P+ TS     
Sbjct: 144 IAAGMKYL-ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-SDPTYTSALGGK 201
Query: 80  --LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
             + + APE  + +++ T  +DV+S+G+++ E+++ G+ P+ D+
Sbjct: 202 IPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/142 (21%), Positives = 67/142 (47%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        + EP   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++  K  F           ++ + G+  P +++ +
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKL 252
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 253 QPTVRNYVENRPKYAGYSFEKL 274

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 45/211 (21%)
Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
           G    L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL    
Sbjct: 109 GSQYLLNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161
Query: 68  NPDSVE---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL--- 120
             +  E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +   
Sbjct: 162 GAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220
Query: 121 ----VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
               +LE G  +P+               PP            +  I + C  +  ++RP
Sbjct: 221 EISSILEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRP 258
Query: 177 VMREV----SKMIRDSRAEAQMSSNSSDHSP 203
             RE+    SKM RD +    +  +   H P
Sbjct: 259 KFRELIIEFSKMARDPQRYLVIQGDERMHLP 289

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+   P+  
Sbjct: 116 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGA 174
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 175 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 231
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 232 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 278

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 1/93 (1%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +     +  +    +  Y A
Sbjct: 122 IVSAVQYCHQK-FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE  +  K    + DV+S GV+L  L++G  PF
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 127 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 180 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 239 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 276
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 277 IIEFSKMARDPQRYLVIQGDERMHLP 302

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++   L Y+H    + + +LK  N+LL  +    +TD+G   +  PD       T   
Sbjct: 112 AAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYXLCGTPD- 168
Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           Y APE     K   +  D +SFG+L+ E+L G TPF D
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 16/112 (14%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSA 77
           + +D+AS L ++H N G+ H +LK  N+L     +     + D+GLGS    +    P +
Sbjct: 116 VVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 78  T--------SLFYKAPECREIWKQPT----QQADVYSFGVLLLELLTGKTPF 117
           T        S  Y APE  E + +      ++ D++S GV+L  LL+G  PF
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 122 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 175 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 234 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 271
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 272 IIEFSKMARDPQRYLVIQGDERMHLP 297

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/93 (25%), Positives = 49/93 (52%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLVGIKHLH-SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S GV++ E++ G   F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 127 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 180 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 239 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 276
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 277 IIEFSKMARDPQRYLVIQGDERMHLP 302

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 127 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 180 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 239 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 276
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 277 IIEFSKMARDPQRYLVIQGDERMHLP 302

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H    + H ++K  N+LLG+  E  + ++G  S   P S       +L Y 
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGW-SVHAPSSRRTTLCGTLDYL 176
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG 143
            PE  E  +   ++ D++S GVL  E L GK PF     E  +    + R  R E T   
Sbjct: 177 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFT--- 227
Query: 144 DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             P    E + + +  LL          P  RP++REV
Sbjct: 228 -FPDFVTEGARDLISRLLK-------HNPSQRPMLREV 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYK 83
           +LA+ L Y H +  + H ++K  N+LLG++ E  + D+G  S   P S       +L Y 
Sbjct: 120 ELANALSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGW-SVHAPSSRRTTLCGTLDYL 177
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            PE  E  +   ++ D++S GVL  E L G  PF+
Sbjct: 178 PPEMIE-GRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+   P+  
Sbjct: 115 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGA 173
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 174 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 230
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 231 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 277

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A S    
Sbjct: 141 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGT 198
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 199 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 236

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 120 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 232 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 269
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLP 295

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 120 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 232 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 269
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLP 295

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 126 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 179 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 237
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 238 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 275
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 276 IIEFSKMARDPQRYLVIQGDERMHLP 301

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 145 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 198 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 256
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 257 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 294
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 295 IIEFSKMARDPQRYLVIQGDERMHLP 320

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 121 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 174 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 233 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 270
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 271 IIEFSKMARDPQRYLVIQGDERMHLP 296

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 154 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 207 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 265
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 266 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 303
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 304 IIEFSKMARDPQRYLVIQGDERMHLP 329

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 123 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 176 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 235 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 272
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 273 IIEFSKMARDPQRYLVIQGDERMHLP 298

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 120 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 232 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 269
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLP 295

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 122 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 175 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 234 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 271
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 272 IIEFSKMARDPQRYLVIQGDERMHLP 297

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 121 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 174 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 233 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 270
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 271 IIEFSKMARDPQRYLVIQGDERMHLP 296

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 120 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 232 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 269
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLP 295

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 123 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 176 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 235 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 272
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 273 IIEFSKMARDPQRYLVIQGDERMHLP 298

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 123 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 176 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 235 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 272
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 273 IIEFSKMARDPQRYLVIQGDERMHLP 298

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 124 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 177 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 236 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 273
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 274 IIEFSKMARDPQRYLVIQGDERMHLP 299

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 59/134 (44%), Gaps = 35/134 (26%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-- 69
           L++A   A GL ++H         P + H + KS NVL+ ++ + C+ D GL    +   
Sbjct: 108 LRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGS 167
Query: 70  ---DSVEEPSATSLFYKAPE---------CREIWKQPTQQADVYSFGVLLLE-----LLT 112
              D    P   +  Y APE         C E +K      D+++FG++L E     ++ 
Sbjct: 168 DYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYK----WTDIWAFGLVLWEIARRTIVN 223
Query: 113 G-----KTPFQDLV 121
           G     + PF D+V
Sbjct: 224 GIVEDYRPPFYDVV 237

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H NL + N L+G +    + D+GL      D+    +  
Sbjct: 321 LYMATQISSAMEYL-EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 380 KFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 436
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 437 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 483

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 7/101 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL   +   S ++    
Sbjct: 105 LKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKL 161
Query: 79  SLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + APE  RE  K+ + ++DV+SFG+LL E+ + G+ P+
Sbjct: 162 PVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 7/101 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL   +   S ++    
Sbjct: 292 LKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKL 348
Query: 79  SLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + APE  RE  K+ + ++DV+SFG+LL E+ + G+ P+
Sbjct: 349 PVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGS 65
           G K L   +C      +   + Y+H+N G+ H +LK  NVLL +  E CL   TD+G   
Sbjct: 246 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 304
Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
                S+      +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 305 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEE 74
           L  A+ +  G+ Y+H    + H  L + NVLL  D    + D+GL            V E
Sbjct: 115 LLFAQQICEGMAYLHAQHYI-HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 173
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC +  K     +DV+SFGV L ELLT
Sbjct: 174 DGDSPVFWYAPECLKECKF-YYASDVWSFGVTLYELLT 210

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSVEEPS 76
           +I   + SG+ Y H+N  + H +LK  N+LL     D    + D+GL +        +  
Sbjct: 130 RIIRQVLSGITYXHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK 188
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             + +Y APE   +     ++ DV+S GV+L  LL+G  PF
Sbjct: 189 IGTAYYIAPEV--LHGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 21/123 (17%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A +++ GL ++H+  G+ + +LK  NV+L ++    + D+G+      D V     T  F
Sbjct: 126 AAEISIGLFFLHKR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV----TTREF 180
Query: 82  -----YKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGSD 127
                Y APE   I  QP  +  D +++GVLL E+L G+ PF           ++EH   
Sbjct: 181 CGTPDYIAPEI--IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 238
Query: 128 IPR 130
            P+
Sbjct: 239 YPK 241

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  A D+A G+ Y+ Q     H NL + N+L+G ++ + + D+GL   +     +     
Sbjct: 142 LHFAADVARGMDYLSQKQ-FIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + A E    +   T  +DV+S+GVLL E+++ G TP+
Sbjct: 201 PVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 7/101 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL   +   S ++    
Sbjct: 120 LKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKL 176
Query: 79  SLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + APE  RE  K+ + ++DV+SFG+LL E+ + G+ P+
Sbjct: 177 PVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEE 74
           L  A+ +  G+ Y+H    + H  L + NVLL  D    + D+GL            V E
Sbjct: 114 LLFAQQICEGMAYLHAQHYI-HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 172
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC +  K     +DV+SFGV L ELLT
Sbjct: 173 DGDSPVFWYAPECLKECKF-YYASDVWSFGVTLYELLT 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A S    
Sbjct: 137 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGT 194
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 195 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 232

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 61/104 (58%), Gaps = 11/104 (10%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +A+G+ Y+  +    H  L + N+L+ ++    ++D+GL  F   D+  +P+ TS     
Sbjct: 118 IAAGMKYL-ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDT-SDPTYTSALGGK 175
Query: 80  --LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
             + + APE  + +++ T  +DV+S+G+++ E+++ G+ P+ D+
Sbjct: 176 IPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           ++  GGK L     +  +  +A G+ YI +     H +L+++NVL+       + D+GL 
Sbjct: 99  KSDEGGKVLL-PKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLA 156
Query: 65  SF--RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF---- 117
                N  +  E +   + + APE    +   T +++V+SFG+LL E++T GK P+    
Sbjct: 157 RVIEDNEYTAREGAKFPIKWTAPEAIN-FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRT 215
Query: 118 -QDLV--LEHGSDIPR 130
             D++  L  G  +PR
Sbjct: 216 NADVMSALSQGYRMPR 231

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 31/155 (20%)
Query: 15  WTSCLKIAEDLASGLLYIH--------QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           W S  ++A  +  GL Y+H          P ++H +L S NVL+  D    ++D+GL   
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 67  RNPDSVEEPS---------ATSLFYKAPECRE------IWKQPTQQADVYSFGVLLLELL 111
              + +  P            ++ Y APE  E        +   +Q D+Y+ G++  E+ 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 112 TGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDP 146
              T      L  G  +P +  +    +TE G+ P
Sbjct: 230 MRCTD-----LFPGESVPEYQMAF---QTEVGNHP 256

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 31/183 (16%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+ +     +TD+GL    + D  
Sbjct: 122 LNW--CMQIAK----GMSYL-EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDI 128
           E   +     + + A E   + ++ T Q+DV+S+GV + EL+T G  P+  +      +I
Sbjct: 175 EYHADGGKVPIKWMALESI-LRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI---PAREI 230
Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKM 184
           P  +     E+ E    PP            +  I + C  +  E RP  RE+    S+M
Sbjct: 231 PDLL-----EKGERLPQPPICT-------IDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278
Query: 185 IRD 187
            RD
Sbjct: 279 ARD 281

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H NL + N L+G +    + D+GL      D+    +  
Sbjct: 360 LYMATQISSAMEYL-EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 418
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
               K  APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 419 KFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 475
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 476 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 522

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 118 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 176
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y APE R      + Q+D++S G+ L+EL  G+ P 
Sbjct: 177 RSYMAPE-RLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/142 (21%), Positives = 67/142 (47%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        + EP   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++  K  F           ++ + G+  P +++ +
Sbjct: 194 PEVI-LGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKL 274

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 471 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 529
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 530 QTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 582
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 583 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 629

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NVL+  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 470 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 529 QTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 581
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 582 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 628

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 185
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 228
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 229 --XECQHLIR---WCLALRPSDRPTFEEI 252

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A +    
Sbjct: 138 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANAFVGT 195
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 196 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 112 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKA 170
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 171 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 223
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 224 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 270

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 29/133 (21%)
Query: 17  SCLKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FR 67
           S LK+A    SGL ++H         P + H +LKS N+L+  +   C+ D GL      
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
Query: 68  NPDSVEEPSATSL---FYKAPEC------REIWKQPTQQADVYSFGVLLLEL----LTG- 113
           + + V+ P  T +    Y  PE       R  + Q    AD+YSFG++L E+    ++G 
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF-QSYIMADMYSFGLILWEVARRCVSGG 253
Query: 114 -----KTPFQDLV 121
                + P+ DLV
Sbjct: 254 IVEEYQLPYHDLV 266

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 14/113 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KIA  +   L ++H    + H ++K SNVL+ A  +  + D+G+  +   D  ++  A  
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGC 172
Query: 80  LFYKAPECREIWKQPTQ-----QADVYSFGVLLLELLTGK-------TPFQDL 120
             Y APE   I  +  Q     ++D++S G+ ++EL   +       TPFQ L
Sbjct: 173 KPYMAPE--RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 237
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 238 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 280
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 281 --XECQHLIR---WCLALRPSDRPTFEEI 304

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 17/99 (17%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF------RNPDSVEEPSATSLF 81
           G+ Y+H N  + H +LK  N+ L  D +  + D+GL +       R  D    P+     
Sbjct: 154 GVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN----- 207
Query: 82  YKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           Y APE  C+   K  + + D++S G +L  LL GK PF+
Sbjct: 208 YIAPEVLCK---KGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 106 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 164
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 165 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 217
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 218 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 264

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 171 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 171 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 189
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 232
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 233 --SECQHLIR---WCLALRPSDRPTFEEI 256

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 217
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 260
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 261 --SECQHLIR---WCLALRPSDRPTFEEI 284

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 190
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 233
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 234 --SECQHLIR---WCLALRPSDRPTFEEI 257

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++ G   F           ++ + G+  P +++ +
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKL 274

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 112 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 170
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 171 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 223
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 224 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 270

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 205
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 248
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 249 --SECQHLIR---WCLALRPSDRPTFEEI 272

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 171 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 185
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 228
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 229 --SECQHLIR---WCLALRPSDRPTFEEI 252

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 136 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++ G   F           ++ + G+  P +++ +
Sbjct: 195 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKL 275

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++ G   F           ++ + G+  P +++ +
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKL 274

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 224
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 267
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 268 --SECQHLIR---WCLALRPSDRPTFEEI 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 4/112 (3%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPD 70
           PL     L +A  +A+G++Y+       H +L + N L+G      + D+G+     + D
Sbjct: 125 PLGLGQLLAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183
Query: 71  SVEEPSATSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
                  T L  +  P    ++++ T ++DV+SFGV+L E+ T GK P+  L
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 235

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 232
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 275
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 276 --SECQHLIR---WCLALRPSDRPTFEEI 299

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 189
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 232
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 233 --SECQHLIR---WCLALRPSDRPTFEEI 256

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 4/112 (3%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPD 70
           PL     L +A  +A+G++Y+       H +L + N L+G      + D+G+     + D
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 71  SVEEPSATSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
                  T L  +  P    ++++ T ++DV+SFGV+L E+ T GK P+  L
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 188
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 189 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 231
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 232 --SECQHLIR---WCLALRPSDRPTFEEI 255

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 108 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 167 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 219
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 220 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 266

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 190
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 233
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 234 --SECQHLIR---WCLALRPSDRPTFEEI 257

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+ L     L++ E +  G+ YIH    L + +LK SN+ L    +  + D+GL +    
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 70  DSVEEPSATSLFYKAPECREIWKQPT-QQADVYSFGVLLLELL 111
           D     S  +L Y +PE  +I  Q   ++ D+Y+ G++L ELL
Sbjct: 175 DGKRXRSKGTLRYMSPE--QISSQDYGKEVDLYALGLILAELL 215

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 205
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 248
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 249 --XECQHLIR---WCLALRPSDRPTFEEI 272

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 190
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 233
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 234 --SECQHLIR---WCLALRPSDRPTFEEI 257

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 54/121 (44%), Gaps = 14/121 (11%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-------LTDYG 62
           GK L      ++ + + + L Y H    + H +LK  N+L    F+         + D+G
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENIL----FQDTSPHSPIKIIDFG 172
Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
           L      D     +A +  Y APE  +  +  T + D++S GV++  LLTG  PF    L
Sbjct: 173 LAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 123 E 123
           E
Sbjct: 231 E 231

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 205
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 248
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 249 --XECQHLIR---WCLALRPXDRPTFEEI 272

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 118 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 177 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 229
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 230 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 276

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 204
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 247
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 248 --XECQHLIR---WCLALRPSDRPTFEEI 271

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 17/99 (17%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF------RNPDSVEEPSATSLF 81
           G+ Y+H N  + H +LK  N+ L  D +  + D+GL +       R  D    P+     
Sbjct: 138 GVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN----- 191
Query: 82  YKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           Y APE  C+   K  + + D++S G +L  LL GK PF+
Sbjct: 192 YIAPEVLCK---KGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 204
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 247
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 248 --SECQHLIR---WCLALRPSDRPTFEEI 271

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 212
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 213 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 255
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 256 --XECQHLIR---WCLALRPSDRPTFEEI 279

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 232
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 275
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 276 --XECQHLIR---WCLALRPSDRPTFEEI 299

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 126 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 184
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 185 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 237
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 238 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 284

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 232
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I R     R+  +            
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVS------------ 275
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
              + Q L+     C++L P +RP   E+
Sbjct: 276 --SECQHLIR---WCLALRPSDRPTFEEI 299

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 4/112 (3%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPD 70
           PL     L +A  +A+G++Y+       H +L + N L+G      + D+G+     + D
Sbjct: 131 PLGLGQLLAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 71  SVEEPSATSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
                  T L  +  P    ++++ T ++DV+SFGV+L E+ T GK P+  L
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 241

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 128 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 186
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 187 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 239
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 240 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 286

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS 76
           + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      D     +
Sbjct: 128 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 186
Query: 77  ATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRW 131
            T     + + APEC   +K  + ++DV+SFGVL+ E  + G+ P++ +    GS++   
Sbjct: 187 QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEV--- 239
Query: 132 VRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             +   E+ E    P         ++  L+N+   C +   ENRP    V   +R+
Sbjct: 240 --TAMLEKGERMGCPA----GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRN 286

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 138 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 140 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 197
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 198 AQYVSPELL-TEKSAXKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 21/150 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPEC--REIWK 92
            H +L + N+L+ ++    + D+GL      D     V EP  + +F+ APE     I+ 
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF- 194
Query: 93  QPTQQADVYSFGVLLLELLT----GKTPFQDLVLEHGS--DIPRWVRSVREEETESGDDP 146
             ++Q+DV+SFGV+L EL T      +P  + +   GS  D+P   R +   E       
Sbjct: 195 --SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPA 252
Query: 147 PSSNEASEEKLQALLNIAIACVSLAPENRP 176
           P +  A   +L  L      C + +P++RP
Sbjct: 253 PPACPAEVHELMKL------CWAPSPQDRP 276

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 123 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 124 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 117 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 174
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 175 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 212

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 138 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 236

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 139 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 237

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 143 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 118 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 175
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 176 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 138 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 195
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 196 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 144 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 202
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 203 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 242

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 138 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 195
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 196 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD+   V++    ++ Y  PE  
Sbjct: 127 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 140 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 197
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 198 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   + +      Y 
Sbjct: 130 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYI 188
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  + + DV+S G ++  LL GK PF+
Sbjct: 189 APEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 141 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 198
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 199 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 236

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           ++   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 137 EILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  K PF      HG D
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-----HGHD 235

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 138 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 195
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 196 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 115 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 172
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 173 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 116 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 173
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 174 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 211

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   + +      Y 
Sbjct: 126 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYI 184
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  + + DV+S G ++  LL GK PF+
Sbjct: 185 APEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 143 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 200
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 201 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   + +      Y 
Sbjct: 126 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYI 184
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  + + DV+S G ++  LL GK PF+
Sbjct: 185 APEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 145 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 202
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 203 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 240

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 21/150 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGSF----RNPDSVEEPSATSLFYKAPEC--REIWK 92
            H +L + N+L+ ++    + D+GL       ++   V EP  + +F+ APE     I+ 
Sbjct: 133 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF- 191
Query: 93  QPTQQADVYSFGVLLLELLT----GKTPFQDLVLEHGS--DIPRWVRSVREEETESGDDP 146
             ++Q+DV+SFGV+L EL T      +P  + +   G   D+P   R +   E       
Sbjct: 192 --SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPA 249
Query: 147 PSSNEASEEKLQALLNIAIACVSLAPENRP 176
           P +  A   +L  L      C + +P++RP
Sbjct: 250 PPACPAEVHELMKL------CWAPSPQDRP 273

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 140 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 197
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 198 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 122 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 179
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 180 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 140 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 197
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 198 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 140 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 197
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 198 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETES 142
           PE   +     +  D++S G ++ E++ G   F       G+D I +W + + +  T S
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFP------GTDHIDQWNKVIEQLGTPS 245

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 137 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++ G   F           ++ + G+  P +++ +
Sbjct: 196 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 254
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 255 QPTVRTYVENRPKYAGYSFEKL 276

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYKAPE 86
           G+ Y+H N  + H +LK  N+ L  D +  + D+GL +    D   + +      Y APE
Sbjct: 154 GVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE 212
Query: 87  --CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
             C+   K  + + D++S G +L  LL GK PF+   L+
Sbjct: 213 VLCK---KGHSFEVDIWSLGCILYTLLVGKPPFETSCLK 248

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETES 142
           PE   +     +  D++S G ++ E++ G   F       G+D I +W + + +  T S
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFP------GTDHIDQWNKVIEQLGTPS 245

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETES 142
           PE   +     +  D++S G ++ E++ G   F       G+D I +W + + +  T S
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFP------GTDHIDQWNKVIEQLGTPS 245

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +  + + S + Y H++  + H +LK  N+LL       + D+GL +     +  + S  S
Sbjct: 117 RFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 175
Query: 80  LFYKAPECR--EIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE    +++  P  + DV+S GV+L  +L  + PF D
Sbjct: 176 PNYAAPEVISGKLYAGP--EVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETES 142
           PE   +     +  D++S G ++ E++ G   F       G+D I +W + + +  T S
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFP------GTDHIDQWNKVIEQLGTPS 245

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 16/112 (14%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-----ADFESCLTDYGLGSFRNPDS--VE 73
           + +D+AS L ++H N G+ H +LK  N+L       +  + C  D G G   N D   + 
Sbjct: 116 VVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 74  EPS----ATSLFYKAPECREIWKQPT----QQADVYSFGVLLLELLTGKTPF 117
            P       S  Y APE  E + +      ++ D++S GV+L  LL+G  PF
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +  + + S + Y H++  + H +LK  N+LL       + D+GL +     +  + S  S
Sbjct: 107 RFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 165
Query: 80  LFYKAPECR--EIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE    +++  P  + DV+S GV+L  +L  + PF D
Sbjct: 166 PNYAAPEVISGKLYAGP--EVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLVGIKHLH-SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-IPRWVRSVREEETES 142
           PE   +     +  D++S G ++ E++ G   F       G+D I +W + + +  T S
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFP------GTDHIDQWNKVIEQLGTPS 245

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 111 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +  + + S + Y H++  + H +LK  N+LL       + D+GL +     +  + S  S
Sbjct: 116 RFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 174
Query: 80  LFYKAPECR--EIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE    +++  P  + DV+S GV+L  +L  + PF D
Sbjct: 175 PNYAAPEVISGKLYAGP--EVDVWSCGVILYVMLCRRLPFDD 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 115 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%)
Query: 30  LYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE 89
           L++    G+ H +L   N+LL  + +  + D+ L      D+ +    T  +Y+APE   
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 90  IWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            +K  T+  D++S G ++ E+   K  F+
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGSFRNPDSVEEPSATSL 80
           D++S L Y+H+N  + H +LK  N++L    +  +    D G     +   +      +L
Sbjct: 130 DISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 188
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            Y APE  E  K+ T   D +SFG L  E +TG  PF
Sbjct: 189 QYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL---TDYGLGSFRNPDSVEEPSATSL 80
           D++S L Y+H+N  + H +LK  N++L    +  +    D G     +   +      +L
Sbjct: 129 DISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            Y APE  E  K+ T   D +SFG L  E +TG  PF
Sbjct: 188 QYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           + E +   L Y+H   G+ H ++KS ++LL  D    L+D+G  +  + D  +       
Sbjct: 146 VCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGT 204
Query: 81  -FYKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            ++ APE   R ++     + D++S G++++E++ G+ P+
Sbjct: 205 PYWMAPEVISRSLY---ATEVDIWSLGIMVIEMVDGEPPY 241

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 21/150 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPEC--REIWK 92
            H +L + N+L+ ++    + D+GL      D     V EP  + +F+ APE     I+ 
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF- 195
Query: 93  QPTQQADVYSFGVLLLELLT----GKTPFQDLVLEHGS--DIPRWVRSVREEETESGDDP 146
             ++Q+DV+SFGV+L EL T      +P  + +   G   D+P   R +   E       
Sbjct: 196 --SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPA 253
Query: 147 PSSNEASEEKLQALLNIAIACVSLAPENRP 176
           P +  A   +L  L      C + +P++RP
Sbjct: 254 PPACPAEVHELMKL------CWAPSPQDRP 277

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H   G+ H +LK  N+LL  D    +TD+G     +P+S ++  A      
Sbjct: 137 EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFVGT 194
Query: 82  --YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             Y +PE     K   + +D+++ G ++ +L+ G  PF+
Sbjct: 195 AQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFR 232

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 127 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 185
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 186 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 77/177 (43%), Gaps = 24/177 (13%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 133 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGA 191
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    +   + ++DV++FGVLL E+ T G +P+  + L    D+    +  
Sbjct: 192 KFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE--KGY 248
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK----MIRDS 188
           R E+ E    PP   E           +  AC   +P +RP   E  +    M  DS
Sbjct: 249 RMEQPEGC--PPKVYE-----------LMRACWKWSPADRPSFAETHQAFETMFHDS 292

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           +  + + S + Y H++  + H +LK  N+LL       + D+GL +     +  + S  S
Sbjct: 111 RFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 169
Query: 80  LFYKAPECR--EIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE    +++  P  + DV+S GV+L  +L  + PF D
Sbjct: 170 PNYAAPEVISGKLYAGP--EVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%)
Query: 30  LYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE 89
           L++    G+ H +L   N+LL  + +  + D+ L      D+ +    T  +Y+APE   
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 90  IWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            +K  T+  D++S G ++ E+   K  F+
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 116 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 174
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATS 79
           + +   + Y H N G+ H NLK  N+LL +  +     L D+GL    N        A +
Sbjct: 111 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 169
Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             Y +PE  +  K P ++  D+++ GV+L  LL G  PF D
Sbjct: 170 PGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWD 208

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           +  A  ++ G+ Y+ +   L H +L + N+L+    +  ++D+GL       DS  + S 
Sbjct: 153 ISFAWQISQGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ 211
Query: 78  TSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
             +  K      ++    T Q+DV+SFGVLL E++T G  P+  +  E   ++       
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL------- 264
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                ++G      +  SEE  + +L     C    P+ RPV  ++SK
Sbjct: 265 ----LKTGHRMERPDNCSEEMYRLMLQ----CWKQEPDKRPVFADISK 304

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ A     L D+GL  +    
Sbjct: 105 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS 164
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 165 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 224 RIENGERLP 232

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/117 (23%), Positives = 66/117 (56%), Gaps = 14/117 (11%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNPDSVEEPSATSL-- 80
           +A+G+ Y+  + G  H +L + N+L+ ++    ++D+GL      +P++V   +   +  
Sbjct: 154 IAAGMRYL-ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------VLEHGSDIP 129
            + APE  + +++ T  +DV+S+G+++ E+++ G+ P+ D+        +E G  +P
Sbjct: 213 RWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLP 268

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 185
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF+                  +EE   G        +
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEIIGGQVFFRQRVS 228
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           SE   Q L+     C++L P +RP   E+
Sbjct: 229 SE--CQHLIR---WCLALRPSDRPTFEEI 252

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 113 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 105 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 165 TXXKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 224 RIENGERLP 232

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 115 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 114 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 113 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 111 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATS 79
           + +   + Y H N G+ H NLK  N+LL +  +     L D+GL    N        A +
Sbjct: 135 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193
Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             Y +PE   + K P ++  D+++ GV+L  LL G  PF D
Sbjct: 194 PGYLSPEV--LKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 114 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 111 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATS 79
           + +   + Y H N G+ H NLK  N+LL +  +     L D+GL    N        A +
Sbjct: 112 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             Y +PE  +  K P ++  D+++ GV+L  LL G  PF D
Sbjct: 171 PGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 60/104 (57%), Gaps = 11/104 (10%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+ +     H +L + N+L+ ++    ++D+GL  F   +S  +P+ TS     
Sbjct: 125 IASGMRYLAEM-SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS-SDPTYTSSLGGK 182
Query: 80  --LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
             + + APE    +++ T  +D +S+G+++ E+++ G+ P+ D+
Sbjct: 183 IPIRWTAPEAIA-FRKFTSASDAWSYGIVMWEVMSFGERPYWDM 225

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 166
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 167 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATS 79
           + +   + Y H N G+ H NLK  N+LL +  +     L D+GL    N        A +
Sbjct: 112 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             Y +PE  +  K P ++  D+++ GV+L  LL G  PF D
Sbjct: 171 PGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           +  A  ++ G+ Y+ +   L H +L + N+L+    +  ++D+GL       DS  + S 
Sbjct: 153 ISFAWQISQGMQYLAEM-SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQ 211
Query: 78  TSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
             +  K      ++    T Q+DV+SFGVLL E++T G  P+  +  E   ++       
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL------- 264
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                ++G      +  SEE  + +L     C    P+ RPV  ++SK
Sbjct: 265 ----LKTGHRMERPDNCSEEMYRLMLQ----CWKQEPDKRPVFADISK 304

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 111 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 111 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 114 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 115 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 166
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 167 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 116 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 174
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 115 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 111 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 113 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 171
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 115 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 113 LLQGLAFCHSHRVL-HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLAFCHSHRVL-HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 32  IHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC- 87
           IHQ+ G+ H +LK +N L+  D    L D+G+ +   PD    V++    ++ Y  PE  
Sbjct: 143 IHQH-GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 88  ------RE---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLV 121
                 RE      + + ++DV+S G +L  +  GKTPFQ ++
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 193
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 194 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 166
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 167 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 113 LLQGLAFCHSHRVL-HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 114 LLQGLAFCHSHRVL-HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYKAPE 86
           GL Y+HQ+  + H +LK +N+LL  +    L D+GL  SF +P+        + +Y+APE
Sbjct: 124 GLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPE 182
Query: 87  CREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                +      D+++ G +L ELL  + PF
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 170 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 228
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 229 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 115 LLQGLAFCHSHRVL-HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 166
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 167 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 166
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             Y +PE R      + Q+D++S G+ L+E+  G+ P 
Sbjct: 167 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           +  A  ++ G+ Y+ +   L H +L + N+L+    +  ++D+GL       DS  + S 
Sbjct: 153 ISFAWQISQGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQ 211
Query: 78  TSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
             +  K      ++    T Q+DV+SFGVLL E++T G  P+  +  E   ++       
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL------- 264
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                ++G      +  SEE  + +L     C    P+ RPV  ++SK
Sbjct: 265 ----LKTGHRMERPDNCSEEMYRLMLQ----CWKQEPDKRPVFADISK 304

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 123 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 176 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I   C  +  ++RP  RE+
Sbjct: 235 LEKGERLPQ---------------PPICT-------IDVYMIMRKCWMIDADSRPKFREL 272
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 273 IIEFSKMARDPQRYLVIQGDERMHLP 298

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  A D+A G+ Y+ Q     H +L + N+L+G ++ + + D+GL   +     +     
Sbjct: 145 LHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + A E    +   T  +DV+S+GVLL E+++ G TP+
Sbjct: 204 PVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++    +   L D+GL  F +P         S ++
Sbjct: 140 ELLKALDYCH-SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYF 198
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  + PF      HG D
Sbjct: 199 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF-----FHGQD 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 130 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 182
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 183 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 241
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I   C  +  ++RP  RE+
Sbjct: 242 LEKGERLPQ---------------PPICT-------IDVYMIMRKCWMIDADSRPKFREL 279
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 280 IIEFSKMARDPQRYLVIQGDERMHLP 305

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 119 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 60/104 (57%), Gaps = 11/104 (10%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+ +     H +L + N+L+ ++    ++D+GL  F   +S  +P+ TS     
Sbjct: 127 IASGMRYLAEM-SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS-SDPTETSSLGGK 184
Query: 80  --LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
             + + APE    +++ T  +D +S+G+++ E+++ G+ P+ D+
Sbjct: 185 IPIRWTAPEAIA-FRKFTSASDAWSYGIVMWEVMSFGERPYWDM 227

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   +        Y 
Sbjct: 148 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 206
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  + + DV+S G ++  LL GK PF+
Sbjct: 207 APEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 119 LLQGLAFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+G       +  
Sbjct: 120 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 232 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 269
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLP 295

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRN--------PDS 71
           +   L   + Y+H   GL H ++K SN+LL A+    + D+GL  SF N        P S
Sbjct: 114 VVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 72  VEEPS-------------ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           + E +               + +Y+APE      + T+  D++S G +L E+L GK  F
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+G       +  
Sbjct: 122 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 175 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 234 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 271
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 272 IIEFSKMARDPQRYLVIQGDERMHLP 297

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ A     L D+GL  +    
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS 544
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 545 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 604 RIENGERLP 612

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GLG     D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   +        Y 
Sbjct: 150 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 208
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  + + DV+S G ++  LL GK PF+
Sbjct: 209 APEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  A D+A G+ Y+ Q     H +L + N+L+G ++ + + D+GL   +     +     
Sbjct: 135 LHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + A E    +   T  +DV+S+GVLL E+++ G TP+
Sbjct: 194 PVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYKAPE 86
           G+ Y+H N  + H +LK  N+ L  D +  + D+GL +    D   +        Y APE
Sbjct: 154 GVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE 212
Query: 87  --CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
             C+   K  + + D++S G +L  LL GK PF+
Sbjct: 213 VLCK---KGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL-FYK 83
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   +        Y 
Sbjct: 124 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  + + DV+S G ++  LL GK PF+
Sbjct: 183 APEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+G       +  
Sbjct: 127 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 180 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 239 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 276
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 277 IIEFSKMARDPQRYLVIQGDERMHLP 302

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+G       +  
Sbjct: 124 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 176
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 177 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I + C  +  ++RP  RE+
Sbjct: 236 LEKGERLPQ---------------PPICT-------IDVYMIMVKCWMIDADSRPKFREL 273
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 274 IIEFSKMARDPQRYLVIQGDERMHLP 299

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 13/103 (12%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF 81
           A ++ S L+++H + G+ + +LK  NVLL  +    L D+G+      + +     T+ F
Sbjct: 130 AAEIISALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGVTTATF 184
Query: 82  -----YKAPEC-REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                Y APE  +E+   P    D ++ GVLL E+L G  PF+
Sbjct: 185 CGTPDYIAPEILQEMLYGPA--VDWWAMGVLLYEMLCGHAPFE 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/179 (21%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPDSVEEPSATS 79
           + +++  GL Y+H    + H ++K++NVLL    +  L D+G+ G   +          +
Sbjct: 125 MLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 183
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE 139
            F+ APE  +       +AD++S G+  +EL  G+ P  D+              +R   
Sbjct: 184 PFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDM------------HPMRVLF 230
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK---MIRDSRAEAQMS 195
               ++PP+      +  +  ++   AC++  P  RP  +E+ K   ++++S+  + ++
Sbjct: 231 LIPKNNPPTLVGDFTKSFKEFID---ACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLT 286

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 106 LGMCLDVCEGMAYL-EEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++
Sbjct: 165 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 217
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF+                  +EE   G        +
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEIIGGQVFFRQRVS 260
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           SE   Q L+     C++L P +RP   E+
Sbjct: 261 SE--CQHLIR---WCLALRPSDRPTFEEI 284

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 217
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF+                  +EE   G        +
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEIIGGQVFFRQRVS 260
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           SE   Q L+     C++L P +RP   E+
Sbjct: 261 SE--CQHLIR---WCLALRPSDRPTFEEI 284

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 218
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF+                  +EE   G        +
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEIIGGQVFFRQRVS 261
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           SE   Q L+     C++L P +RP   E+
Sbjct: 262 SE--CQHLIR---WCLALRPSDRPTFEEI 285

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 9/80 (11%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPEC--REIWK 92
            H +L + N+L+ ++    + D+GL      D     V EP  + +F+ APE     I+ 
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF- 207
Query: 93  QPTQQADVYSFGVLLLELLT 112
             ++Q+DV+SFGV+L EL T
Sbjct: 208 --SRQSDVWSFGVVLYELFT 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 218
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF+                  +EE   G        +
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEIIGGQVFFRQRVS 261
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           SE   Q L+     C++L P +RP   E+
Sbjct: 262 SE--CQHLIR---WCLALRPSDRPTFEEI 285

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/135 (21%), Positives = 66/135 (48%), Gaps = 10/135 (7%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           PL   + +     +  G+ + H +  + H ++K  N+L+ ++    + D+G+    +  S
Sbjct: 107 PLSVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165
Query: 72  VEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ-----DLVLEH 124
           + + +    ++ Y +PE  +  +   +  D+YS G++L E+L G+ PF       + ++H
Sbjct: 166 LTQTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224
Query: 125 GSD-IPRWVRSVREE 138
             D +P     VR++
Sbjct: 225 IQDSVPNVTTDVRKD 239

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 7/105 (6%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++    +   L D+GL  F +P         S ++
Sbjct: 145 ELLKALDYCH-SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYF 203
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           K PE    ++      D++S G +L  ++  + PF      HG D
Sbjct: 204 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF-----FHGQD 243

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 3/97 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
             E+LA  L Y H+   + H ++K  N+L+G   E  + D+G  S   P         +L
Sbjct: 120 FMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRXMCGTL 177
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            Y  PE  E  K   ++ D++  GVL  E L G  PF
Sbjct: 178 DYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPDSVEEPSATS 79
           I +    GL Y+H    + H ++K+ N+LL  +  + L D+G+ G   +  +       +
Sbjct: 130 ILQSTLKGLEYLHFMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGT 188
Query: 80  LFYKAPEC-REIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
            F+ APE  +EI       AD++S G+  +E+  GK P+ D+
Sbjct: 189 PFWMAPEVIQEIGYNCV--ADIWSLGITAIEMAEGKPPYADI 228

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 4/117 (3%)
Query: 4   TRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
           +R   G K +   + LK   D+A G+ Y+  N    H +L + N +L  D   C+ D+GL
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYL-SNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
Query: 64  GS-FRNPDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPF 117
                + D   +     +  K      +  +  T ++DV++FGV + E+ T G TP+
Sbjct: 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 3/97 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
             E+LA  L Y H+   + H ++K  N+L+G   E  + D+G  S   P         +L
Sbjct: 119 FMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRXMCGTL 176
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            Y  PE  E  K   ++ D++  GVL  E L G  PF
Sbjct: 177 DYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 3/108 (2%)
Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-FRNP 69
           KP            + +G+LY+H + G+ H +L  SN+LL  +    + D+GL +  + P
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165
Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                    +  Y +PE          ++DV+S G +   LL G+ PF
Sbjct: 166 HEKHYTLCGTPNYISPEI-ATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 18  CLKIAEDLASGLLYIH--QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           CL+ ++    G+ Y+H  Q   L H +LK  N+LL A   + L     G+  +  +    
Sbjct: 109 CLQCSQ----GVAYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTACDIQTHMTN 163
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSV 135
           +  S  + APE  E     +++ DV+S+G++L E++T + PF ++    G    R + +V
Sbjct: 164 NKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEI----GGPAFRIMWAV 218
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
                 +G  PP       + +++L+     C S  P  RP M E+ K++
Sbjct: 219 -----HNGTRPPLIKNLP-KPIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 18  CLKIAEDLASGLLYIH--QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP 75
           CL+ ++    G+ Y+H  Q   L H +LK  N+LL A   + L     G+  +  +    
Sbjct: 108 CLQCSQ----GVAYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTACDIQTHMTN 162
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSV 135
           +  S  + APE  E     +++ DV+S+G++L E++T + PF ++    G    R + +V
Sbjct: 163 NKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEI----GGPAFRIMWAV 217
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
                 +G  PP       + +++L+     C S  P  RP M E+ K++
Sbjct: 218 -----HNGTRPPLIKNLP-KPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 545 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 604 RIENGERLP 612

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 109 LGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++
Sbjct: 168 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD----SVEE 74
           LK A  +  G+ Y+       H +L + NVL+ ++ +  + D+GL      D    +V++
Sbjct: 129 LKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC  +  +    +DV+SFGV L ELLT
Sbjct: 188 DRDSPVFWYAPECL-MQSKFYIASDVWSFGVTLHELLT 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 107 LGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++
Sbjct: 166 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL + H +  L H +LK  N+L+  +    L D+GL  +F  P         +L+Y+
Sbjct: 112 LLQGLSFCHSHRVL-HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           APE     K  +   D++S G +  E++T +  F
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 107 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 166
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 167 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 225
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 226 RIENGERLP 234

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 112 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGA 170
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D P  V  +
Sbjct: 171 KFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYP------GID-PSQVYEL 222
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 223 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 274

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 106 LGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++
Sbjct: 165 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 57/105 (54%), Gaps = 15/105 (14%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +A+G+ Y+  N    H +L + N+L+ ++    ++D+GL      D    P AT      
Sbjct: 156 IAAGMKYL-ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD----PEATYTTSGG 210
Query: 80  ---LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
              + + APE    +++ T  +DV+SFG+++ E++T G+ P+ +L
Sbjct: 211 KIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLXGIKHLH-SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 105 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 165 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 224 RIENGERLP 232

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 104 LGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++
Sbjct: 163 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLXGIKHLH-SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 140 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++  K  F           ++ + G+  P +++ +
Sbjct: 199 PEVI-LGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 257
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 258 QPTVRTYVENRPKYAGYSFEKL 279

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           I   L   + ++H N  + H +LK  N+LL  + +  L+D+G      P         + 
Sbjct: 205 IMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 81  FYKAPECREIWKQPT-----QQADVYSFGVLLLELLTGKTPF 117
            Y APE  +     T     ++ D+++ GV+L  LL G  PF
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD----SVEE 74
           LK A  +  G+ Y+       H +L + NVL+ ++ +  + D+GL      D    +V++
Sbjct: 117 LKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
              + +F+ APEC  +  +    +DV+SFGV L ELLT
Sbjct: 176 DRDSPVFWYAPECL-MQSKFYIASDVWSFGVTLHELLT 212

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 105 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 165 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 224 RIENGERLP 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 110 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 170 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 229 RIENGERLP 237

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 108 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 167
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 168 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 226
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 227 RIENGERLP 235

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 126 LGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 184
Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++
Sbjct: 185 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATS 79
           + +  GL Y+H N  + H ++K  NVL+   +   L     G+ +    +    E    +
Sbjct: 129 KQILEGLKYLHDNQ-IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGT 186
Query: 80  LFYKAPECREIWKQPT---QQADVYSFGVLLLELLTGKTPFQDL 120
           L Y APE   I K P    + AD++S G  ++E+ TGK PF +L
Sbjct: 187 LQYMAPEI--IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           +S G  PL     L IA  +A+G+ Y+ +     H +L + N L+G +    + D+GL  
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLS- 221
Query: 66  FRNPDSVEEPSA-----TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
            RN  S +   A       + +  PE    + + T ++DV+++GV+L E+ + G  P+  
Sbjct: 222 -RNIYSADYYKADGNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 120 LVLE 123
           +  E
Sbjct: 280 MAHE 283

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 119 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 178 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 234
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 235 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 281

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 112 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 170
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D P  V  +
Sbjct: 171 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GID-PSQVYEL 222
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 223 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 274

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 128 MLXGIKHLH-SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 187 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 133 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 192
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 193 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 251
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 252 RIENGERLP 260

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 119 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 178 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 234
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 235 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSA 77
           L IA+ +A+G++Y+  +    H +L + N L+G +    + D+G+     + D       
Sbjct: 131 LHIAQQIAAGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 78  TSLFYK-APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
           T L  +  P    ++++ T ++DV+S GV+L E+ T GK P+  L
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 64/129 (49%), Gaps = 20/129 (15%)
Query: 20  KIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           K + DLAS +LY +Q         +    H ++ + NVL+ ++    L D+GL  +    
Sbjct: 102 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 71  SVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQ-----DLV- 121
           +  + S   L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ     D++ 
Sbjct: 162 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220
Query: 122 -LEHGSDIP 129
            +E+G  +P
Sbjct: 221 RIENGERLP 229

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 114 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 173 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 224
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 225 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/111 (26%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           GK L  +  L++  D+  G+ ++ ++    H +L + N L+  D    ++D+G+  +   
Sbjct: 98  GKGLEPSQLLEMCYDVCEGMAFL-ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
Query: 70  DSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
           D       T    K  APE    +K  + ++DV++FG+L+ E+ + GK P+
Sbjct: 157 DQYVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 116 LYMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 174
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 175 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 226
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 227 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 278

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 129 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF---------QDLVLEHGSDIPRWVRSV 135
           PE   +     +  D++S G ++ E++  K  F           ++ + G+  P +++ +
Sbjct: 188 PEVI-LGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 246
Query: 136 REEETESGDDPPSSNEASEEKL 157
           +       ++ P     S EKL
Sbjct: 247 QPTVRTYVENRPKYAGYSFEKL 268

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 136 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 195 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL ++H N  + H +LK  N+L+ +     L D+GL    +     +P   +L+Y+APE 
Sbjct: 124 GLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 88  --REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             +  +  P    D++S G +  E+   K  F
Sbjct: 183 LLQSTYATPV---DMWSVGCIFAEMFRRKPLF 211

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 114 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 173 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 224
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 225 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+PL     L  +  +A G+ ++  +    H ++ + NVLL     + + D+GL      
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 70  DS---VEEPSATSLFYKAPE----CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV 121
           DS   V+  +   + + APE    C       T Q+DV+S+G+LL E+ + G  P+  ++
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVY-----TVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           +       ++ + V++    +       N         + +I  AC +L P +RP  +++
Sbjct: 266 VN-----SKFYKLVKDGYQMAQPAFAPKN---------IYSIMQACWALEPTHRPTFQQI 311
Query: 182 SKMIRDSRAE 191
              +++   E
Sbjct: 312 CSFLQEQAQE 321

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 6   TSGGGKPLHWTSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC 57
            +GG    H     K+ E+        ++  L Y+H+  G+ + +LK  NVLL ++    
Sbjct: 103 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIK 161
Query: 58  LTDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLT 112
           LTDYG+      + +     TS F     Y APE     +      D ++ GVL+ E++ 
Sbjct: 162 LTDYGMCK----EGLRPGDTTSXFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMA 216
Query: 113 GKTPFQDLV 121
           G++PF D+V
Sbjct: 217 GRSPF-DIV 224

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 114 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 173 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 224
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 225 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+PL     L  +  +A G+ ++  +    H ++ + NVLL     + + D+GL      
Sbjct: 146 GRPLELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 204
Query: 70  DS---VEEPSATSLFYKAPE----CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV 121
           DS   V+  +   + + APE    C       T Q+DV+S+G+LL E+ + G  P+  ++
Sbjct: 205 DSNYIVKGNARLPVKWMAPESIFDCVY-----TVQSDVWSYGILLWEIFSLGLNPYPGIL 259
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           +       ++ + V++    +       N         + +I  AC +L P +RP  +++
Sbjct: 260 VN-----SKFYKLVKDGYQMAQPAFAPKN---------IYSIMQACWALEPTHRPTFQQI 305
Query: 182 SKMIRDSRAE 191
              +++   E
Sbjct: 306 CSFLQEQAQE 315

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 112 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 170
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D P  V  +
Sbjct: 171 KFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYP------GID-PSQVYEL 222
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 223 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 274

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 173 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 232 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 114 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 173 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 224
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 225 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 134 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 193 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 224

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+PL     L  +  +A G+ ++  +    H ++ + NVLL     + + D+GL      
Sbjct: 154 GRPLELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 212
Query: 70  DS---VEEPSATSLFYKAPE----CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV 121
           DS   V+  +   + + APE    C       T Q+DV+S+G+LL E+ + G  P+  ++
Sbjct: 213 DSNYIVKGNARLPVKWMAPESIFDCVY-----TVQSDVWSYGILLWEIFSLGLNPYPGIL 267
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           +       ++ + V++    +       N         + +I  AC +L P +RP  +++
Sbjct: 268 VN-----SKFYKLVKDGYQMAQPAFAPKN---------IYSIMQACWALEPTHRPTFQQI 313
Query: 182 SKMIRDSRAE 191
              +++   E
Sbjct: 314 CSFLQEQAQE 323

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 135 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 194 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 136 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 195 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPS--ATSLF 81
           ++   L ++H+  G+ + ++K  N+LL ++    LTD+GL      D  E       ++ 
Sbjct: 167 EIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 82  YKAPECREIWKQPTQQA-DVYSFGVLLLELLTGKTPF 117
           Y AP+          +A D +S GVL+ ELLTG +PF
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 129 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 188 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 19/125 (15%)
Query: 6   TSGGGKPLHWTSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC 57
            +GG    H     K+ E+        ++  L Y+H+  G+ + +LK  NVLL ++    
Sbjct: 88  VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIK 146
Query: 58  LTDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLT 112
           LTDYG+      + +     TS F     Y APE     +      D ++ GVL+ E++ 
Sbjct: 147 LTDYGMCK----EGLRPGDTTSXFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMA 201
Query: 113 GKTPF 117
           G++PF
Sbjct: 202 GRSPF 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 127 LYMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 185
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 186 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 237
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 238 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 289

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 115 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 173
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 174 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 230
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
           R E            E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 231 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 277

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 128 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 187 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L +G+ Y H    L H +LK  N+L+  + E  + D+GL  +F  P         +L+Y+
Sbjct: 109 LLNGIAYCHDRRVL-HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYR 167
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     K+ +   D++S G +  E++ G   F
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L +G+ Y H    L H +LK  N+L+  + E  + D+GL  +F  P         +L+Y+
Sbjct: 109 LLNGIAYCHDRRVL-HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYR 167
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     K+ +   D++S G +  E++ G   F
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 129 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 188 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/93 (24%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +  G+ ++H + G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+A
Sbjct: 173 MLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE   +     +  D++S G ++ E++  K  F
Sbjct: 232 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    F  
Sbjct: 259 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCG 314
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
              Y APE  E      +  D +  GV++ E++ G+ PF +
Sbjct: 315 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 354

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 6   TSGGGKPLHWTSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC 57
            +GG    H     K+ E+        ++  L Y+H+  G+ + +LK  NVLL ++    
Sbjct: 135 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIK 193
Query: 58  LTDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLT 112
           LTDYG+      + +     TS F     Y APE     +      D ++ GVL+ E++ 
Sbjct: 194 LTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMA 248
Query: 113 GKTPFQDLV 121
           G++PF D+V
Sbjct: 249 GRSPF-DIV 256

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 19/125 (15%)
Query: 6   TSGGGKPLHWTSCLKIAED--------LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC 57
            +GG    H     K+ E+        ++  L Y+H+  G+ + +LK  NVLL ++    
Sbjct: 92  VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIK 150
Query: 58  LTDYGLGSFRNPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLT 112
           LTDYG+      + +     TS F     Y APE     +      D ++ GVL+ E++ 
Sbjct: 151 LTDYGMCK----EGLRPGDTTSXFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMA 205
Query: 113 GKTPF 117
           G++PF
Sbjct: 206 GRSPF 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL   +   S ++    
Sbjct: 111 LKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKL 167
Query: 79  SLFYKAPEC-REIWKQPTQQADVYSFGVLLLELLT-GKTPF 117
            + + APE  RE     + ++DV+SFG+LL E+ + G+ P+
Sbjct: 168 PVKWTAPEALRE--AAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 23  EDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---EPSATS 79
           + +  GL Y+H N  + H ++K  NVL+   +   L     G+ +    +    E    +
Sbjct: 115 KQILEGLKYLHDNQ-IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGT 172
Query: 80  LFYKAPECREIWKQPT---QQADVYSFGVLLLELLTGKTPFQDL 120
           L Y APE   I K P    + AD++S G  ++E+ TGK PF +L
Sbjct: 173 LQYMAPEI--IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 116 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 174
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 175 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 226
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS 195
            E+     D      E   EK+  L+    AC    P +RP   E+ +       E+ +S
Sbjct: 227 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESSIS 278

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 15/107 (14%)
Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA 77
           CL I   +A  + ++H   GL H +LK SN+    D    + D+GL +  + D  E+   
Sbjct: 166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 78  TSL-------------FYKAPECREIWKQPTQQADVYSFGVLLLELL 111
           T +              Y +PE        + + D++S G++L ELL
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIH-GNNYSHKVDIFSLGLILFELL 270

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 16  TSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVE 73
           +  +K A D A G  ++H   P +    L S +V +  D  + ++   +  SF++P    
Sbjct: 111 SQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY 170
Query: 74  EPSATSLFYKAPECREIWKQP----TQQADVYSFGVLLLELLTGKTPFQDL 120
            P+     + APE  +  K+P     + AD +SF VLL EL+T + PF DL
Sbjct: 171 APA-----WVAPEALQ--KKPEDTNRRSADXWSFAVLLWELVTREVPFADL 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 17  SCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEP 75
           + ++   D+A G+ Y+       H +L + N +L  D   C+ D+GL     + D   + 
Sbjct: 138 TLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 76  SATSLFYKAPECREIWKQ-PTQQADVYSFGVLLLELLT-GKTPF 117
            A+ L  K      +     T  +DV++FGV + E++T G+TP+
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    F  
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCG 311
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
              Y APE  E      +  D +  GV++ E++ G+ PF +
Sbjct: 312 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 64/129 (49%), Gaps = 18/129 (13%)
Query: 8   GGGKPLH-----------WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES 56
            GG PLH            ++  ++   ++ G+ Y+ +     H NL + NVLL     +
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYA 475
Query: 57  CLTDYGLGSFRNPDSVEEPSATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
            ++D+GL      D     + ++    L + APEC   +++ + ++DV+S+GV + E L+
Sbjct: 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALS 534
Query: 113 -GKTPFQDL 120
            G+ P++ +
Sbjct: 535 YGQKPYKKM 543

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD--FESCLTDYGLGS-FRNPDSVEEPSA 77
           I   + S L Y+H N G+ H ++K  N L   +  FE  L D+GL   F   ++ E    
Sbjct: 173 IMRQIFSALHYLH-NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 78  TSL----FYKAPECREIWKQPTQ-QADVYSFGVLLLELLTGKTPF 117
           T+     ++ APE      +    + D +S GVLL  LL G  PF
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 217
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I              G         
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEI-------------IGGQVFFRQRV 259
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           S E  Q L+     C++L P +RP   E+
Sbjct: 260 SXE-CQHLIR---WCLALRPSDRPTFEEI 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L +G+ Y H    L H +LK  N+L+  + E  + D+GL  +F  P         +L+Y+
Sbjct: 109 LLNGIAYCHDRRVL-HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           AP+     K+ +   D++S G +  E++ G   F
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H   G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 154 ELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 212
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 213 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 218
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I              G         
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEI-------------IGGQVFFRQRV 260
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           S E  Q L+     C++L P +RP   E+
Sbjct: 261 SXE-CQHLIR---WCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 24/149 (16%)
Query: 34  QNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK 92
            N G+ H ++K  N+L+  +  E  L D+G G+    D+V      +  Y  PE     +
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 218
Query: 93  QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA 152
              + A V+S G+LL +++ G  PF     EH  +I              G         
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEI-------------IGGQVFFRQRV 260
Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREV 181
           S E  Q L+     C++L P +RP   E+
Sbjct: 261 SXE-CQHLIR---WCLALRPSDRPTFEEI 285

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 134 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 192
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 193 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 148 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 206
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 207 WMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 257
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 258 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 292

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  D +      +
Sbjct: 111 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDEMANEFVGT 169
Query: 80  LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP 116
             Y +PE R      + Q+D++S G+ L+E+  G+ P
Sbjct: 170 RSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 135 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 193
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 194 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +      GL ++H N  + H +LK  N+L+ +     L D+GL    +      P   +L
Sbjct: 117 LMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 81  FYKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE   +  +  P    D++S G +  E+   K  F
Sbjct: 176 WYRAPEVLLQSTYATPV---DMWSVGCIFAEMFRRKPLF 211

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 3/98 (3%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           I E+LA  L+Y H    + H ++K  N+LLG   E  + D+G  S   P    +    +L
Sbjct: 128 IMEELADALMYCH-GKKVIHRDIKPENLLLGLKGELKIADFGW-SVHAPSLRRKTMCGTL 185
Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            Y  PE  E  +   ++ D++  GVL  ELL G  PF+
Sbjct: 186 DYLPPEMIE-GRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 133 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 148 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 206
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 207 WMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 257
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 258 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 292

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 157 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLK 215
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 216 WMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 266
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 267 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 301

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 134 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 192
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 193 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 133 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 133 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 133 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 207 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 265
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 266 WMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 316
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 317 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 351

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 133 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 14/113 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KIA  +   L ++H    + H ++K SNVL+ A  +    D+G+  +   D  ++  A  
Sbjct: 140 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGC 199
Query: 80  LFYKAPECREIWKQPTQ-----QADVYSFGVLLLELLTGK-------TPFQDL 120
             Y APE   I  +  Q     ++D++S G+  +EL   +       TPFQ L
Sbjct: 200 KPYXAPE--RINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQL 250

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 153 VAKGMEFLASRKXI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 212 WMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 262
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 263 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 297

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +      GL ++H N  + H +LK  N+L+ +     L D+GL    +      P   +L
Sbjct: 125 LMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 81  FYKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE   +  +  P    D++S G +  E+   K  F
Sbjct: 184 WYRAPEVLLQSTYATPV---DMWSVGCIFAEMFRRKPLF 219

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           +PL  +    + +     L Y+H N  + H +LK+ N+L   D +  L D+G+ S +N  
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGV-SAKNTR 187
Query: 71  SVEEPSAT--SLFYKAPE---CREIWKQPTQ-QADVYSFGVLLLELLTGKTPFQDL 120
           +++   +   + ++ APE   C     +P   +ADV+S G+ L+E+   + P  +L
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 209 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 267
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 268 WMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 318
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 319 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 353

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSATSLFY 82
           +L   L Y H + G+ H ++K  NV++  +     L D+GL  F +P         S ++
Sbjct: 133 ELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           K PE     +      D++S G +   ++  K PF
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 13/106 (12%)
Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA 77
           CL I   +A  + ++H   GL H +LK SN+    D    + D+GL +  + D  E+   
Sbjct: 120 CLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 78  TSLFYKAPECREI----WKQPTQ--------QADVYSFGVLLLELL 111
           T +   A    ++    +  P Q        + D++S G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 21/148 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLFYKAPECREIWKQP- 94
            H +L + N+LL       + D+GL    +++PD V +  A   L + APE   I+ +  
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPET--IFDRVY 223
Query: 95  TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS 153
           T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E     G    + +  +
Sbjct: 224 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFXRRLKE-----GTRMRAPDYTT 273
Query: 154 EEKLQALLNIAIACVSLAPENRPVMREV 181
            E  Q +L+    C    P  RP   E+
Sbjct: 274 PEMYQTMLD----CWHGEPSQRPTFSEL 297

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 21/148 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLFYKAPECREIWKQP- 94
            H +L + N+LL       + D+GL    +++PD V +  A   L + APE   I+ +  
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE--TIFDRVY 227
Query: 95  TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS 153
           T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E     G    + +  +
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-----GTRMRAPDYTT 277
Query: 154 EEKLQALLNIAIACVSLAPENRPVMREV 181
            E  Q +L+    C    P  RP   E+
Sbjct: 278 PEMYQTMLD----CWHGEPSQRPTFSEL 301

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 21/148 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLFYKAPECREIWKQP- 94
            H +L + N+LL       + D+GL    +++PD V +  A   L + APE   I+ +  
Sbjct: 172 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE--TIFDRVY 229
Query: 95  TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS 153
           T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E     G    + +  +
Sbjct: 230 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-----GTRMRAPDYTT 279
Query: 154 EEKLQALLNIAIACVSLAPENRPVMREV 181
            E  Q +L+    C    P  RP   E+
Sbjct: 280 PEMYQTMLD----CWHGEPSQRPTFSEL 303

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 118 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 177 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 233
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           R E            E   EK+  L+    AC    P +RP   E+ +
Sbjct: 234 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 268

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 200 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 258
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 259 WMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 309
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 310 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 344

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLF 81
           +A G+ ++     + H +L + N+LL       + D+GL    +++PD V +  A   L 
Sbjct: 202 VAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEE 139
           + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E  
Sbjct: 261 WMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-- 311
Query: 140 TESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              G    + +  + E  Q +L+    C    P  RP   E+
Sbjct: 312 ---GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSEL 346

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 14/113 (12%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KIA  +   L ++H    + H ++K SNVL+ A  +  + D+G+  +      +   A  
Sbjct: 157 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGC 216
Query: 80  LFYKAPECREIWKQPTQ-----QADVYSFGVLLLELLTGK-------TPFQDL 120
             Y APE   I  +  Q     ++D++S G+ ++EL   +       TPFQ L
Sbjct: 217 KPYMAPE--RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 119 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 178 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 234
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           R E            E   EK+  L+    AC    P +RP   E+ +
Sbjct: 235 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I +D+ S + Y H+   + H +LK  N L   D       L D+GL +   P  +    
Sbjct: 110 RIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             + +Y +P+  E    P  + D +S GV++  LL G  PF
Sbjct: 169 VGTPYYVSPQVLEGLYGP--ECDEWSAGVMMYVLLCGYPPF 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 119 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 178 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 234
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           R E            E   EK+  L+    AC    P +RP   E+ +
Sbjct: 235 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 21/148 (14%)
Query: 39  THGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSA-TSLFYKAPECREIWKQP- 94
            H +L + N+LL       + D+GL    +++PD V +  A   L + APE   I+ +  
Sbjct: 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE--TIFDRVY 264
Query: 95  TQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEAS 153
           T Q+DV+SFGVLL E+ + G +P+  + ++       + R ++E     G    + +  +
Sbjct: 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE-----GTRMRAPDYTT 314
Query: 154 EEKLQALLNIAIACVSLAPENRPVMREV 181
            E  Q +L+    C    P  RP   E+
Sbjct: 315 PEMYQTMLD----CWHGEPSQRPTFSEL 338

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 45/190 (23%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+GL      +  
Sbjct: 120 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I   C  +  ++RP  RE+
Sbjct: 232 LEKGERLPQ---------------PPICT-------IDVYMIMRKCWMIDADSRPKFREL 269
Query: 182 ----SKMIRD 187
               SKM RD
Sbjct: 270 IIEFSKMARD 279

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    F  
Sbjct: 116 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFCG 171
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
              Y APE  E      +  D +  GV++ E++ G+ PF +
Sbjct: 172 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 119 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 177
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+  + L    ++    +  
Sbjct: 178 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDY 234
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           R E            E   EK+  L+    AC    P +RP   E+ +
Sbjct: 235 RMERP----------EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I +D+ S + Y H+   + H +LK  N L   D       L D+GL +   P  +    
Sbjct: 127 RIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 185
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
             + +Y +P+  E    P  + D +S GV++  LL G  PF
Sbjct: 186 VGTPYYVSPQVLEGLYGP--ECDEWSAGVMMYVLLCGYPPF 224

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 61/122 (50%), Gaps = 14/122 (11%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYG--------LGSFRNPDSVEEPS 76
           +  GL  IH   G  H +LK +N+LLG + +  L D G        +   R   ++++ +
Sbjct: 143 ICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 77  A--TSLFYKAPECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWV 132
           A   ++ Y+APE   +       ++ DV+S G +L  ++ G+ P+ D+V + G  +   V
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-DMVFQKGDSVALAV 260
Query: 133 RS 134
           ++
Sbjct: 261 QN 262

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    F  
Sbjct: 117 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFCG 172
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
              Y APE  E      +  D +  GV++ E++ G+ PF +
Sbjct: 173 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 24  DLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLF-- 81
           ++ S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    F  
Sbjct: 118 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFCG 173
Query: 82  ---YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
              Y APE  E      +  D +  GV++ E++ G+ PF +
Sbjct: 174 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 17/118 (14%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFES---CLTDYGLGSFRNPDSVEEPSATSLFYKA 84
            + Y+H+  G+ H +LK  N+L  +  E     ++D+GL        V   +  +  Y A
Sbjct: 132 AVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVA 190
Query: 85  PECREIWKQPTQQA-DVYSFGVLLLELLTGKTPFQD----------LVLEHGSDIPRW 131
           PE   + ++P  +A D +S GV+   LL G  PF D          L  E+  D P W
Sbjct: 191 PEV--LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYW 246

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 114 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 173 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 224
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
            E+     D      E   EK+  L+    AC    P +RP   E+ +
Sbjct: 225 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +A  ++S + Y+ +     H +L + N L+G +    + D+GL      D+    +  
Sbjct: 114 LYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 79  S--LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
              + + APE    + + + ++DV++FGVLL E+ T G +P+       G D+ + V  +
Sbjct: 173 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQ-VYEL 224
Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
            E+     D      E   EK+  L+    AC    P +RP   E+ +
Sbjct: 225 LEK-----DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 127 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 183
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 184 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 241
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 242 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280
Query: 187 D 187
           +
Sbjct: 281 N 281

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+G       +  
Sbjct: 122 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 175 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I   C  +  ++RP  RE+
Sbjct: 234 LEKGERLPQ---------------PPICT-------IDVYMIMRKCWMIDADSRPKFREL 271
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 272 IIEFSKMARDPQRYLVIQGDERMHLP 297

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 41/137 (29%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL       +
Sbjct: 109 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-------A 161
Query: 72  VEEPSATSLFYKAPECREIWK-----------------QPTQQADVYSFGVLLLEL---- 110
           V   SAT     AP  R   K                 +  ++AD+Y+ G++  E+    
Sbjct: 162 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 221
Query: 111 -LTG-----KTPFQDLV 121
            + G     + P+ DLV
Sbjct: 222 SIGGIHEDYQLPYYDLV 238

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 2/94 (2%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYK 83
           L  GL Y H+   L H +LK  N+L+    E  L D+GL   ++ P    +    +L+Y+
Sbjct: 109 LLRGLAYCHRQKVL-HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167
Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            P+        + Q D++  G +  E+ TG+  F
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +      GL ++H N  + H +LK  N+L+ +     L D+GL    +      P   +L
Sbjct: 117 LMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 81  FYKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +Y+APE   +  +  P    D++S G +  E+   K  F
Sbjct: 176 WYRAPEVLLQSTYATPV---DMWSVGCIFAEMFRRKPLF 211

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 45/206 (21%)
Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV 72
           L+W  C++IA+    G+ Y+ ++  L H +L + NVL+       +TD+G       +  
Sbjct: 122 LNW--CVQIAK----GMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 73  E---EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-------V 121
           E   E     + + A E   + +  T Q+DV+S+GV + EL+T G  P+  +       +
Sbjct: 175 EYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           LE G  +P+               PP            +  I   C  +  ++RP  RE+
Sbjct: 234 LEKGERLPQ---------------PPICT-------IDVYMIMRKCWMIDADSRPKFREL 271
Query: 182 ----SKMIRDSRAEAQMSSNSSDHSP 203
               SKM RD +    +  +   H P
Sbjct: 272 IIEFSKMARDPQRYLVIQGDERMHLP 297

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 154 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 210
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 211 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 268
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 269 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307
Query: 187 D 187
           +
Sbjct: 308 N 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 127 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 183
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 184 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 241
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 242 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280
Query: 187 D 187
           +
Sbjct: 281 N 281

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESC--LTDYGLGSFRNPDSVEEPSATSLFYKAP 85
           GL ++H++  + H ++K  N++      S   + D+GL +  NPD + + +  +  + AP
Sbjct: 161 GLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 86  ECREIWKQPTQ-QADVYSFGVLLLELLTGKTPF 117
           E  +  ++P     D+++ GVL   LL+G +PF
Sbjct: 220 EIVD--REPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 41/137 (29%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL       +
Sbjct: 106 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-------A 158
Query: 72  VEEPSATSLFYKAPECREIWK-----------------QPTQQADVYSFGVLLLEL---- 110
           V   SAT     AP  R   K                 +  ++AD+Y+ G++  E+    
Sbjct: 159 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 218
Query: 111 -LTG-----KTPFQDLV 121
            + G     + P+ DLV
Sbjct: 219 SIGGIHEDYQLPYYDLV 235

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 41/137 (29%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL       +
Sbjct: 104 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-------A 156
Query: 72  VEEPSATSLFYKAPECREIWK-----------------QPTQQADVYSFGVLLLEL---- 110
           V   SAT     AP  R   K                 +  ++AD+Y+ G++  E+    
Sbjct: 157 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 216
Query: 111 -LTG-----KTPFQDLV 121
            + G     + P+ DLV
Sbjct: 217 SIGGIHEDYQLPYYDLV 233

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 41/137 (29%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL       +
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-------A 155
Query: 72  VEEPSATSLFYKAPECREIWK-----------------QPTQQADVYSFGVLLLEL---- 110
           V   SAT     AP  R   K                 +  ++AD+Y+ G++  E+    
Sbjct: 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215
Query: 111 -LTG-----KTPFQDLV 121
            + G     + P+ DLV
Sbjct: 216 SIGGIHEDYQLPYYDLV 232

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 144 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 200
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 201 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 258
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 259 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297
Query: 187 D 187
           +
Sbjct: 298 N 298

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 31/116 (26%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL       +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-------A 194
Query: 72  VEEPSATSLFYKAPECREIWK-----------------QPTQQADVYSFGVLLLEL 110
           V   SAT     AP  R   K                 +  ++AD+Y+ G++  E+
Sbjct: 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           +PL  +    + +     L Y+H N  + H +LK+ N+L   D +  L D+G+ S +N  
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGV-SAKNTR 187
Query: 71  SVEEPSAT--SLFYKAPE---CREIWKQPTQ-QADVYSFGVLLLELLTGKTPFQDL 120
            ++   +   + ++ APE   C     +P   +ADV+S G+ L+E+   + P  +L
Sbjct: 188 XIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 6/98 (6%)
Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEE 74
           L+    +  G+ Y+       H NL + N+L+  +    + D+GL      D     V+E
Sbjct: 118 LQYTSQICKGMEYL-GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 176
Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT 112
           P  + +F+ APE     K     +DV+SFGV+L EL T
Sbjct: 177 PGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFT 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 31/116 (26%)
Query: 19  LKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL       +
Sbjct: 129 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-------A 181
Query: 72  VEEPSATSLFYKAPECREIWK-----------------QPTQQADVYSFGVLLLEL 110
           V   SAT     AP  R   K                 +  ++AD+Y+ G++  E+
Sbjct: 182 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPS 76
           +I  D+ + + ++H +  + H ++K  N+L  +   D    LTD+G       ++++ P 
Sbjct: 132 EIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            T  +Y APE     K   +  D++S GV++  LL G  PF
Sbjct: 191 YTP-YYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF--ESCLTDYGLGSFRNPDSVEEP 75
            ++    +  GL ++H+N    H +LK  N++       E  L D+GL +  +P    + 
Sbjct: 257 AVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +  +  + APE  E  K      D++S GVL   LL+G +PF
Sbjct: 316 TTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 31/173 (17%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRN----PDSVEEPS 76
           +  G+ Y+H N  + H +LK +N+L+  +        + D G     N    P +  +P 
Sbjct: 137 ILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVR 136
             + +Y+APE     +  T+  D+++ G +  ELLT +  F                  R
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH----------------CR 239
Query: 137 EEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSR 189
           +E+ +      +SN    ++L  + N+         E+   M E S +++D R
Sbjct: 240 QEDIK------TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR 286

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPS 76
           +I  D+ + + ++H +  + H ++K  N+L  +   D    LTD+G       ++++ P 
Sbjct: 113 EIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 171
Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
            T  +Y APE     K   +  D++S GV++  LL G  PF
Sbjct: 172 YTP-YYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPF 210

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF--ESCLTDYGLGSFRNPDSVEEP 75
            ++    +  GL ++H+N    H +LK  N++       E  L D+GL +  +P    + 
Sbjct: 151 AVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 209
Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           +  +  + APE  E  K      D++S GVL   LL+G +PF
Sbjct: 210 TTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 44/181 (24%)
Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS----- 79
           +ASG+ Y+  + G  H +L + N+L+ ++    ++D+GL      D   E + T+     
Sbjct: 156 IASGMKYL-SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKI 212
Query: 80  -LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPF-----QDLV--LEHGSDIPR 130
            + + +PE    +++ T  +DV+S+G++L E+++ G+ P+     QD++  ++ G  +P 
Sbjct: 213 PIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270
Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
                          PP    A      AL  + + C      NRP   ++     K+IR
Sbjct: 271 ---------------PPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 187 D 187
           +
Sbjct: 310 N 310

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           +PL  +    + +     L Y+H N  + H +LK+ N+L   D +  L D+G+ S +N  
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGV-SAKNTR 187
Query: 71  SVE--EPSATSLFYKAPE---CREIWKQPTQ-QADVYSFGVLLLELLTGKTPFQDL 120
            ++  +    + ++ APE   C     +P   +ADV+S G+ L+E+   + P  +L
Sbjct: 188 XIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 25/182 (13%)
Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           P   +  +++A ++A G+ Y++ N    H +L + N ++  DF   + D+G+        
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177
Query: 72  VEEPSATSLF---YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSD 127
                   L    + +PE  +     T  +DV+SFGV+L E+ T  + P+Q L  E    
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 233
Query: 128 IPRWVRSVREEETESG--DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
           + R+V        E G  D P +  +        LL +   C    P+ RP   E+   I
Sbjct: 234 VLRFV-------MEGGLLDKPDNCPD-------MLLELMRMCWQYNPKMRPSFLEIISSI 279
Query: 186 RD 187
           ++
Sbjct: 280 KE 281

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 16/113 (14%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           ++  D+A+ L ++H   G+ H +LK  N+L  +  +     + D+ LGS    ++   P 
Sbjct: 115 RVVRDVAAALDFLH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI 173
Query: 77  AT--------SLFYKAPECREIW-KQPT---QQADVYSFGVLLLELLTGKTPF 117
            T        S  Y APE  E++  Q T   ++ D++S GV+L  +L+G  PF
Sbjct: 174 TTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 6/103 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KI   L   +  +H+   + H +LK  N+LL  D    LTD+G     +P         +
Sbjct: 128 KIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGT 186
Query: 80  LFYKAPECREIWKQPT-----QQADVYSFGVLLLELLTGKTPF 117
             Y APE  E           ++ D++S GV++  LL G  PF
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSAT 78
           A ++  GL ++H N  + + +LK +N+LL       ++D GL    S + P +    S  
Sbjct: 297 AAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 351
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +  Y APE  +        AD +S G +L +LL G +PF+    +   +I R   ++  E
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 411
Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACV 168
             +S    P      E  LQ  +N  + C+
Sbjct: 412 LPDSFS--PELRSLLEGLLQRDVNRRLGCL 439

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSAT 78
           A ++  GL ++H N  + + +LK +N+LL       ++D GL    S + P +    S  
Sbjct: 298 AAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 352
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +  Y APE  +        AD +S G +L +LL G +PF+    +   +I R   ++  E
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACV 168
             +S    P      E  LQ  +N  + C+
Sbjct: 413 LPDSFS--PELRSLLEGLLQRDVNRRLGCL 440

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 15/105 (14%)
Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA 77
           CL + + L+     +H   G+ H ++KS ++LL  D    L+D+G   F    S E P  
Sbjct: 253 CLAVLQALS----VLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRR 304
Query: 78  TSL----FYKAPECREIWKQPT-QQADVYSFGVLLLELLTGKTPF 117
             L    ++ APE   I + P   + D++S G++++E++ G+ P+
Sbjct: 305 KXLVGTPYWMAPEL--ISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 6/103 (5%)
Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KI   L   +  +H+   + H +LK  N+LL  D    LTD+G     +P         +
Sbjct: 128 KIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 186
Query: 80  LFYKAPECREIWKQPT-----QQADVYSFGVLLLELLTGKTPF 117
             Y APE  E           ++ D++S GV++  LL G  PF
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSAT 78
           A ++  GL ++H N  + + +LK +N+LL       ++D GL    S + P +    S  
Sbjct: 298 AAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 352
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +  Y APE  +        AD +S G +L +LL G +PF+    +   +I R   ++  E
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACV 168
             +S    P      E  LQ  +N  + C+
Sbjct: 413 LPDSFS--PELRSLLEGLLQRDVNRRLGCL 440

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 22  AEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSAT 78
           A ++  GL ++H N  + + +LK +N+LL       ++D GL    S + P +    S  
Sbjct: 298 AAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 352
Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
           +  Y APE  +        AD +S G +L +LL G +PF+    +   +I R   ++  E
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACV 168
             +S    P      E  LQ  +N  + C+
Sbjct: 413 LPDSFS--PELRSLLEGLLQRDVNRRLGCL 440

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	221
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-31
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-30
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-30
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-24
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-23
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-23
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-22
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-21
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-21
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-20
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-15
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-14
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-13
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-13
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-13
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-13
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-13
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-12
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-12
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-12
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-12
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-11
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-11
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-11
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-11
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-11
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-11
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-11
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-11
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-10
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-10
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-10
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-10
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-10
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-10
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-09
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-09
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-09
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-09
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-09
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-09
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-08
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-08
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-08
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-08
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-08
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-08
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-08
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-08
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-08
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-08
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-07
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-07
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-07
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-07
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-07
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-07
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-07
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-07
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-06
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-06
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-06
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-06
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-06
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-06
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-06
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-06
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-06
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-06
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-06
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-06
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-05
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-05
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-05
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-05
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-05
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-05
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-05
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-05
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-05
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-05
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-05
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-05
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-05
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-05
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-05
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-05
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-05
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-05
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-05
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-05
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-04
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-04
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-04
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-04
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-04
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-04
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-04
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-04
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-04
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-04
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  115 bits (291), Expect = 3e-31
 Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 10/186 (5%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQ--NPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
                PL W    +IA   A GL Y+H   +P + H ++K++N+LL  +FE+ + D+GL 
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

Query: 65  SFRNPDSVEEPS---ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF--QD 119
                      +     ++ + APE      + +++ DV+ +GV+LLEL+TG+  F    
Sbjct: 182 KL-MDYKDTHVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

Query: 120 LVLEHGSDIPRWVRSVREEETESG-DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVM 178
           L  +    +  WV+ + +E+      D        +E+++ L+ +A+ C   +P  RP M
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299

Query: 179 REVSKM 184
            EV +M
Sbjct: 300 SEVVRM 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  113 bits (285), Expect = 2e-30
 Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 23/201 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQ---------NPGLTHGNLKSSNVLLGADFESCLTD 60
              + W     IAE +A GL Y+H+          P ++H ++KS NVLL  +  +C+ D
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174

Query: 61  YGLGSFRNPDSVEEPSAT---SLFYKAPE----CREIWKQPTQQADVYSFGVLLLELLTG 113
           +GL            +     +  Y APE         +    + D+Y+ G++L EL + 
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

Query: 114 KTPFQDLVLEHGSDIPRWVRSVREEE-------TESGDDPPSSNEASEEKLQALLNIAIA 166
            T     V E+       +      E        +               +  L      
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294

Query: 167 CVSLAPENRPVMREVSKMIRD 187
           C     E R     V + I  
Sbjct: 295 CWDHDAEARLSAGCVGERITQ 315

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  111 bits (281), Expect = 5e-30
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 27/190 (14%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
            G  PL W    KIA+  A+G+ ++H+N    H ++KS+N+LL   F + ++D+GL   R
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH-HIHRDIKSANILLDEAFTAKISDFGLA--R 181

Query: 68  NPDSVEEPSATSLF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF----- 117
             +   +   TS       Y APE   +  + T ++D+YSFGV+LLE++TG         
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA--LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 118 -QDLVLEHGSDIPRWVRSVREEETESGD--DPPSSNEASEEKLQALLNIAIACVSLAPEN 174
            Q L+             + +EE    D  D    N+A    ++A+ ++A  C+      
Sbjct: 240 PQLLL--------DIKEEIEDEEKTIEDYID-KKMNDADSTSVEAMYSVASQCLHEKKNK 290

Query: 175 RPVMREVSKM 184
           RP +++V ++
Sbjct: 291 RPDIKKVQQL 300

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  106 bits (268), Expect = 5e-28
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 8/186 (4%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
            +      + W   L+I    A GL Y+H    + H ++KS N+LL  +F   +TD+G+ 
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDENFVPKITDFGI- 185

Query: 65  SFRNPDSVEEPSAT----SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           S +  +  +   +T    +L Y  PE   I  + T+++DVYSFGV+L E+L  ++     
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244

Query: 121 VLEHGSDIPRWVRSVREEET-ESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMR 179
           +     ++  W          E   DP  +++   E L+   + A+ C++L+ E+RP M 
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304

Query: 180 EVSKMI 185
           +V   +
Sbjct: 305 DVLWKL 310

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 95.8 bits (239), Expect = 6e-24
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 19/199 (9%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
             SG  + L     L +A D+A G+ Y+H +NP + H NLKS N+L+   +   + D+GL
Sbjct: 126 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185

Query: 64  GSFRNPDSVEEPSAT-SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLV 121
              +    +   SA  +  + APE   +  +P  +++DVYSFGV+L EL T + P+ +L 
Sbjct: 186 SRLKASTFLSSKSAAGTPEWMAPEV--LRDEPSNEKSDVYSFGVILWELATLQQPWGNL- 242

Query: 122 LEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             + + +   V                    + +    +  I   C +  P  RP    +
Sbjct: 243 --NPAQVVAAV-------GFKCKRLEIPRNLNPQ----VAAIIEGCWTNEPWKRPSFATI 289

Query: 182 SKMIRDSRAEAQMSSNSSD 200
             ++R     A    N SD
Sbjct: 290 MDLLRPLIKSAVPPPNRSD 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 95.4 bits (238), Expect = 7e-24
 Identities = 39/183 (21%), Positives = 76/183 (41%), Gaps = 16/183 (8%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
                    + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++ 
Sbjct: 114 ETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172

Query: 70  DSVEEPSATSLF---YKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
            S             + APE    +     + Q+DVY+FG++L EL+TG+ P+ ++    
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI---- 228

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
            ++  + +  V       G   P  ++      + +  +   C+    + RP    +   
Sbjct: 229 -NNRDQIIEMV-----GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

Query: 185 IRD 187
           I +
Sbjct: 283 IEE 285

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 95.7 bits (238), Expect = 1e-23
 Identities = 45/232 (19%), Positives = 78/232 (33%), Gaps = 45/232 (19%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQ--------NPGLTHGNLKSSNVLLGADFESCLTDYG 62
               W S  ++A  +  GL Y+H          P ++H +L S NVL+  D    ++D+G
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 63  LGSFRNPDSVEEPSATSLF---------YKAPE------CREIWKQPTQQADVYSFGVLL 107
           L      + +  P               Y APE           +   +Q D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 108 LELLTGKT-------------PFQDLVLEHGSDIPRWVRSVREEETESGDDP--PSSNEA 152
            E+    T              FQ  V  H +     V   RE        P  P + + 
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE-----KQRPKFPEAWKE 280

Query: 153 SEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD--SRAEAQMSSNSSDHS 202
           +   +++L      C     E R   +   + + +     E   S + + H 
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 94.2 bits (235), Expect = 1e-23
 Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 25/186 (13%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
            G    +  +  +K A D+A G+ ++H   P +    L S +V++  D  + ++   +  
Sbjct: 102 EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161

Query: 66  FRNPDSVEEPSATSLFYKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
                        +  + APE   ++      + AD++SF VLL EL+T + PF DL   
Sbjct: 162 SFQSPGR----MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--- 214

Query: 124 HGSDIPRWV--RSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
              +I   V    +R         P      S   +  L+ I   C++  P  RP    +
Sbjct: 215 SNMEIGMKVALEGLR---------PTIPPGISPH-VSKLMKI---CMNEDPAKRPKFDMI 261

Query: 182 SKMIRD 187
             ++  
Sbjct: 262 VPILEK 267

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 21/185 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESC-----LTDYGL 63
             P+ W+  L++  D+A G+ Y+  QNP + H +L+S N+ L +  E+      + D+GL
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175

Query: 64  GSFRNPDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVL 122
                          +  + APE     ++  T++AD YSF ++L  +LTG+ PF +   
Sbjct: 176 SQQSVHSVSGL--LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-- 231

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
                I +++  +REE    G  P    +        L N+   C S  P+ RP    + 
Sbjct: 232 -SYGKI-KFINMIREE----GLRPTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIV 281

Query: 183 KMIRD 187
           K + +
Sbjct: 282 KELSE 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 90.9 bits (226), Expect = 4e-22
 Identities = 42/218 (19%), Positives = 76/218 (34%), Gaps = 27/218 (12%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQN--PGLTHGNLKSSNVLLGADFESC-LTDY 61
             +           +      + G+ Y+H      L H +LK  N+LL A      + D+
Sbjct: 91  HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150

Query: 62  GLGSFRNPDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
           G     +  +    +  S  + APE         +++ DV+S+G++L E++T + PF ++
Sbjct: 151 GTA--CDIQTHMTNNKGSAAWMAPEV--FEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

Query: 121 VLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMRE 180
                +    W   V          PP      +     + ++   C S  P  RP M E
Sbjct: 207 --GGPAFRIMWA--VHNGTR-----PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEE 253

Query: 181 VSKMIRDSRAEAQMSSNSSDHSPGRWSDTVQSLPREEH 218
           + K++        +                 SLP  E 
Sbjct: 254 IVKIMTH------LMRYFPGADEPLQYPCQHSLPPGED 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 44/205 (21%), Positives = 78/205 (38%), Gaps = 33/205 (16%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIH-------QNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
             L   SCL+I   +ASGL ++H         P + H +LKS N+L+  + + C+ D GL
Sbjct: 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159

Query: 64  GSFRNPDSVEEPSATS-----LFYKAPE-----CREIWKQPTQQADVYSFGVLLLELLTG 113
               +  + +     +       Y APE      +       ++ D+++FG++L E+   
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

Query: 114 ----------KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPP-SSNEASEEKLQALLN 162
                     K PF D+V    S          +++      P   +   S+  L +L  
Sbjct: 220 MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-----PNIPNRWFSDPTLTSLAK 274

Query: 163 IAIACVSLAPENRPVMREVSKMIRD 187
           +   C    P  R     + K +  
Sbjct: 275 LMKECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 89.0 bits (221), Expect = 3e-21
 Identities = 48/205 (23%), Positives = 75/205 (36%), Gaps = 33/205 (16%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIH-------QNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
             L   S LK+A    SGL ++H         P + H +LKS N+L+  +   C+ D GL
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188

Query: 64  GSFRNPDSVEEPSATS-----LFYKAPE-----CREIWKQPTQQADVYSFGVLLLELLTG 113
                 D+ E     +       Y  PE           Q    AD+YSFG++L E+   
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

Query: 114 ----------KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPP-SSNEASEEKLQALLN 162
                     + P+ DLV    S          +        P   +  +S+E L+ +  
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK-----KLRPSFPNRWSSDECLRQMGK 303

Query: 163 IAIACVSLAPENRPVMREVSKMIRD 187
           +   C +  P +R     V K +  
Sbjct: 304 LMTECWAHNPASRLTALRVKKTLAK 328

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 88.2 bits (219), Expect = 5e-21
 Identities = 44/208 (21%), Positives = 75/208 (36%), Gaps = 32/208 (15%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRN 68
              L      +IA+++  G+ Y+H   G+ H +LKS NV    D     +TD+GL S   
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFY--DNGKVVITDFGLFSISG 180

Query: 69  PDSVEEPSAT------SLFYKAPE-------CREIWKQP-TQQADVYSFGVLLLELLTGK 114
                            L + APE         E  K P ++ +DV++ G +  EL   +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

Query: 115 TPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPEN 174
            PF+         I   +         +G  P  S     +++  +L     C +   E 
Sbjct: 241 WPFKTQ---PAEAIIWQM--------GTGMKPNLSQIGMGKEISDILL---FCWAFEQEE 286

Query: 175 RPVMREVSKMIRDSRAEAQMSSNSSDHS 202
           RP   ++  M+       +  S+     
Sbjct: 287 RPTFTKLMDMLEKLPKRNRRLSHPGHFW 314

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 87.5 bits (217), Expect = 1e-20
 Identities = 44/205 (21%), Positives = 75/205 (36%), Gaps = 33/205 (16%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGL 63
             +     +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193

Query: 64  GSFRNPDSVEEPSATS-----LFYKAPE-----CREIWKQPTQQADVYSFGVLLLELLTG 113
               +  +     A +       Y APE           +  ++AD+Y+ G++  E+   
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

Query: 114 ----------KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPP-SSNEASEEKLQALLN 162
                     + P+ DLV    S     V  +R+   E    P   +   S E L+ +  
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPS-----VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 308

Query: 163 IAIACVSLAPENRPVMREVSKMIRD 187
           I   C       R     + K +  
Sbjct: 309 IMRECWYANGAARLTALRIKKTLSQ 333

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 85.8 bits (213), Expect = 2e-20
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 50/200 (25%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQN--PGLTHGNLKSSNVLLGADFESC--------LT 59
           GK +     +  A  +A G+ Y+H      + H +LKSSN+L+    E+         +T
Sbjct: 99  GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158

Query: 60  DYGLGSFRNPDSVEEPSAT-SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
           D+GL   R      + SA  +  + APE   I     ++ +DV+S+GVLL ELLTG+ PF
Sbjct: 159 DFGLA--REWHRTTKMSAAGAYAWMAPEV--IRASMFSKGSDVWSYGVLLWELLTGEVPF 214

Query: 118 QDL--------VLEHGS--DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC 167
           + +        V  +     IP                P                +   C
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTC-------------PE-----------PFAKLMEDC 250

Query: 168 VSLAPENRPVMREVSKMIRD 187
            +  P +RP    +   +  
Sbjct: 251 WNPDPHSRPSFTNILDQLTT 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 86.2 bits (214), Expect = 2e-20
 Identities = 43/218 (19%), Positives = 73/218 (33%), Gaps = 36/218 (16%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-------ADF-------E 55
                W+  +  A+D+ASG+ Y+H    + H +L S N L+        ADF       +
Sbjct: 102 DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160

Query: 56  SCLTDYGLGSFRNPDSVEEPSAT-SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTG 113
                 GL S + PD  +  +   + ++ APE   I  +   ++ DV+SFG++L E++  
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM--INGRSYDEKVDVFSFGIVLCEIIGR 218

Query: 114 KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPE 173
                D                         D             +   I + C  L PE
Sbjct: 219 VNADPD---------YLPRTMDFGLNVRGFLDRYCPPNCPP----SFFPITVRCCDLDPE 265

Query: 174 NRPVMREVS----KMIRDSRAEAQMSSNSSDHSPGRWS 207
            RP   ++      +         +         G W 
Sbjct: 266 KRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWE 303

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 83.2 bits (205), Expect = 4e-19
 Identities = 25/199 (12%), Positives = 49/199 (24%), Gaps = 20/199 (10%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
                       +   +   L      +    GL HG+    N+ +  D    L D    
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 65  SFRNPDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLE 123
                 +    S+  + Y   E         T   + +  G+ +  +     PF  +   
Sbjct: 242 --WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENR-------- 175
                 R    V   ++ +        +  +  +   LN            R        
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN-------FDRRRRLLPLEAME 352

Query: 176 -PVMREVSKMIRDSRAEAQ 193
            P   ++   I  S +  Q
Sbjct: 353 TPEFLQLQNEISSSLSTGQ 371

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.9 bits (194), Expect = 2e-17
 Identities = 26/143 (18%), Positives = 50/143 (34%), Gaps = 22/143 (15%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            K L   + L++   +   L  +H   GL H  L+  +++L       LT +        
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLV---R 255

Query: 70  DSVEEPSATSLFYKAPE----------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           D     S+ S  ++ PE           R+     T   D ++ G+++  +     P   
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 120 --------LVLEHGSDIPRWVRS 134
                    +     +IP+ VR+
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRA 338

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 77.4 bits (190), Expect = 7e-17
 Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 19/142 (13%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            K L   + L++   +   L  +H   GL H  L+  +++L       LT +        
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRD 261

Query: 70  DSVEEPSATSLF----YKAPECREIWKQP----TQQADVYSFGVLLLELLTGKTPFQD-- 119
            +         F      A       +      T   D ++ G+ +  +     P  D  
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321

Query: 120 ------LVLEHGSDIPRWVRSV 135
                  +     +IP+ VR++
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRAL 343

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 73.2 bits (180), Expect = 1e-15
 Identities = 40/182 (21%), Positives = 77/182 (42%), Gaps = 30/182 (16%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPS 76
           L +   +  GL  IH      H +LK +N+LLG + +  L D G  +    + +   +  
Sbjct: 137 LWLLLGICRGLEAIHAKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 77  A--------TSLFYKAPECREIWK--QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
                     ++ Y+APE   +       ++ DV+S G +L  ++ G+ P+ D+V + G 
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-DMVFQKGD 254

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMREVS 182
            +   V+        +    P S   S   L  LLN   + +++ P  RP    ++ ++ 
Sbjct: 255 SVALAVQ--------NQLSIPQSPRHSSA-LWQLLN---SMMTVDPHQRPHIPLLLSQLE 302

Query: 183 KM 184
            +
Sbjct: 303 AL 304

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 73.3 bits (180), Expect = 1e-15
 Identities = 29/117 (24%), Positives = 51/117 (43%), Gaps = 16/117 (13%)

Query: 19  LKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA 77
           LKI       + ++H Q P + H +LK  N+LL       L D+G  +  +       SA
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 78  -------------TSLFYKAPECREIW-KQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                        T+  Y+ PE  +++   P  ++ D+++ G +L  L   + PF+D
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 18/136 (13%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           PL     + I   + S L   H   G TH ++K  N+L+ AD  + L D+G+ S     +
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIAS-----A 183

Query: 72  VEEPSAT-------SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD----L 120
             +   T       +L+Y APE R      T +AD+Y+   +L E LTG  P+Q     +
Sbjct: 184 TTDEKLTQLGNTVGTLYYMAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242

Query: 121 VLEHGSDIPRWVRSVR 136
           +  H +       +VR
Sbjct: 243 MGAHINQAIPRPSTVR 258

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 33/184 (17%), Positives = 79/184 (42%), Gaps = 29/184 (15%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           PL   + +     +  G+ + H    + H ++K  N+L+ ++    + D+G+    +  S
Sbjct: 107 PLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165

Query: 72  VEEPSAT--SLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ-----DLVLE 123
           + + +    ++ Y +PE  +   +   +  D+YS G++L E+L G+ PF       + ++
Sbjct: 166 LTQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
           H          +++        P  + +  ++  Q+L N+ +        NR   + + +
Sbjct: 224 H----------IQD------SVPNVTTDVRKDIPQSLSNVILRATEKDKANRY--KTIQE 265

Query: 184 MIRD 187
           M  D
Sbjct: 266 MKDD 269

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 6/103 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
            I + + +   YIH    + H ++K SN+L+  +    L+D+G  S    D   + S  +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE-SEYMVDKKIKGSRGT 213

Query: 80  LFYKAPECREIWKQPT---QQADVYSFGVLLLELLTGKTPFQD 119
             +  PE      + +    + D++S G+ L  +     PF  
Sbjct: 214 YEFMPPEF--FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 67.2 bits (165), Expect = 1e-13
 Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 17/107 (15%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT- 78
               +LA+ L Y H    + H ++K  N+LLG+  E  + D+G        SV  PS+  
Sbjct: 113 TYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRR 164

Query: 79  -----SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                +L Y  PE   I  +   ++ D++S GVL  E L GK PF+ 
Sbjct: 165 TDLCGTLDYLPPEM--IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 65.4 bits (160), Expect = 5e-13
 Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 31/173 (17%)

Query: 19  LKIAEDLASGLLYIHQNPGLT----HGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE 74
           L++   L   L   H+         H +LK +NV L       L D+GL    N D+   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF- 172

Query: 75  PSATSL----FYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
             A +     +Y +PE           +++D++S G LL EL     PF           
Sbjct: 173 --AKTFVGTPYYMSPE---QMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQ 221

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                 +RE     G         S+E L  ++      ++L   +RP + E+
Sbjct: 222 KELAGKIRE-----GKFRRIPYRYSDE-LNEIIT---RMLNLKDYHRPSVEEI 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 65.1 bits (159), Expect = 9e-13
 Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 28/164 (17%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L     +   L ++H    + H ++KS N+ L  D    L D+G+    N        A 
Sbjct: 128 LDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---AR 183

Query: 79  SL----FYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWV 132
           +     +Y +PE   I + +P   ++D+++ G +L EL T K  F          +   V
Sbjct: 184 ACIGTPYYLSPE---ICENKPYNNKSDIWALGCVLYELCTLKHAF------EAGSMKNLV 234

Query: 133 RSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
             +       G  PP S   S + L++L++         P +RP
Sbjct: 235 LKIIS-----GSFPPVSLHYSYD-LRSLVS---QLFKRNPRDRP 269

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 64.7 bits (158), Expect = 9e-13
 Identities = 35/168 (20%), Positives = 72/168 (42%), Gaps = 18/168 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLL-GADFESCLTDYGLGSFRN 68
           K +           +  GL ++H + P + H +LK  N+ + G      + D GL + + 
Sbjct: 124 KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183

Query: 69  PDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
               +    T   + APE     ++  +  DVY+FG+ +LE+ T + P+ +   ++ + I
Sbjct: 184 ASFAKAVIGT-PEFMAPEM--YEEKYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQI 238

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
            R V         SG  P S ++ +  +++ ++     C+    + R 
Sbjct: 239 YRRVT--------SGVKPASFDKVAIPEVKEIIE---GCIRQNKDERY 275

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 64.2 bits (157), Expect = 1e-12
 Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 5/96 (5%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           LA  L Y H+   + H ++K  N+L+G   E  + D+G  S   P         +L Y  
Sbjct: 123 LADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRTMCGTLDYLP 180

Query: 85  PECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           PE   I  +   ++ D++  GVL  E L G  PF  
Sbjct: 181 PEM--IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 64.6 bits (157), Expect = 1e-12
 Identities = 19/123 (15%), Positives = 37/123 (30%), Gaps = 18/123 (14%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES-----------CL 58
            K +     +  A  +   +  +H    + HG++K  N +LG  F              L
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224

Query: 59  TDYGLGSFRN---PDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGK 114
            D G           ++      +  ++  E      +P   Q D +     +  +L G 
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--NKPWNYQIDYFGVAATVYCMLFGT 282

Query: 115 TPF 117
              
Sbjct: 283 YMK 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 40/193 (20%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
           P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+        
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170

Query: 72  VEEPSATSLF----YKAPECREIWKQ-----PTQQADVYSFGVLLLELLTGKTPFQ---- 118
                  ++     Y +PE      Q        ++DVYS G +L E+LTG+ PF     
Sbjct: 171 NSVTQTAAVIGTAQYLSPE------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

Query: 119 -DLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPV 177
             +  +H          VRE       DP   +   E     L  + +  ++  PENR  
Sbjct: 225 VSVAYQH----------VRE-------DPIPPSARHEGLSADLDAVVLKALAKNPENRY- 266

Query: 178 MREVSKMIRDSRA 190
            +  ++M  D   
Sbjct: 267 -QTAAEMRADLVR 278

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 63.5 bits (155), Expect = 3e-12
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 23/189 (12%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
            K    L S L ++H    + H ++K +NV + A     L D GLG F +  +    S  
Sbjct: 139 WKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197

Query: 79  -SLFYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSV 135
            + +Y +PE            ++D++S G LL E+   ++PF    +   S   +  +  
Sbjct: 198 GTPYYMSPE---RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-- 252

Query: 136 REEETESGDDPP-SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSRAEA 192
                   D PP  S+  SEE L+ L+N    C++  PE RP +  V  +     +   +
Sbjct: 253 -------CDYPPLPSDHYSEE-LRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTAS 301

Query: 193 QMSSNSSDH 201
            +  +   H
Sbjct: 302 SLEHHHHHH 310

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 63.6 bits (155), Expect = 4e-12
 Identities = 23/112 (20%), Positives = 47/112 (41%), Gaps = 13/112 (11%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL-----GADFESCLTDYGLGSFRNPDSVEE 74
            + +   SGL ++H    + H +LK  N+L+         ++ ++D+GL           
Sbjct: 122 TLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180

Query: 75  PSATSL----FYKAPE--CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQD 119
              + +     + APE    +  + PT   D++S G +   +++ G  PF  
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 62.5 bits (152), Expect = 7e-12
 Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 12/112 (10%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC----LTDYGLGSFRNPDSVEE 74
           L +  D+  G+ ++ +N G+ H N+K  N++     +      LTD+G       D    
Sbjct: 115 LIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 75  PSATSLFYKAPE-------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
               +  Y  P+        ++  K+     D++S GV      TG  PF+ 
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 62.8 bits (153), Expect = 7e-12
 Identities = 28/120 (23%), Positives = 52/120 (43%), Gaps = 27/120 (22%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG------ADFESCLTDYGLGSFRNPDSVE 73
              +++   +  IHQ+ G+ H +LK +N L+        DF       G+ +   PD+  
Sbjct: 112 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGMLKLIDF-------GIANQMQPDTTS 163

Query: 74  EPSAT---SLFYKAPE----------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
               +   ++ Y  PE            +   + + ++DV+S G +L  +  GKTPFQ +
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 62.6 bits (152), Expect = 8e-12
 Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 12/112 (10%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC----LTDYGLGSFRNPDSVEE 74
           L +  D+  G+ ++ +N G+ H N+K  N++     +      LTD+G       D    
Sbjct: 115 LIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 75  PSATSLFYKAPE-------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
               +  Y  P+        ++  K+     D++S GV      TG  PF+ 
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 61.9 bits (151), Expect = 9e-12
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 4/112 (3%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS-FRNP 69
           KPL         +DL  G+ Y+H    + H ++K SN+L+G D    + D+G+ + F+  
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 70  DSVEEPSATSLFYKAPE-CREIWKQPT-QQADVYSFGVLLLELLTGKTPFQD 119
           D++   +  +  + APE   E  K  + +  DV++ GV L   + G+ PF D
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 1/95 (1%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y HQ   + H +LK+ N+LL AD    + D+G  +        +    +  Y A
Sbjct: 123 IVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           PE  +  K    + DV+S GV+L  L++G  PF  
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 62.0 bits (150), Expect = 1e-11
 Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEP 75
             +  D++S L Y+H+N  + H +LK  N++L    +     + D G     +   +   
Sbjct: 124 RTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

Query: 76  SATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
              +L Y APE  E  K+ T   D +SFG L  E +TG  PF  
Sbjct: 183 FVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 26/110 (23%), Positives = 48/110 (43%), Gaps = 3/110 (2%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           L S + Y+     + H ++K  N+++  DF   L D+G  ++     +      ++ Y A
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL--VLEHGSDIPRWV 132
           PE          + +++S GV L  L+  + PF +L   +E     P  V
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 28/120 (23%), Positives = 52/120 (43%), Gaps = 27/120 (22%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG------ADFESCLTDYGLGSFRNPDSVE 73
              +++   +  IHQ+ G+ H +LK +N L+        DF       G+ +   PD+  
Sbjct: 131 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGMLKLIDF-------GIANQMQPDTTS 182

Query: 74  EPSAT---SLFYKAPE----------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
               +   ++ Y  PE            +   + + ++DV+S G +L  +  GKTPFQ +
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 28/120 (23%), Positives = 52/120 (43%), Gaps = 27/120 (22%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG------ADFESCLTDYGLGSFRNPDSVE 73
              +++   +  IHQ+ G+ H +LK +N L+        DF       G+ +   PD+  
Sbjct: 159 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGMLKLIDF-------GIANQMQPDTTS 210

Query: 74  EPSAT---SLFYKAPE----------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
               +   ++ Y  PE            +   + + ++DV+S G +L  +  GKTPFQ +
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 26/100 (26%), Positives = 39/100 (39%), Gaps = 5/100 (5%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPDSVEEPSA 77
                D    L ++H   GL H ++K +N+ LG      L D+GL        + E    
Sbjct: 160 WGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG 218

Query: 78  TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
               Y APE   +       ADV+S G+ +LE+       
Sbjct: 219 DP-RYMAPEL--LQGSYGTAADVFSLGLTILEVACNMELP 255

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 6/103 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
            I + + SG+ Y+H++  + H +LK  N+LL +  +     + D+GL +        +  
Sbjct: 140 VIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             + +Y APE   + K+  ++ DV+S GV+L  LL G  PF  
Sbjct: 199 LGTAYYIAPE--VLRKKYDEKCDVWSIGVILFILLAGYPPFGG 239

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 61.3 bits (149), Expect = 3e-11
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 6/103 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
            I + + SG+ Y+H++  + H ++K  N+LL          + D+GL SF + D      
Sbjct: 150 NIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             + +Y APE   + K+  ++ DV+S GV++  LL G  PF  
Sbjct: 209 LGTAYYIAPE--VLKKKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 6/103 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I   + SG+ Y+H+N  + H +LK  N+LL +  +     + D+GL +        +  
Sbjct: 130 RIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             + +Y APE   +     ++ DV+S GV+L  LL+G  PF  
Sbjct: 189 IGTAYYIAPE--VLHGTYDEKCDVWSTGVILYILLSGCPPFNG 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 60.7 bits (148), Expect = 3e-11
 Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATSLFYKA 84
            L Y H   G+ H ++K  NV++  D E     L D+GL  F +P         S ++K 
Sbjct: 142 ALDYCHSM-GIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
           PE    ++      D++S G +L  ++  K PF
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 60.3 bits (146), Expect = 4e-11
 Identities = 35/181 (19%), Positives = 64/181 (35%), Gaps = 34/181 (18%)

Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL---------GSFRN 68
           CL I   +A  + ++H   GL H +LK SN+    D    + D+GL              
Sbjct: 166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224

Query: 69  PDSVEEPSATSL----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLE 123
                  + T       Y +PE         + + D++S G++L ELL   +   + V  
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIH--GNNYSHKVDIFSLGLILFELLYSFSTQMERVRI 282

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                   +  VR  +      P    +   +    ++      +S +P  RP   ++ +
Sbjct: 283 --------ITDVRNLKF-----PLLFTQKYPQ-EHMMVQ---DMLSPSPTERPEATDIIE 325

Query: 184 M 184
            
Sbjct: 326 N 326

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 59.7 bits (145), Expect = 6e-11
 Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 36/179 (20%)

Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA 77
           CL I   +A  + ++H   GL H +LK SN+    D    + D+GL +  + D  E+   
Sbjct: 120 CLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 78  TSL-------------FYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQDLVL 122
           T +              Y +PE          + + D++S G++L ELL    PF     
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE---QIHGNSYSHKVDIFSLGLILFELL---YPF----- 227

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
               +  R +  VR         PP   +        ++      +S +P  RP    +
Sbjct: 228 STQMERVRTLTDVRN-----LKFPPLFTQKYPC-EYVMVQ---DMLSPSPMERPEAINI 277

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.1 bits (146), Expect = 6e-11
 Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 13/105 (12%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE + S L Y+H    + + +LK  N++L  D    +TD+GL      + +++ +    
Sbjct: 254 GAE-IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKT 308

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           F     Y APE   +      +  D +  GV++ E++ G+ PF +
Sbjct: 309 FCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 59.5 bits (144), Expect = 8e-11
 Identities = 27/109 (24%), Positives = 50/109 (45%), Gaps = 10/109 (9%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-------GSFRN-PDSV 72
           I + +   L YIH   G  H ++K+S++L+  D +  L+           G  +      
Sbjct: 133 ILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 73  EEPSATSLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
            + S   L + +PE  ++  +    ++D+YS G+   EL  G  PF+D+
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.5 bits (145), Expect = 9e-11
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 14/105 (13%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +AE LA  L ++H   G+ + +LK  N+LL  +    LTD+GL      +S++       
Sbjct: 132 LAE-LALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS 185

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           F     Y APE   + ++  TQ AD +SFGVL+ E+LTG  PFQ 
Sbjct: 186 FCGTVEYMAPEV--VNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 59.5 bits (144), Expect = 9e-11
 Identities = 31/158 (19%), Positives = 60/158 (37%), Gaps = 4/158 (2%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  DS+      +
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDSMANSFVGT 193

Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
             Y +PE   +     + Q+D++S G+ L+E+  G+ P      +    +          
Sbjct: 194 RSYMSPE--RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           ET      P                    +       P
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 58.9 bits (143), Expect = 1e-10
 Identities = 31/178 (17%), Positives = 60/178 (33%), Gaps = 43/178 (24%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL--------------GADFESCLTDYGLG 64
             +   +  GL YIH    L H ++K SN+ +                D+ S    + +G
Sbjct: 118 KDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 65  SFRNPDSVEEPSA---TSLFYKAPECREIWKQP---TQQADVYSFGVLLLELLTGKTPFQ 118
              +   +  P      S  + A E   + ++      +AD+++  + ++     +   +
Sbjct: 177 DLGHVTRISSPQVEEGDS-RFLANE---VLQENYTHLPKADIFALALTVVCAAGAEPLPR 232

Query: 119 DLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           +    H  +I +            G  P      S+E    LL      +   PE RP
Sbjct: 233 NGDQWH--EIRQ------------GRLPRIPQVLSQE-FTELLK---VMIHPDPERRP 272

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 6/103 (5%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L++ E +  G+ YIH    L + +LK SN+ L    +  + D+GL +    D     S  
Sbjct: 125 LELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183

Query: 79  SLFYKAPECREIWK-QP-TQQADVYSFGVLLLELLTGKTPFQD 119
           +L Y +PE       Q   ++ D+Y+ G++L ELL       +
Sbjct: 184 TLRYMSPE---QISSQDYGKEVDLYALGLILAELLHVCDTAFE 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 42/199 (21%), Positives = 81/199 (40%), Gaps = 25/199 (12%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L     +A G+ Y+ ++ G+ H NL + NVLL +  +  + D+G+     PD  +   + 
Sbjct: 118 LNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176

Query: 79  SLF---YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRS 134
           +     + A E    + + T Q+DV+S+GV + EL+T G  P+  L     +++P  +  
Sbjct: 177 AKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGL---RLAEVPDLL-- 230

Query: 135 VREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMREVSKMIRDSRA 190
                 E G+        + +    +  + + C  +    RP    +  E ++M RD   
Sbjct: 231 ------EKGERLAQPQICTID----VYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280

Query: 191 EAQMSSNSSDHSPGRWSDT 209
              +   S           
Sbjct: 281 YLVIKRESGPGIAPGPEPH 299

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 9/108 (8%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL--TDYGLGSFRNPDSVEEPSA 77
            I   + S L Y+H   G+ H ++K  N L   +    +   D+GL       +  E   
Sbjct: 172 NIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230

Query: 78  T-----SLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
                 + ++ APE      +    + D +S GVLL  LL G  PF  
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 27/180 (15%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L     +A G+ Y+     L H +L + NVL+       +TD+GL      +  E  +  
Sbjct: 120 LNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 79  SLF---YKAPECREI-WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVR 133
                 + A E   I  +  T Q+DV+S+GV + EL+T G  P+  +     S+I   + 
Sbjct: 179 GKVPIKWMALES--ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSIL- 232

Query: 134 SVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMREVSKMIRDSR 189
                  E G+  P     + +    +  I   C  +  ++RP    ++ E SKM RD +
Sbjct: 233 -------EKGERLPQPPICTID----VYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 57.9 bits (141), Expect = 2e-10
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLF 81
           + +G+LY+H + G+ H +L  SN+LL  +    + D+GL +        E   T   +  
Sbjct: 121 IITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPN 177

Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           Y +PE     +     ++DV+S G +   LL G+ PF  
Sbjct: 178 YISPEI--ATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.0 bits (141), Expect = 2e-10
 Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 14/105 (13%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +AS L Y+H    + + +LK  N+LL +     LTD+GL      +++E  S TS 
Sbjct: 145 AAE-IASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTST 198

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           F     Y APE   + KQP  +  D +  G +L E+L G  PF  
Sbjct: 199 FCGTPEYLAPEV--LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 58.2 bits (141), Expect = 3e-10
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 6/103 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + + SG+ Y+H++  + H +LK  N+LL +  + C   + D+GL +    ++  +  
Sbjct: 125 RIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             + +Y APE   +     ++ DV+S GV+L  LL+G  PF  
Sbjct: 184 IGTAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 57.6 bits (140), Expect = 4e-10
 Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 22/126 (17%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE + S L Y+H    + + ++K  N++L  D    +TD+GL      + + + +    
Sbjct: 111 GAE-IVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKT 164

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGS 126
           F     Y APE   +      +  D +  GV++ E++ G+ PF         +L+L    
Sbjct: 165 FCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

Query: 127 DIPRWV 132
             PR +
Sbjct: 223 RFPRTL 228

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 57.2 bits (139), Expect = 4e-10
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLF 81
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   E       +  
Sbjct: 124 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPN 180

Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           Y APE   + K+  + + DV+S G ++  LL GK PF+ 
Sbjct: 181 YIAPEV--LSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 57.2 bits (139), Expect = 4e-10
 Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 14/105 (13%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +AE ++  L ++HQ  G+ + +LK  N++L       LTD+GL      +S+ + + T  
Sbjct: 127 LAE-ISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDGTVTHT 180

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           F     Y APE   + +    +  D +S G L+ ++LTG  PF  
Sbjct: 181 FCGTIEYMAPEI--LMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 57.2 bits (139), Expect = 5e-10
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 14/113 (12%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE ++  L Y+H+  G+ + +LK  NVLL ++    LTDYG+      + +     TS 
Sbjct: 116 SAE-ISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTST 169

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           F     Y APE   +  +      D ++ GVL+ E++ G++PF  +      D
Sbjct: 170 FCGTPNYIAPEI--LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLF 81
           +  G  Y+H+N  + H +LK  N+ L  D E  + D+GL +    D   E       +  
Sbjct: 150 IVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPN 206

Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           Y APE   + K+  + + DV+S G ++  LL GK PF+ 
Sbjct: 207 YIAPEV--LSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 57.0 bits (138), Expect = 5e-10
 Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 13/115 (11%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATSLF 81
           +   + + H   G+ H ++K  N+L+  D       L D+G G+    D+V      +  
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILI--DLNRGELKLIDFGSGALL-KDTVYTDFDGTRV 213

Query: 82  YKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD--LVLEHGSDIPRWV 132
           Y  PE   I       + A V+S G+LL +++ G  PF+    ++       + V
Sbjct: 214 YSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 57.2 bits (139), Expect = 5e-10
 Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 22/126 (17%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE + S L+++H   G+ + +LK  NVLL  +    L D+G+      + +     T+ 
Sbjct: 130 AAE-IISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGVTTAT 183

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF--------QDLVLEHGS 126
           F     Y APE   + +       D ++ GVLL E+L G  PF         + +L    
Sbjct: 184 FCGTPDYIAPEI--LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241

Query: 127 DIPRWV 132
             P W+
Sbjct: 242 VYPTWL 247

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 57.6 bits (139), Expect = 6e-10
 Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 13/118 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G+ L     +    ++   L Y+H   GL + +LK  N++L  + +  L D G  S    
Sbjct: 176 GQKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVS---- 229

Query: 70  DSVEEPSAT--SLFYKAPE-CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
             +        +  ++APE  R     PT   D+Y+ G  L  L           ++ 
Sbjct: 230 -RINSFGYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 57.0 bits (138), Expect = 7e-10
 Identities = 46/193 (23%), Positives = 80/193 (41%), Gaps = 25/193 (12%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L     +A G+ Y+     L H +L + NVL+       +TD+GL      +  E  +  
Sbjct: 120 LNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 79  SLF---YKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRS 134
                 + A E     +  T Q+DV+S+GV + EL+T G  P+  +     S+I   +  
Sbjct: 179 GKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSIL-- 232

Query: 135 VREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMREVSKMIRDSRA 190
                 E G+  P     + +    +  I + C  +  ++RP    ++ E SKM RD + 
Sbjct: 233 ------EKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282

Query: 191 EAQMSSNSSDHSP 203
              +  +   H P
Sbjct: 283 YLVIQGDERMHLP 295

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 56.9 bits (138), Expect = 7e-10
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 22/126 (17%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +A GL ++    G+ + +LK  NV+L ++    + D+G+      +++ +   T  
Sbjct: 127 AAE-IAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKT 180

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGS 126
           F     Y APE   I  QP  +  D ++FGVLL E+L G+ PF+          ++EH  
Sbjct: 181 FCGTPDYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238

Query: 127 DIPRWV 132
             P+ +
Sbjct: 239 AYPKSM 244

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 56.9 bits (138), Expect = 7e-10
 Identities = 27/103 (26%), Positives = 42/103 (40%), Gaps = 12/103 (11%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           I E L   L Y+     + H ++K  N+LL       +TD+ + +        E   T++
Sbjct: 121 ICE-LVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAA----MLPRETQITTM 174

Query: 81  ----FYKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                Y APE          +   D +S GV   ELL G+ P+
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 21/128 (16%)

Query: 20  KIAEDLA--------SGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRN 68
            + E  +        + + + H   G+ H ++K  N+L+  D       L D+G G+   
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILI--DLRRGCAKLIDFGSGALL- 190

Query: 69  PDSVEEPSATSLFYKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD--LVLEH 124
            D        +  Y  PE   I +       A V+S G+LL +++ G  PF+    +LE 
Sbjct: 191 HDEPYTDFDGTRVYSPPEW--ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA 248

Query: 125 GSDIPRWV 132
               P  V
Sbjct: 249 ELHFPAHV 256

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 6/105 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
                +   + Y+H+N G+ H +LK  NVLL +  E C   +TD+G        S+    
Sbjct: 243 LYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301

Query: 77  ATSLFYKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             +  Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 38/184 (20%), Positives = 72/184 (39%), Gaps = 20/184 (10%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
               + +     L +A  ++S + Y+ +     H NL + N L+G +    + D+GL   
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRL 367

Query: 67  RNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
              D+    +      K  APE    + + + ++DV++FGVLL E+ T G +P+  + L 
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
               +   +        E            E+    +  +  AC    P +RP   E+ +
Sbjct: 427 ---QVYELL--------EKDYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQ 471

Query: 184 MIRD 187
               
Sbjct: 472 AFET 475

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 20/184 (10%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
              GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL   
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARL 329

Query: 67  RNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
              +            K  APE    + + T ++DV+SFG+LL EL T G+ P+  +   
Sbjct: 330 IEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--- 385

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
              ++   V        E G   P   E  E     L ++   C    PE RP    +  
Sbjct: 386 VNREVLDQV--------ERGYRMPCPPECPES----LHDLMCQCWRKEPEERPTFEYLQA 433

Query: 184 MIRD 187
            + D
Sbjct: 434 FLED 437

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 14/113 (12%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE ++  L Y+H+  G+ + +LK  NVLL ++    LTDYG+      + +     TS 
Sbjct: 159 SAE-ISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTST 212

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           F     Y APE   +  +      D ++ GVL+ E++ G++PF  +      D
Sbjct: 213 FCGTPNYIAPEI--LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 22/126 (17%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +A GL ++    G+ + +LK  NV+L ++    + D+G+      +++ +   T  
Sbjct: 448 AAE-IAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKT 501

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGS 126
           F     Y APE   I  QP  +  D ++FGVLL E+L G+ PF+          ++EH  
Sbjct: 502 FCGTPDYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 559

Query: 127 DIPRWV 132
             P+ +
Sbjct: 560 AYPKSM 565

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 22/126 (17%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +  GL ++H   G+ + +LK  N+LL  D    + D+G+      +++   + T+ 
Sbjct: 124 AAE-IILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNT 177

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ--------DLVLEHGS 126
           F     Y APE   +  Q      D +SFGVLL E+L G++PF           +     
Sbjct: 178 FCGTPDYIAPEI--LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 127 DIPRWV 132
             PRW+
Sbjct: 236 FYPRWL 241

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 12/109 (11%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           K+   +   L Y+ +  G+ H ++K SN+LL    +  L D+G+ S R  D     +   
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI-SGRLVDDK---AKDR 183

Query: 80  L----FYKAPE---CREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
                 Y APE     +  K     +ADV+S G+ L+EL TG+ P+++ 
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 54.9 bits (133), Expect = 2e-09
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 1/95 (1%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + S + Y H++  + H +LK  NVLL A   + + D+GL +  +       S  S  Y A
Sbjct: 120 ILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           PE          + D++S GV+L  LL G  PF D
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 27/105 (25%), Positives = 45/105 (42%), Gaps = 15/105 (14%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA-TS 79
            AE +  GL ++H    + + +LK +N+LL       ++D GL       + +       
Sbjct: 298 AAE-IILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGL-------ACDFSKKKPH 348

Query: 80  LF-----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
                  Y APE  +        AD +S G +L +LL G +PF+ 
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 55.3 bits (134), Expect = 2e-09
 Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 10/104 (9%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE + S L Y+H   G+ H +LK  N+LL  D    +TD+G  +       ++  A S 
Sbjct: 136 TAE-IVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSF 192

Query: 81  F----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                Y +PE   + ++   + +D+++ G ++ +L+ G  PF+ 
Sbjct: 193 VGTAQYVSPEL--LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 55.2 bits (133), Expect = 3e-09
 Identities = 25/127 (19%), Positives = 52/127 (40%), Gaps = 26/127 (20%)

Query: 18  CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-------------LTDYGLG 64
            + +   +ASG+ ++H    + H +LK  N+L+                    ++D+GL 
Sbjct: 117 PISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 65  SFRNPDSVEEPSAT-----SLFYKAPE------CREIWKQPTQQADVYSFGVLLLELLT- 112
              +       +       +  ++APE        +  ++ T+  D++S G +   +L+ 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 113 GKTPFQD 119
           GK PF D
Sbjct: 236 GKHPFGD 242

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 11/103 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           + E +   L ++H+  G+ + ++K  N+LL ++    LTD+GL         +E      
Sbjct: 165 VGE-IVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLS---KEFVADETERAYD 219

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPF 117
           F     Y AP+          +  D +S GVL+ ELLTG +PF
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.1 bits (133), Expect = 3e-09
 Identities = 28/117 (23%), Positives = 51/117 (43%), Gaps = 11/117 (9%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC------LTDYG 62
             + +      +I++ L  GL Y+H+  G+ H ++K  NVL+             + D G
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183

Query: 63  LGSFRNPDSVEEPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ 118
              + +       S  +  Y++PE   +   P    AD++S   L+ EL+TG   F+
Sbjct: 184 NACWYDEHYT--NSIQTREYRSPEV--LLGAPWGCGADIWSTACLIFELITGDFLFE 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 1/95 (1%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           +   + Y H++  + H +LK  N+LL  +    + D+GL +     +  + S  S  Y A
Sbjct: 117 IICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAA 175

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           PE          + DV+S G++L  +L G+ PF D
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 54.7 bits (132), Expect = 4e-09
 Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 11/114 (9%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I  D+ + + ++H +  + H ++K  N+L  +  +     LTD+G       ++++ P 
Sbjct: 132 EIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP- 189

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
             + +Y APE   +  +   +  D++S GV++  LL G  PF       G  I 
Sbjct: 190 CYTPYYVAPEV--LGPEKYDKSCDMWSLGVIMYILLCGFPPFYS---NTGQAIS 238

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.8 bits (130), Expect = 6e-09
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL YIH + G+ H +LK  N+ +  D E  + D+GL    + +       T  +Y+APE 
Sbjct: 138 GLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-VVTR-WYRAPEV 194

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              W    Q  D++S G ++ E+LTGKT F+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 53.9 bits (130), Expect = 6e-09
 Identities = 31/178 (17%), Positives = 61/178 (34%), Gaps = 30/178 (16%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-------GSFRNPDS 71
            ++   +   L YIH   G+ H +LK  N+ +       + D+GL             DS
Sbjct: 119 WRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 72  VEEPSATSL--------FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE 123
              P ++           Y A E  +      ++ D+YS G++  E++            
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FS------ 229

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
            G +    ++ +R    E    P   +   +   + ++      +   P  RP  R +
Sbjct: 230 TGMERVNILKKLRSVSIE--FPPDFDDNKMKV-EKKIIR---LLIDHDPNKRPGARTL 281

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 54.1 bits (130), Expect = 7e-09
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 20/184 (10%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
              GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL   
Sbjct: 354 GETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARL 412

Query: 67  RNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
              +            K  APE    + + T ++DV+SFG+LL EL T G+ P+  +   
Sbjct: 413 IEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--- 468

Query: 124 HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
              ++   V        E G   P   E  E     L ++   C    PE RP    +  
Sbjct: 469 VNREVLDQV--------ERGYRMPCPPECPES----LHDLMCQCWRKEPEERPTFEYLQA 516

Query: 184 MIRD 187
            + D
Sbjct: 517 FLED 520

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 54.0 bits (130), Expect = 7e-09
 Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 14/105 (13%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            A+ + SGL ++HQ   + + +LK  NVLL  D    ++D GL      +     + T  
Sbjct: 295 TAQ-IVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAV----ELKAGQTKTKG 348

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           +     + APE   +  +      D ++ GV L E++  + PF+ 
Sbjct: 349 YAGTPGFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 53.8 bits (130), Expect = 8e-09
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT----SLFYK 83
           GL YIH    + H +LK SN+LL    +  + D+GL    +PD       T    + +Y+
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198

Query: 84  APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           APE     K  T+  D++S G +L E+L+ +  F 
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.6 bits (129), Expect = 9e-09
 Identities = 29/114 (25%), Positives = 45/114 (39%), Gaps = 14/114 (12%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFR 67
           +        K A  +   L  +H+N  + H +LK  N+LL          + D+G   + 
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILL-KQQGRSGIKVIDFGSSCYE 252

Query: 68  NPDSVEEPSAT--SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ 118
           +    +       S FY+APE   I         D++S G +L ELLTG     
Sbjct: 253 H----QRVYTYIQSRFYRAPEV--ILGARYGMPIDMWSLGCILAELLTGYPLLP 300

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 53.5 bits (129), Expect = 9e-09
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL YIH   G+ H +LK  N+ +  D E  + D+GL    + +       T  +Y+APE 
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-VVTR-WYRAPEV 196

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              W + TQ  D++S G ++ E++TGKT F+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 26/197 (13%), Positives = 53/197 (26%), Gaps = 42/197 (21%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           ++  + LA+     H+  G+       S V +  D +  L                    
Sbjct: 132 IRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPATMP------------- 177

Query: 79  SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE 138
                             Q D+   G  L  LL  + P  +  +  G         +   
Sbjct: 178 --------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG---------LAPA 214

Query: 139 ETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNS 198
           E ++   P    +   +    +  +A   V      R     +  +++ + A A      
Sbjct: 215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQATAVAD----R 269

Query: 199 SDHSPGRWSDTVQSLPR 215
           ++         V + PR
Sbjct: 270 TEVLGPIDEAPVSAAPR 286

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 53.0 bits (128), Expect = 1e-08
 Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 8/104 (7%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + + SG+ Y+H++  + H +LK  N+LL +  + C   + D+GL +    ++  +  
Sbjct: 125 RIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             + +Y APE   + +    ++ DV+S GV+L  LL+G  PF  
Sbjct: 184 IGTAYYIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 35/139 (25%), Positives = 56/139 (40%), Gaps = 20/139 (14%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
            + +D+AS L ++H   G+ H +LK  N+L     +     + D+ LGS    +    P 
Sbjct: 115 VVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 77  AT--------SLFYKAPE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
           +T        S  Y APE      E      ++ D++S GV+L  LL+G  PF       
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG----R 229

Query: 125 GSDIPRWVRSVREEETESG 143
                 W R       ++ 
Sbjct: 230 CGSDCGWDRGEACPACQNM 248

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 19/107 (17%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE--EPSAT 78
            AE +  GL  +H+   + + +LK  N+LL       ++D GL       +V   E    
Sbjct: 292 AAE-ICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTI 342

Query: 79  SLF-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                   Y APE   +  +  T   D ++ G LL E++ G++PFQ 
Sbjct: 343 KGRVGTVGYMAPEV--VKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 52.6 bits (127), Expect = 1e-08
 Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 8/104 (7%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I +D+ S + Y H+   + H +LK  N L   D       L D+GL +   P  +    
Sbjct: 110 RIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             + +Y +P+   + +     + D +S GV++  LL G  PF  
Sbjct: 169 VGTPYYVSPQ---VLEGLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.0 bits (128), Expect = 1e-08
 Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 12/102 (11%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL--GSFRNPDSVEEPSATSLF---- 81
            +  +H +  + H +LK SN+L+ ++ +  + D+GL      +     EP+         
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 82  -----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                Y+APE      + ++  DV+S G +L EL   +  F 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 1/95 (1%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKA 84
           + SG+ Y H++  + H +LK  NVLL A   + + D+GL +  +       S  S  Y A
Sbjct: 125 ILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 183

Query: 85  PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           PE          + D++S GV+L  LL G  PF D
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 16/110 (14%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +AE +   +  +H+  G  H ++K  N+LL       L D+G       D       + +
Sbjct: 168 LAE-IVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---GTVRSLV 222

Query: 81  F-----YKAPE------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
                 Y +PE                + D ++ GV   E+  G+TPF  
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 23/91 (25%), Positives = 45/91 (49%), Gaps = 2/91 (2%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           G+ ++H   G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+APE 
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                   +  D++S G ++ E++ G   F 
Sbjct: 198 ILGMGY-KENVDIWSVGCIMGEMIKGGVLFP 227

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 1/91 (1%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL  +H+  G+ H +L   N+LL  + +  + D+ L      D+ +    T  +Y+APE 
Sbjct: 146 GLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPEL 204

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              +K  T+  D++S G ++ E+   K  F+
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 52.5 bits (126), Expect = 2e-08
 Identities = 25/108 (23%), Positives = 47/108 (43%), Gaps = 14/108 (12%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +AE +   +  +HQ     H ++K  N+L+  +    L D+G    +  +  +    +S+
Sbjct: 181 LAE-MVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGS-CLKLME--DGTVQSSV 235

Query: 81  F-----YKAPE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
                 Y +PE          +   + D +S GV + E+L G+TPF  
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 10/114 (8%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + +   + Y+H    + H ++K  N+L  +   +    LTD+G        +     
Sbjct: 165 EIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
             + +Y APE   +  +   +  D++S GV++  LL G  PF      HG  I 
Sbjct: 224 CYTPYYVAPEV--LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAIS 272

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 42/201 (20%), Positives = 72/201 (35%), Gaps = 46/201 (22%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC--------LTDYGLGSFRNPD 70
           L++A+ LA+ + ++ +N  L HGN+ + N+LL  + +          L+D G+     P 
Sbjct: 116 LEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

Query: 71  SVEEPSATSLFYK------APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLE 123
                       +       PEC E  K      D +SFG  L E+ + G  P   L   
Sbjct: 175 D---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--- 222

Query: 124 HGSDIPRWVRSVREEETESGD--DPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                 ++         E       P + E        L N+   C+   P++RP  R +
Sbjct: 223 DSQRKLQFY--------EDRHQLPAPKAAE--------LANLINNCMDYEPDHRPSFRAI 266

Query: 182 SKMIRDSRAEAQMSSNSSDHS 202
            + +        +   S  H 
Sbjct: 267 IRDLNSLFTPDLVPRGSHHHH 287

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 7/106 (6%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSA-- 77
           KIA  +   L ++H    + H ++K SNVL+ A  +  + D+G+ S    D V +     
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI-SGYLVDDVAKDIDAG 171

Query: 78  TSLFYKAPE---CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
               Y APE        K  + ++D++S G+ ++EL   + P+   
Sbjct: 172 CK-PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 6/100 (6%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATSLF 81
           +   + Y+H+N G+ H +LK  NVLL +  E C   +TD+G        S+      +  
Sbjct: 123 MLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181

Query: 82  YKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           Y APE           +  D +S GV+L   L+G  PF +
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 22/97 (22%), Positives = 42/97 (43%), Gaps = 10/97 (10%)

Query: 28  GLLYIHQN-PGLTHGNLKSSNVLLGADFESC---LTDYGL--GSFRNPDSVEEPSATSLF 81
            +  +H     + H ++K  NVL+  +       L D+G       +  +V      S +
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAY--ICSRY 196

Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           Y+APE     +  T   D++S G +  E++ G+  F+
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 9/125 (7%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           S  G        +  +  +A G+ +I Q     H +L+++N+L+ A     + D+GL   
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARV 333

Query: 67  RNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL--- 120
              +            K  APE    +   T ++DV+SFG+LL+E++T G+ P+  +   
Sbjct: 334 IEDNEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392

Query: 121 -VLEH 124
            V+  
Sbjct: 393 EVIRA 397

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 51.9 bits (125), Expect = 3e-08
 Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 6/103 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           ++ + + + L Y H    + H +LK  N+L           + D+GL      D     +
Sbjct: 128 ELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           A +  Y APE     +  T + D++S GV++  LLTG  PF  
Sbjct: 187 AGTALYMAPEV--FKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 52.1 bits (126), Expect = 3e-08
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 17/105 (16%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            AE +   L Y+H    + + +LK  N+LL  +    +TD+G        +   P  T  
Sbjct: 112 AAE-VCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGF-------AKYVPDVTYT 162

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                 Y APE   +  +P  +  D +SFG+L+ E+L G TPF D
Sbjct: 163 LCGTPDYIAPEV--VSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.0 bits (125), Expect = 3e-08
 Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 10/96 (10%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGL--GSFRNPDSVEEPSATSLFY 82
            + +IH   G+ H ++K  N+L+  + +     L D+G       +  SV      S FY
Sbjct: 153 AVGFIHSL-GICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSEPSVAY--ICSRFY 207

Query: 83  KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +APE      + T   D++S G +  EL+ GK  F 
Sbjct: 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 51.9 bits (125), Expect = 3e-08
 Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 6/105 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KI   L   +  +H+   + H +LK  N+LL  D    LTD+G     +P         +
Sbjct: 128 KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 186

Query: 80  LFYKAPE-----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE       +      ++ D++S GV++  LL G  PF  
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.0 bits (125), Expect = 3e-08
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           GL YIH    + H +LK SN+ +  D E  + D+GL   R+          + +Y+APE 
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAPEI 200

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
              W    Q  D++S G ++ ELLTG+T F 
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 51.9 bits (125), Expect = 3e-08
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 7/99 (7%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS--FRNPDSVEEPSATSL----F 81
           GL Y+H+N G  H ++K+ N+LLG D    + D+G+ +      D        +      
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
           + APE  E  +    +AD++SFG+  +EL TG  P+   
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 51.5 bits (124), Expect = 4e-08
 Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 12/107 (11%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
            I   L S + ++H   G+ H +LK  N+L   + ++    + D+G    + PD+  +P 
Sbjct: 110 YIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL 166

Query: 77  AT---SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            T   +L Y APE   + +    +  D++S GV+L  +L+G+ PFQ 
Sbjct: 167 KTPCFTLHYAAPEL--LNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 51.6 bits (124), Expect = 4e-08
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 11/108 (10%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
           KI       L ++ +N  + H ++K SN+LL       L D+G+ S +  DS+   + T 
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI-SGQLVDSI---AKTR 184

Query: 80  L----FYKAPE---CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL 120
                 Y APE        +    ++DV+S G+ L EL TG+ P+   
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 51.1 bits (123), Expect = 5e-08
 Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 5/99 (5%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLF 81
           L  GL Y+H   G+ H ++K  N+LL       ++  G+    +P + ++   T   S  
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 82  YKAPECREIWKQ-PTQQADVYSFGVLLLELLTGKTPFQD 119
           ++ PE           + D++S GV L  + TG  PF+ 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 51.1 bits (123), Expect = 5e-08
 Identities = 29/117 (24%), Positives = 51/117 (43%), Gaps = 13/117 (11%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC----LTDYGLGSFRNPDSVEEP 75
            +   +   + Y+H   G+ H +LK SN+L   +  +     + D+G       +     
Sbjct: 120 AVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGL 176

Query: 76  SAT---SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
             T   +  + APE   + +Q      D++S GVLL  +LTG TPF +   +   +I
Sbjct: 177 LMTPCYTANFVAPEV--LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 51.2 bits (123), Expect = 6e-08
 Identities = 32/127 (25%), Positives = 47/127 (37%), Gaps = 20/127 (15%)

Query: 9   GGKPLHWTSCLKIAEDLA--------SGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
           GG  ++  S   + E  A          L  IH   G  H ++K  N+LL       L D
Sbjct: 153 GGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLAD 211

Query: 61  YGLGSFRNPDSVEEPSATSLF-----YKAPE---CREIWKQPTQQADVYSFGVLLLELLT 112
           +G     N + +              Y +PE    +       ++ D +S GV L E+L 
Sbjct: 212 FGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

Query: 113 GKTPFQD 119
           G TPF  
Sbjct: 269 GDTPFYA 275

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 51.0 bits (123), Expect = 6e-08
 Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLF 81
           L +G++Y+H   G+TH ++K  N+LL       ++D+GL +    ++ E        +L 
Sbjct: 114 LMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 82  YKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
           Y APE   + ++    +  DV+S G++L  +L G+ P+  
Sbjct: 173 YVAPEL--LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 50.7 bits (122), Expect = 7e-08
 Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 10/98 (10%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSAT----SL 80
           GL YIH    + H +LK +N+ +    E     + D+GL    +P    +   +    + 
Sbjct: 132 GLKYIHSA-NVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +Y++P         T+  D+++ G +  E+LTGKT F 
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 51.0 bits (122), Expect = 8e-08
 Identities = 23/91 (25%), Positives = 45/91 (49%), Gaps = 2/91 (2%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC 87
           G+ ++H   G+ H +LK SN+++ +D    + D+GL        +  P   + +Y+APE 
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234

Query: 88  REIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                   +  D++S G ++ E++  K  F 
Sbjct: 235 ILGMGY-KENVDIWSVGCIMGEMVRHKILFP 264

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 11/102 (10%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSAT------S 79
            GL Y+H    + HG++K+ NVLL +D     L D+G      PD + +   T      +
Sbjct: 161 EGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 80  LFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
             + APE   +  +P   + D++S   ++L +L G  P+   
Sbjct: 220 ETHMAPEV--VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 50.3 bits (121), Expect = 1e-07
 Identities = 37/184 (20%), Positives = 71/184 (38%), Gaps = 25/184 (13%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           G  L   + L++  D A+G+ Y+       H +L + N L+       ++D+G+      
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265

Query: 70  DSVEEPSATSLF-YK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHG 125
                         K  APE    + + + ++DV+SFG+LL E  + G +P+ +L     
Sbjct: 266 GVYAASGGLRQVPVKWTAPEAL-NYGRYSSESDVWSFGILLWETFSLGASPYPNL----- 319

Query: 126 SDIPRWVRSVRE--EETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK 183
                   S ++  E  E G   P      +     +  +   C +  P  RP    + +
Sbjct: 320 --------SNQQTREFVEKGGRLPCPELCPDA----VFRLMEQCWAYEPGQRPSFSTIYQ 367

Query: 184 MIRD 187
            ++ 
Sbjct: 368 ELQS 371

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 49.6 bits (119), Expect = 2e-07
 Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT---SLF 81
           L +G++Y+H   G+TH ++K  N+LL       ++D+GL +    ++ E        +L 
Sbjct: 114 LMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 82  YKAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
           Y APE   + ++    +  DV+S G++L  +L G+ P+  
Sbjct: 173 YVAPEL--LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 6/105 (5%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATS 79
            I   L   + ++H N  + H +LK  N+LL  + +  L+D+G      P         +
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGT 262

Query: 80  LFYKAPE-----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
             Y APE       E      ++ D+++ GV+L  LL G  PF  
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 7/99 (7%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCL--TDYGLGSFRNPDSVEEPSATSLFY 82
           L SG+ Y H    + H +LK  N LL       L   D+G        S  + +  +  Y
Sbjct: 125 LLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183

Query: 83  KAPECREIWKQP--TQQADVYSFGVLLLELLTGKTPFQD 119
            APE   + +Q    + ADV+S GV L  +L G  PF+D
Sbjct: 184 IAPEV--LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 49.2 bits (118), Expect = 2e-07
 Identities = 28/117 (23%), Positives = 55/117 (47%), Gaps = 5/117 (4%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
               + +     L +A  ++S + Y+ +     H +L + N L+G +    + D+GL   
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRL 160

Query: 67  RNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
              D+    +      K  APE    + + + ++DV++FGVLL E+ T G +P+  +
Sbjct: 161 MTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 49.2 bits (118), Expect = 3e-07
 Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 17/105 (16%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
            A+ +     Y+H    L + +LK  N+L+       +TD+G        +      T  
Sbjct: 147 AAQ-IVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGF-------AKRVKGRTWT 197

Query: 81  F-----YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
                   APE   I  +   +  D ++ GVL+ E+  G  PF  
Sbjct: 198 LCGTPEALAPEI--ILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 48.9 bits (117), Expect = 4e-07
 Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 11/118 (9%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           S G   L     LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL   
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLT-- 336

Query: 67  RNPDSVEEPSATSLF-YK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
           +          T     K  APE     K+ + ++DV+SFG+LL E+ + G+ P+  +
Sbjct: 337 KE---ASSTQDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 48.1 bits (115), Expect = 6e-07
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 10/100 (10%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSAT-SLFYKA 84
            GL Y+H N  + H ++K  NVL+        ++D+G        +    + T +L Y A
Sbjct: 133 EGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191

Query: 85  PECREIWKQPTQ----QADVYSFGVLLLELLTGKTPFQDL 120
           PE   I  +  +     AD++S G  ++E+ TGK PF +L
Sbjct: 192 PE---IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.0 bits (114), Expect = 7e-07
 Identities = 39/197 (19%), Positives = 74/197 (37%), Gaps = 33/197 (16%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
              L     +  +  +A G+ ++       H +L + N+LL       + D+GL      
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245

Query: 70  DSVEEPSATSLF---YKAPECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
           D        +     + APE   I+ +  T Q+DV+SFGVLL E+ + G +P+    ++ 
Sbjct: 246 DPDYVRKGDARLPLKWMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKI 301

Query: 125 GSDIPRWVRSVREEETESG---DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             +  R ++         G     P      + E    +    + C    P  RP   E+
Sbjct: 302 DEEFCRRLK--------EGTRMRAPDY---TTPE----MYQTMLDCWHGEPSQRPTFSEL 346

Query: 182 SKMIRDSRAEAQMSSNS 198
            + +        + +N+
Sbjct: 347 VEHL-----GNLLQANA 358

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 47.6 bits (114), Expect = 8e-07
 Identities = 31/125 (24%), Positives = 59/125 (47%), Gaps = 9/125 (7%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           +  G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL   
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARL 158

Query: 67  RNPDSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL--- 120
              +            K  APE    +   T ++DV+SFG+LL E++T G+ P+  +   
Sbjct: 159 IEDNEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217

Query: 121 -VLEH 124
            V+++
Sbjct: 218 EVIQN 222

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 47.6 bits (114), Expect = 8e-07
 Identities = 28/119 (23%), Positives = 48/119 (40%), Gaps = 10/119 (8%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE-EPSA 77
            + A  +A G+ Y+       H +L + N+LL       + D+GL      +        
Sbjct: 124 SRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

Query: 78  TSLF-YK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWV 132
                +   APE     +  +  +D + FGV L E+ T G+ P+  L   +GS I   +
Sbjct: 183 HRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKI 237

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 47.8 bits (114), Expect = 9e-07
 Identities = 26/96 (27%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCL--TDYGLGSFRNPDSVEEPSATSLFYKA 84
            GL ++H++  + H ++K  N++      S +   D+GL +  NPD + + +  +  + A
Sbjct: 160 EGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAA 218

Query: 85  PECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           PE   + ++P     D+++ GVL   LL+G +PF  
Sbjct: 219 PEI--VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 20/172 (11%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           +  A  L++ L Y+       H ++ + NVL+ ++    L D+GL  +    +  + S  
Sbjct: 494 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
            L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ +     +D+   +   
Sbjct: 553 KLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRI--- 605

Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
                E+G+  P            L ++   C +  P  RP   E+   +  
Sbjct: 606 -----ENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLST 648

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 46.9 bits (112), Expect = 1e-06
 Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 40/200 (20%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            + +   + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      
Sbjct: 111 NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169

Query: 70  DSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-GKTPF 117
           D           YKA    +    W  P        + ++DV+SFGVL+ E  + G+ P+
Sbjct: 170 DENY--------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

Query: 118 QDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP- 176
           + +    GS++   +        E G+          E    + ++   C +   ENRP 
Sbjct: 222 RGM---KGSEVTAML--------EKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPG 266

Query: 177 ---VMREVSKMIRDSRAEAQ 193
              V   +     D   E  
Sbjct: 267 FAAVELRLRNYYYDVVNEGH 286

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 46.4 bits (111), Expect = 2e-06
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 7/104 (6%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
              + +   + Y H N G+ H NLK  N+LL +  +     L D+GL    N        
Sbjct: 109 HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           A +  Y +PE   + K P ++  D+++ GV+L  LL G  PF D
Sbjct: 168 AGTPGYLSPEV--LKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 46.5 bits (111), Expect = 2e-06
 Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 6/96 (6%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCL--TDYGLGSFRNPDSVEEPSATSLFYKA 84
             L ++H +  + H +++  N++      S +   ++G      P        T+  Y A
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171

Query: 85  PECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           PE         +   D++S G L+  LL+G  PF  
Sbjct: 172 PEV--HQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 46.0 bits (110), Expect = 2e-06
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 15/126 (11%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           S G   L     LK + D+   + Y+  N    H +L + NVL+  D  + ++D+GL   
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLT-- 164

Query: 67  RNPDSVEEPSATSLF-YK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL-- 120
           +          T     K  APE     K+ + ++DV+SFG+LL E+ + G+ P+  +  
Sbjct: 165 KE---ASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220

Query: 121 --VLEH 124
             V+  
Sbjct: 221 KDVVPR 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 46.1 bits (110), Expect = 2e-06
 Identities = 41/180 (22%), Positives = 79/180 (43%), Gaps = 24/180 (13%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           +  A  L++ L Y+       H ++ + NVL+ ++    L D+GL  +    +  + S  
Sbjct: 119 ILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSV 135
            L  K  APE    +++ T  +DV+ FGV + E+L  G  PFQ +     +D+   +   
Sbjct: 178 KLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRI--- 230

Query: 136 REEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMREVSKMIRDSRAE 191
                E+G+  P            L ++   C +  P  RP    +  ++S ++ + +A+
Sbjct: 231 -----ENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 7/104 (6%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
              + +   + Y+H+N G+ H +LK  N+L           + D+GL        + +  
Sbjct: 152 DAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             +  Y APE   +       + D++S G++   LL G  PF D
Sbjct: 211 CGTPGYCAPEI--LRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 46.4 bits (110), Expect = 3e-06
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 6/96 (6%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCL--TDYGLGSFRNPDSVEEPSATSLFYKA 84
            GL ++H+N    H +LK  N++      + L   D+GL +  +P    + +  +  + A
Sbjct: 266 KGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324

Query: 85  PECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           PE      +P     D++S GVL   LL+G +PF  
Sbjct: 325 PEV--AEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 45.7 bits (109), Expect = 3e-06
 Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 22/128 (17%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
                   L     +  +  +A G+ ++       H +L + N+LL       + D+GL 
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 195

Query: 65  SFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT- 112
             R+     +       Y       +   W  P        T Q+DV+SFGVLL E+ + 
Sbjct: 196 --RDIYKDPD-------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

Query: 113 GKTPFQDL 120
           G +P+  +
Sbjct: 247 GASPYPGV 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 40/197 (20%), Positives = 84/197 (42%), Gaps = 26/197 (13%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRN 68
            + +  ++  ++   ++ G+ Y+ +     H NL + NVLL     + ++D+GL  +   
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

Query: 69  PDSVEEPSATSLF-YK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
            DS     +   +  K  APEC   +++ + ++DV+S+GV + E L+ G+ P++ +    
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---K 544

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMRE 180
           G ++  ++        E G       E   E    L  +   C     E+RP    V + 
Sbjct: 545 GPEVMAFI--------EQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQR 592

Query: 181 VSKMIRDSRAEAQMSSN 197
           +        ++ +  S 
Sbjct: 593 MRACYYSLASKVEGGSA 609

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 45.3 bits (108), Expect = 6e-06
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 8/104 (7%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
            + + + S + Y+H+N G+ H +LK  N+L     E+    +TD+GL        +    
Sbjct: 110 LVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA- 167

Query: 77  ATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
             +  Y APE   + ++P ++  D +S GV+   LL G  PF +
Sbjct: 168 CGTPGYVAPEV--LAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 45.0 bits (107), Expect = 6e-06
 Identities = 30/128 (23%), Positives = 54/128 (42%), Gaps = 22/128 (17%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           R       L   + ++   D+A G+ Y+       H +L + N +L  D   C+ D+GL 
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLS 184

Query: 65  SFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT- 112
             R   S +        Y+     ++   W           T  +DV++FGV + E++T 
Sbjct: 185 --RKIYSGDY-------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

Query: 113 GKTPFQDL 120
           G+TP+  +
Sbjct: 236 GQTPYAGI 243

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 45.0 bits (107), Expect = 7e-06
 Identities = 31/129 (24%), Positives = 54/129 (41%), Gaps = 25/129 (19%)

Query: 4   TRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL 63
              +     L     L  A D+A G+ Y+ Q     H +L + N+L+G ++ + + D+GL
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGL 188

Query: 64  GSFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT 112
              R  +           Y       +   W           T  +DV+S+GVLL E+++
Sbjct: 189 S--RGQE----------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

Query: 113 -GKTPFQDL 120
            G TP+  +
Sbjct: 237 LGGTPYCGM 245

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 44.5 bits (106), Expect = 7e-06
 Identities = 29/122 (23%), Positives = 58/122 (47%), Gaps = 9/122 (7%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
           GK L  +  L++  D+  G+ ++  +    H +L + N L+  D    ++D+G+  +   
Sbjct: 98  GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156

Query: 70  DSVEEPSATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL----VL 122
           D       T    K  APE    + + + ++DV++FG+L+ E+ + GK P+       V+
Sbjct: 157 DQYVSSVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215

Query: 123 EH 124
             
Sbjct: 216 LK 217

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 44.5 bits (106), Expect = 9e-06
 Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLL-GADFESC---LTDYGLGSFRNPDSVEEPSATSL 80
           +  G+ Y+H    + H +LK  N++L   +  +    L D+G+       +  +    + 
Sbjct: 117 ILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 175

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            + APE   +  +P   +AD++S GV+   LL+G +PF  
Sbjct: 176 EFVAPEI--VNYEPLGLEADMWSIGVITYILLSGASPFLG 213

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 44.6 bits (106), Expect = 9e-06
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 7/99 (7%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATSLF 81
           +   + Y H N G+ H NLK  N+LL +  +     L D+GL    N        A +  
Sbjct: 137 ILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 195

Query: 82  YKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           Y +PE   + K P ++  D+++ GV+L  LL G  PF D
Sbjct: 196 YLSPEV--LKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 22/107 (20%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATS---- 79
           L +GL YIH+N  + H ++K++NVL+  D    L D+GL  +F    + +    T+    
Sbjct: 133 LLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 80  LFYKAPE--------CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           L+Y+ PE           I        D++  G ++ E+ T     Q
Sbjct: 192 LWYRPPELLLGERDYGPPI--------DLWGAGCIMAEMWTRSPIMQ 230

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 44.1 bits (105), Expect = 1e-05
 Identities = 30/132 (22%), Positives = 55/132 (41%), Gaps = 22/132 (16%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
            + +      + L     +  A  ++ G+ Y+ +   L H +L + N+L+    +  ++D
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAEGRKMKISD 193

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLE 109
           +GL   R+    +        Y       I   W           T Q+DV+SFGVLL E
Sbjct: 194 FGLS--RDVYEEDS-------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244

Query: 110 LLT-GKTPFQDL 120
           ++T G  P+  +
Sbjct: 245 IVTLGGNPYPGI 256

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 7/97 (7%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPSATSLFYK 83
            G+ Y+HQN  + H +LK  N+LL + +      + D+G+               +  Y 
Sbjct: 142 EGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200

Query: 84  APECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           APE   +   P T   D+++ G++   LLT  +PF  
Sbjct: 201 APEI--LNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 26/135 (19%)

Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           +    + L     +  A  +A G+ Y+       H +L + NVL+  D    + D+GL  
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLA- 238

Query: 66  FRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-G 113
            R+   ++        YK      +   W  P        T Q+DV+SFGVLL E+ T G
Sbjct: 239 -RDIHHIDY-------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290

Query: 114 KTPFQDL----VLEH 124
            +P+  +    + + 
Sbjct: 291 GSPYPGVPVEELFKL 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 30/127 (23%), Positives = 55/127 (43%), Gaps = 22/127 (17%)

Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
                + + +   +     LA G+ Y+       H +L + NVL+  +    + D+GL  
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLA- 204

Query: 66  FRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-G 113
            R+ ++++        YK      +   W  P        T Q+DV+SFGVL+ E+ T G
Sbjct: 205 -RDINNIDY-------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256

Query: 114 KTPFQDL 120
            +P+  +
Sbjct: 257 GSPYPGI 263

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 25/98 (25%), Positives = 48/98 (48%), Gaps = 8/98 (8%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLG-ADFESC---LTDYGLGSFRNPDSVEEPSATSLFY 82
           +G+ Y+H    + H +LK  N++L   +       + D+GL    +  +  +    +  +
Sbjct: 125 NGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 83  KAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            APE   +  +P   +AD++S GV+   LL+G +PF  
Sbjct: 184 VAPEI--VNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 8/98 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGSFRNPDSVEEPSAT---SL 80
           L   L YIH   G+ H ++K  N+LL  D     L D+G           EP+ +   S 
Sbjct: 165 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSR 220

Query: 81  FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +Y+APE        T   DV+S G +L ELL G+  F 
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 12/114 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLGADFESC--LTDYGLGSFR 67
           + +      K A+ + + LL++      + H +LK  N+LL     S   + D+G     
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211

Query: 68  NPDSVEEPSAT--SLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQ 118
                +       S FY++PE   +   P     D++S G +L+E+ TG+  F 
Sbjct: 212 G----QRIYQYIQSRFYRSPEV--LLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 39/201 (19%), Positives = 85/201 (42%), Gaps = 26/201 (12%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRN 68
            + +  ++  ++   ++ G+ Y+ +     H +L + NVLL     + ++D+GL  +   
Sbjct: 104 REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

Query: 69  PDSVEEPSATSLF-YK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
            DS     +   +  K  APEC   +++ + ++DV+S+GV + E L+ G+ P++ +    
Sbjct: 163 DDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---K 218

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMRE 180
           G ++  ++        E G       E   E    L  +   C     E+RP    V + 
Sbjct: 219 GPEVMAFI--------EQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQR 266

Query: 181 VSKMIRDSRAEAQMSSNSSDH 201
           +        ++ +   +   H
Sbjct: 267 MRACYYSLASKVEGHHHHHHH 287

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 33/135 (24%), Positives = 62/135 (45%), Gaps = 26/135 (19%)

Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
            +    P   +  +++A ++A G+ Y++ N    H +L + N ++  DF   + D+G+  
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMT- 185

Query: 66  FRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-G 113
            R+   + E    + +Y+      +   W  P        T  +DV+SFGV+L E+ T  
Sbjct: 186 -RD---IYE----TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237

Query: 114 KTPFQDL----VLEH 124
           + P+Q L    VL  
Sbjct: 238 EQPYQGLSNEQVLRF 252

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 43.7 bits (104), Expect = 1e-05
 Identities = 30/113 (26%), Positives = 59/113 (52%), Gaps = 9/113 (7%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D     + T
Sbjct: 107 LGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL----VLEH 124
               K  +PE    + + + ++DV+SFGVL+ E+ + GK P+++     V+E 
Sbjct: 166 KFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 43.8 bits (104), Expect = 1e-05
 Identities = 32/128 (25%), Positives = 55/128 (42%), Gaps = 22/128 (17%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG 64
           R   G K +   + LK   D+A G+ Y+       H +L + N +L  D   C+ D+GL 
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGLS 194

Query: 65  SFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT- 112
             +   S +        Y+     ++   W           T ++DV++FGV + E+ T 
Sbjct: 195 --KKIYSGDY-------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

Query: 113 GKTPFQDL 120
           G TP+  +
Sbjct: 246 GMTPYPGV 253

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 29/109 (26%), Positives = 57/109 (52%), Gaps = 11/109 (10%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           + +   +A+G+ Y+       H +L + N+L+ ++    ++D+GL   R  +   E + T
Sbjct: 150 VGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLS--RVLEDDPEATYT 206

Query: 79  SLFYK------APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
           +   K      APE     K  T  +DV+SFG+++ E++T G+ P+ +L
Sbjct: 207 TSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWEL 254

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 29/113 (25%), Positives = 46/113 (40%), Gaps = 23/113 (20%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-------------GSFRNPDSVEE 74
            + Y+H   GL H ++K SN+LL A+    + D+GL                   ++ E 
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 75  PSATSLF---------YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                           Y+APE      + T+  D++S G +L E+L GK  F 
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 26/100 (26%), Positives = 46/100 (46%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLL-GADFESC---LTDYGLGSFRNPDSVEEPSATSL 80
           +  G+ Y+H    + H +LK  N++L   +       L D+GL          +    + 
Sbjct: 124 ILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            + APE   +  +P   +AD++S GV+   LL+G +PF  
Sbjct: 183 EFVAPEI--VNYEPLGLEADMWSIGVITYILLSGASPFLG 220

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 6/97 (6%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLG--SFRNPDSVEEPSATSLF 81
           L   L YIH   G+ H ++K  N+LL        L D+G          +V      S +
Sbjct: 150 LLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRY 206

Query: 82  YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           Y+APE        T   D++S G ++ EL+ G+  F 
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 27/127 (21%), Positives = 42/127 (33%), Gaps = 35/127 (27%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP---- 75
               ++   L Y+ +   LTH +LK  N+LL   +                         
Sbjct: 141 LYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 76  --------SAT-----------SLFYKAPECREI-----WKQPTQQADVYSFGVLLLELL 111
                    AT           +  Y+APE   +     W      +D++SFG +L EL 
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPE---VILNLGWDVS---SDMWSFGCVLAELY 253

Query: 112 TGKTPFQ 118
           TG   F+
Sbjct: 254 TGSLLFR 260

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 24/96 (25%), Positives = 43/96 (44%), Gaps = 6/96 (6%)

Query: 27  SGLLYIHQNPGLTHGNLKSSNVLLGADFESCL--TDYGLGSFRNPDSVEEPSATSLFYKA 84
            G+ ++HQ   + H +LK  N+L        +   D+GL     P    + +  +  + A
Sbjct: 198 EGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256

Query: 85  PECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
           PE   +     +   D++S GV+   LL+G +PF  
Sbjct: 257 PEV--VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 43.4 bits (103), Expect = 2e-05
 Identities = 26/100 (26%), Positives = 46/100 (46%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLL-GADFESC---LTDYGLGSFRNPDSVEEPSATSL 80
           +  G+ Y+H    + H +LK  N++L   +       L D+GL          +    + 
Sbjct: 124 ILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            + APE   +  +P   +AD++S GV+   LL+G +PF  
Sbjct: 183 EFVAPEI--VNYEPLGLEADMWSIGVITYILLSGASPFLG 220

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 30/127 (23%), Positives = 55/127 (43%), Gaps = 22/127 (17%)

Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
                + + +   +     LA G+ Y+       H +L + NVL+  +    + D+GL  
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLA- 250

Query: 66  FRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-G 113
            R+ ++++        YK      +   W  P        T Q+DV+SFGVL+ E+ T G
Sbjct: 251 -RDINNIDY-------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302

Query: 114 KTPFQDL 120
            +P+  +
Sbjct: 303 GSPYPGI 309

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNPDSVEEPSATSLFYKAPE 86
           GL ++HQ+  + H ++K  NVLL  + E  L D+G+                + ++ APE
Sbjct: 141 GLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 87  ---CREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
              C E        ++D++S G+  +E+  G  P  D+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 43.1 bits (102), Expect = 3e-05
 Identities = 26/107 (24%), Positives = 54/107 (50%), Gaps = 10/107 (9%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +   +   L ++H    + H +LK+ NVL+  + +  L D+G+ S +N  ++ +   + +
Sbjct: 122 VCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGV-SAKNLKTL-QKRDSFI 178

Query: 81  ---FYKAPE--CREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDL 120
              ++ APE    E  K      +AD++S G+ L+E+   + P  +L
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 3e-05
 Identities = 32/121 (26%), Positives = 49/121 (40%), Gaps = 29/121 (23%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLL-GADFESCLTDYGLGSFRNPDSVEEP--- 75
           K+A  +   + ++H N  LTH +LK  N+L   +D+            R   + +     
Sbjct: 122 KMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 76  --SAT-----------SLFYKAPECREI-----WKQPTQQADVYSFGVLLLELLTGKTPF 117
             SAT           +  Y+APE   +     W QP    DV+S G +L+E   G T F
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPE---VILALGWSQP---CDVWSIGCILIEYYLGFTVF 234

Query: 118 Q 118
            
Sbjct: 235 P 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 17/108 (15%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-------GSFRNPDSVE 73
           I  ++  GL Y+H      H ++K++NVLL    E  L D+G+          RN   V 
Sbjct: 124 ILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-TFVG 181

Query: 74  EPSATSLFYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
            P     F+ APE   I +     +AD++S G+  +EL  G+ P  +L
Sbjct: 182 TP-----FWMAPEV--IKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 11/105 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           +  +    L ++H N  + H ++KS N+LLG D    LTD+G  +   P   E+   +++
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTM 176

Query: 81  ----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
               ++ APE   + ++    + D++S G++ +E++ G+ P+ + 
Sbjct: 177 VGTPYWMAPEV--VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 12/98 (12%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG---SFRNPDSVEEPSATSLFYKA 84
           GL Y+H +  + H ++K+ N+LL       L D+G     +  N   V  P     ++ A
Sbjct: 166 GLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-SFVGTP-----YWMA 218

Query: 85  PECREIWKQPT--QQADVYSFGVLLLELLTGKTPFQDL 120
           PE      +     + DV+S G+  +EL   K P  ++
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 35/123 (28%), Positives = 47/123 (38%), Gaps = 33/123 (26%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEP---- 75
            +A  L   L ++H+N  LTH +LK  N+L         T Y         SV+      
Sbjct: 127 HMAYQLCHALRFLHEN-QLTHTDLKPENILFVNS--EFETLYNEHKSCEEKSVKNTSIRV 183

Query: 76  ----SAT-----------SLFYKAPECREI-----WKQPTQQADVYSFGVLLLELLTGKT 115
               SAT           +  Y+ PE   +     W QP    DV+S G +L E   G T
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPE---VILELGWAQP---CDVWSIGCILFEYYRGFT 237

Query: 116 PFQ 118
            FQ
Sbjct: 238 LFQ 240

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 42.2 bits (100), Expect = 4e-05
 Identities = 27/119 (22%), Positives = 52/119 (43%), Gaps = 8/119 (6%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           +  +  +   + Y+       H ++   N+L+ +     L D+GL  +   +   + S T
Sbjct: 116 VLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRS 134
            L  K  +PE    +++ T  +DV+ F V + E+L+ GK PF  L      D+   +  
Sbjct: 175 RLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWL---ENKDVIGVLEK 229

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 41.9 bits (99), Expect = 6e-05
 Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 20/196 (10%)

Query: 13  LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDS 71
           +     L  A+ +  G+ Y+H      H +L + NVLL  D    + D+GL   +  P+ 
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLA--KAVPEG 187

Query: 72  VEEPSATS-----LFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLV-LEH 124
            E           +F+ APEC + +K     +DV+SFGV L ELLT   +          
Sbjct: 188 HEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

Query: 125 GSDIPRWVRSVRE--EETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
              I +   +V    E  E G+  P  ++   E    + ++   C       RP    + 
Sbjct: 247 LIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENLI 302

Query: 183 KMIRD--SRAEAQMSS 196
            +++    + + Q  S
Sbjct: 303 PILKTVHEKYQGQAPS 318

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 41.9 bits (99), Expect = 7e-05
 Identities = 27/100 (27%), Positives = 43/100 (43%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLG-SFRNPDSVEEPSATSL 80
           +   L Y H N  + H ++K   VLL +   S    L  +G+         V      + 
Sbjct: 139 ILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            + APE   + ++P  +  DV+  GV+L  LL+G  PF  
Sbjct: 198 HFMAPEV--VKREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 42.0 bits (99), Expect = 7e-05
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 11/105 (10%)

Query: 21  IAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSL 80
           + E +   L Y+H   G+ H ++KS ++LL  D    L+D+G   F    S + P   SL
Sbjct: 146 VCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSL 201

Query: 81  ----FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
               ++ APE   I +     + D++S G++++E++ G+ P+   
Sbjct: 202 VGTPYWMAPEV--ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 41.6 bits (98), Expect = 8e-05
 Identities = 29/109 (26%), Positives = 59/109 (54%), Gaps = 11/109 (10%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           + +   +ASG+ Y+    G  H +L + N+L+ ++    ++D+GLG  R  +   E + T
Sbjct: 150 VGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLG--RVLEDDPEAAYT 206

Query: 79  SLFYK------APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL 120
           +   K      +PE     K  T  +DV+S+G++L E+++ G+ P+ ++
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEM 254

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 41.5 bits (98), Expect = 8e-05
 Identities = 37/187 (19%), Positives = 69/187 (36%), Gaps = 32/187 (17%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           LK A  +  G+ Y+       H +L + NVL+ ++ +  + D+GL   +  ++ +E    
Sbjct: 129 LKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLT--KAIETDKE---- 181

Query: 79  SLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-GKTPFQ-DLVLEHG 125
             +Y   + R+    W  P           +DV+SFGV L ELLT   +      +    
Sbjct: 182 --YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239

Query: 126 SDIPRWVRSVRE--EETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP----VMR 179
                   +V       + G   P      +E    +  +   C    P NR     ++ 
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIE 295

Query: 180 EVSKMIR 186
               +++
Sbjct: 296 GFEALLK 302

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 41.5 bits (98), Expect = 8e-05
 Identities = 30/126 (23%), Positives = 51/126 (40%), Gaps = 26/126 (20%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            +       +     +A G+ Y+ +     H +L + N +L   F   + D+GL   R+ 
Sbjct: 118 QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLA--RDI 174

Query: 70  DSVEEPSATSLFYKAPECREIWKQP--------------TQQADVYSFGVLLLELLT-GK 114
              E        Y + +     + P              T ++DV+SFGVLL ELLT G 
Sbjct: 175 LDRE--------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226

Query: 115 TPFQDL 120
            P++ +
Sbjct: 227 PPYRHI 232

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 41.9 bits (99), Expect = 9e-05
 Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 8/100 (8%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFES---CLTDYGLGS-FRNPDSVEEPSATSL 80
           +   +L+ HQ  G+ H NLK  N+LL +  +     L D+GL              A + 
Sbjct: 119 ILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQD 119
            Y +PE   + K P  +  D+++ GV+L  LL G  PF D
Sbjct: 178 GYLSPEV--LRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 24/113 (21%), Positives = 53/113 (46%), Gaps = 9/113 (7%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L++ +D+   + Y+       H +L + N L+       ++D+GL  +   D       +
Sbjct: 123 LEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181

Query: 79  SLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL----VLEH 124
               +   PE   ++ + + ++D+++FGVL+ E+ + GK P++        EH
Sbjct: 182 KFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 27/115 (23%), Positives = 59/115 (51%), Gaps = 11/115 (9%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF--RNPDSVEEPS 76
           + +   + +G+ Y+    G  H +L + NVL+ ++    ++D+GL      +PD+    +
Sbjct: 154 VGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

Query: 77  ATSLFYK--APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDL----VLEH 124
              +  +  APE    ++  +  +DV+SFGV++ E+L  G+ P+ ++    V+  
Sbjct: 213 GGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 10/109 (9%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF---RNPDSVEEP 75
           +     +A G+ ++       H +L + N +L   F   + D+GL      +  DSV   
Sbjct: 195 IGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 76  SATSLFYK--APECREIWKQP-TQQADVYSFGVLLLELLT-GKTPFQDL 120
           +   L  K  A E   +  Q  T ++DV+SFGVLL EL+T G  P+ D+
Sbjct: 254 TGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 25/114 (21%), Positives = 49/114 (42%), Gaps = 22/114 (19%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           L  +  +A G+ ++       H +L + N+LL     + + D+GL   R+   ++     
Sbjct: 148 LSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLA--RD---IKN---- 197

Query: 79  SLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-GKTPFQDL 120
              Y       +   W  P        T ++DV+S+G+ L EL + G +P+  +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 17/101 (16%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-------GSFRNPDSVEEPSATSL 80
           GL Y+H      H ++K+ N+LL  +  + L D+G+        + RN   +  P     
Sbjct: 137 GLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTP----- 189

Query: 81  FYKAPECREIWKQP-TQQADVYSFGVLLLELLTGKTPFQDL 120
           F+ APE   I +      AD++S G+  +E+  GK P+ D+
Sbjct: 190 FWMAPEV--IQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 26/112 (23%), Positives = 42/112 (37%), Gaps = 24/112 (21%)

Query: 28  GLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL--------------GSFRNPDSVE 73
           G  +IH++ G+ H +LK +N LL  D    + D+GL                  N +   
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 74  EPSATSLF---------YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP 116
                            Y+APE   + +  T+  D++S G +  ELL     
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 25/160 (15%), Positives = 45/160 (28%), Gaps = 56/160 (35%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD---------------- 53
            + L      KI + +  GL Y+H    + H ++K  N+LL  +                
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199

Query: 54  ---------------------------------FESCLTDYGLGSFRNPDSVEEPSATSL 80
                                             +  + D G   +            + 
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTR 257

Query: 81  FYKAPE--CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            Y++ E      +  P   AD++S   +  EL TG   F+
Sbjct: 258 QYRSLEVLIGSGYNTP---ADIWSTACMAFELATGDYLFE 294

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 27/126 (21%), Positives = 49/126 (38%), Gaps = 22/126 (17%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
                 L +   L  A  +A G+ ++       H +L + NVL+       + D+GL   
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLA-- 219

Query: 67  RNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-GK 114
           R+   +         Y       +   W  P        T ++DV+S+G+LL E+ + G 
Sbjct: 220 RD---IMS----DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272

Query: 115 TPFQDL 120
            P+  +
Sbjct: 273 NPYPGI 278

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 33/139 (23%), Positives = 58/139 (41%), Gaps = 26/139 (18%)

Query: 2   TGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDY 61
                     PL     L +A  +A+G++Y+       H +L + N L+G      + D+
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDF 202

Query: 62  GLGSFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLEL 110
           G+   R+  S +       +Y+      +   W  P        T ++DV+SFGV+L E+
Sbjct: 203 GM--SRDIYSTD-------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

Query: 111 LT-GKTPFQDL----VLEH 124
            T GK P+  L     ++ 
Sbjct: 254 FTYGKQPWYQLSNTEAIDC 272

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 40.3 bits (95), Expect = 2e-04
 Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 24/116 (20%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSAT 78
           +     +A G+ Y+       H +L + N +L   F   + D+GL   R+    E     
Sbjct: 131 IGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLA--RDMYDKE----- 182

Query: 79  SLFYKAPECREI-----WKQP--------TQQADVYSFGVLLLELLT-GKTPFQDL 120
             +Y             W           T ++DV+SFGVLL EL+T G  P+ D+
Sbjct: 183 --YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 39.6 bits (93), Expect = 3e-04
 Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 26/103 (25%)

Query: 20  KIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC---LTDYGLGSFRNPDSVEEPS 76
           +I + +   + Y+H    + H ++K  N+L  +   +    LTD+G              
Sbjct: 121 EIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGF------------- 166

Query: 77  ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
                  A E     ++  +  D++S GV++  LL G  PF  
Sbjct: 167 -------AKETTG--EKYDKSCDMWSLGVIMYILLCGYPPFYS 200

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 39.6 bits (93), Expect = 4e-04
 Identities = 41/197 (20%), Positives = 76/197 (38%), Gaps = 16/197 (8%)

Query: 19  LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEE 74
           L  +  +  G+ Y+       H +L + N+L+ ++    + D+GL      D     V E
Sbjct: 130 LLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188

Query: 75  PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVR 133
           P  + +F+ APE        ++Q+DV+SFGV+L EL T                      
Sbjct: 189 PGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247

Query: 134 -SVRE--EETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD--S 188
            ++    E  E G   P+      E    +  +   C + +P++RP    +   +    S
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303

Query: 189 RAEAQMSSNSSDHSPGR 205
            +    +   + H  G+
Sbjct: 304 GSRGCETHAFTAHPEGK 320

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 39.6 bits (93), Expect = 4e-04
 Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 22/125 (17%)

Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
            +           L  +  +A G+ ++       H ++ + NVLL     + + D+GL  
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLA- 211

Query: 66  FRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLELLT-G 113
            R  D + +       Y       +   W  P        T Q+DV+S+G+LL E+ + G
Sbjct: 212 -R--DIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263

Query: 114 KTPFQ 118
             P+ 
Sbjct: 264 LNPYP 268

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 39.2 bits (92), Expect = 5e-04
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 26/140 (18%)

Query: 1   MTGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTD 60
                +S G  PL     L IA  +A+G+ Y+ +     H +L + N L+G +    + D
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIAD 217

Query: 61  YGLGSFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLE 109
           +GL   RN  S +        YKA     I   W  P        T ++DV+++GV+L E
Sbjct: 218 FGL--SRNIYSADY-------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

Query: 110 LLT-GKTPFQDL----VLEH 124
           + + G  P+  +    V+ +
Sbjct: 269 IFSYGLQPYYGMAHEEVIYY 288

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 39.1 bits (92), Expect = 6e-04
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 26/139 (18%)

Query: 2   TGTRTSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDY 61
              +       L  +  L IA  +ASG++Y+       H +L + N L+GA+    + D+
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDF 177

Query: 62  GLGSFRNPDSVEEPSATSLFYKAPECREI---WKQP--------TQQADVYSFGVLLLEL 110
           G+   R+  S +       +Y+      +   W  P        T ++DV+SFGV+L E+
Sbjct: 178 GM--SRDVYSTD-------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

Query: 111 LT-GKTPFQDL----VLEH 124
            T GK P+  L    V+E 
Sbjct: 229 FTYGKQPWFQLSNTEVIEC 247

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 38.7 bits (91), Expect = 7e-04
 Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 10/99 (10%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  GL Y H+   + H +LK  N+L+    E  L D+GL  +   P    +    +L+Y+
Sbjct: 109 LLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167

Query: 84  APE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
            P+      +     + Q D++  G +  E+ TG+  F 
Sbjct: 168 PPDILLGSTDY----STQIDMWGVGCIFYEMATGRPLFP 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 38.6 bits (90), Expect = 8e-04
 Identities = 16/57 (28%), Positives = 27/57 (47%), Gaps = 3/57 (5%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC--LTDYGL 63
               L   S L++A  L   L ++H+N    HGN+ + N+ +  + +S   L  YG 
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQSQVTLAGYGF 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 38.7 bits (91), Expect = 8e-04
 Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 10/99 (10%)

Query: 25  LASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNPDSVEEPSATSLFYK 83
           L  G+ + HQ+  + H +LK  N+L+ +D    L D+GL  +F  P         +L+Y+
Sbjct: 128 LLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 84  APE----CREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           AP+     ++     +   D++S G +  E++TGK  F 
Sbjct: 187 APDVLMGSKKY----STSVDIWSIGCIFAEMITGKPLFP 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	221
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.95
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.93
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.93
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.93
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.91
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.9
3uqc_A	286	Probable conserved transmembrane protein; structur	99.88
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.88
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.72
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.38
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	98.98
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.3
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.93
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	96.83
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	96.69
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.68
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	96.63
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	94.55
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	94.27
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	91.99
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	91.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	90.03
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	89.43
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	88.49
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	87.93
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	87.23
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	87.06
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.75
3ats_A	357	Putative uncharacterized protein; hypothetical pro	86.71
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.82
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	84.43
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	83.13
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.63
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	81.02

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=250.54  Aligned_cols=169  Identities=24%  Similarity=0.422  Sum_probs=127.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ..++++..++.++.||+.||+|||+. +|+||||||.|||++.++.+||+|||+++......   ......||+.|+|||
T Consensus       126 ~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE  204 (307)
T 3omv_A          126 ETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE  204 (307)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHH
Confidence            45799999999999999999999998 99999999999999999999999999997654321   234567899999999


Q ss_pred             cchh--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           87 CREI--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        87 ~~~~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .+..  ...++.++|||||||++|||++|+.||.+.     ... .............    +........++..+.+||
T Consensus       205 ~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~-----~~~-~~~~~~~~~~~~~----p~~~~~~~~~~~~l~~li  274 (307)
T 3omv_A          205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI-----NNR-DQIIFMVGRGYAS----PDLSKLYKNCPKAMKRLV  274 (307)
T ss_dssp             HHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCH-HHHHHHHHTTCCC----CCSTTSCTTSCHHHHHHH
T ss_pred             HhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC-----ChH-HHHHHHHhcCCCC----CCcccccccchHHHHHHH
Confidence            8752  234788999999999999999999999742     111 2222222211111    111111222335699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      .+||+.||++|||+.+|++.|+.+.
T Consensus       275 ~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          275 ADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             HHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            9999999999999999999998775

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.4e-37  Score=249.05  Aligned_cols=166  Identities=22%  Similarity=0.406  Sum_probs=127.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ...+|++..++.++.||+.||+|||+. +|+||||||.|||++.++.+||+|||+++......   ......+|+.|+||
T Consensus       151 ~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          151 APGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             -CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence            356899999999999999999999998 99999999999999999999999999997653322   22345678999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++ |+.||.+.      ........+...     ..++.+..++    ..+.+||
T Consensus       230 E~~~-~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~------~~~~~~~~i~~g-----~~~~~p~~~~----~~~~~li  293 (329)
T 4aoj_A          230 ESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------SNTEAIDCITQG-----RELERPRACP----PEVYAIM  293 (329)
T ss_dssp             HHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS------CHHHHHHHHHHT-----CCCCCCTTCC----HHHHHHH
T ss_pred             hhhc-CCCCCccccccchHHHHHHHHcCCCCCCCCC------CHHHHHHHHHcC-----CCCCCccccc----HHHHHHH
Confidence            9987 7788999999999999999998 89999743      223333333322     1222223333    4589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||++|||+.||++.|+.+...
T Consensus       294 ~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          294 RGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-37  Score=248.31  Aligned_cols=167  Identities=20%  Similarity=0.411  Sum_probs=134.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....|++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......   ......+|+.|+||
T Consensus       121 ~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          121 PPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCH
Confidence            456899999999999999999999998 99999999999999999999999999997543322   12334578899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++ |+.||.+.      ........+....     .++.+..++    ..+.+||
T Consensus       200 E~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~------~~~~~~~~i~~~~-----~~~~p~~~~----~~~~~li  263 (299)
T 4asz_A          200 ESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL------SNNEVIECITQGR-----VLQRPRTCP----QEVYELM  263 (299)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHHTC-----CCCCCTTCC----HHHHHHH
T ss_pred             HHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHcCC-----CCCCCccch----HHHHHHH
Confidence            9987 6788999999999999999998 89999743      2333334333322     222223333    4589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+||+.||++|||+.+|++.|+++....
T Consensus       264 ~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          264 LGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            9999999999999999999999987643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6e-37  Score=246.66  Aligned_cols=162  Identities=20%  Similarity=0.375  Sum_probs=131.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      ...|++..++.++.||+.||+|||+. +++||||||.|||++.++.+||+|||+++.....   .......+|+.|+|||
T Consensus       139 ~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  217 (308)
T 4gt4_A          139 KSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE  217 (308)
T ss_dssp             ECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHH
Confidence            45799999999999999999999998 9999999999999999999999999999754322   2234457889999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|||||||++|||++ |..||.+.      ........+...     ..++.+..++    ..+.+||.
T Consensus       218 ~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~------~~~~~~~~i~~~-----~~~~~p~~~~----~~~~~li~  281 (308)
T 4gt4_A          218 AIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------SNQDVVEMIRNR-----QVLPCPDDCP----AWVYALMI  281 (308)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC------CHHHHHHHHHTT-----CCCCCCTTCC----HHHHHHHH
T ss_pred             HHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcC-----CCCCCcccch----HHHHHHHH
Confidence            987 6788999999999999999998 89999743      333344433322     2223333333    46899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +||+.||.+|||+.||++.|+..
T Consensus       282 ~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          282 ECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcCCChhHCcCHHHHHHHHHhc
Confidence            99999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.7e-37  Score=247.91  Aligned_cols=174  Identities=20%  Similarity=0.238  Sum_probs=132.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCC------CCCCCCCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDS------VEEPSATSLFY   82 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~------~~~~~~~~~~~   82 (221)
                      .++|++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++......      ......||+.|
T Consensus       144 ~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y  222 (336)
T 4g3f_A          144 MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH  222 (336)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccc
Confidence            35799999999999999999999998 999999999999999987 69999999997654322      12234689999


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      +|||.+. +..++.++|||||||++|+|++|..||.+....   .+   ...+........       ..++..+..+.+
T Consensus       223 mAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~---~~~i~~~~~~~~-------~~~~~~s~~~~~  288 (336)
T 4g3f_A          223 MAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PL---CLKIASEPPPIR-------EIPPSCAPLTAQ  288 (336)
T ss_dssp             CCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CC---HHHHHHSCCGGG-------GSCTTSCHHHHH
T ss_pred             cCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HH---HHHHHcCCCCch-------hcCccCCHHHHH
Confidence            9999987 678899999999999999999999999753221   11   112211111100       111122346899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCC
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNS  198 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  198 (221)
                      |+.+||+.||.+|||+.||++.|.....+...-..+
T Consensus       289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP  324 (336)
T 4g3f_A          289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP  324 (336)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred             HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence            999999999999999999999999888765533333

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-36  Score=238.64  Aligned_cols=156  Identities=24%  Similarity=0.379  Sum_probs=116.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .++++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++............||+.|+|||.+.
T Consensus       106 ~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~  184 (275)
T 3hyh_A          106 RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS  184 (275)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhc
Confidence            46799999999999999999999998 99999999999999999999999999998766555555678999999999987


Q ss_pred             hcCC-CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQ-PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~-~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       +.. ++.++||||+||++|+|++|..||.+      .+.......+.....    ..+  ...+    ..+.+|+.+||
T Consensus       185 -~~~y~~~~~DiwSlGvily~lltg~~PF~~------~~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~~L  247 (275)
T 3hyh_A          185 -GKLYAGPEVDVWSCGVILYVMLCRRLPFDD------ESIPVLFKNISNGVY----TLP--KFLS----PGAAGLIKRML  247 (275)
T ss_dssp             -SSSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTCC----CCC--TTSC----HHHHHHHHHHS
T ss_pred             -CCCCCCChhhhHHHHHHHHHHHHCCCCCCC------CCHHHHHHHHHcCCC----CCC--CCCC----HHHHHHHHHHc
Confidence             444 46799999999999999999999964      233333333333221    111  2222    35899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||++|||+.|+++
T Consensus       248 ~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          248 IVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhHCcCHHHHHc
Confidence            999999999999976

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.9e-37  Score=249.51  Aligned_cols=167  Identities=22%  Similarity=0.319  Sum_probs=133.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....|++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......   ......+|+.|+||
T Consensus       178 ~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          178 YKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            356789999999999999999999998 99999999999999999999999999997654332   12344678899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++ |..||.+..     ........+...     .+++.+..++    ..+.++|
T Consensus       257 E~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~-----~~~~~~~~i~~g-----~~~~~p~~~~----~~~~~li  321 (353)
T 4ase_A          257 ETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----IDEEFCRRLKEG-----TRMRAPDYTT----PEMYQTM  321 (353)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-----CSHHHHHHHHHT-----CCCCCCTTCC----HHHHHHH
T ss_pred             HHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHHcC-----CCCCCCccCC----HHHHHHH
Confidence            9987 6888999999999999999998 999997532     111222222221     2222223333    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||.+|||+.+|++.|+++.+.
T Consensus       322 ~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          322 LDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999988753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.8e-36  Score=242.75  Aligned_cols=158  Identities=18%  Similarity=0.303  Sum_probs=127.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.
T Consensus       165 ~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          165 TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS  243 (346)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHC
Confidence            4689999999999999999999998 9999999999999999999999999999765443 3345678999999999986


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|||||||++|+|++|..||.+.      +.......+....   ..........+    ..+.+|+.+||+
T Consensus       244 -~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~~---~~~~~~~~~~s----~~~~dli~~~L~  309 (346)
T 4fih_A          244 -RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMIRDNL---PPRLKNLHKVS----PSLKGFLDRLLV  309 (346)
T ss_dssp             -TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSS---CCCCSCGGGSC----HHHHHHHHHHSC
T ss_pred             -CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCC---CCCCCccccCC----HHHHHHHHHHcC
Confidence             678899999999999999999999999642      2233333332211   11111112222    468999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||++|||+.|+++
T Consensus       310 ~dP~~R~ta~e~l~  323 (346)
T 4fih_A          310 RDPAQRATAAELLK  323 (346)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-35  Score=239.24  Aligned_cols=181  Identities=20%  Similarity=0.266  Sum_probs=128.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCC-------CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQN-------PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSA   77 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~-------~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~   77 (221)
                      ..++++..+++++.|++.||+|||++       ++|+||||||.|||++.++.+||+|||+++......     ......
T Consensus        94 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~  173 (303)
T 3hmm_A           94 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV  173 (303)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccc
Confidence            35689999999999999999999974       279999999999999999999999999987654322     122356


Q ss_pred             CCccccCcccchhcC-----CCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhhhccC
Q 048055           78 TSLFYKAPECREIWK-----QPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEETESG  143 (221)
Q Consensus        78 ~~~~~~~pe~~~~~~-----~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~  143 (221)
                      ||+.|+|||.+....     .++.++|||||||++|||++|..||.......         ......    +........
T Consensus       174 GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~----~~~~~~~~~  249 (303)
T 3hmm_A          174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE----MRKVVCEQK  249 (303)
T ss_dssp             CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH----HHHHHTTSC
T ss_pred             ccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH----HHHHHhccc
Confidence            899999999876221     24568999999999999999977664221100         011111    111111122


Q ss_pred             CCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhc
Q 048055          144 DDPPSS-NEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQM  194 (221)
Q Consensus       144 ~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~  194 (221)
                      .++..+ .....+.+..+.+||.+||+.||.+|||+.+|++.|+++..+.++
T Consensus       250 ~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i  301 (303)
T 3hmm_A          250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence            222222 223335567899999999999999999999999999998876543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-35  Score=233.60  Aligned_cols=157  Identities=20%  Similarity=0.376  Sum_probs=121.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEcC-CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+++++..+..++.||+.||+|||++ +  |+||||||+|||++. ++.+||+|||+++..... ...+..||+.|+|||
T Consensus       123 ~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-~~~~~~GTp~YmAPE  200 (290)
T 3fpq_A          123 FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPE  200 (290)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-ccCCcccCccccCHH
Confidence            35789999999999999999999998 7  999999999999974 789999999999754332 334568999999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+.  ..++.++|||||||++|+|++|..||.+.     .........+....     .++.   .+......+.+|+.+
T Consensus       201 ~~~--~~y~~~~DiwSlGvilyelltg~~Pf~~~-----~~~~~~~~~i~~~~-----~~~~---~~~~~~~~~~~li~~  265 (290)
T 3fpq_A          201 MYE--EKYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAAQIYRRVTSGV-----KPAS---FDKVAIPEVKEIIEG  265 (290)
T ss_dssp             GGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-----SSHHHHHHHHTTTC-----CCGG---GGGCCCHHHHHHHHH
T ss_pred             HcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CcHHHHHHHHHcCC-----CCCC---CCccCCHHHHHHHHH
Confidence            875  35899999999999999999999999642     22222223222211     1111   111112358999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.|+++
T Consensus       266 ~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          266 CIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HSCSSGGGSCCHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=243.65  Aligned_cols=158  Identities=18%  Similarity=0.307  Sum_probs=127.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.
T Consensus       242 ~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          242 TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS  320 (423)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHC
Confidence            4689999999999999999999998 9999999999999999999999999999765443 3345678999999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|||||||++|+|++|..||.+.      ........+.....   .........+    ..+.+|+.+||+
T Consensus       321 -~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~~~---~~~~~~~~~s----~~~~dli~~~L~  386 (423)
T 4fie_A          321 -RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMIRDNLP---PRLKNLHKVS----PSLKGFLDRLLV  386 (423)
T ss_dssp             -TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC---CCCSCTTSSC----HHHHHHHHHHSC
T ss_pred             -CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCCC---CCCcccccCC----HHHHHHHHHHcC
Confidence             678899999999999999999999999642      23333333332211   1111112223    358999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||++|||+.|+++
T Consensus       387 ~dP~~R~ta~ell~  400 (423)
T 4fie_A          387 RDPAQRATAAELLK  400 (423)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-35  Score=235.10  Aligned_cols=156  Identities=21%  Similarity=0.337  Sum_probs=126.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      .+.|+...+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....   ....+..||+.|+|||
T Consensus       126 ~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPE  204 (311)
T 4aw0_A          126 IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE  204 (311)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHH
Confidence            35799999999999999999999998 9999999999999999999999999999865432   2334568999999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+||+||++|+|++|..||.+      .+.......+.....    ..+  ...+    ..+.+|+.+
T Consensus       205 vl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~------~~~~~~~~~i~~~~~----~~p--~~~s----~~~~dli~~  267 (311)
T 4aw0_A          205 LLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA------GNEGLIFAKIIKLEY----DFP--EKFF----PKARDLVEK  267 (311)
T ss_dssp             HHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTCC----CCC--TTCC----HHHHHHHHH
T ss_pred             HHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHcCCC----CCC--cccC----HHHHHHHHH
Confidence            987 67889999999999999999999999964      233344444433221    112  2223    358999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.|++.
T Consensus       268 lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          268 LLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HSCSSGGGSTTSGGGTC
T ss_pred             HccCCHhHCcChHHHcC
Confidence            99999999999998743

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-34  Score=232.63  Aligned_cols=151  Identities=27%  Similarity=0.304  Sum_probs=120.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++...+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.... .....+..||+.|+|||.+
T Consensus       120 ~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~  198 (304)
T 3ubd_A          120 EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV  198 (304)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHh
Confidence            35789999999999999999999998 999999999999999999999999999976433 3334567899999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||.+      .+.......+.....    ..+  ...+    ..+.+|+.+||
T Consensus       199 ~-~~~y~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~~L  261 (304)
T 3ubd_A          199 N-RRGHTQSADWWSFGVLMFEMLTGTLPFQG------KDRKETMTMILKAKL----GMP--QFLS----PEAQSLLRMLF  261 (304)
T ss_dssp             H-TSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCCC----CCC--TTSC----HHHHHHHHHHT
T ss_pred             c-cCCCCCCCcccchHHHHHHHHhCCCCCCC------cCHHHHHHHHHcCCC----CCC--CcCC----HHHHHHHHHHc
Confidence            7 67889999999999999999999999974      233333333332211    111  2223    35899999999


Q ss_pred             cCCCCCCCCH
Q 048055          169 SLAPENRPVM  178 (221)
Q Consensus       169 ~~dp~~Rps~  178 (221)
                      +.||++|||+
T Consensus       262 ~~dP~~R~ta  271 (304)
T 3ubd_A          262 KRNPANRLGA  271 (304)
T ss_dssp             CSSGGGSTTC
T ss_pred             ccCHHHCCCC
Confidence            9999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-35  Score=239.68  Aligned_cols=157  Identities=23%  Similarity=0.346  Sum_probs=126.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      +..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+
T Consensus       119 ~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l  197 (350)
T 4b9d_A          119 GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC  197 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHH
Confidence            45678999999999999999999998 99999999999999999999999999997654321 12345689999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|||||||++|+|++|..||.+      .+.......+....     .++.....+    ..+.+|+.+||
T Consensus       198 ~-~~~y~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~-----~~~~~~~~s----~~~~~li~~~L  261 (350)
T 4b9d_A          198 E-NKPYNNKSDIWALGCVLYELCTLKHAFEA------GSMKNLVLKIISGS-----FPPVSLHYS----YDLRSLVSQLF  261 (350)
T ss_dssp             T-TCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHTC-----CCCCCTTSC----HHHHHHHHHHT
T ss_pred             C-CCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHcCC-----CCCCCccCC----HHHHHHHHHHc
Confidence            7 67889999999999999999999999964      23333333333322     112222233    35899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||.+|||+.|+++
T Consensus       262 ~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          262 KRNPRDRPSVNSILE  276 (350)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-33  Score=230.51  Aligned_cols=167  Identities=19%  Similarity=0.263  Sum_probs=124.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-----CCCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-----SVEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~~   84 (221)
                      .++|++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.....     .......||+.|+|
T Consensus       152 ~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~A  230 (398)
T 4b99_A          152 SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA  230 (398)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcC
Confidence            56899999999999999999999998 9999999999999999999999999999754322     23345689999999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC--------------------C
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG--------------------D  144 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~  144 (221)
                      ||.+.....++.++||||+||++|+|++|..||.+.      +.......+........                    .
T Consensus       231 PEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~------~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  304 (398)
T 4b99_A          231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK------NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPP  304 (398)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS------SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCC
T ss_pred             HHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC------CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCC
Confidence            998764456789999999999999999999999743      22222222221111100                    0


Q ss_pred             CCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          145 DPPSS-NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       145 ~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+.. ....+.....+.+|+.+||..||.+|||+.|+++
T Consensus       305 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          305 RQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000 0000111245889999999999999999999976

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=7.2e-33  Score=222.18  Aligned_cols=152  Identities=24%  Similarity=0.397  Sum_probs=109.8

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-------------CCCCCCC
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-------------EEPSATS   79 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~   79 (221)
                      .++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......             .....||
T Consensus       115 ~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT  193 (299)
T 4g31_A          115 RERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT  193 (299)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CC
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccC
Confidence            45667889999999999999998 999999999999999999999999999976543221             1234689


Q ss_pred             ccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           80 LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        80 ~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      +.|+|||.+. +..++.++|||||||++|||++   ||....        .....+...  .....+    .........
T Consensus       194 ~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~~~--------~~~~~~~~~--~~~~~p----~~~~~~~~~  255 (299)
T 4g31_A          194 KLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQM--------ERVRTLTDV--RNLKFP----PLFTQKYPC  255 (299)
T ss_dssp             CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSSHH--------HHHHHHHHH--HTTCCC----HHHHHHCHH
T ss_pred             ccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCCcc--------HHHHHHHHH--hcCCCC----CCCcccCHH
Confidence            9999999987 6788999999999999999995   775321        111111111  111111    122223345


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH
Q 048055          160 LLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.+|+.+||+.||.+|||+.|+++
T Consensus       256 ~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          256 EYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            788999999999999999999976

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=3e-32  Score=223.91  Aligned_cols=108  Identities=30%  Similarity=0.441  Sum_probs=91.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCC------------------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      +.+++..+..++.||+.||+|||+. ||+||||||+|||++.+ +.+||+|||+++......                  
T Consensus       112 ~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  190 (361)
T 4f9c_A          112 NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQ  190 (361)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-----------
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccc
Confidence            3589999999999999999999998 99999999999999877 799999999997543221                  


Q ss_pred             -----------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           72 -----------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        72 -----------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                                 ...+..||+.|+|||.+.....++.++|+||+||++|+|++|..||..
T Consensus       191 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          191 NKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             ---------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence                       113346899999999887445688999999999999999999999964

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=2.8e-31  Score=230.90  Aligned_cols=158  Identities=22%  Similarity=0.225  Sum_probs=124.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.|+...+..++.||+.||.|||+. ||+||||||+|||++.+|.+||+|||+++...... ..+..||+.|+|||.+.
T Consensus       286 ~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          286 HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHh
Confidence            35799999999999999999999998 99999999999999999999999999997655443 34568999999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .+..++.++|+||+||++|+|++|..||.+...   ..............    ...+  ...+    ..+.+|+.+||+
T Consensus       364 ~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~---~~~~~i~~~i~~~~----~~~p--~~~S----~~a~dLI~~lL~  430 (689)
T 3v5w_A          364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT---KDKHEIDRMTLTMA----VELP--DSFS----PELRSLLEGLLQ  430 (689)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC---CCHHHHHHHHHHCC----CCCC--TTSC----HHHHHHHHHHTC
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhcCCC----CCCC--ccCC----HHHHHHHHHHcc
Confidence            456789999999999999999999999975322   22222222222211    1111  1222    358999999999


Q ss_pred             CCCCCCCC-----HHHHH
Q 048055          170 LAPENRPV-----MREVS  182 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~  182 (221)
                      .||.+|++     +.||+
T Consensus       431 ~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          431 RDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             SCGGGCTTCSSSTHHHHT
T ss_pred             CCHhHCCCCCCCCHHHHh
Confidence            99999997     67775

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=2.5e-31  Score=212.52  Aligned_cols=185  Identities=15%  Similarity=0.230  Sum_probs=138.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc-----eEEeccCCccccCCCC--------CCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE-----SCLTDYGLGSFRNPDS--------VEEPS   76 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~-----~~l~dfg~~~~~~~~~--------~~~~~   76 (221)
                      ++++++..+..++.||+.||.|||+. +++|+||||.||+++.++.     ++|+|||++.......        .....
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  178 (298)
T 1csn_A          100 GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL  178 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCC
Confidence            45699999999999999999999998 9999999999999987766     9999999987544322        12345


Q ss_pred             CCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           77 ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        77 ~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      .++..|+|||.+. +..++.++|+||||+++|++++|..||.....   .........+........     ........
T Consensus       179 ~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~  249 (298)
T 1csn_A          179 SGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKA---ATNKQKYERIGEKKQSTP-----LRELCAGF  249 (298)
T ss_dssp             CSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS---CCHHHHHHHHHHHHHHSC-----HHHHTTTS
T ss_pred             CCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHcCCCCcchhhc---cccHHHHHHHHhhccCcc-----HHHHHhhC
Confidence            6788999999886 66778999999999999999999999975321   122222222222211111     00000112


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCccc
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSD  208 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~  208 (221)
                      +..+.+++.+||+.||.+||++.+|++.|+++....    +.....+.+|+.
T Consensus       250 ~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~----~~~~~~~~dw~~  297 (298)
T 1csn_A          250 PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL----NTTEDENFDWNL  297 (298)
T ss_dssp             CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT----TCCSCSCCGGGC
T ss_pred             cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc----CCCCCCccccCC
Confidence            246999999999999999999999999999998754    344567788864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=6.8e-32  Score=222.19  Aligned_cols=185  Identities=19%  Similarity=0.313  Sum_probs=135.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc--CCCceEEeccCCccccCCCC--------CCCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG--ADFESCLTDYGLGSFRNPDS--------VEEPSATS   79 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~--~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~   79 (221)
                      .+.+++..++.++.||+.||.|||+. +++||||||.||+++  .++.++|+|||+++......        ......++
T Consensus       146 ~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt  224 (364)
T 3op5_A          146 AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT  224 (364)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCC
Confidence            46799999999999999999999998 999999999999999  88999999999986543221        11334588


Q ss_pred             ccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc----CCCCCCCChhhHH
Q 048055           80 LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES----GDDPPSSNEASEE  155 (221)
Q Consensus        80 ~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  155 (221)
                      +.|+|||.+. +..++.++|||||||++|+|++|..||......     ..............    ...+.....    
T Consensus       225 ~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~----  294 (364)
T 3op5_A          225 IEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-----PKYVRDSKIRYRENIASLMDKCFPAAN----  294 (364)
T ss_dssp             TTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-----HHHHHHHHHHHHHCHHHHHHHHSCTTC----
T ss_pred             CCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccC-----HHHHHHHHHHhhhhHHHHHHHhccccc----
Confidence            8999999887 667889999999999999999999999853211     11111111000000    000000011    


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCcccc
Q 048055          156 KLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDT  209 (221)
Q Consensus       156 ~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~~  209 (221)
                      .+..+.+++..||+.||.+||++.+|++.|+++.......    ...+.+|+..
T Consensus       295 ~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~----~~~~~dw~~~  344 (364)
T 3op5_A          295 APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK----DDGKLDLSVV  344 (364)
T ss_dssp             CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC----CCCCCCC---
T ss_pred             CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC----cCCccceEec
Confidence            1246999999999999999999999999999998865433    4456777654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=4.9e-31  Score=210.50  Aligned_cols=185  Identities=16%  Similarity=0.232  Sum_probs=138.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCC--------CCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDS--------VEEPSAT   78 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~   78 (221)
                      .+.+++..++.++.||+.||.|||+. +++|+||||.||++   +.++.++|+|||++.......        ......+
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  177 (296)
T 4hgt_A           99 SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  177 (296)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCC
Confidence            45789999999999999999999998 99999999999999   788999999999987543322        1234567


Q ss_pred             CccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           79 SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      +..|+|||.+. +..++.++|+||||+++|++++|..||............   ...........     ........+.
T Consensus       178 t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~  248 (296)
T 4hgt_A          178 TARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---ERISEKKMSTP-----IEVLCKGYPS  248 (296)
T ss_dssp             CGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH---HHHHHHHHHSC-----HHHHTTTSCH
T ss_pred             CccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh---hhhhcccccch-----hhhhhccCCH
Confidence            88999999887 667788999999999999999999999764332222221   11111111110     0000001124


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCccc
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSD  208 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~  208 (221)
                      .+.+++.+||+.||++||++.++++.|+++....+.    ....+.+|+.
T Consensus       249 ~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~----~~~~~~dw~~  294 (296)
T 4hgt_A          249 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF----SYDYVFDWNM  294 (296)
T ss_dssp             HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC----CTTCCCGGGG
T ss_pred             HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC----CccCccchhh
Confidence            699999999999999999999999999999986553    3455667764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=7.2e-31  Score=209.63  Aligned_cols=186  Identities=16%  Similarity=0.229  Sum_probs=139.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCCC--------CCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSV--------EEPSAT   78 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~   78 (221)
                      .+++++..++.++.||+.||.|||+. +++|+||||.||++   +.++.++|+|||++........        .....+
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~g  177 (296)
T 3uzp_A           99 SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  177 (296)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccc
Confidence            45799999999999999999999998 99999999999999   4888999999999875443321        234567


Q ss_pred             CccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           79 SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      +..|+|||.+. +..++.++|+||||+++|++++|..||............   ..+.........     .......+.
T Consensus       178 t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~  248 (296)
T 3uzp_A          178 TARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---ERISEKKMSTPI-----EVLCKGYPS  248 (296)
T ss_dssp             CTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH---HHHHHHHHHSCH-----HHHTTTSCH
T ss_pred             ccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh---hhhcccccCCch-----HHHHhhCCH
Confidence            88999999987 667788999999999999999999999754322222211   111111111100     000001124


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCcccc
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDT  209 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~~  209 (221)
                      .+.+++.+||+.||.+||++.+|++.|+++..+...+    ...+.+|+.+
T Consensus       249 ~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~----~~~~~dw~~~  295 (296)
T 3uzp_A          249 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS----YDYVFDWNML  295 (296)
T ss_dssp             HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC----SSCCCGGGGC
T ss_pred             HHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc----cccccccccc
Confidence            6999999999999999999999999999998765433    4556888764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=2.6e-30  Score=209.13  Aligned_cols=179  Identities=26%  Similarity=0.432  Sum_probs=137.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       133 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  211 (321)
T 2qkw_B          133 TMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE  211 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHH
Confidence            34689999999999999999999998 99999999999999999999999999986543221   123345688999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-CCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-GDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++|..||.............+........... ...+..........+..+.+++.
T Consensus       212 ~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  290 (321)
T 2qkw_B          212 YFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV  290 (321)
T ss_dssp             HHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred             Hhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHH
Confidence            886 5677899999999999999999999997654443444333322221111111 11112223345567788999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||++|||+.++++.|+.+..
T Consensus       291 ~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          291 KCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHHHHHHHhh
Confidence            9999999999999999999998875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=4.5e-31  Score=228.73  Aligned_cols=160  Identities=21%  Similarity=0.292  Sum_probs=126.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC--CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD--FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      ...|+...+..++.||+.||.|||++ +|+||||||+|||++.+  +.+||+|||+++............||+.|+|||.
T Consensus       249 ~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv  327 (573)
T 3uto_A          249 HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV  327 (573)
T ss_dssp             TSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHH
Confidence            45799999999999999999999998 99999999999999854  8899999999987765554455678999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++||||+||++|+|++|..||.+.      ........+.....    .++  ..........+.+|+.+|
T Consensus       328 ~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~------~~~~~~~~i~~~~~----~~~--~~~~~~~s~~~~dli~~~  394 (573)
T 3uto_A          328 AE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNVKSCDW----NMD--DSAFSGISEDGKDFIRKL  394 (573)
T ss_dssp             HT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTCC----CCC--SGGGTTSCHHHHHHHHTT
T ss_pred             hC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHhCCC----CCC--cccccCCCHHHHHHHHHH
Confidence            87 678899999999999999999999999742      22233333322111    111  111111224589999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.|+++
T Consensus       395 L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          395 LLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=8.9e-31  Score=214.54  Aligned_cols=188  Identities=17%  Similarity=0.237  Sum_probs=137.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC--ceEEeccCCccccCCCC--------CCCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF--ESCLTDYGLGSFRNPDS--------VEEPSATS   79 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~   79 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++  .++|+|||+++......        ......++
T Consensus       153 ~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  231 (352)
T 2jii_A          153 KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD  231 (352)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCC
Confidence            36799999999999999999999998 999999999999999998  89999999986543221        12334678


Q ss_pred             ccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           80 LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        80 ~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      +.|+|||.+. +..++.++|+||||+++|++++|..||.....    ......... ....................+..
T Consensus       232 ~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  305 (352)
T 2jii_A          232 LEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP----NTEDIMKQK-QKFVDKPGPFVGPCGHWIRPSET  305 (352)
T ss_dssp             TTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT----CHHHHHHHH-HHHHHSCCCEECTTSCEECCCHH
T ss_pred             ccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCCc----CHHHHHHHH-HhccCChhhhhhhccccCCCcHH
Confidence            8999999886 56778899999999999999999999975421    111111111 11111111111000000011246


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCccc
Q 048055          160 LLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSD  208 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~  208 (221)
                      +.+|+.+||+.||.+||++.+|++.|+++.....    .....+.+|..
T Consensus       306 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~----~~~~~~~dw~~  350 (352)
T 2jii_A          306 LQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR----VSPYDPIGLPM  350 (352)
T ss_dssp             HHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT----CCTTSCCCCCC
T ss_pred             HHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC----CCcCccccCcC
Confidence            9999999999999999999999999999987654    33455677764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=8.5e-31  Score=209.69  Aligned_cols=173  Identities=26%  Similarity=0.434  Sum_probs=128.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhc--------CCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----CCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIH--------QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----EEPS   76 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH--------~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~   76 (221)
                      ...+++..++.++.||+.||.|||        +. +++|+||||.||+++.++.++|+|||+++.......     ....
T Consensus        99 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  177 (301)
T 3q4u_A           99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR  177 (301)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCC
T ss_pred             hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccc
Confidence            357899999999999999999999        87 999999999999999999999999999865433221     2334


Q ss_pred             CCCccccCcccchhcC-----CCCCcccchHHHHHHHHHHhC----------CCCCcccccccCCChHHHHHHhhhhhhc
Q 048055           77 ATSLFYKAPECREIWK-----QPTQQADVYSFGVLLLELLTG----------KTPFQDLVLEHGSDIPRWVRSVREEETE  141 (221)
Q Consensus        77 ~~~~~~~~pe~~~~~~-----~~~~~~di~slG~~l~~~~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~  141 (221)
                      .+++.|+|||.+....     .++.++||||||+++|+|++|          ..||...... ....... ...   ...
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~-~~~~~~~-~~~---~~~  252 (301)
T 3q4u_A          178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN-DPSFEDM-RKV---VCV  252 (301)
T ss_dssp             CCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS-SCCHHHH-HHH---HTT
T ss_pred             ccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC-Ccchhhh-hHH---Hhc
Confidence            6788999999876322     223589999999999999999          8888654322 1111111 111   111


Q ss_pred             cCCCCC-CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          142 SGDDPP-SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       142 ~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      ....+. .........+..+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            111221 12223445667899999999999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=3.4e-30  Score=207.72  Aligned_cols=166  Identities=27%  Similarity=0.406  Sum_probs=120.8

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      .+++..++.++.||+.||+|||+. +  ++|+||||.||+++.++.++|+|||+++...... ......++..|+|||.+
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  211 (309)
T 3p86_A          133 QLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL  211 (309)
T ss_dssp             HSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhh
Confidence            489999999999999999999998 8  9999999999999999999999999986543322 23345678899999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||...      ...........    .......+...+    ..+.+|+.+||
T Consensus       212 ~-~~~~~~~~DiwslG~il~elltg~~Pf~~~------~~~~~~~~~~~----~~~~~~~~~~~~----~~l~~li~~~l  276 (309)
T 3p86_A          212 R-DEPSNEKSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVGF----KCKRLEIPRNLN----PQVAAIIEGCW  276 (309)
T ss_dssp             T-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTS------CHHHHHHHHHH----SCCCCCCCTTSC----HHHHHHHHHHT
T ss_pred             c-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHh----cCCCCCCCccCC----HHHHHHHHHHc
Confidence            7 667789999999999999999999999643      22222222211    111111122222    35899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          169 SLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      +.||.+|||+.++++.|+.+.....
T Consensus       277 ~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          277 TNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             cCChhhCcCHHHHHHHHHHHHHhCC
Confidence            9999999999999999999886543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=3.1e-30  Score=209.64  Aligned_cols=156  Identities=24%  Similarity=0.328  Sum_probs=125.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ++++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++.............+++.|+|||.+. 
T Consensus       109 ~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-  186 (328)
T 3fe3_A          109 GRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ-  186 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHH-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCccccc-
Confidence            5689999999999999999999998 99999999999999999999999999997665554455667899999999887 


Q ss_pred             cCCC-CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~-~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +..+ +.++|+||+||++|+|++|..||.+.      ........+......    .+  ...+    ..+.+|+.+||+
T Consensus       187 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~----~p--~~~s----~~~~~li~~~L~  250 (328)
T 3fe3_A          187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------NLKELRERVLRGKYR----IP--FYMS----TDCENLLKRFLV  250 (328)
T ss_dssp             TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC----CC--TTSC----HHHHHHHHHHCC
T ss_pred             CCCcCCchhhhhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC----CC--CCCC----HHHHHHHHHHCC
Confidence            4444 57899999999999999999999742      333333333332211    11  1122    358899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .||.+|||+.++++.
T Consensus       251 ~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          251 LNPIKRGTLEQIMKD  265 (328)
T ss_dssp             SSTTTSCCHHHHTTC
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=5.8e-30  Score=207.89  Aligned_cols=185  Identities=16%  Similarity=0.200  Sum_probs=139.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc-----eEEeccCCccccCCCCC--------CCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE-----SCLTDYGLGSFRNPDSV--------EEPS   76 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~-----~~l~dfg~~~~~~~~~~--------~~~~   76 (221)
                      ++.+++..++.++.||+.||.|||+. +++||||||+||+++.++.     ++|+|||+++.......        ....
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~  177 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL  177 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCc
Confidence            46799999999999999999999998 9999999999999998887     99999999975433221        2355


Q ss_pred             CCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           77 ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        77 ~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      .+++.|+|||.+. +..++.++|+||||+++|+|++|..||....   ..........+.........     .......
T Consensus       178 ~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~---~~~~~~~~~~i~~~~~~~~~-----~~~~~~~  248 (330)
T 2izr_A          178 TGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLK---ADTLKERYQKIGDTKRATPI-----EVLCENF  248 (330)
T ss_dssp             CSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CSSHHHHHHHHHHHHHHSCH-----HHHTTTC
T ss_pred             CCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccc---cccHHHHHHHHHhhhccCCH-----HHHhccC
Confidence            7789999999987 6777889999999999999999999997542   22233333333222211110     0000011


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCcccc
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDT  209 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~~  209 (221)
                      + .+.+++..||+.||.+||++.+|++.|+++....+..    .....+|...
T Consensus       249 p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~----~~~~~dw~~~  296 (330)
T 2izr_A          249 P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM----FDYEYDWIGK  296 (330)
T ss_dssp             H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC----CSCCCTTTTS
T ss_pred             h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC----CCCCccCCCC
Confidence            2 6999999999999999999999999999888765433    2345677643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=6.1e-30  Score=205.91  Aligned_cols=169  Identities=21%  Similarity=0.387  Sum_probs=129.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC---------------C
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE---------------E   74 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---------------~   74 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.........               .
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (310)
T 3s95_A          102 DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY  180 (310)
T ss_dssp             CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------C
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccccc
Confidence            46789999999999999999999998 9999999999999999999999999998754332211               1


Q ss_pred             CCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhH
Q 048055           75 PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE  154 (221)
Q Consensus        75 ~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (221)
                      ...+++.|+|||.+. +..++.++||||||+++|++++|..||.............. .......  ....         
T Consensus       181 ~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~---------  247 (310)
T 3s95_A          181 TVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDRY--CPPN---------  247 (310)
T ss_dssp             CCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHHT--CCTT---------
T ss_pred             ccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hcccccc--CCCC---------
Confidence            456788999999987 67788999999999999999999999875432221111111 1111110  0111         


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          155 EKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       155 ~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                       .+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       248 -~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          248 -CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             -CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence             11258999999999999999999999999999887644

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.3e-29  Score=209.89  Aligned_cols=171  Identities=22%  Similarity=0.333  Sum_probs=134.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++......   ......++..|+||
T Consensus       184 ~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          184 PEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            356799999999999999999999998 99999999999999999999999999987554322   22334556789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++||||||+++|++++ |..||...      ........+....     ....+..++    ..+.+|+
T Consensus       263 E~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li  326 (382)
T 3tt0_A          263 EALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGH-----RMDKPSNCT----NELYMMM  326 (382)
T ss_dssp             HHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHTTC-----CCCCCSSCC----HHHHHHH
T ss_pred             HHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcCC-----CCCCCccCC----HHHHHHH
Confidence            9886 6778889999999999999999 99999643      2223333332211     111122222    3599999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHhhcCC
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEAQMSS  196 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~  196 (221)
                      .+||+.||.+||++.+|++.|+++........
T Consensus       327 ~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          327 RDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999987654333

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=1e-29  Score=209.79  Aligned_cols=165  Identities=21%  Similarity=0.354  Sum_probs=130.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.||+++.++.+||+|||+++......   ......+++.|+|||
T Consensus       197 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  275 (370)
T 2psq_A          197 EEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  275 (370)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence            45689999999999999999999998 99999999999999999999999999987544322   123345567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+|||||++|+|++ |..||....      .......+...     ..+..+..++    ..+.+++.
T Consensus       276 ~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~  339 (370)
T 2psq_A          276 ALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLKEG-----HRMDKPANCT----NELYMMMR  339 (370)
T ss_dssp             HHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------GGGHHHHHHTT-----CCCCCCTTSC----HHHHHHHH
T ss_pred             Hhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcC-----CCCCCCCCCC----HHHHHHHH
Confidence            886 6778899999999999999999 999997532      22222222211     1112122222    46999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+||++.++++.|+++...
T Consensus       340 ~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          340 DCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=4.7e-30  Score=208.43  Aligned_cols=165  Identities=22%  Similarity=0.366  Sum_probs=124.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...++...++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.......   .....++..|+|||
T Consensus       111 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3lzb_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHH
Confidence            45689999999999999999999998 999999999999999999999999999876543221   22334566899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....      ......+..     ....+.....+    ..+.+++.
T Consensus       190 ~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~-----~~~~~~~~~~~----~~l~~li~  253 (327)
T 3lzb_A          190 SIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSILEK-----GERLPQPPICT----IDVYMIMR  253 (327)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHHHHT-----TCCCCCCTTBC----HHHHHHHH
T ss_pred             HHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHc-----CCCCCCCccCC----HHHHHHHH
Confidence            887 6778899999999999999999 9999975322      112222211     11122222233    35899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+||++.++++.|+++...
T Consensus       254 ~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          254 KCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            99999999999999999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=5.1e-30  Score=207.66  Aligned_cols=181  Identities=24%  Similarity=0.338  Sum_probs=130.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCC---------CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQN---------PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSAT   78 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~---------~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~   78 (221)
                      +.+++..++.++.|++.||.|||+.         .+++|+||||.||+++.++.+||+|||+++......   ......+
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  195 (322)
T 3soc_A          116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG  195 (322)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCcc
Confidence            4589999999999999999999984         189999999999999999999999999996544322   2233567


Q ss_pred             CccccCcccchhc----CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHH------HHHhhhhhhccCCCCCC
Q 048055           79 SLFYKAPECREIW----KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRW------VRSVREEETESGDDPPS  148 (221)
Q Consensus        79 ~~~~~~pe~~~~~----~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~  148 (221)
                      ++.|+|||.+...    ..++.++|||||||++|++++|..||..............      ...+..........+..
T Consensus       196 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (322)
T 3soc_A          196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL  275 (322)
T ss_dssp             CGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             CccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCc
Confidence            8999999987632    2334577999999999999999999975433222111110      01111111111112211


Q ss_pred             CC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          149 SN-EASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       149 ~~-~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .. .........+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          276 RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11 12234456799999999999999999999999999998764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=7e-30  Score=205.40  Aligned_cols=165  Identities=19%  Similarity=0.258  Sum_probs=125.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.||+.||+|||+. +++|+||||.||+++.++.++|+|||++.............+++.|+|||.+. 
T Consensus       115 ~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-  192 (308)
T 3g33_A          115 PGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL-  192 (308)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHc-
Confidence            4489999999999999999999998 99999999999999999999999999997665554445567789999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-CCC----------------CCCChhh
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-DDP----------------PSSNEAS  153 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----------------~~~~~~~  153 (221)
                      +..++.++|+|||||++|+|++|..||...      ........+........ ...                .......
T Consensus       193 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (308)
T 3g33_A          193 QSTYATPVDMWSVGCIFAEMFRRKPLFCGN------SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVV  266 (308)
T ss_dssp             TSCCCSTHHHHHHHHHHHHTTTSSCSCCCS------SHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHS
T ss_pred             CCCCCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhC
Confidence            677889999999999999999999999642      22222222222111100 000                0000111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.....+.+|+.+||+.||.+|||+.++++
T Consensus       267 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          267 PEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            122356899999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=7.9e-30  Score=203.81  Aligned_cols=174  Identities=22%  Similarity=0.354  Sum_probs=126.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+|||
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  187 (295)
T 3ugc_A          109 ERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE  187 (295)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcH
Confidence            4589999999999999999999998 99999999999999999999999999987654322    122334566799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccc------cCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE------HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      .+. +..++.++||||||+++|++++|..||......      ............... .......+.+..++    ..+
T Consensus       188 ~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~l  261 (295)
T 3ugc_A          188 SLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCP----DEI  261 (295)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH-HHTTCCCCCCTTCC----HHH
T ss_pred             Hhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH-HhccCcCCCCcCcC----HHH
Confidence            887 677889999999999999999999988642211      000000001111111 11112222222333    469


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+++.+||+.||.+|||+.++++.|+++.++
T Consensus       262 ~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          262 YMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999998765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=2.4e-29  Score=213.23  Aligned_cols=165  Identities=19%  Similarity=0.263  Sum_probs=120.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||+|||+. +++||||||.||+++.++.+||+|||+++............+++.|+|||.+. 
T Consensus       159 ~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-  236 (464)
T 3ttj_A          159 MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-  236 (464)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHT-
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHc-
Confidence            3488999999999999999999998 99999999999999999999999999997765554455667899999999987 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc-------------------cC--------
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE-------------------SG--------  143 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~--------  143 (221)
                      +..++.++||||+||++|+|++|..||.+..      .......+......                   ..        
T Consensus       237 ~~~~~~~~DiwSlG~il~ell~g~~pF~g~~------~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (464)
T 3ttj_A          237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD------YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  310 (464)
T ss_dssp             TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChH
Confidence            6788899999999999999999999997432      11111111111000                   00        


Q ss_pred             -----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          144 -----DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       144 -----~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                           ...+............+.+|+.+||+.||.+|||+.|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0011111222223567999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=2.7e-29  Score=213.63  Aligned_cols=174  Identities=17%  Similarity=0.282  Sum_probs=132.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCCC--------CCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSV--------EEPSAT   78 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~   78 (221)
                      .+.+++..++.++.||+.||.|||+. +|+|+||||.|||+   +.++.++|+|||+++.......        .....+
T Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g  175 (483)
T 3sv0_A           97 SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG  175 (483)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCC
Confidence            46799999999999999999999998 99999999999999   5889999999999875443221        124567


Q ss_pred             CccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           79 SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      +..|++||.+. +..++.++|||||||++|+|++|..||.....   ......+..+........     ........+.
T Consensus       176 t~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~i~~~~~~~~-----~~~l~~~~p~  246 (483)
T 3sv0_A          176 TARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA---GTKKQKYEKISEKKVATS-----IEALCRGYPT  246 (483)
T ss_dssp             CTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC---SSHHHHHHHHHHHHHHSC-----HHHHHTTSCH
T ss_pred             CccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccc---hhHHHHHHHHhhcccccc-----HHHHhcCCcH
Confidence            88999999987 67788999999999999999999999975321   122222222222211110     0000011224


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      .+.+|+.+||+.+|++||++.+|++.|+++.....
T Consensus       247 ~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          247 EFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            69999999999999999999999999999876543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=1.1e-29  Score=202.58  Aligned_cols=171  Identities=23%  Similarity=0.395  Sum_probs=119.6

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++......   .......++..|+||
T Consensus       113 ~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (289)
T 3og7_A          113 SETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP  191 (289)
T ss_dssp             C---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCc
Confidence            356789999999999999999999998 9999999999999999999999999998654321   122344678899999


Q ss_pred             ccch--hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           86 ECRE--IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        86 e~~~--~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      |.+.  ....++.++|+||||+++|++++|..||...     .............. ....    ........+..+.+|
T Consensus       192 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~l~~l  261 (289)
T 3og7_A          192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NNRDQIIEMVGRGS-LSPD----LSKVRSNCPKRMKRL  261 (289)
T ss_dssp             HHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC-----CCHHHHHHHHHHTS-CCCC----TTSSCTTSCHHHHHH
T ss_pred             hhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc-----chHHHHHHHhcccc-cCcc----hhhccccCCHHHHHH
Confidence            9764  1345577899999999999999999999642     22222222222211 1111    111111223469999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +.+||+.||.+||++.++++.|+++..
T Consensus       262 i~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          262 MAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            999999999999999999999998753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=8.5e-30  Score=206.79  Aligned_cols=165  Identities=22%  Similarity=0.377  Sum_probs=128.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++.......   .....++..|+|||
T Consensus       111 ~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3poz_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChH
Confidence            45789999999999999999999998 999999999999999999999999999876543321   12334567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....      ......+..     ....+....++    ..+.+++.
T Consensus       190 ~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~-----~~~~~~~~~~~----~~~~~li~  253 (327)
T 3poz_A          190 SIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSILEK-----GERLPQPPICT----IDVYMIMV  253 (327)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHHHHT-----TCCCCCCTTBC----HHHHHHHH
T ss_pred             Hhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH------HHHHHHHHc-----CCCCCCCccCC----HHHHHHHH
Confidence            987 6778899999999999999999 9999974322      111122211     11112222222    35899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+||++.++++.|+.+...
T Consensus       254 ~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          254 KCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999987654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4e-29  Score=202.95  Aligned_cols=177  Identities=25%  Similarity=0.362  Sum_probs=129.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCC-------CceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----CCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNP-------GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----EEPSAT   78 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~-------~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~   78 (221)
                      ..+++..++.++.|++.||.|||+..       +++|+||||.||+++.++.++|+|||++........     .....+
T Consensus       129 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g  208 (337)
T 3mdy_A          129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG  208 (337)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence            46899999999999999999999841       899999999999999999999999999865433221     124567


Q ss_pred             CccccCcccchhcCCCCCc------ccchHHHHHHHHHHhC----------CCCCcccccccCCChHHHHHHhhhhhhcc
Q 048055           79 SLFYKAPECREIWKQPTQQ------ADVYSFGVLLLELLTG----------KTPFQDLVLEHGSDIPRWVRSVREEETES  142 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~------~di~slG~~l~~~~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  142 (221)
                      +..|+|||.+. +......      +|||||||++|+|++|          ..||....... ...... ...   ....
T Consensus       209 t~~y~aPE~~~-~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~-~~~~~~-~~~---~~~~  282 (337)
T 3mdy_A          209 TKRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD-PSYEDM-REI---VCIK  282 (337)
T ss_dssp             CGGGCCHHHHT-TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-CCHHHH-HHH---HTTS
T ss_pred             CcceeChhhcc-cccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC-Cchhhh-HHH---Hhhh
Confidence            88999999876 4444443      8999999999999999          66765432221 111111 111   1111


Q ss_pred             CCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          143 GDDPPSS-NEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       143 ~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      ...+..+ .......+..+.+|+.+||+.||.+|||+.++++.|+++....+
T Consensus       283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            1111111 22233566789999999999999999999999999999987644

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.96  E-value=1.9e-29  Score=204.10  Aligned_cols=168  Identities=20%  Similarity=0.343  Sum_probs=123.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++......   ......+++.|+|||
T Consensus       131 ~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          131 PFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence            34689999999999999999999998 99999999999999999999999999987543322   112334566899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....      ......+....     ........+    ..+.+++.
T Consensus       210 ~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~  273 (323)
T 3qup_A          210 SLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------AEIYNYLIGGN-----RLKQPPECM----EEVYDLMY  273 (323)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHHHHTTC-----CCCCCTTCC----HHHHHHHH
T ss_pred             hhc-CCCCCCccchhhHHHHHHHHHhCCCCCccccCh------HHHHHHHhcCC-----CCCCCCccC----HHHHHHHH
Confidence            886 6778899999999999999999 9999974321      12222221111     111122222    35999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHHhhc
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAEAQM  194 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~~~~  194 (221)
                      +||+.||.+|||+.++++.|+++......
T Consensus       274 ~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          274 QCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            99999999999999999999998876443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=2.5e-29  Score=203.78  Aligned_cols=165  Identities=23%  Similarity=0.407  Sum_probs=127.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++......   ......++..|+|||
T Consensus       109 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  187 (325)
T 3kex_A          109 RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE  187 (325)
T ss_dssp             GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChH
Confidence            35789999999999999999999998 99999999999999999999999999997654332   223345667899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||....      .......+....     ....+..++    ..+.+++.
T Consensus       188 ~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~-----~~~~~~~~~----~~~~~li~  251 (325)
T 3kex_A          188 SIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR------LAEVPDLLEKGE-----RLAQPQICT----IDVYMVMV  251 (325)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------TTHHHHHHHTTC-----BCCCCTTBC----TTTTHHHH
T ss_pred             Hhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccC------HHHHHHHHHcCC-----CCCCCCcCc----HHHHHHHH
Confidence            987 6778899999999999999999 999997432      122222222211     111111122    24889999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+||++.++++.|+++...
T Consensus       252 ~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          252 KCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             HHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999988654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=1.9e-29  Score=206.17  Aligned_cols=170  Identities=21%  Similarity=0.335  Sum_probs=125.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC--ceEEeccCCccccCCCC--------CCCCCCCCc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF--ESCLTDYGLGSFRNPDS--------VEEPSATSL   80 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~   80 (221)
                      +.+++..++.++.||+.||.|||+. +++|+||||.||+++.++  .++|+|||+++......        ......++.
T Consensus       146 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~  224 (345)
T 2v62_A          146 GTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI  224 (345)
T ss_dssp             GBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCc
Confidence            3789999999999999999999998 999999999999999887  99999999986543221        113446788


Q ss_pred             cccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChh--hHHHHH
Q 048055           81 FYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA--SEEKLQ  158 (221)
Q Consensus        81 ~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  158 (221)
                      .|+|||.+. +..++.++|+||||+++|++++|..||.....    ..... ...........  +......  ....+.
T Consensus       225 ~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~  296 (345)
T 2v62_A          225 EFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLK----DPVAV-QTAKTNLLDEL--PQSVLKWAPSGSSCC  296 (345)
T ss_dssp             TTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----CHHHH-HHHHHHHHHTT--THHHHHHSCTTSCCH
T ss_pred             cccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCcccccc----ccHHH-HHHHHhhcccc--cHHHHhhccccccHH
Confidence            999999887 66778999999999999999999999964211    11111 11111111000  0000000  001224


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      .+.+++.+||+.||++||++.+|++.|++..
T Consensus       297 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          297 EIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            6999999999999999999999999998865

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.9e-29  Score=204.59  Aligned_cols=181  Identities=20%  Similarity=0.331  Sum_probs=138.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............++..|+|||.+.
T Consensus       136 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  214 (327)
T 1fvr_A          136 ASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  214 (327)
T ss_dssp             SCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhc
Confidence            46789999999999999999999998 99999999999999999999999999986443322233345567899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       +..++.++|+||||+++|++++ |..||...      ........+...     .........+    ..+.+++.+||
T Consensus       215 -~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~~~l  278 (327)
T 1fvr_A          215 -YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQG-----YRLEKPLNCD----DEVYDLMRQCW  278 (327)
T ss_dssp             -HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHGGGT-----CCCCCCTTBC----HHHHHHHHHHT
T ss_pred             -cccCCchhcchHHHHHHHHHHcCCCCCCCCC------cHHHHHHHhhcC-----CCCCCCCCCC----HHHHHHHHHHc
Confidence             5667889999999999999998 99999642      222333332221     1111122222    35899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCcc
Q 048055          169 SLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWS  207 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~  207 (221)
                      +.||.+||++.++++.|+++..+.....+........+.
T Consensus       279 ~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~  317 (327)
T 1fvr_A          279 REKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA  317 (327)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCCC
T ss_pred             cCChhhCcCHHHHHHHHHHHHHhhcCccccchhccCCcC
Confidence            999999999999999999999877666665555555444

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.6e-29  Score=202.70  Aligned_cols=158  Identities=20%  Similarity=0.371  Sum_probs=123.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++...+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++....... ......+++.|+|||.+.
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  189 (297)
T 3fxz_A          111 TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  189 (297)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhc
Confidence            3588999999999999999999998 99999999999999999999999999986654332 334557889999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|+|++|..||...      ..............   .....+..    ....+.+++.+||+
T Consensus       190 -~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~li~~~l~  255 (297)
T 3fxz_A          190 -RKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNGT---PELQNPEK----LSAIFRDFLNRCLE  255 (297)
T ss_dssp             -CSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHHCS---CCCSCGGG----SCHHHHHHHHHHSC
T ss_pred             -CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCC---CCCCCccc----cCHHHHHHHHHHcc
Confidence             677889999999999999999999999642      22222222211111   11111122    22468999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+|||+.++++
T Consensus       256 ~dp~~Rps~~ell~  269 (297)
T 3fxz_A          256 MDVEKRGSAKELLQ  269 (297)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhh
Confidence            99999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=5.1e-29  Score=201.34  Aligned_cols=174  Identities=20%  Similarity=0.190  Sum_probs=132.4

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE----cCCCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL----GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .+++..++.++.||+.||.|||+. +++|+||||.||++    +.++.++|+|||+++............++..|+|||.
T Consensus       108 ~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  186 (319)
T 4euu_A          108 GLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM  186 (319)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHH
Confidence            489999999999999999999998 99999999999999    7788899999999977655554455678899999998


Q ss_pred             chh-------cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc---------------CCC
Q 048055           88 REI-------WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES---------------GDD  145 (221)
Q Consensus        88 ~~~-------~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~  145 (221)
                      +..       +..++.++|+|||||++|++++|..||......  .........+.......               ...
T Consensus       187 ~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  264 (319)
T 4euu_A          187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD  264 (319)
T ss_dssp             HHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG--GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESS
T ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--chhHHHHHHHhcCCCcccchhhhcccCCccccCcc
Confidence            652       356688999999999999999999999743211  11122222222211100               012


Q ss_pred             CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          146 PPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       146 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+............+.+++.+||+.||++|||+.|+++...+.
T Consensus       265 ~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          265 MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            2233345566777899999999999999999999998876643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=2.3e-29  Score=203.83  Aligned_cols=179  Identities=28%  Similarity=0.526  Sum_probs=134.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCC--CceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNP--GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKA   84 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~--~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~   84 (221)
                      ...++++..+..++.|++.||.|||+..  +++|+||||.||+++.++.++|+|||++.......  ......++..|+|
T Consensus       124 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a  203 (326)
T 3uim_A          124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA  203 (326)
T ss_dssp             TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCC
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccC
Confidence            4556999999999999999999999952  89999999999999999999999999987654322  2233457889999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc--CCChHHHHHHhhhhhhcc-CCCCCCCChhhHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH--GSDIPRWVRSVREEETES-GDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~  161 (221)
                      ||.+. +..++.++|+||||+++|++++|..||.......  ......+........... .................+.
T Consensus       204 PE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  282 (326)
T 3uim_A          204 PEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI  282 (326)
T ss_dssp             HHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHH
T ss_pred             HHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHH
Confidence            99886 5667889999999999999999999996332111  111222222211111111 1111222344566778899


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +++.+||+.||.+|||+.+|++.|+..
T Consensus       283 ~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          283 QVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            999999999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=6.7e-29  Score=202.50  Aligned_cols=155  Identities=22%  Similarity=0.291  Sum_probs=123.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........+++.|+|||.+.
T Consensus       100 ~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  178 (337)
T 1o6l_A          100 RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhc
Confidence            5689999999999999999999998 999999999999999999999999999875432 23344567889999999986


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|+|++|..||...      ........+....    ...+  ...+    ..+.+|+.+||+
T Consensus       179 -~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~----~~~p--~~~s----~~~~~li~~lL~  241 (337)
T 1o6l_A          179 -DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEE----IRFP--RTLS----PEAKSLLAGLLK  241 (337)
T ss_dssp             -SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC----CCCC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCCCchhhcccchhHHHHHhcCCCCCCCC------CHHHHHHHHHcCC----CCCC--CCCC----HHHHHHHHHHhh
Confidence             677889999999999999999999999642      2223333332211    1111  1222    358999999999


Q ss_pred             CCCCCCC-----CHHHHHH
Q 048055          170 LAPENRP-----VMREVSK  183 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~  183 (221)
                      .||.+||     ++.++++
T Consensus       242 ~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHT
T ss_pred             cCHHHhcCCCCCCHHHHHc
Confidence            9999999     8999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=2.7e-29  Score=203.79  Aligned_cols=165  Identities=21%  Similarity=0.410  Sum_probs=127.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+||
T Consensus       145 ~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          145 DGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCH
Confidence            45789999999999999999999998 99999999999999999999999999987654322    11223346679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++||||||+++|++++ |..||...      ........+...     ...+....++    ..+.+|+
T Consensus       224 E~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li  287 (325)
T 3kul_A          224 EAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNM------TNRDVISSVEEG-----YRLPAPMGCP----HALHQLM  287 (325)
T ss_dssp             HHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHHHHHTT-----CCCCCCTTCC----HHHHHHH
T ss_pred             hHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccC------CHHHHHHHHHcC-----CCCCCCCCcC----HHHHHHH
Confidence            9886 5677889999999999999998 99999643      222222222221     1222222233    4699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||.+||++.+|++.|+.+...
T Consensus       288 ~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          288 LDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=2.7e-29  Score=199.48  Aligned_cols=167  Identities=22%  Similarity=0.402  Sum_probs=121.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++........  .....+++.|+|||.
T Consensus       110 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (281)
T 1mp8_A          110 KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES  188 (281)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhh
Confidence            34689999999999999999999998 999999999999999999999999999876543321  123345668999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||.....      ......+...     ...+....++    ..+.+++.+
T Consensus       189 ~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~------~~~~~~i~~~-----~~~~~~~~~~----~~l~~li~~  252 (281)
T 1mp8_A          189 IN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENG-----ERLPMPPNCP----PTLYSLMTK  252 (281)
T ss_dssp             HH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHHHHTT-----CCCCCCTTCC----HHHHHHHHH
T ss_pred             cc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH------HHHHHHHHcC-----CCCCCCCCCC----HHHHHHHHH
Confidence            86 6777889999999999999996 9999974321      1222222211     1111122222    468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      ||+.||.+||++.++++.|+++..+.+
T Consensus       253 ~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          253 CWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            999999999999999999999887654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=1.2e-29  Score=209.85  Aligned_cols=164  Identities=21%  Similarity=0.401  Sum_probs=127.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe~   87 (221)
                      ..+++..++.++.||+.||+|||+. +++|+||||.||+++.++.+||+|||+++.......   .....++..|+|||.
T Consensus       208 ~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~  286 (377)
T 3cbl_A          208 ARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA  286 (377)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhH
Confidence            4689999999999999999999998 999999999999999999999999999865432211   112234567999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||....      .......+..     ...++.+..++    ..+.+||.+
T Consensus       287 ~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~~~----~~l~~li~~  350 (377)
T 3cbl_A          287 LN-YGRYSSESDVWSFGILLWETFSLGASPYPNLS------NQQTREFVEK-----GGRLPCPELCP----DAVFRLMEQ  350 (377)
T ss_dssp             HH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC------HHHHHHHHHT-----TCCCCCCTTCC----HHHHHHHHH
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-----CCCCCCCCCCC----HHHHHHHHH
Confidence            86 5667889999999999999998 999997432      2222222211     12222222233    468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ||+.||++|||+.+|++.|+++...
T Consensus       351 cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          351 CWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCchhCcCHHHHHHHHHHHHhh
Confidence            9999999999999999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=204.68  Aligned_cols=154  Identities=21%  Similarity=0.213  Sum_probs=118.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............+++.|+|||.+.
T Consensus       151 ~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  229 (311)
T 3p1a_A          151 GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ  229 (311)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhc
Confidence            35699999999999999999999998 99999999999999999999999999987665554445567889999999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       + .++.++||||||+++|++++|..+|....         ....+...     ..   ...........+.+++.+||+
T Consensus       230 -~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~-----~~---~~~~~~~~~~~l~~li~~~L~  290 (311)
T 3p1a_A          230 -G-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQG-----YL---PPEFTAGLSSELRSVLVMMLE  290 (311)
T ss_dssp             -T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTT-----CC---CHHHHTTSCHHHHHHHHHHSC
T ss_pred             -C-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhcc-----CC---CcccccCCCHHHHHHHHHHcC
Confidence             3 67899999999999999999976664321         01111110     00   111111223569999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||++|||+.++++
T Consensus       291 ~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          291 PDPKLRATAEALLA  304 (311)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CChhhCcCHHHHHh
Confidence            99999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=206.16  Aligned_cols=167  Identities=21%  Similarity=0.297  Sum_probs=114.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC-------------C
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE-------------E   74 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-------------~   74 (221)
                      .+++++..++.++.||+.||.|||+. +  ++|+||||.||+++.++.++|+|||++.........             .
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  208 (337)
T 3ll6_A          130 RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI  208 (337)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhc
Confidence            45799999999999999999999998 8  999999999999999999999999998765432211             1


Q ss_pred             CCCCCccccCcccch--hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChh
Q 048055           75 PSATSLFYKAPECRE--IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEA  152 (221)
Q Consensus        75 ~~~~~~~~~~pe~~~--~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (221)
                      ...+++.|+|||.+.  .+..++.++||||||+++|++++|..||......      .    .....    ...+.....
T Consensus       209 ~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~----~~~~~----~~~~~~~~~  274 (337)
T 3ll6_A          209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------R----IVNGK----YSIPPHDTQ  274 (337)
T ss_dssp             ---------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------------------CCCCTTCCS
T ss_pred             cccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH------H----hhcCc----ccCCccccc
Confidence            334778899999873  2455678999999999999999999999642111      0    00100    011111111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcC
Q 048055          153 SEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMS  195 (221)
Q Consensus       153 ~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~  195 (221)
                      +    ..+.+|+.+||+.||.+||++.++++.|+.+.......
T Consensus       275 ~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          275 Y----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             S----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             c----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence            1    24889999999999999999999999999998765433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=6.6e-29  Score=197.61  Aligned_cols=164  Identities=26%  Similarity=0.478  Sum_probs=124.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEcCCCc-----eEEeccCCccccCCCCCCCCCCCCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLGADFE-----SCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      ..++++..++.++.|++.||.|||+. +  ++|+||||.||+++.++.     ++|+|||+++.....  .....++..|
T Consensus       116 ~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y  192 (287)
T 4f0f_A          116 AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQW  192 (287)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTT
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccc
Confidence            45789999999999999999999998 8  999999999999988776     999999998643332  2345678899


Q ss_pred             cCcccchh-cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           83 KAPECREI-WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        83 ~~pe~~~~-~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      +|||.+.. ...++.++|+||||+++|++++|..||.....    ...........    ....+.....++    ..+.
T Consensus       193 ~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~----~~~~~~~~~~~~----~~l~  260 (287)
T 4f0f_A          193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----GKIKFINMIRE----EGLRPTIPEDCP----PRLR  260 (287)
T ss_dssp             SCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----CHHHHHHHHHH----SCCCCCCCTTSC----HHHH
T ss_pred             cCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----cHHHHHHHHhc----cCCCCCCCcccC----HHHH
Confidence            99998731 34457789999999999999999999974321    11111121111    111111122222    4699


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      +++.+||+.||.+|||+.++++.|+++
T Consensus       261 ~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          261 NVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=3.1e-29  Score=205.45  Aligned_cols=166  Identities=22%  Similarity=0.342  Sum_probs=128.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||+|||+. +++|+||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE  265 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  265 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChh
Confidence            44599999999999999999999998 99999999999999999999999999987543322   223345677899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++||||||+++|+|++ |..||.....     .......+...     .....+...+    ..+.+++.
T Consensus       266 ~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~  330 (359)
T 3vhe_A          266 TIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCRRLKEG-----TRMRAPDYTT----PEMYQTML  330 (359)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-----SHHHHHHHHHT-----CCCCCCTTCC----HHHHHHHH
T ss_pred             hhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-----hHHHHHHHHcC-----CCCCCCCCCC----HHHHHHHH
Confidence            887 6778899999999999999998 9999975321     11111222111     1111112222    35899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+|||+.++++.|+++...
T Consensus       331 ~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=9.4e-30  Score=207.43  Aligned_cols=156  Identities=21%  Similarity=0.321  Sum_probs=122.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.............+++.|+|||.+. 
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~-  180 (336)
T 3h4j_B          103 KRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN-  180 (336)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHc-
Confidence            5689999999999999999999998 99999999999999999999999999997665554455667899999999886 


Q ss_pred             cCCC-CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~-~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +..+ +.++|+||||+++|++++|..||........          .........  ..+...+    ..+.+|+.+||+
T Consensus       181 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------~~~i~~~~~--~~p~~~s----~~~~~li~~~L~  244 (336)
T 3h4j_B          181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------FKKVNSCVY--VMPDFLS----PGAQSLIRRMIV  244 (336)
T ss_dssp             CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------BCCCCSSCC--CCCTTSC----HHHHHHHHTTSC
T ss_pred             CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------HHHHHcCCC--CCcccCC----HHHHHHHHHHcC
Confidence            4443 6789999999999999999999975321110          000000011  1111222    358999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .||.+|||+.|+++.
T Consensus       245 ~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          245 ADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSGGGSCCHHHHTTC
T ss_pred             CChhHCcCHHHHHhC
Confidence            999999999999753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=206.16  Aligned_cols=171  Identities=20%  Similarity=0.294  Sum_probs=131.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccccCC---CCCCCCCCCCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSFRNP---DSVEEPSATSLFY   82 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~~~~---~~~~~~~~~~~~~   82 (221)
                      ....+++..++.++.||+.||.|||+. +++||||||.||+++.++   .++|+|||+++....   ........+++.|
T Consensus       174 ~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y  252 (367)
T 3l9p_A          174 QPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW  252 (367)
T ss_dssp             SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGG
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccE
Confidence            345789999999999999999999998 999999999999999554   599999999864321   1222344567889


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALL  161 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (221)
                      +|||.+. +..++.++|||||||++|+|++ |..||...      ........+....     .......++    ..+.
T Consensus       253 ~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~------~~~~~~~~i~~~~-----~~~~~~~~~----~~l~  316 (367)
T 3l9p_A          253 MPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------SNQEVLEFVTSGG-----RMDPPKNCP----GPVY  316 (367)
T ss_dssp             CCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHTTC-----CCCCCTTCC----HHHH
T ss_pred             ECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcCC-----CCCCCccCC----HHHH
Confidence            9999886 6778899999999999999998 99999643      2223333222211     111122222    3589


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCC
Q 048055          162 NIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSS  196 (221)
Q Consensus       162 ~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~  196 (221)
                      +|+.+||+.||.+||++.+|++.|+..........
T Consensus       317 ~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~  351 (367)
T 3l9p_A          317 RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN  351 (367)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhcc
Confidence            99999999999999999999999999887654433

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=2.1e-29  Score=198.63  Aligned_cols=164  Identities=23%  Similarity=0.410  Sum_probs=127.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~~   88 (221)
                      +.+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++........  .....++..|+|||.+
T Consensus        99 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  177 (268)
T 3sxs_A           99 KGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF  177 (268)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHH
Confidence            4689999999999999999999998 999999999999999999999999999875543321  2233445679999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|+||+|+++|++++ |..||...      .............     ....+...+    ..+.+++.+|
T Consensus       178 ~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~~~  241 (268)
T 3sxs_A          178 H-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLY------TNSEVVLKVSQGH-----RLYRPHLAS----DTIYQIMYSC  241 (268)
T ss_dssp             H-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHTTC-----CCCCCTTSC----HHHHHHHHHT
T ss_pred             h-ccCCchhhhhHHHHHHHHHHHcCCCCCcccc------ChHHHHHHHHcCC-----CCCCCCcCh----HHHHHHHHHH
Confidence            6 5667889999999999999998 99999642      2222222221111     111112222    3589999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      |+.||.+|||+.++++.|+++...
T Consensus       242 l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          242 WHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             cCCChhhCcCHHHHHHHHHHhhhc
Confidence            999999999999999999988643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=3.8e-29  Score=211.56  Aligned_cols=162  Identities=25%  Similarity=0.511  Sum_probs=128.5

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccch
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++..++.++.||+.||+|||+. +++||||||.||+++.++.+||+|||+++......  ......++..|+|||.+.
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  358 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  358 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc
Confidence            678899999999999999999998 99999999999999999999999999987654321  122334567899999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       ...++.++||||||+++|+|++ |..||...      ........+...     ..++.+..++    ..+.+||.+||
T Consensus       359 -~~~~~~~~DvwslG~~l~el~t~g~~P~~~~------~~~~~~~~i~~~-----~~~~~~~~~~----~~l~~li~~cl  422 (454)
T 1qcf_A          359 -FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRALERG-----YRMPRPENCP----EELYNIMMRCW  422 (454)
T ss_dssp             -HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHHT-----CCCCCCTTSC----HHHHHHHHHHT
T ss_pred             -cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCCCC----HHHHHHHHHHc
Confidence             6778899999999999999999 99999742      223333333221     2222223333    46999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHH
Q 048055          169 SLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +.||++|||+.+|++.|+++..
T Consensus       423 ~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          423 KNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CSSGGGSCCHHHHHHHHHTSSS
T ss_pred             cCChhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999998763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=8.2e-29  Score=199.47  Aligned_cols=168  Identities=21%  Similarity=0.345  Sum_probs=125.9

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccC
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKA   84 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~   84 (221)
                      ...+.+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......+++.|+|
T Consensus       139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  217 (313)
T 3brb_A          139 TGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA  217 (313)
T ss_dssp             TSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred             cCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence            3457799999999999999999999998 99999999999999999999999999986543321   1223345678999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|+||||+++|++++ |..||.....      ..........     ..+.....++    ..+.++
T Consensus       218 PE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~l~~l  281 (313)
T 3brb_A          218 IESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------HEMYDYLLHG-----HRLKQPEDCL----DELYEI  281 (313)
T ss_dssp             HHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTT-----CCCCCBTTCC----HHHHHH
T ss_pred             chhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHHcC-----CCCCCCcccc----HHHHHH
Confidence            99886 6777889999999999999999 8889864321      1222222111     1111112222    469999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      +.+||+.||.+||++.++++.|+++....
T Consensus       282 i~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          282 MYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=4.9e-29  Score=200.46  Aligned_cols=168  Identities=22%  Similarity=0.393  Sum_probs=129.4

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........   .....++..|+||
T Consensus       138 ~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          138 DELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            345799999999999999999999998 999999999999999999999999999876543322   2233456789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++ |..||......     ....... ...    .........+    ..+.+++
T Consensus       217 E~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~-~~~----~~~~~~~~~~----~~l~~li  281 (313)
T 1t46_A          217 ESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFYKMI-KEG----FRMLSPEHAP----AEMYDIM  281 (313)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----HHHHHHH-HHT----CCCCCCTTSC----HHHHHHH
T ss_pred             HHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-----hHHHHHh-ccC----CCCCCcccCC----HHHHHHH
Confidence            9886 6778899999999999999998 99999743211     1111111 111    1111112222    4689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+||+.||.+|||+.++++.|+++..+.
T Consensus       282 ~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          282 KTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999988753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=2.8e-29  Score=205.92  Aligned_cols=155  Identities=21%  Similarity=0.278  Sum_probs=119.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........+++.|+|||.+.
T Consensus       119 ~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  197 (353)
T 3txo_A          119 RRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ  197 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcC
Confidence            5789999999999999999999998 999999999999999999999999999875332 22334567899999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||...      ........+......    .+  ...+    ..+.+++.+||+
T Consensus       198 -~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~----~p--~~~~----~~~~~li~~lL~  260 (353)
T 3txo_A          198 -EMLYGPAVDWWAMGVLLYEMLCGHAPFEAE------NEDDLFEAILNDEVV----YP--TWLH----EDATGILKSFMT  260 (353)
T ss_dssp             -HHHCTTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC----CC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCcCCccCCCcchHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC----CC--CCCC----HHHHHHHHHHhh
Confidence             667789999999999999999999999642      223333333332211    11  1122    358999999999


Q ss_pred             CCCCCCCCH------HHHHH
Q 048055          170 LAPENRPVM------REVSK  183 (221)
Q Consensus       170 ~dp~~Rps~------~~l~~  183 (221)
                      .||.+||++      .++++
T Consensus       261 ~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          261 KNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             SSGGGSTTSGGGTCTHHHHT
T ss_pred             hCHHHccCCcccCCHHHHhh
Confidence            999999998      67753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=5.5e-29  Score=210.36  Aligned_cols=162  Identities=23%  Similarity=0.418  Sum_probs=126.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...++.++.||+.||.|||+. +++||||||.||+++.++.+||+|||+++......  ....++..|+|||.+. 
T Consensus       284 ~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~-  359 (450)
T 1k9a_A          284 SVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR-  359 (450)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHH-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhc-
Confidence            3478999999999999999999998 99999999999999999999999999987543221  2235567899999987 


Q ss_pred             cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           91 WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      +..++.++|+||||+++|+|++ |..||.....      ......+...     ..++.+..++    ..+.+||.+||+
T Consensus       360 ~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~-----~~~~~p~~~~----~~l~~li~~cl~  424 (450)
T 1k9a_A          360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKG-----YKMDAPDGCP----PAVYDVMKNCWH  424 (450)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT------TTHHHHHHTT-----CCCCCCTTCC----HHHHHHHHHHTC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC-----CCCCCCCcCC----HHHHHHHHHHcC
Confidence            6778899999999999999998 9999975321      1222222221     1222222333    469999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhHHH
Q 048055          170 LAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .||.+|||+.+|++.|+++...
T Consensus       425 ~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          425 LDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CChhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999988753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=5e-29  Score=205.01  Aligned_cols=160  Identities=19%  Similarity=0.235  Sum_probs=125.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||+||+++.++    .++|+|||++.............+++.|+||
T Consensus       109 ~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aP  187 (361)
T 2yab_A          109 KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP  187 (361)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECc
Confidence            45789999999999999999999998 999999999999998877    7999999999776555444556789999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++|+||+|+++|+|++|..||.+.      ........+....    ...+  ..........+.+|+.
T Consensus       188 E~~~-~~~~~~~~DiwslGvil~~ll~g~~Pf~~~------~~~~~~~~i~~~~----~~~~--~~~~~~~s~~~~~li~  254 (361)
T 2yab_A          188 EIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANITAVS----YDFD--EEFFSQTSELAKDFIR  254 (361)
T ss_dssp             HHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTC----CCCC--HHHHTTSCHHHHHHHH
T ss_pred             hHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcC----CCCC--chhccCCCHHHHHHHH
Confidence            9886 667889999999999999999999999642      2222222222211    1111  1111122346899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||..||.+|||+.++++
T Consensus       255 ~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          255 KLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHCCCChhHCcCHHHHhc
Confidence            999999999999999973

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=6.3e-29  Score=198.36  Aligned_cols=168  Identities=18%  Similarity=0.214  Sum_probs=123.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ++.++...+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        95 ~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~  173 (292)
T 3o0g_A           95 NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL  173 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHH
Confidence            46799999999999999999999998 9999999999999999999999999999765432 233455778899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCC-------------------CCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDD-------------------PPSS  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~  149 (221)
                      .....++.++|+||+|+++|+|++|..||..     +.........+..........                   ....
T Consensus       174 ~~~~~~~~~~DiwslG~il~~l~~~~~p~~~-----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (292)
T 3o0g_A          174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFP-----GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL  248 (292)
T ss_dssp             TTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-----CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCC
T ss_pred             cCCCCcCchHHHHHHHHHHHHHHHcCCCCcC-----CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcch
Confidence            6444478999999999999999998877542     222222222222211110000                   0000


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..........+.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            1111122346899999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=1.2e-28  Score=204.84  Aligned_cols=156  Identities=22%  Similarity=0.303  Sum_probs=120.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcccc-CCCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR-NPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||+++.. ..........+|+.|+|||.+.
T Consensus       148 ~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~  226 (396)
T 4dc2_A          148 RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR  226 (396)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhc
Confidence            5789999999999999999999998 9999999999999999999999999999753 3333445667899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---CCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                       +..++.++|+|||||++|+|++|..||.......   ..........+....    ...+  ...+    ..+.+|+.+
T Consensus       227 -~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----~~~p--~~~s----~~~~~li~~  295 (396)
T 4dc2_A          227 -GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----IRIP--RSLS----VKAASVLKS  295 (396)
T ss_dssp             -TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----CCCC--TTSC----HHHHHHHHH
T ss_pred             -CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----cCCC--CcCC----HHHHHHHHH
Confidence             6778999999999999999999999996422111   111111222222211    1111  1122    358999999


Q ss_pred             cccCCCCCCCCH
Q 048055          167 CVSLAPENRPVM  178 (221)
Q Consensus       167 cl~~dp~~Rps~  178 (221)
                      ||+.||.+||++
T Consensus       296 lL~~dP~~R~~~  307 (396)
T 4dc2_A          296 FLNKDPKERLGC  307 (396)
T ss_dssp             HTCSCTTTSTTC
T ss_pred             HhcCCHhHcCCC
Confidence            999999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=8.1e-29  Score=198.88  Aligned_cols=176  Identities=27%  Similarity=0.467  Sum_probs=130.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ..++++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       127 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE  205 (307)
T 2nru_A          127 TPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE  205 (307)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChH
Confidence            45689999999999999999999998 99999999999999999999999999986544322   123346788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-CCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-GDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+.  ..++.++|+||||+++|++++|..||......  .....+........... .................+.+++.
T Consensus       206 ~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  281 (307)
T 2nru_A          206 ALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS  281 (307)
T ss_dssp             HHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHH
T ss_pred             Hhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcch--HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHH
Confidence            875  34678999999999999999999999754321  11122222211111000 00011112234455678999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||.+||++.++++.|+++..
T Consensus       282 ~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          282 QCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHcCCCcccCcCHHHHHHHHHHHhc
Confidence            9999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=6.7e-29  Score=195.93  Aligned_cols=162  Identities=26%  Similarity=0.387  Sum_probs=119.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCC---ceeeCcCCCCeEEcC--------CCceEEeccCCccccCCCCCCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPG---LTHGNLKSSNVLLGA--------DFESCLTDYGLGSFRNPDSVEEPSAT   78 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~---i~h~dlk~~nil~~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~   78 (221)
                      ++++++..++.++.|++.||.|||+. +   ++|+||||.||+++.        ++.++|+|||.+....... .....+
T Consensus        99 ~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  176 (271)
T 3dtc_A           99 GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG  176 (271)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------C
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCC
Confidence            46789999999999999999999998 7   889999999999986        6789999999986544332 224467


Q ss_pred             CccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           79 SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      +..|+|||.+. +..++.++|+||||+++|++++|..||....      ..........    .....+.+..++    .
T Consensus       177 ~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~----~~~~~~~~~~~~----~  241 (271)
T 3dtc_A          177 AYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAM----NKLALPIPSTCP----E  241 (271)
T ss_dssp             CGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHT----SCCCCCCCTTCC----H
T ss_pred             ccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhc----CCCCCCCCcccC----H
Confidence            88999999886 6777889999999999999999999997421      1111111111    111111122222    4


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+.+++.+||+.||.+|||+.++++.|+++
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          242 PFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            699999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=1.1e-28  Score=209.51  Aligned_cols=157  Identities=23%  Similarity=0.393  Sum_probs=125.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++.............+++.|+|||.+.
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (476)
T 2y94_A          110 NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS  188 (476)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhcc
Confidence            46799999999999999999999998 99999999999999999999999999997765554455667899999999887


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .....+.++|+||+||++|+|++|..||...      ........+......    .  +...+    ..+.+|+.+||+
T Consensus       189 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~----~--p~~~s----~~~~~Li~~~L~  252 (476)
T 2y94_A          189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDD------HVPTLFKKICDGIFY----T--PQYLN----PSVISLLKHMLQ  252 (476)
T ss_dssp             TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------SSHHHHHHHHTTCCC----C--CTTCC----HHHHHHHHHHTC
T ss_pred             CCCCCCCcceehhhHHHHHHHhhCCCCCCCC------CHHHHHHHHhcCCcC----C--CccCC----HHHHHHHHHHcC
Confidence            3333367899999999999999999999642      223333333322111    1  11222    358999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+|||+.++++
T Consensus       253 ~dP~~Rpt~~eil~  266 (476)
T 2y94_A          253 VDPMKRATIKDIRE  266 (476)
T ss_dssp             SSTTTSCCHHHHHT
T ss_pred             CCchhCcCHHHHHh
Confidence            99999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=8.4e-29  Score=195.35  Aligned_cols=164  Identities=21%  Similarity=0.386  Sum_probs=128.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.
T Consensus       100 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  178 (269)
T 4hcu_A          100 RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV  178 (269)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred             CcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHH
Confidence            45689999999999999999999998 99999999999999999999999999987544322  2233445678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||+|+++|++++ |..||...      ........+...     .....+...+    ..+.+++.+
T Consensus       179 ~~-~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~~~~li~~  242 (269)
T 4hcu_A          179 FS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTG-----FRLYKPRLAS----THVYQIMNH  242 (269)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTT-----CCCCCCTTSC----HHHHHHHHH
T ss_pred             hc-CCCCCchhhhHHHHHHHHHHhcCCCCCCCCC------CHHHHHHHHhcC-----ccCCCCCcCC----HHHHHHHHH
Confidence            86 6778899999999999999999 99999642      222222222221     1111112222    358999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||+.||.+||++.++++.|+++..
T Consensus       243 ~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          243 CWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HccCCcccCcCHHHHHHHHHHHHH
Confidence            999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.8e-28  Score=195.23  Aligned_cols=172  Identities=20%  Similarity=0.379  Sum_probs=133.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKA   84 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~   84 (221)
                      ....+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++........    .....++..|+|
T Consensus       103 ~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  181 (287)
T 1u59_A          103 KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA  181 (287)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCC
T ss_pred             CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccC
Confidence            346799999999999999999999998 999999999999999999999999999876543221    223345678999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|+||||+++|++++ |..||....      .......+...     ..+..+..++    ..+.++
T Consensus       182 PE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~i~~~-----~~~~~~~~~~----~~l~~l  245 (287)
T 1u59_A          182 PECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------GPEVMAFIEQG-----KRMECPPECP----PELYAL  245 (287)
T ss_dssp             HHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------THHHHHHHHTT-----CCCCCCTTCC----HHHHHH
T ss_pred             HHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHhcC-----CcCCCCCCcC----HHHHHH
Confidence            99886 5667889999999999999998 999996421      22222222221     1111112222    469999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCC
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRAEAQMSSN  197 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~  197 (221)
                      +.+||+.||.+||++.++++.|+++..+......
T Consensus       246 i~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  279 (287)
T 1u59_A          246 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  279 (287)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence            9999999999999999999999999887665443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=1.4e-28  Score=198.42  Aligned_cols=170  Identities=19%  Similarity=0.255  Sum_probs=121.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus       113 ~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  191 (311)
T 3niz_A          113 KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL  191 (311)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHh
Confidence            45689999999999999999999998 9999999999999999999999999999765432 233445678899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc---------------CCCCC--CCCh
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES---------------GDDPP--SSNE  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~--~~~~  151 (221)
                      .....++.++|+||+||++|++++|..||......  .....+.... ......               .....  ....
T Consensus       192 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (311)
T 3niz_A          192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSIL-GTPNPREWPQVQELPLWKQRTFQVFEKKPWSS  268 (311)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHH-CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH
T ss_pred             cCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHH-CCCChHHhhhhhccchhhhcccccccCCcHHH
Confidence            64456789999999999999999999999753221  1111111100 000000               00000  0000


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+.....+.+|+.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          269 IIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            01112246889999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=8.4e-29  Score=196.64  Aligned_cols=165  Identities=19%  Similarity=0.355  Sum_probs=129.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.
T Consensus       114 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (283)
T 3gen_A          114 RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV  192 (283)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHH
Confidence            35689999999999999999999998 99999999999999999999999999987543321  1233345678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||+|+++|++++ |..||...      ........+....     ....+...+    ..+.+++.+
T Consensus       193 ~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~~  256 (283)
T 3gen_A          193 LM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------TNSETAEHIAQGL-----RLYRPHLAS----EKVYTIMYS  256 (283)
T ss_dssp             HH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHTTC-----CCCCCTTCC----HHHHHHHHH
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHhCCCCCcccc------ChhHHHHHHhccc-----CCCCCCcCC----HHHHHHHHH
Confidence            87 6678889999999999999998 99999643      2222222222211     111111222    358999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ||+.||.+|||+.++++.|+++..+
T Consensus       257 ~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          257 CWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HccCChhHCcCHHHHHHHHHHHhhc
Confidence            9999999999999999999998765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=5.2e-29  Score=207.55  Aligned_cols=165  Identities=19%  Similarity=0.288  Sum_probs=118.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ...+++..+..++.||+.||.|||+. +++||||||.||+++.   ++.+||+|||+++............+++.|+|||
T Consensus       155 ~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE  233 (400)
T 1nxk_A          155 DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE  233 (400)
T ss_dssp             --CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHh
Confidence            35689999999999999999999998 9999999999999998   7889999999997655444445567788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|||||||++|+|++|..||.........  ......+.....    ..+...  .......+.+|+.+
T Consensus       234 ~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~----~~~~~~--~~~~s~~~~~li~~  304 (400)
T 1nxk_A          234 VLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQY----EFPNPE--WSEVSEEVKMLIRN  304 (400)
T ss_dssp             GSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCC----CCCTTT--TTTSCHHHHHHHHT
T ss_pred             hcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcc----cCCCcc--cccCCHHHHHHHHH
Confidence            986 677889999999999999999999999753221111  011122221111    111110  01122458999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+|||+.++++.
T Consensus       305 ~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          305 LLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TSCSSGGGSCCHHHHHHS
T ss_pred             HCCCChhHCcCHHHHhcC
Confidence            999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=3.2e-29  Score=208.44  Aligned_cols=167  Identities=19%  Similarity=0.182  Sum_probs=125.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-CCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||+|||+. +++||||||.||+++ .++.++|+|||+++............+++.|+|||.+
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~  213 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELI  213 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHH
Confidence            56789999999999999999999998 999999999999999 7899999999999776555445556778899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh-------------hccCCCCCCCCh----
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE-------------TESGDDPPSSNE----  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~----  151 (221)
                      .....++.++|+||+||++|+|++|..||.+...      ......+....             .......+....    
T Consensus       214 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (394)
T 4e7w_A          214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG------IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFS  287 (394)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHH
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHH
Confidence            6445688999999999999999999999975321      11111111100             000011111000    


Q ss_pred             --hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 --ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 --~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        ........+.+|+.+||+.||.+|||+.++++
T Consensus       288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          288 KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence              01112346999999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=5.7e-29  Score=206.37  Aligned_cols=167  Identities=20%  Similarity=0.253  Sum_probs=120.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC--------------------
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD--------------------   70 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~--------------------   70 (221)
                      ..++...+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||+++.....                    
T Consensus       104 ~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (388)
T 3oz6_A          104 NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD  182 (388)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccc
Confidence            4688999999999999999999998 9999999999999999999999999998754321                    


Q ss_pred             --CCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCC----
Q 048055           71 --SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGD----  144 (221)
Q Consensus        71 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  144 (221)
                        .......+++.|+|||.+.....++.++||||+||++|+|++|..||.+..      .......+.........    
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~p~~~~~~  256 (388)
T 3oz6_A          183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS------TMNQLERIIGVIDFPSNEDVE  256 (388)
T ss_dssp             -------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHH
Confidence              112334678899999988644678899999999999999999999997432      12222222111100000    


Q ss_pred             --------------------CCCCCChhhH-------------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          145 --------------------DPPSSNEASE-------------EKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       145 --------------------~~~~~~~~~~-------------~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                                          .........+             .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          257 SIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             TSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence                                0000000000             112368999999999999999999999765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=8.4e-29  Score=200.95  Aligned_cols=160  Identities=18%  Similarity=0.238  Sum_probs=124.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++    .++|+|||++.............+++.|+||
T Consensus       108 ~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          108 KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP  186 (326)
T ss_dssp             SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCH
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCc
Confidence            46789999999999999999999998 999999999999999887    7999999999766544444456788999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++|+||||+++|+|++|..||...      ........+....    ...+  ..........+.+|+.
T Consensus       187 E~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~li~  253 (326)
T 2y0a_A          187 EIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANVSAVN----YEFE--DEYFSNTSALAKDFIR  253 (326)
T ss_dssp             HHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHTC----CCCC--HHHHTTSCHHHHHHHH
T ss_pred             eeec-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCC------CHHHHHHHHHhcC----CCcC--ccccccCCHHHHHHHH
Confidence            9886 677889999999999999999999999642      2222222222111    1111  1111122346899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.++++
T Consensus       254 ~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          254 RLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHSCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=7e-29  Score=199.66  Aligned_cols=165  Identities=22%  Similarity=0.389  Sum_probs=128.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       144 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  222 (314)
T 2ivs_A          144 ERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE  222 (314)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred             ccCcCHHHHHHHHHHHHHHHHHHHHC-CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence            45689999999999999999999998 99999999999999999999999999987554322   123345567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|+|++ |..||.....      ......+...     .........+    ..+.+++.
T Consensus       223 ~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~~~~li~  286 (314)
T 2ivs_A          223 SLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP------ERLFNLLKTG-----HRMERPDNCS----EEMYRLML  286 (314)
T ss_dssp             HHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTT-----CCCCCCTTCC----HHHHHHHH
T ss_pred             hhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHhhcC-----CcCCCCccCC----HHHHHHHH
Confidence            886 5667889999999999999999 9999975322      1222222111     1111112222    46999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+||++.++++.|+++..+
T Consensus       287 ~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          287 QCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999988753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=5.4e-29  Score=202.76  Aligned_cols=165  Identities=22%  Similarity=0.430  Sum_probs=127.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      ..++++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++......   .......+++.|+|||
T Consensus       168 ~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  246 (343)
T 1luf_A          168 PPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE  246 (343)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence            47899999999999999999999998 9999999999999999999999999998654322   1223345677899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ........+....     ....+..++    ..+.+++.
T Consensus       247 ~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~  310 (343)
T 1luf_A          247 SIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM------AHEEVIYYVRDGN-----ILACPENCP----LELYNLMR  310 (343)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHTTC-----CCCCCTTCC----HHHHHHHH
T ss_pred             hhc-cCCcCcccccHHHHHHHHHHHhcCCCcCCCC------ChHHHHHHHhCCC-----cCCCCCCCC----HHHHHHHH
Confidence            887 6678899999999999999998 99999642      2222222222211     111112222    46999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +||+.||.+||++.++++.|+++...
T Consensus       311 ~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          311 LCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             HHcccCcccCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999997654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=2e-28  Score=202.80  Aligned_cols=160  Identities=19%  Similarity=0.269  Sum_probs=124.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||.|||+. |++||||||.||+++.++.++|+|||++.............+++.|+|||.+.
T Consensus       109 ~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~  187 (384)
T 4fr4_A          109 NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS  187 (384)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeec
Confidence            45789999999999999999999998 99999999999999999999999999998766555556678899999999875


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  +..++.++|+|||||++|+|++|..||....   ................    ..+  ...+    ..+.+|+.+|
T Consensus       188 ~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~----~~p--~~~s----~~~~~li~~l  254 (384)
T 4fr4_A          188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS---STSSKEIVHTFETTVV----TYP--SAWS----QEMVSLLKKL  254 (384)
T ss_dssp             CCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT---TSCHHHHHHHHHHCCC----CCC--TTSC----HHHHHHHHHH
T ss_pred             cCCCCCCCccceeechHHHHHHHHhCCCCCCCCC---CccHHHHHHHHhhccc----CCC--CcCC----HHHHHHHHHH
Confidence            2  2346889999999999999999999996432   1222222222222111    111  1222    4689999999


Q ss_pred             ccCCCCCCCC-HHHHHH
Q 048055          168 VSLAPENRPV-MREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps-~~~l~~  183 (221)
                      |+.||.+||+ +.+++.
T Consensus       255 L~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          255 LEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             SCSSGGGSCCSHHHHHT
T ss_pred             hcCCHhHhcccHHHHHc
Confidence            9999999998 666653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=1e-28  Score=197.76  Aligned_cols=160  Identities=23%  Similarity=0.358  Sum_probs=122.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~   87 (221)
                      ..+++++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......+++.|+|||.
T Consensus       130 ~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  208 (298)
T 2zv2_A          130 TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES  208 (298)
T ss_dssp             CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGG
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhh
Confidence            356799999999999999999999998 9999999999999999999999999998755432 22344577889999998


Q ss_pred             chhcCC--CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           88 REIWKQ--PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        88 ~~~~~~--~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      +.....  .+.++|+||||+++|++++|..||...      ........+....    ...+.....+    ..+.+++.
T Consensus       209 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~~~~~~----~~~~~~~~~~----~~l~~li~  274 (298)
T 2zv2_A          209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE------RIMCLHSKIKSQA----LEFPDQPDIA----EDLKDLIT  274 (298)
T ss_dssp             CCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC----CCCCSSSCCC----HHHHHHHH
T ss_pred             hccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc------cHHHHHHHHhccc----CCCCCccccC----HHHHHHHH
Confidence            763221  256789999999999999999999642      2222222222211    1111112222    35899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+||++.++++
T Consensus       275 ~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          275 RMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHTCSCTTTSCCHHHHTT
T ss_pred             HHhhcChhhCCCHHHHhc
Confidence            999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=1.2e-28  Score=200.61  Aligned_cols=177  Identities=23%  Similarity=0.338  Sum_probs=130.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhc--------CCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIH--------QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSA   77 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH--------~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~   77 (221)
                      .++++..++.++.|++.||.|||        +. +++|+||||.||+++.++.++|+|||++.......     ......
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~  212 (342)
T 1b6c_B          134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV  212 (342)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCC
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCC
Confidence            46899999999999999999999        77 99999999999999999999999999986544332     123456


Q ss_pred             CCccccCcccchhcCC-----CCCcccchHHHHHHHHHHhC----------CCCCcccccccCCChHHHHHHhhhhhhcc
Q 048055           78 TSLFYKAPECREIWKQ-----PTQQADVYSFGVLLLELLTG----------KTPFQDLVLEHGSDIPRWVRSVREEETES  142 (221)
Q Consensus        78 ~~~~~~~pe~~~~~~~-----~~~~~di~slG~~l~~~~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  142 (221)
                      ++..|+|||.+.....     ++.++|+||||+++|+|++|          ..||...... ......+...+.    ..
T Consensus       213 gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~----~~  287 (342)
T 1b6c_B          213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS-DPSVEEMRKVVC----EQ  287 (342)
T ss_dssp             CCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS-SCCHHHHHHHHT----TS
T ss_pred             cCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC-cccHHHHHHHHH----HH
Confidence            7889999998763211     12579999999999999998          7788653221 111222222221    11


Q ss_pred             CCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          143 GDDPPSSN-EASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       143 ~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      ...+..+. .........+.+|+.+||+.||.+|||+.+|++.|+++..+..
T Consensus       288 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          288 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            11111111 1234566789999999999999999999999999999987643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=1.7e-28  Score=201.35  Aligned_cols=155  Identities=23%  Similarity=0.368  Sum_probs=122.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........+++.|+|||.+.
T Consensus       116 ~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (353)
T 2i0e_A          116 GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA  194 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhc
Confidence            5689999999999999999999998 999999999999999999999999999875332 22344567899999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ...+    ..+.+|+.+||+
T Consensus       195 -~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~lL~  257 (353)
T 2i0e_A          195 -YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHNV----AYP--KSMS----KEAVAICKGLMT  257 (353)
T ss_dssp             -TCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC----CCC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCcCCcccccchHHHHHHHHcCCCCCCCC------CHHHHHHHHHhCCC----CCC--CCCC----HHHHHHHHHHhh
Confidence             677889999999999999999999999642      22233333332211    111  1222    358999999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 048055          170 LAPENRPV-----MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~  183 (221)
                      .||.+||+     +.+|++
T Consensus       258 ~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          258 KHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             SCTTSCTTCSTTHHHHHHT
T ss_pred             cCHHHcCCCCCCCHHHHhc
Confidence            99999995     466653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=1.3e-28  Score=195.34  Aligned_cols=165  Identities=19%  Similarity=0.343  Sum_probs=126.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.
T Consensus       107 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  185 (281)
T 3cc6_A          107 KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES  185 (281)
T ss_dssp             TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchh
Confidence            35689999999999999999999998 99999999999999999999999999987544322  1223345678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||.....      ......+...     ...+.+...+    ..+.+++.+
T Consensus       186 ~~-~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~~  249 (281)
T 3cc6_A          186 IN-FRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------KDVIGVLEKG-----DRLPKPDLCP----PVLYTLMTR  249 (281)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG------GGHHHHHHHT-----CCCCCCTTCC----HHHHHHHHH
T ss_pred             hc-cCCCCchhccHHHHHHHHHHHhCCCCCcccCCh------HHHHHHHhcC-----CCCCCCCCCC----HHHHHHHHH
Confidence            86 6777889999999999999998 9999964321      1112222111     1111122222    359999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ||+.||.+||++.++++.|+++...
T Consensus       250 ~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          250 CWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HccCCchhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=3.1e-29  Score=200.61  Aligned_cols=168  Identities=19%  Similarity=0.335  Sum_probs=124.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      +++++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......+++.|+|||.+
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~  184 (294)
T 4eqm_A          106 GPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA  184 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHh
Confidence            5689999999999999999999998 99999999999999999999999999987654332  12334578899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||....      ..........     ...+..........+..+.+++.+||
T Consensus       185 ~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l  252 (294)
T 4eqm_A          185 K-GEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQ-----DSVPNVTTDVRKDIPQSLSNVILRAT  252 (294)
T ss_dssp             H-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHS-----SCCCCHHHHSCTTSCHHHHHHHHHHS
T ss_pred             c-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhh-----ccCCCcchhcccCCCHHHHHHHHHHh
Confidence            7 6777889999999999999999999997432      1111111111     01111001111122356999999999


Q ss_pred             cCCCCCCC-CHHHHHHHHHhhHHH
Q 048055          169 SLAPENRP-VMREVSKMIRDSRAE  191 (221)
Q Consensus       169 ~~dp~~Rp-s~~~l~~~L~~~~~~  191 (221)
                      +.||.+|| ++.++.+.|+....+
T Consensus       253 ~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          253 EKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             CSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             cCCHhHccccHHHHHHHHHHHHhh
Confidence            99999999 899999999887643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=9.4e-29  Score=203.46  Aligned_cols=160  Identities=24%  Similarity=0.319  Sum_probs=124.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++   .++|+|||++.............+++.|+|||
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE  200 (362)
T 2bdw_A          122 REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE  200 (362)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHH
Confidence            45689999999999999999999998 999999999999998654   59999999997665554445567899999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+|||||++|+|++|..||...      ........+....    ...+..  ........+.+|+.+
T Consensus       201 ~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~------~~~~~~~~i~~~~----~~~~~~--~~~~~~~~~~~li~~  267 (362)
T 2bdw_A          201 VLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQIKAGA----YDYPSP--EWDTVTPEAKSLIDS  267 (362)
T ss_dssp             HHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTC----CCCCTT--GGGGSCHHHHHHHHH
T ss_pred             HHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCC----CCCCcc--cccCCCHHHHHHHHH
Confidence            886 667889999999999999999999999642      2222223322221    111111  111123468999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+||++.++++
T Consensus       268 ~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          268 MLTVNPKKRITADQALK  284 (362)
T ss_dssp             HSCSSGGGSCCHHHHTT
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=6.5e-29  Score=200.77  Aligned_cols=179  Identities=24%  Similarity=0.355  Sum_probs=130.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+|||
T Consensus       129 ~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE  207 (318)
T 3lxp_A          129 HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE  207 (318)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChH
Confidence            3589999999999999999999998 99999999999999999999999999987654332    123345677899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc----CCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH----GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      .+. +..++.++|+||||+++|++++|..||.......    ......................+....++    ..+.+
T Consensus       208 ~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~  282 (318)
T 3lxp_A          208 CLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCP----AEVYH  282 (318)
T ss_dssp             HHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCC----HHHHH
T ss_pred             Hhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCcccc----HHHHH
Confidence            886 5667789999999999999999999986432110    00000000000011111112222222233    46999


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcC
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDSRAEAQMS  195 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~  195 (221)
                      |+.+||+.||.+|||+.++++.|+.+......+
T Consensus       283 li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          283 LMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            999999999999999999999999998776543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=8.1e-29  Score=209.44  Aligned_cols=163  Identities=26%  Similarity=0.495  Sum_probs=124.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      +.+++..++.++.||+.||+|||+. +++||||||.||+++.++.+||+|||+++......  ......++..|+|||.+
T Consensus       275 ~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~  353 (452)
T 1fmk_A          275 KYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA  353 (452)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHH
Confidence            4689999999999999999999998 99999999999999999999999999987544321  12233456789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++||||||+++|++++ |..||...      ........+..     ...++.+..++    ..+.+||.+|
T Consensus       354 ~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~------~~~~~~~~i~~-----~~~~~~~~~~~----~~l~~li~~c  417 (452)
T 1fmk_A          354 L-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVER-----GYRMPCPPECP----ESLHDLMCQC  417 (452)
T ss_dssp             H-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHT-----TCCCCCCTTSC----HHHHHHHHHH
T ss_pred             h-cCCCCccccHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHc-----CCCCCCCCCCC----HHHHHHHHHH
Confidence            7 6778899999999999999999 99999643      22233333222     12222222333    4689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHH
Q 048055          168 VSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      |+.||++|||+.+|++.|+++..
T Consensus       418 l~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          418 WRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ccCChhhCcCHHHHHHHHHHHhc
Confidence            99999999999999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=1.5e-28  Score=202.83  Aligned_cols=166  Identities=19%  Similarity=0.252  Sum_probs=116.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............++..|+|||.+. 
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-  199 (371)
T 2xrw_A          122 MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-  199 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHT-
T ss_pred             hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhc-
Confidence            3578999999999999999999998 99999999999999999999999999987655443344567788999999987 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-------------------ccC--------
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-------------------ESG--------  143 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~--------  143 (221)
                      +..++.++|+|||||++|+|++|..||.+...      ......+.....                   ...        
T Consensus       200 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (371)
T 2xrw_A          200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE  273 (371)
T ss_dssp             TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHH
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchh
Confidence            56788999999999999999999999974321      111111111000                   000        


Q ss_pred             -----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          144 -----DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       144 -----~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                           ...+............+.+|+.+||+.||.+|||+.++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          274 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                 00111122233345679999999999999999999999763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.8e-29  Score=203.95  Aligned_cols=167  Identities=21%  Similarity=0.312  Sum_probs=125.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........   .....+++.|+|||
T Consensus       166 ~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  244 (344)
T 1rjb_A          166 LNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  244 (344)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence            45689999999999999999999998 999999999999999999999999999865433221   22334567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|+|++ |..||.....     .......+.. .    ..+..+...+    ..+.+|+.
T Consensus       245 ~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~-~----~~~~~~~~~~----~~l~~li~  309 (344)
T 1rjb_A          245 SLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-----DANFYKLIQN-G----FKMDQPFYAT----EEIYIIMQ  309 (344)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-----SHHHHHHHHT-T----CCCCCCTTCC----HHHHHHHH
T ss_pred             Hhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-----HHHHHHHHhc-C----CCCCCCCCCC----HHHHHHHH
Confidence            886 6778899999999999999998 9999975321     1111111111 1    1111112222    46999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      +||+.||.+||++.++++.|+.+....
T Consensus       310 ~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          310 SCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            999999999999999999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=4.7e-29  Score=202.66  Aligned_cols=180  Identities=19%  Similarity=0.273  Sum_probs=125.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCC--------CceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---------CC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNP--------GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---------VE   73 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~--------~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---------~~   73 (221)
                      ..+++..++.++.||+.||.|||+..        +++|+||||.||+++.++.++|+|||+++......         ..
T Consensus       106 ~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~  185 (336)
T 3g2f_A          106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA  185 (336)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------
T ss_pred             cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccc
Confidence            34588899999999999999999851        89999999999999999999999999987543221         12


Q ss_pred             CCCCCCccccCcccchhc------CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCC-----------hHHHHHHhh
Q 048055           74 EPSATSLFYKAPECREIW------KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-----------IPRWVRSVR  136 (221)
Q Consensus        74 ~~~~~~~~~~~pe~~~~~------~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~-----------~~~~~~~~~  136 (221)
                      ....++..|+|||.+...      ..++.++|||||||++|+|++|..||..........           .........
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (336)
T 3g2f_A          186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV  265 (336)
T ss_dssp             CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHH
T ss_pred             ccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhh
Confidence            234678899999987521      234568999999999999999976654321111110           001111111


Q ss_pred             hhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          137 EEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ....... ..+............+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       266 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          266 SREKQRP-KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             TTSCCCC-CCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccccCC-CCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1111111 11111112223456799999999999999999999999999998854

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.3e-28  Score=213.65  Aligned_cols=167  Identities=22%  Similarity=0.403  Sum_probs=128.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.|||++.++.+||+|||+++.......    .....+++.|+||
T Consensus       430 ~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          430 REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP  508 (613)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCH
Confidence            56799999999999999999999998 999999999999999999999999999976543221    1122345789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++||||||+++|+|++ |..||...      ........+...     ..+..+..++    ..+.+||
T Consensus       509 E~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~------~~~~~~~~i~~~-----~~~~~p~~~~----~~l~~li  572 (613)
T 2ozo_A          509 ECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM------KGPEVMAFIEQG-----KRMECPPECP----PELYALM  572 (613)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CSHHHHHHHHTT-----CCCCCCTTCC----HHHHHHH
T ss_pred             hhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCcCC----HHHHHHH
Confidence            9986 6778899999999999999998 99999743      222333333222     1222222232    4699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      .+||+.||++||++.+|++.|+.+.....
T Consensus       573 ~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          573 SDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             HHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=2e-28  Score=206.70  Aligned_cols=156  Identities=21%  Similarity=0.284  Sum_probs=122.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..+..++.||+.||.|||+ . +++||||||.||+++.++.++|+|||+++.... ........+++.|+|||.
T Consensus       242 ~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  320 (446)
T 4ejn_A          242 ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV  320 (446)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhh
Confidence            3568999999999999999999998 7 999999999999999999999999999875332 223345678999999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ...+    ..+.+|+.+|
T Consensus       321 ~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~----~~p--~~~~----~~~~~li~~~  383 (446)
T 4ejn_A          321 LE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMEEI----RFP--RTLG----PEAKSLLSGL  383 (446)
T ss_dssp             HH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC----CCC--TTSC----HHHHHHHHHH
T ss_pred             cC-CCCCCCccchhhhHHHHHHHhhCCCCCCCC------CHHHHHHHHHhCCC----CCC--ccCC----HHHHHHHHHH
Confidence            86 677899999999999999999999999642      22233333322211    111  1122    3589999999


Q ss_pred             ccCCCCCCC-----CHHHHHH
Q 048055          168 VSLAPENRP-----VMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rp-----s~~~l~~  183 (221)
                      |+.||.+||     ++.++++
T Consensus       384 L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          384 LKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHT
T ss_pred             cccCHHHhCCCCCCCHHHHHh
Confidence            999999999     9999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.1e-29  Score=203.17  Aligned_cols=161  Identities=17%  Similarity=0.235  Sum_probs=125.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC--CCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA--DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||+||+++.  ++.++|+|||++.............+++.|+|||.
T Consensus        96 ~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  174 (321)
T 1tki_A           96 AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV  174 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHH
Confidence            35789999999999999999999998 9999999999999987  78999999999976655443444567889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||+|+++|++++|..||...      ........+.....    ..+  .......+..+.+|+.+|
T Consensus       175 ~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~----~~~--~~~~~~~s~~~~~li~~~  241 (321)
T 1tki_A          175 HQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMNAEY----TFD--EEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             HT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCC----CCC--HHHHTTSCHHHHHHHHTT
T ss_pred             hc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCC------CHHHHHHHHHcCCC----CCC--hhhhccCCHHHHHHHHHH
Confidence            86 556688999999999999999999999642      22233333322111    111  111112234689999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |..||.+|||+.++++.
T Consensus       242 L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          242 LVKERKSRMTASEALQH  258 (321)
T ss_dssp             SCSSGGGSCCHHHHHHS
T ss_pred             cCCChhHCcCHHHHhcC
Confidence            99999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=3.4e-28  Score=203.84  Aligned_cols=167  Identities=22%  Similarity=0.197  Sum_probs=123.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||.|||+. +|+||||||.|||++.+ +.+||+|||+++............++..|+|||.+
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~  228 (420)
T 1j1b_A          150 KQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI  228 (420)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHH
Confidence            46789999999999999999999998 99999999999999965 67899999999765544444456778899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhh------------hh-ccCCCCCCCCh----
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREE------------ET-ESGDDPPSSNE----  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------~~-~~~~~~~~~~~----  151 (221)
                      .....++.++|||||||++|+|++|+.||.+...      ......+...            .. ......+....    
T Consensus       229 ~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~------~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~  302 (420)
T 1j1b_A          229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT  302 (420)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHH
T ss_pred             cCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHH
Confidence            6445788999999999999999999999975321      1111111110            00 00011111000    


Q ss_pred             --hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 --ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 --~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        ........+.+|+.+||+.||.+||++.++++
T Consensus       303 ~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              00112346899999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=8.3e-29  Score=197.40  Aligned_cols=167  Identities=17%  Similarity=0.254  Sum_probs=119.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~  172 (288)
T 1ob3_A           94 EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL  172 (288)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchhe
Confidence            35789999999999999999999998 9999999999999999999999999998654422 223344678899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-----------CC--------CCCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-----------GD--------DPPSS  149 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~--------~~~~~  149 (221)
                      .....++.++|+||+|+++|+|++|..||....      .......+.......           ..        .+...
T Consensus       173 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (288)
T 1ob3_A          173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS------EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW  246 (288)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG
T ss_pred             eCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccH
Confidence            644567899999999999999999999997432      111112111110000           00        00000


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..........+.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0011112346899999999999999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=1.5e-28  Score=199.11  Aligned_cols=160  Identities=19%  Similarity=0.343  Sum_probs=124.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus       135 ~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  213 (321)
T 2c30_A          135 QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI  213 (321)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhh
Confidence            34689999999999999999999998 9999999999999999999999999998655432 223445788899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|+|++|..||...      ........+....   .........    ....+.+++.+||
T Consensus       214 ~-~~~~~~~~Dv~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~---~~~~~~~~~----~~~~l~~li~~~l  279 (321)
T 2c30_A          214 S-RSLYATEVDIWSLGIMVIEMVDGEPPYFSD------SPVQAMKRLRDSP---PPKLKNSHK----VSPVLRDFLERML  279 (321)
T ss_dssp             T-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSS---CCCCTTGGG----SCHHHHHHHHHHS
T ss_pred             c-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHhcCC---CCCcCcccc----CCHHHHHHHHHHc
Confidence            6 667788999999999999999999999642      2222222222211   111111111    2246899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.||.+|||+.++++.
T Consensus       280 ~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          280 VRDPQERATAQELLDH  295 (321)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-28  Score=203.67  Aligned_cols=165  Identities=22%  Similarity=0.329  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~   84 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.+||+|||+++......     ......++..|+|
T Consensus       186 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~a  264 (373)
T 3c1x_A          186 THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA  264 (373)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccC
Confidence            45678999999999999999999998 99999999999999999999999999987543221     1123345678999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|+||||+++|++++ |.+||.....   ...   ...+...     .....+..++    ..+.++
T Consensus       265 PE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~---~~~~~~~-----~~~~~p~~~~----~~l~~l  328 (373)
T 3c1x_A          265 LESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI---TVYLLQG-----RRLLQPEYCP----DPLYEV  328 (373)
T ss_dssp             HHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCH---HHHHHTT-----CCCCCCTTCC----HHHHHH
T ss_pred             hHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHH---HHHHHcC-----CCCCCCCCCC----HHHHHH
Confidence            99887 6778899999999999999999 6777764321   111   1111111     1112122222    469999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +.+||+.||.+||++.++++.|+++...
T Consensus       329 i~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          329 MLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999998865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.96  E-value=5.1e-29  Score=204.99  Aligned_cols=163  Identities=22%  Similarity=0.256  Sum_probs=112.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc--eEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE--SCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .++++...+..++.||+.||.|||+. +++||||||.||+++.++.  ++|+|||+++............+++.|+|||.
T Consensus       110 ~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  188 (361)
T 3uc3_A          110 AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV  188 (361)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhh
Confidence            35689999999999999999999998 9999999999999987765  99999999875444433445578899999998


Q ss_pred             chhcCCCC-CcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPT-QQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~-~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..+. .++|+||+||++|+|++|..||.....  ..........+...    ....+.....+    ..+.+|+.+
T Consensus       189 ~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~s----~~~~~li~~  257 (361)
T 3uc3_A          189 LL-RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--PRDYRKTIQRILSV----KYSIPDDIRIS----PECCHLISR  257 (361)
T ss_dssp             HH-CSSCCHHHHHHHHHHHHHHHHHHSSCSCC------CCCHHHHHHHHHTT----CCCCCTTSCCC----HHHHHHHHH
T ss_pred             hc-CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhcC----CCCCCCcCCCC----HHHHHHHHH
Confidence            86 44444 448999999999999999999975321  12222222222221    11122111222    358999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+|||+.++++.
T Consensus       258 ~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          258 IFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HSCSCTTTSCCHHHHHTS
T ss_pred             HccCChhHCcCHHHHHhC
Confidence            999999999999999754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=1e-28  Score=201.16  Aligned_cols=151  Identities=21%  Similarity=0.323  Sum_probs=122.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............+++.|+|||.+.
T Consensus       124 ~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  202 (335)
T 3dls_A          124 HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM  202 (335)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhc
Confidence            45789999999999999999999998 99999999999999999999999999997766555445567889999999886


Q ss_pred             hcCCC-CCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQP-TQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~-~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       +..+ +.++|+||||+++|++++|..||......                .......  +...+    ..+.+|+.+||
T Consensus       203 -~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~~~--~~~~~----~~l~~li~~~L  259 (335)
T 3dls_A          203 -GNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------VEAAIHP--PYLVS----KELMSLVSGLL  259 (335)
T ss_dssp             -TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------TTTCCCC--SSCCC----HHHHHHHHHHT
T ss_pred             -CCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------HhhccCC--CcccC----HHHHHHHHHHc
Confidence             4443 77899999999999999999999642111                0001111  11122    35899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.||.+|||+.++++.
T Consensus       260 ~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          260 QPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CSSGGGSCCHHHHHHC
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=5.6e-28  Score=203.75  Aligned_cols=160  Identities=23%  Similarity=0.276  Sum_probs=124.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc---CCCceEEeccCCccccCCC-CCCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG---ADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~---~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~p   85 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||+||+++   .++.++|+|||++...... .......+++.|+||
T Consensus       104 ~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~AP  182 (444)
T 3soa_A          104 REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP  182 (444)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCH
Confidence            45689999999999999999999998 999999999999998   4678999999999765433 233456789999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++||||+||++|+|++|..||.+.      ........+........  .+.....    ...+.+|+.
T Consensus       183 E~l~-~~~~~~~~DIwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~--~~~~~~~----s~~~~~li~  249 (444)
T 3soa_A          183 EVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDE------DQHRLYQQIKAGAYDFP--SPEWDTV----TPEAKDLIN  249 (444)
T ss_dssp             HHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCCCC--TTTTTTS----CHHHHHHHH
T ss_pred             HHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHhCCCCCC--ccccccC----CHHHHHHHH
Confidence            9886 667889999999999999999999999642      22233333322221111  0111112    245899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.++++
T Consensus       250 ~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          250 KMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHSCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhHCCCHHHHhc
Confidence            999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=4.7e-28  Score=194.88  Aligned_cols=164  Identities=24%  Similarity=0.391  Sum_probs=121.3

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcC---CCCceeeCcCCCCeEEcCCCc-eEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQ---NPGLTHGNLKSSNVLLGADFE-SCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~---~~~i~h~dlk~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .++...++.++.||+.||.|||+   . +++|+||||.||+++.++. ++|+|||++......  .....++..|+|||.
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~  174 (307)
T 2eva_A           98 YYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEV  174 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhh
Confidence            47889999999999999999999   6 8999999999999988876 799999998654322  223457889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||||+++|++++|..||....    ............     ...++.....+    ..+.+++.+|
T Consensus       175 ~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~-----~~~~~~~~~~~----~~l~~li~~~  240 (307)
T 2eva_A          175 FE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIG----GPAFRIMWAVHN-----GTRPPLIKNLP----KPIESLMTRC  240 (307)
T ss_dssp             HT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC----SSHHHHHHHHHT-----TCCCCCBTTCC----HHHHHHHHHH
T ss_pred             hC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhC----ccHHHHHHHHhc-----CCCCCcccccC----HHHHHHHHHH
Confidence            86 6678899999999999999999999996421    111111111111     11112122222    3589999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      |+.||.+|||+.++++.|+.+....
T Consensus       241 l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          241 WSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             hcCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999987654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=2.1e-28  Score=196.79  Aligned_cols=173  Identities=23%  Similarity=0.322  Sum_probs=122.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...++.++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++....... ......++..|+|||.+
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  208 (310)
T 2wqm_A          130 KRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI  208 (310)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHh
Confidence            45689999999999999999999998 99999999999999999999999999986543322 22334678889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||....    .........+....    .........+    ..+.+++.+||
T Consensus       209 ~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~----~~l~~li~~~l  275 (310)
T 2wqm_A          209 H-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQCD----YPPLPSDHYS----EELRQLVNMCI  275 (310)
T ss_dssp             T-TCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHHTTC----SCCCCTTTSC----HHHHHHHHHHT
T ss_pred             C-CCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHHhhccc----CCCCcccccC----HHHHHHHHHHc
Confidence            6 5677889999999999999999999996431    12222222221111    1111111222    35999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHHhhcCC
Q 048055          169 SLAPENRPVMREVSKMIRDSRAEAQMSS  196 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~~~~~~  196 (221)
                      +.||.+||++.++++.|+++....+.+.
T Consensus       276 ~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          276 NPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             CCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            9999999999999999999998765443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=2.5e-28  Score=199.81  Aligned_cols=168  Identities=18%  Similarity=0.231  Sum_probs=122.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-----CCCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-----SVEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~~   84 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++......     .......+++.|+|
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  196 (351)
T 3mi9_A          118 LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP  196 (351)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccC
Confidence            35689999999999999999999998 9999999999999999999999999998754322     12234567889999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCC-CCC---------------
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDD-PPS---------------  148 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---------------  148 (221)
                      ||.+.....++.++|+|||||++|+|++|..||....      .......+.......... .+.               
T Consensus       197 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (351)
T 3mi9_A          197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT------EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG  270 (351)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSS
T ss_pred             chhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhhccccccchhhcccccccc
Confidence            9987644567899999999999999999999997432      112222221111111100 000               


Q ss_pred             -CChhhHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          149 -SNEASEE-----KLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       149 -~~~~~~~-----~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                       .......     ....+.+|+.+||+.||.+|||+.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          271 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             0000000     02358899999999999999999999763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=1.8e-28  Score=202.54  Aligned_cols=166  Identities=20%  Similarity=0.458  Sum_probs=120.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      +..+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.......    .....++..|+||
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          141 DAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccCh
Confidence            45789999999999999999999998 999999999999999999999999999876543221    1122335679999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++ |..||...      ........+....     ..+....++    ..+.+++
T Consensus       220 E~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~------~~~~~~~~i~~~~-----~~~~~~~~~----~~l~~li  283 (373)
T 2qol_A          220 EAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEM------SNQDVIKAVDEGY-----RLPPPMDCP----AALYQLM  283 (373)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC------CHHHHHHHHHTTE-----ECCCCTTCB----HHHHHHH
T ss_pred             hhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcCC-----CCCCCcccc----HHHHHHH
Confidence            9887 6778889999999999999998 99999643      2222222222211     111122222    4699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+||+.||.+||++.+|++.|+++....
T Consensus       284 ~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          284 LDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            9999999999999999999999987653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=1.8e-28  Score=202.53  Aligned_cols=156  Identities=19%  Similarity=0.221  Sum_probs=122.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++... .........+++.|+|||.+.
T Consensus       134 ~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  212 (373)
T 2r5t_A          134 RCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH  212 (373)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhC
Confidence            5688999999999999999999998 99999999999999999999999999987532 333345567899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||...      +.......+......    .+  ...+    ..+.+|+.+||+
T Consensus       213 -~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~----~~--~~~~----~~~~~li~~lL~  275 (373)
T 2r5t_A          213 -KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNILNKPLQ----LK--PNIT----NSARHLLEGLLQ  275 (373)
T ss_dssp             -TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------BHHHHHHHHHHSCCC----CC--SSSC----HHHHHHHHHHTC
T ss_pred             -CCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcccC----CC--CCCC----HHHHHHHHHHcc
Confidence             677889999999999999999999999642      222333333322111    11  1122    358999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .||.+||++.+..+.
T Consensus       276 ~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          276 KDRTKRLGAKDDFME  290 (373)
T ss_dssp             SSGGGSTTTTTTHHH
T ss_pred             cCHHhCCCCCCCHHH
Confidence            999999997544333

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=2.9e-28  Score=198.22  Aligned_cols=167  Identities=21%  Similarity=0.354  Sum_probs=129.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       151 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  229 (334)
T 2pvf_A          151 EEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  229 (334)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence            34689999999999999999999998 99999999999999999999999999987554332   122334567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ........+....     .......++    ..+.+++.
T Consensus       230 ~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~  293 (334)
T 2pvf_A          230 ALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------PVEELFKLLKEGH-----RMDKPANCT----NELYMMMR  293 (334)
T ss_dssp             HHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHHTC-----CCCCCTTCC----HHHHHHHH
T ss_pred             Hhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcC------CHHHHHHHHhcCC-----CCCCCccCC----HHHHHHHH
Confidence            886 5667889999999999999999 99999643      2223322222211     111112222    45899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      +||+.||.+||++.++++.|+++.....
T Consensus       294 ~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          294 DCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            9999999999999999999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=9.4e-29  Score=202.22  Aligned_cols=154  Identities=25%  Similarity=0.367  Sum_probs=122.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........+++.|+|||.+.
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  191 (345)
T 1xjd_A          113 HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL  191 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhc
Confidence            5689999999999999999999998 999999999999999999999999999875432 22334567899999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||...      ........+....    ...+  ...+    ..+.+++.+||+
T Consensus       192 -~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~----~~~p--~~~s----~~~~~li~~lL~  254 (345)
T 1xjd_A          192 -GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------DEEELFHSIRMDN----PFYP--RWLE----KEAKDLLVKLFV  254 (345)
T ss_dssp             -TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC----CCCC--TTSC----HHHHHHHHHHSC
T ss_pred             -CCCCCChhhhHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHhCC----CCCC--cccC----HHHHHHHHHHhc
Confidence             667889999999999999999999999642      2223333332221    1111  1222    358999999999


Q ss_pred             CCCCCCCCHH-HHH
Q 048055          170 LAPENRPVMR-EVS  182 (221)
Q Consensus       170 ~dp~~Rps~~-~l~  182 (221)
                      .||.+||++. +|+
T Consensus       255 ~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          255 REPEKRLGVRGDIR  268 (345)
T ss_dssp             SSGGGSBTTBSCGG
T ss_pred             CCHhHcCCChHHHH
Confidence            9999999987 664

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.5e-28  Score=196.65  Aligned_cols=167  Identities=18%  Similarity=0.418  Sum_probs=125.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+||
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          141 DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCc
Confidence            45789999999999999999999998 99999999999999999999999999987544321    11222346689999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++ |..||...      ........+...     ...+....++    ..+.+++
T Consensus       220 E~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li  283 (333)
T 1mqb_A          220 EAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMKAINDG-----FRLPTPMDCP----SAIYQLM  283 (333)
T ss_dssp             HHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTT-----CCCCCCTTCB----HHHHHHH
T ss_pred             hhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccC------CHHHHHHHHHCC-----CcCCCcccCC----HHHHHHH
Confidence            9886 6677889999999999999998 99999642      222222222221     1222222233    4589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      .+||+.||.+||++.++++.|+++.....
T Consensus       284 ~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          284 MQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            99999999999999999999999876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=1.4e-28  Score=210.25  Aligned_cols=163  Identities=21%  Similarity=0.408  Sum_probs=127.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.|||++.++.+||+|||+++......  ......++..|+|||.
T Consensus       312 ~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~  390 (495)
T 1opk_A          312 RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  390 (495)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhH
Confidence            45689999999999999999999998 99999999999999999999999999987654322  1223344678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++||||||+++|+|++ |..||....      .......+..     ......+..++    ..+.+||.+
T Consensus       391 ~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~------~~~~~~~~~~-----~~~~~~~~~~~----~~l~~li~~  454 (495)
T 1opk_A          391 LA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEK-----DYRMERPEGCP----EKVYELMRA  454 (495)
T ss_dssp             HH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------GGGHHHHHHT-----TCCCCCCTTCC----HHHHHHHHH
T ss_pred             Hh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-----CCCCCCCCCCC----HHHHHHHHH
Confidence            86 5677889999999999999999 999997532      2222222221     11222222232    468999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      ||+.||.+|||+.+|++.|+.+.
T Consensus       455 cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          455 CWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HcCcChhHCcCHHHHHHHHHHHH
Confidence            99999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=5.5e-28  Score=195.59  Aligned_cols=153  Identities=22%  Similarity=0.289  Sum_probs=122.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++.....  .....+++.|+|||.+.
T Consensus       100 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~  176 (318)
T 1fot_A          100 SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVS  176 (318)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhc
Confidence            45789999999999999999999998 9999999999999999999999999998754432  23457888999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ...+    ..+.+++.+||+
T Consensus       177 -~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~----~~p--~~~~----~~~~~li~~lL~  239 (318)
T 1fot_A          177 -TKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKILNAEL----RFP--PFFN----EDVKDLLSRLIT  239 (318)
T ss_dssp             -TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHCCC----CCC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCC----CCC--CCCC----HHHHHHHHHHhc
Confidence             677889999999999999999999999642      22233333322211    111  1122    358999999999


Q ss_pred             CCCCCCC-----CHHHHH
Q 048055          170 LAPENRP-----VMREVS  182 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~  182 (221)
                      .||.+||     ++.+++
T Consensus       240 ~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          240 RDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             SCTTTCTTSSTTTTHHHH
T ss_pred             cCHHHcCCCcCCCHHHHh
Confidence            9999999     888886

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=7.6e-29  Score=201.31  Aligned_cols=167  Identities=22%  Similarity=0.375  Sum_probs=128.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......++..|+|||
T Consensus       158 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  236 (333)
T 2i1m_A          158 NSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE  236 (333)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHH
Confidence            45789999999999999999999998 99999999999999999999999999987543222   122344567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|+|++ |..||.....      ............    ....+...    +..+.+++.
T Consensus       237 ~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~~~----~~~~~~~~----~~~l~~li~  301 (333)
T 2i1m_A          237 SIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV------NSKFYKLVKDGY----QMAQPAFA----PKNIYSIMQ  301 (333)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS------SHHHHHHHHHTC----CCCCCTTC----CHHHHHHHH
T ss_pred             Hhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccch------hHHHHHHHhcCC----CCCCCCCC----CHHHHHHHH
Confidence            886 6678899999999999999998 9999974321      111111111111    11111122    246899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      +||+.||.+|||+.++++.|++...+.
T Consensus       302 ~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          302 ACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            999999999999999999999987653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=3.1e-28  Score=194.71  Aligned_cols=165  Identities=21%  Similarity=0.311  Sum_probs=125.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~   84 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......     ......+++.|+|
T Consensus       122 ~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~a  200 (298)
T 3f66_A          122 THNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA  200 (298)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccC
Confidence            45689999999999999999999998 99999999999999999999999999986543321     1223455678999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|+||+|+++|++++ |.+||.....      ..........     .....+...+    ..+.++
T Consensus       201 PE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~l~~l  264 (298)
T 3f66_A          201 LESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQG-----RRLLQPEYCP----DPLYEV  264 (298)
T ss_dssp             HHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT------TTHHHHHHTT-----CCCCCCTTCC----HHHHHH
T ss_pred             hHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhcC-----CCCCCCccCC----HHHHHH
Confidence            99886 6778889999999999999999 5666653211      1111111111     1111112222    359999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      +.+||+.||.+||++.++++.|+++...
T Consensus       265 i~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          265 MLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=1.9e-28  Score=198.09  Aligned_cols=167  Identities=21%  Similarity=0.301  Sum_probs=122.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus       102 ~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~  180 (317)
T 2pmi_A          102 PRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL  180 (317)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHh
Confidence            45689999999999999999999998 9999999999999999999999999998765432 233445678899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC------------------CCCCCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG------------------DDPPSSN  150 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~  150 (221)
                      .....++.++|+|||||++|+|++|..||....      .......+........                  ...+...
T Consensus       181 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (317)
T 2pmi_A          181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN------DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL  254 (317)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCS
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhH
Confidence            634567899999999999999999999997432      1122222211100000                  0000000


Q ss_pred             ------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 ------EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 ------~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                            .........+.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          255 RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                  000011246899999999999999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=3.2e-30  Score=209.10  Aligned_cols=174  Identities=24%  Similarity=0.386  Sum_probs=126.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+|||
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  200 (327)
T 3lxl_A          122 ARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE  200 (327)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHH
Confidence            4689999999999999999999998 99999999999999999999999999987654332    223345677899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc------CCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH------GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      .+. +..++.++|+||||+++|++++|..||.......      ....... ...... .......+....++    ..+
T Consensus       201 ~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~----~~l  273 (327)
T 3lxl_A          201 SLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL-SRLLEL-LEEGQRLPAPPACP----AEV  273 (327)
T ss_dssp             HHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH-HHHHHH-HHTTCCCCCCTTCC----HHH
T ss_pred             Hhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH-HHHHHH-hhcccCCCCCCccc----HHH
Confidence            886 5667889999999999999999999986432110      0000000 011111 11111222222222    459


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       274 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          274 HELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            99999999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=1.4e-28  Score=195.17  Aligned_cols=159  Identities=23%  Similarity=0.308  Sum_probs=127.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............++..|+|||.+. 
T Consensus       117 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-  194 (284)
T 2a19_B          117 EKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS-  194 (284)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhc-
Confidence            5789999999999999999999998 99999999999999999999999999987665544444556788999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||||+++|++++|..||....        .....+...     .. +  ...    +..+.+++.+||+.
T Consensus       195 ~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~~~~~-----~~-~--~~~----~~~~~~li~~~l~~  254 (284)
T 2a19_B          195 SQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTDLRDG-----II-S--DIF----DKKEKTLLQKLLSK  254 (284)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHHHHTT-----CC-C--TTS----CHHHHHHHHHHTCS
T ss_pred             cCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHHhhcc-----cc-c--ccC----CHHHHHHHHHHccC
Confidence            6677899999999999999999998875321        111111111     11 1  111    23588999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhHHH
Q 048055          171 APENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       171 dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ||.+||++.++++.|+.+...
T Consensus       255 dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          255 KPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             SGGGSCCHHHHHHHHHHHTC-
T ss_pred             ChhhCcCHHHHHHHHHHHhhC
Confidence            999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=3.8e-28  Score=192.47  Aligned_cols=164  Identities=23%  Similarity=0.470  Sum_probs=128.6

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccch
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECRE   89 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.+.
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  183 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN  183 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhc
Confidence            689999999999999999999998 99999999999999999999999999987654332  122334567899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                       +..++.++|+||||+++|++++ |..||...      ........+...     .........+    ..+.+++.+||
T Consensus       184 -~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~~~l  247 (279)
T 1qpc_A          184 -YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERG-----YRMVRPDNCP----EELYQLMRLCW  247 (279)
T ss_dssp             -HCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTT-----CCCCCCTTCC----HHHHHHHHHHT
T ss_pred             -cCCCCchhhhHHHHHHHHHHHhCCCCCCccc------CHHHHHHHHhcc-----cCCCCccccc----HHHHHHHHHHh
Confidence             5667889999999999999999 89999642      222222222221     1111112222    46999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          169 SLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      +.||++|||+.++++.|+++....
T Consensus       248 ~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          248 KERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccChhhCCCHHHHHHHHHHHHHhc
Confidence            999999999999999999987654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.7e-28  Score=194.04  Aligned_cols=167  Identities=21%  Similarity=0.295  Sum_probs=127.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-----CCCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-----SVEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~~~   84 (221)
                      ++.+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++......     .......++..|++
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  196 (298)
T 3pls_A          118 QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA  196 (298)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccC
Confidence            56789999999999999999999998 9999999999999999999999999998654322     12233456778999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ||.+. +..++.++|+||||+++|++++|..|+...     .........+....     ..+.....+    ..+.+++
T Consensus       197 PE~~~-~~~~~~~~Di~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li  261 (298)
T 3pls_A          197 LESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRH-----IDPFDLTHFLAQGR-----RLPQPEYCP----DSLYQVM  261 (298)
T ss_dssp             HHHHT-TCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCGGGHHHHHHTTC-----CCCCCTTCC----HHHHHHH
T ss_pred             hhhhc-cCCCChhhchhhHHHHHHHHhhCCCCCCcc-----CCHHHHHHHhhcCC-----CCCCCccch----HHHHHHH
Confidence            99886 667788999999999999999955554321     11112222221111     111122222    3689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+||+.||.+|||+.++++.|+++....
T Consensus       262 ~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          262 QQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            9999999999999999999999988753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=3.1e-28  Score=202.27  Aligned_cols=160  Identities=23%  Similarity=0.368  Sum_probs=116.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||.|||+. +|+||||||.||+++ ++.+||+|||+++......   ......+++.|+|||
T Consensus       149 ~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  226 (390)
T 2zmd_A          149 KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE  226 (390)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChH
Confidence            34788899999999999999999998 999999999999995 5889999999997654322   223457899999999


Q ss_pred             cchh----------cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           87 CREI----------WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        87 ~~~~----------~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      .+..          ...++.++|||||||++|+|++|..||....     ........+...    ......+...    
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~----~~~~~~~~~~----  293 (390)
T 2zmd_A          227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDP----NHEIEFPDIP----  293 (390)
T ss_dssp             HHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCT----TSCCCCCCCS----
T ss_pred             HhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCc----cccCCCCccc----
Confidence            8752          1356788999999999999999999996421     111112222111    1111111111    


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ...+.+|+.+||+.||.+||++.++++.
T Consensus       294 ~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          294 EKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            2358999999999999999999999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.95  E-value=2.8e-28  Score=194.48  Aligned_cols=167  Identities=20%  Similarity=0.395  Sum_probs=128.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      .+.++...++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........    .....++..|+||
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          111 NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeCh
Confidence            35689999999999999999999998 999999999999999999999999999875543321    1223445789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++ |..||....      .......+...     ..+..+..++    ..+.+++
T Consensus       190 E~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li  253 (291)
T 1xbb_A          190 ECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLEKG-----ERMGCPAGCP----REMYDLM  253 (291)
T ss_dssp             HHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTT-----CCCCCCTTCC----HHHHHHH
T ss_pred             HHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcC-----CCCCCCCCCC----HHHHHHH
Confidence            9886 5666789999999999999999 999996432      22222222211     1111112222    4699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      .+||+.||.+||++.++++.|+++-...+
T Consensus       254 ~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          254 NLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999886653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=6.1e-28  Score=191.38  Aligned_cols=155  Identities=25%  Similarity=0.380  Sum_probs=119.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ++++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++....... .....++..|+|||.+. 
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~-  180 (279)
T 3fdn_A          104 SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIE-  180 (279)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHT-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhc-
Confidence            5689999999999999999999998 99999999999999999999999999875433222 23456788999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||||+++|++++|..||...      ........+......    .+  ...    ...+.+|+.+||+.
T Consensus       181 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~----~~--~~~----~~~~~~li~~~l~~  244 (279)
T 3fdn_A          181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEFT----FP--DFV----TEGARDLISRLLKH  244 (279)
T ss_dssp             TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCC----CC--TTS----CHHHHHHHHHHCCS
T ss_pred             cCCCCccchhHhHHHHHHHHHHCCCCCCCC------cHHHHHHHHHhCCCC----CC--CcC----CHHHHHHHHHHhcc
Confidence            667788999999999999999999999642      222222332221111    11  112    23589999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048055          171 APENRPVMREVSKM  184 (221)
Q Consensus       171 dp~~Rps~~~l~~~  184 (221)
                      ||.+||++.++++.
T Consensus       245 ~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          245 NPSQRPMLREVLEH  258 (279)
T ss_dssp             SGGGSCCHHHHHHC
T ss_pred             ChhhCCCHHHHhhC
Confidence            99999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=3.9e-28  Score=201.04  Aligned_cols=167  Identities=20%  Similarity=0.218  Sum_probs=124.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-CCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ++.+++..+..++.||+.||.|||+. |++|+||||.||+++ .++.++|+|||+++............++..|+|||.+
T Consensus       135 ~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~  213 (383)
T 3eb0_A          135 GRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELM  213 (383)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHh
Confidence            56789999999999999999999998 999999999999997 6889999999999866555445556778899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-------------ccCCCCCCCC-h---
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-------------ESGDDPPSSN-E---  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~-~---  151 (221)
                      .....++.++|+||+||++|+|++|..||.+..      .......+.....             ......+... .   
T Consensus       214 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (383)
T 3eb0_A          214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGET------SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR  287 (383)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH
T ss_pred             cCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH
Confidence            644557899999999999999999999997432      1111111111000             0000001000 0   


Q ss_pred             --hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 --ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 --~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              01112346899999999999999999999973

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=3.4e-28  Score=199.19  Aligned_cols=161  Identities=20%  Similarity=0.243  Sum_probs=114.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.   ++.++|+|||+++............+++.|+|||
T Consensus       142 ~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  220 (349)
T 2w4o_A          142 KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE  220 (349)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHH
Confidence            45689999999999999999999998 9999999999999975   8899999999987655443344567788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+|||||++|++++|..||....     ........+......  ...+....    ....+.+|+.+
T Consensus       221 ~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~i~~~~~~--~~~~~~~~----~~~~~~~li~~  288 (349)
T 2w4o_A          221 ILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDER-----GDQFMFRRILNCEYY--FISPWWDE----VSLNAKDLVRK  288 (349)
T ss_dssp             HHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-----CHHHHHHHHHTTCCC--CCTTTTTT----SCHHHHHHHHT
T ss_pred             Hhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCc-----ccHHHHHHHHhCCCc--cCCchhhh----CCHHHHHHHHH
Confidence            887 6678899999999999999999999996421     111122222221111  00111111    22468999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||++|||+.++++
T Consensus       289 ~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          289 LIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=2.7e-28  Score=196.42  Aligned_cols=167  Identities=22%  Similarity=0.338  Sum_probs=129.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........   .....++..|+|||
T Consensus       142 ~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (316)
T 2xir_A          142 KDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  220 (316)
T ss_dssp             TTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence            34489999999999999999999998 999999999999999999999999999875443321   12334567899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||.....     .......+....     ........+    ..+.+++.
T Consensus       221 ~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~  285 (316)
T 2xir_A          221 TIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCRRLKEGT-----RMRAPDYTT----PEMYQTML  285 (316)
T ss_dssp             HHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-----SHHHHHHHHHTC-----CCCCCTTCC----HHHHHHHH
T ss_pred             hhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccch-----hHHHHHHhccCc-----cCCCCCCCC----HHHHHHHH
Confidence            886 6778899999999999999998 9999964321     112222222211     111112222    35899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      +||+.||.+|||+.++++.|+.+....
T Consensus       286 ~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          286 DCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            999999999999999999999988654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.6e-28  Score=204.29  Aligned_cols=178  Identities=19%  Similarity=0.175  Sum_probs=134.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE----cCCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL----GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||||.||++    +.++.++|+|||+++............++..|+|||
T Consensus       107 ~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE  185 (396)
T 4eut_A          107 YGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD  185 (396)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHH
Confidence            3489999999999999999999998 99999999999999    777889999999997665554445567889999999


Q ss_pred             cchhc-------CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc---------------CC
Q 048055           87 CREIW-------KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES---------------GD  144 (221)
Q Consensus        87 ~~~~~-------~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~  144 (221)
                      .+...       ..++.++|+|||||++|++++|..||......  .........+.......               ..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  263 (396)
T 4eut_A          186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG  263 (396)
T ss_dssp             HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT--TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEES
T ss_pred             HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc--cchHHHHHHHhcCCCcccchhheeccCCCcccCc
Confidence            87521       34567899999999999999999999753221  11222222222211100               01


Q ss_pred             CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          145 DPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       145 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ..+.....+......+.+++.+||+.||++||++.++++.|+++...
T Consensus       264 ~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            12223344566778899999999999999999999999998887643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=4.8e-28  Score=198.02  Aligned_cols=156  Identities=22%  Similarity=0.290  Sum_probs=118.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++... .........+++.|+|||.+.
T Consensus       105 ~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  183 (345)
T 3a8x_A          105 RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR  183 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccC
Confidence            5689999999999999999999998 99999999999999999999999999987533 223344567899999999887


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---CCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                       +..++.++|+|||||++|+|++|..||.......   ..........+...    ....+  ...+    ..+.+++.+
T Consensus       184 -~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~----~~~~p--~~~s----~~~~~li~~  252 (345)
T 3a8x_A          184 -GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----QIRIP--RSLS----VKAASVLKS  252 (345)
T ss_dssp             -TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----CCCCC--TTSC----HHHHHHHHH
T ss_pred             -CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----CCCCC--CCCC----HHHHHHHHH
Confidence             6677899999999999999999999996421110   01111122222221    11111  1222    358999999


Q ss_pred             cccCCCCCCCCH
Q 048055          167 CVSLAPENRPVM  178 (221)
Q Consensus       167 cl~~dp~~Rps~  178 (221)
                      ||+.||.+||++
T Consensus       253 lL~~dP~~R~~~  264 (345)
T 3a8x_A          253 FLNKDPKERLGC  264 (345)
T ss_dssp             HTCSSTTTSTTC
T ss_pred             HhcCCHhHCCCC
Confidence            999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=6.8e-28  Score=189.79  Aligned_cols=159  Identities=23%  Similarity=0.325  Sum_probs=121.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.||+.||.|||+. +  ++|+||||.||+++.++.+++.+||+......    ....+++.|+|||.+
T Consensus       106 ~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~  180 (271)
T 3kmu_A          106 FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEAL  180 (271)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhh
Confidence            3689999999999999999999998 8  99999999999999999999998887643222    234667899999987


Q ss_pred             hhcCCCCC---cccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 EIWKQPTQ---QADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~~~~~~~~---~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      . +.....   ++|+||||+++|++++|..||...      ...........    ....+..+...+    ..+.+++.
T Consensus       181 ~-~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~~~~~~~~~----~~~~~~~~~~~~----~~~~~li~  245 (271)
T 3kmu_A          181 Q-KKPEDTNRRSADMWSFAVLLWELVTREVPFADL------SNMEIGMKVAL----EGLRPTIPPGIS----PHVSKLMK  245 (271)
T ss_dssp             H-SCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS------CHHHHHHHHHH----SCCCCCCCTTCC----HHHHHHHH
T ss_pred             c-cCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc------ChHHHHHHHHh----cCCCCCCCCCCC----HHHHHHHH
Confidence            6 333333   799999999999999999999642      22222222211    111112122222    35999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +||+.||.+|||+.++++.|+++.
T Consensus       246 ~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          246 ICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHcCCChhhCcCHHHHHHHHHHhh
Confidence            999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.95  E-value=1.4e-28  Score=206.62  Aligned_cols=105  Identities=27%  Similarity=0.361  Sum_probs=93.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc--eEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE--SCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.||+.||.|||+. +++||||||.||+++.++.  ++|+|||++......  .....+++.|+|||.+
T Consensus       195 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          195 QGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVI  271 (429)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHH
Confidence            4589999999999999999999998 9999999999999999887  999999998654332  2345778899999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      . +..++.++|||||||++|+|++|..||..
T Consensus       272 ~-~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          272 L-GARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             H-TBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             h-CCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            7 67789999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.95  E-value=8.7e-29  Score=205.08  Aligned_cols=171  Identities=20%  Similarity=0.231  Sum_probs=124.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-----------------------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-----------------------------------   54 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-----------------------------------   54 (221)
                      .+.+++..+..++.||+.||.|||++.+++||||||.||+++.++                                   
T Consensus       140 ~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (397)
T 1wak_A          140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN  219 (397)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccc
Confidence            356899999999999999999999954899999999999998775                                   


Q ss_pred             --------------ceEEeccCCccccCCCCCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 048055           55 --------------ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        55 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~  120 (221)
                                    .++|+|||++......  .....++..|+|||.+. +..++.++|||||||++|+|++|..||...
T Consensus       220 ~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          220 FLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI-GSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             TSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc-CCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence                          7999999998765432  23456788999999987 667889999999999999999999999754


Q ss_pred             ccccCCChHHHHHHhhhhhhccC-----------------------CCCCC---------CChhhHHHHHHHHHHHHHcc
Q 048055          121 VLEHGSDIPRWVRSVREEETESG-----------------------DDPPS---------SNEASEEKLQALLNIAIACV  168 (221)
Q Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~---------~~~~~~~~~~~l~~l~~~cl  168 (221)
                      ..............+........                       .....         ...........+.+|+.+||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  376 (397)
T 1wak_A          297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML  376 (397)
T ss_dssp             CCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGG
T ss_pred             cccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHh
Confidence            32211111111111111000000                       00000         01123455678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||++|||+.++++
T Consensus       377 ~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          377 ELIPEKRATAAECLR  391 (397)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             ccChhhcCCHHHHhh
Confidence            999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.5e-28  Score=197.00  Aligned_cols=167  Identities=18%  Similarity=0.253  Sum_probs=118.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      +..+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        94 ~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  172 (324)
T 3mtl_A           94 GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL  172 (324)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhh
Confidence            45689999999999999999999998 9999999999999999999999999998654322 223344668899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCC-CCCC-------------------
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGD-DPPS-------------------  148 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-------------------  148 (221)
                      .....++.++|+||+|+++|+|++|..||....      .......+......... ..+.                   
T Consensus       173 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (324)
T 3mtl_A          173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST------VEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEA  246 (324)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCC
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchh
Confidence            644667899999999999999999999997432      22222222111111000 0000                   


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          247 LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00001112246899999999999999999999976

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=4.3e-28  Score=198.67  Aligned_cols=153  Identities=18%  Similarity=0.172  Sum_probs=122.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++.....  .....+++.|+|||.+. 
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~-  211 (350)
T 1rdq_E          136 GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIIL-  211 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHT-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhc-
Confidence            4689999999999999999999998 9999999999999999999999999998755432  23456789999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ...+    ..+.+++.+||+.
T Consensus       212 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~----~~p--~~~~----~~~~~li~~lL~~  275 (350)
T 1rdq_E          212 SKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIVSGKV----RFP--SHFS----SDLKDLLRNLLQV  275 (350)
T ss_dssp             TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC----CCC--TTCC----HHHHHHHHHHSCS
T ss_pred             CCCCCCcCCEecccHhHhHHhhCCCCCCCC------CHHHHHHHHHcCCC----CCC--CCCC----HHHHHHHHHHhhc
Confidence            667789999999999999999999999642      22333333333221    111  1222    3589999999999


Q ss_pred             CCCCCCC-----HHHHHH
Q 048055          171 APENRPV-----MREVSK  183 (221)
Q Consensus       171 dp~~Rps-----~~~l~~  183 (221)
                      ||.+||+     +.+|++
T Consensus       276 dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          276 DLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHT
T ss_pred             CHHhccCCccCCHHHHHh
Confidence            9999998     888864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=2.8e-28  Score=199.08  Aligned_cols=160  Identities=23%  Similarity=0.377  Sum_probs=115.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||.|||+. +++||||||.||+++ ++.++|+|||+++......   ......+++.|+|||
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  179 (343)
T 3dbq_A          102 KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE  179 (343)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHH
Confidence            35789999999999999999999998 999999999999997 6789999999997654332   223456889999999


Q ss_pred             cchh----------cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           87 CREI----------WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        87 ~~~~----------~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      .+..          ...++.++|||||||++|+|++|..||....     .............    .....+...+   
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~---  247 (343)
T 3dbq_A          180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPN----HEIEFPDIPE---  247 (343)
T ss_dssp             HHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTT----SCCCCCCCSC---
T ss_pred             HHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCC----cccCCcccCC---
Confidence            8752          1556788999999999999999999996421     1111111111111    1111111111   


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                       ..+.+|+.+||+.||.+|||+.++++.
T Consensus       248 -~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          248 -KDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             358999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.95  E-value=1.2e-28  Score=196.20  Aligned_cols=162  Identities=22%  Similarity=0.338  Sum_probs=113.4

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+..+++..++.++.|++.||.|||+..+++|+||||.||+++.++.++|+|||++.............+++.|+|||.+
T Consensus       102 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          102 KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI  181 (290)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhc
Confidence            35679999999999999999999998438999999999999999999999999998765544444445678899999985


Q ss_pred             h---hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           89 E---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        89 ~---~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .   ....++.++|+||+|+++|++++|..||...     .............   .... ......+    ..+.+++.
T Consensus       182 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~---~~~~-~~~~~~~----~~~~~li~  248 (290)
T 3fme_A          182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-----GTPFQQLKQVVEE---PSPQ-LPADKFS----AEFVDFTS  248 (290)
T ss_dssp             SCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-----SCHHHHHHHHHHS---CCCC-CCTTTSC----HHHHHHHH
T ss_pred             ChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-----CchHHHHHHHhcc---CCCC-cccccCC----HHHHHHHH
Confidence            2   2456678999999999999999999999642     1111111111111   1111 1111222    35899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.++++
T Consensus       249 ~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          249 QCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHTCSSGGGSCCHHHHTT
T ss_pred             HHhhcChhhCcCHHHHHh
Confidence            999999999999999976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=3e-28  Score=213.55  Aligned_cols=165  Identities=21%  Similarity=0.414  Sum_probs=127.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .+.+++..++.++.||+.||.|||+. +|+||||||.||+++.++.+||+|||+++......    ......++..|+||
T Consensus       463 ~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~AP  541 (635)
T 4fl3_A          463 NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  541 (635)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeCh
Confidence            45789999999999999999999998 99999999999999999999999999987654332    11223446789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++||||||+++|+|++ |..||...      ........+....     .+..+..++    ..+.+||
T Consensus       542 E~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~------~~~~~~~~i~~~~-----~~~~p~~~~----~~l~~li  605 (635)
T 4fl3_A          542 ECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM------KGSEVTAMLEKGE-----RMGCPAGCP----REMYDLM  605 (635)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTTC-----CCCCCTTCC----HHHHHHH
T ss_pred             hhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcCC-----CCCCCCCCC----HHHHHHH
Confidence            9986 6778899999999999999998 99999743      2223333332221     122222232    4699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||++||++.+|++.|+++-.+
T Consensus       606 ~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=3.4e-28  Score=191.35  Aligned_cols=164  Identities=21%  Similarity=0.387  Sum_probs=127.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ......++..|+|||.
T Consensus        98 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  176 (267)
T 3t9t_A           98 RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV  176 (267)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhh
Confidence            35689999999999999999999998 99999999999999999999999999987543321  1223345678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||...      ........+....     ....+...+    ..+.+++.+
T Consensus       177 ~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~i~~~~-----~~~~~~~~~----~~l~~li~~  240 (267)
T 3t9t_A          177 FS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGF-----RLYKPRLAS----THVYQIMNH  240 (267)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTTC-----CCCCCTTSC----HHHHHHHHH
T ss_pred             hc-CCCccchhchhhhHHHHHHHhccCCCCCCCC------CHHHHHHHHhcCC-----cCCCCccCc----HHHHHHHHH
Confidence            86 5677889999999999999999 89999642      2222222222211     111111222    358999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||+.||.+||++.++++.|+++.+
T Consensus       241 ~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          241 CWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=2.4e-28  Score=201.84  Aligned_cols=165  Identities=19%  Similarity=0.212  Sum_probs=127.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE--cCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL--GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.||+.||.|||+. +++|+||||.||++  +.++.++|+|||++.............+++.|+|||.+
T Consensus       182 ~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  260 (373)
T 2x4f_A          182 YNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV  260 (373)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhc
Confidence            4689999999999999999999998 99999999999999  56788999999999776555444555788999999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||...      ........+.....    ..+  ..........+.+|+.+||
T Consensus       261 ~-~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~~~~----~~~--~~~~~~~~~~~~~li~~~L  327 (373)
T 2x4f_A          261 N-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGD------NDAETLNNILACRW----DLE--DEEFQDISEEAKEFISKLL  327 (373)
T ss_dssp             T-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCC----CSC--SGGGTTSCHHHHHHHHTTS
T ss_pred             c-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccC----CCC--hhhhccCCHHHHHHHHHHc
Confidence            6 567788999999999999999999999642      22222233222111    111  1111112346899999999


Q ss_pred             cCCCCCCCCHHHHHH--HHHhhH
Q 048055          169 SLAPENRPVMREVSK--MIRDSR  189 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~--~L~~~~  189 (221)
                      +.||.+||++.++++  .+.+..
T Consensus       328 ~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          328 IKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             CCChhhCCCHHHHhcCcCcCCCc
Confidence            999999999999986  555443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.95  E-value=2.8e-28  Score=197.81  Aligned_cols=161  Identities=19%  Similarity=0.289  Sum_probs=120.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.|++.||.|||+. +++|+||||.||+++.   ++.++|+|||++.............+++.|+|||
T Consensus       125 ~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  203 (327)
T 3lm5_A          125 AEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE  203 (327)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCe
Confidence            46789999999999999999999998 9999999999999988   7899999999997665444444567889999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+||||+++|+|++|..||...      ........+.......  .......    ....+.+++.+
T Consensus       204 ~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~--~~~~~~~----~~~~~~~li~~  270 (327)
T 3lm5_A          204 ILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGE------DNQETYLNISQVNVDY--SEETFSS----VSQLATDFIQS  270 (327)
T ss_dssp             HHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCC--CTTTTTT----SCHHHHHHHHH
T ss_pred             eec-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CchHHHHHHHhccccc--Cchhhcc----cCHHHHHHHHH
Confidence            886 677789999999999999999999999642      2222222222211111  1111111    22468999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+|||+.++++.
T Consensus       271 ~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          271 LLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HSCSSGGGSCCHHHHTTC
T ss_pred             HcCCChhhCcCHHHHhCC
Confidence            999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=4e-28  Score=196.33  Aligned_cols=165  Identities=16%  Similarity=0.246  Sum_probs=123.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.||+.||.|||+. |++|+||||.||+++.++.++|+|||++.............++..|+|||.+. 
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-  192 (326)
T 1blx_A          115 PGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL-  192 (326)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHh-
Confidence            4589999999999999999999998 99999999999999999999999999987654433334556788999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-----------------CCCCCCCChhh
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-----------------GDDPPSSNEAS  153 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~  153 (221)
                      +..++.++|+||||+++|++++|..||....      .......+.......                 ...........
T Consensus       193 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 1blx_A          193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV  266 (326)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTC
T ss_pred             cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhcc
Confidence            5677899999999999999999999996432      122222222111000                 00000001111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ......+.+|+.+||+.||.+||++.++++
T Consensus       267 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          267 TDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            122346899999999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.2e-28  Score=208.66  Aligned_cols=102  Identities=26%  Similarity=0.390  Sum_probs=85.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      ...++...+..++.||+.||.|||+. +|+||||||.|||++.++.+||+|||+++......                  
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  228 (458)
T 3rp9_A          150 PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV  228 (458)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-----------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccc
Confidence            45689999999999999999999998 99999999999999999999999999997643211                  


Q ss_pred             ----------CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHh
Q 048055           72 ----------VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT  112 (221)
Q Consensus        72 ----------~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~  112 (221)
                                ......+|+.|+|||.+.....++.++|||||||++|+|++
T Consensus       229 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             ----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence                      12334668899999976546678999999999999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=5e-28  Score=213.49  Aligned_cols=154  Identities=23%  Similarity=0.380  Sum_probs=123.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC-CCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN-PDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++... .........+|+.|+|||.+.
T Consensus       437 ~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~  515 (674)
T 3pfq_A          437 GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA  515 (674)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhc
Confidence            5689999999999999999999998 99999999999999999999999999997533 233345567899999999986


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|+|++|..||...      +.......+.....    ..+  ...+    ..+.+|+.+||+
T Consensus       516 -~~~~~~~~DvwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~lL~  578 (674)
T 3pfq_A          516 -YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHNV----AYP--KSMS----KEAVAICKGLMT  578 (674)
T ss_dssp             -CCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHSSCC----CCC--TTSC----HHHHHHHHHHSC
T ss_pred             -CCCCCccceEechHHHHHHHHcCCCCCCCC------CHHHHHHHHHhCCC----CCC--ccCC----HHHHHHHHHHcc
Confidence             678899999999999999999999999742      22333333332221    111  1222    458999999999


Q ss_pred             CCCCCCCCH-----HHHH
Q 048055          170 LAPENRPVM-----REVS  182 (221)
Q Consensus       170 ~dp~~Rps~-----~~l~  182 (221)
                      .||.+||++     .+|+
T Consensus       579 ~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          579 KHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             SSSTTCTTCSTTHHHHHH
T ss_pred             CCHHHCCCCCCCcHHHHh
Confidence            999999987     6665

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=6.4e-28  Score=192.04  Aligned_cols=158  Identities=23%  Similarity=0.387  Sum_probs=116.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ++.+++..++.++.|++.||.|||+. +++|+||||.||++   +.++.++|+|||++.............++..|+|||
T Consensus       118 ~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE  196 (285)
T 3is5_A          118 GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE  196 (285)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChH
Confidence            36789999999999999999999998 99999999999999   556789999999997655444445567788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+.  ..++.++|+||||+++|++++|..||...      ..............   .........+    ..+.+++.+
T Consensus       197 ~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~------~~~~~~~~~~~~~~---~~~~~~~~~~----~~~~~li~~  261 (285)
T 3is5_A          197 VFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGT------SLEEVQQKATYKEP---NYAVECRPLT----PQAVDLLKQ  261 (285)
T ss_dssp             HHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC---CCCC--CCCC----HHHHHHHHH
T ss_pred             Hhc--cCCCcccCeehHHHHHHHHHhCCCCCCCC------CHHHHHhhhccCCc---ccccccCcCC----HHHHHHHHH
Confidence            874  45688999999999999999999999643      22222222211111   1111111122    358899999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.|+++
T Consensus       262 ~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          262 MLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HTCSCTTTSCCHHHHHT
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=1.8e-28  Score=196.33  Aligned_cols=172  Identities=22%  Similarity=0.337  Sum_probs=126.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      ...+++..++.++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+||
T Consensus       120 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          120 KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCC
Confidence            35689999999999999999999998 99999999999999999999999999987654332    22344567779999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccc------cCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE------HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      |.+. +..++.++|+||||+++|++++|..|+......      ....... ........ ......+.....+    ..
T Consensus       199 E~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~----~~  271 (302)
T 4e5w_A          199 ECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT-VTRLVNTL-KEGKRLPCPPNCP----DE  271 (302)
T ss_dssp             HHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH-HHHHHHHH-HTTCCCCCCTTCC----HH
T ss_pred             eeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC-HHHHHHHH-hccCCCCCCCCCC----HH
Confidence            9886 566778999999999999999999887432100      0000000 01111111 1111222222222    46


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          160 LLNIAIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.+|+.+||+.||.+|||+.++++.|+++.
T Consensus       272 l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          272 VYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            999999999999999999999999998864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=8.3e-28  Score=190.87  Aligned_cols=159  Identities=23%  Similarity=0.327  Sum_probs=124.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.++...+..++.|++.||.|||+. +++|+||||.||+++.++.   ++|+|||.+.............++..|+|||.
T Consensus       100 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          100 EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV  178 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchh
Confidence            5689999999999999999999998 9999999999999976655   99999999876665554555678899999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||+|+++|++++|..||...      ........+........  .+.....+    ..+.+++.+|
T Consensus       179 ~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~--~~~~~~~~----~~~~~li~~~  245 (284)
T 3kk8_A          179 LK-KDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQIKAGAYDYP--SPEWDTVT----PEAKSLIDSM  245 (284)
T ss_dssp             HT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCCC--TTTTTTSC----HHHHHHHHHH
T ss_pred             hc-CCCCCcccchHHHHHHHHHHHHCCCCCCCC------chhHHHHHHHhccccCC--chhhcccC----HHHHHHHHHH
Confidence            86 667788999999999999999999999642      22222233222211111  11111222    3589999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       246 l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          246 LTVNPKKRITADQALK  261 (284)
T ss_dssp             SCSSTTTSCCHHHHTT
T ss_pred             cccChhhCCCHHHHhc
Confidence            9999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=6.7e-29  Score=207.09  Aligned_cols=110  Identities=24%  Similarity=0.371  Sum_probs=87.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE----cCCCceEEeccCCccccCCC----CCCCCCCCCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL----GADFESCLTDYGLGSFRNPD----SVEEPSATSLF   81 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~   81 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.||++    +.++.++|+|||+++.....    .......+++.
T Consensus       122 ~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  200 (405)
T 3rgf_A          122 PVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  200 (405)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCc
Confidence            34689999999999999999999998 99999999999999    67789999999999765432    12234567889


Q ss_pred             ccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCccc
Q 048055           82 YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        82 ~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~  120 (221)
                      |+|||.+.....++.++|||||||++|+|++|..||.+.
T Consensus       201 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             TCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999998864455788999999999999999999999643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.95  E-value=4.7e-28  Score=191.92  Aligned_cols=160  Identities=23%  Similarity=0.412  Sum_probs=121.0

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcC
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWK   92 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~   92 (221)
                      ++...++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++.......  ....++..|+|||.+. +.
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~-~~  189 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR-EK  189 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHH-HC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeeccccccccccc--cCCCccccccCHHHhC-CC
Confidence            78889999999999999999998 99999999999999999999999999986543321  2234567899999886 67


Q ss_pred             CCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCC
Q 048055           93 QPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLA  171 (221)
Q Consensus        93 ~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  171 (221)
                      .++.++|+||||+++|++++ |..||.....      ......+...     ........++    ..+.+++.+||+.|
T Consensus       190 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~~~l~~~  254 (278)
T 1byg_A          190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKG-----YKMDAPDGCP----PAVYEVMKNCWHLD  254 (278)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGHHHHHTTT-----CCCCCCTTCC----HHHHHHHHHHTCSS
T ss_pred             CCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC-----CCCCCcccCC----HHHHHHHHHHhcCC
Confidence            77889999999999999998 9999964321      1222222111     1111122222    46999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhHHH
Q 048055          172 PENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       172 p~~Rps~~~l~~~L~~~~~~  191 (221)
                      |.+||++.++++.|+++...
T Consensus       255 p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          255 AAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             GGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=1.8e-28  Score=198.84  Aligned_cols=162  Identities=20%  Similarity=0.284  Sum_probs=121.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~p   85 (221)
                      ..+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++......   .......+++.|+||
T Consensus        98 ~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  176 (323)
T 3tki_A           98 PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP  176 (323)
T ss_dssp             TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCc
Confidence            345799999999999999999999998 9999999999999999999999999998654221   223345788899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+......+.++|+||||+++|+|++|..||......     ..........    ....+.....    ...+.+|+.
T Consensus       177 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~----~~~~~~~~~~----~~~~~~li~  243 (323)
T 3tki_A          177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYSDWKEK----KTYLNPWKKI----DSAPLALLH  243 (323)
T ss_dssp             HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-----SHHHHHHHTT----CTTSTTGGGS----CHHHHHHHH
T ss_pred             HHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhcc----cccCCccccC----CHHHHHHHH
Confidence            98863333367899999999999999999999743211     1111111111    1111111122    245889999


Q ss_pred             HcccCCCCCCCCHHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~  184 (221)
                      +||+.||.+|||+.|+++.
T Consensus       244 ~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          244 KILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTC
T ss_pred             HHccCChhhCcCHHHHhhC
Confidence            9999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=9.7e-28  Score=194.75  Aligned_cols=155  Identities=21%  Similarity=0.263  Sum_probs=117.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++..... .......+++.|+|||.+.
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (327)
T 3a62_A          116 GIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM  194 (327)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCc
Confidence            4688999999999999999999998 9999999999999999999999999998654322 2234456789999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|+|++|..||...      ........+.....    ..+  ...    ...+.+++.+||+
T Consensus       195 -~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~----~~p--~~~----~~~~~~li~~~L~  257 (327)
T 3a62_A          195 -RSGHNRAVDWWSLGALMYDMLTGAPPFTGE------NRKKTIDKILKCKL----NLP--PYL----TQEARDLLKKLLK  257 (327)
T ss_dssp             -TSCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCC----CCC--TTS----CHHHHHHHHHHSC
T ss_pred             -CCCCCCcccchhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCC----CCC--CCC----CHHHHHHHHHHHh
Confidence             567789999999999999999999999642      22222333322211    111  112    2458999999999


Q ss_pred             CCCCCCC-----CHHHHHH
Q 048055          170 LAPENRP-----VMREVSK  183 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~  183 (221)
                      .||.+||     ++.++++
T Consensus       258 ~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          258 RNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             SCGGGSTTSSTTTHHHHHH
T ss_pred             cCHhhccCCCCCCHHHHHc
Confidence            9999999     6777764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=7.3e-28  Score=197.58  Aligned_cols=105  Identities=28%  Similarity=0.398  Sum_probs=92.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-------------------------CCceEEeccCCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-------------------------DFESCLTDYGLGS   65 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-------------------------~~~~~l~dfg~~~   65 (221)
                      ..+++..+..++.||+.||.|||+. +++|+||||.||+++.                         ++.++|+|||++.
T Consensus       132 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~  210 (360)
T 3llt_A          132 NGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT  210 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence            4589999999999999999999998 9999999999999975                         7889999999987


Q ss_pred             ccCCCCCCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           66 FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      .....  .....+++.|+|||.+. +..++.++|||||||++|+|++|..||..
T Consensus       211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          211 FKSDY--HGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             ETTSC--CCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecCCC--CcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence            54332  23456788999999987 67789999999999999999999999964

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.95  E-value=6e-29  Score=205.56  Aligned_cols=155  Identities=17%  Similarity=0.170  Sum_probs=117.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..++.++.||+.||+|||+. +++||||||.||+++.++.+||+|||+++....  ......+ ..|+|||.+. 
T Consensus       201 ~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~-  275 (377)
T 3byv_A          201 KSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEA-  275 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHH-
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhc-
Confidence            4556788889999999999999998 999999999999999999999999999875332  1233455 8899999987 


Q ss_pred             cC-----------CCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           91 WK-----------QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        91 ~~-----------~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      +.           .++.++|+|||||++|+|++|..||.........          .......      ...    +..
T Consensus       276 ~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~----------~~~~~~~------~~~----~~~  335 (377)
T 3byv_A          276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS----------EWIFRSC------KNI----PQP  335 (377)
T ss_dssp             HHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS----------GGGGSSC------CCC----CHH
T ss_pred             ccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch----------hhhhhhc------cCC----CHH
Confidence            44           6789999999999999999999999653221100          0000000      111    236


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH--HHHhhHH
Q 048055          160 LLNIAIACVSLAPENRPVMREVSK--MIRDSRA  190 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~~--~L~~~~~  190 (221)
                      +.+|+.+||+.||.+||++.++++  .+.++..
T Consensus       336 ~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            899999999999999999999985  4444443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=3.3e-28  Score=201.85  Aligned_cols=160  Identities=18%  Similarity=0.283  Sum_probs=123.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC--CCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA--DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +..+++..++.++.||+.||.|||+. +++|+||||.||+++.  .+.++|+|||++.............+++.|+|||.
T Consensus       143 ~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~  221 (387)
T 1kob_A          143 DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI  221 (387)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchh
Confidence            45789999999999999999999998 9999999999999974  46799999999976654443344567889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+|||||++|+|++|..||...      ........+........  .......    ...+.+|+.+|
T Consensus       222 ~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~i~~~~~~~~--~~~~~~~----s~~~~~li~~~  288 (387)
T 1kob_A          222 VD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKRCDWEFD--EDAFSSV----SPEAKDFIKNL  288 (387)
T ss_dssp             HT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHCCCCCC--SSTTTTS----CHHHHHHHHTT
T ss_pred             cc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCC--ccccccC----CHHHHHHHHHH
Confidence            86 567788999999999999999999999642      22222222222111111  0111112    24689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       289 L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          289 LQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             cCCChhHCcCHHHHhh
Confidence            9999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=2.8e-28  Score=197.25  Aligned_cols=160  Identities=19%  Similarity=0.233  Sum_probs=124.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      .+.++...+..++.|++.||.|||+. +++|+||||.||+++.++    .++|+|||++.............+++.|+||
T Consensus       109 ~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          109 KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP  187 (321)
T ss_dssp             CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCc
Confidence            45789999999999999999999998 999999999999999888    7999999998766554444556688899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++|+||||+++|++++|..||...      ........+....    ...+  .......+..+.+++.
T Consensus       188 E~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~----~~~~--~~~~~~~~~~~~~li~  254 (321)
T 2a2a_A          188 EIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANITSVS----YDFD--EEFFSHTSELAKDFIR  254 (321)
T ss_dssp             HHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTC----CCCC--HHHHTTCCHHHHHHHH
T ss_pred             cccc-CCCCCCccccHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhcc----cccC--hhhhcccCHHHHHHHH
Confidence            9886 677789999999999999999999999642      2222222221111    1111  1111122346899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.++++
T Consensus       255 ~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          255 KLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTSCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=9.9e-28  Score=196.52  Aligned_cols=159  Identities=19%  Similarity=0.256  Sum_probs=121.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccccCCCC-CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSFRNPDS-VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~p   85 (221)
                      +..++...+..++.||+.||.|||+. +++|+||||+||+++.++.   ++|+|||++....... ......+++.|+||
T Consensus       124 ~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP  202 (351)
T 3c0i_A          124 GFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP  202 (351)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCH
Confidence            34689999999999999999999998 9999999999999986654   9999999987654433 23445788999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++|+|||||++|++++|..||....       ......+....    ....  ..........+.+|+.
T Consensus       203 E~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~----~~~~--~~~~~~~s~~~~~li~  268 (351)
T 3c0i_A          203 EVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGK----YKMN--PRQWSHISESAKDLVR  268 (351)
T ss_dssp             HHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTC----CCCC--HHHHTTSCHHHHHHHH
T ss_pred             HHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCC----CCCC--ccccccCCHHHHHHHH
Confidence            9886 5677899999999999999999999996421       12222222111    1111  1111112346899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.++++
T Consensus       269 ~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          269 RMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCSSTTTSCCHHHHHT
T ss_pred             HHCCCChhHCcCHHHHhc
Confidence            999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=9e-28  Score=197.95  Aligned_cols=170  Identities=22%  Similarity=0.305  Sum_probs=124.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.....  .....++..|+|||.+..
T Consensus       123 ~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~  199 (367)
T 1cm8_A          123 EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN  199 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhC
Confidence            4688999999999999999999998 9999999999999999999999999998764432  234567889999998764


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc--------------------cCCCCC-CC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE--------------------SGDDPP-SS  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~-~~  149 (221)
                      ...++.++|+||+||++|+|++|..||.+..      .......+......                    ...... ..
T Consensus       200 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (367)
T 1cm8_A          200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD------HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF  273 (367)
T ss_dssp             TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred             CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH
Confidence            4678899999999999999999999997432      11111111110000                    000000 00


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK--MIRDSR  189 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~--~L~~~~  189 (221)
                      ..........+.+|+.+||+.||.+|||+.++++  .+++..
T Consensus       274 ~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          274 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            0011112346899999999999999999999986  344443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=3e-28  Score=193.76  Aligned_cols=167  Identities=20%  Similarity=0.408  Sum_probs=129.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++........  .....++..|+|||.
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  183 (288)
T 3kfa_A          105 RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  183 (288)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHH
T ss_pred             cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhh
Confidence            45689999999999999999999998 999999999999999999999999999876543321  122344667999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||....      .......+...     .........+    ..+.+++.+
T Consensus       184 ~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~~  247 (288)
T 3kfa_A          184 LA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKD-----YRMERPEGCP----EKVYELMRA  247 (288)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------GGGHHHHHHTT-----CCCCCCTTCC----HHHHHHHHH
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcc-----CCCCCCCCCC----HHHHHHHHH
Confidence            86 6677889999999999999999 999997432      12222222211     1111112222    469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      ||+.||.+||++.++++.|+++..+..
T Consensus       248 ~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          248 CWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            999999999999999999999876644

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=9.5e-28  Score=193.55  Aligned_cols=167  Identities=22%  Similarity=0.306  Sum_probs=120.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC------CCCCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD------SVEEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~~~   83 (221)
                      +..+++..++.++.||+.||.|||+. +++|+||||.||+++ ++.++|+|||++......      .......++..|+
T Consensus       124 ~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~  201 (319)
T 2y4i_B          124 KIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL  201 (319)
T ss_dssp             CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCccccc
Confidence            45789999999999999999999998 999999999999998 679999999987643211      1223345778899


Q ss_pred             Ccccchh--------cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHH
Q 048055           84 APECREI--------WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEE  155 (221)
Q Consensus        84 ~pe~~~~--------~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (221)
                      |||.+..        ...++.++|+||||+++|++++|..||...      ........+.......    ......+  
T Consensus       202 aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~~~----~~~~~~~--  269 (319)
T 2y4i_B          202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ------PAEAIIWQMGTGMKPN----LSQIGMG--  269 (319)
T ss_dssp             CHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC------CHHHHHHHHHTTCCCC----CCCSSCC--
T ss_pred             ChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHhccCCCCC----CCcCCCC--
Confidence            9998752        134577899999999999999999999642      2222222222211110    0011111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          156 KLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       156 ~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                        ..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       270 --~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          270 --KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             --TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             --HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence              25899999999999999999999999999988653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.3e-28  Score=198.20  Aligned_cols=168  Identities=20%  Similarity=0.180  Sum_probs=124.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus       106 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  184 (346)
T 1ua2_A          106 SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL  184 (346)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHH
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHh
Confidence            45689999999999999999999998 9999999999999999999999999998765432 233455678899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-CC---------------CCCC--C
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-DD---------------PPSS--N  150 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---------------~~~~--~  150 (221)
                      .....++.++|+|||||++|++++|..||...      ........+........ ..               .+..  .
T Consensus       185 ~~~~~~~~~~DiwslG~il~ell~g~~~~~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (346)
T 1ua2_A          185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGD------SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH  258 (346)
T ss_dssp             TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHH
T ss_pred             hCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChH
Confidence            63455788999999999999999999999643      22222222222111100 00               0000  0


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          259 HIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0011223569999999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.4e-28  Score=195.57  Aligned_cols=167  Identities=17%  Similarity=0.239  Sum_probs=118.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus        96 ~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (311)
T 4agu_A           96 QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL  174 (311)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHH
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHH
Confidence            46689999999999999999999998 9999999999999999999999999998765432 223445678889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh---------------hhhccCCCCCCCCh--
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE---------------EETESGDDPPSSNE--  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~--  151 (221)
                      .....++.++|+||+|+++|++++|..||.....      ......+..               .........+....  
T Consensus       175 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (311)
T 4agu_A          175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD------VDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME  248 (311)
T ss_dssp             HTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC
T ss_pred             hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhcccccccccccccccccccCcCCCccccc
Confidence            6446678999999999999999999999974321      111111111               01111111111100  


Q ss_pred             ----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ----ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ----~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                          ..+.....+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                00112345899999999999999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=1.2e-27  Score=196.09  Aligned_cols=168  Identities=18%  Similarity=0.166  Sum_probs=124.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhc--CCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIH--QNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH--~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      ....++...+..++.|++.||.|||  +. +++|+||||.||+++. ++.++|+|||++.............++..|+||
T Consensus       122 ~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          122 RQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP  200 (360)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCH
Confidence            3567889999999999999999999  87 9999999999999997 899999999999776655545556778899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC----------------CCCCCC
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG----------------DDPPSS  149 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~  149 (221)
                      |.+.....++.++|+||||+++|++++|..||....      .......+........                ......
T Consensus       201 E~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (360)
T 3e3p_A          201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN------SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGI  274 (360)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCC
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC------hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccC
Confidence            987644557899999999999999999999997432      1122222111100000                000000


Q ss_pred             ------ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 ------NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                            ..........+.+|+.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          275 PWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  0000012356999999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=3.2e-28  Score=209.71  Aligned_cols=163  Identities=25%  Similarity=0.480  Sum_probs=128.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      +.+++..++.++.||+.||.|||+. +++||||||.|||++.++.+||+|||+++......  ......++..|+|||.+
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~  436 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA  436 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHh
Confidence            4589999999999999999999998 99999999999999999999999999987543221  12233456789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++||||||+++|+|++ |..||...      ........+...     ...+....++    ..+.+||.+|
T Consensus       437 ~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~------~~~~~~~~i~~~-----~~~~~~~~~~----~~l~~li~~c  500 (535)
T 2h8h_A          437 L-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVERG-----YRMPCPPECP----ESLHDLMCQC  500 (535)
T ss_dssp             H-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC------CHHHHHHHHHTT-----CCCCCCTTCC----HHHHHHHHHH
T ss_pred             c-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcC-----CCCCCCCCCC----HHHHHHHHHH
Confidence            7 6778899999999999999999 99999643      222333333221     2222222333    4689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHH
Q 048055          168 VSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      |+.||++|||+.+|++.|+++..
T Consensus       501 l~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          501 WRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             TCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             cCCChhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=3.8e-28  Score=198.83  Aligned_cols=156  Identities=24%  Similarity=0.379  Sum_probs=121.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++......   ....+++.|+|||.+.
T Consensus       148 ~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~  223 (348)
T 1u5q_A          148 KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVIL  223 (348)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhc
Confidence            46789999999999999999999998 9999999999999999999999999998655432   3456788999999874


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ...++.++|+||||+++|+|++|..||...      ........+.....    ........+    ..+.+|+.+|
T Consensus       224 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~~~~~----~~l~~li~~~  289 (348)
T 1u5q_A          224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES----PALQSGHWS----EYFRNFVDSC  289 (348)
T ss_dssp             TTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC----CCCCCTTSC----HHHHHHHHHH
T ss_pred             cccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCC----CCCCCCCCC----HHHHHHHHHH
Confidence            1  355688999999999999999999999642      22222222222111    111111222    3589999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       290 l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             cccChhhCcCHHHHhh
Confidence            9999999999999974

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=5.3e-28  Score=196.00  Aligned_cols=175  Identities=21%  Similarity=0.339  Sum_probs=128.7

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~pe   86 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........    .....++..|+|||
T Consensus       140 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  218 (326)
T 2w1i_A          140 ERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE  218 (326)
T ss_dssp             TSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECch
Confidence            5689999999999999999999998 999999999999999999999999999876543321    22334566799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccc------cCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLE------HGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      .+. +..++.++|+||||+++|++++|..||......      ...........+.... ......+....++    ..+
T Consensus       219 ~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~l  292 (326)
T 2w1i_A          219 SLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRPDGCP----DEI  292 (326)
T ss_dssp             HHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH-HTTCCCCCCTTCC----HHH
T ss_pred             hhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh-hcCCCCCCCCccc----HHH
Confidence            876 566788999999999999999999988632100      0000000011111111 1111222222232    469


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          161 LNIAIACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      .+++.+||+.||.+||++.+|++.|+++.+..
T Consensus       293 ~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          293 YMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999988653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.95  E-value=3e-28  Score=193.94  Aligned_cols=164  Identities=21%  Similarity=0.414  Sum_probs=125.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~pe   86 (221)
                      +.+++..+..++.|++.||.|||+. +++|+||||.||+++.++.++|+|||++........    .....++..|+|||
T Consensus       116 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (291)
T 1u46_A          116 GHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE  194 (291)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCch
Confidence            5689999999999999999999998 999999999999999999999999999866543321    12334566799999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|+||||+++|++++ |..||...      ........+..    .....+.....+    ..+.+++.
T Consensus       195 ~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~----~~~~~~~~~~~~----~~l~~li~  259 (291)
T 1u46_A          195 SLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDK----EGERLPRPEDCP----QDIYNVMV  259 (291)
T ss_dssp             HHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHT----SCCCCCCCTTCC----HHHHHHHH
T ss_pred             hhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccC------CHHHHHHHHHc----cCCCCCCCcCcC----HHHHHHHH
Confidence            886 5666789999999999999999 99999643      22222222211    111222222232    46999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||.+||++.++++.|++...
T Consensus       260 ~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          260 QCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHccCCcccCcCHHHHHHHHHHhCc
Confidence            9999999999999999999988764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=1.5e-28  Score=197.94  Aligned_cols=165  Identities=22%  Similarity=0.329  Sum_probs=116.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      +++++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......++..|+|||
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  189 (311)
T 3ork_A          111 GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE  189 (311)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHH
Confidence            5689999999999999999999998 99999999999999999999999999987543322    122345788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+||||+++|+|++|..||....      ...........    ...++  .......+..+.+++.+
T Consensus       190 ~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~----~~~~~--~~~~~~~~~~l~~li~~  256 (311)
T 3ork_A          190 QAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVRE----DPIPP--SARHEGLSADLDAVVLK  256 (311)
T ss_dssp             HHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHC----CCCCH--HHHSTTCCHHHHHHHHH
T ss_pred             Hhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcC----CCCCc--ccccCCCCHHHHHHHHH
Confidence            886 6677889999999999999999999996432      11221111111    11111  11111123469999999


Q ss_pred             cccCCCCCCCCHHHH-HHHHHhhH
Q 048055          167 CVSLAPENRPVMREV-SKMIRDSR  189 (221)
Q Consensus       167 cl~~dp~~Rps~~~l-~~~L~~~~  189 (221)
                      ||+.||.+||++.++ ...|.+..
T Consensus       257 ~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          257 ALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHhcCHhhChhhHHHHHHHHHHHh
Confidence            999999999975554 44554443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=6e-28  Score=190.95  Aligned_cols=157  Identities=23%  Similarity=0.391  Sum_probs=114.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++.............++..|+|||.+..
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  184 (276)
T 2h6d_A          106 GRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG  184 (276)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcC
Confidence            4688999999999999999999998 999999999999999999999999999876554443445567888999998863


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ....+.++|+||||+++|++++|..||...      ........+......    .+  ...    ...+.+++.+||+.
T Consensus       185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~~----~~--~~~----~~~l~~li~~~l~~  248 (276)
T 2h6d_A          185 RLYAGPEVDIWSCGVILYALLCGTLPFDDE------HVPTLFKKIRGGVFY----IP--EYL----NRSVATLLMHMLQV  248 (276)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC----CC--TTS----CHHHHHHHHHHTCS
T ss_pred             CCCCCccchHHHHHHHHHHHHhCCCCCCCC------cHHHHHHHhhcCccc----Cc--hhc----CHHHHHHHHHHccC
Confidence            233357899999999999999999999642      222333333221111    11  112    23589999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048055          171 APENRPVMREVSKM  184 (221)
Q Consensus       171 dp~~Rps~~~l~~~  184 (221)
                      ||.+|||+.++++.
T Consensus       249 ~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          249 DPLKRATIKDIREH  262 (276)
T ss_dssp             SGGGSCCHHHHHHS
T ss_pred             ChhhCCCHHHHHhC
Confidence            99999999999763

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=3.7e-28  Score=199.49  Aligned_cols=167  Identities=19%  Similarity=0.274  Sum_probs=116.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.............++..|+|||.+.
T Consensus       128 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~  206 (362)
T 3pg1_A          128 RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM  206 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhc
Confidence            45789999999999999999999998 99999999999999999999999999987554444445557788899999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh--------------------ccCCCCCCC
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET--------------------ESGDDPPSS  149 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  149 (221)
                      ....++.++|+|||||++|++++|..||....      .......+.....                    ......+..
T Consensus       207 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (362)
T 3pg1_A          207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGST------FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR  280 (362)
T ss_dssp             TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC
T ss_pred             CCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh
Confidence            44677899999999999999999999996422      1122222111000                    000000100


Q ss_pred             --ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 --NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 --~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        ..........+.+|+.+||+.||.+|||+.++++
T Consensus       281 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          281 AWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence              0111122346899999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=1.9e-28  Score=198.66  Aligned_cols=167  Identities=19%  Similarity=0.243  Sum_probs=121.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++.++ .++|+|||+++............++..|+|||.+.
T Consensus       125 ~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          125 QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV  203 (330)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHT
T ss_pred             HhCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhc
Confidence            3478899999999999999999998 999999999999999776 89999999997665555455667888999999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh---------hccCCCCC-------------
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE---------TESGDDPP-------------  147 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~-------------  147 (221)
                      ....++.++|+|||||++|+|++|..||....     .............         ........             
T Consensus       204 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (330)
T 3nsz_A          204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-----DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK  278 (330)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS-----SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCC
T ss_pred             CCCcCCchhhHHHHHHHHHHHHhCCCCcccCC-----chHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhcccc
Confidence            44677899999999999999999999995321     1111111100000         00000000             


Q ss_pred             -----CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          148 -----SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       148 -----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                           ............+.+|+.+||+.||.+|||+.++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          279 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 000001112346999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=1.3e-27  Score=195.15  Aligned_cols=163  Identities=21%  Similarity=0.264  Sum_probs=121.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE-------------------cCCCceEEeccCCccccCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL-------------------GADFESCLTDYGLGSFRNPDS   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~-------------------~~~~~~~l~dfg~~~~~~~~~   71 (221)
                      .++++..+..++.||+.||.|||+. +++|+||||.||++                   +.++.++|+|||++...... 
T Consensus       118 ~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-  195 (355)
T 2eu9_A          118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-  195 (355)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-
Confidence            5689999999999999999999998 99999999999999                   56789999999998754432 


Q ss_pred             CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC--------
Q 048055           72 VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG--------  143 (221)
Q Consensus        72 ~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  143 (221)
                       .....++..|+|||.+. +..++.++|+||||+++|+|++|..||.....      ......+.......+        
T Consensus       196 -~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~p~~~~~~~~  267 (355)
T 2eu9_A          196 -HTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN------REHLVMMEKILGPIPSHMIHRTR  267 (355)
T ss_dssp             -CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCHHHHHHCS
T ss_pred             -ccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCcHHHhhhcc
Confidence             23456788999999886 67788999999999999999999999974321      111111111000000        


Q ss_pred             -------C--CC-----------------CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          144 -------D--DP-----------------PSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       144 -------~--~~-----------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                             .  ..                 .............+.+|+.+||+.||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          268 KQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                   0  00                 0000011123457999999999999999999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=2.9e-28  Score=204.90  Aligned_cols=107  Identities=27%  Similarity=0.371  Sum_probs=89.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------------------
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------------------   71 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   71 (221)
                      ...+++..+..++.||+.||.|||+. +++||||||.||+++.++.+||+|||+++......                  
T Consensus       123 ~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  201 (432)
T 3n9x_A          123 PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN  201 (432)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccc
Confidence            45689999999999999999999998 99999999999999999999999999997643321                  


Q ss_pred             -----CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCC
Q 048055           72 -----VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF  117 (221)
Q Consensus        72 -----~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf  117 (221)
                           ......+++.|+|||.+.....++.++||||+||++|+|++|..||
T Consensus       202 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ---------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence                 1245577889999998654677899999999999999999855444

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=1.6e-28  Score=195.49  Aligned_cols=161  Identities=24%  Similarity=0.354  Sum_probs=119.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc--------eEEeccCCccccCCCCCCCCCCCCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE--------SCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.        ++|+|||++......   ....++..|
T Consensus       108 ~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y  183 (289)
T 4fvq_A          108 NCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPW  183 (289)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcc
Confidence            3489999999999999999999998 9999999999999998887        999999988543322   123456789


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      +|||.+.....++.++|+||||+++|++++|..|+..     .............    ....+.   ..    ...+.+
T Consensus       184 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~-----~~~~~~~~~~~~~----~~~~~~---~~----~~~l~~  247 (289)
T 4fvq_A          184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-----ALDSQRKLQFYED----RHQLPA---PK----AAELAN  247 (289)
T ss_dssp             SCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT-----TSCHHHHHHHHHT----TCCCCC---CS----SCTTHH
T ss_pred             cCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc-----ccchHHHHHHhhc----cCCCCC---CC----CHHHHH
Confidence            9999887336678899999999999999995544432     1111121111111    111111   11    124889


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      ++.+||+.||.+|||+.++++.|+++..-
T Consensus       248 li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          248 LINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            99999999999999999999999998753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=1.9e-29  Score=208.10  Aligned_cols=154  Identities=13%  Similarity=0.078  Sum_probs=112.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhc--CCCCC
Q 048055           19 LKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIW--KQPTQ   96 (221)
Q Consensus        19 ~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~   96 (221)
                      ..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++......  ....+++.|+|||.+. +  ..++.
T Consensus       197 ~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~-~~~~~~~~  272 (371)
T 3q60_A          197 HILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLN-ASTATFTH  272 (371)
T ss_dssp             HHHHHHHHHHHHHHHHT-TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHT-CSEEECCH
T ss_pred             HHHHHHHHHHHHHHHHC-CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhcc-CCCCCcCc
Confidence            67779999999999998 99999999999999999999999999987554321  1334558899999886 4  56789


Q ss_pred             cccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 048055           97 QADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP  176 (221)
Q Consensus        97 ~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp  176 (221)
                      ++|+|||||++|+|++|..||.............   .............+.....    +..+.+|+.+||+.||++||
T Consensus       273 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rp  345 (371)
T 3q60_A          273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR---PSLRVPGTDSLAFGSCTPL----PDFVKTLIGRFLNFDRRRRL  345 (371)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB---CCTTSCCCCSCCCTTSSCC----CHHHHHHHHHHTCSSTTTCC
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCcCcccccchhh---hhhhhccccccchhhccCC----CHHHHHHHHHHcCCChhhCC
Confidence            9999999999999999999997643221110000   0000000001111111122    24699999999999999999


Q ss_pred             CHHHHHH
Q 048055          177 VMREVSK  183 (221)
Q Consensus       177 s~~~l~~  183 (221)
                      |+.++++
T Consensus       346 t~~e~l~  352 (371)
T 3q60_A          346 LPLEAME  352 (371)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999974

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=1.4e-27  Score=188.97  Aligned_cols=159  Identities=21%  Similarity=0.299  Sum_probs=123.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..++.++.|++.||.|||+. +++|+||||.||++   +.++.++|+|||++.............+++.|+|||
T Consensus       100 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE  178 (277)
T 3f3z_A          100 KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ  178 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChH
Confidence            35689999999999999999999998 99999999999999   788999999999987665555555667888999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+.  ..++.++|+||||+++|++++|..||...      ........+....    ...+  .......+..+.+++.+
T Consensus       179 ~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~li~~  244 (277)
T 3f3z_A          179 VLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAP------TDSEVMLKIREGT----FTFP--EKDWLNVSPQAESLIRR  244 (277)
T ss_dssp             HHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC----CCCC--HHHHTTSCHHHHHHHHH
T ss_pred             Hhc--ccCCchhhehhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCC----CCCC--chhhhcCCHHHHHHHHH
Confidence            875  34788999999999999999999999642      2222222222211    1111  11111123469999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+||++.++++
T Consensus       245 ~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          245 LLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.95  E-value=4e-28  Score=200.08  Aligned_cols=165  Identities=21%  Similarity=0.288  Sum_probs=113.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+..++.||+.||.|||+. |++|+||||.||+++.++.++|+|||+++.....  .....++..|+|||.+..
T Consensus       127 ~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          127 QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcC
Confidence            5789999999999999999999998 9999999999999999999999999998654332  234567889999998764


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc--------------------cCCCCCCC-
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE--------------------SGDDPPSS-  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~-  149 (221)
                      ...++.++|+||+||++|+|++|..||.+..      .......+......                    ....+... 
T Consensus       204 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (367)
T 2fst_X          204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF  277 (367)
T ss_dssp             CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCH
Confidence            4677899999999999999999999997432      11111211111000                    00000000 


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ..........+.+|+.+||+.||.+|||+.++++.
T Consensus       278 ~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          278 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00001122468999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=5.2e-28  Score=195.42  Aligned_cols=163  Identities=23%  Similarity=0.396  Sum_probs=126.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      .++++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......   ......+++.|+|||.
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            5678999999999999999999998 99999999999999999999999999986543221   1123345678999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|++++ |..||...      ........+....     ........+    ..+.+++.+
T Consensus       212 ~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~li~~  275 (322)
T 1p4o_A          212 LK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEGG-----LLDKPDNCP----DMLFELMRM  275 (322)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTTC-----CCCCCTTCC----HHHHHHHHH
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHhcCCCccccC------CHHHHHHHHHcCC-----cCCCCCCCC----HHHHHHHHH
Confidence            86 6777889999999999999999 88999642      2222222222111     111112222    458999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||+.||.+||++.++++.|++...
T Consensus       276 ~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          276 CWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HcCCCcccCcCHHHHHHHHHHhhc
Confidence            999999999999999999988753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.95  E-value=2.8e-27  Score=195.86  Aligned_cols=106  Identities=24%  Similarity=0.357  Sum_probs=91.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCC-CCceeeCcCCCCeEEc--CCCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQN-PGLTHGNLKSSNVLLG--ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~-~~i~h~dlk~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.+++..+..++.||+.||.|||++ .+|+||||||.||+++  .++.++|+|||++......  .....+++.|+|||.
T Consensus       152 ~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~  229 (382)
T 2vx3_A          152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEV  229 (382)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHH
Confidence            5689999999999999999999963 3899999999999995  4778999999998765432  234567889999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      +. +..++.++|||||||++|+|++|..||..
T Consensus       230 ~~-~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          230 LL-GMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             HT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Hc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            87 66788999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=2.2e-28  Score=198.45  Aligned_cols=166  Identities=23%  Similarity=0.366  Sum_probs=107.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccccCCCC-CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSFRNPDS-VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++   .++|+|||+++...... ......++..|+||
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aP  178 (325)
T 3kn6_A          100 KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP  178 (325)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCH
Confidence            46789999999999999999999998 999999999999997765   89999999987554332 23445668899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC-CChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG-SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|+||||+++|++++|..||........ .........+...      ...............+.+|+
T Consensus       179 E~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~------~~~~~~~~~~~~s~~~~~li  251 (325)
T 3kn6_A          179 ELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------DFSFEGEAWKNVSQEAKDLI  251 (325)
T ss_dssp             ------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT------CCCCCSHHHHTSCHHHHHHH
T ss_pred             HHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC------CCCCCcccccCCCHHHHHHH
Confidence            9986 67788899999999999999999999975432211 1122222222211      11112222223345799999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+|||+.++++
T Consensus       252 ~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          252 QGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHCCCTTTCCCTTTSTT
T ss_pred             HHHCCCChhHCCCHHHHhc
Confidence            9999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=2.3e-28  Score=196.86  Aligned_cols=167  Identities=25%  Similarity=0.334  Sum_probs=118.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      +++++..++.++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++.......  ......++..|+|||.+
T Consensus       129 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  207 (309)
T 2h34_A          129 GPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF  207 (309)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHH
Confidence            4689999999999999999999998 99999999999999999999999999986544322  12344678889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||.....      ......+ ....   ..   ........+..+.+++.+||
T Consensus       208 ~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~-~~~~---~~---~~~~~~~~~~~l~~li~~~l  273 (309)
T 2h34_A          208 S-ESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMGAHI-NQAI---PR---PSTVRPGIPVAFDAVIARGM  273 (309)
T ss_dssp             C-C----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHHHHH-HSCC---CC---GGGTSTTCCTHHHHHHHHHT
T ss_pred             c-CCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHHHHh-ccCC---CC---ccccCCCCCHHHHHHHHHhc
Confidence            6 56778899999999999999999999964321      1111111 1110   00   01111112236899999999


Q ss_pred             cCCCCCCC-CHHHHHHHHHhhHHHh
Q 048055          169 SLAPENRP-VMREVSKMIRDSRAEA  192 (221)
Q Consensus       169 ~~dp~~Rp-s~~~l~~~L~~~~~~~  192 (221)
                      +.||++|| ++.++++.|++.....
T Consensus       274 ~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          274 AKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             CSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            99999999 9999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.95  E-value=2e-27  Score=192.66  Aligned_cols=163  Identities=21%  Similarity=0.297  Sum_probs=121.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-------------------CCceEEeccCCccccCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-------------------DFESCLTDYGLGSFRNPDS   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-------------------~~~~~l~dfg~~~~~~~~~   71 (221)
                      .++++..+..++.||+.||+|||+. +++|+||||.||+++.                   ++.++|+|||++...... 
T Consensus       113 ~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-  190 (339)
T 1z57_A          113 LPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-  190 (339)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-
Confidence            4689999999999999999999998 9999999999999987                   667999999998754432 


Q ss_pred             CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC--------
Q 048055           72 VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG--------  143 (221)
Q Consensus        72 ~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  143 (221)
                       .....++..|+|||.+. +..++.++|+||||+++|++++|..||.....      ......+........        
T Consensus       191 -~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~p~~~~~~~~  262 (339)
T 1z57_A          191 -HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS------KEHLAMMERILGPLPKHMIQKTR  262 (339)
T ss_dssp             -CCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH------HHHHHHHHHHHCSCCHHHHHHCS
T ss_pred             -cccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCHHHHhhcc
Confidence             23456788999999886 67788999999999999999999999974321      111111111000000        


Q ss_pred             --------------------------CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          144 --------------------------DDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       144 --------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                                                ................+.+|+.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          263 KRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence                                      0000000111234567999999999999999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=3.6e-27  Score=194.21  Aligned_cols=160  Identities=21%  Similarity=0.335  Sum_probs=122.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.||+.||.|||+. |++|+|+||.||+++.++.++|+|||++.............+++.|+|||.+..
T Consensus       195 ~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~  273 (365)
T 2y7j_A          195 VALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC  273 (365)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccc
Confidence            5689999999999999999999998 999999999999999999999999999876655444455678899999998752


Q ss_pred             -----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           91 -----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        91 -----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                           ...++.++|+||||+++|+|++|..||...      ........+....    ...+  .......+..+.+++.
T Consensus       274 ~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~------~~~~~~~~i~~~~----~~~~--~~~~~~~~~~~~~li~  341 (365)
T 2y7j_A          274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR------RQILMLRMIMEGQ----YQFS--SPEWDDRSSTVKDLIS  341 (365)
T ss_dssp             TTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTC----CCCC--HHHHSSSCHHHHHHHH
T ss_pred             cccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCC----CCCC--CcccccCCHHHHHHHH
Confidence                 124678999999999999999999999642      1122222221111    1111  0011112246899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+||++.++++
T Consensus       342 ~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          342 RLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHSCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=1.7e-27  Score=203.01  Aligned_cols=159  Identities=21%  Similarity=0.333  Sum_probs=121.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc---CCCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG---ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++   .++.++|+|||++.............+++.|+|||.
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          116 KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV  194 (486)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHH
Confidence            5689999999999999999999998 999999999999995   456799999999976655444455678999999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.  ..++.++||||+||++|++++|..||.+.      ........+......    .+  ..........+.+|+.+|
T Consensus       195 ~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~----~~--~~~~~~~s~~~~~li~~~  260 (486)
T 3mwu_A          195 LR--GTYDEKCDVWSAGVILYILLSGTPPFYGK------NEYDILKRVETGKYA----FD--LPQWRTISDDAKDLIRKM  260 (486)
T ss_dssp             GG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC----SC--SGGGGGSCHHHHHHHHHH
T ss_pred             hC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC----CC--CcccCCCCHHHHHHHHHH
Confidence            86  35788999999999999999999999642      222333333222111    11  111112234689999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 048055          168 VSLAPENRPVMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~  184 (221)
                      |+.||.+|||+.++++.
T Consensus       261 L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          261 LTFHPSLRITATQCLEH  277 (486)
T ss_dssp             TCSSTTTSCCHHHHHHC
T ss_pred             cCCChhhCcCHHHHhcC
Confidence            99999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=8e-28  Score=197.88  Aligned_cols=166  Identities=21%  Similarity=0.276  Sum_probs=121.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.......    ......+++.|+|||
T Consensus       123 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  201 (364)
T 3qyz_A          123 QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE  201 (364)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCH
Confidence            4689999999999999999999998 99999999999999999999999999987544321    123457788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh--------------------ccCCCC
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET--------------------ESGDDP  146 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  146 (221)
                      .+.....++.++|+|||||++|+|++|..||......      .....+.....                    ......
T Consensus       202 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (364)
T 3qyz_A          202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL------DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN  275 (364)
T ss_dssp             HHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG------GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred             HhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCcc
Confidence            8664566789999999999999999999999743211      11111110000                    000000


Q ss_pred             -CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          147 -PSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       147 -~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       .............+.+|+.+||+.||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          276 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0000011112346899999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=3.5e-28  Score=196.75  Aligned_cols=154  Identities=23%  Similarity=0.345  Sum_probs=117.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-------------CCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-------------VEEPSA   77 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~   77 (221)
                      ...++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++......             ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            3346667899999999999999998 99999999999999999999999999987654331             223346


Q ss_pred             CCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHH
Q 048055           78 TSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKL  157 (221)
Q Consensus        78 ~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (221)
                      +++.|+|||.+. +..++.++|+||||+++|++++|..|+....        ......    . ...    .........
T Consensus       238 gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~~----~-~~~----~~~~~~~~~  299 (332)
T 3qd2_B          238 GTKLYMSPEQIH-GNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITDV----R-NLK----FPLLFTQKY  299 (332)
T ss_dssp             -CGGGSCHHHHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHHH----H-TTC----CCHHHHHHC
T ss_pred             CCcCccChHHhc-CCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHHh----h-ccC----CCcccccCC
Confidence            788999999887 6778899999999999999999877764211        001111    0 111    112223334


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          158 QALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       158 ~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+.+++.+||+.||.+||++.++++
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            56799999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.8e-27  Score=195.76  Aligned_cols=161  Identities=12%  Similarity=0.084  Sum_probs=126.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-----------CCceEEeccCCccccC---CCCCCC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-----------DFESCLTDYGLGSFRN---PDSVEE   74 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-----------~~~~~l~dfg~~~~~~---~~~~~~   74 (221)
                      ..+.+++..++.++.||+.||.|||+. +|+||||||+||+++.           ++.++|+|||+++...   ......
T Consensus       165 ~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  243 (365)
T 3e7e_A          165 PEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT  243 (365)
T ss_dssp             TTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEEC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceee
Confidence            456799999999999999999999998 9999999999999998           8999999999996432   222334


Q ss_pred             CCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhH
Q 048055           75 PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE  154 (221)
Q Consensus        75 ~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (221)
                      ...++..|+|||.+. +..++.++|+|||||++|+|++|..||.......               ......... ...  
T Consensus       244 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------------~~~~~~~~~-~~~--  304 (365)
T 3e7e_A          244 AKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---------------CKPEGLFRR-LPH--  304 (365)
T ss_dssp             CSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---------------EEECSCCTT-CSS--
T ss_pred             eecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---------------eeechhccc-cCc--
Confidence            567899999999987 6678999999999999999999999996432110               000011111 111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhHHH
Q 048055          155 EKLQALLNIAIACVSLAPENR-PVMREVSKMIRDSRAE  191 (221)
Q Consensus       155 ~~~~~l~~l~~~cl~~dp~~R-ps~~~l~~~L~~~~~~  191 (221)
                        ...+.+++..|++.+|.+| |++.++.+.|++....
T Consensus       305 --~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          305 --LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence              2358899999999999999 4788888888887754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=5.3e-28  Score=196.38  Aligned_cols=167  Identities=17%  Similarity=0.168  Sum_probs=115.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-----CCCceEEeccCCccccCCC-CCCCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-----ADFESCLTDYGLGSFRNPD-SVEEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-----~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~   83 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++     ..+.++|+|||++...... .......++..|+
T Consensus       126 ~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~  204 (329)
T 3gbz_A          126 NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR  204 (329)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCcccc
Confidence            34689999999999999999999998 999999999999994     5556999999998654422 2233446688999


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCC-CC-------------CC-
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGD-DP-------------PS-  148 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------------~~-  148 (221)
                      |||.+.....++.++|||||||++|++++|..||....      .......+......... ..             +. 
T Consensus       205 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (329)
T 3gbz_A          205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS------EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF  278 (329)
T ss_dssp             CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred             CHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC------HHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhh
Confidence            99988644557899999999999999999999996432      12222222111111100 00             00 


Q ss_pred             CCh-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNE-----ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...     ........+.+|+.+||+.||.+|||+.|+++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000     00012246899999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=1.1e-27  Score=194.86  Aligned_cols=155  Identities=25%  Similarity=0.384  Sum_probs=122.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|++||.+.
T Consensus       136 ~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  214 (335)
T 2owb_A          136 KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS  214 (335)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhc
Confidence            5689999999999999999999998 9999999999999999999999999998755422 2234456788999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|+|++|..||...      ........+.....    ..+  ...+    ..+.+|+.+||+
T Consensus       215 -~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~----~~~--~~~~----~~~~~li~~~l~  277 (335)
T 2owb_A          215 -KKGHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEY----SIP--KHIN----PVAASLIQKMLQ  277 (335)
T ss_dssp             -TSCBCTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCC----CCC--TTSC----HHHHHHHHHHTC
T ss_pred             -cCCCCchhhHHHHHHHHHHHHHCcCCCCCC------CHHHHHHHHhcCCC----CCC--ccCC----HHHHHHHHHHcc
Confidence             667788999999999999999999999642      22222222222111    111  1222    358899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+||++.++++
T Consensus       278 ~dp~~Rps~~ell~  291 (335)
T 2owb_A          278 TDPTARPTINELLN  291 (335)
T ss_dssp             SSGGGSCCGGGGGG
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999976

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=6.3e-28  Score=191.11  Aligned_cols=156  Identities=21%  Similarity=0.330  Sum_probs=102.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++...++.++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus       106 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  184 (278)
T 3cok_A          106 VKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA  184 (278)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC---------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchh
Confidence            36789999999999999999999998 9999999999999999999999999998754422 222345678889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||......      .......    ......  +...    ...+.+++.+||
T Consensus       185 ~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~----~~~~~~--~~~~----~~~~~~li~~~l  247 (278)
T 3cok_A          185 T-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK------NTLNKVV----LADYEM--PSFL----SIEAKDLIHQLL  247 (278)
T ss_dssp             --------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC----SSCCCC--CTTS----CHHHHHHHHHHS
T ss_pred             c-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH------HHHHHHh----hcccCC--cccc----CHHHHHHHHHHc
Confidence            6 566788999999999999999999999743211      1111110    011111  1112    235899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||.+||++.++++
T Consensus       248 ~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          248 RRNPADRLSLSSVLD  262 (278)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             ccCHhhCCCHHHHhc
Confidence            999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=2.8e-27  Score=189.68  Aligned_cols=157  Identities=20%  Similarity=0.314  Sum_probs=121.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++......   .......++..|+|||
T Consensus       103 ~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  181 (305)
T 2wtk_C          103 EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE  181 (305)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChh
Confidence            46789999999999999999999998 9999999999999999999999999998754422   1223456788999999


Q ss_pred             cchhcCC--CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           87 CREIWKQ--PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        87 ~~~~~~~--~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .+. +..  .+.++|+||||+++|++++|..||...      ........+.....      ..+..++    ..+.+++
T Consensus       182 ~~~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~i~~~~~------~~~~~~~----~~l~~li  244 (305)
T 2wtk_C          182 IAN-GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------NIYKLFENIGKGSY------AIPGDCG----PPLSDLL  244 (305)
T ss_dssp             HHT-CCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCC------CCCSSSC----HHHHHHH
T ss_pred             hcc-CcccCCcchhhHHHHHHHHHHHHhCCCCCCCc------hHHHHHHHHhcCCC------CCCCccC----HHHHHHH
Confidence            875 322  256899999999999999999999642      22233333322211      1112222    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~  184 (221)
                      .+||+.||.+||++.++++.
T Consensus       245 ~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          245 KGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHccCChhhCCCHHHHhcC
Confidence            99999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=3.5e-27  Score=187.42  Aligned_cols=155  Identities=22%  Similarity=0.299  Sum_probs=121.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++....... .....++..|+|||.+. 
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~-  185 (284)
T 2vgo_A          109 GRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIE-  185 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHT-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhc-
Confidence            4689999999999999999999998 99999999999999999999999999986543322 23456788999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +..++.++|+||||+++|++++|..||...      ........+....    ...+  ...    ...+.+++.+||+.
T Consensus       186 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~----~~~~--~~~----~~~~~~li~~~l~~  249 (284)
T 2vgo_A          186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSP------SHTETHRRIVNVD----LKFP--PFL----SDGSKDLISKLLRY  249 (284)
T ss_dssp             TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTTC----CCCC--TTS----CHHHHHHHHHHSCS
T ss_pred             cCCCCcccchhhHHHHHHHHHHCCCCCCCC------CHhHHHHHHhccc----cCCC--CcC----CHHHHHHHHHHhhc
Confidence            567788999999999999999999999642      1122222222111    1111  112    23589999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048055          171 APENRPVMREVSKM  184 (221)
Q Consensus       171 dp~~Rps~~~l~~~  184 (221)
                      ||.+||++.++++.
T Consensus       250 ~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          250 HPPQRLPLKGVMEH  263 (284)
T ss_dssp             SGGGSCCHHHHHTC
T ss_pred             CHhhCCCHHHHhhC
Confidence            99999999999763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.95  E-value=2.1e-27  Score=208.89  Aligned_cols=166  Identities=23%  Similarity=0.411  Sum_probs=128.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..++.++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++.......  .....+++.|+|||.+
T Consensus       486 ~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~  564 (656)
T 2j0j_A          486 FSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI  564 (656)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHh
Confidence            4689999999999999999999998 999999999999999999999999999876543321  1223456789999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|+||||+++|+|++ |..||.+.      ........+....     ..+.+..++    ..+.+++.+|
T Consensus       565 ~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~------~~~~~~~~i~~~~-----~~~~~~~~~----~~l~~li~~~  628 (656)
T 2j0j_A          565 N-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV------KNNDVIGRIENGE-----RLPMPPNCP----PTLYSLMTKC  628 (656)
T ss_dssp             H-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHHTC-----CCCCCTTCC----HHHHHHHHHH
T ss_pred             c-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHcCC-----CCCCCcccc----HHHHHHHHHH
Confidence            6 6778899999999999999997 99999643      2223333332211     111122222    4689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      |+.||.+||++.+|++.|+++..+.+
T Consensus       629 l~~dP~~RPs~~el~~~L~~il~~~k  654 (656)
T 2j0j_A          629 WAYDPSRRPRFTELKAQLSTILEEEK  654 (656)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            99999999999999999999887654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=1.3e-27  Score=197.11  Aligned_cols=165  Identities=21%  Similarity=0.332  Sum_probs=119.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++.....  .....++..|+|||.+..
T Consensus       139 ~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          139 MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcC
Confidence            4589999999999999999999998 9999999999999999999999999998654332  234567889999998764


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-------------------CCCCCCC--
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-------------------GDDPPSS--  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~--  149 (221)
                      ...++.++|+||||+++|++++|..||...      ........+.......                   ....+..  
T Consensus       216 ~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (371)
T 4exu_A          216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGK------DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF  289 (371)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCH
T ss_pred             CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhH
Confidence            467889999999999999999999999642      1112222111100000                   0000000  


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ....+.....+.+|+.+||+.||.+|||+.++++.
T Consensus       290 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          290 TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00111123569999999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=2.9e-28  Score=194.99  Aligned_cols=168  Identities=24%  Similarity=0.407  Sum_probs=118.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC------CCCCCCCCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS------VEEPSATSLFY   82 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~   82 (221)
                      ....+++..+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++.......      ......++..|
T Consensus       114 ~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y  192 (303)
T 2vwi_A          114 KSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW  192 (303)
T ss_dssp             TTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTT
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccc
Confidence            356789999999999999999999998 99999999999999999999999999876543221      12334678889


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      +|||.+.....++.++|+||||+++|++++|..||......      ...........................+..+.+
T Consensus       193 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (303)
T 2vwi_A          193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK  266 (303)
T ss_dssp             CCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHHTSSCCCTTC-----CCCCCCCHHHHH
T ss_pred             cCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh------hHHHHHhccCCCccccccccchhhhhhhHHHHH
Confidence            99998764456788999999999999999999999753211      111111111000000000000000112246899


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 048055          163 IAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ++.+||+.||.+||++.++++
T Consensus       267 li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          267 MISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCcCHHHHhh
Confidence            999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=6.5e-28  Score=198.49  Aligned_cols=171  Identities=19%  Similarity=0.236  Sum_probs=120.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc------CCCceEEeccCCccccCCCCCCCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG------ADFESCLTDYGLGSFRNPDSVEEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~   83 (221)
                      .+.+++..+..++.||+.||.|||+..+++|+||||.||+++      ..+.++|+|||++......  .....+++.|+
T Consensus       125 ~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~  202 (373)
T 1q8y_A          125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYR  202 (373)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCcccc
Confidence            356899999999999999999999943899999999999994      4457999999998755432  23446788999


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC--------------------
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG--------------------  143 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------  143 (221)
                      |||.+. +..++.++|+||||+++|+|++|..||.................+.......+                    
T Consensus       203 aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  281 (373)
T 1q8y_A          203 SPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL  281 (373)
T ss_dssp             CHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CB
T ss_pred             CcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchh
Confidence            999987 66778999999999999999999999975432211111111111111000000                    


Q ss_pred             -C--CCC---------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          144 -D--DPP---------SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       144 -~--~~~---------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       .  ...         .....+......+.+|+.+||+.||.+|||+.++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          282 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             SSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             cccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence             0  000         001123455678999999999999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=5.1e-28  Score=202.72  Aligned_cols=163  Identities=23%  Similarity=0.326  Sum_probs=115.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      ..+.+++..+..++.|++.||.|||+. +++|+||||.||+++.++   .++|+|||+++............+++.|+||
T Consensus       232 ~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aP  310 (419)
T 3i6u_A          232 GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP  310 (419)
T ss_dssp             SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCT
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCc
Confidence            356799999999999999999999998 999999999999997544   5999999999876655444556788999999


Q ss_pred             ccchh--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           86 ECREI--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        86 e~~~~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      |.+..  ...++.++|+||||+++|+|++|..||......  ....   ..+....    .  .............+.+|
T Consensus       311 E~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~---~~i~~~~----~--~~~~~~~~~~~~~~~~l  379 (419)
T 3i6u_A          311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLK---DQITSGK----Y--NFIPEVWAEVSEKALDL  379 (419)
T ss_dssp             TTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHH---HHHHTTC----C--CCCHHHHTTSCHHHHHH
T ss_pred             eeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHH---HHHhcCC----C--CCCchhhcccCHHHHHH
Confidence            98642  345677899999999999999999999753211  1111   1111110    0  10111111223569999


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.+||+.||.+||++.++++
T Consensus       380 i~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          380 VKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHhC
Confidence            99999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=1.1e-27  Score=206.85  Aligned_cols=160  Identities=22%  Similarity=0.282  Sum_probs=124.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||+++............+++.|+|||.+.
T Consensus       280 ~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~  358 (576)
T 2acx_A          280 QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK  358 (576)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHc
Confidence            34589999999999999999999998 99999999999999999999999999997665544444567899999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+|||||++|+|++|..||.....  ..........+...    ....+  ...+    ..+.+|+.+||+
T Consensus       359 -~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~--~~~~~~i~~~i~~~----~~~~p--~~~s----~~~~dLI~~lL~  425 (576)
T 2acx_A          359 -NERYTFSPDWWALGCLLYEMIAGQSPFQQRKK--KIKREEVERLVKEV----PEEYS--ERFS----PQARSLCSQLLC  425 (576)
T ss_dssp             -TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS--CCCHHHHHHHHHHC----CCCCC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCCCccchHHHHHHHHHHHHhCCCCCccccc--chhHHHHHHHhhcc----cccCC--ccCC----HHHHHHHHHhcc
Confidence             56678999999999999999999999975321  11122222222211    11111  1122    358999999999


Q ss_pred             CCCCCCC-----CHHHHHH
Q 048055          170 LAPENRP-----VMREVSK  183 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~  183 (221)
                      .||.+||     ++.|+++
T Consensus       426 ~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          426 KDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             SSGGGSTTCSSSHHHHHHT
T ss_pred             CCHHHcCCCCCCCHHHHHh
Confidence            9999999     6788864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=1.6e-27  Score=190.39  Aligned_cols=156  Identities=24%  Similarity=0.368  Sum_probs=122.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++...... .......++..|+|||.+.
T Consensus       110 ~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  188 (294)
T 2rku_A          110 KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS  188 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhc
Confidence            5689999999999999999999998 9999999999999999999999999998765422 2233456788899999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|+||||+++|++++|..||....      .............      ..+...+    ..+.+++.+||+
T Consensus       189 -~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~------~~~~~~~----~~~~~li~~~l~  251 (294)
T 2rku_A          189 -KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEY------SIPKHIN----PVAASLIQKMLQ  251 (294)
T ss_dssp             -TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC------CCCTTSC----HHHHHHHHHHTC
T ss_pred             -cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhccC------CCccccC----HHHHHHHHHHcc
Confidence             5667889999999999999999999996422      2222222221111      1111222    358999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048055          170 LAPENRPVMREVSKM  184 (221)
Q Consensus       170 ~dp~~Rps~~~l~~~  184 (221)
                      .||.+||++.++++.
T Consensus       252 ~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          252 TDPTARPTINELLND  266 (294)
T ss_dssp             SSGGGSCCGGGGGGS
T ss_pred             cChhhCcCHHHHhhC
Confidence            999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=2.6e-27  Score=203.66  Aligned_cols=159  Identities=22%  Similarity=0.255  Sum_probs=123.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||+++....... .....+++.|+|||.+
T Consensus       283 ~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l  361 (543)
T 3c4z_A          283 NPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL  361 (543)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHH
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhh
Confidence            45799999999999999999999998 999999999999999999999999999976544332 2345789999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+|||||++|+|++|..||.....  ..........+.....    ..+  ...+    ..+.+|+.+||
T Consensus       362 ~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~--~~~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~lL  428 (543)
T 3c4z_A          362 L-GEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVLEQAV----TYP--DKFS----PASKDFCEALL  428 (543)
T ss_dssp             T-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC--CCCHHHHHHHHHHCCC----CCC--TTSC----HHHHHHHHHHS
T ss_pred             c-CCCCChHHhcCcchHHHHHHHhCCCCCCCCcc--chhHHHHHHHHhhccc----CCC--cccC----HHHHHHHHHhc
Confidence            7 67788999999999999999999999975321  1122233333322111    111  1222    36899999999


Q ss_pred             cCCCCCCCCH-----HHHH
Q 048055          169 SLAPENRPVM-----REVS  182 (221)
Q Consensus       169 ~~dp~~Rps~-----~~l~  182 (221)
                      +.||.+||++     .+|+
T Consensus       429 ~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          429 QKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             CSSGGGSCCCBTTBSHHHH
T ss_pred             cCCHhHCCCCcccCHHHHH
Confidence            9999999965     5665

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.95  E-value=1.4e-27  Score=193.60  Aligned_cols=168  Identities=21%  Similarity=0.318  Sum_probs=127.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCC---CCCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDS---VEEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~   83 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.   +..++|+|||++.......   ......++..|+
T Consensus       134 ~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  212 (327)
T 2yfx_A          134 PSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM  212 (327)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGC
T ss_pred             cccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCccee
Confidence            35689999999999999999999998 9999999999999984   4569999999886432221   123345677899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      |||.+. +..++.++|+||||+++|++++ |..||...      ........+....     .......++    ..+.+
T Consensus       213 aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~~~~~~~~~~~~~-----~~~~~~~~~----~~l~~  276 (327)
T 2yfx_A          213 PPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------SNQEVLEFVTSGG-----RMDPPKNCP----GPVYR  276 (327)
T ss_dssp             CHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHTTC-----CCCCCTTCC----HHHHH
T ss_pred             CHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCc------CHHHHHHHHhcCC-----CCCCCCCCC----HHHHH
Confidence            999886 5677889999999999999998 99999642      2222222222211     111122222    35899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhHHHhhc
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDSRAEAQM  194 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~  194 (221)
                      ++.+||+.||.+||++.++++.|+........
T Consensus       277 li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          277 IMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence            99999999999999999999999998876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=7.1e-28  Score=191.16  Aligned_cols=165  Identities=19%  Similarity=0.262  Sum_probs=122.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      +.+++..+..++.||+.||.|||+. +++|+||+|.||+++.++    .++|+|||++.............++..|+|||
T Consensus       103 ~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE  181 (283)
T 3bhy_A          103 ESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE  181 (283)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcc
Confidence            5689999999999999999999998 999999999999998877    79999999987655443344456788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+||||+++|++++|..||....      .......+...    ....  ........+..+.+++.+
T Consensus       182 ~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~li~~  248 (283)
T 3bhy_A          182 IVN-YEPLGLEADMWSIGVITYILLSGASPFLGET------KQETLTNISAV----NYDF--DEEYFSNTSELAKDFIRR  248 (283)
T ss_dssp             HHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTT----CCCC--CHHHHTTCCHHHHHHHHT
T ss_pred             eec-CCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------hHHHHHHhHhc----ccCC--cchhcccCCHHHHHHHHH
Confidence            886 5677889999999999999999999996432      11222222111    1111  111111223468999999


Q ss_pred             cccCCCCCCCCHHHHHH--HHHhhH
Q 048055          167 CVSLAPENRPVMREVSK--MIRDSR  189 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~--~L~~~~  189 (221)
                      ||+.||.+||++.++++  .++.+.
T Consensus       249 ~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          249 LLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             TSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHhCHHHHHHH
Confidence            99999999999999986  344443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.95  E-value=4.2e-28  Score=202.84  Aligned_cols=150  Identities=17%  Similarity=0.148  Sum_probs=116.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .++++++..++.++.||+.||.|||+. +++||||||.|||++.++.+||+|||+++.....  .....+ +.|+|||.+
T Consensus       204 ~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             TSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhh
Confidence            356678889999999999999999998 9999999999999999999999999998654433  233455 889999987


Q ss_pred             h---------hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHH
Q 048055           89 E---------IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQA  159 (221)
Q Consensus        89 ~---------~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (221)
                      .         ....++.++|||||||++|+|++|..||.........      ...    ....      ...+    ..
T Consensus       280 ~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~------~~~----~~~~------~~~~----~~  339 (413)
T 3dzo_A          280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------EWI----FRSC------KNIP----QP  339 (413)
T ss_dssp             HHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS------GGG----GSSC------CCCC----HH
T ss_pred             hccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH------HHH----Hhhc------ccCC----HH
Confidence            3         1344577999999999999999999999753221110      000    0000      1111    46


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHH
Q 048055          160 LLNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       160 l~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      +.+|+.+||+.||++||++.+++
T Consensus       340 ~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          340 VRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999999999987774

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=5.7e-28  Score=194.77  Aligned_cols=167  Identities=23%  Similarity=0.352  Sum_probs=124.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC----------CCCCC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE----------EPSAT   78 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~   78 (221)
                      .+..+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++.........          ....+
T Consensus       127 ~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~g  205 (317)
T 2buj_A          127 KGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC  205 (317)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHS
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccC
Confidence            356789999999999999999999998 9999999999999999999999999987543221100          11234


Q ss_pred             CccccCcccchhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           79 SLFYKAPECREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        79 ~~~~~~pe~~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      +..|+|||.+...  ..++.++|+||||+++|++++|..||...... .......   ...     ....+.....+   
T Consensus       206 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~---~~~-----~~~~~~~~~~~---  273 (317)
T 2buj_A          206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDSVALA---VQN-----QLSIPQSPRHS---  273 (317)
T ss_dssp             CGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSCHHHH---HHC-----C--CCCCTTSC---
T ss_pred             CcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cchhhHH---hhc-----cCCCCccccCC---
Confidence            7789999987521  12578999999999999999999999653221 1111111   111     11111112222   


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                       ..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       274 -~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          274 -SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             -HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence             36999999999999999999999999998875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=1.1e-27  Score=194.48  Aligned_cols=173  Identities=20%  Similarity=0.337  Sum_probs=118.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus       118 ~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~  196 (331)
T 4aaa_A          118 PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL  196 (331)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccc
Confidence            45689999999999999999999998 9999999999999999999999999998654332 233445678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCccccccc---------CCChHHHHHHhhhhhhccCCCCCCC------Chhh
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH---------GSDIPRWVRSVREEETESGDDPPSS------NEAS  153 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  153 (221)
                      .....++.++|+||||+++|++++|..||.......         +.....................+..      ....
T Consensus       197 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (331)
T 4aaa_A          197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY  276 (331)
T ss_dssp             TTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHS
T ss_pred             cCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcc
Confidence            644467889999999999999999999997432110         0000000000111111111111110      0011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          154 EEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       154 ~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +..+..+.+|+.+||+.||.+|||+.|+++
T Consensus       277 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            122356999999999999999999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=8.7e-28  Score=199.24  Aligned_cols=169  Identities=18%  Similarity=0.251  Sum_probs=118.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC--------CCCCCCCCCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD--------SVEEPSATSLF   81 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~   81 (221)
                      ...++...+..++.||+.||.|||+. +++||||||.||+++.++.++|+|||.+......        .......++..
T Consensus       122 ~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~  200 (389)
T 3gni_B          122 MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP  200 (389)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccccc
Confidence            35689999999999999999999998 9999999999999999999999999987532111        11223467788


Q ss_pred             ccCcccchhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc------------------
Q 048055           82 YKAPECREIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES------------------  142 (221)
Q Consensus        82 ~~~pe~~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------  142 (221)
                      |+|||.+... ..++.++|+|||||++|+|++|..||.+....     ..............                  
T Consensus       201 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (389)
T 3gni_B          201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-----QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS  275 (389)
T ss_dssp             GSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-----THHHHC--------------------------
T ss_pred             ccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhcCCCCcccccccccccccccccccc
Confidence            9999987632 56788999999999999999999999753211     01111000000000                  


Q ss_pred             -----------------CCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          143 -----------------GDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       143 -----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                                       .................+.+|+.+||+.||.+|||+.++++.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                             000000011122233569999999999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=9.9e-28  Score=196.10  Aligned_cols=166  Identities=16%  Similarity=0.188  Sum_probs=120.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-----------CCCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-----------EEPSATS   79 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------~~~~~~~   79 (221)
                      +.+++..+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++........           .....++
T Consensus       107 ~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt  185 (353)
T 2b9h_A          107 QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT  185 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccc
Confidence            4689999999999999999999998 999999999999999999999999999875432211           1224568


Q ss_pred             ccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc------------------
Q 048055           80 LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE------------------  141 (221)
Q Consensus        80 ~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------  141 (221)
                      ..|+|||.+.....++.++|+||||+++|++++|..||.+...      ......+......                  
T Consensus       186 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (353)
T 2b9h_A          186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY------RHQLLLIFGIIGTPHSDNDLRCIESPRAREY  259 (353)
T ss_dssp             GGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHH
T ss_pred             ccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCchhccccccccchhhHH
Confidence            8899999876456778899999999999999999999974321      1111111110000                  


Q ss_pred             ---cCCCCC-CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          142 ---SGDDPP-SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       142 ---~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                         ....+. .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          260 IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               000000 000011122356899999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=1.2e-27  Score=193.50  Aligned_cols=150  Identities=21%  Similarity=0.346  Sum_probs=118.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-CCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...++.++.||+.||.|||+. +++|+||||.||+++ .++.++|+|||++...... ......++..|+|||.+
T Consensus       143 ~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~  220 (320)
T 3a99_A          143 RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI  220 (320)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHh
Confidence            35689999999999999999999998 999999999999999 7789999999998765433 23345678899999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      ......+.++|+||||+++|++++|..||....            .........      ....+    ..+.+|+.+||
T Consensus       221 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~~~------~~~~~----~~~~~li~~~l  278 (320)
T 3a99_A          221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVFF------RQRVS----SECQHLIRWCL  278 (320)
T ss_dssp             HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCCC------SSCCC----HHHHHHHHHHT
T ss_pred             ccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccccc------cccCC----HHHHHHHHHHc
Confidence            633333678899999999999999999996421            111111111      11122    35899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||.+||++.++++
T Consensus       279 ~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          279 ALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=3.5e-27  Score=193.18  Aligned_cols=164  Identities=20%  Similarity=0.303  Sum_probs=118.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++......  .....++..|+|||.+..
T Consensus       121 ~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          121 LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhC
Confidence            4589999999999999999999998 9999999999999999999999999998654322  233467889999998764


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh--------------------ccCCC-CCCC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET--------------------ESGDD-PPSS  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~-~~~~  149 (221)
                      ...++.++|+||||+++|++++|..||....      .......+.....                    ..... ....
T Consensus       198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (353)
T 3coi_A          198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF  271 (353)
T ss_dssp             CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC------HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH
Confidence            4677889999999999999999999997432      1111111111000                    00000 0000


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..........+.+|+.+||+.||.+|||+.++++
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          272 TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0111122346999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=5.4e-28  Score=205.92  Aligned_cols=160  Identities=23%  Similarity=0.341  Sum_probs=124.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||.|||+. +++|+||||.||++   +.++.++|+|||++.............+++.|+|||
T Consensus       120 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  198 (484)
T 3nyv_A          120 RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE  198 (484)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCce
Confidence            46789999999999999999999998 99999999999999   567899999999987655444334456889999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. + .++.++|+||+||++|++++|..||...      ........+.....    ..+  ..........+.+|+.+
T Consensus       199 ~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~----~~~--~~~~~~~s~~~~~li~~  264 (484)
T 3nyv_A          199 VLH-G-TYDEKCDVWSTGVILYILLSGCPPFNGA------NEYDILKKVEKGKY----TFE--LPQWKKVSESAKDLIRK  264 (484)
T ss_dssp             HHH-T-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC----CCC--SGGGGGSCHHHHHHHHH
T ss_pred             eec-C-CCCCcceeHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCC----CCC--CcccccCCHHHHHHHHH
Confidence            875 3 6789999999999999999999999742      22233333322211    111  11111223468999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+|||+.++++.
T Consensus       265 ~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          265 MLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HTCSSGGGSCCHHHHHTS
T ss_pred             HCCCChhHCcCHHHHhhC
Confidence            999999999999999753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=191.12  Aligned_cols=161  Identities=25%  Similarity=0.349  Sum_probs=113.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.||+.||.|||+ . +++|+||+|.||+++.++.++|+|||++.............++..|+|||.+
T Consensus       118 ~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          118 QGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI  196 (318)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhc
Confidence            4578999999999999999999998 5 8999999999999999999999999998665444334445678899999987


Q ss_pred             h----hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 E----IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~----~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .    ....++.++|+||||+++|++++|..||...     ..............   ....+.....+    ..+.+++
T Consensus       197 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~----~~l~~li  264 (318)
T 2dyl_A          197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-----KTDFEVLTKVLQEE---PPLLPGHMGFS----GDFQSFV  264 (318)
T ss_dssp             C--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHHHHHSC---CCCCCSSSCCC----HHHHHHH
T ss_pred             ccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-----CccHHHHHHHhccC---CCCCCccCCCC----HHHHHHH
Confidence            4    1345678999999999999999999999642     11222222222211   11111111222    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+||++.++++
T Consensus       265 ~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          265 KDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHTCSCTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhh
Confidence            9999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=2.4e-27  Score=202.42  Aligned_cols=158  Identities=22%  Similarity=0.339  Sum_probs=123.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC---CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD---FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      .+++...+..++.||+.||.|||+. +++||||||.||+++..   +.++|+|||++.............+++.|+|||.
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~  209 (494)
T 3lij_A          131 MKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV  209 (494)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHH
Confidence            5688999999999999999999998 99999999999999764   5599999999876655444455678999999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.  ..++.++||||+||++|++++|..||...      ........+......    .+.  .........+.+|+.+|
T Consensus       210 l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~----~~~--~~~~~~s~~~~~li~~~  275 (494)
T 3lij_A          210 LR--KKYDEKCDVWSIGVILFILLAGYPPFGGQ------TDQEILRKVEKGKYT----FDS--PEWKNVSEGAKDLIKQM  275 (494)
T ss_dssp             HT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC----CCS--GGGTTSCHHHHHHHHHH
T ss_pred             Hc--ccCCCchhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC----CCc--hhcccCCHHHHHHHHHH
Confidence            75  46788999999999999999999999742      223333333322211    111  11111224689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       276 L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          276 LQFDSQRRISAQQALE  291 (494)
T ss_dssp             TCSSTTTSCCHHHHHT
T ss_pred             CCCChhhCccHHHHhc
Confidence            9999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=1.8e-27  Score=194.37  Aligned_cols=163  Identities=19%  Similarity=0.264  Sum_probs=122.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC----CceEEeccCCccccCCC-CCCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD----FESCLTDYGLGSFRNPD-SVEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~----~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~   84 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||+||++...    +.++|+|||+++..... .......+++.|+|
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~a  188 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA  188 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccC
Confidence            45789999999999999999999998 99999999999998543    35999999998754332 23345677889999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ||.+. +..++.++|+|||||++|+|++|..||....   ..........+.......    +  ..........+.+|+
T Consensus       189 PE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~~~~i~~~~~~~----~--~~~~~~~s~~~~~li  258 (342)
T 2qr7_A          189 PEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGP---DDTPEEILARIGSGKFSL----S--GGYWNSVSDTAKDLV  258 (342)
T ss_dssp             HHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSST---TSCHHHHHHHHHHCCCCC----C--STTTTTSCHHHHHHH
T ss_pred             HHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCC---cCCHHHHHHHHccCCccc----C--ccccccCCHHHHHHH
Confidence            99876 4556789999999999999999999997421   122333333332222111    1  111111224689999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+||++.++++
T Consensus       259 ~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          259 SKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHCCCChhHCcCHHHHhc
Confidence            9999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=2e-27  Score=191.56  Aligned_cols=170  Identities=22%  Similarity=0.264  Sum_probs=116.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccccCCCC--------CCCCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSFRNPDS--------VEEPSATS   79 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~--------~~~~~~~~   79 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++.++.   ++|+|||++.......        ......++
T Consensus       106 ~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt  184 (316)
T 2ac3_A          106 RHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS  184 (316)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCC
Confidence            5689999999999999999999998 9999999999999988776   9999999986543211        11234578


Q ss_pred             ccccCcccchh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCC-----ChHHHHHHhhhhhhccCCCCCCCC
Q 048055           80 LFYKAPECREI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS-----DIPRWVRSVREEETESGDDPPSSN  150 (221)
Q Consensus        80 ~~~~~pe~~~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  150 (221)
                      ..|+|||.+..    ...++.++|+|||||++|+|++|..||.........     ........+...........+  .
T Consensus       185 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~  262 (316)
T 2ac3_A          185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP--D  262 (316)
T ss_dssp             GGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC--H
T ss_pred             cCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC--c
Confidence            89999998752    134678999999999999999999999754221100     000000111111111111111  1


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 ~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .........+.+|+.+||+.||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            111112346999999999999999999999976

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.6e-27  Score=194.27  Aligned_cols=161  Identities=23%  Similarity=0.280  Sum_probs=120.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      +.++...+..++.||+.||.|||+. +++|+||||.||+++.++.++|+|||+++......  ......+++.|+|||.+
T Consensus       154 ~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~  232 (355)
T 1vzo_A          154 ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV  232 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhh
Confidence            4689999999999999999999998 99999999999999999999999999986543221  12334678899999987


Q ss_pred             hhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      ... ..++.++|+|||||++|+|++|..||.....  ......+........      ++.+...+    ..+.+|+.+|
T Consensus       233 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~----~~~~~li~~~  300 (355)
T 1vzo_A          233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE------PPYPQEMS----ALAKDLIQRL  300 (355)
T ss_dssp             TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS--CCCHHHHHHHHHHCC------CCCCTTSC----HHHHHHHHHH
T ss_pred             cCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc--cchHHHHHHHHhccC------CCCCcccC----HHHHHHHHHH
Confidence            632 3457889999999999999999999964321  122222222222111      11112222    3589999999


Q ss_pred             ccCCCCCCC-----CHHHHHHH
Q 048055          168 VSLAPENRP-----VMREVSKM  184 (221)
Q Consensus       168 l~~dp~~Rp-----s~~~l~~~  184 (221)
                      |+.||.+||     ++.++++.
T Consensus       301 L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          301 LMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             TCSSGGGSTTSSTTTHHHHHTS
T ss_pred             hhhCHHHhcCCCCCCHHHHHcC
Confidence            999999999     89999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=7.5e-27  Score=199.87  Aligned_cols=158  Identities=22%  Similarity=0.332  Sum_probs=124.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC---ceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF---ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.+++..+..++.||+.||.|||+. +++|+||||.||+++.++   .++|+|||++.............+++.|+|||.
T Consensus       141 ~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  219 (504)
T 3q5i_A          141 HKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV  219 (504)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHH
Confidence            5689999999999999999999998 999999999999998776   699999999977665544556678999999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.  ..++.++|+||+||++|++++|..||...      ........+.....    ..+  ..........+.+|+.+|
T Consensus       220 ~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~----~~~--~~~~~~~s~~~~~li~~~  285 (504)
T 3q5i_A          220 LK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ------NDQDIIKKVEKGKY----YFD--FNDWKNISDEAKELIKLM  285 (504)
T ss_dssp             HT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC----CCC--HHHHTTSCHHHHHHHHHH
T ss_pred             hc--cCCCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCC----CCC--ccccCCCCHHHHHHHHHH
Confidence            75  45788999999999999999999999742      22333333322211    111  111111234699999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       286 L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          286 LTYDYNKRCTAEEALN  301 (504)
T ss_dssp             TCSSTTTSCCHHHHHT
T ss_pred             cCCChhHCCCHHHHhc
Confidence            9999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=4.2e-27  Score=191.79  Aligned_cols=159  Identities=21%  Similarity=0.224  Sum_probs=116.8

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC--ceEEeccCCccccCCCC-----CCCCCCCCccccC
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF--ESCLTDYGLGSFRNPDS-----VEEPSATSLFYKA   84 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~   84 (221)
                      .++...+..++.||+.||.|||+. +++|+||||.||+++.++  .++|+|||++.......     ......+++.|+|
T Consensus       164 ~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          164 VQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            456788889999999999999998 999999999999998776  89999999986532211     1234567889999


Q ss_pred             cccchh-cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREI-WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~-~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+.. ...++.++||||||+++|+|++|..||...      ........+.....    ..+  ..........+.+|
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~----~~~--~~~~~~~~~~~~~l  310 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV------NDADTISQVLNKKL----CFE--NPNYNVLSPLARDL  310 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC----CTT--SGGGGGSCHHHHHH
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------ChHHHHHHHHhccc----ccC--CcccccCCHHHHHH
Confidence            998752 256788999999999999999999999643      22222222222111    111  11111123468999


Q ss_pred             HHHcccCCCCCCCCHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +.+||+.||.+||++.++++
T Consensus       311 i~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          311 LSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHcCCChhHCCCHHHHhc
Confidence            99999999999999999976

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=3.4e-27  Score=186.52  Aligned_cols=160  Identities=21%  Similarity=0.301  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~pe   86 (221)
                      ...++...+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||.+......   .......++..|+|||
T Consensus        99 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  177 (276)
T 2yex_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE  177 (276)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChH
Confidence            45789999999999999999999998 9999999999999999999999999998653221   1233456788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+......+.++|+||||+++|++++|..||......     ...........    ...+.....    ...+.+++.+
T Consensus       178 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~----~~~~~~li~~  244 (276)
T 2yex_A          178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYSDWKEKK----TYLNPWKKI----DSAPLALLHK  244 (276)
T ss_dssp             GGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-----SHHHHHHHTTC----TTSTTGGGS----CHHHHHHHHH
T ss_pred             HHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHhhhcc----cccCchhhc----CHHHHHHHHH
Confidence            8763233367899999999999999999999753211     11111111111    111111112    2468999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.++++
T Consensus       245 ~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          245 ILVENPSARITIPDIKK  261 (276)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HCCCCchhCCCHHHHhc
Confidence            99999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=4.2e-27  Score=187.53  Aligned_cols=156  Identities=19%  Similarity=0.384  Sum_probs=119.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEc-CCCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.+++..++.++.||+.||.|||+. +  ++|+||||.||+++ .++.++|+|||++...... ......+++.|+|||.
T Consensus       124 ~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~  201 (290)
T 1t4h_A          124 KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEM  201 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHH
Confidence            5689999999999999999999998 8  99999999999997 7889999999998654333 2234467889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.  ..++.++|+||||+++|++++|..||...     ..............     .+.   .........+.+++.+|
T Consensus       202 ~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~-----~~~---~~~~~~~~~l~~li~~~  266 (290)
T 1t4h_A          202 YE--EKYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAAQIYRRVTSGV-----KPA---SFDKVAIPEVKEIIEGC  266 (290)
T ss_dssp             GG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-----SSHHHHHHHHTTTC-----CCG---GGGGCCCHHHHHHHHHH
T ss_pred             Hh--ccCCCcchHHHHHHHHHHHHhCCCCCCCc-----CcHHHHHHHHhccC-----Ccc---ccCCCCCHHHHHHHHHH
Confidence            75  45788999999999999999999999642     22222222221111     111   11111123599999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       267 l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          267 IRQNKDERYSIKDLLN  282 (290)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhhCCCHHHHhh
Confidence            9999999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=4.4e-27  Score=196.34  Aligned_cols=160  Identities=21%  Similarity=0.259  Sum_probs=123.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      ..++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++......  ......+++.|+|||.+
T Consensus       163 ~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l  241 (410)
T 3v8s_A          163 YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL  241 (410)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHh
Confidence            4588999999999999999999998 99999999999999999999999999997654433  23356789999999987


Q ss_pred             hhcCC----CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 EIWKQ----PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~~~~~----~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      . ...    ++.++|+|||||++|+|++|..||..      .........+.......  ..+.....+    ..+.+|+
T Consensus       242 ~-~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~~~~--~~p~~~~~s----~~~~~li  308 (410)
T 3v8s_A          242 K-SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNHKNSL--TFPDDNDIS----KEAKNLI  308 (410)
T ss_dssp             H-TTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHTHHHHC--CCCTTCCCC----HHHHHHH
T ss_pred             h-ccCCCcCCCCcceEecchHHHHHHHhCCCCCCC------CChhhHHHHHHhccccc--cCCCccccc----HHHHHHH
Confidence            6 333    57899999999999999999999964      22333333333322111  111111222    3589999


Q ss_pred             HHcccCCCCC--CCCHHHHHHH
Q 048055          165 IACVSLAPEN--RPVMREVSKM  184 (221)
Q Consensus       165 ~~cl~~dp~~--Rps~~~l~~~  184 (221)
                      .+||..+|.+  ||++.||++.
T Consensus       309 ~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          309 CAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHccChhhhCCCCCHHHHhcC
Confidence            9999999988  9999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=7.1e-27  Score=188.11  Aligned_cols=159  Identities=21%  Similarity=0.314  Sum_probs=122.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++...... .......++..|+|||.+
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  197 (314)
T 3com_A          119 NKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI  197 (314)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhc
Confidence            45789999999999999999999998 9999999999999999999999999998654332 223345678899999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||....      ..........   ...........    .+..+.+++.+||
T Consensus       198 ~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~---~~~~~~~~~~~----~~~~l~~li~~~l  263 (314)
T 3com_A          198 Q-EIGYNCVADIWSLGITAIEMAEGKPPYADIH------PMRAIFMIPT---NPPPTFRKPEL----WSDNFTDFVKQCL  263 (314)
T ss_dssp             S-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHH---SCCCCCSSGGG----SCHHHHHHHHHHT
T ss_pred             C-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhc---CCCcccCCccc----CCHHHHHHHHHHc
Confidence            6 5667889999999999999999999996421      1111111111   11111111111    2246999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||.+||++.++++
T Consensus       264 ~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          264 VKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSCTTTSCCHHHHTT
T ss_pred             cCChhhCcCHHHHHh
Confidence            999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=5.2e-27  Score=188.09  Aligned_cols=158  Identities=26%  Similarity=0.413  Sum_probs=123.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      .+++++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++....... ......++..|+|||.+
T Consensus       113 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  191 (303)
T 3a7i_A          113 PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI  191 (303)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHH
Confidence            35789999999999999999999998 99999999999999999999999999986544332 23345678889999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||||+++|++++|..||...      ........+...     ..+......+    ..+.+++.+||
T Consensus       192 ~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li~~~l  255 (303)
T 3a7i_A          192 K-QSAYDSKADIWSLGITAIELARGEPPHSEL------HPMKVLFLIPKN-----NPPTLEGNYS----KPLKEFVEACL  255 (303)
T ss_dssp             T-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHS-----CCCCCCSSCC----HHHHHHHHHHC
T ss_pred             h-cCCCCchhhhHHHHHHHHHHccCCCCCCCc------CHHHHHHHhhcC-----CCCCCccccC----HHHHHHHHHHc
Confidence            6 567788999999999999999999999642      112222222111     1111112222    35899999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 048055          169 SLAPENRPVMREVSKM  184 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~  184 (221)
                      +.||.+|||+.++++.
T Consensus       256 ~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          256 NKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CSSGGGSCCHHHHTTC
T ss_pred             CCChhhCcCHHHHhhC
Confidence            9999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=8.8e-27  Score=186.16  Aligned_cols=160  Identities=23%  Similarity=0.299  Sum_probs=123.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ..++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++.............++..|+|||.+..
T Consensus       119 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  197 (298)
T 1phk_A          119 VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC  197 (298)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhcc
Confidence            5689999999999999999999998 999999999999999999999999999876655444455677889999998641


Q ss_pred             -----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           91 -----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        91 -----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                           ...++.++|+||||+++|++++|..||...      ........+.....    ..+.+  .....+..+.+++.
T Consensus       198 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~--~~~~~~~~l~~li~  265 (298)
T 1phk_A          198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLRMIMSGNY----QFGSP--EWDDYSDTVKDLVS  265 (298)
T ss_dssp             HHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCC----CCCTT--TGGGSCHHHHHHHH
T ss_pred             ccccccccCCcccccHhHHHHHHHHHHCCCCCcCc------cHHHHHHHHhcCCc----ccCcc--cccccCHHHHHHHH
Confidence                 345678999999999999999999999642      22222222222111    11111  11122346999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+||++.++++
T Consensus       266 ~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          266 RFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHCCSSGGGSCCHHHHTT
T ss_pred             HHccCCcccCCCHHHHHh
Confidence            999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.94  E-value=7.1e-28  Score=195.20  Aligned_cols=164  Identities=24%  Similarity=0.309  Sum_probs=103.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...+++..+..++.|++.||.|||+..+++|+||||.||+++.++.++|+|||++.............++..|+|||.+.
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID  198 (327)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----------------------
T ss_pred             cccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeec
Confidence            56789999999999999999999994389999999999999999999999999987654443334446788999999873


Q ss_pred             ---hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           90 ---IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        90 ---~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                         .+..++.++|+||||+++|+|++|..||......     .   ......  .....+.............+.+|+.+
T Consensus       199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~---~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~  268 (327)
T 3aln_A          199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----F---DQLTQV--VKGDPPQLSNSEEREFSPSFINFVNL  268 (327)
T ss_dssp             -------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------CCC--CCSCCCCCCCCSSCCCCHHHHHHHHH
T ss_pred             cccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----H---HHHHHH--hcCCCCCCCCcccccCCHHHHHHHHH
Confidence               2455788999999999999999999999743110     0   001000  00111110110001122469999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+||++.++++
T Consensus       269 ~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          269 CLTKDESKRPKYKELLK  285 (327)
T ss_dssp             HTCSSGGGSCCHHHHTT
T ss_pred             HhhCChhhCcCHHHHHh
Confidence            99999999999999964

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=3.4e-27  Score=190.03  Aligned_cols=167  Identities=20%  Similarity=0.290  Sum_probs=118.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-CCCceEEeccCCccccCCCC----CCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~   84 (221)
                      .++++...+..++.||+.||.|||+. +++|+||||.||+++ .++.++|+|||++.......    ......++..|+|
T Consensus       114 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  192 (320)
T 2i6l_A          114 QGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS  192 (320)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCC
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccC
Confidence            35689999999999999999999998 999999999999997 56789999999987543221    1233355778999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc-------------------cCCC
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE-------------------SGDD  145 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~  145 (221)
                      ||.+.....++.++|+||||+++|++++|..||....      .......+......                   ....
T Consensus       193 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (320)
T 2i6l_A          193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH------ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTE  266 (320)
T ss_dssp             HHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTS
T ss_pred             cHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccC
Confidence            9987644667889999999999999999999997432      11111111110000                   0000


Q ss_pred             CC-CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          146 PP-SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       146 ~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      +. ............+.+++.+||+.||.+|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          267 PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00 000111122356999999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=6.4e-27  Score=196.79  Aligned_cols=162  Identities=17%  Similarity=0.198  Sum_probs=123.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.......  .....+|+.|+|||.
T Consensus       169 ~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~  247 (437)
T 4aw2_A          169 EDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI  247 (437)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHH
Confidence            46799999999999999999999998 999999999999999999999999999865543322  234578999999998


Q ss_pred             chh----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           88 REI----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        88 ~~~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      +..    ...++.++|+|||||++|+|++|..||...      ........+....... ..+......+    ..+.+|
T Consensus       248 l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~~-~~p~~~~~~s----~~~~dL  316 (437)
T 4aw2_A          248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKERF-QFPTQVTDVS----ENAKDL  316 (437)
T ss_dssp             HHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHC-CCCSSCCCSC----HHHHHH
T ss_pred             HhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC------ChhHHHHhhhhccccc-cCCcccccCC----HHHHHH
Confidence            752    345688999999999999999999999642      2233333332222111 1111111222    358999


Q ss_pred             HHHcccCCCCC--CCCHHHHHH
Q 048055          164 AIACVSLAPEN--RPVMREVSK  183 (221)
Q Consensus       164 ~~~cl~~dp~~--Rps~~~l~~  183 (221)
                      +.+||..+|++  ||++.|+++
T Consensus       317 i~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          317 IRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHHHhcccccccCCCCHHHHhC
Confidence            99999888888  999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=8.2e-27  Score=194.82  Aligned_cols=160  Identities=16%  Similarity=0.188  Sum_probs=120.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe~~   88 (221)
                      ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.......  .....+++.|+|||.+
T Consensus       157 ~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l  235 (412)
T 2vd5_A          157 ERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL  235 (412)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHH
Confidence            4789999999999999999999998 999999999999999999999999999976544332  2345789999999987


Q ss_pred             hh------cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           89 EI------WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        89 ~~------~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      ..      ...++.++|+|||||++|+|++|..||...      ........+....... ..+......+    ..+.+
T Consensus       236 ~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~-~~p~~~~~~s----~~~~d  304 (412)
T 2vd5_A          236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD------STAETYGKIVHYKEHL-SLPLVDEGVP----EEARD  304 (412)
T ss_dssp             HHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHC-CCC----CCC----HHHHH
T ss_pred             hhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC------CHHHHHHHHHhcccCc-CCCccccCCC----HHHHH
Confidence            52      245688999999999999999999999642      2223333332221111 1111111122    36899


Q ss_pred             HHHHcccCCCCCC---CCHHHHHH
Q 048055          163 IAIACVSLAPENR---PVMREVSK  183 (221)
Q Consensus       163 l~~~cl~~dp~~R---ps~~~l~~  183 (221)
                      |+.+||. +|.+|   |++.++++
T Consensus       305 li~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          305 FIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHcC-ChhhcCCCCCHHHHhc
Confidence            9999999 99998   58988864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.9e-27  Score=189.54  Aligned_cols=149  Identities=21%  Similarity=0.353  Sum_probs=117.6

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc-CCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+++..++.++.||+.||.|||+. +++|+||||.||+++ .++.++|+|||++....... .....++..|+|||.+.
T Consensus       134 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~  211 (312)
T 2iwi_A          134 GPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWIS  211 (312)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeee
Confidence            4689999999999999999999998 999999999999999 78999999999987654432 33456788999999876


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .....+.++|+||||+++|++++|..||....            ......    ...+  ...    ...+.+++.+||+
T Consensus       212 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~----~~~~--~~~----~~~~~~li~~~l~  269 (312)
T 2iwi_A          212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAE----LHFP--AHV----SPDCCALIRRCLA  269 (312)
T ss_dssp             HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTC----CCCC--TTS----CHHHHHHHHHHTC
T ss_pred             cCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhc----cCCc--ccC----CHHHHHHHHHHcc
Confidence            33333458999999999999999999996421            111111    0111  112    2358999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||++||++.++++
T Consensus       270 ~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          270 PKPSSRPSLEEILL  283 (312)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=4.4e-27  Score=186.52  Aligned_cols=151  Identities=17%  Similarity=0.172  Sum_probs=114.5

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-------------------CceEEeccCCccccCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-------------------FESCLTDYGLGSFRNPDS   71 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-------------------~~~~l~dfg~~~~~~~~~   71 (221)
                      +.+++..++.++.||+.||.|||+. +++|+||||.||+++.+                   ..++|+|||.+.......
T Consensus       110 ~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          110 SYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc
Confidence            5689999999999999999999998 99999999999999844                   478999999987654332


Q ss_pred             CCCCCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCCh
Q 048055           72 VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNE  151 (221)
Q Consensus        72 ~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (221)
                         ...++..|+|||.+.....++.++|+||||+++|++++|..++....         ....+...     ..+..+..
T Consensus       189 ---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~~-----~~~~~~~~  251 (289)
T 1x8b_A          189 ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWHEIRQG-----RLPRIPQV  251 (289)
T ss_dssp             ---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------HHHHHHTT-----CCCCCSSC
T ss_pred             ---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------HHHHHHcC-----CCCCCCcc
Confidence               23578899999987633355578999999999999999887764211         11111111     11111122


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+    ..+.+++.+||+.||.+|||+.++++
T Consensus       252 ~~----~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          252 LS----QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            22    35899999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=1.4e-26  Score=184.68  Aligned_cols=160  Identities=22%  Similarity=0.289  Sum_probs=118.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-CCceEEeccCCccccCCC-CCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-DFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~   87 (221)
                      ...++...+..++.||+.||.|||+. +++|+||+|.||+++. ++.++|+|||++...... .......++..|+|||.
T Consensus       116 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  194 (295)
T 2clq_A          116 PLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI  194 (295)
T ss_dssp             CCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHH
T ss_pred             CCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhh
Confidence            34567889999999999999999998 9999999999999987 899999999998755432 22334567889999998


Q ss_pred             chhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +... ..++.++|+||||+++|++++|..||.....     ........  ...  ...+..+...+    ..+.+++.+
T Consensus       195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~--~~~--~~~~~~~~~~~----~~~~~li~~  261 (295)
T 2clq_A          195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMFKV--GMF--KVHPEIPESMS----AEAKAFILK  261 (295)
T ss_dssp             HHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHHHH--HHH--CCCCCCCTTSC----HHHHHHHHH
T ss_pred             hcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHHhh--ccc--cccccccccCC----HHHHHHHHH
Confidence            7632 2367899999999999999999999964311     11111111  011  11111112222    358999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||++||++.++++
T Consensus       262 ~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          262 CFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TTCSSTTTSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=1.3e-27  Score=189.27  Aligned_cols=160  Identities=24%  Similarity=0.326  Sum_probs=120.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCC-----ceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC-CCCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPG-----LTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV-EEPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~-----i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~   83 (221)
                      ...+++..++.++.|++.||.|||+. +     ++|+||+|.||+++.++.++|+|||++........ .....++..|+
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~  183 (279)
T 2w5a_A          105 RQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM  183 (279)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCcccc
Confidence            34589999999999999999999998 7     99999999999999999999999999865443221 12235677899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      |||.+. +..++.++|+||||+++|++++|..||...      ........+.....     ...+...+    ..+.++
T Consensus       184 aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~i~~~~~-----~~~~~~~~----~~l~~l  247 (279)
T 2w5a_A          184 SPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREGKF-----RRIPYRYS----DELNEI  247 (279)
T ss_dssp             CHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCC-----CCCCTTSC----HHHHHH
T ss_pred             ChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCccc------CHHHHHHHHhhccc-----ccCCcccC----HHHHHH
Confidence            999886 567788999999999999999999999643      22222222222111     11112222    469999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHH
Q 048055          164 AIACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      +.+||+.||.+||++.+|++.+.
T Consensus       248 i~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          248 ITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHcCCCcccCCCHHHHHhChh
Confidence            99999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=1.5e-27  Score=192.92  Aligned_cols=162  Identities=23%  Similarity=0.328  Sum_probs=119.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++.++.   ++|+|||++.............++..|+|||
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE  186 (322)
T 2ycf_A          108 NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE  186 (322)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCch
Confidence            46789999999999999999999998 9999999999999987654   9999999987654332222345678899999


Q ss_pred             cch--hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           87 CRE--IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        87 ~~~--~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .+.  ....++.++|+||||+++|++++|..||......  ....   ..+.....    ..  ...........+.+++
T Consensus       187 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~~~----~~--~~~~~~~~~~~~~~li  255 (322)
T 2ycf_A          187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLK---DQITSGKY----NF--IPEVWAEVSEKALDLV  255 (322)
T ss_dssp             HHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHH---HHHHHTCC----CC--CHHHHTTSCHHHHHHH
T ss_pred             hhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHH---HHHHhCcc----cc--CchhhhhcCHHHHHHH
Confidence            863  1356678999999999999999999999743211  1111   11111110    00  0111112234689999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+||++.++++
T Consensus       256 ~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          256 KKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcccCHhhCCCHHHHhh
Confidence            9999999999999999973

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.94  E-value=1.2e-26  Score=186.81  Aligned_cols=160  Identities=22%  Similarity=0.361  Sum_probs=114.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||||.||+++. +.++|+|||++.......   ......++..|+|||
T Consensus       121 ~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (313)
T 3cek_A          121 KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE  198 (313)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHH
Confidence            35789999999999999999999998 9999999999999964 899999999987554322   123346788999999


Q ss_pred             cchh----------cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           87 CREI----------WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        87 ~~~~----------~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      .+..          ...++.++|+||||+++|++++|..||....     ...........    ...........    
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~----~~~~~~~~~~~----  265 (313)
T 3cek_A          199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIID----PNHEIEFPDIP----  265 (313)
T ss_dssp             HHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHC----TTSCCCCCCCS----
T ss_pred             HHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----HHHHHHHHHHh----cccccCCcccc----
Confidence            8752          1356778999999999999999999996421     11111111111    11111111111    


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                      ...+.+++.+||+.||.+||++.++++.
T Consensus       266 ~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          266 EKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            2358999999999999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=1e-26  Score=186.58  Aligned_cols=158  Identities=21%  Similarity=0.323  Sum_probs=120.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEE---cCCCceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.++...+..++.|++.||.|||+. +++|+||+|.||++   +.++.++|+|||++...... ......++..|+|||.
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~  178 (304)
T 2jam_A          101 GVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEV  178 (304)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHH
Confidence            4688999999999999999999998 99999999999999   77889999999998654322 1223356788999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. +..++.++|+||||+++|++++|..||...      ........+........  .+....    .+..+.+++.+|
T Consensus       179 ~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~~~~~--~~~~~~----~~~~~~~li~~~  245 (304)
T 2jam_A          179 LA-QKPYSKAVDCWSIGVITYILLCGYPPFYEE------TESKLFEKIKEGYYEFE--SPFWDD----ISESAKDFICHL  245 (304)
T ss_dssp             BS-SCSCCHHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHCCCCCC--TTTTTT----SCHHHHHHHHHH
T ss_pred             hc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCCCC--cccccc----CCHHHHHHHHHH
Confidence            86 667788999999999999999999999642      22222222222211110  111111    224689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+||++.++++
T Consensus       246 l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          246 LEKDPNERYTCEKALS  261 (304)
T ss_dssp             HCSSTTTSCCHHHHHT
T ss_pred             cCCChhHCcCHHHHhc
Confidence            9999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.94  E-value=8.5e-27  Score=188.58  Aligned_cols=158  Identities=20%  Similarity=0.300  Sum_probs=113.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ..++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++...... .......++..|+|||.+.
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhc
Confidence            5689999999999999999999998 9999999999999999999999999998654322 2223456788999999864


Q ss_pred             h----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           90 I----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        90 ~----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .    ...++.++|+||||+++|++++|..||....      ............   .... .....    +..+.+++.
T Consensus       203 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~---~~~~-~~~~~----~~~l~~li~  268 (326)
T 2x7f_A          203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMRALFLIPRNP---APRL-KSKKW----SKKFQSFIE  268 (326)
T ss_dssp             --------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC---CCCC-SCSCS----CHHHHHHHH
T ss_pred             cccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCc---cccC-Ccccc----CHHHHHHHH
Confidence            2    3456789999999999999999999996421      112111111111   1111 11112    246899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+||++.++++
T Consensus       269 ~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          269 SCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHCCSSGGGSCCHHHHHT
T ss_pred             HHhccChhhCCCHHHHhh
Confidence            999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=9.3e-27  Score=189.98  Aligned_cols=167  Identities=17%  Similarity=0.212  Sum_probs=121.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcC-CCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQ-NPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~-~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ...+++..++.++.||+.||.|||+ . +++|+||+|.||+++.++.++|+|||.+...... ......++..|+|||.+
T Consensus       145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~  222 (348)
T 2pml_X          145 TCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFF  222 (348)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhh
Confidence            6789999999999999999999998 7 9999999999999999999999999998654333 23445678899999987


Q ss_pred             hhcCCCCC-cccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCC---------CCCChhhHHHHH
Q 048055           89 EIWKQPTQ-QADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDP---------PSSNEASEEKLQ  158 (221)
Q Consensus        89 ~~~~~~~~-~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~  158 (221)
                      .....+.. ++|+||||+++|++++|..||.....     .......+...........         ..........+.
T Consensus       223 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (348)
T 2pml_X          223 SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-----LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN  297 (348)
T ss_dssp             SSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-----SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCH
T ss_pred             cCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCH
Confidence            63324444 89999999999999999999974321     1222222222111111000         000000012234


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+.+|+.+||+.||.+||++.++++
T Consensus       298 ~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          298 EDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence            6899999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=1.6e-27  Score=194.17  Aligned_cols=163  Identities=20%  Similarity=0.322  Sum_probs=101.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.||+.||.|||+. +++|+||||.||+++.   ++.++|+|||++....... .....+++.|+|||
T Consensus       122 ~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE  199 (336)
T 3fhr_A          122 DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPE  199 (336)
T ss_dssp             CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChh
Confidence            35799999999999999999999998 9999999999999976   4559999999986544322 23456688899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|+||||+++|++++|..||.........  .............  ...+....    ....+.+|+.+
T Consensus       200 ~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~li~~  270 (336)
T 3fhr_A          200 VLG-PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLGQYG--FPNPEWSE----VSEDAKQLIRL  270 (336)
T ss_dssp             -----CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C--CCTTTSTT----CCHHHHHHHHH
T ss_pred             hhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhccccc--cCchhhcc----CCHHHHHHHHH
Confidence            875 566678999999999999999999999653221100  0000111111000  00111112    22468999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.++++
T Consensus       271 ~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          271 LLKTDPTERLTITQFMN  287 (336)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HCCCChhHCcCHHHHhc
Confidence            99999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=4.9e-27  Score=188.00  Aligned_cols=160  Identities=18%  Similarity=0.262  Sum_probs=117.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++|+||+|.||+++.++.++|+|||++..... ........++..|+|||.+
T Consensus       111 ~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          111 DRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeee
Confidence            45689999999999999999999998 999999999999999999999999998643211 1112334678889999986


Q ss_pred             h----hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 E----IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~----~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .    ....++.++|+||||+++|++++|..||....      ...........   ...........    +..+.+++
T Consensus       190 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~---~~~~~~~~~~~----~~~l~~li  256 (302)
T 2j7t_A          190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKS---DPPTLLTPSKW----SVEFRDFL  256 (302)
T ss_dssp             HHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS---CCCCCSSGGGS----CHHHHHHH
T ss_pred             ccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhcc---CCcccCCcccc----CHHHHHHH
Confidence            3    24556789999999999999999999996432      12222222111   11111111222    24689999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+|||+.++++
T Consensus       257 ~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          257 KIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHSCSCTTTSCCHHHHTT
T ss_pred             HHHcccChhhCCCHHHHhc
Confidence            9999999999999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.3e-26  Score=194.85  Aligned_cols=156  Identities=19%  Similarity=0.279  Sum_probs=108.7

Q ss_pred             cCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-----CCceEEeccCCccccCCCC----CCCCCCCCcccc
Q 048055           13 LHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-----DFESCLTDYGLGSFRNPDS----VEEPSATSLFYK   83 (221)
Q Consensus        13 l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-----~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~   83 (221)
                      ++...++.++.||+.||.|||+. +++||||||.||+++.     ...++|+|||+++......    ......+++.|+
T Consensus       115 ~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~  193 (432)
T 3p23_A          115 HLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI  193 (432)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSC
T ss_pred             ccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCcc
Confidence            44456778999999999999998 9999999999999953     2357899999987654321    223456889999


Q ss_pred             Ccccchh--cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHH
Q 048055           84 APECREI--WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQAL  160 (221)
Q Consensus        84 ~pe~~~~--~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  160 (221)
                      |||.+..  ...++.++|||||||++|++++ |..||.....       ........   ..........   ......+
T Consensus       194 APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~~---~~~~~~~~~~---~~~~~~~  260 (432)
T 3p23_A          194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILLG---ACSLDCLHPE---KHEDVIA  260 (432)
T ss_dssp             CGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHTT---CCCCTTSCTT---CHHHHHH
T ss_pred             ChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHhc---cCCccccCcc---ccccHHH
Confidence            9998752  2445678999999999999999 8999953211       11111111   1111111111   1223458


Q ss_pred             HHHHHHcccCCCCCCCCHHHHH
Q 048055          161 LNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       161 ~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      .+|+.+||+.||.+|||+.+++
T Consensus       261 ~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          261 RELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHhCCHhhCCCHHHHH
Confidence            8999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=2.2e-26  Score=183.22  Aligned_cols=158  Identities=21%  Similarity=0.333  Sum_probs=120.0

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC---CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD---FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.++...++.++.||+.||.|||+. +++|+||+|.||+++.+   +.++|+|||++.............++..|+|||.
T Consensus       116 ~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          116 KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV  194 (287)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHH
Confidence            4689999999999999999999998 99999999999999764   4699999999876554433334456788999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +.  ..++.++|+||||+++|++++|..||...      ........+......    .+  .......+..+.+++.+|
T Consensus       195 ~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~li~~~  260 (287)
T 2wei_A          195 LR--GTYDEKCDVWSAGVILYILLSGTPPFYGK------NEYDILKRVETGKYA----FD--LPQWRTISDDAKDLIRKM  260 (287)
T ss_dssp             HT--TCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC----CC--SGGGTTSCHHHHHHHHHH
T ss_pred             hc--CCCCCchhhHhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC----CC--chhhhhcCHHHHHHHHHH
Confidence            75  34788999999999999999999999642      222222332221111    11  011111224689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       261 l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          261 LTFHPSLRITATQCLE  276 (287)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             cccChhhCcCHHHHhc
Confidence            9999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.93  E-value=1.8e-26  Score=184.36  Aligned_cols=159  Identities=19%  Similarity=0.332  Sum_probs=112.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---------------CCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---------------SVEE   74 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---------------~~~~   74 (221)
                      +..++...++.++.||+.||.|||+. +++|+||||.||+++.++.++|+|||++......               ....
T Consensus       110 ~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (303)
T 1zy4_A          110 NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT  188 (303)
T ss_dssp             CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--------------------
T ss_pred             ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccc
Confidence            34678889999999999999999998 9999999999999999999999999998654321               1123


Q ss_pred             CCCCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhH
Q 048055           75 PSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASE  154 (221)
Q Consensus        75 ~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (221)
                      ...++..|+|||.+.....++.++|+||||+++|++++   ||.....     .......+...    ....+  .....
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-----~~~~~~~~~~~----~~~~~--~~~~~  254 (303)
T 1zy4_A          189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-----RVNILKKLRSV----SIEFP--PDFDD  254 (303)
T ss_dssp             -----CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHHHHHHST----TCCCC--TTCCT
T ss_pred             cCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-----HHHHHHhcccc----ccccC--ccccc
Confidence            34567889999987634467889999999999999997   4532110     11111222111    11111  11112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          155 EKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       155 ~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..+..+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          255 NKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             TTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            22346899999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.93  E-value=1.8e-26  Score=194.08  Aligned_cols=157  Identities=19%  Similarity=0.296  Sum_probs=111.0

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-------------CceEEeccCCccccCCCCC-----CCCC
Q 048055           15 WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-------------FESCLTDYGLGSFRNPDSV-----EEPS   76 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-------------~~~~l~dfg~~~~~~~~~~-----~~~~   76 (221)
                      ...++.++.||+.||.|||+. +++|+||||.||+++.+             +.++|+|||+++.......     ....
T Consensus       114 ~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~  192 (434)
T 2rio_A          114 EYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP  192 (434)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC------------
T ss_pred             chhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCC
Confidence            345678999999999999998 99999999999999754             4899999999976543321     1234


Q ss_pred             CCCccccCcccchh------cCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCC
Q 048055           77 ATSLFYKAPECREI------WKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSS  149 (221)
Q Consensus        77 ~~~~~~~~pe~~~~------~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (221)
                      .+++.|+|||.+..      ...++.++|||||||++|+|++ |..||......       . ..+........ ..  .
T Consensus       193 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~-~~i~~~~~~~~-~~--~  261 (434)
T 2rio_A          193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-------E-SNIIRGIFSLD-EM--K  261 (434)
T ss_dssp             --CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-------H-HHHHHTCCCCC-CC--T
T ss_pred             CCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-------H-HHHhcCCCCcc-cc--c
Confidence            67889999998752      1457889999999999999998 99999643211       1 11111111111 11  1


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..........+.+++.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1122344567999999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.93  E-value=1.7e-26  Score=189.52  Aligned_cols=107  Identities=22%  Similarity=0.347  Sum_probs=90.4

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+..++.|++.||.|||+..+++|+||||.||+++.++.++|+|||++...... ......++..|+|||.+. 
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~-  203 (360)
T 3eqc_A          126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ-  203 (360)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHT-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHc-
Confidence            468899999999999999999998328999999999999999999999999998543221 123346788999999886 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                      +..++.++|+||||+++|++++|..||..
T Consensus       204 ~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             TCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            66778899999999999999999999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=8.5e-26  Score=197.35  Aligned_cols=178  Identities=21%  Similarity=0.210  Sum_probs=124.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc---eEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE---SCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ...+++..++.++.|++.||.|||+. +++|+||||.||+++.++.   ++|+|||++.............++..|+|||
T Consensus       115 ~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE  193 (676)
T 3qa8_A          115 CCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE  193 (676)
T ss_dssp             TTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChH
Confidence            34689999999999999999999998 9999999999999997664   8999999997766555555667889999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccC--CCh-HHHHHH-h----hhhhhccCCCCCCCChhhHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG--SDI-PRWVRS-V----REEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~--~~~-~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      .+. +..++.++|+||||+++|++++|..||........  ... ...... .    ...........+.+.......+.
T Consensus       194 ~l~-~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~  272 (676)
T 3qa8_A          194 LLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG  272 (676)
T ss_dssp             SSC-CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHH
T ss_pred             Hhc-cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhH
Confidence            986 67788999999999999999999999964210000  000 000000 0    00000011111222333334556


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHH-----HHHHHhhH
Q 048055          159 ALLNIAIACVSLAPENRPVMREV-----SKMIRDSR  189 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l-----~~~L~~~~  189 (221)
                      .+.+++.+||..||.+|||+.++     .+.++++.
T Consensus       273 ~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          273 KLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             HHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            79999999999999999999884     34444444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.91  E-value=7.2e-25  Score=175.53  Aligned_cols=144  Identities=17%  Similarity=0.241  Sum_probs=103.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      +..+++..++.++.|++.||.|||+. +++|+||||.||+++.   ++.++|+|||++....                  
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------  171 (299)
T 3m2w_A          111 DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------  171 (299)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------
Confidence            35789999999999999999999998 9999999999999998   7889999999875322                  


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                          +..++.++|+||||+++|+|++|..||.......      .........  .......+..........+.+++.+
T Consensus       172 ----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~  239 (299)
T 3m2w_A          172 ----GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ISPGMKTRI--RMGQYEFPNPEWSEVSEEVKMLIRN  239 (299)
T ss_dssp             ----TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCSS--CTTCCSSCHHHHTTSCHHHHHHHHH
T ss_pred             ----cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh------hhHHHHHHH--hhccccCCchhcccCCHHHHHHHHH
Confidence                1234568999999999999999999996432110      000000000  0001111111111223569999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+|||+.++++.
T Consensus       240 ~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          240 LLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HTCSSTTTSCCHHHHHTS
T ss_pred             HcccChhhCCCHHHHhcC
Confidence            999999999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.90  E-value=4.2e-24  Score=188.94  Aligned_cols=151  Identities=20%  Similarity=0.236  Sum_probs=118.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      .++++..++.++.||+.||.|||+. +|+||||||.||+++.+ .++|+|||+++.....   ....+++.|++||.+. 
T Consensus       177 ~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~-  250 (681)
T 2pzi_A          177 QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVR-  250 (681)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHH-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHc-
Confidence            3789999999999999999999998 99999999999999885 8999999998765433   3456788999999876 


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      +. .+.++||||||+++|+|++|..||.......                     .+ ...........+.+|+.+||+.
T Consensus       251 ~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------~~-~~~~~~~~~~~l~~li~~~l~~  307 (681)
T 2pzi_A          251 TG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------LP-EDDPVLKTYDSYGRLLRRAIDP  307 (681)
T ss_dssp             HC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------CC-TTCHHHHHCHHHHHHHHHHTCS
T ss_pred             CC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------------------cc-ccccccccCHHHHHHHhhhccC
Confidence            33 3789999999999999999988886432110                     00 0111112235689999999999


Q ss_pred             CCCCCCC-HHHHHHHHHhhHH
Q 048055          171 APENRPV-MREVSKMIRDSRA  190 (221)
Q Consensus       171 dp~~Rps-~~~l~~~L~~~~~  190 (221)
                      ||.+||+ +.++...|.....
T Consensus       308 dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          308 DPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             SGGGSCSSHHHHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHHHHH
Confidence            9999995 6667777776553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.88  E-value=1.2e-23  Score=167.68  Aligned_cols=140  Identities=16%  Similarity=0.187  Sum_probs=102.2

Q ss_pred             CHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhcCC
Q 048055           14 HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIWKQ   93 (221)
Q Consensus        14 ~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   93 (221)
                      ....+..++.|++.||.|||+. |++|+||||.||+++.++.++|++++.                   ++        .
T Consensus       127 ~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~~-------------------~~--------~  178 (286)
T 3uqc_A          127 SPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPAT-------------------MP--------D  178 (286)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCCC-------------------CT--------T
T ss_pred             ChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEeccc-------------------cC--------C
Confidence            4557888999999999999998 999999999999999999999985442                   12        2


Q ss_pred             CCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccCCCC
Q 048055           94 PTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPE  173 (221)
Q Consensus        94 ~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~  173 (221)
                      ++.++|+|||||++|+|++|..||..........         ..........+.........+..+.+++.+||+.||.
T Consensus       179 ~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  249 (286)
T 3uqc_A          179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGG  249 (286)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSS
T ss_pred             CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCc
Confidence            4678999999999999999999997543211000         0000000011111111112334699999999999999


Q ss_pred             CCCCHHHHHHHHHhhHHH
Q 048055          174 NRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       174 ~Rps~~~l~~~L~~~~~~  191 (221)
                      +| |+.++++.|++....
T Consensus       250 ~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          250 IR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CC-CHHHHHHHHHHHHC-
T ss_pred             cC-CHHHHHHHHHHHhcc
Confidence            99 999999999997754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.88  E-value=9.7e-23  Score=165.68  Aligned_cols=151  Identities=13%  Similarity=0.132  Sum_probs=112.9

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhc-CCCCceeeCcCCCCeEEcCCC--------------------ceEEeccCCccccCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADF--------------------ESCLTDYGLGSFRNP   69 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH-~~~~i~h~dlk~~nil~~~~~--------------------~~~l~dfg~~~~~~~   69 (221)
                      +.+++..+..++.||+.||.||| +. +|+||||||+|||++.++                    .+||+|||+++....
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            56899999999999999999999 88 999999999999999887                    899999999976543


Q ss_pred             CCCCCCCCCCccccCcccchhcCCCCCcccchHHHHH-HHHHHhCCCCCcccccccCCChHHHHHHhhhhhh-ccCCCCC
Q 048055           70 DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVL-LLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET-ESGDDPP  147 (221)
Q Consensus        70 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~di~slG~~-l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  147 (221)
                      .    ...+++.|+|||.+. +.. +.++||||++++ .+++++|..||...         .+......... .......
T Consensus       235 ~----~~~gt~~y~aPE~~~-g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~  299 (336)
T 2vuw_A          235 G----IVVFCDVSMDEDLFT-GDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKTK  299 (336)
T ss_dssp             T----EEECCCCTTCSGGGC-CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSSC
T ss_pred             C----cEEEeecccChhhhc-CCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCcc
Confidence            2    346788999999986 444 778999998776 67788899998641         11111111111 1111112


Q ss_pred             CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048055          148 SSNEASEEKLQALLNIAIACVSLAPENRPVMREVS  182 (221)
Q Consensus       148 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~  182 (221)
                      ............+.+|+.+||+.|     |+.|++
T Consensus       300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            223445566778999999999977     888886

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.72  E-value=3e-19  Score=154.71  Aligned_cols=99  Identities=20%  Similarity=0.173  Sum_probs=65.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~~   88 (221)
                      +++++..   +++.||+.||.|+|++ ||+||||||.|||++.++.+||+|||+++...... ...+..+|+.|++||.+
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l  411 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELF  411 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHh
Confidence            3456554   4788999999999999 99999999999999999999999999997654332 23345678999999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGK  114 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~  114 (221)
                      .  ..+...+|+|++|++.+++.++.
T Consensus       412 ~--g~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          412 A--ENKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             -------------------CCCCTTH
T ss_pred             C--CCCCCcccccccccchhhhcccc
Confidence            6  34566789999999877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.38  E-value=2.1e-14  Score=123.67  Aligned_cols=97  Identities=21%  Similarity=0.290  Sum_probs=77.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--------CCCCCCCccccCcccch
Q 048055           18 CLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--------EEPSATSLFYKAPECRE   89 (221)
Q Consensus        18 ~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~pe~~~   89 (221)
                      +..++.|++.||.|||++ +++||||||+||+++.  .+||+|||+++.......        .....+|+.|+|||.+.
T Consensus       433 ~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence            457899999999999998 9999999999999998  999999999976654321        12446788999999876


Q ss_pred             h-cCCCCCcccchHHHHHHHHHHhCCCCC
Q 048055           90 I-WKQPTQQADVYSFGVLLLELLTGKTPF  117 (221)
Q Consensus        90 ~-~~~~~~~~di~slG~~l~~~~~g~~pf  117 (221)
                      . ...|+..+|+|+..+-..+.+.++.+|
T Consensus       510 ~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          510 RFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2 134566789999888777776666555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=98.98  E-value=3.9e-10  Score=89.30  Aligned_cols=48  Identities=17%  Similarity=0.277  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           16 TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .....++.||+.||.|||+. +++|+||||.||+++ ++.++|+|||++.
T Consensus       193 ~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          193 ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            45667999999999999998 999999999999999 9999999999985

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.89  E-value=1.3e-09  Score=85.06  Aligned_cols=49  Identities=16%  Similarity=0.191  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHHhc-CCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           15 WTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        15 ~~~~~~~~~~i~~gl~~lH-~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      ...+..++.|++.||.||| +. +++|+|+||.|||++.  .++|+|||++..
T Consensus       169 ~~~~~~i~~qi~~~l~~lH~~~-givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          169 ELDVEGIFNDVVENVKRLYQEA-ELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHTS-CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            3467889999999999999 87 9999999999999988  899999999854

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.30  E-value=3.8e-07  Score=75.04  Aligned_cols=49  Identities=18%  Similarity=0.326  Sum_probs=42.6

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----------ceEEeccCCcc
Q 048055           16 TSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----------ESCLTDYGLGS   65 (221)
Q Consensus        16 ~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----------~~~l~dfg~~~   65 (221)
                      ..+..++.||+.+|.+||+. |++||||||.|||++.++          .+.|+||+-+.
T Consensus       205 ~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          205 PDPASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence            45667889999999999998 999999999999998876          37899998653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.93  E-value=0.014  Score=43.79  Aligned_cols=89  Identities=12%  Similarity=0.071  Sum_probs=54.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      +.+|+.++++.++.|.+.+|.-+-..+.-..+=+.+..+++..+|.+.+.+ ..+.           .....+.+||...
T Consensus        43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~~~~~pe~~~  110 (229)
T 2yle_A           43 NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEPPPVAGKLGY  110 (229)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------------CCSS
T ss_pred             CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccccCCCChhhcc
Confidence            679999999999999999987662110111223346778888888877664 1110           1112356777642


Q ss_pred             hcCCCCCcccchHHHHHHHHHHh
Q 048055           90 IWKQPTQQADVYSFGVLLLELLT  112 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~  112 (221)
                        ...+.+.-|||||+++|.-+-
T Consensus       111 --~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          111 --SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             --SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccchHHHHHHHHHHHHHHHhh
Confidence              233456679999999999886

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=96.83  E-value=0.00091  Score=51.13  Aligned_cols=27  Identities=26%  Similarity=0.281  Sum_probs=24.0

Q ss_pred             ceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           38 LTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        38 i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      ++|+|+++.||+++.++.+.|+||+.+
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhc
Confidence            899999999999987766779999976

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=96.69  E-value=0.00081  Score=51.78  Aligned_cols=28  Identities=29%  Similarity=0.428  Sum_probs=24.0

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .++|+|+++.||+++.+..+.|+||+.+
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhc
Confidence            5889999999999987666679999865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.68  E-value=0.00043  Score=54.73  Aligned_cols=79  Identities=20%  Similarity=0.342  Sum_probs=47.8

Q ss_pred             CceeeCcCCCCeEEcC--CCceEEeccCCccccCCCC----CCCCC--CCCc-------cc--cC-cccchhcCCCCCcc
Q 048055           37 GLTHGNLKSSNVLLGA--DFESCLTDYGLGSFRNPDS----VEEPS--ATSL-------FY--KA-PECREIWKQPTQQA   98 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~--~~~~~l~dfg~~~~~~~~~----~~~~~--~~~~-------~~--~~-pe~~~~~~~~~~~~   98 (221)
                      .++|+|+++.||+++.  ...+.++||+.+....+..    .....  .+..       .|  .. |+...   ......
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~---r~~~~~  268 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLE---KYRMKE  268 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHH---HHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHH---HHHHHH
Confidence            5799999999999998  5567899999875432211    00000  0000       01  11 11111   001225


Q ss_pred             cchHHHHHHHHHHhCCCCCc
Q 048055           99 DVYSFGVLLLELLTGKTPFQ  118 (221)
Q Consensus        99 di~slG~~l~~~~~g~~pf~  118 (221)
                      +.|+++.++|.+.+|..+|.
T Consensus       269 ~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          269 KYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHH
Confidence            78999999999999988774

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=96.63  E-value=0.002  Score=52.14  Aligned_cols=55  Identities=13%  Similarity=0.266  Sum_probs=44.8

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCC--------------------------------------------------------
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQN--------------------------------------------------------   35 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~--------------------------------------------------------   35 (221)
                      .++......++.+++..|+.||..                                                        
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            356777888889999999999961                                                        


Q ss_pred             -CCceeeCcCCCCeEEcCCCc--eEEeccCCccc
Q 048055           36 -PGLTHGNLKSSNVLLGADFE--SCLTDYGLGSF   66 (221)
Q Consensus        36 -~~i~h~dlk~~nil~~~~~~--~~l~dfg~~~~   66 (221)
                       ..++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence             26899999999999987653  68999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=94.55  E-value=0.057  Score=42.75  Aligned_cols=29  Identities=28%  Similarity=0.421  Sum_probs=26.1

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .+++|+|+.+.||+++.++.+.++||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            38999999999999987888999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=91.99  E-value=0.17  Score=41.59  Aligned_cols=32  Identities=22%  Similarity=0.434  Sum_probs=27.3

Q ss_pred             cCCCCceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           33 HQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        33 H~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      +.. .++|+|+++.||+++.++ +.++||+.+..
T Consensus       230 ~~~-~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQ-ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCC-EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCC-eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            444 899999999999998776 99999988754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=91.81  E-value=0.24  Score=38.90  Aligned_cols=29  Identities=24%  Similarity=0.453  Sum_probs=24.2

Q ss_pred             CceeeCcCCCCeEEcC---CCc-eEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGA---DFE-SCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~---~~~-~~l~dfg~~~   65 (221)
                      .++|+|+.+.|++++.   ++. +.|+||+.+.
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence            6799999999999987   344 5799998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=90.03  E-value=0.14  Score=39.16  Aligned_cols=28  Identities=21%  Similarity=0.235  Sum_probs=24.6

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .++|+|+.+.||+++..+.+-|+||+.+
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccc
Confidence            4789999999999998777789999876

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=88.49  E-value=0.13  Score=40.43  Aligned_cols=28  Identities=32%  Similarity=0.419  Sum_probs=24.6

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      +++|+|+.+.||+++.+..+.++||+.+
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhc
Confidence            7899999999999988766689999865

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.04  E-value=0.56  Score=39.24  Aligned_cols=15  Identities=40%  Similarity=0.408  Sum_probs=14.1

Q ss_pred             CceeeCcCCCCeEEc
Q 048055           37 GLTHGNLKSSNVLLG   51 (221)
Q Consensus        37 ~i~h~dlk~~nil~~   51 (221)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            678999999999998

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=87.93  E-value=0.79  Score=35.65  Aligned_cols=28  Identities=14%  Similarity=0.184  Sum_probs=24.0

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.|++ ..++.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            6899999999999 556678999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=87.23  E-value=0.23  Score=39.31  Aligned_cols=30  Identities=13%  Similarity=0.235  Sum_probs=26.1

Q ss_pred             CceeeCcCCCCeEEcCC----CceEEeccCCccc
Q 048055           37 GLTHGNLKSSNVLLGAD----FESCLTDYGLGSF   66 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~----~~~~l~dfg~~~~   66 (221)
                      .++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            78999999999999874    6789999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=87.06  E-value=0.71  Score=36.25  Aligned_cols=27  Identities=22%  Similarity=0.288  Sum_probs=23.8

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+++.||+++ + .+.++||+.+.
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            688999999999998 4 88999998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.75  E-value=0.68  Score=34.65  Aligned_cols=51  Identities=14%  Similarity=0.072  Sum_probs=40.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHH-HhcCCCCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           11 KPLHWTSCLKIAEDLASGLL-YIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~-~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      +.++...+++++.+|+.-.. +++   .-+|.-++|.|++++.++.+++.-.|+-
T Consensus        80 ~~~~~~eKlrll~nl~~L~~~~~~---~r~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A           80 RKTTLLSRIRAAIHLVSKVKHHSA---RRLIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             HTSCHHHHHHHHHHHHHHHSSCCS---SSEECCCCGGGEEECTTCCEEESCCEET
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhhh---CceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence            34677788888888877544 343   3468889999999999999999988864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=86.71  E-value=0.18  Score=40.29  Aligned_cols=29  Identities=21%  Similarity=0.223  Sum_probs=24.6

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.||+++.+..+.|+||+.+.
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            78999999999999864457899998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.82  E-value=0.56  Score=38.81  Aligned_cols=17  Identities=29%  Similarity=0.544  Sum_probs=14.9

Q ss_pred             CceeeCcCCCCeEEcCC
Q 048055           37 GLTHGNLKSSNVLLGAD   53 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~   53 (221)
                      .++|+|+.+.||+++.+
T Consensus       250 v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEECSCCCGGGEEEEC-
T ss_pred             EEEeCCCCCCeEEeeCC
Confidence            68999999999999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=84.43  E-value=0.37  Score=38.48  Aligned_cols=29  Identities=24%  Similarity=0.404  Sum_probs=26.0

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.|++++.++.+.+.||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            68999999999999887889999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=83.13  E-value=0.45  Score=38.27  Aligned_cols=28  Identities=18%  Similarity=0.326  Sum_probs=23.3

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      +++|+|+.+.||+++.+. +.++||+.+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            689999999999997654 8999998763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.63  E-value=1.1  Score=33.40  Aligned_cols=84  Identities=14%  Similarity=0.094  Sum_probs=57.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      +.++...+++++.+|+.-..++++   -+|.-++|.|++++.++.+++.-.|+...+                +|.-.  
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f~~~~~p~i~~RGik~~l----------------~P~~~--  134 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFFTRDGLPIAKTRGLQNVV----------------DPLPV--  134 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEECTTSCEEESCCEETTTB----------------SCCCC--
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEEcCCCCEEEEEccCccCC----------------CCCCC--
Confidence            456788899999999886654444   368889999999999999999988763221                11100  


Q ss_pred             cCCCCCcccc-hHHHHHHHHHHhCCCCCccc
Q 048055           91 WKQPTQQADV-YSFGVLLLELLTGKTPFQDL  120 (221)
Q Consensus        91 ~~~~~~~~di-~slG~~l~~~~~g~~pf~~~  120 (221)
                           ...|. -..=|++..+++++..|...
T Consensus       135 -----~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          135 -----SEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             -----CHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             -----CHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence                 01122 23456777888898888654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=81.02  E-value=0.67  Score=37.62  Aligned_cols=28  Identities=21%  Similarity=0.396  Sum_probs=24.4

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .++|+|+.+.||+++.+ .+.+.||..+.
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            89999999999999765 48899998764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	221
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-26
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-26
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-25
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-25
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-25
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-25
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-25
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-25
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-25
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-25
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-25
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-24
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-24
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-24
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-23
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-23
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-23
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-22
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-21
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-20
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-20
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-20
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-19
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-19
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-19
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-19
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-18
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-18
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-18
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-17
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-17
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-17
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-17
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-17
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-17
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-17
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-17
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-16
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-16
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-16
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-14
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-14
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-14
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-14
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-13
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-12
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-12
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 7e-34
 Identities = 39/182 (21%), Positives = 76/182 (41%), Gaps = 16/182 (8%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
                    + IA   A G+ Y+H    + H +LKS+N+ L  D    + D+GL + ++ 
Sbjct: 98  ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156

Query: 70  DSVEEPSAT---SLFYKAPEC--REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
            S          S+ + APE    +     + Q+DVY+FG++L EL+TG+ P+ ++    
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI---- 212

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
             +    +  +      S D     +   +     +  +   C+    + RP+  ++   
Sbjct: 213 --NNRDQIIFMVGRGYLSPDLSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILAS 266

Query: 185 IR 186
           I 
Sbjct: 267 IE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 6e-28
 Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 18/181 (9%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
            G  L     L +A  +A G+ +I +     H +L+++N+L+       + D+GL     
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

Query: 69  PDSVEEPS--ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
            +           + + APE    +   T ++DV+SFG+LL E++T            G 
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYP-----GM 214

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
             P  ++++       G      +   EE    L  +   C    PE+RP    +  ++ 
Sbjct: 215 TNPEVIQNLER-----GYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265

Query: 187 D 187
           D
Sbjct: 266 D 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 7e-28
 Identities = 40/207 (19%), Positives = 73/207 (35%), Gaps = 23/207 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQ-------NPGLTHGNLKSSNVLLGADFESCLTDYGL 63
             +     +K+A   ASGL ++H         P + H +LKS N+L+  +   C+ D GL
Sbjct: 95  YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154

Query: 64  GSFRNPDSVEEPSAT-----SLFYKAPECRE-----IWKQPTQQADVYSFGVLLLELLTG 113
               +  +     A      +  Y APE  +        +  ++AD+Y+ G++  E+   
Sbjct: 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

Query: 114 KTPF-----QDLVLEHGSDIPRWVRSVREEETESGDDPP-SSNEASEEKLQALLNIAIAC 167
            +         L           V  +R+   E    P   +   S E L+ +  I   C
Sbjct: 215 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 274

Query: 168 VSLAPENRPVMREVSKMIRDSRAEAQM 194
                  R     + K +     +  +
Sbjct: 275 WYANGAARLTALRIKKTLSQLSQQEGI 301

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (256), Expect = 4e-27
 Identities = 40/184 (21%), Positives = 76/184 (41%), Gaps = 19/184 (10%)

Query: 6   TSGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGS 65
           +S G  PL     L IA  +A+G+ Y+ +     H +L + N L+G +    + D+GL  
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSR 188

Query: 66  FRNPDSVEEPS---ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVL 122
                   +     A  + +  PE    + + T ++DV+++GV+L E+ +          
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQP----- 242

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
            +G      +  VR+     G+          E    L N+   C S  P +RP    + 
Sbjct: 243 YYGMAHEEVIYYVRD-----GNILACPENCPLE----LYNLMRLCWSKLPADRPSFCSIH 293

Query: 183 KMIR 186
           ++++
Sbjct: 294 RILQ 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 5e-26
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 23/198 (11%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
            GK L     + +A  +ASG+ Y+ +     H +L+++N+L+G +    + D+GL     
Sbjct: 106 TGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIE 164

Query: 69  PD--SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
            +  +  + +   + + APE    + + T ++DV+SFG+LL EL T            G 
Sbjct: 165 DNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYP-----GM 218

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
                +  V     E G   P   E  E     L ++   C    PE RP    +   + 
Sbjct: 219 VNREVLDQV-----ERGYRMPCPPECPES----LHDLMCQCWRKEPEERPTFEYLQAFLE 269

Query: 187 DSRAEAQMSSNSSDHSPG 204
           D       +S    + PG
Sbjct: 270 DY-----FTSTEPQYQPG 282

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (246), Expect = 7e-26
 Identities = 38/180 (21%), Positives = 73/180 (40%), Gaps = 20/180 (11%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
           G   L     LK + D+   + Y+  N    H +L + NVL+  D  + ++D+G    + 
Sbjct: 96  GRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFG--LTKE 152

Query: 69  PDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSD 127
             S ++     + + APE     K+ + ++DV+SFG+LL E+ + G+ P+         D
Sbjct: 153 ASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKD 208

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
           +   V        E G    + +         +  +   C  L    RP   ++ + +  
Sbjct: 209 VVPRV--------EKGYKMDAPDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.0 bits (246), Expect = 1e-25
 Identities = 39/185 (21%), Positives = 80/185 (43%), Gaps = 22/185 (11%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
           G  + +  ++  ++   ++ G+ Y+ +     H +L + NVLL     + ++D+GL    
Sbjct: 101 GKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159

Query: 68  NPDSVEEPSAT----SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVL 122
             D     + +     L + APEC   +++ + ++DV+S+GV + E L+ G+ P++    
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKK--- 215

Query: 123 EHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
             G ++  ++        E G       E   E    L  +   C     E+RP    V 
Sbjct: 216 MKGPEVMAFI--------EQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVE 263

Query: 183 KMIRD 187
           + +R 
Sbjct: 264 QRMRA 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 1e-25
 Identities = 39/194 (20%), Positives = 76/194 (39%), Gaps = 18/194 (9%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSF 66
           +     L     L  A D+A G+ Y+ Q     H +L + N+L+G ++ + + D+GL   
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRG 176

Query: 67  RNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHG 125
           +     +      + + A E    +   T  +DV+S+GVLL E+++ G TP+       G
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPY------CG 229

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
                    + +     G          +E    + ++   C    P  RP   ++   +
Sbjct: 230 MTCAELYEKLPQ-----GYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSL 280

Query: 186 RDSRAEAQMSSNSS 199
                E +   N++
Sbjct: 281 NRMLEERKTYVNTT 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 2e-25
 Identities = 39/183 (21%), Positives = 82/183 (44%), Gaps = 22/183 (12%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            + +   + +++   ++ G+ Y+ ++    H +L + NVLL     + ++D+GL      
Sbjct: 101 NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159

Query: 70  DSVEEPSAT----SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
           D     + T     + + APEC   + + + ++DV+SFGVL+ E  + G+ P++ +    
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---K 215

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
           GS++   +        E G+          E    + ++   C +   ENRP    V   
Sbjct: 216 GSEVTAML--------EKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELR 263

Query: 185 IRD 187
           +R+
Sbjct: 264 LRN 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 3e-25
 Identities = 34/175 (19%), Positives = 73/175 (41%), Gaps = 18/175 (10%)

Query: 15  WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE 74
             + L +  D+  G+ Y+ +   + H +L + N L+G +    ++D+G+  F   D    
Sbjct: 100 AETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158

Query: 75  PSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWV 132
            + T   + + +PE    + + + ++DV+SFGVL+ E+ +      +      S++   +
Sbjct: 159 STGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVEDI 215

Query: 133 RSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
                    +G        AS      +  I   C    PE+RP    + + + +
Sbjct: 216 S--------TGFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 4e-25
 Identities = 37/181 (20%), Positives = 72/181 (39%), Gaps = 20/181 (11%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN 68
               L +   L  A  +A G+ ++       H +L + NVL+       + D+GL     
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 69  PDS---VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
            DS   V   +   + + APE        T ++DV+S+G+LL E+ + G  P+    +  
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPG--IPV 272

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
            ++  + ++        +G        A+EE    +  I  +C +     RP    ++  
Sbjct: 273 DANFYKLIQ--------NGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 185 I 185
           +
Sbjct: 321 L 321

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 5e-25
 Identities = 36/197 (18%), Positives = 65/197 (32%), Gaps = 26/197 (13%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
                    +     +A G+ ++       H +L + N +L   F   + D+GL      
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 70  DSVEEPSAT-----SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
              +           + + A E  +  ++ T ++DV+SFGVLL EL+T   P        
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPP-----YP 236

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
             +       + +     G          +     L  + + C     E RP   E+   
Sbjct: 237 DVNTFDITVYLLQ-----GRRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSR 287

Query: 185 IRDSRAEAQMSSNSSDH 201
           I      A  S+   +H
Sbjct: 288 I-----SAIFSTFIGEH 299

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (240), Expect = 5e-25
 Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 19/171 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                        +LA+ L Y H    + H ++K  N+LLG+  E  + D+G  S   P 
Sbjct: 101 SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPS 158

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPR 130
           S       +L Y  PE  E  +   ++ D++S GVL  E L GK PF+       +    
Sbjct: 159 SRRTTLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQE 211

Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             + +   E          +  +E       ++    +   P  RP++REV
Sbjct: 212 TYKRISRVE------FTFPDFVTEG----ARDLISRLLKHNPSQRPMLREV 252

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (240), Expect = 6e-25
 Identities = 32/174 (18%), Positives = 71/174 (40%), Gaps = 18/174 (10%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIH-QNPGLTHGNLKSSNVLL-GADFESCLTDYGLGSFR 67
            K +           +  GL ++H + P + H +LK  N+ + G      + D GL + +
Sbjct: 106 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
                +    T   + APE     ++  +  DVY+FG+ +LE+ T + P+ +        
Sbjct: 166 RASFAKAVIGT-PEFMAPEM--YEEKYDESVDVYAFGMCMLEMATSEYPYSE-------- 214

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                 +       SG  P S ++ +  +++ ++     C+    + R  ++++
Sbjct: 215 --CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDL 263

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 8e-25
 Identities = 28/180 (15%), Positives = 71/180 (39%), Gaps = 20/180 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                   + +   +A+G+ Y+  N    H +L + N+L+ ++    ++D+GL      D
Sbjct: 105 GEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163

Query: 71  SVEEPSAT----SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
                + +     + + APE    +++ T  +DV+SFG+++ E++T              
Sbjct: 164 PEATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPY-----WEL 217

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
                ++++ +     G   P+  +        +  + + C       RP   ++  ++ 
Sbjct: 218 SNHEVMKAIND-----GFRLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.0 bits (241), Expect = 9e-25
 Identities = 38/174 (21%), Positives = 64/174 (36%), Gaps = 20/174 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            KPL       +      GL Y+H +  + H ++K+ N+LL       L D+G  S   P
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167

Query: 70  DSVEEPSATSLFYKAPECREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
            +       + ++ APE        Q   + DV+S G+  +EL   K P          +
Sbjct: 168 ANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMN 218

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
               +  + + E         S   SE       N   +C+   P++RP    +
Sbjct: 219 AMSALYHIAQNE----SPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.8 bits (238), Expect = 1e-24
 Identities = 41/182 (22%), Positives = 67/182 (36%), Gaps = 21/182 (11%)

Query: 5   RTSGGGKPLHWTSCLKIAEDLASGLLYIHQ----NPGLTHGNLKSSNVLLGADFESCLTD 60
           + +   + L     L++   L   L   H+       + H +LK +NV L       L D
Sbjct: 98  KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157

Query: 61  YGLGSFRNPD-SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           +GL    N D S  +    + +Y +PE         +++D++S G LL EL     PF  
Sbjct: 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFT- 215

Query: 120 LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMR 179
                          +RE     G         S+E    L  I    ++L   +RP + 
Sbjct: 216 -----AFSQKELAGKIRE-----GKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVE 261

Query: 180 EV 181
           E+
Sbjct: 262 EI 263

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.4 bits (237), Expect = 2e-24
 Identities = 40/199 (20%), Positives = 76/199 (38%), Gaps = 29/199 (14%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRN 68
            +PL  +    + +     L Y+H N  + H +LK+ N+L   D +  L D+G+      
Sbjct: 104 ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162

Query: 69  PDSVEEPSATSLFYKAPEC----REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEH 124
                +    + ++ APE         +    +ADV+S G+ L+E+   + P       H
Sbjct: 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------H 216

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV--- 181
             +  R +  + + E  +   P      S    +  L     C+    + R    ++   
Sbjct: 217 ELNPMRVLLKIAKSEPPTLAQPS---RWSSN-FKDFLK---KCLEKNVDARWTTSQLLQH 269

Query: 182 -------SKMIRDSRAEAQ 193
                  +K IR+  AEA+
Sbjct: 270 PFVTVDSNKPIRELIAEAK 288

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 95.2 bits (236), Expect = 3e-24
 Identities = 31/183 (16%), Positives = 73/183 (39%), Gaps = 22/183 (12%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                   + +   +A+G+ Y+       H +L + N+L+ ++    ++D+GL  F   D
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 71  SVEEPSATSLFYKAPE-----CREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEH 124
           + +    ++L  K P          +++ T  +DV+S+G+++ E+++ G+ P+ D     
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---MT 238

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM 184
             D+   +        E     P   +        L  + + C      +RP   ++   
Sbjct: 239 NQDVINAI--------EQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 185 IRD 187
           +  
Sbjct: 287 LDK 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.0 bits (233), Expect = 8e-24
 Identities = 36/190 (18%), Positives = 74/190 (38%), Gaps = 18/190 (9%)

Query: 8   GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFR 67
              + +     L +A  ++S + Y+ +     H +L + N L+G +    + D+GL    
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165

Query: 68  NPDSVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
             D+    +     + + APE    + + + ++DV++FGVLL E+ T            G
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP-----YPG 219

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            D+ +    + +                E+    +  +  AC    P +RP   E+ +  
Sbjct: 220 IDLSQVYELLEK-----DYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAF 270

Query: 186 RDSRAEAQMS 195
                E+ +S
Sbjct: 271 ETMFQESSIS 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.7 bits (235), Expect = 8e-24
 Identities = 27/109 (24%), Positives = 54/109 (49%), Gaps = 2/109 (1%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             +      K++  +  GL Y+ +   + H ++K SN+L+ +  E  L D+G+ S +  D
Sbjct: 99  GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-SGQLID 157

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           S+      +  Y +PE  +     + Q+D++S G+ L+E+  G+ P   
Sbjct: 158 SMANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (232), Expect = 8e-24
 Identities = 35/174 (20%), Positives = 72/174 (41%), Gaps = 17/174 (9%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             +      +    L +G++Y+H   G+TH ++K  N+LL       ++D+GL +    +
Sbjct: 98  IGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156

Query: 71  SVEEPSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           + E        +L Y APE  +  +   +  DV+S G++L  +L G+ P+     +  SD
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW-----DQPSD 211

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             +     +E++T         +          L +    +   P  R  + ++
Sbjct: 212 SCQEYSDWKEKKTYLNPWKKIDSAP--------LALLHKILVENPSARITIPDI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.2 bits (231), Expect = 1e-23
 Identities = 32/180 (17%), Positives = 70/180 (38%), Gaps = 20/180 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                   L++ +D+   + Y+       H +L + N L+       ++D+GL  +   D
Sbjct: 95  HRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153

Query: 71  SVEEPSAT--SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSD 127
                  +   + +  PE    + + + ++D+++FGVL+ E+ + GK P++         
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYE------RFT 206

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
                  + +     G      + ASE+    +  I  +C     + RP  + +   I D
Sbjct: 207 NSETAEHIAQ-----GLRLYRPHLASEK----VYTIMYSCWHEKADERPTFKILLSNILD 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 91.7 bits (227), Expect = 4e-23
 Identities = 37/176 (21%), Positives = 64/176 (36%), Gaps = 18/176 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             L      KI   L   +  +H+   + H +LK  N+LL  D    LTD+G     +P 
Sbjct: 105 VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163

Query: 71  SVEEPSATSLFYKAPECREIW-----KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
                   +  Y APE  E           ++ D++S GV++  LL G  PF        
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF------WH 217

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                 +R +     +     P  ++ S+     + ++    + + P+ R    E 
Sbjct: 218 RKQMLMLRMIMSGNYQF--GSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.7 bits (227), Expect = 4e-23
 Identities = 32/183 (17%), Positives = 69/183 (37%), Gaps = 19/183 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                 +  + A  +A G+ Y+       H +L + N+LL       + D+GL      +
Sbjct: 106 GHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

Query: 71  SVEEPSATSL---FYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
                        F          +  +  +D + FGV L E+ T G+ P+       G 
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW------IGL 218

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
           +  + +  + +E    G+  P   +  ++    + N+ + C +  PE+RP    +   + 
Sbjct: 219 NGSQILHKIDKE----GERLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

Query: 187 DSR 189
           +++
Sbjct: 271 EAQ 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 5e-23
 Identities = 41/190 (21%), Positives = 75/190 (39%), Gaps = 21/190 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             L     L  +  +A G+ ++       H +L + N+LL     + + D+GL      D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 71  S---VEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           S   V+  +   + + APE        T ++DV+S+G+ L EL +  +         G  
Sbjct: 199 SNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMP 252

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
           +      + +E    G    S   A  E    + +I   C    P  RP  +++ ++I  
Sbjct: 253 VDSKFYKMIKE----GFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 188 SRAEAQMSSN 197
             +E   S+N
Sbjct: 305 QISE---STN 311

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 2e-22
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 25/197 (12%)

Query: 15  WTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEE 74
               L     +A G+ Y+     L H +L + NVL+       +TD+GL      +  E 
Sbjct: 110 SQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168

Query: 75  PSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPR 130
            +      + + A E     +  T Q+DV+S+GV + EL+T G  P+  +     S+I  
Sbjct: 169 HAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISS 224

Query: 131 WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV----SKMIR 186
            +        E G+  P     + +    +  I + C  +  ++RP  RE+    SKM R
Sbjct: 225 IL--------EKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

Query: 187 DSRAEAQMSSNSSDHSP 203
           D +    +  +   H P
Sbjct: 273 DPQRYLVIQGDERMHLP 289

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.3 bits (221), Expect = 5e-22
 Identities = 34/172 (19%), Positives = 67/172 (38%), Gaps = 16/172 (9%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRNP 69
             +       +  +    L ++H N  + H ++KS N+LLG D    LTD+G        
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
            S       + ++ APE     K    + D++S G++ +E++ G+ P+         +  
Sbjct: 170 QSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENPL 222

Query: 130 RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
           R +  +    T    +P   +    + L   L++         E R   +E+
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM-------DVEKRGSAKEL 267

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 87.2 bits (215), Expect = 3e-21
 Identities = 24/191 (12%), Positives = 60/191 (31%), Gaps = 23/191 (12%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES-----CLTDYGLG 64
           G+     +    A+ + + +  IH+   L + ++K  N L+G           + D+G+ 
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153

Query: 65  SFRNPDSVEEPSAT--------SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTP 116
            F      ++            +  Y +       ++ +++ D+ + G + +  L G  P
Sbjct: 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLP 212

Query: 117 FQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           +Q       +   +    + E             E      +          +LA +  P
Sbjct: 213 WQG---LKAATNKQKYERIGE-----KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264

Query: 177 VMREVSKMIRD 187
               +  +   
Sbjct: 265 DYDYLQGLFSK 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 85.5 bits (211), Expect = 2e-20
 Identities = 35/174 (20%), Positives = 69/174 (39%), Gaps = 16/174 (9%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES--CLTDYGLGSFR 67
              +     ++    +  GL ++H+N    H +LK  N++      +   L D+GL +  
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +P    + +  +  + APE  E  K      D++S GVL   LL+G +PF       G +
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPF------GGEN 229

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
               +R+V+  +    +   S+     E  +  +      +   P  R  + + 
Sbjct: 230 DDETLRNVKSCD---WNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.0 bits (207), Expect = 4e-20
 Identities = 35/179 (19%), Positives = 66/179 (36%), Gaps = 18/179 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             L   S +  A  L++ L Y+       H ++ + NVL+ ++    L D+GL  +    
Sbjct: 103 YSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 71  SVEEPS--ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
           +  + S     + + APE    +++ T  +DV+ FGV + E+L             G   
Sbjct: 162 TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKN 215

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
              +  +       G+  P            L ++   C +  P  RP   E+   +  
Sbjct: 216 NDVIGRIEN-----GERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 84.3 bits (208), Expect = 7e-20
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 16/174 (9%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES--CLTDYGLGSFR 67
              +     +        GL ++H++  + H ++K  N++      S   + D+GL +  
Sbjct: 121 DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           NPD + + +  +  + APE  +  +      D+++ GVL   LL+G +PF       G D
Sbjct: 180 NPDEIVKVTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFA------GED 232

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
               +++V+  + E  +D  SS   S E  +  +      +   P  R  + + 
Sbjct: 233 DLETLQNVKRCDWEFDEDAFSS--VSPE-AKDFIK---NLLQKEPRKRLTVHDA 280

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (203), Expect = 1e-19
 Identities = 37/181 (20%), Positives = 64/181 (35%), Gaps = 18/181 (9%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
              L     +  +  +A G+ ++       H +L + N+LL       + D+GL      
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 70  DSVEEPSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
           D            L + APE     +  T Q+DV+SFGVLL E+ +            G 
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGV 240

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIR 186
            I        +E    G    + +  + E    +    + C    P  RP   E+ + + 
Sbjct: 241 KIDEEFCRRLKE----GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292

Query: 187 D 187
           +
Sbjct: 293 N 293

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (203), Expect = 1e-19
 Identities = 34/185 (18%), Positives = 66/185 (35%), Gaps = 17/185 (9%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
              +   +   +   L  GL ++H +  + H +LK  N+L+ +  +  L D+GL    + 
Sbjct: 110 EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD---------- 119
                    +L+Y+APE            D++S G +  E+   K  F+           
Sbjct: 169 QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

Query: 120 ---LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
              + L    D PR V   R+        P    +   +  +   ++ + C++  P  R 
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRI 285

Query: 177 VMREV 181
                
Sbjct: 286 SAYSA 290

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 29/174 (16%), Positives = 61/174 (35%), Gaps = 16/174 (9%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES--CLTDYGLGSFR 67
              L+    +     +   L ++H +  + H +++  N++      S   + ++G     
Sbjct: 96  AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
            P        T+  Y APE  +     +   D++S G L+  LL+G  PF          
Sbjct: 155 KPGDNFRLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFL------AET 207

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             + + ++   E     D  +  E S E     ++     +    ++R    E 
Sbjct: 208 NQQIIENIMNAEYTF--DEEAFKEISIE----AMDFVDRLLVKERKSRMTASEA 255

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 7e-19
 Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 21/179 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           + L     +  A  +A G+ Y+       H +L + NVL+  D    + D+GL    +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 71  SVEEPSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGS 126
              + +      + + APE     +  T Q+DV+SFGVLL E+ T G +P+       G 
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYP------GV 241

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMI 185
            +    + ++E     G      +  + E    L  +   C    P  RP  +++ + +
Sbjct: 242 PVEELFKLLKE-----GHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 1e-18
 Identities = 37/180 (20%), Positives = 70/180 (38%), Gaps = 19/180 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
            P   +  +++A ++A G+ Y++ N    H +L + N ++  DF   + D+G+       
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 71  SVEEPSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
                       + + +PE  +     T  +DV+SFGV+L E+ T            G  
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLS 240

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             + +R V E     G      +   +     L  +   C    P+ RP   E+   I++
Sbjct: 241 NEQVLRFVME-----GGLLDKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.5 bits (198), Expect = 1e-18
 Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 13/176 (7%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES---CLTDYGLGS 65
           G +        +I + +   + Y+H    + H ++K  N+L  +   +    LTD+G   
Sbjct: 104 GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
                +       + +Y APE     ++  +  D++S GV++  LL G  PF      HG
Sbjct: 163 ETTSHNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHG 218

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             I   +++          +P  S   SEE ++ L+      +   P  R  + E 
Sbjct: 219 LAISPGMKTRIRMGQYEFPNPEWSE-VSEE-VKMLIR---NLLKTEPTQRMTITEF 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 78.0 bits (191), Expect = 6e-18
 Identities = 33/185 (17%), Positives = 70/185 (37%), Gaps = 15/185 (8%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNP 69
             L   +       L +G+ Y H    + H +LK  N+L+  + E  + D+GL  +F  P
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD---------- 119
                    +L+Y+AP+     K+ +   D++S G +  E++ G   F            
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

Query: 120 ---LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
              L   +  + P      + +   +  +P       +   ++ +++    + L P  R 
Sbjct: 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273

Query: 177 VMREV 181
             ++ 
Sbjct: 274 TAKQA 278

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.5 bits (190), Expect = 2e-17
 Identities = 35/167 (20%), Positives = 61/167 (36%), Gaps = 15/167 (8%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
                       A ++  GL ++H    + + +LK +N+LL       ++D GL +    
Sbjct: 101 HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGL-ACDFS 158

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
                 S  +  Y APE  +        AD +S G +L +LL G +PF+    +   +I 
Sbjct: 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

Query: 130 RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           R   +               +  S E L++LL      +      R 
Sbjct: 219 RMTLT---------MAVELPDSFSPE-LRSLLE---GLLQRDVNRRL 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.1 bits (189), Expect = 2e-17
 Identities = 43/189 (22%), Positives = 64/189 (33%), Gaps = 15/189 (7%)

Query: 7   SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC-LTDYGLGS 65
           S   + L           L   L YIH   G+ H ++K  N+LL  D     L D+G   
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD------ 119
                        S +Y+APE        T   DV+S G +L ELL G+  F        
Sbjct: 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

Query: 120 ---LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA----CVSLAP 172
              ++   G+     +R +    TE       ++  ++         AIA     +   P
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291

Query: 173 ENRPVMREV 181
             R    E 
Sbjct: 292 TARLTPLEA 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 76.4 bits (187), Expect = 3e-17
 Identities = 30/189 (15%), Positives = 63/189 (33%), Gaps = 21/189 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVL---LGADFESCLTDYGLGSF 66
            +     + L +A+ + S + YIH      H ++K  N L           + D+GL   
Sbjct: 97  SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155

Query: 67  RNPDSVEEPSAT--------SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
                  +            +  Y +        + +++ D+ S G +L+    G  P+Q
Sbjct: 156 YRDARTHQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQ 214

Query: 119 DLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVM 178
                      +  +  R  E +         +    +    LN    C SL  +++P  
Sbjct: 215 -----GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDY 266

Query: 179 REVSKMIRD 187
             + ++ R+
Sbjct: 267 SYLRQLFRN 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.2 bits (187), Expect = 3e-17
 Identities = 32/174 (18%), Positives = 67/174 (38%), Gaps = 21/174 (12%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                T       ++ S L Y+H    + H +LK  N+LL  D    +TD+G     +P+
Sbjct: 103 GSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

Query: 71  SVEEPSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           S +  + +   +  Y +PE     K   + +D+++ G ++ +L+ G  PF+        +
Sbjct: 162 SKQARANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFR------AGN 214

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                + + + E           +   +  + L+      + L    R    E+
Sbjct: 215 EYLIFQKIIKLE------YDFPEKFFPK-ARDLVE---KLLVLDATKRLGCEEM 258

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.8 bits (188), Expect = 3e-17
 Identities = 39/190 (20%), Positives = 68/190 (35%), Gaps = 20/190 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           + L           +  GL YIH    + H +LK SN+LL    +  + D+GL    +PD
Sbjct: 104 QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162

Query: 71  SVEEPSATS----LFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD------- 119
                  T      +Y+APE     K  T+  D++S G +L E+L+ +  F         
Sbjct: 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222

Query: 120 ---LVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKL-----QALLNIAIACVSLA 171
              L +            +  +        P  N+    +L        L++    ++  
Sbjct: 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282

Query: 172 PENRPVMREV 181
           P  R  + + 
Sbjct: 283 PHKRIEVEQA 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.5 bits (185), Expect = 4e-17
 Identities = 38/173 (21%), Positives = 65/173 (37%), Gaps = 25/173 (14%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRN 68
              L           +   + + H   G+ H ++K  N+L+  +  E  L D+G G+   
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162

Query: 69  PDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
                +   T   Y  PE     +   + A V+S G+LL +++ G  PF     EH  +I
Sbjct: 163 DTVYTDFDGT-RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEI 216

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
            R     R+               S E      ++   C++L P +RP   E+
Sbjct: 217 IRGQVFFRQ-------------RVSSE----CQHLIRWCLALRPSDRPTFEEI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 75.2 bits (184), Expect = 7e-17
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
            P+     +++  D    L + HQN G+ H ++K +N+++ A     + D+G+       
Sbjct: 106 GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164

Query: 71  SVEEPSATSLF----YKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGS 126
                   ++     Y +PE          ++DVYS G +L E+LTG+ PF        S
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DS 218

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
            +    + VRE+       P + +E     L A++      ++  PENR 
Sbjct: 219 PVSVAYQHVREDPI----PPSARHEGLSADLDAVVL---KALAKNPENRY 261

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 75.1 bits (184), Expect = 9e-17
 Identities = 36/174 (20%), Positives = 66/174 (37%), Gaps = 17/174 (9%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLL---GADFESCLTDYGLGSFR 67
                    ++   +   + Y+H    + H +LK  N+L      D +  ++D+GL    
Sbjct: 102 GFYTERDASRLIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD 127
           +P SV   +  +  Y APE     K  ++  D +S GV+   LL G  PF      +  +
Sbjct: 161 DPGSVLSTACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPF------YDEN 213

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
             +    + + E E   D P  ++ S+       +     +   PE R    + 
Sbjct: 214 DAKLFEQILKAEYEF--DSPYWDDISDS----AKDFIRHLMEKDPEKRFTCEQA 261

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 1e-16
 Identities = 35/185 (18%), Positives = 65/185 (35%), Gaps = 15/185 (8%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNP 69
             +           L  GL + H +  + H +LK  N+L+  +    L D+GL  +F  P
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ-----DLVLEH 124
                    +L+Y+APE     K  +   D++S G +  E++T +  F      D +   
Sbjct: 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

Query: 125 GSDIPRWVRSVREEETESGDDPPSSNEASEEKL--------QALLNIAIACVSLAPENRP 176
              +      V    T   D  PS  + + +          +   ++    +   P  R 
Sbjct: 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275

Query: 177 VMREV 181
             +  
Sbjct: 276 SAKAA 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (181), Expect = 2e-16
 Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 14/186 (7%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFR 67
               L  +           GL Y+HQ+  + H +LK +N+LL  +    L D+GL  SF 
Sbjct: 93  NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151

Query: 68  NPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ-DLVLEHGS 126
           +P+        + +Y+APE     +      D+++ G +L ELL        D  L+  +
Sbjct: 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT 211

Query: 127 DIPRWVRSVREEETESGDDPPSSNEASEEKL-----------QALLNIAIACVSLAPENR 175
            I   + +  EE+       P                       LL++        P  R
Sbjct: 212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271

Query: 176 PVMREV 181
               + 
Sbjct: 272 ITATQA 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.0 bits (181), Expect = 3e-16
 Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 19/168 (11%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGL-GSFRN 68
                 +     A ++  GL ++H   G+ + +LK  N+LL  D    + D+G+      
Sbjct: 97  CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155

Query: 69  PDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
            D+       +  Y APE     ++     D +SFGVLL E+L G++PF     +   ++
Sbjct: 156 GDAKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEEL 211

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
              +R          D+P       +E      ++ +      PE R 
Sbjct: 212 FHSIRM---------DNPFYPRWLEKE----AKDLLVKLFVREPEKRL 246

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.1 bits (173), Expect = 2e-15
 Identities = 37/186 (19%), Positives = 62/186 (33%), Gaps = 16/186 (8%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLG-SFRNP 69
             L           L  GL + H    + H +LK  N+L+  + E  L ++GL  +F  P
Sbjct: 96  GDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF--QDLVLEHGSD 127
                    +L+Y+ P+     K  +   D++S G +  EL     P    + V +    
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214

Query: 128 IPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLA------------PENR 175
           I R + +  EE+  S    P             L   +  ++              P  R
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274

Query: 176 PVMREV 181
               E 
Sbjct: 275 ISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 71.4 bits (174), Expect = 2e-15
 Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 2/108 (1%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES-CLTDYGLGSFRNP 69
           + L          ++   L Y H   G+ H ++K  NV++  +     L D+GL  F +P
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPF 117
                    S ++K PE    ++      D++S G +L  ++  K PF
Sbjct: 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 1e-14
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 3/109 (2%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           + L       +   +  GL YIH   G+ H +LK  N+ +  D E  + D+GL   R  D
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGL--ARQAD 172

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           S       + +Y+APE    W + TQ  D++S G ++ E++TGKT F+ 
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 2e-14
 Identities = 33/176 (18%), Positives = 69/176 (39%), Gaps = 18/176 (10%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFES----CLTDYGLGS 65
            + L      +  + + +G+ Y+H    + H +LK  N++L           + D+GL  
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

Query: 66  FRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHG 125
             +  +  +    +  + APE    ++    +AD++S GV+   LL+G +PF       G
Sbjct: 166 KIDFGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFL------G 218

Query: 126 SDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREV 181
                 + +V     E  D+  S    S    +  +      +   P+ R  +++ 
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFS--NTSAL-AKDFIR---RLLVKDPKKRMTIQDS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.4 bits (164), Expect = 4e-14
 Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 20/169 (11%)

Query: 14  HWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE 73
                   A ++   L Y+H    + + +LK  N+LL  +    +TD+G    +    V 
Sbjct: 102 PNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFG--FAKYVPDVT 158

Query: 74  EPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVR 133
                +  Y APE     K   +  D +SFG+L+ E+L G TPF      + S+  +   
Sbjct: 159 YTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPF------YDSNTMKTYE 211

Query: 134 SVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVS 182
            +   E             +E+ ++ LL+     ++     R    +  
Sbjct: 212 KILNAE------LRFPPFFNED-VKDLLS---RLITRDLSQRLGNLQNG 250

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.2 bits (163), Expect = 7e-14
 Identities = 35/192 (18%), Positives = 69/192 (35%), Gaps = 22/192 (11%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                +   ++ + L +GL Y      + H ++K++NVL+  D    L D+GL    +  
Sbjct: 112 VKFTLSEIKRVMQMLLNGL-YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170

Query: 71  SVEEPS-----ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ------- 118
              +P+       +L+Y+ PE     +      D++  G ++ E+ T     Q       
Sbjct: 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230

Query: 119 -DLVLEHGSDIPR--WVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA------CVS 169
             L+ +    I    W      E  E  +         +++L+A +    A       + 
Sbjct: 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290

Query: 170 LAPENRPVMREV 181
           L P  R    + 
Sbjct: 291 LDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.6 bits (159), Expect = 2e-13
 Identities = 30/167 (17%), Positives = 56/167 (33%), Gaps = 17/167 (10%)

Query: 10  GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP 69
            +            ++ S L Y+H    + + ++K  N++L  D    +TD+GL      
Sbjct: 99  ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157

Query: 70  DSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIP 129
           D     +                   +  D +  GV++ E++ G+ PF      +  D  
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDHE 211

Query: 130 RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
           R    +  EE             S E  ++LL      +   P+ R 
Sbjct: 212 RLFELILMEE------IRFPRTLSPE-AKSLLA---GLLKKDPKQRL 248

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 63.5 bits (153), Expect = 1e-12
 Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 5/114 (4%)

Query: 9   GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESC----LTDYGLG 64
             + +      +I++ L  GL Y+H+  G+ H ++K  NVL+           +    LG
Sbjct: 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 177

Query: 65  SFRNPDSVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQ 118
           +    D     S  +  Y++PE           AD++S   L+ EL+TG   F+
Sbjct: 178 NACWYDEHYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFE 230

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 2e-12
 Identities = 35/168 (20%), Positives = 60/168 (35%), Gaps = 16/168 (9%)

Query: 12  PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS 71
                       ++   L ++H+  G+ + ++K  N+LL ++    LTD+GL      D 
Sbjct: 125 RFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

Query: 72  VEEPSAT---SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDI 128
            E          +      R       +  D +S GVL+ ELLTG +PF           
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT------VDGE 237

Query: 129 PRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRP 176
                 +     +S  +PP   E S    + L+      +   P+ R 
Sbjct: 238 KNSQAEISRRILKS--EPPYPQEMSAL-AKDLIQ---RLLMKDPKKRL 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.9 bits (152), Expect = 2e-12
 Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 4/109 (3%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
                      A  +     Y+H    L + +LK  N+L+       +TD+G        
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
           +            APE     K   +  D ++ GVL+ E+  G  PF  
Sbjct: 195 TWTLCGTPE--ALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.2 bits (150), Expect = 4e-12
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 3/109 (2%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
           + L       +   +  GL YIH    + H +LK SN+ +  D E  + D+GL    + +
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQD 119
                   + +Y+APE    W    Q  D++S G ++ ELLTG+T F  
Sbjct: 175 MTGYV--ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.2 bits (142), Expect = 4e-11
 Identities = 31/178 (17%), Positives = 67/178 (37%), Gaps = 3/178 (1%)

Query: 11  KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD 70
             L       +   +  G+ ++H      H +LK SN+++ +D    + D+GL       
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 71  SVEEPSATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDL-VLEHGSDIP 129
            +  P   + +Y+APE         +  D++S G ++ E++  K  F     ++  + + 
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

Query: 130 RWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRD 187
             + +   E  +       +   +  K   L    +   SL P +    +  +   RD
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	221
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.98
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.98
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.98
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.98
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.98
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.98
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.98
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.09
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.08
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	89.53
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	87.41
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	83.25
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	81.74

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-37  Score=240.70  Aligned_cols=171  Identities=24%  Similarity=0.425  Sum_probs=127.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      +.++++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......   ......+|+.|+|||
T Consensus        98 ~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  176 (276)
T d1uwha_          98 ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE  176 (276)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHH
Confidence            45799999999999999999999998 99999999999999999999999999997654322   224457889999999


Q ss_pred             cchhc--CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           87 CREIW--KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        87 ~~~~~--~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .+...  ..++.++|||||||++|||++|+.||.+.     .......... ....    ..+.........+..+.+||
T Consensus       177 ~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~-----~~~~~~~~~~-~~~~----~~p~~~~~~~~~~~~l~~li  246 (276)
T d1uwha_         177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NNRDQIIFMV-GRGY----LSPDLSKVRSNCPKAMKRLM  246 (276)
T ss_dssp             HHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCHHHHHHHH-HHTS----CCCCGGGSCTTCCHHHHHHH
T ss_pred             HHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC-----ChHHHHHHHH-hcCC----CCCcchhccccchHHHHHHH
Confidence            87522  34678899999999999999999999742     1111222222 1111    11111112222335699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||.+|||+.+|++.|+.+...
T Consensus       247 ~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         247 AECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            999999999999999999999988753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-35  Score=235.21  Aligned_cols=165  Identities=18%  Similarity=0.431  Sum_probs=123.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCC------CCCCCCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVE------EPSATSLFYK   83 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~   83 (221)
                      .+.+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++........      ....+++.|+
T Consensus       122 ~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~  200 (299)
T d1jpaa_         122 DGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT  200 (299)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCcccc
Confidence            55799999999999999999999998 9999999999999999999999999999765433211      1234578899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      |||.+. +..++.++|||||||++|||++ |..||.+.      ........+..     ...++.+..++    ..+.+
T Consensus       201 aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~------~~~~~~~~i~~-----~~~~~~~~~~~----~~l~~  264 (299)
T d1jpaa_         201 APEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM------TNQDVINAIEQ-----DYRLPPPMDCP----SALHQ  264 (299)
T ss_dssp             CHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHT-----TCCCCCCTTCC----HHHHH
T ss_pred             CHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCC------CHHHHHHHHHc-----CCCCCCCccch----HHHHH
Confidence            999987 6778889999999999999998 89999743      22233333322     22233333333    46899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      |+.+||+.||.+|||+.+|++.|+++..+
T Consensus       265 li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         265 LMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            99999999999999999999999988753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=229.57  Aligned_cols=167  Identities=17%  Similarity=0.341  Sum_probs=125.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKA   84 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~   84 (221)
                      ..+.+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++......    ......+|+.|+|
T Consensus       103 ~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~A  181 (283)
T d1mqba_         103 KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA  181 (283)
T ss_dssp             TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSC
T ss_pred             ccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccC
Confidence            346799999999999999999999998 99999999999999999999999999997653322    1223456889999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ||.+. +..++.++|||||||++|||+++..||..     ..........+..     ...++.+..++    ..+.+|+
T Consensus       182 PE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~-----~~~~~~~~~~i~~-----~~~~~~~~~~~----~~l~~li  246 (283)
T d1mqba_         182 PEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYW-----ELSNHEVMKAIND-----GFRLPTPMDCP----SAIYQLM  246 (283)
T ss_dssp             HHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTT-----TCCHHHHHHHHHT-----TCCCCCCTTCB----HHHHHHH
T ss_pred             HHHHc-cCCCCCcccccccHHHHHHHHhCCCCccc-----cCCHHHHHHHHhc-----cCCCCCchhhH----HHHHHHH
Confidence            99887 67888999999999999999996655542     2222233333222     22233333333    4589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||++|||+.+|++.|+++.+.
T Consensus       247 ~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         247 MQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            999999999999999999999987753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-35  Score=228.84  Aligned_cols=155  Identities=25%  Similarity=0.381  Sum_probs=125.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++...... .....||+.|+|||.+.
T Consensus       100 ~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~  177 (263)
T d2j4za1         100 LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIE  177 (263)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHc
Confidence            45789999999999999999999998 99999999999999999999999999997654332 34457899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|||||||++|+|++|+.||.+.      ........+.....    ..+  ...+    ..+.+|+.+||+
T Consensus       178 -~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~~L~  240 (263)
T d2j4za1         178 -GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEF----TFP--DFVT----EGARDLISRLLK  240 (263)
T ss_dssp             -TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTTCC----CCC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCCCchhhhhhHhHHHHHHhcCCCCCCCC------CHHHHHHHHHcCCC----CCC--ccCC----HHHHHHHHHHcc
Confidence             677889999999999999999999999642      23333333322211    111  1222    358999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+|||+.|+++
T Consensus       241 ~dp~~R~t~~eil~  254 (263)
T d2j4za1         241 HNPSQRPMLREVLE  254 (263)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CCHhHCcCHHHHHc
Confidence            99999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=229.37  Aligned_cols=167  Identities=22%  Similarity=0.415  Sum_probs=132.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccC
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKA   84 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~   84 (221)
                      ..+.+++..++.++.||+.||.|||+. +++||||||.||+++.++.+||+|||+++......    ......+++.|+|
T Consensus       102 ~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~a  180 (285)
T d1u59a_         102 KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA  180 (285)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccC
Confidence            346799999999999999999999998 99999999999999999999999999997654332    1233457789999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|||||||++|||++ |..||.+.      ........+..     ..+++.+..++    ..+.+|
T Consensus       181 PE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~------~~~~~~~~i~~-----~~~~~~p~~~~----~~l~~l  244 (285)
T d1u59a_         181 PECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM------KGPEVMAFIEQ-----GKRMECPPECP----PELYAL  244 (285)
T ss_dssp             HHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CTHHHHHHHHT-----TCCCCCCTTCC----HHHHHH
T ss_pred             hHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCC------CHHHHHHHHHc-----CCCCCCCCcCC----HHHHHH
Confidence            99987 6678899999999999999998 89999743      22233333322     22222223333    458999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhHHHh
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSRAEA  192 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~~~~  192 (221)
                      |.+||+.||++|||+.+|++.|+..-...
T Consensus       245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         245 MSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999998866543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-35  Score=228.02  Aligned_cols=165  Identities=21%  Similarity=0.371  Sum_probs=121.4

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPE   86 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe   86 (221)
                      ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++......  ......+++.|+|||
T Consensus        94 ~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE  172 (263)
T d1sm2a_          94 QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE  172 (263)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChH
Confidence            356789999999999999999999998 99999999999999999999999999997654332  223356788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhC-CCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTG-KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      .+. +..++.++|||||||++|||+++ .+||..      .........+...     ..+..+..++    ..+.+|+.
T Consensus       173 ~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~------~~~~~~~~~i~~~-----~~~~~p~~~~----~~l~~li~  236 (263)
T d1sm2a_         173 VFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------RSNSEVVEDISTG-----FRLYKPRLAS----THVYQIMN  236 (263)
T ss_dssp             HHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCS------CCHHHHHHHHHHT-----CCCCCCTTSC----HHHHHHHH
T ss_pred             Hhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCC------CCHHHHHHHHHhc-----CCCCCccccC----HHHHHHHH
Confidence            987 67789999999999999999995 555542      2233333333222     1122222222    35899999


Q ss_pred             HcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          166 ACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      +||+.||++|||+++|++.|+++.+
T Consensus       237 ~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-35  Score=233.36  Aligned_cols=166  Identities=21%  Similarity=0.299  Sum_probs=123.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......   ......+|+.|+||
T Consensus       127 ~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         127 YKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             ---CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             hcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            355789999999999999999999998 99999999999999999999999999997654332   23345788999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhC-CCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTG-KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++| ..||....     ........+...     ..+..+...+    ..+.+++
T Consensus       206 E~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~----~~l~~li  270 (299)
T d1ywna1         206 ETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----IDEEFCRRLKEG-----TRMRAPDYTT----PEMYQTM  270 (299)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----CSHHHHHHHHHT-----CCCCCCTTCC----HHHHHHH
T ss_pred             hHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcC-----CCCCCCccCC----HHHHHHH
Confidence            9987 67789999999999999999986 56775421     111222222221     1222222233    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      .+||+.||.+|||+.+|++.|+++.+
T Consensus       271 ~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         271 LDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-35  Score=229.39  Aligned_cols=163  Identities=21%  Similarity=0.431  Sum_probs=128.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .+++++..++.++.||+.||+|||+. +++||||||+||+++.++.++++|||+++......    ......+++.|+||
T Consensus       101 ~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~AP  179 (277)
T d1xbba_         101 NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  179 (277)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred             ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCc
Confidence            46799999999999999999999998 99999999999999999999999999997654332    12334678899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++ |+.||.+.      ........+..     ...++.+..++    ..+.+||
T Consensus       180 E~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~------~~~~~~~~i~~-----~~~~~~p~~~~----~~~~~li  243 (277)
T d1xbba_         180 ECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM------KGSEVTAMLEK-----GERMGCPAGCP----REMYDLM  243 (277)
T ss_dssp             HHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHT-----TCCCCCCTTCC----HHHHHHH
T ss_pred             hhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCC------CHHHHHHHHHc-----CCCCCCCcccC----HHHHHHH
Confidence            9887 6677889999999999999998 89999743      22233333322     22222223333    4689999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      .+||+.||++|||+++|++.|+..-
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            9999999999999999999998754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-35  Score=236.82  Aligned_cols=162  Identities=21%  Similarity=0.312  Sum_probs=125.6

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......   .....+|+.|+||
T Consensus       157 ~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             ----CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            346789999999999999999999998 999999999999999999999999999976543321   2344568899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++ |..||.+...      ..........    ...++.+..++    ..+.+||
T Consensus       236 E~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~------~~~~~~~~~~----~~~~~~p~~~~----~~l~~li  300 (325)
T d1rjba_         236 ESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------DANFYKLIQN----GFKMDQPFYAT----EEIYIIM  300 (325)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------SHHHHHHHHT----TCCCCCCTTCC----HHHHHHH
T ss_pred             HHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCCH------HHHHHHHHhc----CCCCCCCCcCC----HHHHHHH
Confidence            9887 6788999999999999999997 8999975321      1111222111    12222223333    3699999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIR  186 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~  186 (221)
                      .+||+.||++|||+.||++.|.
T Consensus       301 ~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         301 QSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHh
Confidence            9999999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=227.87  Aligned_cols=163  Identities=23%  Similarity=0.420  Sum_probs=128.1

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCcccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPECR   88 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~~   88 (221)
                      .++++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++......  ......+++.|+|||.+
T Consensus       104 ~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~  182 (272)
T d1qpca_         104 IKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI  182 (272)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHH
Confidence            3589999999999999999999998 99999999999999999999999999998654432  23345678899999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|||||||++|||++|..|+..     ..........+..     ...++.+..++    ..+.+|+.+||
T Consensus       183 ~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-----~~~~~~~~~~i~~-----~~~~~~p~~~~----~~l~~li~~cl  247 (272)
T d1qpca_         183 N-YGTFTIKSDVWSFGILLTEIVTHGRIPYP-----GMTNPEVIQNLER-----GYRMVRPDNCP----EELYQLMRLCW  247 (272)
T ss_dssp             H-HCEECHHHHHHHHHHHHHHHHTTTCCSST-----TCCHHHHHHHHHT-----TCCCCCCTTCC----HHHHHHHHHHT
T ss_pred             h-CCCCCchhhhhhhHHHHHHHHhCCCCCCC-----CCCHHHHHHHHHh-----cCCCCCcccCh----HHHHHHHHHHc
Confidence            7 56778999999999999999996555432     2223333333322     12222222333    35899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhH
Q 048055          169 SLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.||++|||+.+|++.|+++-
T Consensus       248 ~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         248 KERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhhhh
Confidence            999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=229.27  Aligned_cols=158  Identities=21%  Similarity=0.378  Sum_probs=125.2

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccch
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~~   89 (221)
                      ++++...+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.
T Consensus       111 ~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~  189 (293)
T d1yhwa1         111 TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT  189 (293)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhc
Confidence            4689999999999999999999998 9999999999999999999999999999765433 2345567899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++||||+||++|+|++|..||.+.      ..............   .....+...    ...+.+|+.+||+
T Consensus       190 -~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~~~~~~~---~~~~~~~~~----s~~~~~li~~~L~  255 (293)
T d1yhwa1         190 -RKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNGT---PELQNPEKL----SAIFRDFLNRCLD  255 (293)
T ss_dssp             -SSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHHCS---CCCSSGGGS----CHHHHHHHHHHTC
T ss_pred             -CCCCCchhceehHhHHHHHHhhCCCCCCCC------CHHHHHHHHHhCCC---CCCCCcccC----CHHHHHHHHHHcc
Confidence             677889999999999999999999999642      22222222222211   111111222    2458999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 048055          170 LAPENRPVMREVSK  183 (221)
Q Consensus       170 ~dp~~Rps~~~l~~  183 (221)
                      .||.+|||+.|+++
T Consensus       256 ~dP~~R~s~~eil~  269 (293)
T d1yhwa1         256 MDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999964

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-34  Score=228.23  Aligned_cols=166  Identities=20%  Similarity=0.359  Sum_probs=129.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC--CCCCCCCccccCcc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV--EEPSATSLFYKAPE   86 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~pe   86 (221)
                      ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......  .....+++.|+|||
T Consensus       108 ~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE  186 (287)
T d1opja_         108 NRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE  186 (287)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHH
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChH
Confidence            356789999999999999999999998 999999999999999999999999999976544322  22334678899999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|||||||++|+|++|..||..     +.........+...     ..++.+..++    ..+.+|+.+
T Consensus       187 ~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-----~~~~~~~~~~i~~~-----~~~~~~~~~~----~~l~~li~~  251 (287)
T d1opja_         187 SLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYP-----GIDLSQVYELLEKD-----YRMERPEGCP----EKVYELMRA  251 (287)
T ss_dssp             HHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSST-----TCCHHHHHHHHHTT-----CCCCCCTTCC----HHHHHHHHH
T ss_pred             HHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCC-----cchHHHHHHHHhcC-----CCCCCCccch----HHHHHHHHH
Confidence            887 67789999999999999999997666543     22333333322221     2222222333    358999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||+.||++|||+.+|++.|+.+..
T Consensus       252 cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         252 CWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999988653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-35  Score=228.23  Aligned_cols=161  Identities=20%  Similarity=0.297  Sum_probs=122.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~p   85 (221)
                      ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....   .......||+.|+||
T Consensus        96 ~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~AP  174 (271)
T d1nvra_          96 PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP  174 (271)
T ss_dssp             TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCT
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCH
Confidence            356899999999999999999999998 9999999999999999999999999999764322   233456789999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+.....++.++||||+||++|+|++|+.||.....     ...........    ..........+    ..+.+|+.
T Consensus       175 E~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~~~~~~----~~~~~~~~~~s----~~~~~li~  241 (271)
T d1nvra_         175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-----SCQEYSDWKEK----KTYLNPWKKID----SAPLALLH  241 (271)
T ss_dssp             HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST-----TSHHHHHHHTT----CTTSTTGGGSC----HHHHHHHH
T ss_pred             hHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC----CCCCCccccCC----HHHHHHHH
Confidence            9987333346789999999999999999999964321     11111111111    11111112222    35889999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.|+++
T Consensus       242 ~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         242 KILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999854

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-34  Score=226.48  Aligned_cols=167  Identities=22%  Similarity=0.402  Sum_probs=123.6

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ..++++..++.++.||+.||.|||+. +++||||||.||+++.++.+||+|||+++......  ......+++.|+|||.
T Consensus       102 ~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~  180 (273)
T d1mp8a_         102 KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES  180 (273)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhH
Confidence            46789999999999999999999998 99999999999999999999999999997654322  2234466889999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|||||||++|||++ |.+||....      .......+...     ..++.+..++    ..+.+||.+
T Consensus       181 l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~------~~~~~~~i~~~-----~~~~~~~~~~----~~~~~li~~  244 (273)
T d1mp8a_         181 IN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENG-----ERLPMPPNCP----PTLYSLMTK  244 (273)
T ss_dssp             HH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC------GGGHHHHHHTT-----CCCCCCTTCC----HHHHHHHHH
T ss_pred             hc-cCCCCCccccccchHHHHHHHhcCCCCCCCCC------HHHHHHHHHcC-----CCCCCCCCCC----HHHHHHHHH
Confidence            87 6788899999999999999998 899996432      22222332221     2222222333    469999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhHHHhh
Q 048055          167 CVSLAPENRPVMREVSKMIRDSRAEAQ  193 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~~~~~  193 (221)
                      ||+.||.+|||+.+|++.|+++..+.+
T Consensus       245 cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         245 CWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            999999999999999999999876654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-34  Score=229.36  Aligned_cols=166  Identities=22%  Similarity=0.373  Sum_probs=129.5

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC---CCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV---EEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~p   85 (221)
                      ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++.......   .....+|+.|+||
T Consensus       104 ~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  182 (317)
T d1xkka_         104 HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL  182 (317)
T ss_dssp             TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccCh
Confidence            356789999999999999999999998 999999999999999999999999999976543321   2234578899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++|||||||++|||++ |..||....      .......+..     ...++.+..++    ..+.+|+
T Consensus       183 E~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~------~~~~~~~i~~-----~~~~~~p~~~~----~~~~~li  246 (317)
T d1xkka_         183 ESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEISSILEK-----GERLPQPPICT----IDVYMIM  246 (317)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------GGGHHHHHHH-----TCCCCCCTTBC----HHHHHHH
T ss_pred             HHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC------HHHHHHHHHc-----CCCCCCCcccC----HHHHHHH
Confidence            9987 6778999999999999999998 788886432      1222222222     12222223333    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||.+|||+.+|++.|+++...
T Consensus       247 ~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         247 VKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999887643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-34  Score=220.96  Aligned_cols=161  Identities=20%  Similarity=0.375  Sum_probs=129.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      ...+++..++.++.||+.||.|||+. +++||||||.||+++.++.+||+|||+++......  ......++..|+|||.
T Consensus        94 ~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~  172 (258)
T d1k2pa_          94 RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV  172 (258)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHH
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHH
Confidence            45788999999999999999999998 99999999999999999999999999997544332  2234567889999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++||||||+++|||++ |..||...      ........+..     ...++.+...+    ..+.+|+.+
T Consensus       173 ~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~------~~~~~~~~i~~-----~~~~~~p~~~~----~~l~~li~~  236 (258)
T d1k2pa_         173 LM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------TNSETAEHIAQ-----GLRLYRPHLAS----EKVYTIMYS  236 (258)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHHHHHT-----TCCCCCCTTCC----HHHHHHHHH
T ss_pred             hc-CCCCCcceeecccchhhHhHHhcCCCCCCCC------CHHHHHHHHHh-----CCCCCCccccc----HHHHHHHHH
Confidence            87 6778899999999999999998 89999643      23333333322     12222223333    368999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHh
Q 048055          167 CVSLAPENRPVMREVSKMIRD  187 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~  187 (221)
                      ||+.||.+|||+.+|++.|.+
T Consensus       237 cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHC
T ss_pred             HccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999998865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-34  Score=227.96  Aligned_cols=171  Identities=20%  Similarity=0.331  Sum_probs=134.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ....|++..++.++.||+.||.|+|+. +++||||||.|||++.++.+||+|||+++............++..|+|||.+
T Consensus       120 ~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l  198 (309)
T d1fvra_         120 TASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL  198 (309)
T ss_dssp             BSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHh
Confidence            457899999999999999999999998 9999999999999999999999999998765544444455678899999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCC-CCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGK-TPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      . +..++.++|||||||++|||++|. +||.      +.+.......+...     .+++.+..++    ..+.+|+.+|
T Consensus       199 ~-~~~~~~~sDvwSfGvil~ell~~~~~p~~------~~~~~~~~~~i~~~-----~~~~~~~~~~----~~~~~li~~c  262 (309)
T d1fvra_         199 N-YSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEKLPQG-----YRLEKPLNCD----DEVYDLMRQC  262 (309)
T ss_dssp             H-HCEECHHHHHHHHHHHHHHHHTTSCCTTT------TCCHHHHHHHGGGT-----CCCCCCTTBC----HHHHHHHHHH
T ss_pred             c-cCCCCccceeehhHHHHHHHHhcCCCCCC------CCCHHHHHHHHHhc-----CCCCCCccCC----HHHHHHHHHH
Confidence            7 677889999999999999999965 5664      33334444443322     2222223333    3599999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHHHhhcCC
Q 048055          168 VSLAPENRPVMREVSKMIRDSRAEAQMSS  196 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  196 (221)
                      |+.||++|||+.+|++.|+++..+.+...
T Consensus       263 l~~dP~~RPs~~eil~~L~~i~~~~~~~~  291 (309)
T d1fvra_         263 WREKPYERPSFAQILVSLNRMLEERKTYV  291 (309)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             cCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence            99999999999999999999887654433

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-33  Score=224.36  Aligned_cols=167  Identities=23%  Similarity=0.364  Sum_probs=132.2

Q ss_pred             CCCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCcccc
Q 048055            7 SGGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYK   83 (221)
Q Consensus         7 ~~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~   83 (221)
                      ....+.+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++......   ......+++.|+
T Consensus       126 ~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  204 (299)
T d1fgka_         126 HNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM  204 (299)
T ss_dssp             ---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGS
T ss_pred             cCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhh
Confidence            34567899999999999999999999998 99999999999999999999999999987554332   223456788899


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHH
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLN  162 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (221)
                      |||.+. +..++.++||||||+++|+|++ |..||.+.      ........+..     ...++.+..++    ..+.+
T Consensus       205 aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------~~~~~~~~i~~-----~~~~~~p~~~~----~~l~~  268 (299)
T d1fgka_         205 APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKE-----GHRMDKPSNCT----NELYM  268 (299)
T ss_dssp             CHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHT-----TCCCCCCSSCC----HHHHH
T ss_pred             hhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCC------CHHHHHHHHHc-----CCCCCCCccch----HHHHH
Confidence            999987 6788999999999999999998 78888642      22233333222     22223233333    35899


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          163 IAIACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       163 l~~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      |+.+||+.||.+|||+.||++.|+++.+
T Consensus       269 li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         269 MMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            9999999999999999999999998865

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-34  Score=227.55  Aligned_cols=165  Identities=22%  Similarity=0.412  Sum_probs=128.1

Q ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC---CCCCCCCCCccccC
Q 048055            8 GGGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD---SVEEPSATSLFYKA   84 (221)
Q Consensus         8 ~~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~   84 (221)
                      .....+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++.....   .......+++.|+|
T Consensus       132 ~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~a  210 (301)
T d1lufa_         132 PGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP  210 (301)
T ss_dssp             ---CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC
T ss_pred             cCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCC
Confidence            3456799999999999999999999998 9999999999999999999999999998754322   22334567789999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCC-CCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGK-TPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNI  163 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  163 (221)
                      ||.+. +..++.++|||||||++|||++|. +||..      .........+....     .++.+...+    ..+.+|
T Consensus       211 PE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~------~~~~e~~~~v~~~~-----~~~~p~~~~----~~~~~l  274 (301)
T d1lufa_         211 PESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYG------MAHEEVIYYVRDGN-----ILACPENCP----LELYNL  274 (301)
T ss_dssp             HHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTT------SCHHHHHHHHHTTC-----CCCCCTTCC----HHHHHH
T ss_pred             HHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCC------CCHHHHHHHHHcCC-----CCCCCccch----HHHHHH
Confidence            99987 678899999999999999999975 56753      23333334333222     222222333    358999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHhhH
Q 048055          164 AIACVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       164 ~~~cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      +.+||+.||.+||||.+|++.|+++.
T Consensus       275 i~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         275 MRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            99999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-34  Score=225.17  Aligned_cols=158  Identities=24%  Similarity=0.345  Sum_probs=115.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCC----CceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNP----GLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~----~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~   84 (221)
                      ++.+++..++.++.||+.||.|||+..    +|+||||||+|||++.++.+||+|||+++...... ......+|+.|+|
T Consensus       103 ~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~A  182 (269)
T d2java1         103 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS  182 (269)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCC
Confidence            567999999999999999999999861    39999999999999999999999999997654432 3345678999999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ||.+. +..++.++|||||||++|+|++|+.||...      ........+.....     ...+...+    ..+.+|+
T Consensus       183 PE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~------~~~~~~~~i~~~~~-----~~~~~~~s----~~l~~li  246 (269)
T d2java1         183 PEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREGKF-----RRIPYRYS----DELNEII  246 (269)
T ss_dssp             HHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCC-----CCCCTTSC----HHHHHHH
T ss_pred             HHHHc-CCCCChHHHHHhhCHHHHHHhhCCCCCCCC------CHHHHHHHHHcCCC-----CCCCcccC----HHHHHHH
Confidence            99987 677889999999999999999999999642      22333333322211     11122233    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+|||+.|+++
T Consensus       247 ~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         247 TRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCChhHCcCHHHHHh
Confidence            9999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-34  Score=226.48  Aligned_cols=156  Identities=24%  Similarity=0.379  Sum_probs=122.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+++++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......   ....||+.|+|||.+.
T Consensus       109 ~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~  184 (309)
T d1u5ra_         109 KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVIL  184 (309)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCC---CccccCccccCHHHHh
Confidence            46799999999999999999999998 9999999999999999999999999999764432   3457899999999875


Q ss_pred             h--cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           90 I--WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        90 ~--~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .  ...++.++|||||||++|+|++|..||.+.      ........+.....    ........+    ..+.+|+.+|
T Consensus       185 ~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------~~~~~~~~i~~~~~----~~~~~~~~s----~~~~~li~~~  250 (309)
T d1u5ra_         185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES----PALQSGHWS----EYFRNFVDSC  250 (309)
T ss_dssp             TTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC----CCCSCTTSC----HHHHHHHHHH
T ss_pred             ccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCC----CCCCCCCCC----HHHHHHHHHH
Confidence            2  235688999999999999999999999642      22222222222111    111112222    3589999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |+.||.+|||+.++++
T Consensus       251 L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             CcCChhHCcCHHHHHh
Confidence            9999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=226.51  Aligned_cols=160  Identities=20%  Similarity=0.308  Sum_probs=122.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      .+++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+
T Consensus       104 ~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l  182 (288)
T d2jfla1         104 ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV  182 (288)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHH
Confidence            46799999999999999999999998 9999999999999999999999999998653321 122356789999999986


Q ss_pred             h----hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           89 E----IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        89 ~----~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .    ....++.++|||||||++|+|++|..||.+...      ......+....   ......+...+    ..+.+|+
T Consensus       183 ~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~------~~~~~~i~~~~---~~~~~~~~~~s----~~~~~li  249 (288)
T d2jfla1         183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP------MRVLLKIAKSE---PPTLAQPSRWS----SNFKDFL  249 (288)
T ss_dssp             TTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG------GGHHHHHHHSC---CCCCSSGGGSC----HHHHHHH
T ss_pred             hhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC---CCCCCccccCC----HHHHHHH
Confidence            3    134567899999999999999999999975321      12222222211   11111112222    4689999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+|||+.|+++
T Consensus       250 ~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999965

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-33  Score=221.03  Aligned_cols=157  Identities=19%  Similarity=0.369  Sum_probs=121.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCC--ceeeCcCCCCeEEc-CCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPG--LTHGNLKSSNVLLG-ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~--i~h~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.||+.||+|||+. +  |+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||
T Consensus       106 ~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE  183 (270)
T d1t4ha_         106 FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPE  183 (270)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGG
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHH
Confidence            35789999999999999999999998 7  99999999999996 5789999999999754333 234567899999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+.  ..++.++|||||||++|+|++|+.||...     .........+...     ..++   .........+.+|+.+
T Consensus       184 ~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~-----~~~~~~~~~i~~~-----~~~~---~~~~~~~~~~~~li~~  248 (270)
T d1t4ha_         184 MYE--EKYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAAQIYRRVTSG-----VKPA---SFDKVAIPEVKEIIEG  248 (270)
T ss_dssp             GGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-----SSHHHHHHHHTTT-----CCCG---GGGGCCCHHHHHHHHH
T ss_pred             HhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCc-----ccHHHHHHHHHcC-----CCCc---ccCccCCHHHHHHHHH
Confidence            885  35889999999999999999999999642     2222222222211     1111   1111112358999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||++|||+.|+++
T Consensus       249 ~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         249 CIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HSCSSGGGSCCHHHHHT
T ss_pred             HccCCHhHCcCHHHHhC
Confidence            99999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-34  Score=223.51  Aligned_cols=163  Identities=21%  Similarity=0.405  Sum_probs=127.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCC----CCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSV----EEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~p   85 (221)
                      .+.+++..++.++.||+.||.|||++ +++||||||.||+++.++.+||+|||+++.......    .....++..|+||
T Consensus       105 ~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         105 QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCH
Confidence            45799999999999999999999998 999999999999999999999999999976543321    2234567789999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++||||||+++|||++ |..||.+      .+.......+...    ...++.+...+    ..+.+|+
T Consensus       184 E~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~------~~~~~~~~~i~~~----~~~~~~~~~~~----~~l~~li  248 (273)
T d1u46a_         184 ESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKE----GERLPRPEDCP----QDIYNVM  248 (273)
T ss_dssp             HHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTT------CCHHHHHHHHHTS----CCCCCCCTTCC----HHHHHHH
T ss_pred             HHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCC------cCHHHHHHHHHhC----CCCCCCccccc----HHHHHHH
Confidence            9987 6777889999999999999998 8999964      2333333333222    22333333333    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhh
Q 048055          165 IACVSLAPENRPVMREVSKMIRDS  188 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~  188 (221)
                      .+||+.||++|||+.+|++.|++.
T Consensus       249 ~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         249 VQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999988764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-33  Score=224.26  Aligned_cols=160  Identities=24%  Similarity=0.346  Sum_probs=113.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc---CCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG---ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+++++..+..++.||+.||.|||+. +++||||||+||++.   .++.+||+|||+++............||+.|+|||
T Consensus       101 ~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE  179 (307)
T d1a06a_         101 KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE  179 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcH
Confidence            46799999999999999999999998 999999999999995   47889999999998765555455667899999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++||||+||++|+|++|..||.+.      ........+.......  ..+.....+    ..+.+|+.+
T Consensus       180 ~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~~--~~~~~~~~s----~~~~~li~~  246 (307)
T d1a06a_         180 VLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDE------NDAKLFEQILKAEYEF--DSPYWDDIS----DSAKDFIRH  246 (307)
T ss_dssp             HHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHTTCCCC--CTTTTTTSC----HHHHHHHHH
T ss_pred             HHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHhccCCCC--CCccccCCC----HHHHHHHHH
Confidence            987 677899999999999999999999999642      2222223322221111  111112222    358999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.|+++
T Consensus       247 ~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HccCCHhHCcCHHHHhc
Confidence            99999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=222.30  Aligned_cols=165  Identities=25%  Similarity=0.427  Sum_probs=124.8

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC--CCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS--VEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~pe~   87 (221)
                      .+.+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++......  ......+++.|+|||.
T Consensus       107 ~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~  185 (285)
T d1fmka3         107 GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA  185 (285)
T ss_dssp             HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHH
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHH
Confidence            35689999999999999999999998 99999999999999999999999999997654332  2334567889999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      +. ...++.++|||||||++|||++|..||..     ..........+...     ..++.+..++    ..+.+|+.+|
T Consensus       186 ~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~-----~~~~~~~~~~i~~~-----~~~~~~~~~~----~~l~~li~~c  250 (285)
T d1fmka3         186 AL-YGRFTIKSDVWSFGILLTELTTKGRVPYP-----GMVNREVLDQVERG-----YRMPCPPECP----ESLHDLMCQC  250 (285)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHTTTCCSST-----TCCHHHHHHHHHTT-----CCCCCCTTSC----HHHHHHHHHH
T ss_pred             Hh-CCCCCcHHhhhcchHHHHHHHhCCCCCCC-----CCCHHHHHHHHHhc-----CCCCCCcccC----HHHHHHHHHH
Confidence            87 67788999999999999999996665543     22333333333221     1222223333    3689999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhHH
Q 048055          168 VSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      |+.||++||++.+|++.|++...
T Consensus       251 l~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         251 WRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             TCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             cccCHhHCcCHHHHHHHHhhhhc
Confidence            99999999999999999888653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=224.16  Aligned_cols=157  Identities=22%  Similarity=0.328  Sum_probs=123.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe   86 (221)
                      .+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++......   ......||+.|+|||
T Consensus       102 ~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE  180 (288)
T d1uu3a_         102 IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE  180 (288)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCce
Confidence            45789999999999999999999998 99999999999999999999999999998654332   233457899999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++||||+||++|+|++|..||...      +.......+.....    ..+  ...+    ..+.+|+.+
T Consensus       181 ~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~  243 (288)
T d1uu3a_         181 LLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEYLIFQKIIKLEY----DFP--EKFF----PKARDLVEK  243 (288)
T ss_dssp             HHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHTTCC----CCC--TTCC----HHHHHHHHT
T ss_pred             eec-cCCCCcccceehhhHHHHHHhhCCCCCCCc------CHHHHHHHHHcCCC----CCC--ccCC----HHHHHHHHH
Confidence            987 677889999999999999999999999642      22333333322211    111  2222    358999999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 048055          167 CVSLAPENRPVMREVSKM  184 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~  184 (221)
                      ||+.||.+|||+.|++..
T Consensus       244 ~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         244 LLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             TSCSSGGGSTTSGGGTCH
T ss_pred             HccCCHhHCcCHHHHcCC
Confidence            999999999999987543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-33  Score=222.22  Aligned_cols=167  Identities=16%  Similarity=0.238  Sum_probs=127.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      ..+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++............||+.|+|||.+
T Consensus       109 ~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~  187 (305)
T d1blxa_         109 PEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL  187 (305)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchh
Confidence            456789999999999999999999998 9999999999999999999999999998765555555667889999999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhcc-----------------CCCCCCCCh
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETES-----------------GDDPPSSNE  151 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~  151 (221)
                      . +..++.++||||+||++|+|++|..||.+..      .......+.......                 .........
T Consensus       188 ~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (305)
T d1blxa_         188 L-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK  260 (305)
T ss_dssp             T-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred             c-CCCCChhehhhchHHHHHHHHHCCCCCCCCC------HHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence            7 6788999999999999999999999997432      122222221110000                 000000011


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          152 ASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       152 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ........+.+|+.+||+.||++|||+.|+++
T Consensus       261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11112245889999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-33  Score=226.39  Aligned_cols=164  Identities=18%  Similarity=0.268  Sum_probs=126.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .++|++..+..++.||+.||+|||+. +++||||||+|||++.   .+.+||+|||+++............+++.|+|||
T Consensus       105 ~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE  183 (335)
T d2ozaa1         105 DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE  183 (335)
T ss_dssp             CCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCC
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcH
Confidence            46799999999999999999999998 9999999999999985   4679999999998766655566678999999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++|||||||++|+|++|..||.+.....      ....+...........+  ..........+.+|+.+
T Consensus       184 ~~~-~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~------~~~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~  254 (335)
T d2ozaa1         184 VLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ISPGMKTRIRMGQYEFP--NPEWSEVSEEVKMLIRN  254 (335)
T ss_dssp             CCC-GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCCSCSSSCC--TTHHHHSCHHHHHHHHH
T ss_pred             HHc-CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH------HHHHHHHHHhcCCCCCC--CcccccCCHHHHHHHHH
Confidence            987 6778899999999999999999999997532110      01111111111111112  12222334569999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.++++
T Consensus       255 ~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         255 LLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HSCSSTTTSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHHc
Confidence            99999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.5e-33  Score=221.56  Aligned_cols=184  Identities=21%  Similarity=0.240  Sum_probs=130.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCC-------CCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCC
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQN-------PGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSAT   78 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~-------~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~   78 (221)
                      .++++..++.++.|++.||+|+|+.       .+|+||||||+|||++.++.+||+|||+++......     ......+
T Consensus        95 ~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~g  174 (303)
T d1vjya_          95 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG  174 (303)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceec
Confidence            4689999999999999999999972       389999999999999999999999999987653322     2234578


Q ss_pred             CccccCcccchhcC-----CCCCcccchHHHHHHHHHHhCCCCCcccccccCCC-----hHHHHHHhhhhhhccCCCCCC
Q 048055           79 SLFYKAPECREIWK-----QPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSD-----IPRWVRSVREEETESGDDPPS  148 (221)
Q Consensus        79 ~~~~~~pe~~~~~~-----~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  148 (221)
                      |+.|+|||.+....     .++.++|||||||++|||++|..||..........     .................++..
T Consensus       175 t~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~  254 (303)
T d1vjya_         175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI  254 (303)
T ss_dssp             CGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             ccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCC
Confidence            99999999875221     13567899999999999999987774321110000     000011111112222222222


Q ss_pred             C-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhc
Q 048055          149 S-NEASEEKLQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQM  194 (221)
Q Consensus       149 ~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~  194 (221)
                      + .....+....+.+|+.+||+.||.+|||+.||++.|+++..+.++
T Consensus       255 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         255 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            1 223445567799999999999999999999999999999987654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.98  E-value=5.1e-33  Score=225.66  Aligned_cols=161  Identities=21%  Similarity=0.289  Sum_probs=126.7

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC--CCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA--DFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      ..+++++..+..++.||+.||.|||+. |++||||||+||+++.  ++.+||+|||+++............+|+.|+|||
T Consensus       117 ~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPE  195 (350)
T d1koaa2         117 EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE  195 (350)
T ss_dssp             TTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHH
Confidence            345799999999999999999999998 9999999999999964  5789999999998766555555667899999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++||||+||++|+|++|..||.+.      +.......+.....    ..+  ..........+.+|+.+
T Consensus       196 v~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~----~~~--~~~~~~~s~~~~~li~~  262 (350)
T d1koaa2         196 VAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNVKSCDW----NMD--DSAFSGISEDGKDFIRK  262 (350)
T ss_dssp             HHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCC----CSC--CGGGGGCCHHHHHHHHH
T ss_pred             HHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCC----CCC--cccccCCCHHHHHHHHH
Confidence            987 677788999999999999999999999642      22233333322211    111  11111122458999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.|+++
T Consensus       263 ~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         263 LLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HCCSSGGGSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999976

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.3e-32  Score=220.64  Aligned_cols=156  Identities=22%  Similarity=0.286  Sum_probs=125.3

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCC-CCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNP-DSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.... ........||+.|+|||.+
T Consensus        99 ~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~  177 (337)
T d1o6la_          99 ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGG
T ss_pred             ccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhc
Confidence            46789999999999999999999998 999999999999999999999999999976543 3344556789999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||...      +............    ...+  ...+    ..+.+|+.+||
T Consensus       178 ~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~------~~~~~~~~i~~~~----~~~p--~~~s----~~~~dli~~~L  240 (337)
T d1o6la_         178 E-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEE----IRFP--RTLS----PEAKSLLAGLL  240 (337)
T ss_dssp             S-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC----CCCC--TTSC----HHHHHHHHHHT
T ss_pred             c-CCCCChhhcccchhhHHHHHHHCCCCCCCc------CHHHHHHHHhcCC----CCCC--ccCC----HHHHHHHHhhc
Confidence            7 678899999999999999999999999743      2333333332222    1112  2233    35889999999


Q ss_pred             cCCCCCCCC-----HHHHHH
Q 048055          169 SLAPENRPV-----MREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps-----~~~l~~  183 (221)
                      +.||.+|++     +.++++
T Consensus       241 ~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         241 KKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CSSTTTSTTCSTTTHHHHHT
T ss_pred             cCCchhhcccccccHHHHHc
Confidence            999999995     777765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.98  E-value=7.7e-33  Score=224.78  Aligned_cols=161  Identities=19%  Similarity=0.293  Sum_probs=127.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEc--CCCceEEeccCCccccCCCCCCCCCCCCccccCcc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLG--ADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPE   86 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe   86 (221)
                      .+.+|++..+..++.||+.||.|||+. ||+||||||.|||++  .++.+||+|||+++............+++.|+|||
T Consensus       120 ~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE  198 (352)
T d1koba_         120 EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE  198 (352)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHH
Confidence            345799999999999999999999998 999999999999998  56899999999998776655555567889999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      .+. +..++.++||||+||++|+|++|..||.+.      ........+.........  ......+    ..+.+|+.+
T Consensus       199 ~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~~--~~~~~~s----~~~~~li~~  265 (352)
T d1koba_         199 IVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKRCDWEFDE--DAFSSVS----PEAKDFIKN  265 (352)
T ss_dssp             HHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHCCCCCCS--STTTTSC----HHHHHHHHT
T ss_pred             HHc-CCCCCCccchHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCCc--ccccCCC----HHHHHHHHH
Confidence            887 677899999999999999999999999742      222333333222111110  0111222    358999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 048055          167 CVSLAPENRPVMREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~  183 (221)
                      ||+.||.+|||+.|+++
T Consensus       266 ~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         266 LLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TSCSSGGGSCCHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=1.6e-32  Score=222.87  Aligned_cols=154  Identities=18%  Similarity=0.171  Sum_probs=124.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....  .....||+.|+|||.+.
T Consensus       135 ~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~  211 (350)
T d1rdqe_         135 IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIIL  211 (350)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHc
Confidence            35789999999999999999999998 9999999999999999999999999999765432  34567899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++|||||||++|+|++|..||.+      .+.......+.....    ..+  ...+    ..+.+|+.+||+
T Consensus       212 -~~~~~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~i~~~~~----~~p--~~~s----~~~~~li~~~L~  274 (350)
T d1rdqe_         212 -SKGYNKAVDWWALGVLIYEMAAGYPPFFA------DQPIQIYEKIVSGKV----RFP--SHFS----SDLKDLLRNLLQ  274 (350)
T ss_dssp             -TCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCCC----CCC--TTCC----HHHHHHHHHHSC
T ss_pred             -CCCCCccccccchhHHHHHHHhCCCCCCC------cCHHHHHHHHhcCCC----CCC--ccCC----HHHHHHHHHHhh
Confidence             67788999999999999999999999964      233333333332221    111  2222    358999999999


Q ss_pred             CCCCCCC-----CHHHHHH
Q 048055          170 LAPENRP-----VMREVSK  183 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~  183 (221)
                      .||.+|+     |+.++++
T Consensus       275 ~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         275 VDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             hCHHhccccccccHHHHHc
Confidence            9999994     8999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.7e-32  Score=214.34  Aligned_cols=160  Identities=23%  Similarity=0.426  Sum_probs=122.4

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchhc
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREIW   91 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   91 (221)
                      .+++..++.++.||+.||.|||+. +++|+||||.||+++.++.++++|||+++.....  .....++..|+|||.+. +
T Consensus        99 ~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~-~  174 (262)
T d1byga_          99 VLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALR-E  174 (262)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHH-H
T ss_pred             CCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHh-C
Confidence            579999999999999999999998 9999999999999999999999999998764433  23345677899999987 6


Q ss_pred             CCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcccC
Q 048055           92 KQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVSL  170 (221)
Q Consensus        92 ~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  170 (221)
                      ..++.++||||||+++|||++ |..||...      ........+..     ...++.+...+    ..+.+|+.+||+.
T Consensus       175 ~~~t~~sDIwSfG~il~el~t~~~~p~~~~------~~~~~~~~i~~-----~~~~~~~~~~~----~~~~~li~~cl~~  239 (262)
T d1byga_         175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRVEK-----GYKMDAPDGCP----PAVYEVMKNCWHL  239 (262)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS------CGGGHHHHHTT-----TCCCCCCTTCC----HHHHHHHHHHTCS
T ss_pred             CCCChHHHHHhHHHHHHHHHHCCCCCCCCC------CHHHHHHHHHc-----CCCCCCCccCC----HHHHHHHHHHccc
Confidence            778999999999999999998 68777642      22233333322     22223223333    3589999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhHH
Q 048055          171 APENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       171 dp~~Rps~~~l~~~L~~~~~  190 (221)
                      ||.+|||+.+|++.|+++..
T Consensus       240 dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         240 DAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.5e-32  Score=218.37  Aligned_cols=165  Identities=20%  Similarity=0.253  Sum_probs=127.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCccccC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYKA   84 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~   84 (221)
                      ...+++..++.++.|++.||.|||+. +++||||||.|||++.++.+||+|||+++......     ......++..|+|
T Consensus       124 ~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~a  202 (311)
T d1r0pa_         124 THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA  202 (311)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSC
T ss_pred             cccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccC
Confidence            44667889999999999999999998 99999999999999999999999999997654332     1223457889999


Q ss_pred             cccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           85 PECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        85 pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      ||.+. ...++.++||||||+++|||++|..||.....     ...+...+...     ..+..+..++    ..+.+||
T Consensus       203 PE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----~~~~~~~i~~g-----~~~~~p~~~~----~~l~~li  267 (311)
T d1r0pa_         203 LESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQG-----RRLLQPEYCP----DPLYEVM  267 (311)
T ss_dssp             HHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTT-----CCCCCCTTCC----HHHHHHH
T ss_pred             hHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcC-----CCCCCcccCc----HHHHHHH
Confidence            99887 67789999999999999999998888764321     11112222221     2222222233    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRA  190 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~  190 (221)
                      .+||+.||++||++.||++.|+++..
T Consensus       268 ~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         268 LKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=2.6e-32  Score=222.60  Aligned_cols=159  Identities=21%  Similarity=0.211  Sum_probs=123.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...++...+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++...... .....||+.|+|||.+.
T Consensus       101 ~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~  178 (364)
T d1omwa3         101 HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ  178 (364)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHS
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhh
Confidence            45678999999999999999999998 99999999999999999999999999997655433 34457899999999886


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                      .+..++.++|||||||++|+|++|..||.....   .........    .....  ...+...+    ..+.+|+.+||+
T Consensus       179 ~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~----~~~~~--~~~~~~~s----~~~~~li~~~L~  245 (364)
T d1omwa3         179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT---KDKHEIDRM----TLTMA--VELPDSFS----PELRSLLEGLLQ  245 (364)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS---SCHHHHHHH----SSSCC--CCCCSSSC----HHHHHHHHHHTC
T ss_pred             cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----cccCC--CCCCCCCC----HHHHHHHHHHcc
Confidence            456788999999999999999999999975321   111111111    11111  11112223    358999999999


Q ss_pred             CCCCCCCC-----HHHHHH
Q 048055          170 LAPENRPV-----MREVSK  183 (221)
Q Consensus       170 ~dp~~Rps-----~~~l~~  183 (221)
                      .||.+|||     +.++++
T Consensus       246 ~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         246 RDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSTTTSTTTSSSTHHHHHT
T ss_pred             cCHHHhCCCcccCHHHHHc
Confidence            99999998     678764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=5.1e-32  Score=217.01  Aligned_cols=154  Identities=22%  Similarity=0.299  Sum_probs=123.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ...++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....  .....||+.|+|||.+.
T Consensus        98 ~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~  174 (316)
T d1fota_          98 SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVS  174 (316)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHT
T ss_pred             cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHc
Confidence            46678899999999999999999998 9999999999999999999999999999765433  34567899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHccc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACVS  169 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  169 (221)
                       +..++.++||||+||++|+|++|..||.+      .+.......+......    .+  ...+    ..+.+++.+||+
T Consensus       175 -~~~y~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~i~~~~~~----~p--~~~s----~~~~~li~~~L~  237 (316)
T d1fota_         175 -TKPYNKSIDWWSFGILIYEMLAGYTPFYD------SNTMKTYEKILNAELR----FP--PFFN----EDVKDLLSRLIT  237 (316)
T ss_dssp             -TCCBCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHCCCC----CC--TTSC----HHHHHHHHHHTC
T ss_pred             -CCCCCchhhccccchhHHHHHhCCCCCCC------cCHHHHHHHHHcCCCC----CC--CCCC----HHHHHHHHHHhh
Confidence             67788999999999999999999999964      2333333333332211    11  1222    358999999999


Q ss_pred             CCCCCCC-----CHHHHHH
Q 048055          170 LAPENRP-----VMREVSK  183 (221)
Q Consensus       170 ~dp~~Rp-----s~~~l~~  183 (221)
                      .||.+|+     |+.++++
T Consensus       238 ~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         238 RDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             hCHHhccccchhhHHHHHc
Confidence            9999996     8999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.5e-32  Score=218.68  Aligned_cols=186  Identities=17%  Similarity=0.245  Sum_probs=134.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC---CCceEEeccCCccccCCCC--------CCCCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA---DFESCLTDYGLGSFRNPDS--------VEEPSAT   78 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~--------~~~~~~~   78 (221)
                      .+.+++..+..++.|++.||+|||++ +++||||||+||++..   +..++++|||+++......        ......|
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~g  175 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  175 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCC
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCC
Confidence            56799999999999999999999998 9999999999998764   4569999999997654322        1234578


Q ss_pred             CccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHH
Q 048055           79 SLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQ  158 (221)
Q Consensus        79 ~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (221)
                      |+.|+|||.+. +..++.++|||||||++|+|++|..||...........   ............     ........+.
T Consensus       176 t~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~p~  246 (299)
T d1ckia_         176 TARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK---YERISEKKMSTP-----IEVLCKGYPS  246 (299)
T ss_dssp             CSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------HHHHHHHHHHSC-----HHHHTTTSCH
T ss_pred             CccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH---HHHhhcccCCCC-----hhHhccCCCH
Confidence            99999999887 67789999999999999999999999975432211111   111111110000     0000011224


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCcccc
Q 048055          159 ALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSDT  209 (221)
Q Consensus       159 ~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~~  209 (221)
                      .+.+|+.+||+.+|.+||++.+|.+.|++.-......    ...+++|+-.
T Consensus       247 ~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~----~~~~~Dw~~~  293 (299)
T d1ckia_         247 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS----YDYVFDWNML  293 (299)
T ss_dssp             HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC----CSCCCHHHHG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC----CCCCcCchhh
Confidence            6899999999999999999999999999876544333    2345677543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.9e-33  Score=217.07  Aligned_cols=150  Identities=21%  Similarity=0.346  Sum_probs=119.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC-CceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD-FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.+++..+..++.||+.||.|||+. +++||||||+||+++.+ +.+||+|||+++..... ......||+.|+|||.+
T Consensus       104 ~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~  181 (273)
T d1xwsa_         104 RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI  181 (273)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHH
Confidence            45789999999999999999999998 99999999999999854 78999999999764433 33456789999999988


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      .....++.++||||+||++|+|++|..||....            .+......    .+  ...+    ..+.+|+.+||
T Consensus       182 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~----~~--~~~s----~~~~~li~~~L  239 (273)
T d1xwsa_         182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF----FR--QRVS----SECQHLIRWCL  239 (273)
T ss_dssp             HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC----CS--SCCC----HHHHHHHHHHT
T ss_pred             cCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC----CC--CCCC----HHHHHHHHHHc
Confidence            743444677899999999999999999996421            11111111    11  1122    35899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 048055          169 SLAPENRPVMREVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~~l~~  183 (221)
                      +.||++|||+.|+++
T Consensus       240 ~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         240 ALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCCHhHCcCHHHHhc
Confidence            999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.1e-33  Score=222.40  Aligned_cols=108  Identities=22%  Similarity=0.337  Sum_probs=93.4

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.|++.||.|||+..+|+||||||+|||++.++.+||+|||+++...... .....||+.|+|||.+.
T Consensus        98 ~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~  176 (322)
T d1s9ja_          98 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQ  176 (322)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHc
Confidence            35689999999999999999999973289999999999999999999999999987543322 23468899999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcc
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQD  119 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~  119 (221)
                       +..++.++||||+||++|+|++|+.||..
T Consensus       177 -~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         177 -GTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             -CSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             -CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             67889999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-32  Score=216.74  Aligned_cols=160  Identities=18%  Similarity=0.238  Sum_probs=126.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC----ceEEeccCCccccCCCCCCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF----ESCLTDYGLGSFRNPDSVEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~p   85 (221)
                      .+.+++..+..++.||+.||+|||+. +++||||||+||+++.++    .+|++|||++.............+++.|+||
T Consensus       107 ~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~AP  185 (293)
T d1jksa_         107 KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP  185 (293)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCH
T ss_pred             ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCH
Confidence            35799999999999999999999998 999999999999998776    4899999999876655555667788999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++||||+||++|+|++|..||.+.      +.......+....    ...+  .......+..+.+|+.
T Consensus       186 E~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~----~~~~--~~~~~~~s~~~~~li~  252 (293)
T d1jksa_         186 EIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANVSAVN----YEFE--DEYFSNTSALAKDFIR  252 (293)
T ss_dssp             HHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHTTC----CCCC--HHHHTTSCHHHHHHHH
T ss_pred             HHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCC------CHHHHHHHHHhcC----CCCC--chhcCCCCHHHHHHHH
Confidence            9987 677899999999999999999999999742      2222222222211    1111  1111122346899999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 048055          166 ACVSLAPENRPVMREVSK  183 (221)
Q Consensus       166 ~cl~~dp~~Rps~~~l~~  183 (221)
                      +||+.||.+|||+.|+++
T Consensus       253 ~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         253 RLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTSCSSGGGSCCHHHHHH
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-32  Score=217.31  Aligned_cols=168  Identities=20%  Similarity=0.165  Sum_probs=125.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~   87 (221)
                      ..+.++...+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..... .......+|+.|+|||.
T Consensus        93 ~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  171 (299)
T d1ua2a_          93 NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL  171 (299)
T ss_dssp             CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHH
Confidence            356789999999999999999999998 9999999999999999999999999999765433 23345578899999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC----------------CCCCCC--
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG----------------DDPPSS--  149 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~--  149 (221)
                      +.....++.++||||+||++|+|++|..||....      .......+........                ...+..  
T Consensus       172 ~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~------~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (299)
T d1ua2a_         172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS------DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL  245 (299)
T ss_dssp             HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred             HccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC------HHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCCh
Confidence            7645667899999999999999999999997432      1122222211110000                000000  


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ..........+.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0001112246899999999999999999999975

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-32  Score=218.22  Aligned_cols=167  Identities=23%  Similarity=0.370  Sum_probs=128.8

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAP   85 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~p   85 (221)
                      ....+++..+..++.||+.||+|||++ +++||||||+||+++.++.++++|||.++......   ......+++.|+||
T Consensus       138 ~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         138 DELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            456799999999999999999999998 99999999999999999999999999997654332   22345678899999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHh-CCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLT-GKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      |.+. +..++.++||||||+++|+|++ |.++|...      .....+..+....    ..+..+...+    ..+.+||
T Consensus       217 E~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~------~~~~~~~~~i~~~----~~~~~~~~~~----~~l~~Li  281 (311)
T d1t46a_         217 ESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGM------PVDSKFYKMIKEG----FRMLSPEHAP----AEMYDIM  281 (311)
T ss_dssp             HHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CSSHHHHHHHHHT----CCCCCCTTSC----HHHHHHH
T ss_pred             HHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcC----CCCCCccccc----HHHHHHH
Confidence            9987 6778999999999999999998 55556432      1112222222221    1222222222    3599999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHhhHHH
Q 048055          165 IACVSLAPENRPVMREVSKMIRDSRAE  191 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~~L~~~~~~  191 (221)
                      .+||+.||.+|||+.+|++.|++...+
T Consensus       282 ~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         282 KTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=9.2e-32  Score=211.77  Aligned_cols=161  Identities=23%  Similarity=0.318  Sum_probs=126.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      ++++++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++............++..|++||.+.
T Consensus       104 ~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~  182 (277)
T d1phka_         104 KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE  182 (277)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhh
Confidence            45799999999999999999999998 99999999999999999999999999998766555555667899999999865


Q ss_pred             h-----cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHH
Q 048055           90 I-----WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIA  164 (221)
Q Consensus        90 ~-----~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  164 (221)
                      .     ...++.++||||+||++|+|++|+.||.+.      ........+......  ...+.....+    ..+.+|+
T Consensus       183 ~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~------~~~~~~~~i~~~~~~--~~~~~~~~~s----~~~~~li  250 (277)
T d1phka_         183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLRMIMSGNYQ--FGSPEWDDYS----DTVKDLV  250 (277)
T ss_dssp             HHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC--CCTTTGGGSC----HHHHHHH
T ss_pred             ccccccCCCCCchheEcccchhhhhhccCCCCCCCC------CHHHHHHHHHhCCCC--CCCcccccCC----HHHHHHH
Confidence            2     233577899999999999999999999743      222323333222211  1111112233    3589999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 048055          165 IACVSLAPENRPVMREVSK  183 (221)
Q Consensus       165 ~~cl~~dp~~Rps~~~l~~  183 (221)
                      .+||+.||.+|||+.|+++
T Consensus       251 ~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         251 SRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHCCSSGGGSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHHc
Confidence            9999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=3.9e-32  Score=214.04  Aligned_cols=166  Identities=23%  Similarity=0.346  Sum_probs=121.7

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAP   85 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~p   85 (221)
                      .+++++..+..++.||+.||.|||+. +++||||||+||+++.++..+++|||.+.......    ......|++.|+||
T Consensus       105 ~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         105 EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCH
Confidence            45789999999999999999999998 99999999999999999999999999876443221    23345688999999


Q ss_pred             ccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHH
Q 048055           86 ECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAI  165 (221)
Q Consensus        86 e~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  165 (221)
                      |.+. +..++.++||||+||++|+|++|..||.+.      ............    ...++  .......+..+.+++.
T Consensus       184 E~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~~~~~----~~~~~--~~~~~~~s~~l~~li~  250 (277)
T d1o6ya_         184 EQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVRE----DPIPP--SARHEGLSADLDAVVL  250 (277)
T ss_dssp             HHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHC----CCCCG--GGTSSSCCHHHHHHHH
T ss_pred             HHHc-CCCCCcceecccchHHHHHHHhCCCCCCCc------CHHHHHHHHHhc----CCCCC--chhccCCCHHHHHHHH
Confidence            9986 677889999999999999999999999742      222222222111    11111  1111112246999999


Q ss_pred             HcccCCCCCCC-CHHHHHHHHHhhH
Q 048055          166 ACVSLAPENRP-VMREVSKMIRDSR  189 (221)
Q Consensus       166 ~cl~~dp~~Rp-s~~~l~~~L~~~~  189 (221)
                      +||+.||.+|| |+.+++..|.++.
T Consensus       251 ~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         251 KALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHccCCHhHCHhHHHHHHHHHHHHh
Confidence            99999999999 8999988887653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.3e-32  Score=214.89  Aligned_cols=162  Identities=23%  Similarity=0.378  Sum_probs=128.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC---CCCCCCCCccccCccc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS---VEEPSATSLFYKAPEC   87 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~pe~   87 (221)
                      ..+++..+..++.|++.||.|||+. +++||||||.|||++.++.+||+|||+++......   ......+++.|++||.
T Consensus       128 ~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         128 APPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHH
Confidence            4578999999999999999999998 99999999999999999999999999997543322   1233457889999999


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhC-CCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTG-KTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +. +..++.++|+||||+++|||++| ..||.+      .........+...     ..++.+..++    ..+.++|.+
T Consensus       207 l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------~~~~~~~~~i~~~-----~~~~~p~~~~----~~l~~li~~  270 (308)
T d1p4oa_         207 LK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQG------LSNEQVLRFVMEG-----GLLDKPDNCP----DMLFELMRM  270 (308)
T ss_dssp             HH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCHHHHHHHHHTT-----CCCCCCTTCC----HHHHHHHHH
T ss_pred             Hc-cCCCCcccccccHHHHHHHHHhCCCCCCCC------CCHHHHHHHHHhC-----CCCCCcccch----HHHHHHHHH
Confidence            87 67788899999999999999997 567753      3333444433322     2222222333    369999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHhhH
Q 048055          167 CVSLAPENRPVMREVSKMIRDSR  189 (221)
Q Consensus       167 cl~~dp~~Rps~~~l~~~L~~~~  189 (221)
                      ||+.||.+|||+.+|++.|++..
T Consensus       271 cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         271 CWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HcCCChhHCcCHHHHHHHHHHhc
Confidence            99999999999999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.3e-32  Score=215.82  Aligned_cols=156  Identities=23%  Similarity=0.340  Sum_probs=124.5

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~~   88 (221)
                      ...++...+..++.||+.||.|||++ +++||||||+|||++.++.+|++|||+++..... .......||+.|+|||.+
T Consensus        97 ~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~  175 (320)
T d1xjda_          97 CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL  175 (320)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHH
Confidence            35689999999999999999999998 9999999999999999999999999999755432 334456789999999998


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHcc
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIACV  168 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  168 (221)
                      . +..++.++|+||+||++|+|++|..||.+      .........+....    ...  +...+    ..+.+|+.+||
T Consensus       176 ~-~~~~~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~----~~~--p~~~s----~~~~dli~~~L  238 (320)
T d1xjda_         176 L-GQKYNHSVDWWSFGVLLYEMLIGQSPFHG------QDEEELFHSIRMDN----PFY--PRWLE----KEAKDLLVKLF  238 (320)
T ss_dssp             T-TCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC----CCC--CTTSC----HHHHHHHHHHS
T ss_pred             c-CCCCCchhhhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHHHcCC----CCC--CccCC----HHHHHHHHHhc
Confidence            7 67789999999999999999999999964      23333333332221    111  12222    35899999999


Q ss_pred             cCCCCCCCCHH-HHHH
Q 048055          169 SLAPENRPVMR-EVSK  183 (221)
Q Consensus       169 ~~dp~~Rps~~-~l~~  183 (221)
                      +.||.+||++. ++++
T Consensus       239 ~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         239 VREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CSSGGGSBTTBSCGGG
T ss_pred             ccCCCCCcCHHHHHHh
Confidence            99999999985 6753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.2e-31  Score=216.31  Aligned_cols=168  Identities=21%  Similarity=0.187  Sum_probs=124.9

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++............++..|+|||.
T Consensus       115 ~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~  193 (350)
T d1q5ka_         115 AKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL  193 (350)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHH
Confidence            355789999999999999999999998 999999999999999775 899999999987665555556678899999997


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh-----------h--ccCCCCCCC-----
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE-----------T--ESGDDPPSS-----  149 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~--~~~~~~~~~-----  149 (221)
                      +.....++.++||||+||++|+|++|..||.....      ......+....           .  ......+..     
T Consensus       194 ~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~------~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (350)
T d1q5ka_         194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW  267 (350)
T ss_dssp             HTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCG
T ss_pred             hhcccCCCcceeecccceEEEehhhCCCCCCCCCH------HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCch
Confidence            76456789999999999999999999999964321      11111111100           0  000000000     


Q ss_pred             -ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          150 -NEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       150 -~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                       ..........+.+|+.+||+.||++|||+.|+++
T Consensus       268 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         268 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0001112245899999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=1.9e-31  Score=211.71  Aligned_cols=185  Identities=14%  Similarity=0.217  Sum_probs=137.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcC-----CCceEEeccCCccccCCCC--------CCCCC
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGA-----DFESCLTDYGLGSFRNPDS--------VEEPS   76 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~-----~~~~~l~dfg~~~~~~~~~--------~~~~~   76 (221)
                      ++.++...+..++.|++.||.|||+. |++||||||+||+++.     .+.++++|||+++......        .....
T Consensus        95 ~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~  173 (293)
T d1csna_          95 GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL  173 (293)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCce
Confidence            45789999999999999999999998 9999999999999974     5679999999997643221        12345


Q ss_pred             CCCccccCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHH
Q 048055           77 ATSLFYKAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEK  156 (221)
Q Consensus        77 ~~~~~~~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (221)
                      .||+.|+|||.+. +..++.++|+||||+++|+|++|..||.....   .........+........     ........
T Consensus       174 ~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~---~~~~~~~~~i~~~~~~~~-----~~~l~~~~  244 (293)
T d1csna_         174 SGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKA---ATNKQKYERIGEKKQSTP-----LRELCAGF  244 (293)
T ss_dssp             CSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS---CCHHHHHHHHHHHHHHSC-----HHHHTTTS
T ss_pred             EEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCCccc---hhHHHHHHHHHhccCCCC-----hHHhcCCC
Confidence            6899999999987 67788999999999999999999999975321   112222222222111110     00000112


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHHHhhcCCCCCCCCCCCccc
Q 048055          157 LQALLNIAIACVSLAPENRPVMREVSKMIRDSRAEAQMSSNSSDHSPGRWSD  208 (221)
Q Consensus       157 ~~~l~~l~~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~~~~~  208 (221)
                      +..+.+++..||..+|++||++..+.+.|+++.......    ...++||+-
T Consensus       245 p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~----~~~~~Dw~~  292 (293)
T d1csna_         245 PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT----EDENFDWNL  292 (293)
T ss_dssp             CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC----SCSCCGGGC
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC----CCCCCCCCc
Confidence            246999999999999999999999999998887654433    345778863

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-31  Score=212.36  Aligned_cols=169  Identities=17%  Similarity=0.185  Sum_probs=125.1

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC-CCCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD-SVEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~pe~   87 (221)
                      ..+.+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+|++|||.++..... .......+++.|+|||.
T Consensus        95 ~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~  173 (298)
T d1gz8a_          95 ALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI  173 (298)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhh
Confidence            456799999999999999999999998 9999999999999999999999999999765433 34455678899999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC--------------CCCCC--CC-
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG--------------DDPPS--SN-  150 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~--~~-  150 (221)
                      +.....++.++|+||+||++|+|++|..||.+..      ................              ...+.  .. 
T Consensus       174 ~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T d1gz8a_         174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS------EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD  247 (298)
T ss_dssp             HTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCC
T ss_pred             hccccCCCccccccccchhhhHHhhCCCCCCCCC------HHHHHHHHHHhcCCCchhhccccccccccccccccccccc
Confidence            7645556889999999999999999999996421      1111111111100000              00000  00 


Q ss_pred             --hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          151 --EASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       151 --~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                        .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence              0011112468999999999999999999999763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=3.8e-31  Score=209.22  Aligned_cols=168  Identities=17%  Similarity=0.245  Sum_probs=121.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      ..+.++...+..++.||+.||.|||+. +|+||||||+||+++.++.+|++|||.+....... ......+++.|++||.
T Consensus        93 ~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~  171 (286)
T d1ob3a_          93 CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV  171 (286)
T ss_dssp             STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHH
T ss_pred             hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHH
Confidence            357799999999999999999999998 99999999999999999999999999987654332 2334467788999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-------------------CCCCC
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-------------------DDPPS  148 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~  148 (221)
                      +.....++.++|+||+||++|+|++|..||.+..      ......+.........                   .....
T Consensus       172 ~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (286)
T d1ob3a_         172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS------EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP  245 (286)
T ss_dssp             HTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred             HhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC------HHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcc
Confidence            7655667899999999999999999999996421      1122222111110000                   00000


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...........+.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01111112346899999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-31  Score=212.27  Aligned_cols=160  Identities=17%  Similarity=0.236  Sum_probs=124.2

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCC--CceEEeccCCccccCCCCCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGAD--FESCLTDYGLGSFRNPDSVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~   87 (221)
                      +.+++...+..++.||+.||.|||+. ||+||||||+||+++.+  ..++++|||++.............+++.|++||.
T Consensus        96 ~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~  174 (321)
T d1tkia_          96 AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV  174 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchh
Confidence            34799999999999999999999998 99999999999999854  4789999999976655444445567889999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHHc
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIAC  167 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  167 (221)
                      .. +..++.++||||+||++|+|++|..||...      ........+....    ..++  ..........+.+|+.+|
T Consensus       175 ~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~------~~~~~~~~i~~~~----~~~~--~~~~~~~s~~~~~li~~~  241 (321)
T d1tkia_         175 HQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMNAE----YTFD--EEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             HT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTC----CCCC--HHHHTTSCHHHHHHHHTT
T ss_pred             cc-CCCCCchhhcccHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC----CCCC--hhhccCCCHHHHHHHHHH
Confidence            76 667788999999999999999999999743      2223333332211    1111  111111234689999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 048055          168 VSLAPENRPVMREVSK  183 (221)
Q Consensus       168 l~~dp~~Rps~~~l~~  183 (221)
                      |..||.+|||+.|+++
T Consensus       242 L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         242 LVKERKSRMTASEALQ  257 (321)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.5e-30  Score=204.92  Aligned_cols=168  Identities=18%  Similarity=0.203  Sum_probs=122.3

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-----CCCCCCCCcccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-----VEEPSATSLFYK   83 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~   83 (221)
                      ....++...+..++.||+.||.|||+. +|+||||||+|||++.++.++++|||++.......     ......+|+.|+
T Consensus       110 ~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~  188 (318)
T d3blha1         110 VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR  188 (318)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGC
T ss_pred             cccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHh
Confidence            456789999999999999999999998 99999999999999999999999999986544221     223346789999


Q ss_pred             CcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCC----------------CC
Q 048055           84 APECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDD----------------PP  147 (221)
Q Consensus        84 ~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~  147 (221)
                      |||.+.....++.++||||+||++|+|++|+.||.+.      ........+..........                ..
T Consensus       189 aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T d3blha1         189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN------TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVK  262 (318)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCS
T ss_pred             hHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC------CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccc
Confidence            9998764456789999999999999999999999642      1122222221111111000                00


Q ss_pred             CCChhhH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          148 SSNEASE------EKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       148 ~~~~~~~------~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      .......      .....+.+|+.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         263 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0000000      11235789999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.8e-30  Score=207.99  Aligned_cols=170  Identities=22%  Similarity=0.317  Sum_probs=124.8

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccchh
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECREI   90 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~~   90 (221)
                      ++|++..+..++.||+.||.|||+. ||+||||||+|||++.++.++++|||+++.....  .....+++.|+|||.+..
T Consensus       116 ~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         116 EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHcC
Confidence            5799999999999999999999998 9999999999999999999999999999765433  345678889999998764


Q ss_pred             cCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhc--------------------cCC-CCCCC
Q 048055           91 WKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETE--------------------SGD-DPPSS  149 (221)
Q Consensus        91 ~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~-~~~~~  149 (221)
                      ...++.++||||+||++|+|++|..||.+...      .............                    ... .....
T Consensus       193 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (346)
T d1cm8a_         193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF  266 (346)
T ss_dssp             TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred             CCCCCccchhhcchHHHHHHHHCcCCCCCCCh------HHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch
Confidence            45668899999999999999999999964311      1111111100000                    000 00000


Q ss_pred             ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhH
Q 048055          150 NEASEEKLQALLNIAIACVSLAPENRPVMREVSKM--IRDSR  189 (221)
Q Consensus       150 ~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~--L~~~~  189 (221)
                      ..........+.+|+.+||+.||.+|||+.|+++.  ++.+.
T Consensus       267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         267 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            01111112357899999999999999999999874  55443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.8e-30  Score=208.57  Aligned_cols=167  Identities=21%  Similarity=0.272  Sum_probs=122.3

Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC----CCCCCCCCccccCcc
Q 048055           11 KPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS----VEEPSATSLFYKAPE   86 (221)
Q Consensus        11 ~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~pe   86 (221)
                      +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......    ......+++.|+|||
T Consensus       104 ~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE  182 (345)
T d1pmea_         104 QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE  182 (345)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHH
Confidence            4689999999999999999999998 99999999999999999999999999987543321    234456788999999


Q ss_pred             cchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhh--------------------ccCCCC
Q 048055           87 CREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEET--------------------ESGDDP  146 (221)
Q Consensus        87 ~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  146 (221)
                      .+.....++.++|+||+||++|+|++|..||......      ...........                    ......
T Consensus       183 ~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (345)
T d1pmea_         183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL------DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN  256 (345)
T ss_dssp             GTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred             HhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH------HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccC
Confidence            8765667789999999999999999999999643211      11111100000                    000000


Q ss_pred             -CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          147 -PSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       147 -~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                       .............+.+|+.+||+.||.+|||+.|+++.
T Consensus       257 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000001112358899999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=1.1e-29  Score=204.47  Aligned_cols=168  Identities=20%  Similarity=0.253  Sum_probs=122.9

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCC-ceEEeccCCccccCCCCCCCCCCCCccccCcccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADF-ESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECR   88 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~   88 (221)
                      .+.++...+..++.||+.||.|||+. ||+||||||+|||++.++ .++++|||++.............+|+.|+|||.+
T Consensus       123 ~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~  201 (328)
T d3bqca1         123 YQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL  201 (328)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHH
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccc
Confidence            45799999999999999999999998 999999999999998655 6899999999876655555666788999999987


Q ss_pred             hhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh------------hh-hc--------cCCCCC
Q 048055           89 EIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE------------EE-TE--------SGDDPP  147 (221)
Q Consensus        89 ~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~-~~--------~~~~~~  147 (221)
                      .....++.++|+||+||++|++++|..||......     ......+..            .. ..        ......
T Consensus       202 ~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~-----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (328)
T d3bqca1         202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-----YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR  276 (328)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-----HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCC
T ss_pred             cCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh-----HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccc
Confidence            64456789999999999999999999999642211     110000000            00 00        000000


Q ss_pred             ------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          148 ------SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       148 ------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                            ............+.+|+.+||+.||.+|||++|+++
T Consensus       277 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         277 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000011112245899999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.4e-29  Score=199.14  Aligned_cols=169  Identities=18%  Similarity=0.195  Sum_probs=123.6

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCC-CCCCCCCCccccCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDS-VEEPSATSLFYKAPEC   87 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~pe~   87 (221)
                      ..+.++...+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.++...... ......++..|.|||.
T Consensus        94 ~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~  172 (292)
T d1unla_          94 CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV  172 (292)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHH
T ss_pred             cccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhH
Confidence            356789999999999999999999998 99999999999999999999999999997655433 3334456778999998


Q ss_pred             chhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-------------------CCCCC
Q 048055           88 REIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-------------------DDPPS  148 (221)
Q Consensus        88 ~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~  148 (221)
                      +.....++.++||||+||++|+|++|..||..     +.+.......+........                   .....
T Consensus       173 ~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T d1unla_         173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-----GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS  247 (292)
T ss_dssp             HTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-----CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred             hccCCCCCchhhccccchHHHHHhhCCCCCCC-----CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccch
Confidence            76445568899999999999999999998743     2222222222222111100                   00000


Q ss_pred             CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          149 SNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       149 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111122246889999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.8e-29  Score=202.26  Aligned_cols=167  Identities=19%  Similarity=0.265  Sum_probs=118.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .+.+++..+..++.||+.||.|||+. ||+||||||.||+++.++.++++|||+++............+|+.|+|||.+.
T Consensus       113 ~~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~  191 (355)
T d2b1pa1         113 QMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL  191 (355)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHT
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhc
Confidence            35689999999999999999999998 99999999999999999999999999987665555555667888999999987


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhh----------------------hhhcc-----
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVRE----------------------EETES-----  142 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------~~~~~-----  142 (221)
                       +..++.++||||+||++|+|++|..||.+..      .......+..                      .....     
T Consensus       192 -~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (355)
T d2b1pa1         192 -GMGYKENVDIWSVGCIMGEMVRHKILFPGRD------YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF  264 (355)
T ss_dssp             -TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCH
T ss_pred             -CCCCCCCcccccccchHHHHhhCCCCCCCCC------HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccc
Confidence             6788999999999999999999999996421      1111111100                      00000     


Q ss_pred             -----CCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048055          143 -----GDDPPSSNEASEEKLQALLNIAIACVSLAPENRPVMREVSKM  184 (221)
Q Consensus       143 -----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~~  184 (221)
                           ....+............+.+|+.+||+.||++|||+.|+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 001111222333445678999999999999999999999743

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.5e-29  Score=202.94  Aligned_cols=165  Identities=22%  Similarity=0.312  Sum_probs=118.1

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCCCCCCCCCCCccccCcccch
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPDSVEEPSATSLFYKAPECRE   89 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~pe~~~   89 (221)
                      .++++...+..++.||+.||+|||+. ||+||||||+||+++.++.++++|||++.....  ......+++.|+|||...
T Consensus       115 ~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~  191 (348)
T d2gfsa1         115 CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIML  191 (348)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHT
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCc--ccccccccccccCchhhc
Confidence            45799999999999999999999998 999999999999999999999999999854432  234456788899999866


Q ss_pred             hcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccC-------------------CCCCCCC
Q 048055           90 IWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESG-------------------DDPPSSN  150 (221)
Q Consensus        90 ~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~  150 (221)
                      ....++.++|+||+||++|+|++|..||.+..      .......+........                   ...+...
T Consensus       192 ~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (348)
T d2gfsa1         192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN  265 (348)
T ss_dssp             TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCC
T ss_pred             CCccCCcccchhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcc
Confidence            44566889999999999999999999996421      1111111111110000                   0000000


Q ss_pred             --hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          151 --EASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       151 --~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                        .........+.+|+.+||+.||.+|||+.|+++
T Consensus       266 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence              000011245889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.4e-28  Score=197.46  Aligned_cols=161  Identities=22%  Similarity=0.264  Sum_probs=119.0

Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccCCC--CCCCCCCCCccccCccc
Q 048055           10 GKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRNPD--SVEEPSATSLFYKAPEC   87 (221)
Q Consensus        10 ~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~pe~   87 (221)
                      .+.++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||+++.....  .......+++.|++||.
T Consensus       123 ~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~  201 (322)
T d1vzoa_         123 RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI  201 (322)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHH
T ss_pred             cccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHH
Confidence            34667889999999999999999998 9999999999999999999999999998754332  22344567889999998


Q ss_pred             chhc-CCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhhhccCCCCCCCChhhHHHHHHHHHHHHH
Q 048055           88 REIW-KQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEETESGDDPPSSNEASEEKLQALLNIAIA  166 (221)
Q Consensus        88 ~~~~-~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  166 (221)
                      +... ..++.++||||+||++|+|++|..||......  ..........    .....  +.+...+    ..+.+|+.+
T Consensus       202 ~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~----~~~~~--~~~~~~s----~~~~~li~~  269 (322)
T d1vzoa_         202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRI----LKSEP--PYPQEMS----ALAKDLIQR  269 (322)
T ss_dssp             HTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHH----HHCCC--CCCTTSC----HHHHHHHHH
T ss_pred             hhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhc----ccCCC--CCcccCC----HHHHHHHHH
Confidence            7532 24577899999999999999999999754221  2222211111    11111  1112222    369999999


Q ss_pred             cccCCCCCCCC-----HHHHHH
Q 048055          167 CVSLAPENRPV-----MREVSK  183 (221)
Q Consensus       167 cl~~dp~~Rps-----~~~l~~  183 (221)
                      ||+.||.+||+     +.|+++
T Consensus       270 ~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         270 LLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HcccCHHHcCCCCcccHHHHHc
Confidence            99999999994     788865

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=2.7e-27  Score=192.57  Aligned_cols=172  Identities=19%  Similarity=0.205  Sum_probs=120.2

Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCc------eEEeccCCccccCCCCCCCCCCCCccc
Q 048055            9 GGKPLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFE------SCLTDYGLGSFRNPDSVEEPSATSLFY   82 (221)
Q Consensus         9 ~~~~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~------~~l~dfg~~~~~~~~~~~~~~~~~~~~   82 (221)
                      ....++...+..++.||+.||.|||+..||+||||||+||+++.++.      ++++|||.+......  .....+++.|
T Consensus       118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y  195 (362)
T d1q8ya_         118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREY  195 (362)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGG
T ss_pred             cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccc
Confidence            45678899999999999999999998339999999999999976553      899999998654322  3455788899


Q ss_pred             cCcccchhcCCCCCcccchHHHHHHHHHHhCCCCCcccccccCCChHHHHHHhhhhh----------------h-----c
Q 048055           83 KAPECREIWKQPTQQADVYSFGVLLLELLTGKTPFQDLVLEHGSDIPRWVRSVREEE----------------T-----E  141 (221)
Q Consensus        83 ~~pe~~~~~~~~~~~~di~slG~~l~~~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------~-----~  141 (221)
                      +|||.+. ...++.++|+||+||++++|++|..||......................                .     .
T Consensus       196 ~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  274 (362)
T d1q8ya_         196 RSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL  274 (362)
T ss_dssp             CCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred             cChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchh
Confidence            9999887 6778899999999999999999999997543221111111111110000                0     0


Q ss_pred             cCCCCC-----------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048055          142 SGDDPP-----------SSNEASEEKLQALLNIAIACVSLAPENRPVMREVSK  183 (221)
Q Consensus       142 ~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~~l~~  183 (221)
                      ......           ............+.+|+.+||..||.+|||+.|+++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             hhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000           011123345567999999999999999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.09  E-value=2.1e-11  Score=89.27  Aligned_cols=55  Identities=15%  Similarity=0.226  Sum_probs=47.6

Q ss_pred             CcCHHHHHHHHHHHHHHHHHhcCCCCceeeCcCCCCeEEcCCCceEEeccCCccccC
Q 048055           12 PLHWTSCLKIAEDLASGLLYIHQNPGLTHGNLKSSNVLLGADFESCLTDYGLGSFRN   68 (221)
Q Consensus        12 ~l~~~~~~~~~~~i~~gl~~lH~~~~i~h~dlk~~nil~~~~~~~~l~dfg~~~~~~   68 (221)
                      .++...+..++.|++.+|.|||+. +++|+|+||.||+++.+ .++++|||.+....
T Consensus        99 ~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2          99 RVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             GCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            456677788999999999999998 99999999999999865 58899999886543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.08  E-value=0.02  Score=43.34  Aligned_cols=29  Identities=31%  Similarity=0.408  Sum_probs=26.2

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .|++|+|+.+.|++++.+....|.||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            37999999999999999887889999976

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=89.53  E-value=0.075  Score=38.58  Aligned_cols=28  Identities=29%  Similarity=0.428  Sum_probs=24.5

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .++|+|+.+.||+++.++.+.|.||+.+
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             EEEEeeccCcceeecCCceEEEeechhc
Confidence            4789999999999998776779999876

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=87.41  E-value=0.094  Score=37.84  Aligned_cols=28  Identities=25%  Similarity=0.232  Sum_probs=24.6

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLG   64 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~   64 (221)
                      .++|+|+.+.||+++.+..+.|+||+.+
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhc
Confidence            5799999999999998766789999865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=83.25  E-value=0.25  Score=38.41  Aligned_cols=29  Identities=17%  Similarity=0.355  Sum_probs=24.9

Q ss_pred             CceeeCcCCCCeEEcCCCceEEeccCCccc
Q 048055           37 GLTHGNLKSSNVLLGADFESCLTDYGLGSF   66 (221)
Q Consensus        37 ~i~h~dlk~~nil~~~~~~~~l~dfg~~~~   66 (221)
                      .++|+|+.+.||+++.+. ++|.||.++..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            689999999999998764 89999988743

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=81.74  E-value=0.84  Score=34.16  Aligned_cols=28  Identities=18%  Similarity=0.208  Sum_probs=22.7

Q ss_pred             CCceeeCcCCCCeEEcCCCceEEeccCCcc
Q 048055           36 PGLTHGNLKSSNVLLGADFESCLTDYGLGS   65 (221)
Q Consensus        36 ~~i~h~dlk~~nil~~~~~~~~l~dfg~~~   65 (221)
                      .+++|+|+.+.||+++.+  ..+.||+.+.
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            378999999999999743  4588998764